<SEC-DOCUMENT>0001193125-22-083443.txt : 20220324
<SEC-HEADER>0001193125-22-083443.hdr.sgml : 20220324
<ACCEPTANCE-DATETIME>20220324090819
ACCESSION NUMBER:		0001193125-22-083443
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		17
CONFORMED PERIOD OF REPORT:	20220323
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20220324
DATE AS OF CHANGE:		20220324

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			LIGAND PHARMACEUTICALS INC
		CENTRAL INDEX KEY:			0000886163
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				770160744
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-33093
		FILM NUMBER:		22764853

	BUSINESS ADDRESS:	
		STREET 1:		3911 SORRENTO VALLEY BLVD
		STREET 2:		SUITE 110
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92121
		BUSINESS PHONE:		858-550-7500

	MAIL ADDRESS:	
		STREET 1:		3911 SORRENTO VALLEY BLVD
		STREET 2:		SUITE 110
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92121
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d337089d8k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8" ?>
<html xmlns:dei="http://xbrl.sec.gov/dei/2021" xmlns:us-types="http://fasb.org/us-types/2021-01-31" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:lgnd="http://www.ligand.com/20220323" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns="http://www.w3.org/1999/xhtml">
<head>
<title>8-K</title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
   <body><div style="display:none"> <ix:header> <ix:hidden> <ix:nonNumeric id="Hidden_dei_EntityRegistrantName" name="dei:EntityRegistrantName" contextRef="duration_2022-03-23_to_2022-03-23">LIGAND PHARMACEUTICALS INC</ix:nonNumeric> <ix:nonNumeric name="dei:AmendmentFlag" contextRef="duration_2022-03-23_to_2022-03-23">false</ix:nonNumeric> <ix:nonNumeric id="Hidden_dei_EntityCentralIndexKey" name="dei:EntityCentralIndexKey" contextRef="duration_2022-03-23_to_2022-03-23">0000886163</ix:nonNumeric> </ix:hidden> <ix:references> <link:schemaRef xlink:type="simple" xlink:href="lgnd-20220323.xsd" xlink:arcrole="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase"></link:schemaRef> </ix:references> <ix:resources> <xbrli:context id="duration_2022-03-23_to_2022-03-23"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-03-23</xbrli:startDate> <xbrli:endDate>2022-03-23</xbrli:endDate> </xbrli:period> </xbrli:context> </ix:resources> </ix:header> </div> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p> <p style="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">UNITED STATES</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">SECURITIES AND EXCHANGE COMMISSION</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">WASHINGTON, DC 20549</p> <p style="font-size:9pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:9pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">FORM <ix:nonNumeric name="dei:DocumentType" contextRef="duration_2022-03-23_to_2022-03-23">8-K</ix:nonNumeric></p> <p style="font-size:9pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:9pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">CURRENT REPORT</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Pursuant to Section 13 or 15(d)</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">of the Securities Exchange Act of 1934</p> <p style="margin-top:9pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Date of Report (Date of earliest event reported): <ix:nonNumeric name="dei:DocumentPeriodEndDate" contextRef="duration_2022-03-23_to_2022-03-23" format="ixt:datemonthdayyearen">March 23, 2022</ix:nonNumeric></p> <p style="font-size:9pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:9pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman;font-weight:bold;text-align:center"> <span style=" -sec-ix-hidden:Hidden_dei_EntityRegistrantName">LIGAND PHARMACEUTICALS INCORPORATED</span> </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Exact Name of Registrant as Specified in its Charter)</p> <p style="font-size:9pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="font-size:9pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"></td>
<td style="vertical-align:bottom"></td>
<td style="width:32%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:32%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" contextRef="duration_2022-03-23_to_2022-03-23" format="ixt-sec:stateprovnameen">Delaware</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityFileNumber" contextRef="duration_2022-03-23_to_2022-03-23">001-33093</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" contextRef="duration_2022-03-23_to_2022-03-23">77-0160744</ix:nonNumeric></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(State or Other Jurisdiction</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">of Incorporation)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Commission</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">File Number)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(IRS Employer</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Identification No.)</p></td></tr></table> <p style="font-size:9pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:50%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:48%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityAddressAddressLine1" contextRef="duration_2022-03-23_to_2022-03-23">5980 Horton Street</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressAddressLine2" contextRef="duration_2022-03-23_to_2022-03-23">Suite 405</ix:nonNumeric></p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityAddressCityOrTown" contextRef="duration_2022-03-23_to_2022-03-23">Emeryville</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressStateOrProvince" contextRef="duration_2022-03-23_to_2022-03-23">CA</ix:nonNumeric></p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:bottom"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityAddressPostalZipCode" contextRef="duration_2022-03-23_to_2022-03-23">94608</ix:nonNumeric></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">(Address of Principal Executive Offices)</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">(Zip Code)</span></td></tr></table> <p style="margin-top:9pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Registrant&#8217;s telephone number, including area code: <ix:nonNumeric name="dei:CityAreaCode" contextRef="duration_2022-03-23_to_2022-03-23">(858)</ix:nonNumeric> <ix:nonNumeric name="dei:LocalPhoneNumber" contextRef="duration_2022-03-23_to_2022-03-23">550-7500</ix:nonNumeric></p> <p style="margin-top:9pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">N/A</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Former Name or Former Address, if Changed Since Last Report.)</p> <p style="font-size:9pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:9pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top"><ix:nonNumeric name="dei:WrittenCommunications" contextRef="duration_2022-03-23_to_2022-03-23" format="ixt-sec:boolballotbox">&#9746;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top"><ix:nonNumeric name="dei:SolicitingMaterial" contextRef="duration_2022-03-23_to_2022-03-23" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top"><ix:nonNumeric name="dei:PreCommencementTenderOffer" contextRef="duration_2022-03-23_to_2022-03-23" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top"><ix:nonNumeric name="dei:PreCommencementIssuerTenderOffer" contextRef="duration_2022-03-23_to_2022-03-23" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</p></td></tr></table> <p style="margin-top:9pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Securities registered pursuant to Section 12(b) of the Act:</p> <p style="font-size:9pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"></td>
<td style="vertical-align:bottom"></td>
<td style="width:32%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:32%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Title of each class</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Trading<br />Symbol</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Name of each exchange<br />on which registered</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:Security12bTitle" contextRef="duration_2022-03-23_to_2022-03-23">Common Stock, par value $0.001 per share</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:TradingSymbol" contextRef="duration_2022-03-23_to_2022-03-23">LGND</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:SecurityExchangeName" contextRef="duration_2022-03-23_to_2022-03-23" format="ixt-sec:exchnameen">The Nasdaq Global Market</ix:nonNumeric></span></td></tr></table> <p style="margin-top:9pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933(&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</p> <p style="margin-top:9pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Emerging growth company <ix:nonNumeric name="dei:EntityEmergingGrowthCompany" contextRef="duration_2022-03-23_to_2022-03-23" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></p> <p style="margin-top:9pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. &#9744;</p> <p style="font-size:9pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p></div></div>

<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#160;1.01</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Entry Into a Material Agreement </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On March&#160;23, 2022, Ligand Pharmaceuticals Incorporated, a Delaware corporation (&#8220;<span style="text-decoration:underline">Ligand</span>&#8221;), Avista Public Acquisition Corp. II, a Cayman Islands exempted company (&#8220;<span style="text-decoration:underline">APAC</span>&#8221;), entered into an Agreement and Plan of Merger (the &#8220;<span style="text-decoration:underline">Merger Agreement</span>&#8221;), by and among APAC, OmniAb, Inc., a Delaware corporation and wholly-owned subsidiary of Ligand (&#8220;<span style="text-decoration:underline">OmniAb</span>&#8221; and, together with Ligand, collectively, the &#8220;<span style="text-decoration:underline">Companies</span>&#8221;), and Orwell Merger Sub Inc., a Delaware corporation and a wholly-owned subsidiary of APAC (&#8220;<span style="text-decoration:underline">Merger Sub</span>&#8221;), pursuant to which APAC will combine with OmniAb, Ligand&#8217;s antibody discovery business (the &#8220;<span style="text-decoration:underline">OmniAb Business</span>&#8221;), in a Reverse Morris Trust transaction. Also on March&#160;23, 2022, and in connection with the execution of the Merger Agreement, (a)&#160;APAC, Ligand, OmniAb and Merger Sub entered into that certain Employee Matters Agreement (the &#8220;<span style="text-decoration:underline">Employee Matters Agreement</span>&#8221;), (b) OmniAb and Avista Acquisition LP II (the &#8220;<span style="text-decoration:underline">Sponsor</span>&#8221;) entered into that certain sponsor insider letter agreement (the &#8220;<span style="text-decoration:underline">Sponsor Insider Agreement</span>&#8221;) with APAC and certain insiders of APAC (the &#8220;<span style="text-decoration:underline">Insiders</span>&#8221;) and (c)&#160;APAC amended and restated that certain previously disclosed forward purchase agreement, dated August&#160;9, 2021, by entering into the amended and restated forward purchase agreement (the &#8220;<span style="text-decoration:underline">A&amp;R FPA</span>&#8221;), by and among APAC, the Sponsor and OmniAb. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Immediately prior to the Merger (as defined below) and pursuant to a Separation and Distribution Agreement, dated as of March&#160;23, 2022, among APAC, Ligand and OmniAb (the &#8220;<span style="text-decoration:underline">Separation Agreement</span>&#8221;), Ligand will, among other things and subject to the terms and conditions of the Separation Agreement, transfer the OmniAb Business, including certain related subsidiaries of Ligand, to OmniAb (the &#8220;<span style="text-decoration:underline">Reorganization</span>&#8221;) and, in connection therewith, will distribute (the &#8220;<span style="text-decoration:underline">Distribution</span>&#8221;) to Ligand stockholders 100% of the common stock of OmniAb, par value $0.001 (the &#8220;<span style="text-decoration:underline">OmniAb Common Stock</span>&#8221;), as further described below. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Immediately following the Distribution, in accordance with and subject to the terms and conditions of the Merger Agreement, Merger Sub will merge with and into OmniAb (the &#8220;<span style="text-decoration:underline">Merger</span>&#8221;), with OmniAb continuing as the surviving company in the Merger and as a wholly-owned subsidiary of APAC. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Transaction Documents </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Agreement and Plan of Merger </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Merger Agreement, along with the Separation Agreement and the other transaction documents to be entered into in connection therewith, provides for, among other things, the consummation of the following transactions (collectively, the &#8220;<span style="text-decoration:underline">Business Combination</span>&#8221;): (i) APAC will redomicile by way of continuation from the Cayman Islands to Delaware and domesticate as a Delaware corporation in accordance with Section&#160;388 of the Delaware General Corporation Law and with Section&#160;206 of the Cayman Islands Companies Act (As Revised) at least one business day prior to the closing of the Business Combination (the &#8220;<span style="text-decoration:underline">Domestication</span>&#8221;), (ii) Ligand will transfer the OmniAb Business (the &#8220;<span style="text-decoration:underline">Separation</span>&#8221;) to its wholly-owned subsidiary, OmniAb, and contribute $15&#160;million in capital thereto (less certain transaction-related and other expenses), and (iii)&#160;following the Separation, Ligand will distribute 100% of the shares of OmniAb Common Stock, to Ligand stockholders by way of the Distribution. Following the completion of the foregoing transactions and subject to the satisfaction or waiver of certain other conditions set forth in the Merger Agreement, the parties shall consummate the Merger. The Distribution and Merger are intended to qualify as <span style="white-space:nowrap">&#8220;tax-free&#8221;</span> transactions. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Upon consummation of the Business Combination, and after the Domestication, APAC will have one class of common stock, par value $0.0001 per share (the &#8220;<span style="text-decoration:underline">APAC Common Stock</span>&#8221;), which will be listed on the Nasdaq Capital Market (&#8220;Nasdaq&#8221;) under the ticker symbol &#8220;OABI&#8221;. The outstanding warrants of APAC will be listed on Nasdaq under the ticker symbol &#8220;OABIW&#8221;. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Consideration Paid </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">At the time the Business Combination is effected (the &#8220;<span style="text-decoration:underline">Closing</span>&#8221;), each share of OmniAb Common Stock outstanding after the Distribution and immediately prior to the effective time of the Merger will be converted into a number of shares of APAC Common Stock based on an exchange ratio determined by reference to a <span style="white-space:nowrap">pre-money</span> equity value for OmniAb of $850&#160;million. Holders of OmniAb options, restricted stock units and performance stock units (determined after </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">2 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
the Distribution and the division of Ligand equity awards into both Ligand equity awards and OmniAb equity awards pursuant to the Employee Matters Agreement, as described below) will have their awards rolled over into APAC equity awards and adjusted pursuant to the exchange ratio. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, at the Closing, holders of OmniAb Common Stock and equity awards will also receive earnout consideration in the form of an additional 15&#160;million shares of APAC Common Stock (the &#8220;OmniAb Earnout Shares&#8221;), with 50% of such earnout shares vesting upon the combined company&#8217;s achievement of a post-transaction volume-weighted average price (&#8220;<span style="text-decoration:underline">VWAP</span>&#8221;) of $12.50 per share of APAC Common Stock for any 20 trading days over a consecutive 30 <span style="white-space:nowrap">trading-day</span> period, and the remainder vesting upon achievement of a post-transaction VWAP of $15 per share of APAC Common Stock for any 20 trading days over a consecutive 30 <span style="white-space:nowrap">trading-day</span> period, in each case provided such vesting occurs during the five-year period following the Closing. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Effect of Domestication on APAC Ordinary Shares </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In connection with the Business Combination, upon the Domestication (i)&#160;all issued and outstanding APAC Class&#160;A ordinary shares and Class&#160;B ordinary shares will convert automatically, on a <span style="white-space:nowrap"><span style="white-space:nowrap">one-for-one</span></span> basis, into shares of APAC Common Stock, (ii)&#160;all issued and outstanding warrants of APAC will convert automatically into warrants to acquire shares of APAC Common Stock and (iii)&#160;all issued and outstanding units of APAC will separate and convert automatically into one share of APAC Common Stock and <span style="white-space:nowrap">one-third</span> of one warrant to purchase APAC Common Stock. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Representations and Warranties&#160;&amp; Covenants </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the Merger Agreement, APAC, OmniAb and Ligand each made customary representations and warranties for transactions of this type regarding themselves and their respective businesses. The representations and warranties made pursuant to the Merger Agreement will not survive the Closing. In addition, the parties to the Merger Agreement agreed to be bound by certain covenants that are customary for transactions of this type. The covenants made under the Merger Agreement generally will not survive the Closing, with the exception that certain covenants and agreements that by their terms are to be performed in whole or in part after the Closing, which will survive in accordance with the terms of the Merger Agreement. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Conditions to Closing </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The consummation of the Business Combination is subject to customary conditions for transactions involving special purpose acquisition companies, including, among others: (i)&#160;the expiration or termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, (ii)&#160;receipt of required consents and approvals from certain governmental authorities, (iii)&#160;no agreement between Ligand or APAC and any governmental authority pursuant to which Ligand or APAC has agreed not to consummate the Business Combination shall have been effected, (iv)&#160;no governmental authority of competent jurisdiction shall have enacted, issued or granted any law (whether temporary, preliminary or permanent), in each case that is in effect and which has the effect of restraining, enjoining or prohibiting the consummation of the transaction, (v)&#160;APAC shall have at least $5,000,001 of net tangible assets as of the Closing, (vi)&#160;the APAC Common Stock issuable pursuant to the Business Combination shall have been approved for listing on NASDAQ, subject to official notice of issuance, (vii)&#160;Ligand, OmniAb, APAC and Merger Sub shall each have performed and complied in all material respects with the obligations, covenants and agreements required by the Agreement and Plan of Merger to be performed or complied with by it at or prior to filing, or a later date as agreed to by the parties, (viii)&#160;customary bring down conditions related to the accuracy of the parties&#8217; respective representations, warranties and <span style="white-space:nowrap">pre-Closing</span> covenants in the Merger Agreement, (ix)&#160;the consummation of the Distribution, Reorganization and other transactions contemplated by the Separation and Distribution Agreement, (x)&#160;each of APAC&#8217;s and OmniAb&#8217;s registration statements to be filed with the SEC shall have become effective, (xi)&#160;APAC&#8217;s shareholder approval shall have been obtained and (xii)&#160;the receipt by Ligand and APAC of certain tax opinions. In addition, the respective obligations of OmniAb and Ligand to consummate the Business Combination is conditioned upon, among other items, the completion of the Forward Purchase and the Redemption Backstop (each as defined below), the resignation of all directors and all executive officers of APAC and the occurrence of the Domestication. APAC&#8217;s obligation to consummate the Business Combination is also conditioned on there having been no &#8220;Material Adverse Effect&#8221; on OmniAb since the date of the Merger Agreement. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">3 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Termination </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Merger Agreement may be terminated under certain customary and limited circumstances at any time prior to the Closing, including (i)&#160;by the mutual written consent of APAC and Ligand, (ii)&#160;by APAC or Ligand, if the Closing shall not have occurred on or before the nine-month anniversary of the signing date, (iii)&#160;by APAC or Ligand, if any law is passed that would make the transaction illegal, (iv)&#160;by APAC or Ligand, if APAC has not obtained the requisite approval from its shareholders, (v)&#160;by APAC or Ligand if the other party breaches certain representations, warranties, or covenants, as specified in the Merger Agreement, and that breach is unable to be cured, or is not cured, within 30 days, (vi)&#160;by Ligand if the Forward Purchase and the Redemption Backstop are not consummated or (vii)&#160;by Ligand on or prior to the earlier of (i) 180 days after the date of the Merger Agreement or (ii)&#160;the date on which the APAC registration statement on Form <span style="white-space:nowrap">S-4</span> in respect of the Business Combination is declared effective, in order to enter into a business combination agreement in respect of at least 75% of Ligand in a transaction conditioned on the termination of the Merger Agreement, provided that Ligand has paid APAC a termination fee of between $40.0&#160;million and $70.0&#160;million, dependent upon when termination occurs (the &#8220;<span style="text-decoration:underline">Termination Fee</span>&#8221;), reimbursed APAC for its transaction expenses in an amount up to $7.5&#160;million and paid the Sponsor a termination fee in an amount up to $12.5&#160;million in connection with the termination of the A&amp;R FPA. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A copy of the Merger Agreement is filed with this Current Report on Form <span style="white-space:nowrap">8-K</span> (this &#8220;<span style="text-decoration:underline">Current Report</span>&#8221;) as Exhibit 2.1, and is incorporated herein by reference, and the foregoing description of the Merger Agreement is qualified in its entirety by reference thereto. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Separation and Distribution Agreement </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On March&#160;23, 2022, in connection with the execution of the Merger Agreement, APAC entered into the Separation Agreement with OmniAb and Ligand, pursuant to which, among other things, (i)&#160;Ligand will undertake a series of internal reorganization and restructuring transactions to effect the transfer of its (direct or indirect) ownership of the OmniAb Business to OmniAb in the Separation and (ii)&#160;immediately prior to the Merger and after the Separation, Ligand will distribute 100% of the outstanding shares of OmniAb Common Stock to Ligand&#8217;s stockholders in the Distribution. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Separation Agreement also sets forth other agreements among Ligand and OmniAb related to the Separation, including provisions concerning the termination and settlement of intercompany accounts and the obtaining of necessary governmental approvals and third-party consents. The Separation Agreement also sets forth agreements that will govern certain aspects of the relationship between Ligand and OmniAb after the Distribution, including provisions with respect to release of claims, indemnification, access to financial and other information and access to and provision of records. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Consummation of the Distribution is subject to a number of conditions, including, among others, (i)&#160;the completion of the Separation, (ii)&#160;Ligand&#8217;s receipt of certain tax opinions and (iii)&#160;the satisfaction or waiver of all conditions under the Merger Agreement (other than those conditions that are to be satisfied substantially contemporaneously with the Distribution and/or the Merger, provided that such conditions are capable of being satisfied at such time). </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A copy of the Separation Agreement is filed with this Current Report as Exhibit 2.2, and is incorporated herein by reference, and the foregoing description of the Separation Agreement is qualified in its entirety by reference thereto. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Employee Matters Agreement </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On March&#160;23, 2022, in connection with the execution of the Merger Agreement, APAC, Ligand, OmniAb and Merger Sub entered into the Employee Matters Agreement, which will provide for employee-related matters in connection with the transaction, including allocation of benefit plan assets and liabilities between Ligand and OmniAb, treatment of incentive equity awards in the Distribution and the Business Combination and related covenants and commitments of the parties. Each existing Ligand equity award will generally be split into (i)&#160;a new Ligand equity award and (ii)&#160;a new OmniAb equity award, with any accrued value in the original Ligand equity award split between such awards based on the relative post-Closing values of Ligand and OmniAb. </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">4 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A copy of the Employee Matters Agreement is filed with this Current Report as Exhibit 10.1, and is incorporated herein by reference, and the foregoing description of the Employee Matters Agreement is qualified in its entirety by reference thereto. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Sponsor Insider Agreement </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On March&#160;23, 2022, in connection with the execution of the Merger Agreement, OmniAb and the Sponsor entered into the Sponsor Insider Agreement with APAC and the Insiders, pursuant to which, among other things, the Insiders agreed to vote any APAC securities held by them to approve the Business Combination and the other APAC shareholder matters required pursuant to the Merger Agreement, and not to seek redemption of any of their APAC securities in connection with the consummation of the Business Combination. Pursuant to the Sponsor Insider Agreement, the Sponsor also agreed to subject up to 1,916,667 Earnout Founder Shares (as defined in the Sponsor Insider Agreement), to the same price-based vesting conditions as the OmniAb Earnout Shares. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A copy of the Sponsor Insider Agreement is filed with this Current Report as Exhibit 2.3, and is incorporated herein by reference, and the foregoing description of the Sponsor Insider Agreement is qualified in its entirety by reference thereto. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Amended and Restated Forward Purchase Agreement </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On March&#160;23, 2022, in connection with the execution of the Merger Agreement, APAC entered into the A&amp;R FPA with the Sponsor and OmniAb. Pursuant to the A&amp;R FPA, APAC has agreed that, in connection with the consummation of the Business Combination, it will issue and sell to the Sponsor 1,500,000 shares of APAC Common Stock and warrants to acquire 1,666,667 shares of APAC Common Stock for an aggregate purchase price of $15.0&#160;million with such purchases to be consummated immediately following the Domestication and prior to the Business Combination (the &#8220;<span style="text-decoration:underline">Forward Purchase</span>&#8221;). In addition to the Forward Purchase, the Sponsor has agreed to purchase up to an additional 10,000,000 shares of APAC Common Stock (the &#8220;<span style="text-decoration:underline">Redemption Backstop</span>&#8221;) and up to an additional 1,666,667 APAC warrants, for an aggregate additional purchase price of up to $100.0&#160;million, in order to backstop shareholder redemptions to the extent such redemptions would result in the cash proceeds to be received by OmniAb stockholders from APAC&#8217;s trust account to be less than $100.0&#160;million. The A&amp;R FPA also provides that in the event the Merger Agreement is terminated by Ligand under circumstances in which the Termination Fee would be payable under the Merger Agreement, Ligand shall pay Sponsor a termination fee of $12.5&#160;million in connection therewith. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">A copy of the A&amp;R FPA is filed with this Current Report as Exhibit 2.4, and is incorporated herein by reference, and the foregoing description of the A&amp;R FPA is qualified in its entirety by reference thereto. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Certain Other Transaction Documents </p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Certain additional agreements will be entered into in connection with the transactions contemplated by the Merger Agreement, the Separation Agreement and the other agreements described above, including, among others: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">a Tax Matters Agreement by and among Ligand, OmniAb and APAC, which governs, among other things, Ligand&#8217;s, OmniAb&#8217;s and APAC&#8217;s respective rights, responsibilities and obligations with respect to taxes, tax attributes and the preparation and filing of tax returns and responsibility for and preservation of the expected <span style="white-space:nowrap">tax-free</span> status of the transactions contemplated by the Separation Agreement and the Merger Agreement; and certain other tax matters; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">an Amended and Restated Registration and Stockholder Rights Agreement by and among APAC, the Sponsor and the other parties signatory thereto, pursuant to which APAC&#8217;s original registration rights agreement will be amended and restated in order to, among other things, provide certain equityholders of OmniAb as of immediately prior to the Closing of the Business Combination with customary registration rights; </p></td></tr></table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">5 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">a Transition Services Agreement by and between Ligand and OmniAb, pursuant to which Ligand will, on a transitional basis, provide OmniAb with certain support services and other assistance after the Closing; and </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:7%">&#160;</td>
<td style="width:3%;vertical-align:top" align="left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt;text-align:left">a Transition Services Agreement by and between Ligand and OmniAb, pursuant to which OmniAb will, on a transitional basis, provide Ligand with certain support services and other assistance after the Closing. </p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Merger Agreement, the Separation Agreement, the Employee Matters Agreement, the Sponsor Insider Agreement and the A&amp;R FPA have each been filed as exhibits to this Current Report, and the above descriptions have been included to provide investors and security holders with information regarding the terms of such agreements. They are not intended to provide any other factual information about APAC, the Sponsor, Merger Sub, Ligand, OmniAb, any of their respective subsidiaries or affiliates, or the OmniAb Business. The Merger Agreement, the Separation Agreement and the Employee Matters Agreement each contain representations and warranties that Ligand and/or OmniAb, on the one hand, and APAC and/or Merger Sub, on the other hand, have made to each other as of specific dates and/or times. The assertions embodied in those representations and warranties were made solely for purposes of the contract(s) between the parties to such agreements and may be subject to important qualifications and limitations agreed to by the parties in connection with negotiating the terms of such agreements. Moreover, some of those representations and warranties may not be accurate or complete as of any specified date, may be subject to a contractual standard of materiality different from those generally applicable to stockholders, or may have been used for the purpose of allocating risk between the parties rather than establishing matters as facts. For the foregoing reasons, such representations and warranties should not be relied upon as statements of factual information. Moreover, information concerning the subject matter of the representations and warranties may change after the date of the Merger Agreement, which subsequent information may or may not be fully reflected in APAC&#8217;s public disclosures. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Important Information and Where to Find It </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In connection with the Business Combination and the Distribution, OmniAb will file with the SEC a registration statement on Form 10 (the &#8220;<span style="text-decoration:underline">Form 10</span>&#8221;) registering shares of OmniAb Common Stock and APAC will file with the SEC a registration statement on Form <span style="white-space:nowrap">S-4</span> (the &#8220;<span style="text-decoration:underline">Form <span style="white-space:nowrap">S-4</span></span>&#8221;) registering shares of APAC Common Stock, warrants and certain equity awards. The Form <span style="white-space:nowrap">S-4</span> to be filed by APAC will include a proxy statement/prospectus in connection with the APAC shareholder vote required in connection with the Business Combination. The Form 10 to be filed by OmniAb will include the Form <span style="white-space:nowrap">S-4</span> filed by APAC, which will serve as an information statement/prospectus in connection with the <span style="white-space:nowrap">spin-off</span> of OmniAb. This communication does not contain all the information that should be considered concerning the Business Combination. This communication is not a substitute for the registration statements that OmniAb and APAC will file with the SEC or any other documents that APAC or OmniAb may file with the SEC, or that APAC, Ligand or OmniAb may send to stockholders in connection with the Business Combination. It is not intended to form the basis of any investment decision or any other decision in respect to the Business Combination. APAC&#8217;s shareholders and Ligand&#8217;s stockholders and other interested persons are advised to read, when available, the preliminary and definitive registration statements, and documents incorporated by reference therein, as these materials will contain important information about APAC, OmniAb and the Business Combination. The proxy statement/prospectus contained in APAC&#8217;s registration statement will be mailed to APAC&#8217;s shareholders as of a record date to be established for voting on the Business Combination. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The registration statements, proxy statement/prospectus and other documents (when they are available) will also be available free of charge, at the SEC&#8217;s website at www.sec.gov, or by directing a request to: Avista Public Acquisition Corp. II, 65 East 55th Street, 18th Floor, New York, NY 10022. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Participants in the Solicitation </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Ligand, APAC and OmniAb, and each of their respective directors, executive officers and other members of their management and employees may be deemed to be participants in the solicitation of proxies from APAC&#8217;s shareholders in connection with the Business Combination. Shareholders are urged to carefully read the proxy statement/prospectus regarding the Business Combination when it becomes available, because it will contain important information. Information regarding the persons who may, under the rules of the SEC, be deemed participants in the solicitation of APAC&#8217;s </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">6 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
shareholders in connection with the Business Combination will be set forth in the registration statement when it is filed with the SEC. Information about APAC&#8217;s executive officers and directors and OmniAb&#8217;s management and directors also will be set forth in the registration statement relating to the Business Combination when it becomes available. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">No Solicitation or Offer </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This communication shall neither constitute an offer to sell nor the solicitation of an offer to buy any securities, or the solicitation of any proxy, vote, consent or approval in any jurisdiction in connection with the Business Combination, nor shall there be any sale of securities in any jurisdiction in which the offer, solicitation or sale would be unlawful prior to any registration or qualification under the securities laws of any such jurisdictions. This communication is restricted by law; it is not intended for distribution to, or use by any person in, any jurisdiction where such distribution or use would be contrary to local law or regulation. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Forward-Looking Statements </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This communication contains forward-looking statements. The words &#8220;anticipate,&#8221; &#8220;believe,&#8221; &#8220;continue,&#8221; &#8220;could,&#8221; &#8220;estimate,&#8221; &#8220;expect,&#8221; &#8220;intend,&#8221; &#8220;may,&#8221; &#8220;might,&#8221; &#8220;plan,&#8221; &#8220;possible,&#8221; &#8220;potential,&#8221; &#8220;predict,&#8221; &#8220;project,&#8221; &#8220;should,&#8221; &#8220;would&#8221; and similar expressions may identify forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking. All statements other than statements of historical facts contained in this communication, including statements regarding the expected timing and structure of the Business Combination, the ability of the parties to complete the Business Combination, the expected benefits of the Business Combination, the tax consequences of the Business Combination, the amount of gross proceeds expected to be available to OmniAb after the Closing and giving effect to any redemptions by APAC shareholders, OmniAb&#8217;s future results of operations and financial position, business strategy and its expectations regarding the application of, and the rate and degree of market acceptance of, the OmniAb technology platform and other technologies, OmniAb&#8217;s expectations regarding the addressable markets for our technologies, including the growth rate of the markets in which it operates, the potential for and timing of receipt of milestones and royalties under OmniAb&#8217;s license agreements with partners, are forward-looking statements. These forward-looking statements are not guarantees of future performance, conditions or results, and involve a number of known and unknown risks, uncertainties, assumptions and other important factors, many of which are outside the control of Ligand, OmniAb and APAC, that could cause actual results or outcomes to differ materially from those discussed in the forward-looking statements. Important factors, among others, that may affect actual results or outcomes include, but are not limited to: the risk that the transactions may not be completed in a timely manner or at all, which may adversely affect the price of Ligand&#8217;s or APAC&#8217;s securities; the risk that APAC shareholder approval of the Business Combination is not obtained; the inability to recognize the anticipated benefits of the Business Combination, which may be affected by, among other things, the amount of funds available in APAC&#8217;s trust account following any redemptions by APAC&#8217;s shareholders; the failure to receive certain governmental and regulatory approvals; the occurrence of any event, change or other circumstance that could give rise to the termination of the merger agreement; changes in general economic conditions, including as a result of the COVID 19 pandemic or the conflict between Russia and Ukraine; the outcome of litigation related to or arising out of the Business Combination, or any adverse developments therein or delays or costs resulting therefrom; the effect of the announcement or pendency of the transactions on Ligand&#8217;s, OmniAb&#8217;s or APAC&#8217;s business relationships, operating results, and businesses generally; the ability to continue to meet Nasdaq&#8217;s listing standards following the consummation of the Business Combination; costs related to the Business Combination; that the price of APAC&#8217;s or Ligand&#8217;s securities may be volatile due to a variety of factors, including Ligand&#8217;s, APAC&#8217;s or OmniAb&#8217;s inability to implement their business plans or meet or exceed their financial projections and changes in the combined capital structure; the ability to implement business plans, forecasts, and other expectations after the completion of the Business Combination, and identify and realize additional opportunities; and the ability of OmniAb to implement its strategic initiatives. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The foregoing list of factors is not exhaustive. You should carefully consider the foregoing factors and the other risks and uncertainties described in the &#8220;Risk Factors&#8221; section of Ligand&#8217;s most recent annual report on Form <span style="white-space:nowrap">10-K,</span> the APAC registration statement on Form <span style="white-space:nowrap">S-4,</span> the OmniAb registration statement on Form 10, the proxy/information statement/prospectus and certain other documents filed or that may be filed by Ligand, APAC or OmniAb from time to time with the SEC following the date hereof. These filings identify and address other important risks and uncertainties that could cause actual events and results to differ materially from those contained in the forward-looking statements. Forward-looking </p>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">7 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
statements speak only as of the date they are made. Readers are cautioned not to put undue reliance on forward-looking statements, and Ligand, OmniAb and APAC assume no obligation and do not intend to update or revise these forward-looking statements, whether as a result of new information, future events, or otherwise. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">None of Ligand, OmniAb, or APAC gives any assurance that Ligand, OmniAb or APAC will achieve their expectations. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Market and Industry Data </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This communication also contains estimates and other statistical data made by independent parties and by us relating to market size and growth and other data about the antibody industry. This data involves a number of assumptions and limitations, and you are cautioned not to give undue weight to such estimates. In addition, projections, assumptions, and estimates of OmniAb&#8217;s future performance and the future performance of the markets in which OmniAb operates are necessarily subject to a high degree of uncertainty and risk. </p> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#160;9.01.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Financial Statements and Exhibits. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">(d)&#160;&#160;&#160;&#160;Exhibits. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">


<tr>

<td></td>

<td style="vertical-align:bottom;width:4%"></td>
<td style="width:93%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"><span style="font-weight:bold">Exhibit<br />No.</span></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold">Description</p></td></tr>


<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">2.1*</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d337089dex21.htm">Agreement and Plan of Merger, dated as of March, 23, 2022, by and among Avista Public Acquisition Corp. II, Ligand Pharmaceuticals Incorporated, OmniAb, Inc. and Orwell Merger Sub Inc. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">2.2*</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d337089dex22.htm">Separation and Distribution Agreement, dated as of March&#160;23, 2022, by and among Avista Public Acquisition Corp. II, Ligand Pharmaceuticals Incorporated and OmniAb, Inc. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">2.3</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d337089dex23.htm">Sponsor Insider Agreement, dated March&#160;23, 2022, by and among OmniAb, Inc., Avista Public Acquisition Corp. II and the other parties signatory thereto. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">2.4</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d337089dex24.htm">Amended and Restated Forward Purchase Agreement, dated March&#160;23, 2022, by and among Avista Public Acquisition Corp. II, Avista Acquisition LP II and OmniAb, Inc. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">10.1*</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d337089dex101.htm">Employee Matters Agreement, dated as of March&#160;23, 2022, by and among Ligand Pharmaceuticals Incorporated, Avista Public Acquisition Corp. II, OmniAb, Inc. and Orwell Merger Sub Inc. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">104</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Cover Page Interactive Data File (embedded within the Inline XBRL document).</td></tr>
</table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:2%;vertical-align:top" align="left">*</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Schedules and exhibits omitted pursuant to Item 601(b)(2) of Regulation <span style="white-space:nowrap">S-K.</span> Ligand Pharmaceuticals Incorporated agrees to furnish supplementally a copy of any omitted schedule to the Securities and Exchange Commission upon request. </p></td></tr></table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">8 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">SIGNATURE </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0">


<tr>

<td style="width:44%"></td>

<td style="vertical-align:bottom;width:1%"></td>
<td style="width:4%"></td>

<td style="vertical-align:bottom"></td>
<td style="width:5%"></td>

<td style="vertical-align:bottom;width:1%"></td>
<td style="width:44%"></td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" colspan="3"><span style="font-weight:bold">LIGAND PHARMACEUTICALS INCORPORATED</span></td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"></td>
<td style="height:12pt" colspan="2"></td>
<td style="height:12pt" colspan="2"></td>
<td style="height:12pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">Date March&#160;23, 2022</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">By:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Charles S. Berkman</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">Name:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">Charles S. Berkman</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">Title:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">Senior Vice President, General Counsel and Secretary</td></tr>
</table>
</div></div>

</body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-2.1
<SEQUENCE>2
<FILENAME>d337089dex21.htm
<DESCRIPTION>EX-2.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-2.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 2.1 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B><U>EXECUTION VERSION </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">AGREEMENT AND PLAN OF MERGER </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">DATED AS OF MARCH&nbsp;23, 2022 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">by and among </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">LIGAND
PHARMACEUTICALS INCORPORATED, </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">OMNIAB, INC., </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">AVISTA PUBLIC ACQUISITION CORP. II </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ORWELL MERGER SUB INC. </P>
<P STYLE="font-size:18pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-i- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>TABLE OF CONTENTS </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="15%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="81%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Page</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Article&nbsp;I&nbsp;DEFINITIONS</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;1.1</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Definitions</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;1.2</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Cross References</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">23</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;1.3</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Interpretation</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">24</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Article&nbsp;II&nbsp;THE&nbsp;MERGER</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">26</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.1</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">The Merger</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">26</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.2</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Closing</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">26</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.3</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Closing Deliverables; Effective Time</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">27</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.4</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Certificate of Incorporation and Bylaws of the Surviving Corporation; Directors and Officers of the Surviving Corporation</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">28</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.5</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Governance Matters</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">29</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Article&nbsp;III&nbsp;CONVERSION OF SHARES</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">29</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.1</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Effect on Capital Stock</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">29</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.2</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Surrender and Payment</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">31</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.3</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Earnout</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">34</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.4</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Appraisal Rights</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">36</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.5</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Treatment of SpinCo Equity Awards</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">36</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Article&nbsp;IV REPRESENTATIONS AND WARRANTIES OF THE COMPANY RELATING TO THE
COMPANY</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">36</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.1</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Organization of the Company</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">36</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.2</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Due Authorization</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">36</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.3</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Governmental Consents</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">37</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.4</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">No Conflict</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">37</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.5</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Litigation and Proceedings</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">38</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.6</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Brokers&#146; Fees</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">38</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.7</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Internal Controls</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">38</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.8</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Company Equity Awards</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">38</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Article&nbsp;V REPRESENTATIONS AND WARRANTIES OF THE COMPANY RELATING TO
SPINCO</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">39</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.1</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Organization of SpinCo</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">39</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.2</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Due Authorization</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">39</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.3</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Capitalization of SpinCo</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">40</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.4</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Subsidiaries</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">40</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.5</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Capitalization of Subsidiaries</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">41</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.6</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Governmental Consents</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">41</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.7</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">No Conflict</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">41</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.8</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Sufficiency of the SpinCo Assets</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">42</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-ii- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="15%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="81%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.9</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Financial Statements</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">42</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.10</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">No Undisclosed Liabilities</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">42</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.11</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Litigation and Proceedings</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">43</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.12</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Real Property</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">43</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.13</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Tax Matters</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">43</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.14</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Absence of Changes</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">44</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.15</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Material Contracts</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">44</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.16</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Labor Relations</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">47</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.17</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Compliance with Law; Permits</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">48</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.18</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">SpinCo Benefit Plans</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">49</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.19</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Intellectual Property</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">50</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.20</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Environmental Matters</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">54</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.21</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Affiliate Matters</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">54</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.22</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Brokers&#146; Fees</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">54</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.23</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Proxy Statement; Registration Statements</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">54</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.24</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Board and Shareholder Approval</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">55</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.25</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Parent Capital Stock</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">55</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.26</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Healthcare Regulatory Matters</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">55</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.27</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Data Privacy</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">56</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.28</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Anti-Bribery, Anti-Corruption and Anti-Money Laundering</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">57</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.29</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Sanctions, Import, and Export Controls</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">58</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.30</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">No Other Representations and Warranties</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">58</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Article&nbsp;VI REPRESENTATIONS AND WARRANTIES OF PARENT AND MERGER SUB</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">59</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.1</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Organization of Parent and Merger Sub</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">59</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.2</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Due Authorization</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">60</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.3</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Capital Stock and Other Matters</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">61</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.4</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Governmental Consents</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">62</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.5</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">No Conflict</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">62</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.6</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Internal Controls; Listing; Financial Statements</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">63</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.7</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">No Undisclosed Liabilities</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">64</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.8</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Litigation and Proceedings</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">64</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.9</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Tax Matters</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">64</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.10</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Absence of Changes</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">65</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.11</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Brokers&#146; Fees</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">66</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.12</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Proxy Statement; Registration Statements</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">66</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.13</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">SEC Filings</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">66</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.14</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Trust Account</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">66</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.15</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Investment Company Act; JOBS Act</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">67</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.16</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Indebtedness</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">67</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.17</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Stock Market Quotation</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">67</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.18</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Business Activities</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">68</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.19</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Section&nbsp;280G</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">69</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.20</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">No Other Representations and Warranties</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">69</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-iii- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="15%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="81%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Article&nbsp;VII COVENANTS</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">70</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.1</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Conduct of Business by Parent and Merger Sub Pending the Merger</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">70</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.2</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Conduct of SpinCo Business Pending the Merger</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">71</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.3</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Tax Matters</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">75</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.4</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Preparation of the Registration Statements and Prospectus; Parent Shareholders Meeting</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">76</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.5</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Modification in Recommendation</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">79</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.6</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Reasonable Best Efforts</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">80</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.7</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">[Intentionally Omitted]</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">81</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.8</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Access to Information</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">82</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.9</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Exclusivity</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">83</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.10</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Public Announcements</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">85</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.11</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Defense of Litigation</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">85</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.12</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Section&nbsp;16 Matters</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">85</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.13</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Control of Other Party&#146;s Business</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">85</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.14</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">SpinCo Share Issuance</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">86</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.15</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Domestication</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">86</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.16</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Transaction Documents</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">86</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.17</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">NASDAQ Listing</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">87</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.18</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Takeover Statutes</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">87</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.19</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Obligations of Merger Sub and SpinCo</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">87</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.20</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Further Assurances</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">87</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.21</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Sole Shareholder Approvals</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">88</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.22</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Financial Information</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">88</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Article&nbsp;VIII CONDITIONS TO THE MERGER</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">89</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;8.1</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Conditions to the Obligations of SpinCo, the Company, Parent and Merger Sub to Effect the Merger</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">89</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;8.2</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Additional Conditions to the Obligations of the Company and SpinCo</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">90</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;8.3</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Additional Conditions to the Obligations of Parent and Merger Sub</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">91</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Article&nbsp;IX TERMINATION</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">92</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.1</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Termination</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">92</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.2</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Effect of Termination</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">94</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.3</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Termination Fee</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">94</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.4</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Fees and Expenses</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">95</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Article&nbsp;X MISCELLANEOUS</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">95</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;10.1</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Trust Account Waiver</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">95</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;10.2</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="white-space:nowrap">Non-Survival</FONT> of Representations, Warranties and Agreements</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">96</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;10.3</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Governing Law; Jurisdiction</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">97</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;10.4</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Notices</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">98</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;10.5</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Headings</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">98</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;10.6</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Entire Agreement</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">98</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;10.7</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Amendments and Waivers</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">99</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;10.8</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Assignment; Parties in Interest; <FONT STYLE="white-space:nowrap">Non-Parties</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">99</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;10.9</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Specific Performance</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">99</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-iv- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="15%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="80%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;10.10</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">WAIVER OF JURY TRIAL</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;10.11</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Severability</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">101</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;10.12</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Counterparts</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">101</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;10.13</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Disclosure Schedules</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">101</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;10.14</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Disclosure Schedules</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">101</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">EXHIBITS </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD WIDTH="88%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>Exhibit&nbsp;A</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Separation and Distribution Agreement</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>Exhibit B</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Form of Tax Matters Agreement</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>Exhibit C</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Employee Matters Agreement</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP><FONT STYLE="white-space:nowrap">Exhibit&nbsp;D-1</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Form of Transition Services Agreement (Company-Provided)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>Exhibit <FONT STYLE="white-space:nowrap">D-2</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Form of Transition Services Agreement (SpinCo-Provided)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>Exhibit E</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Form of A&amp;R Registration Rights Agreement</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>Exhibit F</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Form of Sponsor Insider Agreement</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>Exhibit G</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Form of Parent Charter</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>Exhibit H</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Form of Parent Bylaws</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>Exhibit I</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">A&amp;R Forward Purchase Agreement</TD></TR>
</TABLE> <P STYLE="font-size:18pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-v- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>AGREEMENT AND PLAN OF MERGER </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This AGREEMENT AND PLAN OF MERGER, dated as of March&nbsp;23, 2022, is entered into by and among Ligand Pharmaceuticals Incorporated, a
Delaware corporation (the &#147;<U>Company</U>&#148;), OmniAb, Inc., a Delaware corporation and wholly owned Subsidiary of the Company (&#147;<U>SpinCo</U>&#148;), Avista Public Acquisition Corp. II, a Cayman Islands exempted company (which will
migrate to and domesticate as a Delaware corporation prior to the Closing (as defined below)) (&#147;<U>Parent</U>&#148;), and Orwell Merger Sub Inc., a Delaware corporation and wholly owned Subsidiary of Parent (&#147;<U>Merger Sub</U>&#148;). Each
of the foregoing parties is referred to herein as a &#147;<U>Party</U>&#148; and collectively as the &#147;<U>Parties</U>.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>WHEREAS: </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1) Parent is
a blank check company incorporated as a Cayman Islands exempted company for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities;
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2) At least one day prior to the Effective Time (as defined below), as the first step in the consummation of the Transactions and
subject to the conditions set forth in this Agreement, Parent shall migrate to and domesticate as a Delaware corporation (the &#147;<U>Domestication</U>&#148;) in accordance with Section&nbsp;388 of the Delaware General Corporation Law, as amended
(the &#147;<U>DGCL</U>&#148;) and the Cayman Islands Companies Act (As Revised) (the &#147;<U>CIC</U><U>A</U>&#148;); </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(3) Concurrently
with the Domestication, Parent shall file a certificate of incorporation with the Secretary of State of the State of Delaware and adopt bylaws substantially in the forms attached as <U>Exhibits </U><U>G</U> and <U>H</U> hereto, respectively, with
such changes as may be agreed in writing by Parent and the Company; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(4) In connection with the Domestication, (i)&nbsp;each then issued
and outstanding share of Parent Class&nbsp;A Common Stock (as defined below) shall convert automatically, on a <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">one-for-one</FONT></FONT> basis, into one share of common stock, par
value $0.0001, per share of Parent (after its domestication as a corporation incorporated in the State of Delaware) (the &#147;<U>Domesticated Parent Common Stock</U>&#148;); (ii) each then issued and outstanding share of Parent Class&nbsp;B Common
Stock (as defined below) shall convert automatically, on a <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">one-for-one</FONT></FONT> basis, into one share of Domesticated Parent Common Stock; (iii)&nbsp;each then issued and
outstanding Parent Warrant (as defined below) shall convert automatically into a warrant to acquire one share of Domesticated Parent Common Stock (each, a &#147;<U>Domesticated Parent Warrant</U>&#148;), pursuant to the Warrant Agreement (as defined
below); and (iv)&nbsp;each then issued and outstanding unit of Parent (the &#147;<U>Parent Units</U>&#148;) shall separate and convert automatically into one share of Domesticated Parent Common Stock and
<FONT STYLE="white-space:nowrap">one-third</FONT> of one Domesticated Parent Warrant; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(5) SpinCo is a wholly owned, direct Subsidiary of
the Company; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(6) Contemporaneously with the execution of this Agreement, the Company, SpinCo and Parent are entering into the Separation
and Distribution Agreement, pursuant to which the Company will, upon the terms and conditions set forth therein and in accordance with the Internal Reorganization, separate the SpinCo Business such that, after giving effect to the Separation (as
defined in the Separation and Distribution Agreement), the SpinCo Business is held by the SpinCo Entities (each foregoing capitalized term as defined below); </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(7) Prior to the Distribution (as defined below), in accordance with the Separation and
Distribution Agreement, the Company will make the Contribution (as defined below) to SpinCo; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(8) Upon the terms and subject to the
conditions set forth in the Separation and Distribution Agreement, on the Distribution Date (as defined below), the Company will distribute all of the shares of SpinCo Common Stock (as defined below) to the Company stockholders without consideration
on a <I>pro rata </I>basis as set forth in the Separation and Distribution Agreement (the &#147;<U>Distribution</U>&#148;); </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(9) Following
the Domestication and the Distribution, at the Effective Time, (i)&nbsp;the Parties will effect the merger of Merger Sub with and into SpinCo, with SpinCo continuing as the surviving corporation (the &#147;<U>Merger</U>&#148;), upon the terms and
subject to the conditions set forth herein and (ii)&nbsp;Parent will change its name to &#147;OmniAb, Inc.&#148;; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(10) Pursuant to the
Merger, shares of SpinCo Common Stock will be exchanged for shares of Domesticated Parent Stock (as defined below), on the terms and subject to the conditions set forth herein; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(11) The board of directors of Parent (the &#147;<U>Parent Board</U>&#148;) unanimously has (a)&nbsp;determined that the terms of this
Agreement and the Transactions (as defined below) are in the best interests of Parent, (b)&nbsp;approved and declared advisable the execution, delivery and performance of this Agreement and the consummation of the Transactions, on the terms and
subject to the conditions set forth herein, (c)&nbsp;resolved to recommend that the shareholders of Parent approve the Transaction Proposals (as defined below), on the terms and subject to the conditions set forth herein (the &#147;<U>Parent Board
Recommendation</U>&#148;), and (d)&nbsp;directed that each of the Transaction Proposals be submitted to a vote at a meeting of Parent&#146;s shareholders; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(12) The board of directors of Merger Sub has determined that the Merger and this Agreement are advisable, has approved this Agreement and the
Transactions, including the Merger, and has recommended the approval of this Agreement and the Merger to the sole stockholder of Merger Sub; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(13) Parent, as the sole stockholder of Merger Sub, immediately following the execution and delivery of this Agreement, will approve and adopt
this Agreement and the Transactions; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(14) The board of directors of the Company (the &#147;<U>Company Board</U>&#148;) unanimously has
approved this Agreement and the Transactions, subject to such further action by the Company Board required to establish the Record Date and the Distribution Date (each as defined below), and the declaration of the Distribution by the Company Board
(the effectiveness of which is subject to the satisfaction or, to the extent permitted by applicable Law, waiver of the conditions set forth in the Separation and Distribution Agreement); </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(15) The board of directors of SpinCo (the &#147;<U>SpinCo Board</U>&#148;) has determined that the Merger and this Agreement are advisable,
has approved this Agreement and the Transactions and has recommended the approval of this Agreement and the Merger to the sole stockholder of SpinCo; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-2- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(16) The Company, as the sole stockholder of SpinCo, immediately following the execution and
delivery of this Agreement, will approve and adopt this Agreement and the Transactions; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(17) In accordance with the terms of this
Agreement, Parent shall provide an opportunity to holders of the Parent Class&nbsp;A Common Stock to have their outstanding shares redeemed on the terms and subject to the conditions set forth in this Agreement and Parent&#146;s Governing Documents
(as defined below) in connection with obtaining the Parent Shareholder Approval (as defined below); </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(18) Concurrently with the execution
and delivery of this Agreement, Parent entered into the A&amp;R Forward Purchase Agreement (as defined below) with the Sponsor (as defined below) pursuant to which, and on the terms and subject to the conditions of which, Sponsor has agreed to
purchase from Parent the shares of Domesticated Parent Common Stock and Domesticated Parent Warrants described therein, such purchases to be consummated following the Domestication and immediately prior to the Distribution; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(19) At the Effective Time, Parent, the Sponsor, the independent directors of Parent, and the other Persons named as parties therein shall
amend and restate that certain Registration and Shareholder Rights Agreement, dated August&nbsp;9, 2021, by and among Parent, the Sponsor and the other Persons party thereto, substantially in the form attached hereto as <U>Exhibit E</U> (as so
amended and restated, and with such further changes as may be agreed in writing by Parent and the Company, the &#147;<U>A&amp;R Registration Rights Agreement</U>&#148;), to, among other things, include a three (3)&nbsp;month lockup on shares issued
to directors and officers of the Company and SpinCo; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(20) Concurrently with the execution and delivery of this Agreement, the Sponsor,
Parent and the other Persons named as parties therein have entered into that certain sponsor insider letter agreement (the &#147;<U>Sponsor Insider Agreement</U>&#148;), pursuant to which, among other things, in connection with the Closing, the
Sponsor shall subject the shares of Domesticated Parent Common Stock described therein to potential forfeiture in the event that certain funding and/or share price targets are not achieved, upon the terms and subject to the conditions set forth
therein; and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(21) It is the intention of the Parties that, for U.S. federal income Tax purposes: (a)&nbsp;the Domestication qualify as a
&#147;reorganization&#148; under Section&nbsp;368(a)(1)(F) of the Code, (b)&nbsp;the Contribution and the Distribution, taken together, qualify as a &#147;reorganization&#148; under Sections 368(a)(1)(D) and 355(a) of the Code; (c)&nbsp;the Merger
qualify as a &#147;reorganization&#148; within the meaning of Section&nbsp;368(a) of the Code; and (d)&nbsp;each of this Agreement and the Separation and Distribution Agreement constitute a &#147;plan of reorganization&#148; for purposes of
Section&nbsp;368 of the Code. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-3- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>NOW, THEREFORE: </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In consideration of the premises and mutual covenants contained herein and other good and valuable consideration, the receipt and sufficiency
of which are hereby acknowledged, the Parties agree as follows: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ARTICLE&nbsp;I </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">DEFINITIONS </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;1.1
<U>Definitions</U>. As used herein, the following terms have the following meanings; <U>provided</U>, that terms that are defined by reference to a defined term in the Separation and Distribution Agreement and include herein the term
&#147;SpinCo&#148; shall be understood to be referring to the correlative defined term for &#147;SpinCo&#148; used in the Separation and Distribution Agreement: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1) &#147;<U>A&amp;R Forward Purchase Agreement</U>&#148; means the Amended and Restated Forward Purchase Agreement, dated as of the date
hereof, by and among Parent, the Sponsor and the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2) &#147;<U>A&amp;R Registration Rights Agreement</U>&#148; has the meaning
set forth in the Recitals. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(3) &#147;<U>Action</U>&#148; means any claim, action, suit, litigation, arbitration, mediation, inquiry,
investigation or other proceeding, in each case, by any Person or Governmental Authority, in each case, before, heard by or otherwise involving any Governmental Authority. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(4) &#147;<U>Actual Fraud</U>&#148; means, with respect to a Party, an actual and intentional fraud with respect to the making of the
representations and warranties pursuant to <U>Article</U><U></U><U>&nbsp;IV</U>, <U>Article</U><U></U><U>&nbsp;V</U> or <U>Article</U><U></U><U>&nbsp;VI</U> (as applicable); <U>provided</U>, that such actual and intentional fraud shall only be
deemed to exist if the applicable representations and warranties were, to the Knowledge of the Company or SpinCo, in the case of <U>Article</U><U></U><U>&nbsp;IV</U> or <U>Article</U><U></U><U>&nbsp;V</U>, or to the Knowledge of Parent, in the case
of <U>Article</U><U></U><U>&nbsp;VI</U>, actually breached when made. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(5) &#147;<U>Adjusted Parent Equity Award</U>&#148; has the meaning
set forth in the Employee Matters Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(6) &#147;<U>Adjusted Parent Option</U>&#148; has the meaning set forth in the Employee
Matters Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(7) &#147;<U>Adjusted Parent PSU Award</U>&#148; has the meaning set forth in the Employee Matters Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(8) &#147;<U>Adjusted Parent RSU Award</U>&#148; has the meaning set forth in the Employee Matters Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(9) &#147;<U>Affiliate</U>&#148; means, with respect to any Person, any other Person that, directly or indirectly, controls, is controlled by,
or is under common control with, such Person, through one or more intermediaries or otherwise. For the avoidance of doubt, following the Effective Time, Affiliates of Parent shall include the SpinCo Entities. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-4- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(10) &#147;<U>Aggregate Common Consideration Shares</U>&#148; means the quotient of
(i)&nbsp;the sum of (a) $850,000,000, plus (b)&nbsp;an amount equal to the aggregate exercise price of SpinCo Options that are issued and outstanding as of immediately prior to the Effective Time, divided by (ii) $10; <U>provided</U>, that if the
Aggregate Common Consideration Shares as so calculated (together with the number of Included SpinCo Shares, calculated including shares underlying SpinCo Options, as applicable) would result in the product of (x)&nbsp;the Base Exchange Ratio,
multiplied by (y) $10, being less than the exercise price of any of the SpinCo Options issued and outstanding as of immediately prior to the Effective Time, then the calculation described in this definition shall be repeated by excluding the
exercise price of all of the SpinCo Options with the highest exercise price per share from the calculation of the aggregate exercise price described in clause (i)(b) of this definition and excluding any shares underlying such SpinCo Options from the
calculation of Included SpinCo Shares, in each case, on an iterative basis until the resulting calculations of Aggregate Common Consideration Shares and Included SpinCo Shares causes the product of (I)&nbsp;the Base Exchange Ratio and (II) $10 to be
equal to or in excess of the exercise price of all of the SpinCo Options included in such calculations, and the number of Aggregate Common Consideration Shares so calculated shall be the &#147;Aggregate Common Consideration Shares&#148; for the
purposes of this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(11) &#147;<U>Agreement</U>&#148; means this Agreement and Plan of Merger, including all Annexes, Exhibits
and Schedules hereto (including the SpinCo Disclosure Schedule, the Company Disclosure Schedule and the Parent Disclosure Schedule), as it may be amended, restated, modified or supplemented from time to time in accordance with its terms. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(12) &#147;<U>Antitrust Laws</U>&#148; means the Sherman Act, as amended, the Clayton Act, as amended, the Federal Trade Commission Act, as
amended, the HSR Act and all other applicable Laws issued by a Governmental Authority that are designed or intended to prohibit, restrict or regulate actions having the purpose or effect of monopolization or restraint of trade or lessening of
competition through merger or acquisition. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(13) &#147;<U>Balance Sheet Date</U>&#148; means December&nbsp;31, 2021. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(14) &#147;<U>Base Exchange Ratio</U>&#148; means the quotient of (i)&nbsp;the Aggregate Common Consideration Shares, divided by (ii)&nbsp;the
number of Included SpinCo Shares. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(15) &#147;<U>Benefit Plan</U>&#148; has the meaning given to such term in the Employee Matters
Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(16) &#147;<U>BLA</U>&#148; means a biologics license application submitted to the FDA pursuant to 42 U.S.C. &#167; 262 and 21
C.F.R. Part 601, and all supplements, amendments, variations, extensions and renewals thereto. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(17) &#147;<U>Business
Combination</U>&#148; has the meaning set forth in Parent&#146;s Governing Documents as in effect on the date hereof. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-5- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(18) &#147;<U>Business Day</U>&#148; means any day that is not a Saturday, a Sunday or other
day on which banking institutions in New York, New York or Governmental Authorities in the Cayman Islands (for so long as Parent remains domiciled in the Cayman Islands) are authorized or obligated by Law to be closed. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(19) &#147;<U>Cayman Registrar</U>&#148; means the Registrar of Companies of the Cayman Islands. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(20) &#147;<U>Change of Control</U>&#148; means any transaction or series of transactions (a)&nbsp;in which the holders of all of the
outstanding voting securities of Parent immediately prior to the consummation of such transaction do not directly or indirectly (including through Affiliates) own beneficially or of record immediately upon the consummation of such transaction a
majority of the combined outstanding voting securities of the surviving entity in such transaction or of a parent of the surviving entity in such transaction, (b)&nbsp;in which a majority of Parent&#146;s voting securities (outstanding after such
transaction) are transferred to or acquired by any Person, or any two or more Persons acting as a &#147;group&#148; (as defined in the Exchange Act), and all Affiliates of such Person or Persons (each, a &#147;<U>Group</U>&#148;), (c) constituting a
merger, consolidation, reorganization or other business combination, however effected, following which any Person or Group of Persons (other than Parent, SpinCo or any of their respective Subsidiaries) has direct or indirect beneficial ownership of
securities (or rights convertible into or exchangeable into securities) representing fifty percent (50%) or more of the voting power of or economic rights or interests in Parent or SpinCo or the surviving Person after such merger, consolidation,
reorganization or combination or (d)&nbsp;the result of which is a sale of all or substantially all of the assets of Parent or SpinCo to any Person (other than Parent, SpinCo or any of their respective Subsidiaries). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(21) &#147;<U>Code</U>&#148; means the Internal Revenue Code of 1986, as amended. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(22) &#147;<U>Company Benefit Plan</U>&#148; has the meaning given to such term in the Employee Matters Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(23) &#147;<U>Company Common Stock</U>&#148; means the common stock, par value $0.001 per share, of the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(24) &#147;<U>Company Distribution Tax Representations</U>&#148; means the representations of an officer of the Company and/or SpinCo, dated
as of the Closing Date, in form and substance reasonably satisfactory to LW, delivered to LW in connection with the Company Distribution Tax Opinion. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(25) &#147;<U>Company Disclosure Schedule</U>&#148; means the Disclosure Schedule delivered by the Company to Parent on the date hereof and
identified as such. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(26) &#147;<U>Company Equity Award</U>&#148; has the meaning given to such term in the Employee Matters Agreement.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(27) &#147;<U>Company Material Adverse Effect</U>&#148; means any Effect that has, or would reasonably be expected to, individually or in
the aggregate, materially impair, materially delay or otherwise have a material adverse effect on the ability of the Company to perform its obligations hereunder or under the other Transaction Documents or to consummate the Transactions, including
the Separation and the Distribution, or prevent it from performing such obligations or consummating such Transactions. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-6- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(28) &#147;<U>Company Option</U>&#148; has the meaning given to such term in the Employee
Matters Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(29) &#147;<U>Company PSU Award</U>&#148; has the meaning given to such term in the Employee Matters Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(30) &#147;<U>Company Real Property</U>&#148; means any real property owned, leased, subleased, licensed or otherwise occupied by the Company
or any of its Subsidiaries (other than the SpinCo Entities), in each case, that is used in connection with the SpinCo Business as it is currently conducted or contemplated to be conducted in the future. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(31) &#147;<U>Company RSU Award</U>&#148; has the meaning given to such term in the Employee Matters Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(32) &#147;<U>Company SEC Documents</U>&#148; means all forms, reports, Schedules, statements and other documents required to be filed or
furnished by the Company or SpinCo with the SEC since January&nbsp;1, 2019. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(33) &#147;<U>Company Service Provider</U>&#148; has the
meaning given to such term in the Employee Matters Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(34) &#147;<U>Company Tax Opinions</U>&#148; means the Company Distribution
Tax Opinion and the Company Merger Tax Opinion. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(35) &#147;<U>Confidentiality Agreement</U>&#148; means that certain Confidentiality
Agreement, by and between Parent and the Company, dated as of February&nbsp;21, 2022. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(36) &#147;<U>Consent</U>&#148; means any consent,
clearance, expiration or termination of a waiting period, approval, exemption, waiver, authorization, filing, registration or notification. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(37) &#147;<U>Contract</U>&#148; means any legally binding contract, agreement, understanding, arrangement, loan or credit agreement, note,
bond, indenture, lease, warranty, purchase order, sublicense or license or other instrument. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(38) &#147;<U>Contribution</U>&#148; has the
meaning set forth in the Separation and Distribution Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(39) &#147;<U><FONT STYLE="white-space:nowrap">COVID-19</FONT></U>&#148;
means <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">SARS-CoV-2</FONT></FONT> or <FONT STYLE="white-space:nowrap">COVID-19,</FONT> and any evolutions or mutations thereof or related or associated epidemics, pandemics or disease
outbreaks. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(40) &#147;<U><FONT STYLE="white-space:nowrap">COVID-19</FONT> Measures</U>&#148; means any quarantine, &#147;shelter in
place,&#148; &#147;stay at home,&#148; social distancing, shut down, closure, sequester, workplace safety or similar Law, directive, guidelines or recommendations promulgated by any industry group or any Governmental Authority, including the Centers
for Disease Control and Prevention and the World Health Organization, in each case, in connection with or in response to <FONT STYLE="white-space:nowrap">COVID-19,</FONT> including the CARES Act and Families First Coronavirus Response Act. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-7- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(41) &#147;<U>DGCL</U>&#148; has the meaning set forth in the Recitals. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(42) &#147;<U>Distribution Date</U>&#148; has the meaning set forth in the Separation and Distribution Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(43) &#147;<U>Distribution Time</U>&#148; has the meaning set forth in the Separation and Distribution Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(44) &#147;<U>Domesticated Parent Common Stock</U>&#148; has the meaning set forth in the Recitals. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(45) &#147;<U>Domesticated Parent Stock</U>&#148; means the Domesticated Parent Common Stock and the Earnout Shares. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(46) &#147;<U>Domesticated Parent Warrant</U>&#148; has the meaning set forth in the Recitals. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(47) &#147;<U>Earnout Exchange Ratio</U>&#148; means the quotient of (i) 15,000,000, divided by (ii)&nbsp;the number of Fully Diluted SpinCo
Shares. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(48) &#147;<U>Effect</U>&#148; means any change, event, development, condition, occurrence or effect. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(49) &#147;<U>Employee Matters Agreement</U>&#148; means the Employee Matters Agreement, dated as of the date hereof, by and among Parent, the
Company and SpinCo, attached as <U>Exhibit C</U> to this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(50) &#147;<U>Entity</U>&#148; means any Person that is a legal
entity; <U>provided</U>, that when used in reference to Parent or SpinCo, &#147;Entity&#148; means Parent or SpinCo, in each case together with its respective Subsidiaries, taken as a whole. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(51) &#147;<U>Environmental Laws</U>&#148; means any Law relating to pollution or protection of the environment, natural resources, or human
health and safety (to the extent related to exposure to Hazardous Materials or hazardous conditions). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(52) &#147;<U>ERISA</U>&#148; means
the Employee Retirement Income Security Act of 1974, as amended, and the regulations promulgated and rulings issued thereunder. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(53)
&#147;<U>ERISA Affiliate</U>&#148; means, with respect to any entity, trade or business, any other entity, trade or business that is a member of a group described in Section&nbsp;414(b), (c), (m) or (o)&nbsp;of the Code or Section&nbsp;4001(b)(1) of
ERISA that includes the first entity, trade or business, or that is a member of the same &#147;controlled group&#148; as the first entity, trade or business pursuant to Section&nbsp;4001(a)(14) of ERISA. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(54) &#147;<U>Exchange Act</U>&#148; means the Securities Exchange Act of 1934, as amended. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(55) &#147;<U>EY</U>&#148; means Ernst&nbsp;&amp; Young LLP. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(56) &#147;<U>FDA</U>&#148; means the United States Food and Drug Administration. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-8- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(57) &#147;<U>FDCA</U>&#148; means the Food, Drug and Cosmetic Act, 21 U.S.C. &#167; 301 et
seq., as amended. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(58) &#147;<U>Foreign Benefit Plan</U>&#148; means any Company Benefit Plan or SpinCo Benefit Plan that is maintained
(i)&nbsp;primarily for the benefit of employees outside the United States or (ii)&nbsp;pursuant to the Laws of a country other than the United States. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(59) &#147;<U>Former Company Service Provider</U>&#148; has the meaning given to such term in the Employee Matters Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(60) &#147;<U>Fully Diluted SpinCo Shares</U>&#148; means, without duplication, the sum of (a)&nbsp;the aggregate number of issued and
outstanding shares of SpinCo Common Stock as of immediately prior to the Effective Time, plus (b)&nbsp;the aggregate number of shares of SpinCo Common Stock issuable upon the exercise of all SpinCo Options (whether vested or unvested) as of
immediately prior to the Effective Time, plus (c)&nbsp;the aggregate number of shares of SpinCo Common Stock issuable upon the vesting of all SpinCo RSU Awards as of immediately prior to the Effective Time, plus (d)&nbsp;the aggregate number of
shares of SpinCo Common Stock issuable upon the vesting of all SpinCo PSU Awards as of immediately prior to the Effective Time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(61)
&#147;<U>GAAP</U>&#148; means generally accepted accounting principles in the United States. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(62) &#147;<U>Good Clinical
Practices</U>&#148; means the then current requirements of Law for the conduct of clinical trials (including all applicable requirements relating to protection of human subjects), as set forth in the FDCA and applicable regulations promulgated
thereunder, as amended from time to time, and such applicable regulations for the conduct of human clinical trials (including all applicable requirements relating to protection of human subjects) as are enforced by any Regulatory Authority in any
countries other than the United States in which the SpinCo Products are the subject of clinical trials. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(63) &#147;<U>Good Laboratory
Practices</U>&#148; means the then current requirements of Law for conducting nonclinical laboratory studies, as set forth in the FDCA and applicable regulations promulgated thereunder, as amended from time to time, and such applicable regulations
governing the conduct of nonclinical laboratory studies as are enforced by Regulatory Authorities in any country other than the United States in which the SpinCo Products are studied in nonclinical laboratory studies to which requirements apply.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(64) &#147;<U>Governing Documents</U>&#148; means the legal document(s) by which any Person (other than an individual) establishes its
legal existence or which govern its internal affairs. For example, the &#147;<U>Governing Documents</U>&#148; of a corporation are its certificate of incorporation and <FONT STYLE="white-space:nowrap">by-laws,</FONT> the &#147;<U>Governing
Documents</U>&#148; of a limited partnership are its limited partnership agreement and certificate of limited partnership, the &#147;<U>Governing Documents</U>&#148; of a limited liability company are its operating agreement and certificate of
formation and the &#147;<U>Governing Documents</U>&#148; of an exempted company are its memorandum and articles of association (in each case, as amended, restated, amended and restated or otherwise modified from time to time). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(65) &#147;<U>Governmental Authority</U>&#148; means any federal, state, local, transnational, supranational or foreign government, any Person
exercising executive, legislative, judicial, regulatory or administrative function of or pertaining to government or Law, including any regulatory, self-regulatory or quasi-regulatory authority, agency, commission, body, department or other
instrumentality, and any court, arbitral body or tribunal of competent jurisdiction. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-9- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(66) &#147;<U>Government Official</U>&#148; means any officer or employee of a Governmental
Authority or any department, agency, or instrumentality thereof, including any political subdivision thereof or any corporation or other Person owned or controlled in whole or in part by any Governmental Authority or any sovereign wealth fund, or of
a public international organization, or any Person acting in an official capacity for or on behalf of any such government or department, agency, or instrumentality, or for or on behalf of any such public international organization, or any political
party, party official, or candidate thereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(67) &#147;<U>Hazardous Material</U>&#148; means any toxic, reactive, corrosive, ignitable
or flammable chemical or chemical compound, or hazardous or toxic substance, material or waste, or any pollutant or contaminant, whether solid, liquid or gas, or any other substance, material or waste that is subject to regulation, control or
remediation or for which liability or standards of care are imposed under any Environmental Law, including petroleum (including crude oil or any fraction thereof), radon, asbestos, radioactive materials, <FONT STYLE="white-space:nowrap">per-</FONT>
and polyfluoroalkyl substances and polychlorinated biphenyls. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(68) &#147;<U>Healthcare Laws</U>&#148; means (a)&nbsp;the FDCA, and the
regulations promulgated thereunder, (b)&nbsp;the Public Health Service Act (42 U.S.C. 201 et seq.), and the regulations promulgated thereunder, (c)&nbsp;all federal and state fraud and abuse Laws, including the Federal Anti-Kickback Statute, the
civil False Claims Act, the Anti-Inducement Law, the exclusion Laws, and the regulations promulgated pursuant to such statutes, (d)&nbsp;the Health Insurance Portability and Accountability Act of 1996, and the regulations promulgated thereunder, and
comparable state Laws, (e)&nbsp;Titles XVIII and XIX of the Social Security Act, and the regulations promulgated thereunder and (f)&nbsp;all other applicable healthcare Laws, rules and regulations, ordinances, judgments, decrees, orders, writs and
injunctions administered by Regulatory Authorities, each of clause (a)&nbsp;through (f), as may be amended from time to time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(69)
&#147;<U>HSR Act</U>&#148; means the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, and the rules and regulations promulgated thereunder. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(70) &#147;<U>INAD</U>&#148; means an investigational new animal drug exemption pursuant to 21 C.F.R. Part 511. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(71) &#147;<U>Included SpinCo Shares</U>&#148; means, without duplication, the sum of (a)&nbsp;the aggregate number of issued and outstanding
shares of SpinCo Common Stock as of immediately prior to the Effective Time, plus (b)&nbsp;the aggregate number of shares of SpinCo Common Stock issuable upon the exercise of all SpinCo Options (whether vested or unvested) as of immediately prior to
the Effective Time, other than SpinCo Options excluded from the definition of Aggregate Common Consideration Shares pursuant to the proviso thereto, plus (c)&nbsp;the aggregate number of shares of SpinCo Common Stock issuable upon the vesting of all
SpinCo RSU Awards as of immediately prior to the Effective Time, plus (d)&nbsp;the aggregate number of shares of SpinCo Common Stock issuable upon the vesting of all SpinCo PSU Awards as of immediately prior to the Effective Time. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-10- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(72) &#147;<U>IND</U>&#148; means an investigational new drug application submitted to the
FDA pursuant to 21 C.F.R. Part 312 to permit the introduction of an investigational drug into interstate commerce in the United States for the purposes of conducting human clinical trials, and all supplements, amendments, variations, extensions and
renewals thereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(73) &#147;<U>Intellectual Property</U>&#148; has the meaning set forth in the Separation and Distribution Agreement.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(74) &#147;<U>Interests</U>&#148; means shares, partnership interests, limited liability company interests or any other equity interest
in any Person. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(75) &#147;<U>Internal </U><U>Reorganization</U>&#148; has the meaning set forth in the Separation and Distribution
Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(76) &#147;<U>Intervening Event</U>&#148; means any Effect that (i)&nbsp;was not known to or reasonably foreseeable by the
Parent Board as of the date of this Agreement and (ii)&nbsp;does not relate to (A)&nbsp;any Business Combination (other than the Merger or the other Transactions) or (B)&nbsp;clearance of the Transaction by any Governmental Authority, including
Effects relating to actions taken pursuant to or required to be taken pursuant to <U>Section</U><U></U><U>&nbsp;7.6</U>; <U>provided</U>, that (1)&nbsp;any change in the price or trading volume of Parent Common Stock shall not be taken into account
for purposes of determining whether an Intervening Event has occurred and (2)&nbsp;the Company&#146;s, SpinCo&#146;s or any of their respective Subsidiaries&#146; meeting, failing to meet or exceeding projections (in and of itself, but not the
underlying causes thereof) shall not be taken into account for purposes of determining whether an Intervening Event has occurred. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(77)
&#147;<U>Investment Company Act</U>&#148; means the Investment Company Act of 1940, as amended. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(78) &#147;<U>IRS</U>&#148; means the
United States Internal Revenue Service. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(79) &#147;<U>IT Assets</U>&#148; has the meaning set forth in the Separation and Distribution
Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(80) &#147;<U>Knowledge</U>&#148; means (a)&nbsp;with respect to the Company, the actual knowledge of the persons set forth in
Section&nbsp;1.1(a) of the Company Disclosure Schedule, after reasonable investigation, (b)&nbsp;with respect to SpinCo, the knowledge of the persons set forth in Section&nbsp;1.1(a) of the SpinCo Disclosure Schedule, after reasonable investigation
and (c)&nbsp;with respect to Parent, the actual knowledge of the persons set forth in Section&nbsp;1.1(a) of the Parent Disclosure Schedule, after reasonable investigation. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(81) &#147;<U>Law</U>&#148; means, with respect to any Person, any law, statute, code, ordinance, order, decree, award, directive, judgment,
ruling, rule, regulation or similar requirement issued, promulgated, enforced or enacted by or under the authority of a Governmental Authority that is binding upon or applicable to such Person. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(82) &#147;<U>Liability</U>&#148; means any liability (whether known or unknown, whether asserted or unasserted, whether absolute or
contingent, whether accrued or unaccrued, whether liquidated or unliquidated, whether direct or indirect, and whether due or to become due). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-11- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(83) &#147;<U>Lien</U>&#148; means any mortgage, deed of trust, pledge, hypothecation,
encumbrance, easement, encroachment, license, option, right of first refusal, security interest or other lien or restriction of any kind. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(84) &#147;<U>Ligand Retained Assets</U>&#148; has the meaning set forth in the Separation and Distribution Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(85) &#147;<U>Ligand Retained Business</U>&#148; has the meaning set forth in the Separation and Distribution Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(86) &#147;<U>Losses</U>&#148; means any and all Liabilities, claims, losses, damages, costs, expenses, interest, awards, judgments and
penalties (including reasonable attorneys&#146; and consultants&#146; fees and expenses). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(87) &#147;<U>LW</U>&#148; means
Latham&nbsp;&amp; Watkins LLP. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(88) &#147;<U>Merger Tax Opinions</U>&#148; means the Company Merger Tax Opinion and the Parent Merger Tax
Opinion. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(89) &#147;<U>Multiemployer Plan</U>&#148; means any &#147;multiemployer plan&#148; within the meaning of Section&nbsp;3(37) or
Section&nbsp;4001(a)(3) of ERISA. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(90) &#147;<U>NADA</U>&#148; means a new animal drug application submitted to the FDA pursuant to 21
U.S.C. &#167; 360b to market a new animal drug in the United States, and all supplements, amendments, variations, extensions and renewals thereto. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(91) &#147;<U>NASDAQ</U>&#148; means the Nasdaq Capital Market. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(92) &#147;<U>NDA</U>&#148; means a new drug application submitted to the FDA pursuant to 21&nbsp;U.S.C. &#167; 355(b), and all amendments or
supplements thereto. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(93) &#147;<U>Parent Business Combination Proposal</U>&#148; means any inquiry, offer, proposal or indication of
interest (whether written or oral, binding or <FONT STYLE="white-space:nowrap">non-binding,</FONT> and other than an inquiry, offer, proposal or indication of interest made or submitted by Parent to the Company or by the Company to Parent)
contemplating or otherwise relating to any potential Business Combination (other than the Merger or the other Transactions). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(94)
&#147;<U>Parent Class</U><U></U><U>&nbsp;A Common Stock</U>&#148; means the Class&nbsp;A ordinary fully paid shares, par value $0.0001 each per share in the capital of Parent prior to the Domestication. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(95) &#147;<U>Parent Class</U><U></U><U>&nbsp;B Common Stock</U>&#148; means the Class&nbsp;B ordinary fully paid shares, par value $0.0001
each per share in the capital of Parent prior to the Domestication. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(96) &#147;<U>Parent Common Stock</U>&#148; means the Parent
Class&nbsp;A Common Stock and the Parent Class&nbsp;B Common Stock. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(97) &#147;<U>Parent Disclosure Schedule</U>&#148; means the
Disclosure Schedule delivered by Parent to the Company and SpinCo on the date hereof and identified as such. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-12- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(98) &#147;<U>Parent Distribution Tax Representations</U>&#148; means the representations of
an officer of Parent, dated as of the Closing Date, in form and substance reasonably satisfactory to LW, delivered to LW in connection with the Company Distribution Tax Opinion. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(99) &#147;<U>Parent Equity Plan</U>&#148; has the meaning set forth in the Employee Matters Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(100) &#147;<U>Parent ESPP</U>&#148; has the meaning set forth in the Employee Matters Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(101) &#147;<U>Parent Material Adverse Effect</U>&#148; means any Effect that (a)&nbsp;has, or would reasonably be expected to have,
individually or in the aggregate with any other Effects, a material adverse effect on the business or financial condition of the Parent or Merger Sub, taken as a whole; <U>provided</U>, that none of the following shall be deemed in themselves,
either alone or in combination, to constitute, and none of the following shall be taken into account in determining whether there has been or would reasonably be expected to be, individually or in the aggregate, a Parent Material Adverse Effect for
purposes of this clause (a): (i) any changes resulting from general market, economic, financial, capital markets or regulatory conditions, (ii)&nbsp;any general changes<B> </B>in the credit, debt, financial or capital markets or changes in interest
or exchange rates, (iii)&nbsp;any changes in applicable Law or GAAP (or, in each case, authoritative interpretations thereof), (iv)&nbsp;any changes resulting from any natural disaster, including any hurricane, storm, flood, tornado, volcanic
eruption, earthquake, other weather-related events, or other comparable events, or any worsening thereof, (v)&nbsp;any changes resulting from local, national or international political conditions, including the outbreak or escalation of any military
conflict, declared or undeclared war, armed hostilities, acts of foreign or domestic terrorism or civil unrest, (vi)&nbsp;any changes generally affecting the industries in which the Parent conducts its businesses, (vii)&nbsp;any changes directly
resulting from the execution of this Agreement or the Transaction Documents or the announcement or the pendency of the Merger or the Transactions, including actions of suppliers, landlords, distributors, partners or Governmental Authorities and any
loss of employees, relationships or customers resulting from the transactions contemplated by this Agreement (<U>provided</U>, that this clause (vii)&nbsp;shall not apply to any representation or warranty to the extent the purpose of such
representation or warranty is to address, as applicable, the consequences resulting from the execution of this Agreement or the Separation and Distribution Agreement or the announcement or the pendency of the Merger or the Separation), (viii) any
changes resulting from any action required to be taken by the terms of this Agreement or at the request or direction of the Company, (ix)&nbsp;the failure to meet any internal or analysts&#146; expectations, projections or results of operations (but
not, in each case, the underlying cause of any such changes, unless such underlying cause would otherwise be excepted by another clause of this definition), (x) any changes resulting from any epidemics, pandemics or disease (including <FONT
STYLE="white-space:nowrap">COVID-19</FONT> or any <FONT STYLE="white-space:nowrap">COVID-19</FONT> Measures or any change in <FONT STYLE="white-space:nowrap">COVID-19</FONT> Measures following the date hereof) or (xi)&nbsp;elections to redeem shares
of Parent Class&nbsp;A Common Stock in connection with the Parent Shareholders Meeting as required by Parent&#146;s Governing Documents; <U>provided</U>, that in the case of clauses (i), (ii), (iii), (iv), (v), (vi) and (x), if such Effect
disproportionately impacts the Parent or Merger Sub, taken as a whole, as compared to other participants in similar industries to the industries in which Parent operates, the incremental disproportionate impact thereof may be taken into account in
determining whether a Parent Material Adverse Effect has occurred or would reasonably be expected to occur; or (b)&nbsp;has, or would reasonably be expected to, individually or in the aggregate, materially impair or materially delay the ability of
Parent to perform its obligations hereunder or under the Separation and Distribution Agreement, or to consummate the Transactions, including the Merger and the Separation, or prevent it from performing such obligations or consummating the
Transactions. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-13- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(102) &#147;<U>Parent Merger Tax Representations</U>&#148; means the representations of an
officer of Parent, dated as of the Closing Date, in form and substance reasonably satisfactory to LW and Weil, delivered to LW and Weil in connection with the Merger Tax Opinions. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(103) &#147;<U>Parent Private Placement Warrant</U>&#148; means a warrant to purchase one (1)&nbsp;share of Parent Class&nbsp;A Common Stock
at an exercise price of eleven dollars fifty cents ($11.50) issued to the Sponsor prior to consummation of Parent&#146;s initial public offering. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(104) &#147;<U>Parent Public Warrant</U>&#148; means a warrant to purchase one (1)&nbsp;share of Parent Class&nbsp;A Common Stock at an
exercise price of eleven dollars fifty cents ($11.50), a fraction equal to <FONT STYLE="white-space:nowrap">one-third</FONT> of which was included in each unit sold as part of Parent&#146;s initial public offering. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(105) &#147;<U>Parent Registration Statement</U>&#148; means the registration statement on Form <FONT STYLE="white-space:nowrap">S-4</FONT> to
be filed by Parent with the SEC (as amended and supplemented from time to time) to effect the registration under the Securities Act of the issuance of (a)&nbsp;the shares of Domesticated Parent Common Stock and the Earnout Shares that will be issued
to holders of SpinCo Common Stock and holders of SpinCo Equity Awards pursuant to the Merger, (b)&nbsp;the shares of Domesticated Parent Common Stock and the Domesticated Parent Warrants that will be issued to holders of Parent Common Stock and
Parent Public Warrants in the Domestication and the shares of Domesticated Parent Common Stock underlying such Domesticated Parent Warrants and (c)&nbsp;the Adjusted Parent Equity Awards into which the SpinCo Equity Awards are converted pursuant to
the Merger and the shares of Domesticated Parent Common Stock underlying such Adjusted Parent Equity Awards. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(106) &#147;<U>Parent SEC
Documents</U>&#148; means all forms, reports, schedules, statements and other documents required to be filed or furnished by Parent with the SEC since August&nbsp;12, 2021. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(107) &#147;<U>Parent Share Issuance</U>&#148; means the issuance of shares of Domesticated Parent Stock pursuant to the Domestication, the
PIPE Investment, the Redemption Backstop and the Merger. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(108) &#147;<U>Parent Share Redemption</U>&#148; means the election of an
eligible holder of Parent Class&nbsp;A Common Stock (as determined in accordance with Parent&#146;s Governing Documents) to redeem all or a portion of the shares of Parent Class&nbsp;A Common Stock held by such holder at a <FONT
STYLE="white-space:nowrap">per-share</FONT> price, payable in cash, equal to the pro rata share of the aggregate amount on deposit in the Trust Account (including any interest earned on the funds held in the Trust Account) represented by such
redeemed shares (as determined in accordance with Parent&#146;s Governing Documents and the Trust Agreement) in connection with the Transaction Proposals. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(109) &#147;<U>Parent Share Redemption Amount</U>&#148; means the aggregate amount payable with respect to all Parent Share Redemptions. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-14- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(110) &#147;<U>Parent Shareholder Approval</U>&#148; means the approval of (i)&nbsp;those
Transaction Proposals identified in clauses (A), (B) and (C)&nbsp;of <U>Section</U><U></U><U>&nbsp;7.4(e)(ii)</U>, in each case, by a special resolution under the CICA (being the affirmative vote of the holders of at least <FONT
STYLE="white-space:nowrap">two-thirds</FONT> (2/3) of the ordinary shares who, being present and entitled to vote at the Parent Shareholders Meeting, vote at the Parent Shareholders Meeting), (ii) those Transaction Proposals identified in clauses
(D), (E), (F) and (I)&nbsp;of <U>Section</U><U></U><U>&nbsp;7.4(e)(ii)</U>, in each case, by an ordinary resolution under the CICA (being the affirmative vote of the holders of a majority of the ordinary shares who, being present and entitled to
vote at the Parent Shareholders Meeting, vote at the Parent Shareholders Meeting) and (iii)&nbsp;those Transaction Proposals identified in clauses (G)&nbsp;and (H) of <U>Section</U><U></U><U>&nbsp;7.4(e)(ii)</U>, in each case, by an affirmative vote
of the number of holders of Parent Common Stock required to approve such Transaction Proposals under applicable Law and the Governing Documents of Parent. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(111) &#147;<U>Parent Subsidiaries</U>&#148; means all direct and indirect Subsidiaries of Parent. For the avoidance of doubt, following the
Effective Time, the Parent Subsidiaries shall include the SpinCo Entities. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(112) <U>&#147;</U><U>Parent Tax Opinions</U>&#148; means the
Parent Domestication Tax Opinion and the Parent Merger Tax Opinion. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(113) &#147;<U>Parent Tax Representations</U>&#148; means the Parent
Distribution Tax Representations and the Parent Merger Tax Representations. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(114) &#147;<U>Parent Trading Price</U>&#148; means the share
price equal to the volume weighted average closing sale price of one share of Domesticated Parent Common Stock as reported on NASDAQ (or the exchange on which the shares of Domesticated Parent Common Stock are then listed) for a period of at least
20 days out of 30 consecutive trading days ending on the trading day immediately prior to the date of determination (as adjusted as appropriate to reflect any stock splits, reverse stock splits, stock dividends (including any dividend or
distribution of securities convertible into Domesticated Parent Common Stock), extraordinary cash dividend, reorganization, recapitalization, reclassification, combination, exchange of shares or other like change or transaction with respect to
Domesticated Parent Common Stock). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(115) &#147;<U>Parent Unit</U>&#148; has the meaning set forth in the Recitals. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(116) &#147;<U>Parent Warrant</U>&#148; means any Parent Private Placement Warrant or Parent Public Warrant. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(117) &#147;<U>Patent</U>&#148; has the meaning set forth in the Separation and Distribution Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(118) &#147;<U>Permits</U>&#148; means licenses, franchises, permits, certificates, approvals and authorizations from Governmental
Authorities. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(119) &#147;<U>Permitted Liens</U>&#148; means (a)&nbsp;statutory Liens arising by operation of Law with respect to a
Liability incurred in the ordinary course of business and which is not delinquent; (b)&nbsp;requirements and restrictions of zoning, licensing, permitting, building and other similar <FONT STYLE="white-space:nowrap">land-use</FONT> Laws which are
not violated by the present use or occupancy of the real property subject thereto; (c)&nbsp;Liens for Taxes or mechanics&#146;, materialmen&#146;s and similar Liens arising or incurred in </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-15- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
the ordinary course of business and with respect to any amounts, in each case (i)&nbsp;not yet due and payable or (ii)&nbsp;which are being contested in good faith by appropriate proceedings and
for which adequate reserves have been established in accordance with GAAP; <FONT STYLE="white-space:nowrap">(d)&nbsp;non-exclusive</FONT> licenses of Intellectual Property granted to customers in the ordinary course of business consistent with past
practice; (e)&nbsp;all encroachments, overlaps, overhangs, variations in area or measurement, rights of parties in possession, servitudes or easements (including conservation easements and public trust easements, <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">rights-of-way,</FONT></FONT> road use Contracts, covenants, conditions, restrictions, reservations, licenses, Contracts and other similar <FONT STYLE="white-space:nowrap">non-monetary</FONT> matters) of public record or
any other similar matters not of record which would be disclosed by an accurate survey or physical inspection of the applicable real property; <U>provided</U>, that such Liens, individually or in the aggregate, do not or would not reasonably be
expected to materially impair or interfere with the operation or use of such real property in the ordinary course operation of the respective businesses of SpinCo and its Subsidiaries or Parent and its Subsidiaries, as applicable, in each case, as
currently conducted thereon; (f)&nbsp;with respect to any real property, (i)&nbsp;the interests and rights of the respective lessors with respect thereto, including any statutory landlord liens and any Lien on the lessor&#146;s interest therein and
(ii)&nbsp;any Liens encumbering the underlying fee title of the real property; <U>provided</U>, that such Liens, individually or in the aggregate, do not or would not reasonably be expected to materially impair or interfere with the operation or use
of such real property in the ordinary course operation of the respective businesses of SpinCo and its Subsidiaries or Parent and its Subsidiaries, as applicable, in each case, as currently conducted thereon; (g)&nbsp;any real property Liens that do
not, individually or in the aggregate, result in a Parent Material Adverse Effect or SpinCo Material Adverse Effect, as applicable; (h)&nbsp;reversionary rights in favor of landlords under any real property leases with respect to any of the
buildings or other improvements owned by SpinCo, Parent or any of their Subsidiaries, as applicable; <U>provided</U>, that such Liens, individually or in the aggregate, do not or would not reasonably be expected to materially impair or interfere
with the operation or use of such real property in the ordinary course operation of the respective businesses of SpinCo and its Subsidiaries or Parent and its Subsidiaries, as applicable, in each case, as currently conducted thereon;
(i)&nbsp;purchase money Liens and Liens securing rental payments under capital lease agreements; (j)&nbsp;pledges or deposits made in the ordinary course of business in connection with workers&#146; compensation, unemployment insurance and other
types of social security (other than pursuant to Section&nbsp;303(k) or 4068 of ERISA or Section&nbsp;430(k) of the Code) or to secure the performance of tenders, statutory obligations, surety and appeal bonds, bids, performance and return of money
bonds and similar obligations; (k)&nbsp;liens arising under conditional sales Contracts and equipment leases with third parties entered into in the ordinary course of business to the extent not subject to any default; (l)&nbsp;pledges or deposits to
secure public or statutory obligations unrelated to any default or violation of any Law; (m)&nbsp;Liens arising under or created by this Agreement or any Transaction Document (other than as a result of a breach or default under such Contracts); (n)
Liens securing the Financing; (o)&nbsp;Liens described on Section&nbsp;1.1(b) of the SpinCo Disclosure Schedule or Section&nbsp;1.1(b) of the Parent Disclosure Schedule, as applicable; and (p)&nbsp;Liens (other than Liens on Intellectual Property)
that do not, individually or in the aggregate, materially affect or disrupt the ordinary course operation of the respective businesses of SpinCo and its Subsidiaries or Parent and its Subsidiaries, as applicable, in each case, taken as a whole. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(120) &#147;<U>Person</U>&#148; means any individual, firm, corporation, partnership, limited liability company, incorporated or
unincorporated association, joint venture, joint stock company, Governmental Authority or other organization or entity of any kind. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-16- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(121) &#147;<U>Personal Information</U>&#148; means all information in any form or media
that identifies or could be used to identify an individual person (including any current, prospective, or former customer, end user or employee), in addition to any definition for &#147;personal information&#148; or any similar term provided by
applicable Law or by the Company or SpinCo in any of its privacy policies, notices or contracts (e.g., &#147;personal data,&#148; &#147;personally identifiable information&#148; or &#147;PII&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(122) &#147;<U>PIPE Investment</U>&#148; means the purchase of shares of Domesticated Parent Common Stock and Domesticated Parent Warrants
pursuant to the A&amp;R Forward Purchase Agreement with a purchase price equal to the PIPE Investment Amount. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(123) &#147;<U>PIPE
Investment Amount</U>&#148; means the aggregate gross purchase price of $15,000,000 payable to Parent prior to or substantially concurrently with the Effective Time for shares of Domesticated Parent Common Stock and Domesticated Parent Warrants in
the PIPE Investment. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(124) &#147;<U>PIPE Investor</U>&#148; means Sponsor or any Person to whom such right and obligation is assigned by
Sponsor as permitted by the terms of the A&amp;R Forward Purchase Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(125) &#147;<U>Privacy Laws</U>&#148; means applicable Laws,
and self-regulatory guidelines (including of any applicable foreign jurisdiction) relating to the receipt, collection, compilation, use, storage, processing, sharing, safeguarding, security (technical, physical or administrative), disposal,
destruction, disclosure or transfer (including cross-border) of any Personal Information, including the Federal Trade Commission Act, California Consumer Privacy Act (CCPA), Payment Card Industry Data Security Standard
<FONT STYLE="white-space:nowrap">(PCI-DSS),</FONT> EU General Data Protection Regulation (GDPR), any and all applicable Laws relating to breach notification, the use of biometric identifiers, and the use of Personal Information for marketing
purposes. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(126) &#147;<U>Privacy Requirements</U>&#148; means all applicable Privacy Laws and all of the Company&#146;s and SpinCo&#146;s
policies, notices, and contractual obligations relating to the receipt, collection, compilation, use, storage, processing, sharing, safeguarding, security (technical, physical and administrative), disposal, destruction, disclosure, or transfer
(including cross-border) of Personal Information. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(127) &#147;<U>Proxy Statement</U>&#148; means the proxy statement to be mailed to the
shareholders of Parent relating to the Parent Shareholders Meeting, including any amendments or supplements thereto. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(128)
&#147;<U>Qualified SpinCo Common Stock</U>&#148; means SpinCo Common Stock received by holders of Company Common Stock pursuant to the Distribution, except for any SpinCo Common Stock that is acquired, directly or indirectly, pursuant to a plan (or
series of related transactions) that includes the Distribution, within the meaning of Section&nbsp;355(e) of the Code and the Treasury Regulations promulgated thereunder. This definition (and the application thereof) is intended to monitor
compliance with Section&nbsp;355(e) of the Code and shall be interpreted accordingly. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-17- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(129) &#147;<U>Record Date</U>&#148; means 5:00 p.m. New York time on the date determined by
the Company Board as the record date for determining stockholders of the Company entitled to receive shares of SpinCo Common Stock in the Distribution. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(130) &#147;<U>Redemption Backstop</U>&#148; means the purchase of up to 10,000,000 shares of Domesticated Parent Common Stock at a purchase
price of $10.00 per share pursuant to the A&amp;R Forward Purchase Agreement, excluding the Domesticated Parent Common Stock subject to the PIPE Investment. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(131) &#147;<U>Regulatory Authority</U>&#148; means the FDA or any other comparable Governmental Authority. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(132) &#147;<U>Regulatory Authorizations</U>&#148; means any approvals, clearances, authorizations, registrations, certifications, licenses,
exemptions and permits granted by any Regulatory Authority, including any INDs, NDAs, BLAs, NADAs, and INADs. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(133)
&#147;<U>Release</U>&#148; means any spilling, leaking, pumping, pouring, emitting, emptying, discharging, injecting, depositing, escaping, leaching, disposing or dumping into the environment. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(134) &#147;<U>Representative</U>&#148; means, with respect to any Person, such Person&#146;s directors, managers, members, officers,
employees, agents, partners, attorneys, financial advisors, financing sources, consultants, advisors or other Persons acting on behalf of such Person. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(135) &#147;<U>Requisite Regulatory Approvals</U>&#148; means the expiration or termination of the applicable waiting period under the HSR Act
(and any extension thereof under the HSR Act) and all regulatory authorizations, consents, clearances, orders, approvals or expirations of applicable waiting periods set forth on Section&nbsp;1.1(c) of the Parent Disclosure Schedule. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(136) &#147;<U>Securities Act</U>&#148; means the Securities Act of 1933, as amended. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(137) &#147;<U>Separation and Distribution Agreement</U>&#148; means that Separation and Distribution Agreement, dated as of the date hereof,
by and among the Company, Parent and SpinCo, attached as <U>Exhibit A</U> to this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(138) &#147;<U>Software</U>&#148; has the
meaning set forth in the Separation and Distribution Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(139) &#147;<U>SpinCo Affiliate Contract</U>&#148; means any Contract,
whether or not in writing, (a)&nbsp;between any SpinCo Entity, on the one hand, and any present or former officer or director of the SpinCo Entities or &#147;immediate family member&#148; thereof (as defined in Rule
<FONT STYLE="white-space:nowrap">16a-1</FONT> under the Exchange Act), on the other hand, or (b)&nbsp;between any SpinCo Entity, on the one hand, and the Company and/or any of its Subsidiaries (other than a SpinCo Entity), on the other hand. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(140) &#147;<U>SpinCo Assets</U>&#148; has the meaning set forth in the Separation and Distribution Agreement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-18- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(141) &#147;<U>SpinCo Benefit Plan</U>&#148; has the meaning set forth in the Employee
Matters Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(142) &#147;<U>SpinCo Business</U>&#148; has the meaning set forth in the Separation and Distribution Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(143) &#147;<U>SpinCo Common Stock</U>&#148; means the common stock, par value $0.001 per share, of SpinCo. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(144) &#147;<U>SpinCo Contract</U>&#148; has the meaning set forth in the Separation and Distribution Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(145) &#147;<U>SpinCo Datasite</U>&#148; means the datasite established by the Company for purposes of due diligence of the SpinCo Entities
and the SpinCo Business. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(146) &#147;<U>SpinCo Disclosure Schedule</U>&#148; means the Disclosure Schedule delivered by the Company and
SpinCo to Parent on the date hereof and identified as such. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(147) &#147;<U>SpinCo Entities</U>&#148; means SpinCo and the SpinCo
Subsidiaries, after giving effect to (or assuming the effect of, as applicable) the Internal Reorganization. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(148) &#147;<U>SpinCo
Employee</U>&#148; has the meaning set forth in the Employee Matters Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(149) &#147;<U>SpinCo Equity Award</U>&#148; has the
meaning set forth in the Employee Matters Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(150) &#147;<U>SpinCo Financial Statements</U>&#148; means, collectively, the draft,
combined statements of operations of the SpinCo Business for the fiscal years ended December&nbsp;31, 2019, December&nbsp;31, 2020 and December&nbsp;31, 2021, and the draft, combined balance sheets of the SpinCo Business for the fiscal years ended
December&nbsp;31, 2020 and December&nbsp;31, 2021, attached to Section&nbsp;5.9 of the SpinCo Disclosure Schedules. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(151) &#147;<U>SpinCo
IT Systems</U>&#148; means all IT Assets owned, leased or used by or on behalf of (i)&nbsp;as of the date hereof, the Company or any of its Subsidiaries with respect to the SpinCo Business, and (ii)&nbsp;as of the Distribution, any of the SpinCo
Entities, including, in each case, all IT Assets included in the SpinCo Assets. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(152) <U>&#147;</U><U>SpinCo Independent
Contractor</U>&#148; has the meaning set forth in the Employee Matters Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(153) &#147;<U>SpinCo Licensed Intellectual
Property</U>&#148; means all Intellectual Property licensed from a third party pursuant to a written Contract to, (a)&nbsp;as of the date hereof, the Company or any of its Subsidiaries with respect to the SpinCo Business, and (b)&nbsp;as of the
Distribution, any of the SpinCo Entities, that, in each case of clauses (a)&nbsp;and (b), is used, practiced or held for use or practice by or on behalf of (i)&nbsp;as of the date hereof, the Company or any of its Subsidiaries with respect to the
SpinCo Business, and (ii)&nbsp;as of the Distribution, any of the SpinCo Entities. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-19- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(154) &#147;<U>SpinCo Material Adverse Effect</U>&#148; means any Effect that (a)&nbsp;has,
or would reasonably be expected to have, individually or in the aggregate with any other Effects, a material adverse effect on the business, financial condition or results of operations of the SpinCo Business, taken as a whole; <U>provided</U>, that
none of the following shall be deemed in themselves, either alone or in combination, to constitute, and none of the following shall be taken into account in determining whether there has been or would reasonably be expected to be, individually or in
the aggregate, a SpinCo Material Adverse Effect for purposes of this clause (a): (i) any changes resulting from general market, economic, financial, capital markets or regulatory conditions, (ii)&nbsp;any general changes<B> </B>in the credit, debt,
financial or capital markets or changes in interest or exchange rates, (iii)&nbsp;any changes in applicable Law or GAAP (or, in each case, authoritative interpretations thereof), (iv)&nbsp;any changes resulting from any natural disaster, including
any hurricane, storm, flood, tornado, volcanic eruption, earthquake, other weather-related events, or other comparable events, or any worsening thereof, (v)&nbsp;any changes resulting from local, national or international political conditions,
including the outbreak or escalation of any military conflict, declared or undeclared war, armed hostilities, acts of foreign or domestic terrorism or civil unrest, (vi)&nbsp;any changes generally affecting the industries in which the SpinCo
Entities conduct their businesses, (vii)&nbsp;any changes directly resulting from the execution of this Agreement or the Separation and Distribution Agreement or the announcement or the pendency of the Merger or the Separation, including actions of
suppliers, landlords, distributors, partners or Governmental Authorities and any loss of employees, relationships or customers resulting from the transactions contemplated by this Agreement (<U>provided</U>, that this clause (vii)&nbsp;shall not
apply to any representation or warranty to the extent the purpose of such representation or warranty is to address, as applicable, the consequences resulting from the execution of this Agreement or the Separation and Distribution Agreement or the
announcement or the pendency of the Merger or the Separation), (viii) any changes resulting from any action required to be taken by the terms of this Agreement (other than the first sentence of <U>Section</U><U></U><U>&nbsp;7.2)</U> or at the
request or direction of Parent or Merger Sub, (ix)&nbsp;the failure to meet any internal or analysts&#146; expectations, projections or results of operations (but not, in each case, the underlying cause of any such changes, unless such underlying
cause would otherwise be excepted by another clause of this definition), or (x)&nbsp;any changes resulting from any epidemics, pandemics or disease (including <FONT STYLE="white-space:nowrap">COVID-19</FONT> or any
<FONT STYLE="white-space:nowrap">COVID-19</FONT> Measures or any change in <FONT STYLE="white-space:nowrap">COVID-19</FONT> Measures following the date hereof); <U>provided</U>, that in the case of clauses (i), (ii), (iii), (iv), (v), (vi) and (x),
if such Effect disproportionately impacts the SpinCo Entities or the SpinCo Business, taken as a whole, as compared to other participants in similar industries to the industries in which the SpinCo Business operates, the incremental disproportionate
impact thereof may be taken into account in determining whether a SpinCo Material Adverse Effect has occurred or would reasonably be expected to occur; or (b)&nbsp;has, or would reasonably be expected to, individually or in the aggregate, materially
impair or materially delay the ability of SpinCo to perform its obligations hereunder or under the Separation and Distribution Agreement, or to consummate the Transactions, including the Merger and the Separation, or prevent it from performing such
obligations or consummating the Transactions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(155) &#147;<U>SpinCo Merger Tax Representations</U>&#148; means the representations of an
officer of SpinCo, dated as of the Closing Date, in form and substance reasonably satisfactory to LW and Weil, delivered to LW and Weil in connection with the Merger Tax Opinions. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-20- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(156) &#147;<U>SpinCo Option</U>&#148; has the meaning given to such term in the Employee
Matters Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(157) &#147;<U>SpinCo Owned Intellectual Property</U>&#148; means all Intellectual Property owned or purported to be
owned by any of the SpinCo Entities as of the Distribution, including the SpinCo Intellectual Property (as defined in the Separation and Distribution Agreement). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(158) &#147;<U>SpinCo Products</U>&#148; means any investigational animal created, used, provided, or otherwise made available by or on behalf
of the SpinCo Business, and any antibodies or other products derived from such animals by the SpinCo Business; <U>provided</U>, that &#147;SpinCo Products&#148; shall not include any such products or product candidates to the extent developed,
tested, marketed, manufactured, advertised, promoted or commercialized by customers of the SpinCo Business, in each case, that are not proprietary to, or owned or purported to be owned by, (i)&nbsp;as of the date hereof, the Company or any of its
Subsidiaries with respect to the SpinCo Business, or (ii)&nbsp;as of the Distribution, any of the SpinCo Entities. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(159) &#147;<U>SpinCo
PSU Award</U>&#148; has the meaning given to such term in the Employee Matters Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(160) &#147;<U>SpinCo Registration
Statement</U>&#148; means the registration statement on Form 10 to be filed by SpinCo with the SEC to effect the registration under the Exchange Act of the shares of SpinCo Common Stock in connection with the Distribution, as such registration
statement may be amended or supplemented from time to time prior to the Distribution Time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(161) &#147;<U>SpinCo RSU Award</U>&#148; has
the meaning given to such term in the Employee Matters Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(162) &#147;<U>SpinCo Service Provider</U>&#148; has the meaning given
to such term in the Employee Matters Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(163) &#147;<U>SpinCo Subsidiaries</U>&#148; means all direct and indirect Subsidiaries
of SpinCo, after giving effect to the Internal Reorganization. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(164) &#147;<U>Sponsor</U>&#148; means Avista Acquisition LP II, a Cayman
Islands exempted limited partnership and an Affiliate of Parent. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(165) &#147;<U>Sponsor Insider Agreement</U>&#148; has the meaning set
forth in the Recitals. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(166) &#147;<U>Subsidiary</U>&#148; means, with respect to any Person, a corporation or other entity of which more
than 50% of the voting power of the equity securities or Interests that by their terms have ordinary voting power to elect a majority of the board of directors or other similar body is owned or controlled, directly or indirectly, by such Person, or
any organization of which such Person or any of its Subsidiaries is, directly or indirectly, a general partner or managing member or holds a similar role. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(167) &#147;<U>Tax Matters Agreement</U>&#148; has the meaning set forth in the Separation and Distribution Agreement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-21- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(168) &#147;<U>Tax Returns</U>&#148; has the meaning set forth in the Tax Matters Agreement.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(169) &#147;<U>Taxes</U>&#148; has the meaning set forth in the Tax Matters Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(170) &#147;<U>Trade Secret</U>&#148; has the meaning set forth in the Separation and Distribution Agreement). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(171) &#147;<U>Trademark</U>&#148; has the meaning set forth in the Separation and Distribution Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(172) &#147;<U>Transaction Documents</U>&#148; means the Separation and Distribution Agreement, the Employee Matters Agreement, the Tax
Matters Agreement, the Transition Services Agreements, the A&amp;R Forward Purchase Agreement, the Sponsor Insider Agreement and the A&amp;R Registration Rights Agreement, in each case, including all annexes, Exhibits, Schedules, attachments and
appendices thereto, and any certificate or other instrument delivered by any Party to any other Party pursuant to this Agreement or any of the foregoing. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(173) &#147;<U>Transaction Process</U>&#148; means all matters relating to the separation, disposition or sale of the SpinCo Business and the
review of strategic alternatives with respect to the SpinCo Business (including the potential <FONT STYLE="white-space:nowrap">spin-off</FONT> of the SpinCo Business), including matters relating to (a)&nbsp;the solicitation of proposals from and
negotiations with third parties in connection with the disposition or sale of the SpinCo Business or SpinCo Assets or (b)&nbsp;the drafting, negotiation or interpretation of any of the provisions of this Agreement or the other Transaction Documents,
or the determination of the allocation of any assets or Liabilities pursuant to the foregoing agreements or the transactions contemplated thereby. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(174) &#147;<U>Transactions</U>&#148; shall mean the Domestication, the Separation, the Distribution, the Merger and the other transactions
contemplated by this Agreement and the Transaction Documents. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(175) &#147;<U>Transition Services Agreements</U>&#148; has the meaning set
forth in the Separation and Distribution Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(176) &#147;<U>Treasury Regulations</U>&#148; means the regulations promulgated by
the U.S. Treasury Department under the Code. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(177) &#147;<U>Trust Amount</U>&#148; means the amount of cash available in the Trust
Account following the Parent Shareholders Meeting, after deducting the amount required to satisfy the Parent Share Redemption Amount (prior to payment of any unpaid transaction expenses). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(178) &#147;<U>Warrant Agreement</U>&#148; means the Warrant Agreement, dated as of August&nbsp;9, 2021, between Parent and Continental Stock
Transfer&nbsp;&amp; Trust Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(179) &#147;<U>Weil</U>&#148; means Weil, Gotshal&nbsp;&amp; Manges LLP. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(180) &#147;<U>Willful Breach</U>&#148; means, with respect to any obligation, covenant or agreement of a Party in this Agreement, any
material breach of or material failure to perform such obligation, covenant or agreement that such Party intentionally takes (or intentionally fails to take or perform) with actual knowledge that such action or omission or failure to perform would,
or would reasonably be expected to, cause or result in a material breach of this Agreement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-22- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(181) &#147;<U>Working Capital Loans</U>&#148; means any loan made to Parent by any of the
Sponsor, any Affiliate of the Sponsor, or any of Parent&#146;s officers or directors, and evidenced by a promissory note, for the purpose of financing working capital or costs incurred in connection with a Business Combination. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;1.2 <U>Cross References</U>. Each of the following terms is defined in the Section set forth opposite such term: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="82%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="16%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Term</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Section</B></P></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">A&amp;R Registration Rights Agreement</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Recitals</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Antitrust Division</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Section&nbsp;7.6(b)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Certificate of Merger</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Section&nbsp;2.3(d)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Chosen Courts</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Section&nbsp;10.3</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">CICA</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Recitals</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Class&nbsp;A Merger Consideration</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Section&nbsp;3.1(a)(i)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Closing</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Section&nbsp;2.2</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Closing Date</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Section&nbsp;2.2</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">COBRA</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Section&nbsp;5.18(h)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Company</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Preamble</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Company Board</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Recitals</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Company Distribution Tax Opinion</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Section&nbsp;7.3(b)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Company Group</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Section&nbsp;10.14(b)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">DGCL</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Recitals</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Distribution</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Recitals</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Distribution Documents</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Section&nbsp;5.23</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Domesticated Parent Common Stock</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Recitals</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Domesticated Parent Warrant</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Recitals</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Domestication</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Recitals</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Effective Time</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Section&nbsp;2.3(d)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Evaluation Material</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Section&nbsp;10.2</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Exchange Agent</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Section&nbsp;3.2(b)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Exchange Agent Agreement</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Section&nbsp;3.2(b)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Exchange Fund</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Section&nbsp;3.2(b)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">FTC</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Section&nbsp;7.6(b)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Government Contract</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Section&nbsp;5.15(a)(xiv)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Interim Period</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Section&nbsp;7.1</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Investment</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Section&nbsp;6.3(f)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">JOBS Act</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Section&nbsp;6.6(a)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Merger</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Recitals</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Merger Consideration</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Section&nbsp;3.1(a)(i)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Merger Sub</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Preamble</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Merger Sub Common Stock</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Section&nbsp;3.1(a)(vi)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Merger Sub Shareholder Approval</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Section&nbsp;7.21</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Modification in Recommendation</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Section&nbsp;7.5</TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-23- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="82%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="16%"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Term</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Section</B></P></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Outside Date</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Section&nbsp;9.1(b)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Parent</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Preamble</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Parent Board</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Recitals</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Parent Board Recommendation</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Recitals</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Parent Bylaws</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Section&nbsp;7.15</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Parent Charter</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Section&nbsp;7.15</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Parent Domestication Tax Opinion</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Section&nbsp;7.3(d)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Parent SEC Filings</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Section&nbsp;6.13</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Parent Securities</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Section&nbsp;6.3(a)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Parent Shareholders Meeting</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Section&nbsp;7.4(e)(i)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Parent Units</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Recitals</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Party</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Preamble</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Personnel IP Contract</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Section&nbsp;5.19(h)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Prospectus</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Section&nbsp;10.1</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Remedies Exception</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Section&nbsp;4.2</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">SpinCo</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Preamble</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">SpinCo Board</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Recitals</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">SpinCo CBA</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Section&nbsp;5.16(c)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">SpinCo Material Contracts</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Section&nbsp;5.15(a)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">SpinCo Proposal</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Section&nbsp;7.9(a)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">SpinCo Real Property Lease</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Section&nbsp;5.15(a)(ix)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">SpinCo Registered Intellectual Property</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Section&nbsp;5.19(a)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">SpinCo Shareholder Approval</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Section&nbsp;5.24</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">SpinCo Voting Debt</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Section&nbsp;5.3(b)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Sponsor Insider Agreement</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Recitals</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Subsequent Audited Annual SpinCo Financial Statements</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Section&nbsp;7.22(a)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Subsequent Period SpinCo Financial Statements</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Section&nbsp;7.22(a)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Subsequent Unaudited SpinCo Financial Statements</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Section&nbsp;7.22(a)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Surviving Corporation</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Section&nbsp;2.1</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><FONT STYLE="white-space:nowrap">Tax-Free</FONT> Status</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Section&nbsp;7.3(a)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Transaction Litigation</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Section&nbsp;7.11</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Transaction Proposals</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Section&nbsp;7.4(e)(ii)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Trust Account</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Section&nbsp;10.1</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Unpaid Transaction Expenses</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Section&nbsp;2.3(c)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">WARN</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">Section&nbsp;5.16(e)</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;1.3 <U>Interpretation</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Unless the context of this Agreement otherwise requires: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) (a)&nbsp;words of any gender include each other gender and neuter form; (b)&nbsp;words using the singular or plural number
also include the plural or singular number, respectively; (c)&nbsp;derivative forms of defined terms will have correlative meanings; (d)&nbsp;the terms &#147;hereof,&#148; &#147;herein,&#148; &#147;hereby,&#148; &#147;hereto,&#148;
&#147;herewith,&#148; &#147;hereunder&#148; and derivative or similar words refer to this entire Agreement; (e)&nbsp;the terms &#147;Article,&#148; &#147;Section,&#148; &#147;Annex,&#148; &#147;Exhibit,&#148; &#147;Schedule,&#148; and
&#147;Disclosure Schedule&#148; refer to the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-24- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
specified Article, Section, Annex, Exhibit, Schedule or Disclosure Schedule of this Agreement and references to &#147;paragraphs&#148; or &#147;clauses&#148; shall be to separate paragraphs or
clauses of the Section or subsection in which the reference occurs; (f)&nbsp;the words &#147;include,&#148; &#147;includes&#148; and &#147;including&#148; shall be deemed to be followed by the phrase &#147;without limitation&#148;; and (g)&nbsp;the
word &#147;or&#148; shall be disjunctive but not exclusive; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) any Law defined or referred to in this Agreement or in
any agreement or instrument that is referred to herein means such Law as from time to time amended, modified or supplemented, including (in the case of statutes) by succession of comparable successor Laws and the related regulations thereunder and
published interpretations thereof, and references to any Contract or instrument are to that Contract or instrument as from time to time amended, modified or supplemented; <U>provided</U>, that for purposes of any representations and warranties
contained in this Agreement that are made as of a specific date or dates, references to any Law shall be deemed to refer to such Law, as amended, and the related regulations thereunder and published interpretations thereof, in each case, as of such
date or dates. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iii) references to any federal, state, local, or foreign statute or Law shall include all regulations
promulgated thereunder; and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iv) references to any Person include references to such Person&#146;s successors and
permitted assigns, and in the case of any Governmental Authority, to any Person succeeding to its functions and capacities. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) The
language used in this Agreement shall be deemed to be the language chosen by the Parties to express their mutual intent. The Parties acknowledge that each Party and its attorney has reviewed and participated in the drafting of this Agreement and
that any rule of construction to the effect that any ambiguities are to be resolved against the drafting Party, or any similar rule operating against the drafter of an agreement, shall not be applicable to the construction or interpretation of this
Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Nothing herein (including the SpinCo Disclosure Schedule, Company Disclosure Schedule and the Parent Disclosure Schedule)
shall be deemed an admission by any Party or any of its Affiliates, in any Action, that such Party or any such Affiliate, or any third party, is or is not in breach or violation of, or in default in, the performance or observance of any term or
provisions of any Contract or any Law. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) Whenever this Agreement refers to a number of days, such number shall refer to calendar days
unless Business Days are specified. If any action is to be taken or given on or by a particular calendar day, and such calendar day is not a Business Day, then such action may be deferred until the next Business Day. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) When calculating the period of time before which, within which or following which any act is to be done or step taken pursuant to this
Agreement, the date that is the reference date in calculating such period shall be excluded and if the last day of such period is not a Business Day, the period shall end on the next succeeding Business Day. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-25- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) The phrase &#147;to the extent&#148; shall mean the degree to which a subject or other
thing extends, and such phrase shall not mean simply &#147;if.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) The term &#147;writing,&#148; &#147;written&#148; and comparable
terms refer to printing, typing and other means of reproducing words (including electronic media) in a visible form. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h) All accounting
terms used herein and not expressly defined herein shall have the meanings given to them under GAAP, unless the context otherwise requires. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) All monetary figures shall be in United States dollars unless otherwise specified. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(j) No reference in this Agreement to dollar amount thresholds shall be deemed to be evidence of a SpinCo Material Adverse Effect, Company
Material Adverse Effect or Parent Material Adverse Effect, as applicable, or materiality. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(k) The phrases &#147;furnished,&#148;
&#147;provided,&#148; &#147;delivered&#148; or &#147;made available&#148; when used with respect to information or documents means that such information or documents have been (i)&nbsp;physically or electronically delivered to the relevant Party
(and includes such information or documents that have been furnished to its Representatives acting on its behalf or posted to the SpinCo Datasite) or (ii)&nbsp;are otherwise Parent SEC Reports or Company SEC Reports and made publicly available on
the SEC&#146;s EDGAR website by Parent or the Company, as applicable, in each case, not later than forty eight hours prior to the execution of this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ARTICLE&nbsp;II </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">THE MERGER </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.1 <U>The Merger</U>. At the Effective Time and upon the terms and subject to the conditions of this Agreement, Merger Sub shall
be merged with and into SpinCo in accordance with the applicable provisions of the DGCL, the separate existence of Merger Sub shall cease and SpinCo shall continue as the surviving corporation of the Merger (sometimes referred to herein as the
&#147;<U>Surviving Corporation</U>&#148;) and shall succeed to and assume all the rights, powers and privileges and be subject to all of the obligations of Merger Sub in accordance with the DGCL. As a result of the Merger, SpinCo shall become a
direct, wholly owned Subsidiary of Parent. References herein to &#147;SpinCo&#148; with respect to the period from and after the Effective Time shall be deemed to be references to the Surviving Corporation. At the Effective Time, the effects of the
Merger shall be as provided in this Agreement, the Certificate of Merger and the applicable provisions of the DGCL. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.2
<U>Closing</U>. Unless the Transactions shall have been abandoned and this Agreement terminated pursuant to <U>Section</U><U></U><U>&nbsp;9.1</U>, the closing of the Merger (the &#147;<U>Closing</U>&#148;) shall take place at 10:00 a.m., New York
City time, on the third Business Day after the conditions set forth in <U>Article VIII</U> (other than those, including the Distribution, that are to be satisfied at or immediately prior to the Closing, but subject to the satisfaction or, to the
extent permitted by applicable Law, waiver of such conditions at the Closing) have been satisfied or, to the extent permitted by applicable Law, waived, by electronic exchange of documents and signatures or at the offices of Weil, Gotshal&nbsp;&amp;
Manges LLP, 767 Fifth Avenue, New York, New York 10153, unless another date, time or place is agreed to in writing by the Company and Parent. The date on which the Closing actually occurs is hereinafter referred to as the &#147;<U>Closing
Date</U>.&#147; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-26- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.3 <U>Closing Deliverables; Effective Time</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) At the Closing, the Company or SpinCo, as applicable, will deliver or cause to be delivered: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) to Parent, a certificate signed by an authorized officer of the Company, dated as of the Closing Date, certifying that, to
the knowledge and belief of such authorized officer, the conditions specified in <U>Section</U><U></U><U>&nbsp;8.3(a)</U>, <U>(b)</U>, <U>(c)</U>, and <U>(e)</U>&nbsp;have been satisfied; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) to Parent, the A&amp;R Registration Rights Agreement, duly executed by the parties set forth on Section&nbsp;2.3(a)(ii) of
the Company Disclosure Schedule; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iii) to Parent, a certificate on behalf of SpinCo, prepared in a manner consistent and
in accordance with the requirements of Treasury Regulations Sections <FONT STYLE="white-space:nowrap">1.897-2(g),</FONT> (h) and <FONT STYLE="white-space:nowrap">1.1445-2(c)(3),</FONT> certifying that no interest in the Company is, or has been
during the relevant period specified in Section&nbsp;897(c)(1)(A)(ii) of the Code, a &#147;U.S. real property interest&#148; within the meaning of Section&nbsp;897(c) of the Code, and a form of notice to the Internal Revenue Service prepared in
accordance with the provisions of Treasury Regulations <FONT STYLE="white-space:nowrap">Section&nbsp;1.897-2(h)(2),</FONT> together with written authorization for Parent to deliver such documentation to the Internal Revenue Service on behalf of
SpinCo after the Closing; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iv) to Parent, copies of resolutions and actions taken by the Company&#146;s and SpinCo&#146;s
board of directors and stockholders in connection with the approval of this Agreement and the Transactions; and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(v) to
Parent, all other documents, instruments or certificates required to be delivered by the Company at or prior to the Closing pursuant to <U>Section</U><U></U><U>&nbsp;8.3</U>. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-27- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) At the Closing, Parent will deliver or cause to be delivered: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) to the Exchange Agent, the shares of Domesticated Parent Stock to be paid in respect of shares of SpinCo Common Stock in
accordance with <U>Section</U><U></U><U>&nbsp;3.1(a)</U>, for further distribution to such holders pursuant to <U>Section</U><U></U><U>&nbsp;3.2</U>; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) to the Company, a certificate signed by an authorized officer of Parent, dated the Closing Date, certifying that, to the
knowledge and belief of such authorized officer, the conditions specified in <U>Section</U><U></U><U>&nbsp;8.1(f)</U> and <U>Section</U><U></U><U>&nbsp;8.2(a)</U>, <U>(b)</U> and <U>(d)</U>&nbsp;have been satisfied; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iii) to the Company, the A&amp;R Registration Rights Agreement, duly executed by a duly authorized representative of Parent
and the Sponsor; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iv) to the Company, the written resignations of all of the directors and officers of Parent (other than
those Persons identified as the initial directors and officers, respectively, of Parent after the Effective Time, in accordance with the provisions of <U>Section</U><U></U><U>&nbsp;2.5</U>), effective as of the Effective Time; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(v) to the Company, copies of resolutions and actions taken by Parent&#146;s and Merger Sub&#146;s board of directors and
stockholders (or managers, as applicable) in connection with the approval of this Agreement and the Transactions; and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(vi)
to the Company, all other documents, instruments or certificates required to be delivered by Parent at or prior to the Closing pursuant to <U>Section</U><U></U><U>&nbsp;8.2</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) On the Closing Date, concurrently with the Effective Time, Parent shall pay or cause to be paid by wire transfer of immediately available
funds, all accrued transaction expenses of Parent and those incurred, accrued, paid or payable by Parent&#146;s Affiliates on Parent&#146;s behalf as set forth on a written statement to be delivered to the Company not less than two (2)&nbsp;Business
Days prior to the Closing Date (&#147;<U>Unpaid Transaction Expenses</U>&#148;), which shall include the respective amounts and wire transfer instructions for the payment thereof, together with corresponding invoices for the foregoing.<SUP
STYLE="font-size:85%; vertical-align:top"> </SUP> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) On the Closing Date, SpinCo and Merger Sub shall file a certificate of merger
relating to the Merger (the &#147;<U>Certificate of Merger</U>&#148;) with the Secretary of State of the State of Delaware in accordance with the relevant provisions of the DGCL and shall make all other filings or recordings required under the DGCL.
The Merger shall become effective at the time the Certificate of Merger shall have been duly filed with the Secretary of State of the State of Delaware, or such later time as Parent and SpinCo shall agree and specify in the Certificate of Merger
(such time as the Merger becomes effective being the &#147;<U>Effective Time</U>&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) For the avoidance of doubt, the Closing and
the Effective Time shall occur no sooner than the date that is the day after the completion of the Domestication. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.4
<U>Certificate of Incorporation and Bylaws of the Surviving Corporation; Directors and Officers of the Surviving Corporation</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) The
certificate of incorporation of Merger Sub in effect immediately prior to the Effective Time shall be the certificate of incorporation of the Surviving Corporation until amended in accordance with applicable Law, except the name of the Surviving
Corporation shall be as provided in <U>Section</U><U></U><U>&nbsp;2.4(b)</U> and the reference to the incorporator shall be deleted. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-28- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) The bylaws of Merger Sub in effect immediately prior to the Effective Time shall be the
bylaws of the Surviving Corporation until amended in accordance with applicable Law, except the name of the Surviving Corporation shall be such name as selected by SpinCo in its absolute discretion. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) From and after the Effective Time, until successors are duly elected or appointed and qualified in accordance with applicable Law,
(i)&nbsp;the directors of SpinCo as of immediately prior to the Effective Time shall be the directors of the Surviving Corporation and (ii)&nbsp;the officers of SpinCo as of immediately prior to the Effective Time shall be the officers of the
Surviving Corporation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.5 <U>Governance Matters</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) The Parties shall use reasonable best efforts to ensure that the individuals listed on Section&nbsp;2.5(a) of the Company Disclosure
Schedule are nominated and elected as directors of Parent effective immediately after the Closing, and the identities of such individuals shall be made publicly available as promptly as practicable following the date hereof (but in any event prior
to the date on which the Parent Registration Statement is filed with the SEC in definitive form). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Subject to the terms of
Parent&#146;s Governing Documents, Parent shall take all such action within its power as may be necessary or appropriate such that immediately following the Effective Time (i)&nbsp;the Parent Board shall have a majority of &#147;independent&#148;
directors for purposes of NASDAQ and (ii)&nbsp;the initial officers of Parent shall be as set forth on Section&nbsp;2.5(b) of the Company Disclosure Schedule, in each case, each of whom shall serve in such capacity in accordance with the terms of
Parent&#146;s Governing Documents following the Effective Time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ARTICLE&nbsp;III </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">CONVERSION OF SHARES </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.1 <U>Effect on Capital Stock</U>. At the Effective Time, by virtue of the Merger and without any action on the part of any
party to this Agreement or any holder of the capital stock of the Company, SpinCo, Merger Sub or Parent: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <I>SpinCo Common Stock and
Merger Sub Common Stock</I>. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) Each share of SpinCo Common Stock issued and outstanding as of immediately prior to the
Effective Time (other than shares canceled in accordance with <U>Section</U><U></U><U>&nbsp;3.1(a)(ii))</U> shall be automatically converted into the right to receive (A)&nbsp;a number of fully paid and
<FONT STYLE="white-space:nowrap">non-assessable</FONT> shares of Domesticated Parent Common Stock equal to the Base Exchange Ratio, subject to adjustment in accordance with <U>Section</U><U></U><U>&nbsp;3.1(a)(iv)</U>, with cash paid in lieu of
fractional shares of Domesticated Parent Common Stock in accordance with <U>Section</U><U></U><U>&nbsp;3.2(e)</U> (the &#147;<U>Class</U><U></U><U>&nbsp;A Merger Consideration</U>&#148;) and (B)&nbsp;a number of fully paid and <FONT
STYLE="white-space:nowrap">non-assessable</FONT> Earnout Shares equal to the Earnout Exchange Ratio, subject to adjustment in accordance with <U>Section</U><U></U><U>&nbsp;3.1(a)(iv)</U> (together with the Class&nbsp;A Merger Consideration, the
&#147;<U>Merger Consideration</U>&#148;). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-29- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) Each share of SpinCo Common Stock held by SpinCo as treasury stock or
by Parent or Merger Sub, in each case, as of immediately prior to the Effective Time shall automatically be canceled and shall cease to exist and no stock or other consideration shall be issued or delivered in exchange therefor or in respect
thereof. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iii) Each share of SpinCo Common Stock issued and outstanding as of immediately prior to the Effective Time,
when converted in accordance with this <U>Section</U><U></U><U>&nbsp;3.1</U>, shall no longer be outstanding and shall automatically be canceled and shall cease to exist, and each holder of such shares shall cease to have any rights with respect
thereto, except the right to receive the Merger Consideration as provided in <U>Section</U><U></U><U>&nbsp;3.1(a)(i)</U> and any dividends or distributions and other amounts payable in accordance with <U>Section</U><U></U><U>&nbsp;3.2(d)</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iv) The Base Exchange Ratio and the Earnout Exchange Ratio shall be adjusted to the extent appropriate to reflect the effect
of any stock split, <FONT STYLE="white-space:nowrap">split-up,</FONT> reverse stock split, stock dividend or distribution of Parent Common Stock, or securities convertible into any such securities, reorganization, recapitalization, reclassification
or other like change (any such change, an &#147;<U>Equity Adjustment</U>&#148;) with respect to Parent Common Stock having a record date occurring on or after the date of this Agreement and prior to the Effective Time; <U>provided</U>, that nothing
in this <U>Section</U><U></U><U>&nbsp;3.1(a)(iv)</U> shall be construed to permit Parent to take or to permit any of its Subsidiaries to take any action with respect to its securities that is prohibited by the terms of this Agreement. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(v) If the conditions set forth in <U>Section</U><U></U><U>&nbsp;8.2(h)</U> would be unable to be satisfied because immediately
after the Effective Time, the percentage of outstanding shares of Domesticated Parent Common Stock to be received by the former holders of SpinCo Common Stock with respect to Qualified SpinCo Common Stock would be less than 50.1% (the
&#147;<U>Threshold Percentage</U>&#148;) of all of the stock of Parent (excluding Earnout Shares and, including (i)&nbsp;any other instruments that are treated as stock for U.S. federal income Tax purposes; and (ii)&nbsp;any other stock that may be
issued after the Effective Time that may be regarded as having been acquired or issued as part of a &#147;plan&#148; of which the Distribution is a part within the meaning of Section&nbsp;355(e) of the Code), then (x)&nbsp;SpinCo shall promptly
provide notice to Parent setting forth in detail the reasons the condition set forth in <U>Section</U><U></U><U>&nbsp;8.2(h)</U> would be unable to be satisfied, (y)&nbsp;SpinCo shall consider in good faith any comments provided by Parent,
(z)&nbsp;(A) at the Company&#146;s sole option, the Company may contribute the necessary additional capital to SpinCo to increase, <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">dollar-for-dollar,</FONT></FONT> the <FONT
STYLE="white-space:nowrap">pre-money</FONT> equity valuation of SpinCo and, in such event, the Aggregate Common Consideration Shares, the Base Exchange Ratio and the aggregate number of shares of Domesticated Parent Common Stock into which the
shares of SpinCo Common Stock are converted pursuant to this <U>Section</U><U></U><U>&nbsp;3.1</U> shall be increased to take into account such additional capital contribution such that the number of shares of Domesticated Parent Common Stock to be
received by the former holders of SpinCo Common Stock with respect to Qualified SpinCo Common Stock equals the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-30- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
Threshold Percentage, or (B)&nbsp;if the Company does not elect to make the capital contribution in clause (A), at Parent&#146;s sole option, Parent may elect to increase, with no additional
capital contribution by the Company, the aggregate number of shares of Domesticated Parent Common Stock into which the shares of SpinCo Common Stock are converted pursuant to this <U>Section</U><U></U><U>&nbsp;3.1,</U> such that the number of shares
of Domesticated Parent Common Stock to be received by the former holders of SpinCo Common Stock with respect to Qualified SpinCo Common Stock equals the Threshold Percentage. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(vi) At the Effective Time, all of the shares of common stock, par value $0.01 per share, of Merger Sub (&#147;<U>Merger Sub
Common Stock</U>&#148;) issued and outstanding immediately prior to the Effective Time shall be automatically converted into one fully paid and nonassessable share of common stock, par value $0.01 per share, of the Surviving Corporation. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <I>Parent Securities</I>. Each share of Domesticated Parent Stock and each Domesticated Parent Warrant that is issued and outstanding
immediately prior to and at the Effective Time shall remain outstanding immediately following the Effective Time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.2
<U>Surrender and Payment</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Pursuant to Section&nbsp;3.2 of the Separation and Distribution Agreement, the Exchange Agent shall
hold, for the account of the relevant SpinCo stockholders, book-entry shares representing all of the outstanding shares of SpinCo Common Stock distributed in the Distribution. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Prior to the Effective Time, Parent shall designate a nationally recognized commercial bank or trust company reasonably acceptable to the
Company to act as agent (the &#147;<U>Exchange Agent</U>&#148;) for the benefit of the holders of shares of SpinCo Common Stock and SpinCo Equity Awards whose shares of SpinCo Common Stock and/or SpinCo Equity Awards are exchanged in accordance with
this <U>Section</U><U></U><U>&nbsp;3.2(b),</U> <U>Section</U><U></U><U>&nbsp;3.3</U> or <U>Section</U><U></U><U>&nbsp;3.5</U>. At or substantially concurrently with the Effective Time, Parent shall deposit, or shall cause to be deposited, with the
Exchange Agent, for the benefit of the holders of shares of SpinCo Common Stock and/or SpinCo Equity Awards, for exchange in accordance with this <U>Section</U><U></U><U>&nbsp;3.2(b)</U>, <U>Section</U><U></U><U>&nbsp;3.3</U> or
<U>Section</U><U></U><U>&nbsp;3.5</U> promptly after the Effective Time, book-entry shares representing (i)&nbsp;the Merger Consideration issuable to holders of shares of SpinCo Common Stock as of immediately prior to the Effective Time pursuant to
<U>Section</U><U></U><U>&nbsp;3.1(a)(i)</U> and/or (ii)&nbsp;the Earnout Shares issuable to holders of SpinCo Equity Awards immediately prior to the Effective Time pursuant to <U>Section</U><U></U><U>&nbsp;3.3</U> and
<U>Section</U><U></U><U>&nbsp;3.5</U> (in the case of each of clauses (i)&nbsp;and (ii), without duplication) (such book-entry shares of Domesticated Parent Stock, together with any cash received by the Exchange Agent in respect of dividends or
distributions with respect thereto pursuant to <U>Section</U><U></U><U>&nbsp;3.2(d)</U>, as applicable, and other amounts payable in accordance with <U>Section</U><U></U><U>&nbsp;3.2(e)</U>, the &#147;<U>Exchange Fund</U>&#148;). The Exchange Agent
shall, following the Effective Time, pursuant to irrevocable instructions from Parent, deliver the Merger Consideration to be issued pursuant to this <U>Article</U><U></U><U>&nbsp;III</U> out of the Exchange Fund. The cash portion, if any, of the
Exchange Fund shall be invested by the Exchange Agent as directed by Parent; <U>provided</U>, that (i)&nbsp;no such investment of or losses thereon shall relieve Parent from making or causing to be made the
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-31- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
payments required by this <U>Section</U><U></U><U>&nbsp;3.2</U> or elsewhere in this <U>Article</U><U></U><U>&nbsp;III</U>, or affect the amount payable in respect of the shares of SpinCo Common
Stock and/or SpinCo Equity Awards outstanding as of immediately prior to the Effective Time, (ii)&nbsp;to the extent the Exchange Fund is insufficient at any time to make such payments, Parent shall promptly provide additional funds to the Exchange
Agent in the amount of any such deficiency and (iii)&nbsp;no such investment shall have maturities that would reasonably be expected to prevent or delay the payments to be made pursuant to this <U>Section</U><U></U><U>&nbsp;3.2</U>. Any interest or
other income from such investments shall be paid to and become the property of Parent. The Exchange Fund shall not be used for any purpose other than as specified in this <U>Section</U><U></U><U>&nbsp;3.2(b)</U>. No later than five (5)&nbsp;Business
Days prior to the Effective Time, Parent shall enter into an agreement with the Exchange Agent, in form and substance reasonably satisfactory to the Company, to effect the applicable terms of this Agreement (the &#147;<U>Exchange Agent
Agreement</U>&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) As promptly as practicable after the Effective Time, Parent shall cause the Exchange Agent to deliver to each
holder of shares of SpinCo Common Stock and/or SpinCo Equity Awards as of immediately prior to the Effective Time, from the Exchange Fund, the shares of Domesticated Parent Stock issuable in respect of such shares of SpinCo Common Stock and/or
SpinCo Equity Awards pursuant to the Merger, which shares shall, for the sake of clarity, be delivered to the same Persons who received shares of SpinCo Common Stock and/or SpinCo Equity Awards in the Distribution. Each holder of shares of SpinCo
Common Stock and/or SpinCo Equity Awards as of immediately prior to the Effective Time shall be entitled to receive in respect of such shares of SpinCo Common Stock and/or SpinCo Equity Awards held by such Person (i)&nbsp;a book-entry authorization
representing the number of whole shares of Domesticated Parent Common Stock that such holder has the right to receive pursuant to <U>Section</U><U></U><U>&nbsp;3.1(a)(i)(A)</U> (and cash in lieu of fractional shares of Domesticated Parent Common
Stock, as contemplated by <U>Section</U><U></U><U>&nbsp;3.2(e)</U>, and any dividends or distributions and other amounts pursuant to <U>Section</U><U></U><U>&nbsp;3.2(d)</U>) and/or (ii)&nbsp;a book-entry authorization representing the number of
Earnout Shares that such holder has the right to receive pursuant to <U>Section</U><U></U><U>&nbsp;3.1(a)(i)(B)</U>, <U>Section</U><U></U><U>&nbsp;3.3</U> and <U>Section</U><U></U><U>&nbsp;3.5</U>, in each case, without duplication. The Exchange
Agent shall not be entitled to vote or exercise any rights of ownership with respect to Domesticated Parent Stock held by it from time to time hereunder or under the Exchange Agent Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) <I>Distributions After the Effective Time</I>. Subject to the following sentence, no dividends or other distributions declared after the
Effective Time with respect to Domesticated Parent Common Stock shall be paid with respect to any shares of Domesticated Parent Stock that are not able to be delivered by the Exchange Agent promptly after the Effective Time, whether due to a legal
impediment to such delivery or otherwise. Subject to the effect of abandoned property, escheat, Tax or other applicable Laws, following the delivery of any such previously undelivered shares of Domesticated Parent Stock, there shall be paid to the
record holder of such shares of Domesticated Parent Common Stock, without interest, at the time of delivery, to the extent not previously paid, (i)&nbsp;the amount of cash payable in lieu of a fractional share of Domesticated Parent Common Stock to
which such holder is entitled pursuant to <U>Section</U><U></U><U>&nbsp;3.2(e)</U> and (ii)&nbsp;the amount of dividends or other distributions with a record date after the Effective Time theretofore paid with respect to such whole shares of
Domesticated Parent Stock. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-32- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) <I>No Fractional Shares</I>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) No certificates or scrip representing fractional shares of Domesticated Parent Stock or book-entry credit of the same shall
be issued on conversion of SpinCo Common Stock and/or SpinCo Equity Awards, and such fractional share interests will not entitle the owner thereof to vote, or to any other rights of a stockholder of Parent. All fractional shares of Domesticated
Parent Common Stock that a holder of shares of SpinCo Common Stock would otherwise be entitled to receive as a result of the Merger shall be aggregated by the Exchange Agent. The Exchange Agent shall cause the whole shares obtained thereby to be
sold on behalf of such holders that would otherwise have been entitled to receive a fractional share of Domesticated Parent Common Stock pursuant to the Merger in the open market (or otherwise as reasonably directed by Parent), in each case at
then-prevailing market prices as soon as reasonably practicable and in no case later than ten (10)&nbsp;Business Days after the Effective Time. The Exchange Agent shall make available the net proceeds thereof, subject to the deduction of the amount
of any withholding Taxes as contemplated in <U>Section</U><U></U><U>&nbsp;3.2(j)</U> and brokerage charges, commissions and conveyance and similar Taxes, to the holders of SpinCo Common Stock that would otherwise have been entitled to receive a
fractional share of Domesticated Parent Common Stock pursuant to the Merger (after the aggregation contemplated by this <U>Section</U><U></U><U>&nbsp;3.2(e)</U>) on a pro rata basis based on such fractional interest, without interest, as soon as
practicable thereafter. The payment of cash in lieu of fractional shares is solely for the purpose of avoiding the expense and inconvenience of issuing fractional shares and does not represent separately
<FONT STYLE="white-space:nowrap">bargained-for</FONT> consideration. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) Notwithstanding anything to the contrary herein,
no fraction of an Earnout Share will be issued by virtue of the Merger, and each holder of SpinCo Common Stock and/or SpinCo Equity Awards who would otherwise be entitled to a fraction of an Earnout Share (after aggregating all fractional Earnout
Shares that otherwise would be received by such holder of SpinCo Common Stock and/or SpinCo Equity Awards) shall not receive from Parent any shares of Domesticated Parent Stock or other consideration in lieu of any such fractional share. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) <I>No Further Ownership Rights in SpinCo Common Stock</I>. All shares of Domesticated Parent Stock issued in respect of shares of SpinCo
Common Stock and/or SpinCo Equity Awards in accordance with the terms of this <U>Section</U><U></U><U>&nbsp;3.2</U> (including any cash paid pursuant to <U>Section</U><U></U><U>&nbsp;3.2(d)</U> or <U>Section</U><U></U><U>&nbsp;3.2(e)</U>) shall be
deemed to have been issued in full satisfaction of all rights pertaining to such shares of SpinCo Common Stock and/or SpinCo Equity Awards. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) <I>Termination of Exchange Fund</I>. Any portion of the Exchange Fund made available to the Exchange Agent that remains undistributed to
the former holders of SpinCo Common Stock and/or SpinCo Equity Awards on the <FONT STYLE="white-space:nowrap">one-year</FONT> anniversary of the Effective Time shall be delivered to Parent, and any former holders of SpinCo Common Stock and/or SpinCo
Equity Awards who have not received shares of Domesticated Parent Stock in accordance with this <U>Article</U><U></U><U>&nbsp;III</U> shall thereafter look only to Parent for (i)&nbsp;in the case of former holders of SpinCo Common Stock, the Merger
Consideration to which they are entitled pursuant to <U>Section</U><U></U><U>&nbsp;3.1(a)(i),</U> any cash in lieu of fractional shares of Domesticated Parent Common Stock to which they are entitled pursuant to
<U>Section</U><U></U><U>&nbsp;3.2(e)</U> and any dividends or other distributions with respect to the Domesticated Parent Common Stock to which they are entitled pursuant to </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-33- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
<U>Section</U><U></U><U>&nbsp;3.2(d)</U> (subject to any applicable abandoned property, escheat or similar Law) and (ii)&nbsp;in the case of former holders of SpinCo Equity Awards, the Earnout
Shares to which they are entitled pursuant to <U>Section</U><U></U><U>&nbsp;3.3</U> and <U>Section</U><U></U><U>&nbsp;3.5</U> and any dividends or other distributions with respect to the Earnout Shares to which they are entitled pursuant to
<U>Section</U><U></U><U>&nbsp;3.2(d)</U> or <U>Section</U><U></U><U>&nbsp;3.3(g)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h) <I>No Liability</I>. None of the Company, the
Surviving Corporation, Parent, Merger Sub, the Exchange Agent or any other Person shall be liable to any holder of SpinCo Common Stock, Company Common Stock, SpinCo Equity Awards or Company Equity Awards for shares of Domesticated Parent Stock (or
dividends or distributions with respect thereto or with respect to SpinCo Common Stock) or cash properly delivered to a public official pursuant to any applicable abandoned property, escheat or similar Law. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) <I>Closing of Transfer Books</I>. From and after the Effective Time, the stock transfer books of SpinCo shall be closed and no transfer
shall be made of any shares of capital stock of SpinCo that were outstanding as of immediately prior to the Effective Time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(j) <I>Tax
Withholding</I>. Parent, the Company, SpinCo, Merger Sub and the Exchange Agent shall each be entitled to deduct and withhold from the consideration otherwise payable pursuant to this Agreement to any holder of SpinCo Common Stock or any holder of
SpinCo Equity Awards such amounts as are required to be deducted and withheld with respect to the making of such payment under the Code, or under any provision of state, local or foreign Tax Law (including, for the avoidance of doubt, any
withholding to be made in respect of any Merger Consideration delivered to SpinCo Service Providers through payroll). To the extent that amounts are so deducted or withheld and paid over to the appropriate Governmental Authority, such deducted or
withheld amounts will be treated for all purposes of this Agreement as having been paid to the Person in respect of which such deduction or withholding was made. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.3 <U>Earnout</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Pursuant to the Merger, there shall be issued to each holder of a share of SpinCo Common Stock and each holder of a SpinCo Equity Award,
their pro rata portion, as determined in accordance with the terms of <U>Section</U><U></U><U>&nbsp;3.1(a)</U> and the Employee Matters Agreement, as applicable, of an aggregate of 15,000,000 shares of Domesticated Parent Common Stock (without
duplication), subject to the forfeiture provisions set forth in <U>Section</U><U></U><U>&nbsp;3.3(d)</U> (the &#147;<U>Earnout Shares</U>&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) The Earnout Shares shall be subject to the following vesting conditions: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) If, at any time during the period commencing on the Closing Date and ending on the date that is five years after the
Closing Date (the &#147;<U>Earnout Period</U>&#148;), the Parent Trading Price is greater than or equal to $12.50, 50% of the Earnout Shares held by each holder of Earnout Shares shall immediately vest and no longer be subject to the forfeiture
conditions provided in <U>Section</U><U></U><U>&nbsp;3.3(d)</U>. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) If, at any time during the Earnout Period, the
Parent Trading Price is greater than or equal to $15.00, the remaining 50% of the Earnout Shares held by each holder of Earnout Shares shall immediately vest and no longer be subject to the forfeiture conditions provided in
<U>Section</U><U></U><U>&nbsp;3.3(d)</U>. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-34- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) For the avoidance of doubt, if the vesting conditions applicable to more than one of the
provisions of <U>Section</U><U></U><U>&nbsp;3.3(b)</U> have been satisfied at any one time, then all of the Earnout Shares subject to such satisfied vesting conditions shall immediately vest and no longer be subject to the forfeiture conditions
provided in <U>Section</U><U></U><U>&nbsp;3.3(d)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) If, upon the expiration of the Earnout Period, the vesting of any of the
Earnout Shares has not occurred, then the applicable Earnout Shares that failed to vest pursuant to <U>Section</U><U></U><U>&nbsp;3.3(b)</U>, as applicable, shall be automatically forfeited and deemed transferred to Parent for cancellation for no
consideration, and no Person (other than Parent) shall have any further right with respect thereto. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) If, during the Earnout Period,
the Domesticated Parent Common Stock outstanding as of immediately following the Merger Effective Time shall have been changed into a different number of shares or a different class, by reason of any Equity Adjustment, or any similar event shall
have occurred, then the applicable Parent Trading Price specified in <U>Section</U><U></U><U>&nbsp;3.3(b)</U> shall be equitably adjusted to reflect such change. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) If, during the applicable portion of the Earnout Period, there is a Change of Control that will result in the holders of Domesticated
Parent Common Stock receiving a per share price equal to or in excess of the applicable Parent Trading Price required in connection with an applicable vesting event (an &#147;<U>Acceleration Event</U>&#148;), then immediately prior to the
consummation of such Change of Control, any applicable Earnout Shares that have not previously been vested shall be deemed vested; <U>provided</U>, that such Earnout Shares shall be deemed vested (and such vesting event achieved) only (x)&nbsp;if
such Change of Control has been approved by a majority of the independent directors on the Parent Board and (y)&nbsp;to the extent the price per share of Domesticated Parent Common Stock in the Change of Control equals or exceeds the applicable
Parent Trading Price required in connection with such vesting event. For the avoidance of doubt, in the event of a Change of Control, including where the consideration payable is other than a specified price per share, for purposes of determining
whether a Parent Trading Price required in connection with an applicable vesting event has been achieved, the price paid per share of Domesticated Parent Common Stock shall be calculated taking into account all of the Earnout Shares (whether or not
then vested). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) For so long as any Earnout Shares remains subject to the vesting and forfeiture conditions specified in
<U>Section</U><U></U><U>&nbsp;3.3(b)</U> and <U>Section</U><U></U><U>&nbsp;3.3(d)</U>, the holder thereof shall be entitled to (i)&nbsp;exercise the voting rights carried by such Earnout Shares and (ii)&nbsp;receive any dividends or other
distributions in respect of such Earnout Shares. For the avoidance of doubt, prior to vesting in accordance with the terms of this <U>Section</U><U></U><U>&nbsp;3.3</U>, holders of the Earnout Shares shall not be entitled to transfer such shares,
and such shares shall bear a legend prohibiting transfer until such time as the vesting conditions with respect to such share have been satisfied (the &#147;<U>Transfer Restriction</U>&#148;). Any attempted transfer in violation of the Transfer
Restriction shall be void <I>ab</I> <I>initio</I>. For the avoidance of doubt, the Company, Parent, SpinCo and any other applicable withholding agent shall each be entitled to deduct and withhold from any amounts payable or distributions made in
respect of the Earnout Shares. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-35- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.4 <U>Appraisal Rights.</U><U> </U>In accordance with Section&nbsp;262 of the
DGCL, no appraisal rights shall be available to the holders of SpinCo Common Stock in connection with the Merger. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.5
<U>Treatment of </U><U>SpinCo Equity Awards.</U><U> </U>Each SpinCo Equity Award that is outstanding as of the Effective Time shall be treated as set forth in the Employee Matters Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ARTICLE&nbsp;IV </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">REPRESENTATIONS
AND WARRANTIES OF THE COMPANY RELATING TO THE COMPANY </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Except as otherwise disclosed or identified in (a)&nbsp;the Company SEC Documents
filed and publicly available on the SEC&#146;s EDGAR database at least two (2)&nbsp;Business Days prior to the date hereof (excluding any disclosures of factors or risks contained or references therein under the captions &#147;Risk Factors&#148; or
&#147;Forward-Looking Statements&#148; to the extent they are forward-looking statements and any other similar general, predictive or cautionary statements) or (b)&nbsp;the Company Disclosure Schedule (to the extent that it is reasonably apparent on
the face of such disclosure that it is relevant to or applies to such representation or warranty of the Company under this <U>Article IV</U>), the Company hereby represents and warrants to Parent and Merger Sub as follows: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.1 <U>Organization of the Company</U>. The Company has been duly incorporated and is validly existing and in good standing as a
Delaware corporation. The Company has all requisite corporate power and authority to own, lease and operate its properties and assets in the manner in which such assets and properties are now owned, leased and operated and to conduct its business as
it is now being conducted. The Company has made available to Parent and Merger Sub true and complete copies of the Governing Documents of the Company as in effect on the date hereof. The Company is duly licensed or qualified and in good standing (or
equivalent status as applicable) in each jurisdiction in which the assets owned or leased by it or the character of its activities require it to be so licensed or qualified or in good standing (or equivalent status as applicable), except as would
not, individually or in the aggregate, have a Company Material Adverse Effect. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.2 <U>Due Authorization</U>. The Company has
all requisite corporate power and authority to execute and deliver this Agreement and the Transaction Documents to which it is or will be a party and to consummate the Transactions, except for such further action of the Company Board required, if
applicable, to establish the Record Date and the Distribution Date, and the declaration of the Distribution by the Company Board (the effectiveness of which is subject to the satisfaction or, to the extent permitted by applicable Law, waiver, of the
conditions set forth in the Separation and Distribution Agreement). The execution and delivery by the Company of this Agreement and the Transaction Documents to which it is or will be a party as of the Effective Time and the consummation of the
Transactions have been duly authorized by all necessary and proper corporate action on its part, and no other corporate action on the part of the Company is necessary to authorize this Agreement or the Transaction Documents to which it is or will be
a party as of the Effective Time or, subject to such further action of the Company </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-36- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Board required, if applicable, to establish the Record Date and the Distribution Date, and the declaration of the Distribution by the Company Board (the effectiveness of which is subject to the
satisfaction or, to the extent permitted by applicable Law, waiver of the conditions set forth in the Separation and Distribution Agreement), consummate the Transactions. Each of this Agreement and the Transaction Documents to which the Company is
or will be a party as of the Effective Time has been or will be duly and validly executed and delivered by it and (assuming that this Agreement or such other applicable Transaction Documents to which each of Parent and Merger Sub is or will be a
party as of the Effective Time constitutes a legal, valid and binding obligation of each of Parent and Merger Sub (as applicable)), constitutes or will when executed and delivered constitute the legal, valid and binding obligation of the Company,
enforceable against it in accordance with its terms, subject to applicable bankruptcy, insolvency, fraudulent conveyance, reorganization, moratorium and similar Laws affecting creditors&#146; rights generally and subject, as to enforceability, to
general principles of equity (collectively, the &#147;<U>Remedies Exception</U>&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.3 <U>Governmental Consents</U>. No
Consent of, with or to any Governmental Authority is required to be obtained or made by the Company in connection with the execution or delivery by the Company of this Agreement or the Transaction Documents to which it is or will be a party or the
consummation by the Company of the Transactions, except for or in compliance with (a)&nbsp;any Premerger Notification and Report Form required under and compliance with the HSR Act or other filings in connection with the Requisite Regulatory
Approvals; (b)&nbsp;the filing of the Certificate of Merger and the Parent Charter with the Secretary of State of the State of Delaware pursuant to the provisions of the DGCL; (c)&nbsp;the rules and regulations of NASDAQ; (d)&nbsp;applicable
requirements of state securities or &#147;blue sky&#148; Laws, the Securities Act and the Exchange Act; (e)&nbsp;Consents described in <U>Section</U><U></U><U>&nbsp;5.6</U> and Consents set forth on Section&nbsp;4.3 of the SpinCo Disclosure
Schedule; and (f)&nbsp;Consents the failure of which to be made or obtained would not reasonably be expected to, individually or in the aggregate, have a Company Material Adverse Effect or a SpinCo Material Adverse Effect. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.4 <U>No Conflict</U>. Subject to the receipt of the Consents set forth in <U>Section</U><U></U><U>&nbsp;4.3</U>, the execution
and delivery by the Company of this Agreement and the Transaction Documents to which it is or will be a party as of the Effective Time and the consummation by the Company of the Transactions (for the avoidance of doubt, including performance of the
Transaction Documents following the Closing) do not and will not as of the Effective Time, (a)&nbsp;violate any provision of, or result in the breach of, any Law applicable to the Company or by which any of its assets or properties is bound;
(b)&nbsp;with or without lapse of time or the giving of notice or both, require a consent or approval under, conflict with, result in a violation or breach of, or constitute a default under, result in the acceleration of, create in any party the
right to accelerate, terminate or cancel any Contract to which the Company is a party or by which its assets or properties are bound; or (c)&nbsp;breach or violate any provision of the Governing Documents of the Company, except, in the case of each
of clauses (a)&nbsp;and (b), as would not, individually or in the aggregate, reasonably be expected to have a Company Material Adverse Effect. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-37- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.5 <U>Litigation and Proceedings</U>. (a)&nbsp;There are no Actions pending
or, to the Knowledge of the Company, threatened before or by any Governmental Authority against the Company or any Company Subsidiary that, individually or in the aggregate, would reasonably be expected to result in a Company Material Adverse
Effect, and (b)&nbsp;neither the Company nor any of its Subsidiaries is subject to any judgment, decree, injunction or order of any Governmental Authority that, in each case, would reasonably be expected to result, individually or in the aggregate,
in a Company Material Adverse Effect. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.6 <U>Brokers</U><U>&#146;</U><U> Fees</U>. No broker, investment banker, or other
Person is entitled to any brokerage fee, finders&#146; fee or other similar commission for which Parent or any of its Subsidiaries, including Merger Sub, the Surviving Corporation or the SpinCo Entities, would be liable in connection with the
transactions contemplated by this Agreement based on arrangements made on behalf of the Company or any of its Affiliates (other than the SpinCo Entities). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.7 <U>Internal Controls</U>. The Company has established and maintains a system of internal controls over financial reporting
(as defined in Rule <FONT STYLE="white-space:nowrap">13a-l5(f)</FONT> or <FONT STYLE="white-space:nowrap">15d-15(f),</FONT> as applicable, under the Exchange Act (collectively, &#147;<U>Internal Controls</U>&#148;)) that are designed to provide
reasonable assurances that (i)&nbsp;transactions are executed in accordance with management&#146;s general or specific authorizations, (ii)&nbsp;transactions are recorded as necessary to permit preparation of financial statements in conformity with
GAAP and to maintain accountability for assets, (iii)&nbsp;access to assets is permitted only in accordance with management&#146;s general or specific authorization and (iv)&nbsp;the recorded accountability for assets is compared with the existing
assets at reasonable intervals and appropriate action is taken with respect to any differences. The Internal Controls are overseen by the audit committee of the Company Board (the &#147;<U>Company Audit Committee</U>&#148;). Since January&nbsp;1,
2019, the Company&#146;s principal executive officer and its principal financial officer have disclosed to the Company&#146;s independent auditor and the Company Audit Committee (a)&nbsp;any significant deficiency or material weakness in the
Company&#146;s Internal Controls and (b)&nbsp;any fraud involving management or other employees who have a significant role in the Company&#146;s Internal Controls. Since January&nbsp;1, 2019, neither the Company nor any Company Subsidiary has
received any material, unresolved complaint, allegation, assertion or claim regarding the impropriety of any accounting or auditing practices, procedures, methodologies or methods of the Company or any Company Subsidiary or their respective internal
accounting controls. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.8 <U>Company Equity Awards</U>.<U> </U>Section&nbsp;4.8 of the Company Disclosure Schedule sets forth
a true, correct and complete list of all Company Options, Company RSU Awards and Company PSU Awards that are outstanding as of the date hereof and any other rights to purchase or receive shares of Company Common Stock, and, for each such award or
other right, (i)&nbsp;the number of shares of Company Common Stock or any of its Subsidiaries subject thereto, (ii)&nbsp;the equity plan under which the award is governed, (iii)&nbsp;the terms of vesting (including the extent to which it will become
accelerated as a result of the consummation of the Transactions) and vesting status, (iv)&nbsp;the grant and expiration dates, (v)&nbsp;the exercise price, if applicable, (vi)&nbsp;the name of the holder thereof, (vii)&nbsp;whether such award or
other right is intended to be an &#147;incentive stock option&#148; as defined in Section&nbsp;422 of the Code or a <FONT STYLE="white-space:nowrap">non-qualified</FONT> stock option, and (viii)&nbsp;whether such Company Equity Award is held by a
Company Service Provider, Former Company Service Provider or SpinCo Service Provider. All Company Options were granted with an exercise price per share no lower than the fair market value of one (1)&nbsp;share of stock underlying such Company Equity
Award on the date of the corporate action effectuating the applicable grant and are exempt under Section&nbsp;409A of the Code. All Company Equity Awards were granted in accordance with the applicable equity plan under which such award is governed,
the applicable award agreement, and applicable Law in all material respects. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-38- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ARTICLE&nbsp;V </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">REPRESENTATIONS AND WARRANTIES OF THE COMPANY RELATING TO SPINCO </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Except as otherwise disclosed or identified in (a)&nbsp;the Company SEC Documents filed and publicly available on the SEC&#146;s EDGAR
database at least two (2)&nbsp;Business Days prior to the date hereof (excluding any disclosures of factors or risks contained or references therein under the captions &#147;Risk Factors&#148; or &#147;Forward-Looking Statements&#148; to the extent
they are forward-looking statements and any other similar general, predictive or cautionary statements) or (b)&nbsp;the corresponding section or subsection of the SpinCo Disclosure Schedule (it being understood that each such disclosure shall also
apply to each other representation and warranty contained in this <U>Article V</U> to the extent that it is reasonably apparent on the face of such disclosure that it is relevant to or applies to such representation or warranty), the Company hereby
represents and warrants to Parent and Merger Sub as follows: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.1 <U>Organization of </U><U>SpinCo</U>. SpinCo has been duly
incorporated and is validly existing and in good standing as a Delaware corporation and has all requisite corporate power and authority to own, lease and operate its assets in the manner in which such assets are now (or as of the Effective Time will
be) owned, leased or operated and to conduct its business as it is now being conducted. SpinCo has made available to Parent and Merger Sub true and complete copies of the Governing Documents of SpinCo. SpinCo is duly licensed or qualified and in
good standing (or equivalent status as applicable) in each jurisdiction in which the assets owned or leased by it or the character of its activities require it to be so licensed or qualified or in good standing (or equivalent status as applicable),
except as would not, individually or in the aggregate, reasonably be expected to have a SpinCo Material Adverse Effect. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.2
<U>Due Authorization</U>. SpinCo has all requisite corporate power and authority to execute and deliver this Agreement and the Transaction Documents to which it is or will be a party at the Effective Time and to consummate the Transactions (subject,
in the case of the Merger, to the SpinCo Shareholder Approval, which will occur immediately after the execution of this Agreement), and except for such further action of the Company Board required, if applicable, to establish the Record Date and the
Distribution Date, and the effectiveness of the declaration of the Distribution by the Company (which is subject to the satisfaction or, to the extent permitted by applicable Law, waiver of the conditions set forth in the Separation and Distribution
Agreement). The execution and delivery by SpinCo of this Agreement and the Transaction Documents to which it is or will be a party at the Effective Time and the consummation by SpinCo of the Transactions have been duly and validly authorized and
approved by all necessary and proper corporate action on its part and, except for the SpinCo Shareholder Approval, no other corporate action on the part of SpinCo is necessary to authorize this Agreement or the Transaction Documents to which it is
or will be a party at the Effective Time. Each of this Agreement and the Transaction Documents to which it is or will be a party at the Effective Time has been, or when executed and delivered will be, duly and validly executed and delivered by
SpinCo and (assuming that this Agreement or such other applicable Transaction Document to which Parent or Merger Sub is or will be a party at the Effective Time constitutes a legal, valid and binding obligation of Parent or Merger Sub (as
applicable)) constitutes or will constitute a legal, valid and binding obligation of SpinCo, enforceable against SpinCo in accordance with its terms, subject to the Remedies Exception. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-39- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.3 <U>Capitalization of </U><U>SpinCo</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) As of the date hereof, (i)&nbsp;the authorized capital stock of SpinCo consists of 1,000 shares of SpinCo Common Stock, (ii)&nbsp;the
issued and outstanding shares of capital stock of SpinCo consists of 1,000 shares of SpinCo Common Stock, and (iii)&nbsp;no shares of SpinCo Common Stock are being held by SpinCo in its treasury. All of the issued and outstanding shares of SpinCo
Common Stock are, as of the date hereof (and as of immediately prior to the Distribution will be), owned, of record and beneficially, by the Company and have been duly authorized and validly issued, are fully paid and nonassessable and have not been
issued in violation of any preemptive or similar rights. Immediately prior to the Effective Time, there will be outstanding a number of shares of SpinCo Common Stock determined in accordance with <U>Section</U><U></U><U>&nbsp;7.14</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) No bonds, debentures, notes or other indebtedness of any SpinCo Entity having the right to vote (or convertible into or exercisable for
securities having the right to vote) on any matters on which holders of shares of capital stock of SpinCo (including SpinCo Common Stock) may vote (&#147;<U>SpinCo Voting Debt</U>&#148;) are issued or outstanding. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) There are no (i)&nbsp;outstanding options, warrants, rights or other securities convertible into or exchangeable or exercisable for shares
of capital stock of SpinCo, or any other commitments or agreements providing for the issuance, sale, repurchase or redemption of shares of capital stock of SpinCo, (ii)&nbsp;agreements of any kind which may obligate SpinCo to issue, purchase, redeem
or otherwise acquire any of its shares of capital stock or (iii)&nbsp;voting trusts, proxies or other agreements or understandings with respect to the voting shares of capital stock of SpinCo. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.4 <U>Subsidiaries</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <U>Section 5.4(a)</U> of the SpinCo Disclosure Schedule sets forth a list of the SpinCo Subsidiaries (after giving effect to the Internal
Reorganization) and their respective jurisdictions of organization as of the date hereof. Each SpinCo Subsidiary has been, or will be at the Closing, duly organized and is, or will be at the Closing, validly existing and in good standing (to the
extent applicable under the Laws of its jurisdiction of formation) under the Laws of its jurisdiction of organization and has all requisite organizational power and authority to own, lease and operate its assets in the manner such assets are now (or
as of the Effective Time will be) owned, leased, or operated and to conduct its business as it is now being conducted. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Each SpinCo
Subsidiary is, or will be at the Closing, duly licensed or qualified and in good standing (or equivalent status as applicable) in each jurisdiction in which the assets owned or leased by it or the character of its activities require it to be so
licensed or qualified or in good standing (or equivalent status as applicable), as applicable, except as would not, individually or in the aggregate, reasonably be expected to have a SpinCo Material Adverse Effect. Other than the SpinCo Subsidiaries
set forth on Section&nbsp;5.4(a) of the SpinCo Disclosure Schedule, as of the date hereof (giving effect to the Internal Reorganization), SpinCo does not own or hold, directly or indirectly, any Interest in any other Person. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-40- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.5 <U>Capitalization of Subsidiaries</U>. The issued and outstanding Interests
of each of the SpinCo Subsidiaries have been, or will be at the Closing, duly authorized and are (or will then be) validly issued and, as applicable, fully paid and nonassessable. SpinCo, directly or indirectly, owns, or will own at the Closing, of
record and beneficially, all the issued and outstanding Interests of the SpinCo Subsidiaries, free and clear of any Liens (other than those set forth in their respective Governing Documents or arising pursuant to applicable securities Laws or
created by this Agreement). There are no outstanding options, warrants, rights or other securities exercisable or exchangeable for Interests of such SpinCo Subsidiaries, any other commitments or agreements providing for the issuance, sale,
repurchase or redemption of Interests of such SpinCo Subsidiaries, and there are no agreements of any kind which may obligate any SpinCo Subsidiary to issue, purchase, redeem or otherwise acquire any of its Interests. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.6 <U>Governmental Consents</U>. No Consent of, with or to any Governmental Authority is required to be obtained or made by any
SpinCo Entity in connection with the execution or delivery by SpinCo of this Agreement or the Transaction Documents to which SpinCo is or will be a party at the Effective Time or the consummation by SpinCo of the Transactions, except for:
(a)&nbsp;applicable requirements of the HSR Act (b)&nbsp;the filing of the Certificate of Merger with the Secretary of State of the State of Delaware pursuant to the provisions of the DGCL; (c)&nbsp;applicable requirements of state securities or
&#147;blue sky&#148; Laws, the Securities Act and the Exchange Act; (d)&nbsp;Consents described in <U>Section</U><U></U><U>&nbsp;4.3</U> and Consents set forth on Section&nbsp;5.6 of the SpinCo Disclosure Schedule; and (f)&nbsp;Consents the failure
of which to be made or obtained would not reasonably be expected to, individually or in the aggregate, have a SpinCo Material Adverse Effect. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.7 <U>No Conflict</U>. Subject to the receipt of the Consents described in <U>Section</U><U></U><U>&nbsp;5.6</U>, the execution
and delivery by SpinCo of this Agreement and the Transaction Documents to which SpinCo is or will be a party at the Effective Time and the consummation by SpinCo of the Transactions (for the avoidance of doubt, including performance of the
Transaction Documents following the Closing by the SpinCo Entities) do not and will not: (a)&nbsp;violate any provision of, or result in the material breach of, any Law applicable to any SpinCo Entity or by which any of its assets or properties is
bound; (b)&nbsp;with or without lapse of time or the giving of notice or both, require a consent or approval under, conflict with, result in a violation or breach of, or constitute a default under, result in the acceleration of, or create in any
party the right to accelerate, terminate or cancel any Contract to which a SpinCo Entity is a party or by which their assets or properties is (or will at the Closing be) bound; (c)&nbsp;result in the creation of any Lien upon any of the properties
or assets of SpinCo or any of SpinCo&#146;s Subsidiaries; or (d)&nbsp;violate any provision of the Governing Documents of the SpinCo Entities, except, in the case of clauses (a), (b) and (c), as would not, individually or in the aggregate,
reasonably be expected to have a SpinCo Material Adverse Effect. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-41- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.8 <U>Sufficiency of the SpinCo Assets</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) As of the Effective Time (assuming receipt of all consents, approvals and authorizations relating to the matters set forth in
<U>Section</U><U></U><U>&nbsp;4.3</U> and <U>Section</U><U></U><U>&nbsp;5.6</U>), after giving effect to the Internal Reorganization, the SpinCo Assets owned by the SpinCo Entities will, taking into account all Transaction Documents (including the
services available under the Transition Services Agreements and the other Transaction Documents), constitute all of the assets, properties and rights reasonably necessary for Parent and the SpinCo Entities to conduct the SpinCo Business immediately
following the Closing in all material respects in the same manner as it is conducted on the date hereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Except for Permitted Liens
or Liens created by or through Parent or Merger Sub, SpinCo and the Company collectively have, and at the Closing (after giving effect to the Internal Reorganization and the other Transactions) the SpinCo Entities shall have, good, valid and
marketable title to, or a valid leasehold in, license to or other legal right to use, as the case may be, all of the material SpinCo Assets, free and clear of any Liens. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.9 <U>Financial Statements</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Set forth on Section&nbsp;5.9 of the SpinCo Disclosure Schedule are copies of the SpinCo Financial Statements. Each of the SpinCo
Financial Statements fairly presents, in all material respects, the financial condition and results of operations and cash flows of the SpinCo Business, as of the dates indicated therein and for the periods referred to therein; <U>provided</U>, that
the SpinCo Financial Statements and the representations and warranties in this <U>Section</U><U></U><U>&nbsp;5.9(a)</U> are qualified by the fact that (i)&nbsp;the SpinCo Business has not operated on a separate standalone basis and has historically
been reported within the Company&#146;s combined financial statements, (ii)&nbsp;the SpinCo Financial Statements assume certain allocated charges and credits, which do not necessarily reflect amounts that would have resulted from <FONT
STYLE="white-space:nowrap">arm&#146;s-length</FONT> transactions or that the SpinCo Business would incur on a standalone basis, including after the Closing and (iii)&nbsp;the SpinCo Financial Statements are subject to changes prior to the provision
of final audited SpinCo Financial Statements, none of which are expected to be material. The SpinCo Financial Statements were prepared based on the accrual basis of accounting consistently applied by the Company during the periods involved and were
derived from the financial reporting systems and the consolidated financial statements of the Company, which consolidated financial statements were prepared in accordance with GAAP. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) As of the date hereof, neither SpinCo nor any of its Subsidiaries is required to file or furnish any form, report, registration statement,
prospectus or other document with the SEC. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.10 <U>No Undisclosed Liabilities</U>. There is no Liability of the SpinCo
Entities or related to the SpinCo Business (excluding any Liabilities related or attributable to Taxes) whether or not of a type required to be reflected or reserved for on a consolidated balance sheet of the SpinCo Business or in the notes thereto
prepared in accordance with GAAP, except for (a)&nbsp;Liabilities reflected or reserved for in the combined balance sheets as of December&nbsp;31, 2021 included in the SpinCo Financial Statements; (b)&nbsp;Liabilities that have arisen since the
Balance Sheet Date in the ordinary course of the operation of the SpinCo Business; (c)&nbsp;Liabilities arising out of or in connection with this Agreement, the Transaction Documents and the Transactions; or (d)&nbsp;Liabilities that, individually
or in the aggregate, would not reasonably be expected to be material to the SpinCo Entities taken as a whole. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-42- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.11 <U>Litigation and Proceedings</U>. As of the date hereof, there are no
Actions pending or, to the Knowledge of the Company or SpinCo, threatened before or by any Governmental Authority against any SpinCo Entity or with respect to the SpinCo Business, and neither the Company nor any of its Subsidiaries (solely as they
relate to the SpinCo Business or any SpinCo Entity) is subject to any judgment, decree, injunction or order of or investigation or inquiry by any Governmental Authority, except, in each case, as would not reasonably be expected, individually or in
the aggregate, to be material to the SpinCo Entities taken as a whole. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.12 <U>Real Property</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) The SpinCo Entities do not own and at no time previously have owned, any real property. With respect to the Company Real Property,
(i)&nbsp;the Company or its applicable Subsidiary has good and valid title (or the applicable local equivalent) or a valid and enforceable leasehold interest, as applicable, in such Company Real Property, free and clear of any Liens, subject to the
Remedies Exception and other than Permitted Liens, and (ii)&nbsp;neither the Company nor any of its Subsidiaries has received written notice of any pending condemnation, expropriation, eminent domain or similar Action affecting all or any portion of
such Company Real Property (to the extent relating to or affecting the SpinCo Business). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Subject to the terms of the Transaction
Documents, including the Separation and Distribution Agreement, the SpinCo Entities have, or will have at the Effective Time, a valid and enforceable leasehold interest in the SpinCo Real Property, except as has not and would not reasonably be
expected, individually or in the aggregate, to result in any material Liability to the SpinCo Business, taken as a whole. Other than the SpinCo Real Property Leases set forth on Section&nbsp;5.15(a)(viii) of the SpinCo Disclosure Schedule, there are
no Contracts granting to any Person (other than any SpinCo Entity or any landlord of such property pursuant to a SpinCo Real Property Lease and other than any Person who would be entitled to access any such property in the ordinary course of
business in accordance with the applicable SpinCo Real Property Lease) the right of use or occupancy of any SpinCo Real Property. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.13 <U>Tax Matters</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Except as would not, individually or in the aggregate, have a SpinCo Material Adverse Effect: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) (A)&nbsp;All Tax Returns required to be filed by or with respect to a SpinCo Entity or the SpinCo Business have been timely
filed (taking into account applicable extensions), (B)&nbsp;all such Tax Returns are true, correct and complete, and (C)&nbsp;all Taxes, whether or not shown as due on such Tax Returns, in respect of each SpinCo Entity and the SpinCo Business have
been paid, in the case of each of clauses&nbsp;(A)&nbsp;through (C), except to the extent adequate reserves therefor in accordance with GAAP have been provided on the SpinCo Financial Statements; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-43- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) (A) No Governmental Authority has asserted any written claim,
assessment or deficiency for Taxes against any SpinCo Entity or the SpinCo Business (and, to the Knowledge of the Company and SpinCo, no such claim, assessment or deficiency has been threatened or proposed in writing), except for deficiencies which
have been satisfied by payment, settled or withdrawn and (B)&nbsp;no claim, audit or other proceeding by any Governmental Authority is pending or threatened in writing with respect to any Taxes of any SpinCo Entity or the SpinCo Business; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iii) No SpinCo Entity has any Liability for Taxes of any other Person (other than the Company or any of its subsidiaries)
under Treasury Regulations section <FONT STYLE="white-space:nowrap">1.1502-6</FONT> (or any similar provision of state, local or <FONT STYLE="white-space:nowrap">non-U.S.</FONT> Law), as a transferee or successor or by contract or operation of Law
or otherwise; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iv) Other than in connection with the Separation, within the past two years, no SpinCo Entity has
constituted either a &#147;distributing corporation&#148; or a &#147;controlled corporation&#148; (within the meaning of Section&nbsp;355(a)(1)(A) of the Code) in a distribution of stock qualifying for
<FONT STYLE="white-space:nowrap">tax-free</FONT> treatment under Section&nbsp;355 of the Code; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(v) No SpinCo Entity has
participated in, or is currently participating in, a &#147;listed transaction&#148; within the meaning of Treasury Regulations <FONT STYLE="white-space:nowrap">Section&nbsp;1.6011-4(b)(2);</FONT> and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(vi) There are no Liens for Taxes (other than Permitted Liens) upon the assets of any SpinCo Entity or the SpinCo Business.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Neither the Company nor any of its Subsidiaries has taken or agreed to take any action or knows of any fact, agreement, plan or other
circumstance that could reasonably be expected to prevent or impede (i)&nbsp;the Domestication from qualifying as a &#147;reorganization&#148; within the meaning of Section&nbsp;368(a)(1)(F), (ii)&nbsp;the
<FONT STYLE="white-space:nowrap">Tax-Free</FONT> Status, (iii)&nbsp;the Company from receiving the Company Tax Opinions or (iv)&nbsp;Parent from receiving the Parent Tax Opinions. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) The representations and warranties set forth in this <U>Section</U><U></U><U>&nbsp;5.13</U> and, to the extent relating to Tax matters,
<U>Section</U><U></U><U>&nbsp;5.18</U>, constitute the sole and exclusive representations and warranties of the Company regarding Tax matters. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.14 <U>Absence of Changes</U>. Since the Balance Sheet Date until the date of this Agreement, (a)&nbsp;there has not been any
SpinCo Material Adverse Effect and (b)&nbsp;except in connection with the Transaction Process or as contemplated by this Agreement and the other Transaction Documents,&nbsp;since the Balance Sheet Date and through the date hereof, the Company and
its Subsidiaries, including the SpinCo Entities, have, in all material respects, conducted the SpinCo Business in the ordinary course of business. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.15 <U>Material Contracts</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Except as set forth in Section&nbsp;5.15(a) of the SpinCo Disclosure Schedule and except for Contracts that do not constitute SpinCo
Assets or SpinCo Liabilities, as of the date hereof, neither the Company nor any of its Subsidiaries (other than the SpinCo Entities) (solely with respect to the SpinCo Business), or any of the SpinCo Entities, is party to or otherwise bound by or
subject to Contracts of the following types (together with any SpinCo Affiliate Contracts, the &#147;<U>SpinCo Material Contracts</U>&#148;): </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-44- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) any Contract that relates to the purchase or sale of goods or services
pursuant to which the SpinCo Business has received more than $2,000,000 or paid more than $2,000,000 in the past twelve (12)&nbsp;months; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) any Contract that limits or purports to limit in any material respect the ability of the SpinCo Business to compete with
any Person or in any line of business or in any geographic region in the world; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iii) any Contract that grants exclusive
rights to a customer or a supplier or (to the extent material to the SpinCo Business) any other commercial counterparty that will relate to or affect the SpinCo Business after the Closing; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iv) any Contract that requires any future capital expenditures by the SpinCo Business in excess of $2,000,000 that will not be
paid prior to the Closing; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(v) any Contract that requires any milestone, earn out or similar payments to be made by the
SpinCo Business in excess of $2,000,000 that will not be paid prior to the Closing; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(vi) any Contract that relates to the
creation, incurrence, assumption or guarantee of any indebtedness for borrowed money or any bonds, debentures, notes or similar instruments, in each case, in excess of $2,000,000; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(vii) any Contract pursuant to which (A)&nbsp;any Person grants to any of the SpinCo Entities or, with respect to the SpinCo
Business, to the Company or any of its Subsidiaries other than the SpinCo Entities, any license, right, permission, consent, <FONT STYLE="white-space:nowrap">non-assertion</FONT> or release with respect to any Intellectual Property that is material
to the SpinCo Business, other than <FONT STYLE="white-space:nowrap">(1)&nbsp;non-exclusive</FONT> click-wrap, shrink-wrap or <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">off-the-shelf</FONT></FONT> Software licenses that are
commercially available on standard and reasonable terms to the public generally with license, maintenance, support and other fees of less than $200,000 in any twelve (12)-month period, <FONT STYLE="white-space:nowrap">(2)&nbsp;non-disclosure</FONT>
agreements entered into in the ordinary course of business consistent with past practice and <FONT STYLE="white-space:nowrap">(3)&nbsp;non-exclusive</FONT> licenses granted by any suppliers or service providers to any of the SpinCo Entities in the
ordinary course of business consistent with past practice solely for the receipt of services from such supplier or service provider, and solely where such licenses are ancillary to the primary purpose of such Contract, or (B)&nbsp;any of the SpinCo
Entities or, with respect to the SpinCo Business, the Company or any of its Subsidiaries other than the SpinCo Entities, grants any license, right, permission, consent, <FONT STYLE="white-space:nowrap">non-assertion</FONT> or release with respect to
any Intellectual Property that is material to the SpinCo Business, other than <FONT STYLE="white-space:nowrap">(1)&nbsp;non-exclusive</FONT> licenses granted to customers of any of the SpinCo Entities in the ordinary course of business consistent
with past practice, <FONT STYLE="white-space:nowrap">(2)&nbsp;non-exclusive</FONT> licenses granted to any suppliers or service providers by any of the SpinCo Entities in the ordinary course of business consistent with past practice solely for the
benefit of such SpinCo Entity and <FONT STYLE="white-space:nowrap">(3)&nbsp;non-disclosure</FONT> agreements entered into in the ordinary course of business consistent with past practice; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-45- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(viii) any Contract to which any of the SpinCo Entities or, with respect to
the SpinCo Business, the Company or any of its Subsidiaries other than the SpinCo Entities, is a party with any Governmental Authority or any university, college, research institute, or other educational institution that provides for the provision
of funding by or to any of the SpinCo Entities or the Company or any of its Subsidiaries, in each case, for any research or development activities involving the invention, creation, conception or development of any Intellectual Property that is
material to the SpinCo Business; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ix) any lease, sublease, occupancy agreement or license for real property (each, a
&#147;<U>SpinCo Real Property Lease</U>&#148;); </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(x) any Contract that is a settlement, conciliation or similar agreement
with any Governmental Authority or that otherwise involves any settled or threatened claim, action, suit or proceeding pursuant to which the SpinCo Business has (or will have after the Closing) any monetary or other material outstanding obligation;
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(xi) any Contract that contains &#147;most favored nation&#148; pricing provisions for the benefit of the relevant
counterparty that will relate to or affect the SpinCo Business after the Closing; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(xii) any joint venture, strategic
alliance, joint development, partnership or similar arrangement; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(xiii) any Contract relating to the acquisition or
disposal or divestiture of, or investment in, any joint venture, partnership or similar arrangement or any material assets or businesses; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(xiv) any prime contract, subcontract, purchase order, task order, delivery order, teaming agreement, joint venture agreement,
strategic alliance agreement, basic ordering agreement, pricing agreement, letter contract or other similar arrangement of any kind where the counterparty or the ultimate customer is, or the work performed under such contract was funded by, a
Governmental Authority (each a &#147;<U>Government Contract</U>&#148;); and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(xv) any Contract not otherwise described in
any other subsection of this <U>Section</U><U></U><U>&nbsp;5.15(a)</U> that would be required to be filed by SpinCo as a &#147;material contract&#148; (as such term is defined in Item 601(b)(10) of Regulation
<FONT STYLE="white-space:nowrap">S-K</FONT> of the SEC) if SpinCo were subject to the reporting requirements of the Exchange Act as of the date hereof. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company has made available to Parent copies of each SpinCo Material Contract that are correct and complete. Each SpinCo Material Contract is valid and
binding on the Company or its applicable Subsidiary, including any applicable SpinCo Entity and, to the Knowledge of the Company or SpinCo, the counterparty thereto, and is in full force and effect and enforceable in accordance with its terms,
subject to the Remedies Exception. Neither the Company nor its applicable Subsidiary, including any SpinCo Entity is, and to the Knowledge of the Company or SpinCo, no counterparty thereto is, in breach of, or default under, any SpinCo Material
Contract in any material respect. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-46- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.16 <U>Labor Relations</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Section 5.16(a) of the SpinCo Disclosure Schedules sets forth a true and complete list of all SpinCo Employees, and includes each SpinCo
Employee&#146;s name, title, work location, status (e.g., full- or part-time or temporary), overtime classification (e.g., exempt or <FONT STYLE="white-space:nowrap">non-exempt),</FONT> rate of base salary or hourly wage, target annual bonus
opportunity or other cash incentive opportunity, the amount of accrued but unused paid time off, and whether the employee is on leave (and if so, the category of leave, the date on which such leave commenced and the date of expected return to work).
As of the date hereof, all SpinCo Employees are employed by the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Section 5.16(b) of the SpinCo Disclosure Schedules sets
forth a true and complete list of all SpinCo Independent Contractors. The Company has made available to Parent and Merger Sub true and complete copies of each services agreement with each SpinCo Independent Contractor. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Neither the Company nor any of its Subsidiaries, including any SpinCo Entity, is a party to any agreement with any trade union, works
council, employee representative body or labor organization (covered by the National Labor Relations Act) that represents (or that otherwise governs or relates to the employment of) any of the SpinCo Employees(each, a &#147;<U>SpinCo CBA</U>&#148;).
To the Knowledge of the Company or SpinCo, (i)&nbsp;no petition for recognition of a labor organization or other body for the representation of the SpinCo Employees is pending or threatened, and (ii)&nbsp;there has not during the last five
(5)&nbsp;years been any (or threat of any), there are no pending and no Person has threatened to commence any, strike, slowdown, work stoppage, lockout, job action, picketing, labor dispute, question concerning representation, union organizing
activity, or any threat thereof, or any similar activity or dispute, affecting the Company or any of its Subsidiaries (with respect to the SpinCo Business) or any of the SpinCo Entities. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) There are no pending, or to the Knowledge of the Company or SpinCo, anticipated or threatened, unfair labor or other employment-related
practice charges, complaints or other grievances or Actions by or before any Governmental Authority, arising under any applicable Law governing labor or employment (or pursuant to any SpinCo CBA), SpinCo Service Providers or other Persons (in
respect of which any SpinCo Entity will have any material Liability at the Effective Time). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) For the past three (3)&nbsp;years, the
Company has been in compliance in all material respects with all Laws relating to terms and conditions of employment, employment practices, employment discrimination and harassment, civil rights, the Worker Adjustment and Retraining Notification Act
(&#147;<U>WARN</U>&#148;) and any similar state or local plant closures and mass layoffs Laws, wages (including minimum wage and overtime), hours of work, meal and rest breaks, withholdings and deductions, classification and payment of employees,
independent contractors and consultants, employment equity, collective bargaining, occupational health and safety, workers&#146; compensation, immigration, child labor, employment equity, workforce reduction and all other labor or employment related
matters with respect to any SpinCo Service Provider. During the prior three (3)&nbsp;years, there has been no &#147;mass layoff&#148; or &#147;plant closing&#148; (as defined by WARN) with respect to the Company or any of its Subsidiaries. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-47- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) The execution, delivery and performance of this Agreement and the consummation of the
Transactions do not require the Company or any of its Subsidiaries, including any SpinCo Entity, to seek or obtain any consent, engage in consultation with, or issue any notice to or make any filing with (as applicable) any unions, labor
organizations, or groups of employees of the Company, or any Governmental Authority, with respect to any SpinCo Employee. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) No
judgment, consent decree, or arbitration award imposes continuing remedial obligations or otherwise limits or affects the Company&#146;s or any of its Subsidiaries&#146;, including any SpinCo Entity&#146;s, ability to manage the SpinCo Service
Providers. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h) Except as would not reasonably be expected to result in material Liability to the SpinCo Business (taken as a whole), for
the past three (3)&nbsp;years, neither the Company nor any of its Subsidiaries, including any SpinCo Entity, has incurred, and no circumstances exist under which the Company or any of its Subsidiaries would reasonably be expected to incur with
respect to any SpinCo Service Provider, any liability arising from (i)&nbsp;the failure to pay wages (including overtime wages), (ii) the misclassification of employees as independent contractors or (iii)&nbsp;the misclassification of employees as
exempt from the requirements of the Fair Labor Standards Act or similar state Laws. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.17 <U>Compliance with Law;
Permits</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Except for Environmental Laws (which are addressed exclusively as set forth in <U>Section</U><U></U><U>&nbsp;5.20</U>),
the Company and the Company&#146;s Subsidiaries (in each case, solely with respect to the SpinCo Business) and the SpinCo Entities are, and, during the past two (2)&nbsp;years the SpinCo Entities and, solely with respect to their conduct and
operation of the SpinCo Business, the Company and its other Subsidiaries (i)&nbsp;have been in compliance with all applicable Laws, except where noncompliance has not been and would not reasonably be expected to be material to the SpinCo Business,
taken as a whole, and (ii)&nbsp;have not received notice from any Governmental Authority alleging any material <FONT STYLE="white-space:nowrap">non-compliance</FONT> with or possible material violation of any applicable Law or that the Company or
any of its Subsidiaries (with respect to the SpinCo Business) or the SpinCo Entities, is subject to any inspection, investigation, survey, audit or other review. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Except with respect to Permits required under applicable Environmental Laws (which are addressed exclusively in
<U>Section</U><U></U><U>&nbsp;5.20</U>), and except, in each case, as would not reasonably be expected to have, individually or in the aggregate, a SpinCo Material Adverse Effect, (i)&nbsp;the Company and its Subsidiaries (with respect to the SpinCo
Business) and the SpinCo Entities hold all Permits necessary to conduct the SpinCo Business substantially as conducted as of the date hereof and in compliance with applicable Law and (ii)&nbsp;such Permits are valid and in full force and effect and
the Company or its applicable Subsidiary or the applicable SpinCo Entity is in compliance with the terms thereof. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-48- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.18 <U>SpinCo Benefit Plans</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Section&nbsp;5.18(a) of the SpinCo Disclosure Schedule sets forth a list of each material Company Benefit Plan. As of the date hereof,
there are no SpinCo Benefit Plans or Foreign Benefit Plans. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) As applicable with respect to each of the Company Benefit Plans and
SpinCo Benefit Plans, the Company has made available to Parent true and complete copies of (i)&nbsp;the applicable plan document (including all amendments thereto), (ii) the most recent summary plan description including any summary of material
modifications provided to participants, (iii)&nbsp;the last filed Form 5500 series and all schedules thereto, and (iv)&nbsp;the most recent determination, opinion or advisory letter issued by the IRS and (v)&nbsp;any material, <FONT
STYLE="white-space:nowrap">non-routine</FONT> communications with any Governmental Authority in the past three years. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Each SpinCo
Benefit Plan and Company Benefit Plan intended to be qualified under Section&nbsp;401(a) of the Code has received a favorable determination letter from the IRS (or is entitled to rely upon a favorable opinion letter issued by the IRS), and no such
determination or opinion letter has been revoked nor, to the Knowledge of the Company, has any fact or circumstance occurred that could reasonably be expected to cause the loss of such qualification or the imposition of material Liability to the
SpinCo Business (taken as a whole). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) Each of the Company Benefit Plans and SpinCo Benefit Plans has been operated, funded and
administered in all material respects in accordance with its terms and in compliance with applicable Law, including ERISA and the Code. Except as would not reasonably be expected to result in material Liability to the SpinCo Business (taken as a
whole), there are no pending or, to the Knowledge of the Company, threatened claims, actions, investigations or audits (other than routine claims for benefits) involving any Company Benefit Plan or SpinCo Benefit Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) Within the last six (6)&nbsp;years, neither any Company Benefit Plan nor any SpinCo Benefit Plan has been, and none of the Company, SpinCo
nor any of their ERISA Affiliates has maintained, established, sponsored, participated in, contributed to, or had liability in respect of, an employee benefit plan subject to Section&nbsp;302 or Title IV of ERISA or Section&nbsp;412, 430 or 4971 of
the Code. None of the Company, SpinCo nor any of their ERISA Affiliates has, at any time during the preceding six (6)&nbsp;years, contributed to, been obligated to contribute to or had any liability (including any contingent liability) with respect
to, any Multiemployer Plan or a plan that has two (2)&nbsp;or more contributing sponsors, at least two (2)&nbsp;of whom are not under common control, within the meaning of Section&nbsp;4063 of ERISA. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) Except as would not reasonably be expected to result in material Liability to the SpinCo Business (taken as a whole), no Action with
respect to the administration or the investment of the assets of any SpinCo Benefit Plan or Company Benefit Plan (other than routine claims for benefits) is pending, or to the Knowledge of the Company or SpinCo, threatened. Except as would not
reasonably be expected to result in material Liability to the SpinCo Business (taken as a whole), with respect to each SpinCo Benefit Plan and Company Benefit Plan, (i)&nbsp;all required contributions have been made or properly accrued,
(ii)&nbsp;there have been no &#147;prohibited transactions&#148; (as that term is defined in Section&nbsp;406 of ERISA or Section&nbsp;4975 of the Code) and </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-49- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
(iii) all reports, returns, and similar documents required to be filed with any Governmental Authority or distributed to any SpinCo Benefit Plan or Company Benefit Plan participant have been
timely filed or distributed. The Company and SpinCo have complied in all material respects with their respective obligations under any plan, program or arrangement that is sponsored, maintained or administered by any Governmental Authority. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) Except as set forth in this Agreement or the Employee Matters Agreement, the consummation of the Transactions shall not, either alone or in
combination with another event: (i)&nbsp;entitle any current or former SpinCo Service Provider, to severance pay, unemployment compensation or any other benefits or payments; or (ii)&nbsp;accelerate the time of payment, funding or vesting, or
increase the amount of any payments or benefits due to any SpinCo Service Provider. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h) Except as set forth in Section&nbsp;5.18(h) of the
SpinCo Disclosure Schedule, no Company Benefit Plan or SpinCo Benefit Plan provides for, and SpinCo does not have any current or contingent Liability in respect of, post-retirement or other postemployment health or welfare benefits, other than
health care continuation coverage as required by Section&nbsp;4980B of the Code or any similar state Law (&#147;<U>COBRA</U>&#148;) or ERISA. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) Neither the execution and delivery of this Agreement nor the consummation of the transactions contemplated hereby or by the Transaction
Documents shall, either alone or in combination with any other event(s), result in the payment of any amount to any SpinCo Service Provider or any other current or former employee, director, officer or independent contractor of any SpinCo Entity
that could, individually or in combination with any other such payment, constitute an &#147;excess parachute payment&#148; as defined in Section&nbsp;280G(b)(1) of the Code.<SUP STYLE="font-size:85%; vertical-align:top"> </SUP> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(j) Each Company Benefit Plan that is (and each SpinCo Benefit Plan that will be) a &#147;nonqualified deferred compensation plan&#148; (as
such term is defined in Section&nbsp;409A(d)(1) of the Code and the guidance thereunder) is (or will be, as applicable) in material compliance in both form and operation with Section&nbsp;409A of the Code, and no Taxes are owed (or will be owed, as
applicable) under Section&nbsp;409A(a)(1) for any such plan or arrangement. No SpinCo Entity is under the obligation to gross up any Taxes, including under Section&nbsp;409A of the Code or Sections 280G or 4999 of the Code. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.19 <U>Intellectual Property</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Section 5.19(a) of the SpinCo Disclosure Schedule sets forth a list of, as of the date hereof, all SpinCo Owned Intellectual Property that
is the subject of any registration, issuance, or application for registration or issuance, with any Governmental Authority or Internet domain name registrar (specifying for each such item (i)&nbsp;the record owner (and, if different from the record
owner, the beneficial owner), (ii) the jurisdiction in which such item has been issued, registered or filed, (iii)&nbsp;the issuance, registration or application date and (iv)&nbsp;the issuance, registration or application number) (any Intellectual
Property set forth or required to be set forth on Section&nbsp;5.19(a) of the SpinCo Disclosure Schedule, collectively, the &#147;<U>SpinCo Registered Intellectual Property</U>&#148;). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-50- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) All SpinCo Registered Intellectual Property that is material to the SpinCo Business is
subsisting, and, to the Knowledge of the Company or SpinCo, valid and enforceable. Except as scheduled in Section&nbsp;5.19(b) of the SpinCo Disclosure Schedule, to the Knowledge of the Company or SpinCo, none of the SpinCo Registered Intellectual
Property has been or is subject to any interference, derivation, reexamination, (including ex parte reexamination, inter partes reexamination, inter partes review, post grant review or Covered Business Method (CBM) review), cancellation or
opposition proceeding. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) As of the date hereof, to the Knowledge of the Company or SpinCo, the Company and each of its Subsidiaries,
and, as of the Distribution, each of the SpinCo Entities, have prepared and are preparing to file patent applications for all potentially patentable inventions included in the SpinCo Owned Intellectual Property that are material to the SpinCo
Business as currently conducted and as currently proposed to be conducted, except, where in the exercise of reasonable business judgment, the Company, such Subsidiary or such SpinCo Entity has decided not to file or has decided to defer filing a
patent application on a potentially patentable invention. The Company, each of its Subsidiaries, and each of the SpinCo Entities has complied and does comply in all material respects with all Laws regarding the duty of disclosure, candor and good
faith in connection with each Patent included in the SpinCo Registered Intellectual Property. To the Knowledge of the Company or SpinCo, no public disclosure bar by the Company, any of its Subsidiaries, or any of the SpinCo Entities has occurred,
nor has any <FONT STYLE="white-space:nowrap">on-sale</FONT> bar by the Company, any of its Subsidiaries, or any of the SpinCo Entities arisen, which has rendered any Patent included in the SpinCo Registered Intellectual Property that is material to
the SpinCo Business, invalid, unenforceable or unpatentable. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) As of the date hereof, (i)&nbsp;the Company and its Subsidiaries solely
and exclusively own, and as of the Distribution, a SpinCo Entity solely and exclusively owns, all rights, title and interest in and to the SpinCo Owned Intellectual Property, in each case, free and clear of all Liens (other than Permitted Liens) and
(ii)&nbsp;to the Knowledge of the Company or SpinCo the Company or one of its Subsidiaries has, and, as of the Distribution, a SpinCo Entity has, valid and enforceable rights to use and exploit, pursuant to a written SpinCo Contract, all other
Intellectual Property (except for such other Intellectual Property in the public domain for which no license is necessary) used or practiced by the SpinCo Business that is material to the SpinCo Business. The SpinCo Owned Intellectual Property and
such SpinCo Licensed Intellectual Property collectively constitute all Intellectual Property used in, and necessary and sufficient for, the conduct and operation of the SpinCo Business, as currently conducted; <U>provided</U>, that the foregoing
representation shall not in any way be construed as a representation of <FONT STYLE="white-space:nowrap">non-infringement</FONT> or other violation of the Intellectual Property rights of any Person. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) To the Knowledge of the Company or SpinCo, in the past six (6)&nbsp;years with respect to Patents or in the past three (3)&nbsp;years with
respect to all other Intellectual Property, none of the SpinCo Entities or, with respect to the SpinCo Business, the Company or any of its Subsidiaries other than the SpinCo Entities, the conduct of the SpinCo Business, or any SpinCo Owned
Intellectual Property has infringed, misappropriated (or constituted or resulted from a misappropriation of), diluted or otherwise violated, or is infringing, misappropriating (or constitutes or results from the misappropriation of), diluting or
otherwise violating any Intellectual Property of any Person. To the Knowledge of the Company or SpinCo, none of the SpinCo Entities or, with respect to the SpinCo Business, the Company or any of its Subsidiaries
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-51- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
other than the SpinCo Entities, has received from any Person in the past three (3)&nbsp;years any written notice, charge, complaint, claim or other assertion: (i)&nbsp;of any infringement,
misappropriation, dilution or other violation of any Intellectual Property of any Person or (ii)&nbsp;challenging the ownership, use, validity or enforceability of any SpinCo Owned Intellectual Property that is material to the SpinCo Business as
currently conducted and as currently proposed to be conducted. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) To the Knowledge of the Company or SpinCo, no other Person has
infringed, misappropriated, diluted or violated, or is infringing, misappropriating, diluting or violating, any SpinCo Owned Intellectual Property or any SpinCo Licensed Intellectual Property exclusively licensed to the Company, any of its
Subsidiaries, or any of the SpinCo Entities, in each case, that is material to the SpinCo Business. No such claims have been made in writing or, to the Knowledge of the Company or SpinCo, otherwise made against any Person by any of the SpinCo
Entities or, with respect to the SpinCo Business, the Company or any of its Subsidiaries other than the SpinCo Entities in the past three (3)&nbsp;years. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) To the Knowledge of the Company or SpinCo, each of the SpinCo Entities and, with respect to the SpinCo Business, the Company and each of
its Subsidiaries other than the SpinCo Entities, have taken and currently takes adequate and commercially reasonable steps to maintain the secrecy and confidentiality of all Trade Secrets included in the SpinCo Owned Intellectual Property and all
Trade Secrets of any Person to whom any of the SpinCo Entities or, with respect to the SpinCo Business, the Company or any of its Subsidiaries other than the SpinCo Entities, has a confidentiality obligation with respect to such Trade Secrets. No
Trade Secret material to the SpinCo Business has been authorized by the Company, any of its Subsidiaries, or any of the SpinCo Entities to be disclosed (or, to the Knowledge of the Company or SpinCo, has been disclosed) to any Person other than
(i)&nbsp;pursuant to a written agreement adequately restricting the disclosure and use of such Trade Secret or (ii)&nbsp;to a Person who otherwise has a duty to protect such Trade Secret. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h) Each of the past and present employees, consultants and independent contractors of the Company, any of its Subsidiaries, or any of the
SpinCo Entities who has been or is engaged in inventing, creating, conceiving or developing any Intellectual Property that is material to the SpinCo Business as currently conducted and as currently proposed to be conducted for any of the SpinCo
Entities or, with respect to the SpinCo Business, the Company or any of its Subsidiaries other than the SpinCo Entities has executed and delivered to the Company or such Subsidiary or SpinCo Entity, as applicable, a written agreement, pursuant to
which such Person has (x)&nbsp;agreed to hold all confidential information of the SpinCo Business in confidence both during and after such Person&#146;s employment or retention, as applicable, and (y)&nbsp;presently assigned to the Company, such
Subsidiary, or such SpinCo Entity, as applicable, all of such Person&#146;s rights, title and interest in and to all Intellectual Property invented, created, conceived or developed in the course of such Person&#146;s employment or engagement thereby
(each, a &#147;<U>Personnel IP Contract</U>&#148;). To the Knowledge of the Company or SpinCo, there is no uncured breach by any such Person with respect to any Intellectual Property that is material to the SpinCo Business as currently conducted and
as currently proposed to be conducted under any such Personnel IP Contract. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-52- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) No funding, facilities or personnel of any Governmental Authority or any university,
college, research institute or other educational institution has been or is being used to invent, create, conceive or develop, in whole or in part, (i)&nbsp;any SpinCo Owned Intellectual Property or (ii)&nbsp;to the Knowledge of the Company or
SpinCo any SpinCo Licensed Intellectual Property exclusively licensed to the Company, any of its Subsidiaries, or any of the SpinCo Entities, in each case of clauses (i)&nbsp;and (ii), that is material to the SpinCo Business as currently conducted
and as currently proposed to be conducted, except for any such funding or use of facilities or personnel that (A)&nbsp;does not result in such Governmental Authority, university, college, research institute or other educational institution obtaining
or retaining, or having the right to obtain or retain ownership of, or use rights to (except for use rights during the term of the applicable SpinCo Contract with such Governmental Authority, university, college, research institute or other
educational institution), any SpinCo Owned Intellectual Property, or (B)&nbsp;does not require or otherwise obligate the Company, any of its Subsidiaries, or any of the SpinCo Entities to grant or offer to any Governmental Authority, university,
college, research institute or other educational institution any license or other right to, or covenant not to assert with respect to, any SpinCo Owned Intellectual Property (except for use rights during the term of the applicable SpinCo Contract
with such Governmental Authority, university, college, research institute or other educational institution). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(j) As of the date hereof,
none of the Company or any of its Subsidiaries owns or purports to own any Software included in the SpinCo Owned Intellectual Property that is material to the SpinCo Business, and, as of the Distribution, none of the SpinCo Entities owns or purports
to own any Software included in the SpinCo Owned Intellectual Property that is material to the SpinCo Business. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(k) To the Knowledge of
the Company or SpinCo, (i)&nbsp;as of the date hereof, the Company or one of its Subsidiaries, and (ii)&nbsp;as of the Distribution, a SpinCo Entity, owns or has a valid right to access and use pursuant to a written SpinCo Contract, all SpinCo IT
Systems in the manner in which they are currently accessed or used in the conduct of the SpinCo Business. To the Knowledge of the Company or SpinCo, except for the IT Assets utilized by Company to provide services to SpinCo pursuant to the
applicable Transition Services Agreement, the SpinCo IT Systems are adequate in all material respects for the operation and conduct of the SpinCo Business as currently conducted. To the Knowledge of the Company or SpinCo, the SpinCo IT Systems have
not materially malfunctioned or failed for the past three (3)&nbsp;years. To the Knowledge of the Company or SpinCo, during the past three (3)&nbsp;years, there has been no unauthorized access to or use of, or breach or other violation of, any
SpinCo IT Systems, in each case, that has had, individually or in the aggregate, a material adverse effect on the SpinCo Business or the SpinCo IT Systems. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(l) Neither the execution of this Agreement or any of the other Transaction Documents nor the consummation of the Transaction Process will
result in (i)&nbsp;the loss or impairment of, or any Lien on, any material SpinCo Owned Intellectual Property or material SpinCo Licensed Intellectual Property; (ii)&nbsp;the release, disclosure or delivery of any source code included in the SpinCo
Owned Intellectual Property to any Person; or (iii)&nbsp;the payment of any additional consideration to, or the reduction of any amount(s) payable from, any Person, in each case, with respect to any SpinCo Owned Intellectual Property or SpinCo
Licensed Intellectual Property, and where the applicable consideration or amount(s) exceeds $200,000. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-53- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.20 <U>Environmental Matters</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Except as would not otherwise reasonably be expected to have, individually or in the aggregate, a SpinCo Material Adverse Effect: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) With respect to their operation of the SpinCo Business, the Company and its Subsidiaries are, and during the past three
(3)&nbsp;years the Company and its Subsidiaries have been, in compliance with applicable Environmental Laws, which compliance includes obtaining, maintaining, and complying with all Permits required under Environmental Laws for the operation of the
SpinCo Business, all of which Permits are in full force and effect; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) With respect to their operation of the SpinCo
Business, the Company and its Subsidiaries have not received notice from any Governmental Authority or Person alleging any <FONT STYLE="white-space:nowrap">non-compliance</FONT> with or Liability under any applicable Environmental Law by the Company
or any of its Subsidiaries; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iii) No Actions pursuant to any Environmental Law to the extent affecting the SpinCo Business
or any SpinCo Assets are pending or threatened in writing or, to the Knowledge of the Company or SpinCo, threatened orally against the Company or any of its Subsidiaries; and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iv) Neither the Company nor any of its Subsidiaries nor, to the Knowledge of the Company or SpinCo, any other Person has
Released Hazardous Materials at, on, upon, into or from any SpinCo Real Property at concentrations or under conditions that would result in the Company or any Subsidiary incurring Liability under Environmental Laws. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.21 <U>Affiliate Matters</U>. Except for Contracts solely between or among the SpinCo Entities or Contracts for employment,
compensation or benefit agreements or arrangements with directors, officers and employees made in the ordinary course of business or as set forth in Section&nbsp;5.21 of the SpinCo Disclosure Schedule, no SpinCo Entity is party to any SpinCo
Affiliate Contract. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.22 <U>Brokers</U><U>&#146;</U><U> Fees</U>. No broker, finder, investment banker or other Person is
entitled to any brokerage fee, finders&#146; fee or other similar commission, for which Parent, Merger Sub or any of the SpinCo Entities would be liable in connection with the transactions contemplated by this Agreement or any other Transaction
Document based upon arrangements made by or on behalf of any SpinCo Entity. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.23 <U>Proxy Statement; Registration
Statements</U>. None of the information regarding any of the Company or any of its Subsidiaries (including the SpinCo Entities), the SpinCo Business, or the Transactions to be provided by the Company or SpinCo or any of their respective Subsidiaries
specifically for inclusion in, or incorporation by reference into, the Proxy Statement, the Parent Registration Statement, the SpinCo Registration Statement or the documents relating to the Distribution that are filed with the SEC and/or distributed
to Company stockholders or Parent shareholders (the &#147;<U>Distribution Documents</U>&#148;) will, in the case of the Proxy Statement and the Distribution Documents or any amendment or supplement thereto, at the time
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-54- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
of the first mailing of the Proxy Statement and the Distribution Documents and of any amendment or supplement thereto, or, in the case of the Parent Registration Statement or the SpinCo
Registration Statement, at the time such registration statement becomes effective, on the date of the Parent Shareholders Meeting, at the Distribution Time or at the Effective Time, contain an untrue or false statement of a material fact or omit to
state any material fact required to be stated therein or necessary in order to make the statements therein, in the light of the circumstances under which they are made, not false or misleading. The SpinCo Registration Statement will comply as to
form in all material respects with the provisions of the Securities Act, except that no representation is made by the Company or SpinCo with respect to information provided by Parent specifically for inclusion in, or incorporation by reference into,
the SpinCo Registration Statement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.24 <U>Board and Shareholder Approval</U>. Each of the Company Board and the SpinCo
Board, at a meeting duly called and held or by written consent, has by unanimous vote of all directors present or unanimous consent, (a)&nbsp;approved this Agreement, the Separation and Distribution Agreement and the other Transaction Documents and
authorized and approved the execution, delivery and performance hereof and thereof and the consummation of the Transactions, including the Merger and the Separation, and (b)&nbsp;declared each of them advisable, fair to and in the best interests of
the Company, SpinCo and their respective stockholders. As of the date hereof, the sole shareholder of SpinCo is (and as of immediately prior to the Distribution the sole shareholder of SpinCo will be) the Company. Immediately after the execution of
this Agreement, the Company will approve and adopt, as SpinCo&#146;s sole shareholder, this Agreement and the Transaction Documents and the Transactions, including the Merger (the &#147;<U>SpinCo Shareholder Approval</U>&#148;). The SpinCo
Shareholder approval is the only approval of the shareholders of the Company or any of its Subsidiaries required to approve the Transactions. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.25 <U>Parent Capital Stock</U>. Neither the Company nor any of its Subsidiaries, including SpinCo owns (directly or indirectly,
beneficially or of record) or will own on the Closing Date nor is a party to any Contract for the purpose of acquiring, holding, voting or disposing of, in each case, any shares of capital stock of Parent (other than as contemplated by this
Agreement). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.26 <U>Healthcare Regulatory Matters</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) SpinCo and its Subsidiaries are, and for the past three (3)&nbsp;years have been, in compliance with all applicable Healthcare Laws, except
where such failure to so comply would not reasonably be expected, individually or in the aggregate, to have a material impact on the SpinCo Business. Neither SpinCo nor any of its Subsidiaries has received any written notice or other written
communication from any Regulatory Authority alleging any material violation of any applicable Healthcare Law that remains unresolved. There are no investigations, suits, claims, actions or proceedings pending or, to the Knowledge of the Company,
threatened against SpinCo or any of its Subsidiaries with respect to any of the SpinCo Products or alleging any material violation by SpinCo or the SpinCo Products of any such applicable Healthcare Law. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Neither SpinCo nor any of its Subsidiaries holds any Regulatory Authorization, or has any such application for a Regulatory Authorization
pending with the FDA or any other applicable Regulatory Authority or, to the Knowledge of the Company, has at any time in the past three (3)&nbsp;years has been required to hold a Regulatory Authorization in connection with the SpinCo Products or
operations. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-55- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Neither SpinCo nor any of its Subsidiaries is conducting or sponsoring, and during the
past three (3)&nbsp;years, has not conducted or sponsored, any <FONT STYLE="white-space:nowrap">pre-clinical</FONT> studies or clinical trials that are or were required under any applicable Healthcare Laws to be conducted in compliance with Good
Laboratory Practices or Good Clinical Practices. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) None of the SpinCo Entities or, to the Knowledge of the Company, any person acting on
behalf of any SpinCo Entity has during the past three (3)&nbsp;years, with respect to any SpinCo Product: (i)&nbsp;been subject to a shutdown or import or export prohibition imposed by any Regulatory Authority; or (ii)&nbsp;received any FDA Form
483, or other written notice of inspectional observations, &#147;warning letters,&#148; &#147;untitled letters&#148; or any similar written correspondence from any Regulatory Authority in respect of such SpinCo Entity or its business operations,
alleging or asserting material noncompliance with any applicable Healthcare Law or Regulatory Authorization, and, to the Knowledge of the Company, no Regulatory Authority has threatened such action. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) None of the SpinCo Entities has (i)&nbsp;made an untrue statement of a material fact or fraudulent statement to any Regulatory Authority,
(ii)&nbsp;failed to disclose a material fact required to be disclosed to any Regulatory Authority or (iii)&nbsp;committed an act, made a disclosure, or failed to commit an act or make a disclosure, including with respect to any scientific data or
information, that, at the time of such action, failure to act, disclosure or failure to disclose (as applicable), would reasonably be expected to provide a basis for the FDA to invoke its policy respecting &#147;Fraud, Untrue Statements of Material
Facts, Bribery, and Illegal Gratuities&#148;, set forth in 56 Fed. Reg. 46191 (September 10, 1991), and any amendments thereto, or for the FDA or any other Regulatory Authority to invoke any similar policy. None of SpinCo or, to the Knowledge of
SpinCo, any of its officers, employees or agents has been convicted of any crime or engaged in any conduct that has resulted in, or would reasonably be expected to result in, debarment from participation in any program related to pharmaceutical
products pursuant to 21 U.S.C. Section&nbsp;335a (a)&nbsp;or (b) or exclusion from participation in any federal health care program. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.27 <U>Data Privacy</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) (i) SpinCo and its Subsidiaries (and, with respect to the SpinCo Business, the Company and each of its Subsidiaries other than the SpinCo
Entities) are, and have for the past three (3)&nbsp;years been, in material compliance with all Privacy Requirements. During the past three&nbsp;(3) years, neither SpinCo nor any of its Subsidiaries (and, with respect to the SpinCo Business, neither
the Company nor any of its Subsidiaries other than the SpinCo Entities) has received any written notice of any claims, charges, investigations, or regulatory inquiries related to or alleging the violation of any Privacy Requirements. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Each of the SpinCo Entities (and, with respect to the SpinCo Business, the Company and each of its Subsidiaries other than the SpinCo
Entities), has (i)&nbsp;implemented, and for the past three (3)&nbsp;years has maintained, commercially reasonable technical and organizational safeguards to protect Personal Information and other confidential data in its possession or under its
control, and (ii)&nbsp;taken commercially reasonable steps to ensure that any third party with access to any Personal Information collected by or on behalf of any of the SpinCo Entities (or, with respect to the SpinCo Business, the Company or any of
its Subsidiaries other than the SpinCo Entities) has implemented and maintained commercially reasonable safeguards. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-56- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) During the past three (3)&nbsp;years: (i) there have been no material breaches, security
incidents, misuse of or unauthorized access to or disclosure of any Personal Information (&#147;<U>Security Incident</U>&#148;) maintained by SpinCo or any of its Subsidiaries (or, with respect to the SpinCo Business, the Company or any of its
Subsidiaries other than the SpinCo Entities); nor (ii)&nbsp;to the Knowledge of the Company or SpinCo, has any Person processing Personal Information on behalf of the SpinCo Entities (and, with respect to the SpinCo Business, the Company or any of
its Subsidiaries other than the SpinCo Entities) experienced any Security Incidents with respect to such Personal Information. SpinCo and its Subsidiaries (and, with respect to the SpinCo Business, the Company and its Subsidiaries other than the
SpinCo Entities) have implemented reasonable disaster recovery and business continuity plans. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) To the Knowledge of the Company or
SpinCo, the transfer of Personal Information in connection with the Transactions will not violate in any material respect any Privacy Requirements. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.28 <U>Anti-Bribery, Anti-Corruption and Anti-Money Laundering</U>. None of the Company or the Company&#146;s Subsidiaries (in
each case, with respect to the SpinCo Business), the SpinCo Entities, or any of their respective directors, officers, employees, agents, or any other Person acting for or on behalf of the SpinCo Business or SpinCo Entities has, directly or
indirectly, for the previous five (5)&nbsp;years, (a) made, offered, or promised to make or offer any payment, loan, or transfer of anything of value, including any reward, advantage, or benefit of any kind, to or for the benefit of any Government
Official, candidate for public office, political party, or political campaign, for the purpose of (i)&nbsp;influencing any act or decision of such Government Official, candidate, party or campaign, (ii)&nbsp;inducing such Government Official,
candidate, party or campaign to do or omit to do any act in violation of a lawful duty, (iii)&nbsp;obtaining or retaining business for or with any Person, (iv)&nbsp;expediting or securing the performance of official acts of a routine nature, or
(v)&nbsp;otherwise securing any improper advantage; (b)&nbsp;paid, offered, or promised to pay or offer any bribe, payoff, influence payment, kickback, unlawful rebate, or other similar unlawful payment of any nature; (c)&nbsp;made, offered or
promised to make or offer any unlawful contributions, gifts, entertainment, or other unlawful expenditures; (d)&nbsp;established or maintained any unlawful fund of corporate monies or other properties; (e)&nbsp;created or caused the creation of any
false or inaccurate books and records of the Company or the Company&#146;s Subsidiaries (in each case, with respect to the SpinCo Business) or the SpinCo Entities; or (f)&nbsp;otherwise violated any provision of the Foreign Corrupt Practices Act of
1977, 15 U.S.C. &#167;&#167; <FONT STYLE="white-space:nowrap">78dd-1,</FONT> et seq., the Money Laundering Control Act, the Currency and Foreign Transactions Reporting Act, The Uniting and Strengthening America by Providing Appropriate Tools
Required to Intercept and Obstruct Terrorism Act of 2001, or any other Laws relating to corruption, bribery, or money laundering, in each case of <FONT STYLE="white-space:nowrap">clauses&nbsp;(a)-(e),</FONT> in a manner that would result in a
violation of any of the Laws described in clause (f). Within the past five (5)&nbsp;years, none of the Company, the Company&#146;s Subsidiaries, or the SpinCo Entities has made any voluntary disclosure to any Governmental Authority relating to
corruption, bribery, or money laundering Laws; been the subject of any investigation or inquiry regarding compliance with such Laws; or been assessed any fine or penalty under such Laws. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-57- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.29 <U>Sanctions, Import, and Export Controls</U>. None of the Company or the
Company&#146;s Subsidiaries (in each case, with respect to the SpinCo Business), the SpinCo Entities, or any of their respective directors, officers, employees, agents, or any other Person acting for or on behalf of the SpinCo Business or SpinCo
Entities (a)&nbsp;is a Person with whom transactions are prohibited or limited under any economic sanctions Laws, including those administered by the U.S. government (including, without limitation, the Department of the Treasury&#146;s Office of
Foreign Assets Control, the Department of State, or the Department of Commerce), the United Nations Security Council, the European Union, or Her Majesty&#146;s Treasury, or (b)&nbsp;has violated any Laws relating to economic sanctions within the
last five (5)&nbsp;years. The Company and the Company&#146;s Subsidiaries (in each case, with respect to the SpinCo Business) and the SpinCo Entities are and for the past five (5)&nbsp;years have been in possession of and in compliance with any and
all licenses, registrations, and permits that may be required for their lawful conduct under economic sanctions, import, and export control Laws, including without limitation the Export Administration Regulations, 15 C.F.R. &#167; 730 et seq. Within
the past five (5)&nbsp;years, none of the Company, the Company&#146;s Subsidiaries, or the SpinCo Entities has made any voluntary disclosure to any Governmental Authority relating to sanctions, import, or export control Laws; been the subject of any
investigation or inquiry regarding compliance with such Laws; or been assessed any fine or penalty under such Laws. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.30
<U>No Other Representations and Warranties</U>. Except as expressly set forth in <U>Article VI</U> or in any Transaction Document, (a)&nbsp;the Company and SpinCo each acknowledges and agrees that neither Parent, Merger Sub nor any of their
Affiliates, nor any of their respective Representatives has made, or is making, any express or implied representation or warranty whatsoever with respect to Parent, Merger Sub or any of its Affiliates, or any of their respective businesses,
operations, assets, liabilities, conditions (financial or otherwise) or prospects, and (b)&nbsp;the Company and SpinCo each further acknowledges and agrees that neither Parent nor any of its Affiliates shall be liable in respect of the accuracy or
completeness of any information provided to the Company, SpinCo or any of its respective Affiliates or Representatives. Without limiting the generality of the foregoing, except as expressly set forth in <U>Article</U><U></U><U>&nbsp;VI </U>or in any
Transaction Document, each of the Company and SpinCo acknowledges and agrees that no representations or warranties are made with respect to any projections, forecasts, estimates or budgets with respect to Parent or any of its Subsidiaries that may
have been made available to the Company, SpinCo or any of their Representatives, and expressly disclaim reliance on any other representations, warranties, statements, information or inducements, oral or written, express or implied, or as to the
accuracy or completeness of any statements or other information, made to, or made available to, itself or any of its Representatives, in each case with respect to, or in connection with, the negotiation, execution or delivery of this Agreement, any
instrument or other document delivered pursuant to this Agreement or the transactions contemplated by this Agreement, and notwithstanding the distribution, disclosure or other delivery to the Company, SpinCo or any of their Representatives of any
document or other information with respect to any one or more of the foregoing, and waive any claims or causes of actions relating thereto, other than those for Actual Fraud. Without limiting the generality of the foregoing, it is understood that
any cost estimates, financial or other projections or other predictions that may be contained or referred to in this Agreement (including the Parent Disclosure Schedule), any information, documents or other materials (including any such materials
reviewed by the Company, SpinCo or any of their respective Affiliates or Representatives) or management presentations that have been or shall hereafter be provided to the Company, SpinCo or any of their respective Affiliates or
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-58- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Representatives are not and will not be deemed to be representations or warranties of Parent or Merger Sub, and no representation or warranty is made as to the accuracy or completeness of any of
the foregoing except as expressly set forth in <U>Article</U><U></U><U>&nbsp;VI</U> (including the Disclosure Schedule) of this Agreement or in any Transaction Document. In entering into this Agreement, the Company and SpinCo acknowledge and agree
that they have relied solely upon their own investigation and analysis; and the Company and SpinCo acknowledge and agree, to the fullest extent permitted by Law, that Parent, Merger Sub and their Affiliates and their respective Representatives shall
not have any Liability or responsibility whatsoever to the Company or SpinCo or any of their respective Representatives on any basis (including in contract or tort, under federal or state securities Laws or otherwise) based upon any information
provided or made available, or statements made (or any omissions therefrom), to the Company or SpinCo or their Affiliates or any of their respective Representatives, including in respect of the specific representations and warranties set forth in
<U>Article</U><U></U><U>&nbsp;VI</U> of this Agreement or any Transaction Document, except as and only to the extent expressly set forth herein or therein with respect to such representations and warranties and subject to the limitations and
restrictions contained herein or therein. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ARTICLE&nbsp;VI </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">REPRESENTATIONS AND WARRANTIES OF PARENT AND MERGER SUB </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Except as otherwise disclosed or identified in (a)&nbsp;the Parent SEC Documents filed and publicly available on the SEC&#146;s EDGAR database
at least two (2)&nbsp;Business Days prior to the date hereof (excluding any disclosures of factors or risks contained or references therein under the captions &#147;Risk Factors&#148; or &#147;Forward-Looking Statements&#148; to the extent they are
forward-looking statements and any other similar general, predictive or cautionary statements) or (b)&nbsp;the corresponding section or subsection of the Parent Disclosure Schedule (it being understood that each such disclosure shall also apply to
each other representation and warranty contained in this <U>Article VI</U> to the extent that it is reasonably apparent on the face of such disclosure that it is relevant to or applies to such representation or warranty), Parent and Merger Sub
hereby represent and warrant to the Company and SpinCo as follows: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.1 <U>Organization of Parent and Merger Sub</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Parent has been duly incorporated and is validly existing and in good standing as a Cayman Islands exempted company and has all requisite
corporate power and authority to own, lease and operate its assets in the manner in which such assets are now owned, leased and operated and to conduct its business as it is now being conducted. Parent has made available to the Company true and
complete copies of the Governing Documents of Parent. Parent is duly licensed or qualified and in good standing (or equivalent status as applicable) in each jurisdiction in which the assets owned or leased by it or the character of its activities
require it to be so licensed or qualified or in good standing (or equivalent status as applicable), except as would not, individually or in the aggregate, reasonably be expected to have a Parent Material Adverse Effect. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Merger Sub is a corporation duly incorporated, validly existing and in good standing under the Laws of Delaware. Merger Sub is a wholly
owned Subsidiary of Parent. The copies of the Governing Documents of Merger Sub which were previously furnished or made available to the Company are true and complete copies of such documents as in effect on the date of this Agreement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-59- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.2 <U>Due Authorization</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Each of Parent and Merger Sub has all requisite corporate power and authority to execute and deliver this Agreement and the Transaction
Documents to which it is or will be a party at the Effective Time and (subject to the receipt of the Consents described in <U>Section</U><U></U><U>&nbsp;6.4</U>, the Parent Shareholder Approval and the Merger Sub Shareholder Approval) to consummate
the Transactions. The execution and delivery by each of Parent and Merger Sub of this Agreement and the Transaction Documents to which it is or will be a party at the Effective Time and the consummation by each of Parent and Merger Sub of the
Transactions have been duly and validly authorized and approved by all necessary and proper corporate action on its part, and, except for the Parent Shareholder Approval and the Merger Sub Shareholder Approval, no other corporate action on the part
of Parent or Merger Sub is necessary to authorize this Agreement or the Transaction Documents to which it is or will be a party at the Effective Time. Each of this Agreement and the Transaction Documents to which it is or will be a party at the
Effective Time has been, or when executed and delivered will be, duly and validly executed and delivered by Parent and (assuming that this Agreement or such other applicable Transaction Documents to which each of the Company or SpinCo is or will be
a party at the Effective Time constitutes a legal, valid and binding obligation of each of the Company and SpinCo (as applicable)) constitutes or will constitute a legal, valid and binding obligation of Parent and Merger Sub (as applicable),
enforceable against Parent and Merger Sub (as applicable) in accordance with its terms, subject to the Remedies Exception. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Assuming
that a quorum (as determined pursuant to Parent&#146;s Governing Documents) is present: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) each of those Transaction
Proposals identified in clauses <U>(A)</U>, <U>(B)</U> and <U>(C)</U>&nbsp;of <U>Section</U><U></U><U>&nbsp;7.4(e)(ii)</U> shall require approval by a special resolution under the CICA (being the affirmative vote of the holders of at least <FONT
STYLE="white-space:nowrap">two-thirds</FONT> of the ordinary shares who, being present and entitled to vote at the Parent Shareholders Meeting, vote at the Parent Shareholders Meeting); </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) each of those Transaction Proposals identified in clauses <U>(D)</U>, <U>(E)</U>, <U>(F)</U> and <U>(I)</U>, of
<U>Section</U><U></U><U>&nbsp;7.4(e)(ii)</U>, in each case, shall require approval by an ordinary resolution (being the affirmative vote of the holders of a majority of the ordinary shares who, being present and entitled to vote at the Parent
Shareholders Meeting, vote at the Parent Shareholders Meeting); and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iii) each of those Transaction Proposals identified
in clauses <U>(G)</U>&nbsp;and <U>(H)</U>, of <U>Section</U><U></U><U>&nbsp;7.4(e)(ii)</U>, in each case, shall require approval by the number of holders of Parent Common Stock required to approve such Transaction Proposals under applicable Law and
the Governing Documents of Parent. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-60- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) The foregoing votes are the only votes of any of Parent&#146;s share capital necessary
in connection with entry into this Agreement by Parent and Merger Sub and the consummation of the Transactions, including the Closing. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d)
At a meeting duly called and held, the Parent Board has unanimously approved the Transactions as a Business Combination. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.3
<U>Capital Stock and Other Matters</U>. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) As of the date of this Agreement, the authorized share capital of Parent is 555,000,000
shares, divided into (i) 500,000,000 shares of Parent Class&nbsp;A Common Stock, 23,000,000 of which are issued and outstanding as of the date of this Agreement, (ii) 50,000,000 shares of Parent Class&nbsp;B Common Stock, of which 5,750,000 shares
are issued and outstanding as of the date of this Agreement, and (iii) 5,000,000 preferred shares of par value $0.0001 each, of which no shares are issued and outstanding as of the date of this Agreement ((i), (ii) and (iii)&nbsp;collectively, the
&#147;<U>Parent Securities</U>&#148;). The foregoing represents all of the issued and outstanding Parent Securities as of the date of this Agreement. All issued and outstanding Parent Securities (i)&nbsp;have been duly authorized and validly issued
and are fully paid and <FONT STYLE="white-space:nowrap">non-assessable;</FONT> (ii)&nbsp;have been offered, sold and issued in compliance with applicable Law, including federal and state securities Laws, and all requirements set forth in
(1)&nbsp;Parent&#146;s Governing Documents, and (2)&nbsp;any other applicable Contracts governing the issuance of such securities; and (iii)&nbsp;are not subject to, nor have they been issued in violation of, any purchase option, call option, right
of first refusal, preemptive right, subscription right or any similar right under any provision of any applicable Law, Parent&#146;s Governing Documents or any Contract to which Parent is a party or otherwise bound. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Subject to the terms of conditions of the Warrant Agreement, the Domesticated Parent Warrants will be exercisable after giving effect to
the Merger for one share of Domesticated Parent Common Stock at an exercise price of eleven Dollars fifty cents ($11.50) per share. As of the date of this Agreement, 7,666,667 Parent Common Warrants and 8,233,333 Parent Private Placement Warrants
are issued and outstanding. The Parent Warrants are not exercisable until the later of (x)&nbsp;August&nbsp;12, 2022 and (y)&nbsp;thirty (30) days after the Closing. All outstanding Parent Warrants (i)&nbsp;have been duly authorized and validly
issued and constitute valid and binding obligations of Parent, enforceable against Parent in accordance with their terms, subject to the Remedies Exemption; (ii)&nbsp;have been offered, sold and issued in compliance with applicable Law, including
federal and state securities Laws, and all requirements set forth in (1)&nbsp;Parent&#146;s Governing Documents and (2)&nbsp;any other applicable Contracts governing the issuance of such securities; and (iii)&nbsp;are not subject to, nor have they
been issued in violation of, any purchase option, call option, right of first refusal, preemptive right, subscription right or any similar right under any provision of any applicable Law, Parent&#146;s Governing Documents or any Contract to which
Parent is a party or otherwise bound. Except for the A&amp;R Forward Purchase Agreement, Parent&#146;s Governing Documents and this Agreement, there are no outstanding Contracts of Parent to repurchase, redeem or otherwise acquire any Parent
Securities. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-61- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Except as set forth in this <U>Section</U><U></U><U>&nbsp;6.3</U> or as contemplated by
this Agreement or the other documents contemplated hereby, and other than in connection with the PIPE Investment and the Redemption Backstop, Parent has not granted any outstanding options, stock appreciation rights, warrants, rights or other
securities convertible into or exchangeable or exercisable for Parent Securities, or any other commitments or agreements providing for the issuance of additional shares, the sale of treasury shares, for the repurchase or redemption of any Parent
Securities or the value of which is determined by reference to the Parent Securities, and there are no Contracts of any kind which may obligate Parent to issue, purchase, redeem or otherwise acquire any of its Parent Securities. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) Subject to obtaining the Parent Shareholder Approval, the shares of Domesticated Parent Stock comprising the Merger Consideration, when
issued in accordance with the terms hereof, shall be duly authorized and validly issued, fully paid and <FONT STYLE="white-space:nowrap">non-assessable</FONT> and issued in compliance with all applicable state and federal securities Laws and not
subject to, and not issued in violation of, any Lien, purchase, option, call option, right of first refusal, preemptive right, subscription right or any similar right under any provision of applicable Law, Parent&#146;s Governing Documents, or any
Contract to which Parent is a party or otherwise bound. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) On or prior to the date of this Agreement, Parent has entered into the A&amp;R
Forward Purchase Agreement with the Sponsor, pursuant to which, and on the terms and subject to the conditions of which, Sponsor has agreed, subject to the terms and conditions therein and in connection with the Transactions, to make the PIPE
Investment and the Redemption Backstop. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) Parent has no Subsidiaries apart from Merger Sub, and does not own, directly or indirectly,
any Interest or other interest or investment (whether equity or debt) in any Person, whether incorporated or unincorporated (each, an &#147;<U>Investment</U>&#148;). Parent is not party to any Contract that obligates Parent to invest money in, loan
money to or make any capital contribution to any other Person. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.4 <U>Governmental Consents</U>. No consent, waiver,
approval or authorization of, or designation, declaration or filing with, or notification to, any Governmental Authority or other Person is required on the part of Parent or Merger Sub with respect to Parent&#146;s or Merger Sub&#146;s execution or
delivery of this Agreement or the consummation of the Transactions, except for (i)&nbsp;applicable requirements of the HSR Act, (ii)&nbsp;in connection with the Domestication, the applicable requirements and required approval of the Cayman
Registrar, and (iii)&nbsp;as otherwise disclosed on Section&nbsp;6.4 of the Parent Disclosure Schedule. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.5 <U>No
Conflict</U>. Subject to the receipt of the Consents described in <U>Section</U><U></U><U>&nbsp;6.4</U> and the Parent Shareholder Approval, the execution and delivery by each of Parent and Merger Sub of this Agreement and the other Transaction
Documents to which it is or will be a party at the Effective Time and the consummation by Parent and Merger Sub of the Transactions (for the avoidance of doubt, including performance of the Transaction Documents following the Closing by Parent and
the Parent Subsidiaries, other than the SpinCo Entities) do not and will not as of the Effective Time: (a)&nbsp;violate any provision of, or result in the material breach of, any Law applicable to Parent and the Parent Subsidiaries or by which any
of its assets or properties is bound; (b)&nbsp;with or without lapse of time or the giving of notice or both, require a consent or approval under, conflict with, result in a violation or breach of, or constitute a default under, result in the
acceleration of, or create in any party the right to accelerate, terminate or cancel any Parent Material Contract; or (c)&nbsp;violate any provision of the Governing Documents of Parent, or Merger Sub, except, in the case of clauses (a)&nbsp;and
(b), as would not, individually or in the aggregate, reasonably be expected to have a Parent Material Adverse Effect. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-62- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.6 <U>Internal Controls; Listing; Financial Statements</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Except as not required in reliance on exemptions from various reporting requirements by virtue of Parent&#146;s status as an &#147;emerging
growth company&#148; within the meaning of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (&#147;<U>JOBS Act</U>&#148;), Parent has established and maintains disclosure controls and procedures (as defined in Rule <FONT
STYLE="white-space:nowrap">13a-15</FONT> under the Exchange Act). Such disclosure controls and procedures are designed to ensure that material information relating to Parent, including its consolidated Subsidiaries, if any, is made known to
Parent&#146;s principal executive officer and its principal financial officer by others within those entities, particularly during the periods in which the periodic reports required under the Exchange Act are being prepared. To Parent&#146;s
Knowledge, such disclosure controls and procedures are effective in timely alerting Parent&#146;s principal executive officer and principal financial officer to material information required to be included in Parent&#146;s periodic reports required
under the Exchange Act. Parent has established and maintained a system of internal controls over financial reporting (as defined in Rule <FONT STYLE="white-space:nowrap">13a-15</FONT> under the Exchange Act) that, to Parent&#146;s Knowledge, are
sufficient to provide reasonable assurance regarding the reliability of Parent&#146;s financial reporting and the preparation of Parent&#146;s financial statements for external purposes in accordance with GAAP and there have been no significant
deficiencies or material weakness in Parent&#146;s internal control over financial reporting (whether or not remediated) and no change in Parent&#146;s control over financial reporting that has materially affected, or is reasonably likely to
materially affect Parent&#146;s internal control over financial reporting. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) As of the date hereof, each director and executive officer
of Parent has filed with the SEC on a timely basis all statements required by Section&nbsp;16(a) of the Exchange Act and the rules and regulations promulgated thereunder. Parent has not taken any action prohibited by Section&nbsp;402 of the
Sarbanes-Oxley Act. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) The Parent Class&nbsp;A Common Stock is registered pursuant to Section&nbsp;12(b) of the Exchange Act and is
listed for trading on NASDAQ. There is no Action pending or, to the Knowledge of Parent, threatened against Parent by NASDAQ or the SEC with respect to any intention by such entity to deregister the Parent Class&nbsp;A Common Stock or prohibit or
terminate the listing of Parent Class&nbsp;A Common Stock on NASDAQ. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) The financial statements and notes contained or incorporated by
reference in the Parent SEC Filings fairly present in all material respects the financial condition and the results of operations, changes in stockholders&#146; equity and cash flows of Parent as at the respective dates of, and for the periods
referred to, in such financial statements, all in accordance with: (i)&nbsp;GAAP; and (ii)&nbsp;Regulation <FONT STYLE="white-space:nowrap">S-X</FONT> or Regulation <FONT STYLE="white-space:nowrap">S-K,</FONT> as applicable, subject, in the case of
interim financial statements, to normal recurring <FONT STYLE="white-space:nowrap">year-end</FONT> adjustments (the effect of which will not, individually or in the aggregate, be material) and the omission of notes to the extent permitted by
Regulation <FONT STYLE="white-space:nowrap">S-X</FONT> or Regulation <FONT STYLE="white-space:nowrap">S-K,</FONT> as applicable. Parent has no <FONT STYLE="white-space:nowrap">off-balance</FONT> sheet arrangements that are not disclosed in the
Parent SEC Filings. No financial statements other than those of Parent are required by GAAP to be included in the consolidated financial statements of Parent. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-63- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) There are no outstanding loans or other extensions of credit made by Parent to any
executive officer (as defined in Rule <FONT STYLE="white-space:nowrap">3b-7</FONT> under the Exchange Act) or director of Parent. Parent has not taken any action prohibited by Section&nbsp;402 of the Sarbanes-Oxley Act. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) Neither Parent (including any employee thereof) nor Parent&#146;s independent auditors has identified or been made aware of (i)&nbsp;any
significant deficiency or material weakness in the system of internal accounting controls utilized by Parent, (ii)&nbsp;any Actual Fraud, whether or not material, that involves Parent&#146;s management or other employees who have a role in the
preparation of financial statements or the internal accounting controls utilized by Parent or (iii)&nbsp;any claim or allegation regarding any of the foregoing. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.7 <U>No Undisclosed Liabilities</U>. Except for any fees and expenses payable by Parent or Merger Sub as a result of or in
connection with the consummation of the Transactions, there is no liability, debt or obligation of or claim or judgment against Parent or Merger Sub (whether direct or indirect, absolute or contingent, accrued or unaccrued, known or unknown,
liquidated or unliquidated, or due or to become due), except for liabilities and obligations (i)&nbsp;reflected or reserved for on the financial statements or disclosed in the notes thereto included in Parent SEC Filings, (ii)&nbsp;that have arisen
since the date of the most recent balance sheet included in the Parent SEC Filings in the ordinary course of business of Parent and Merger Sub, or (iii)&nbsp;which would not be, or would not reasonably be expected to be, material to Parent. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.8 <U>Litigation and Proceedings</U>. As of the date of this Agreement, there are no pending or, to the Knowledge of Parent,
threatened Actions against Parent or Merger Sub, their respective properties or assets, or, to the Knowledge of Parent, any of their respective directors, managers, officers or employees (in their capacity as such). As of the date of this Agreement,
there are no investigations or other inquiries pending or, to the Knowledge of Parent, threatened by any Governmental Authority, against Parent or Merger Sub, their respective properties or assets, or, to the Knowledge of Parent, any of their
respective directors, managers, officers or employees (in their capacity as such). As of the date of this Agreement, there is no outstanding Governmental Order imposed upon Parent or Merger Sub, nor are any assets of Parent or Merger Sub&#146;s
respective businesses bound or subject to any Governmental Order the violation of which would, individually or in the aggregate, reasonably be expected to have a Parent Material Adverse Effect. From their respective dates of inception to the date of
this Agreement, Parent and Merger Sub have not received any written notice of or been charged with the violation of any Laws, except where such violation has not been, individually or in the aggregate, that would reasonably be expected to have a
Parent Material Adverse Effect. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.9 <U>Tax Matters</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Except as would not, individually or in the aggregate, have a Parent Material Adverse Effect: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) (A)&nbsp;All Tax Returns required to be filed by Parent or Merger Sub have been timely filed (taking into account
applicable extensions), (B)&nbsp;all such Tax Returns are true, correct and complete, and (C)&nbsp;all Taxes, whether or not shown as due on such Tax Returns, have been paid, in the case of each of clauses (A)&nbsp;through (C), except to the extent
adequate reserves therefor in accordance with GAAP have been provided on the financial statements of Parent contained in the Parent SEC Documents; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-64- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) (A)&nbsp;No Governmental Authority has asserted any written claim,
assessment or deficiency for Taxes against Parent or any Parent Subsidiary (and, to the Knowledge of Parent, no such claim, assessment or deficiency has been threatened or proposed in writing), except for deficiencies which have been satisfied by
payment, settled or withdrawn and (B)&nbsp;no claim, audit or other proceeding by any Governmental Authority is pending or threatened in writing with respect to any Taxes of Parent or Merger Sub; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iii) Neither Parent nor any Parent Subsidiary has any Liability for Taxes of any other Person (other than Parent or any Parent
Subsidiary) under Treasury Regulations section <FONT STYLE="white-space:nowrap">1.1502-6</FONT> (or any similar provision of state, local or <FONT STYLE="white-space:nowrap">non-U.S.</FONT> Law), as a transferee or successor or by contract or
operation of Law or otherwise; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iv) Within the past two years, neither Parent nor any Parent Subsidiary has constituted
either a &#147;distributing corporation&#148; or a &#147;controlled corporation&#148; (within the meaning of Section&nbsp;355(a)(1)(A) of the Code) in a distribution of stock qualifying for <FONT STYLE="white-space:nowrap">tax-free</FONT> treatment
under Section&nbsp;355 of the Code; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(v) Neither Parent nor any Parent Subsidiary has participated in, or is currently
participating in, a &#147;listed transaction&#148; within the meaning of Treasury Regulations <FONT STYLE="white-space:nowrap">Section&nbsp;1.6011-4(b)(2);</FONT> and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(vi) There are no Liens for Taxes (other than Permitted Liens) upon the assets of Parent or Merger Sub. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Neither Parent nor Merger Sub has taken or agreed to take any action or knows of any fact, agreement, plan or other circumstance that could
reasonably be expected to prevent or impede (i)&nbsp;the Domestication from qualifying as a &#147;reorganization&#148; within the meaning of Section&nbsp;368(a)(1)(F), (ii)&nbsp;the <FONT STYLE="white-space:nowrap">Tax-Free</FONT> Status,
(iii)&nbsp;the Company from receiving the Company Tax Opinions or (iv)&nbsp;Parent from receiving the Parent Tax Opinions. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Merger Sub
was formed solely for the purpose of engaging in the Merger, and does not have any assets and has not engaged in any business activities or conducted any operations other than in connection with the Merger. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) The representations and warranties set forth in this <U>Section</U><U></U><U>&nbsp;6.9</U> constitute the sole and exclusive
representations and warranties of Parent regarding Tax matters. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.10 <U>Absence of Changes</U>(a) . Since the Balance Sheet
Date until the date of this Agreement, (a)&nbsp;there has not been any event or occurrence that has had, or would not reasonably be expected to have, individually or in the aggregate a Parent Material Adverse Effect and (b)&nbsp;except as set forth
in Section&nbsp;6.10 of the Parent Disclosure Schedule, Parent and Merger Sub have, in all material respects, conducted their business and operated their properties in the ordinary course of business consistent with past practice. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-65- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.11 <U>Brokers</U><U>&#146;</U><U> Fees</U>. No broker, finder, investment
banker or other Person is entitled to any brokerage fee, finders&#146; fee or other similar commission, for which Parent, Merger Sub or the SpinCo Entities would be liable in connection with the transactions contemplated by this Agreement based upon
arrangements made by Parent or any Parent Subsidiary. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.12 <U>Proxy Statement; Registration Statements</U>. None of the
information regarding Parent, Merger Sub or the Transactions to be provided by Parent specifically for inclusion in, or incorporation by reference into, the Proxy Statement, the Parent Registration Statement, the SpinCo Registration Statement or the
Distribution Documents will, in the case of the Proxy Statement and the Distribution Documents or any amendment or supplement thereto, at the time of the first mailing of the Proxy Statement and the Distribution Documents and of any amendment or
supplement thereto, or, in the case of the Parent Registration Statement and the SpinCo Registration Statement, at the time such registration statement becomes effective, on the date of the Parent Shareholders Meeting, at the Distribution Time and
at the Effective Time, contain an untrue or false statement of a material fact or omit to state any material fact required to be stated therein or necessary in order to make the statements therein, in the light of the circumstances under which they
are made, not false or misleading. The Proxy Statement and the Parent Registration Statement will comply as to form in all material respects with the provisions of the Securities Act and the Exchange Act, as the case may be, except that no
representation is made by Parent with respect to information provided by the Company or SpinCo specifically for inclusion in, or incorporation by reference into, the Proxy Statement or the Parent Registration Statement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.13 <U>SEC Filings</U>. Parent has timely filed or furnished all statements, prospectuses, registration statements, forms,
reports and documents required to be filed by it with the SEC since August&nbsp;12, 2021, pursuant to the Exchange Act or the Securities Act (collectively, as they have been amended since the time of their filing through the date hereof, the
&#147;<U>Parent SEC Filings</U>&#148;). Each of the Parent SEC Filings, as of the respective date of its filing (or if amended or superseded by a filing prior to the date of this Agreement or the Closing Date, then on the date of such filing),
complied in all material respects with the applicable requirements of the Securities Act, the Exchange Act, the Sarbanes-Oxley Act and any rules and regulations promulgated thereunder applicable to the Parent SEC Filings. As of the respective date
of its filing (or if amended or superseded by a filing prior to the date of this Agreement or the Closing Date, then on the date of such filing), the Parent SEC Filings did not contain any untrue statement of a material fact or omit to state a
material fact required to be stated therein or necessary to make the statements made therein, in light of the circumstances under which they were made, not misleading. As of the date hereof, there are no outstanding or unresolved comments in comment
letters received from the SEC with respect to the Parent SEC Filings. To the Knowledge of Parent, none of the Parent SEC Filings filed on or prior to the date hereof is subject to ongoing SEC review or investigation as of the date hereof. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.14 <U>Trust Account</U>.<U> </U>As of the date of this Agreement, Parent has at least $235,750,000 in the Trust Account
(including an aggregate of approximately $8,050,000 of deferred underwriting commissions and other fees being held in the Trust Account), such monies invested in United States government securities or money market funds meeting certain conditions
under Rule <FONT STYLE="white-space:nowrap">2a-7</FONT> promulgated under the Investment Company Act pursuant to the Investment Management Trust Agreement, dated as of August&nbsp;9, 2021, between Parent and
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-66- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Continental Stock Transfer&nbsp;&amp; Trust Company, as trustee (the &#147;<U>Trustee</U>&#148;) (the &#147;<U>Trust Agreement</U>&#148;). There are no separate Contracts, side letters or other
arrangements or understandings (whether written or unwritten, express or implied) that would cause the description of the Trust Agreement in the Parent SEC Filings to be inaccurate or that would entitle any Person (other than the Parent Shareholders
holding shares of Parent Common Stock sold in Parent&#146;s initial public offering who shall have elected to redeem their shares of Parent Common Stock pursuant to Parent&#146;s Governing Documents and the underwriters of Parent&#146;s initial
public offering with respect to deferred underwriting commissions) to any portion of the proceeds in the Trust Account. Prior to the Closing, none of the funds held in the Trust Account may be released other than (i)&nbsp;to pay Taxes and
(ii)&nbsp;payments with respect to all Parent Share Redemptions. There are no claims or proceedings pending or, to the Knowledge of Parent, threatened with respect to the Trust Account. Parent has performed all material obligations required to be
performed by it to date under, and is not in material default, breach or delinquent in performance or any other respect (claimed or actual) in connection with, the Trust Agreement, and no event has occurred which, with due notice or lapse of time or
both, would constitute such a default or breach thereunder. As of the Effective Time, the obligations of Parent to dissolve or liquidate pursuant to Parent&#146;s Governing Documents shall terminate, and as of the Effective Time, Parent shall have
no obligation whatsoever pursuant to Parent&#146;s Governing Documents to dissolve and liquidate the assets of Parent by reason of the consummation of the Transactions. To Parent&#146;s Knowledge, as of the date hereof, following the Effective Time,
no shareholder of Parent shall be entitled to receive any amount from the Trust Account except to the extent such shareholder of Parent is exercising a Parent Share Redemption. As of the date hereof, assuming the accuracy of the representations and
warranties of the Company contained herein and the compliance by the Company and SpinCo with its obligations hereunder and under the other Transaction Documents, neither Parent or Merger Sub have any reason to believe that any of the conditions to
the use of funds in the Trust Account will not be satisfied or funds available in the Trust Account will not be available to Parent and Merger Sub on the Closing Date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.15 <U>Investment Company Act; JOBS Act</U>.<U> </U>Parent is not an &#147;investment company&#148; or a Person directly or
indirectly &#147;controlled&#148; by or acting on behalf of an &#147;investment company&#148;, in each case within the meaning of the Investment Company Act. Parent constitutes an &#147;emerging growth company&#148; within the meaning of the JOBS
Act. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.16 <U>Indebtedness</U>. Section&nbsp;6.16 of the Parent Disclosure Schedule sets forth the principal amount of all of
the outstanding Indebtedness, as of the date hereof, of Parent and Merger Sub. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.17 <U>Stock Market Quotation</U>. As of the
date hereof, the Parent Class&nbsp;A Common Stock is registered pursuant to Section&nbsp;12(b) of the Exchange Act and is listed for trading on NASDAQ under the symbol &#147;AHPA&#148;. As of the date hereof, the Public Parent Warrants are
registered pursuant to Section&nbsp;12(b) of the Exchange Act and are listed for trading on NASDAQ under the symbol &#147;AHPAW.&#148; As of the date hereof, the Parent Units are registered pursuant to Section&nbsp;12(b) of the Exchange Act and are
listed for trading on NASDAQ under the symbol &#147;AHPAU.&#148; There is no Action or proceeding pending or, to the Knowledge of Parent, threatened against Parent by NASDAQ or the SEC with respect to any intention by such entity to deregister the
Parent Class&nbsp;A Common Stock or Parent Warrants or terminate the listing of Parent Class&nbsp;A Common Stock or Parent Warrants on NASDAQ. None of Parent, Merger Sub or their respective Affiliates has taken any action in an attempt to terminate
the registration of the Parent Class&nbsp;A Common Stock or Parent Warrants under the Exchange Act except as contemplated by this Agreement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-67- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.18 <U>Business Activities</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Since formation, neither Parent nor Merger Sub have conducted any business activities other than activities related to Parent&#146;s
initial public offering or directed toward the accomplishment of a Business Combination. Except as set forth in Parent&#146;s Governing Documents or as otherwise contemplated by this Agreement or the Transaction Documents and the Transactions and
thereby, there is no agreement, commitment, or Governmental Order binding upon Parent or Merger Sub or to which Parent or Merger Sub is a party which has or would reasonably be expected to have the effect of prohibiting or impairing any business
practice of Parent or Merger Sub or any acquisition of property by Parent or Merger Sub or the conduct of business by Parent or Merger Sub as currently conducted or as contemplated to be conducted as of the Closing, other than such effects,
individually or in the aggregate, which have not been and would not reasonably be expected to have a Parent Material Adverse Effect. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b)
Except for Merger Sub and the Transactions, Parent does not own or have a right to acquire, directly or indirectly, any Investment in any corporation, partnership, joint venture, business, trust or other entity. Except for this Agreement and the
Transaction Documents and the Transactions and thereby, Parent has no material interests, rights, obligations or Liabilities with respect to, and is not party to, bound by or has its assets or property subject to, in each case whether directly or
indirectly, any Contract or transaction which is, or would reasonably be interpreted as constituting, a Business Combination. Except for the Transactions, Merger Sub does not own or have a right to acquire, directly or indirectly, any Investment in
any corporation, partnership, joint venture, business, trust or other entity. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Merger Sub was formed solely for the purpose of
effecting the Transactions and has not engaged in any business activities or conducted any operations other than incident to the Transactions and has no, and at all times prior to the Effective Time, except as expressly contemplated by this
Agreement, the Transaction Documents and the other documents and Transactions, will have no, assets, liabilities or obligations of any kind or nature whatsoever other than those incident to its formation. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) As of the date hereof and except for this Agreement, the Transaction Documents and the other documents and Transactions (other than with
respect to expenses and fees incurred in connection therewith and the Business Combination), neither Parent nor Merger Sub are party to any Contract with any other Person that would require payments by Parent or any of its Subsidiaries after the
date hereof in excess of $150,000 in the aggregate with respect to any individual Contract, other than Working Capital Loans. Section&nbsp;6.18(d) of the Parent Disclosure Schedule sets forth a true and complete list of all outstanding Working
Capital Loans as of the date hereof. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-68- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.19 <U>Section 280G</U>.<U> </U>Neither the execution and delivery of this
Agreement nor the consummation of the Transactions contemplated hereby or by the Transaction Documents shall, either alone or in connection with any other event(s), result in the payment of any amount to any current or former employee, officer,
director or independent contractor of Parent or other Person that could, individually or in the aggregate, or in combination with any other such payment, constitute an &#147;excess parachute payment&#148; as defined in Section&nbsp;280G(b)(1) of the
Code. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.20 <U>No Other Representations and Warranties</U>. Except as expressly set forth in
<U>Article</U><U></U><U>&nbsp;IV</U> and <U>Article</U><U></U><U>&nbsp;V</U> or in any Transaction Document, (a)&nbsp;each of Parent and Merger Sub acknowledges and agrees that neither the Company nor any of its Affiliates (including the SpinCo
Entities), nor any of their respective Representatives has made, or is making, any representation or warranty whatsoever to with respect to the Company or any of its Affiliates (including the SpinCo Entities), or any of their respective businesses,
operations, assets, liabilities, conditions (financial or otherwise) or prospects, and (b)&nbsp;each of Parent and Merger Sub further acknowledges and agrees that neither the Company nor any of its Affiliates shall be liable in respect of the
accuracy or completeness of any information provided to Parent, Merger Sub or any of its respective Affiliates or Representatives. Without limiting the generality of the foregoing, except as expressly set forth in
<U>Article</U><U></U><U>&nbsp;IV</U> or <U>Article</U><U></U><U>&nbsp;V</U> or in any Transaction Document, each of Parent and Merger Sub acknowledges and agrees that no representations or warranties are made with respect to any projections,
forecasts, estimates or budgets with respect to the Company, SpinCo, any of the SpinCo Entities or the SpinCo Business that may have been made available, in the SpinCo Datasite or otherwise, to Parent, Merger Sub or any of their Representatives, and
expressly disclaim reliance on any other representations, warranties, statements, information or inducements, oral or written, express or implied, or as to the accuracy or completeness of any statements or other information, made to, or made
available to, itself or any of its Representatives, in each case with respect to, or in connection with, the negotiation, execution or delivery of this Agreement, any instrument or other document delivered pursuant to this Agreement or the
transactions contemplated by this Agreement, and notwithstanding the distribution, disclosure or other delivery to Parent, Merger Sub or any of their Representatives of any document or other information with respect to any one or more of the
foregoing, and waive any claims or causes of actions relating thereto, other than those for Actual Fraud. Without limiting the generality of the foregoing, it is understood that any cost estimates, financial or other projections or other predictions
that may be contained or referred to in this Agreement (including the SpinCo Disclosure Schedule), any information, documents or other materials (including any such materials contained in the SpinCo Datasite or otherwise reviewed by Parent, Merger
Sub or any of their respective Affiliates or Representatives) or management presentations that have been or shall hereafter be provided to Parent, Merger Sub or any of their respective Affiliates or Representatives are not and will not be deemed to
be representations or warranties of the Company or SpinCo, and no representation or warranty is made as to the accuracy or completeness of any of the foregoing except as expressly set forth in <U>Article</U><U></U><U>&nbsp;IV</U> or
<U>Article</U><U></U><U>&nbsp;V</U> of this Agreement or in any Transaction Document. In entering into this Agreement, Parent and Merger Sub acknowledge and agree that they have relied solely upon their own investigation and analysis; and Parent and
Merger Sub acknowledge and agree, to the fullest extent permitted by Law, that the Company, the SpinCo Entities and their Affiliates and their respective Representatives shall not have any Liability or responsibility whatsoever to Parent or its
Subsidiaries or any of their respective Representatives on any basis (including in contract or tort, under federal or state securities Laws or otherwise) based upon any information provided or made available, or statements made (or any omissions
therefrom), to Parent or its Subsidiaries or </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-69- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
any of their respective Representatives, including in respect of the specific representations and warranties set forth in <U>Article</U><U></U><U>&nbsp;IV</U> or
<U>Article</U><U></U><U>&nbsp;V</U> of this Agreement or any Transaction Document, except as and only to the extent expressly set forth herein or therein with respect to such representations and warranties and subject to the limitations and
restrictions contained herein or therein. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ARTICLE&nbsp;VII </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">COVENANTS </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.1
<U>Conduct of Business by Parent and Merger Sub Pending the Merger</U>. From the date hereof and prior to the Effective Time (or the earlier termination of this Agreement) (the &#147;<U>Interim Period</U>&#148;), except as (i)&nbsp;required or
otherwise contemplated by this Agreement (including as set forth in Section&nbsp;7.1 of the Parent Disclosure Schedule), the Transaction Documents, the PIPE Investment, the Redemption Backstop or in connection with the Domestication, (ii)&nbsp;as
consented to by the Company in writing (which consent shall not be unreasonably withheld, conditioned, delayed or denied) or (iii)&nbsp;as required by applicable Law, Parent shall, and shall cause its Subsidiaries, including Merger Sub, as
applicable, to, conduct its operations in the ordinary course of business in all material respects. During the Interim Period, Parent shall, and shall cause its Subsidiaries, including Merger Sub, to comply with, and continue performing under, as
applicable, the Governing Documents of Parent, the Trust Agreement and all other agreements or Contracts to which Parent or its Subsidiaries may be a party. Without limiting the generality of the foregoing, during the Interim Period, except as
(i)&nbsp;required or otherwise contemplated by this Agreement (including as set forth in Section&nbsp;7.1 of the Parent Disclosure Schedule), the Transaction Documents, the PIPE Investment or in connection with the Domestication, (ii)&nbsp;as
consented to by the Company in writing (which consent shall not be unreasonably withheld, conditioned, delayed or denied, other than with respect to subsection (b), with respect to which consent may be withheld at the Company&#146;s sole discretion)
or (iii)&nbsp;as required by applicable Law, Parent shall not, and shall cause its Subsidiaries, including Merger Sub, as applicable, not to: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) seek any approval from the Parent Shareholders to amend, modify, restate, waive, rescind or otherwise change the Trust Agreement or the
Governing Documents of Parent or Merger Sub (other than as contemplated by the Transaction Proposals); </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) (i) make or declare any
dividend or distribution to the Parent Shareholders or make any other distributions in respect of any of Parent&#146;s equity interests or Merger Sub capital stock, share capital or equity interests, (ii)&nbsp;split, combine, reclassify or otherwise
amend any terms of any shares or series of Parent&#146;s equity interests or Merger Sub capital stock or equity interests, or (iii)&nbsp;purchase, repurchase, redeem or otherwise acquire any issued and outstanding share capital, outstanding shares
of capital stock, share capital or membership interests, warrants or other equity interests of Parent or Merger Sub, other than a redemption of shares of Parent Class&nbsp;A Common Stock made as part of the Parent Share Redemptions; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) make, change or revoke any material Tax election or (ii)&nbsp;settle or compromise any material Tax liability; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-70- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) enter into, renew or amend in any material respect, any transaction or Contract with an
Affiliate of Parent or Merger Sub (including, for the avoidance of doubt, (i)&nbsp;the Sponsor and (ii)&nbsp;any Person in which the Sponsor has a direct or indirect legal, contractual or beneficial ownership interest of 5% or greater); </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) incur or assume any Indebtedness or guarantee any Indebtedness of another Person, issue or sell any debt securities or warrants or other
rights to acquire any debt securities of the Company or any of the Company&#146;s Subsidiaries or guaranty any debt securities of another Person, other than any indebtedness (x)&nbsp;for borrowed money or guarantee from its Affiliates and
stockholders in order to meet its reasonable capital requirements, with any such loans to be made only as reasonably required by the operation of Parent in due course on a <FONT STYLE="white-space:nowrap">non-interest</FONT> basis and otherwise on <FONT
STYLE="white-space:nowrap">arm&#146;s-length</FONT> terms and conditions and repayable at the Closing, and in any event in an aggregate amount not to exceed $100,000 (or, in the case of Working Capital Loans, up to $150,000), or (y)&nbsp;incurred
between Parent and Merger Sub; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) (i) issue any Parent Securities or securities exercisable for or convertible into Parent Securities,
other than issuances contemplated by the Transactions, (ii)&nbsp;grant any options, warrants or other equity-based awards with respect to Parent Securities not outstanding on the date hereof or (iii)&nbsp;amend, modify or waive any of the material
terms or rights set forth in any Parent Warrant or the Warrant Agreement, including any amendment, modification or reduction of the warrant price set forth therein; or </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) enter into any agreement to do any action prohibited under this <U>Section</U><U></U><U>&nbsp;7.1</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.2 <U>Conduct of SpinCo Business Pending the Merger</U>. During the Interim Period (solely with respect to the SpinCo Entities
or the SpinCo Business), except as (i)&nbsp;required or otherwise contemplated by this Agreement (including as set forth in Section&nbsp;7.2 of the SpinCo Disclosure Schedule), the Internal Reorganization or the Transaction Documents, (ii)&nbsp;as
consented to by Parent in writing (which consent shall not be unreasonably withheld, conditioned or delayed) or (iii)&nbsp;as required by applicable Law or any <FONT STYLE="white-space:nowrap">COVID-19</FONT> Measures, the Company and the SpinCo
Entities shall, and shall cause and ensure that their respective Subsidiaries (including the SpinCo Entities), to (x)&nbsp;conduct the SpinCo Business in the ordinary course of business in all material respects, (y)&nbsp;use commercially reasonable
efforts to manage the SpinCo Business&#146; working capital and maintain the books and records related to the SpinCo Business consistent with past practice and (z)&nbsp;use commercially reasonable efforts to maintain their respective relations and
goodwill with all material suppliers, material customers and other material commercial counterparties and Governmental Authorities (in each case, as related to the SpinCo Business). Without limiting the generality of
<U>Section</U><U></U><U>&nbsp;7.2(a)</U>, during the Interim Period (solely with respect to the SpinCo Entities or the SpinCo Business), except as (A)&nbsp;required or contemplated by this Agreement (including as set forth in Section&nbsp;7.2 of the
SpinCo Disclosure Schedule), the Internal Reorganization or the Transaction Documents, (B)&nbsp;as consented to by Parent in writing (which consent shall not be unreasonably withheld, conditioned or delayed, other than with respect to subsection
(b)&nbsp;or (c), with respect to which consent may be withheld at the Company&#146;s sole discretion) or (C)&nbsp;as required by applicable Law or any <FONT STYLE="white-space:nowrap">COVID-19</FONT> Measures, the Company and SpinCo shall not, and
each shall cause its respective Subsidiaries not to (in each case solely with respect to the SpinCo Entities or the SpinCo Business): </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-71- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) amend, modify, restate, waive, rescind or otherwise change the Governing Documents of
any of the SpinCo Entities, other than an amendment to the certificate of incorporation of SpinCo to increase the number of authorized or outstanding shares of SpinCo Common Stock in connection with the Distribution in accordance with this Agreement
and the Transaction Documents; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) other than as required for the Distribution, (i)&nbsp;declare, set aside or pay any dividends on or
make other distributions in respect of any of the Interests of any of the SpinCo Entities (whether in cash, securities or property), except for the declaration and payment of cash dividends or distributions paid on or with respect to a class of
Interests of any SpinCo Entity that is wholly owned directly or indirectly by SpinCo, (ii)&nbsp;split, combine, subdivide, reduce, or reclassify any of the Interests of any of the SpinCo Entities or issue or authorize or propose the issuance of any
other securities in respect of, in lieu of, or in substitution for, Interests of the SpinCo Entities or (iii)&nbsp;redeem, repurchase or otherwise acquire, or permit any Subsidiary to redeem, repurchase or otherwise acquire, any Interests (including
any securities convertible or exchangeable into such Interests) (except for the acquisition by the Company or any of its Subsidiaries of any shares of capital stock, membership interests or other equity interests of the Company or its Subsidiaries
in connection with the forfeiture of any Company Equity Awards, in each case, in accordance with their respective terms as in effect as of the date hereof); </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) other than as contemplated by the Distribution, issue, sell, pledge, dispose of, grant, transfer or encumber, any shares of capital stock
of, any other Interests in, or any SpinCo Voting Debt of, any of the SpinCo Entities of any class, or securities convertible into, or exchangeable or exercisable for, any shares of such capital stock or other Interests in any of the SpinCo Entities,
or any options, warrants, stock units, or other rights of any kind to acquire any shares of capital stock or other Interests or such convertible or exchangeable securities, or any other ownership interest (including any such interest represented by
Contract right), or any &#147;phantom&#148; stock, &#147;phantom&#148; stock rights, stock appreciation rights or stock based performance rights, in each case, of the SpinCo Entities, other than (i)&nbsp;the issuance by a SpinCo Entity that is a
wholly owned Subsidiary of SpinCo of its capital stock or other Interests to SpinCo or another wholly owned Subsidiary of SpinCo or (ii)&nbsp;the issuance of capital stock or other Interests upon the exercise, vesting or settlement of Company Equity
Awards outstanding as of the date hereof and, in each case, in accordance with their respective terms as in effect as of the date hereof; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) sell, assign, transfer, convey, lease, license, abandon, mortgage, pledge or permit any Lien on (other than a Permitted Lien) or otherwise
dispose of any SpinCo Assets (excluding Intellectual Property, which is the subject of <U>Section</U><U></U><U>&nbsp;7.2(e)</U> below); </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) (i) purchase, sell, license, sublicense, lease, pledge, covenant not to assert, assign, transfer, abandon, cancel, let lapse or expire, or
otherwise dispose, transfer or grant any other rights in or with respect to any Intellectual Property (other than with respect to (A)&nbsp;immaterial or obsolete SpinCo Owned Intellectual Property or (B)&nbsp;the grant of <FONT
STYLE="white-space:nowrap">non-exclusive</FONT> licenses of SpinCo Owned Intellectual Property in the ordinary course of business consistent with past practice); or (ii)&nbsp;disclose any material Trade Secrets of the SpinCo Business to any other
Person (other than in the ordinary course of business consistent with past practice to a Person bound by adequate and enforceable use restrictions and confidentiality obligations with respect to such Trade Secrets); </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-72- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) receive, collect, use, store, process, share, safeguard, secure (technically, physically
or administratively), dispose of, destroy, disclose, or transfer (including cross-border) any Personal Information (or fail to do any of the foregoing, as applicable) in material violation of any Privacy Requirements; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) merge, combine or consolidate (pursuant to a plan of merger or otherwise) any of the SpinCo Entities with any Person or adopt a plan of
complete or partial liquidation or resolutions providing for a complete or partial liquidation, dissolution, restructuring, recapitalization or other reorganization of any of the SpinCo Entities; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h) acquire (including by merger, consolidation, or acquisition of shares or assets), lease or license, (i)&nbsp;any interest in any Person or
(ii)&nbsp;any assets of any Person that would be an asset of the SpinCo Entities at the Effective Time, other than, in the case of clause (ii), (A)&nbsp;in the ordinary course of business with respect to assets having a value not exceeding
$2,000,000, individually, or $4,000,000, in the aggregate, the purchase price for which will be paid by the Company or any of its Subsidiaries prior to the Distribution Date; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) repurchase, repay, prepay, refinance or incur any indebtedness for borrowed money, issue any debt securities, engage in any securitization
transactions or similar arrangements or assume, guarantee or endorse, or otherwise as an accommodation become responsible for (whether directly, contingently or otherwise), the obligations of any Person for borrowed money other than in the ordinary
course of business consistent with past practice and in an aggregate amount not to exceed $500,000; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(j) make any material loans, material
capital contributions or material investments in, or advances of money to, in each case, in excess of $2,000,000 individually or $4,000,000 in the aggregate, any Person (other than the SpinCo Entities), in each case, except for (i)&nbsp;advances to
employees or officers of any SpinCo Entity for expenses incurred in the ordinary course of the SpinCo Business consistent with past practice and in accordance with the Company&#146;s and its Subsidiaries&#146; policies in respect thereof or
(ii)&nbsp;extended payment terms for customers in the ordinary course of the SpinCo Business consistent with past practice; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(k)
(A)&nbsp;amend or modify in any material respect, terminate (excluding any expiration in accordance with its terms), or waive any material right, benefit or remedy under, any SpinCo Material Contract or (B)&nbsp;enter into any Contract that if
entered into prior to the date hereof would be required to be listed on Section&nbsp;5.7 or Section&nbsp;5.15(a) of the SpinCo Disclosure Schedule; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(l) Except as contemplated by the Transaction Documents, as required by applicable Law or as required by any existing Company Benefit Plan, or
in the ordinary course of business consistent with past practice, (i)&nbsp;adopt, enter into, amend or alter in any respect or terminate any Company Benefit Plan in respect of any SpinCo Service Provider (other than the grant of equity awards in the
ordinary course of business consistent with past practice), or any SpinCo Benefit Plan, (ii)&nbsp;grant or agree to grant any material increase in the wages, salary, bonus or other compensation, remuneration or benefits of any SpinCo Service
Provider, or that would result in any material Liability to any SpinCo Entity, (iii)&nbsp;grant or provide any <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">change-in-control,</FONT></FONT> severance, termination, retention or
similar payments or benefits to any SpinCo Service Provider, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-73- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
or that would result in any material Liability to any SpinCo Entity, (iv)&nbsp;hire or engage, or make an offer to hire or engage, any officer, employee, service provider or individual
independent contractor of any SpinCo Entity whose annual base pay exceeds $250,000, or (v)&nbsp;terminate (without cause) the employment of any SpinCo Employee or engagement of any SpinCo Independent Contractor whose annual base pay or retainer
exceeds $250,000; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(m) except as required or permitted by GAAP, make any material change to any financial accounting principles, methods or
practices of any SpinCo Entity or with respect to the SpinCo Business; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(n) waive, release, settle, compromise or otherwise resolve any
Action, litigation or other proceedings, except where such waivers, releases, settlements or compromises involve only the payment of monetary damages in an amount less than $375,000 in the aggregate; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(o) (i)&nbsp;make, change or revoke any material Tax election in respect of the SpinCo Business that would bind any SpinCo Entity for periods
following the Effective Time (other than an election reasonably required in connection with the Separation) or (ii)&nbsp;settle or compromise any material Tax liability for which a SpinCo Entity would be responsible under any Transaction Document;
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(p) make or commit to make any capital expenditures, on an annualized basis, in the aggregate, in excess of $2,000,000, in the aggregate;
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(q) enter into any collective bargaining agreement or other similar Contract with a labor union, works&#146; council, employee
representative body or labor organization that would constitute a SpinCo CBA or in respect of which Parent or its Subsidiaries will have any Liability or obligations following the Effective Time, or amend or modify any SpinCo CBA; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(r) disclose or agree to disclose to any Person (other than Parent or any of its representatives) any material Trade Secret or any other
material confidential or proprietary information, <FONT STYLE="white-space:nowrap">know-how</FONT> or process of the Company or any of its Subsidiaries, in each case other than in the ordinary course of business consistent with past practice and
pursuant to customary contractual obligations or fiduciary or professional duty to maintain the confidentiality thereof; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(s) terminate
without replacement or fail to use reasonable efforts to maintain any license or permit that is material to the conduct of the business of the Company and its Subsidiaries, taken as a whole; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(t) waive the restrictive covenant obligations of any current officer of the Company or any of the SpinCo Entities; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(u) (i) limit the right of the Company or any of the SpinCo Entities to engage in any line of business or in any geographic area, to develop,
market or sell products or services, or to compete with any Person or (ii)&nbsp;grant any exclusive or similar rights to any Person, in each case, except where such limitation or grant does not, and would not be reasonably likely to, individually or
in the aggregate, materially and adversely affect, or materially disrupt, the ordinary course operation of the businesses of the Company or any of the SpinCo Entities, taken as a whole; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-74- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(v) terminate without replacement or amend in a manner materially detrimental to the Company
and its Subsidiaries, taken as a whole, any insurance policy insuring the business of the Company or any of the SpinCo Entities; or </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(w)
authorize or enter into any Contract to do any of the foregoing or otherwise agree or make any commitment to do any of the foregoing. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.3 <U>Tax Matters</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) This Agreement is intended to constitute a &#147;plan of reorganization&#148; for purposes of Section&nbsp;368 of the Code and the Parties
hereby adopt it as such. From and after the date of this Agreement and until the Effective Time, each Party shall use its reasonable best efforts to (A)&nbsp;ensure that (i)&nbsp;the Domestication will qualify as a &#147;reorganization&#148; within
the meaning of Section&nbsp;368(a)(1)(F), (ii) the Contribution and Distribution, taken together, will qualify as a &#147;reorganization&#148; within the meaning of Sections 368(a)(1)(D) and 355(a) of the Code, (iii)&nbsp;the Merger will qualify as
a &#147;reorganization&#148; within the meaning of Section&nbsp;368(a) of the Code and (iv)&nbsp;the Merger (taking into account the PIPE Investment) will not cause Section&nbsp;355(e) of the Code to apply to the Distribution (with respect clauses
(ii)-(iv), the &#147;<U><FONT STYLE="white-space:nowrap">Tax-Free</FONT> Status</U>&#148;) and (B)&nbsp;not take any action, cause or permit any action to be taken, fail to take any action or cause any action to fail to be taken, which action or
failure to act could prevent (i)&nbsp;the Domestication from qualifying as a &#147;reorganization&#148; within the meaning of Section&nbsp;368(a)(1)(F) or (ii)&nbsp;the <FONT STYLE="white-space:nowrap">Tax-Free</FONT> Status. Following the Effective
Time, none of the Company, Parent or any of their respective Affiliates shall take any action, cause or permit any action to be taken, fail to take any action or cause any action to fail to be taken, which action or failure to act could prevent the <FONT
STYLE="white-space:nowrap">Tax-Free</FONT> Status. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Each of the Company, SpinCo and Parent shall cooperate with one another and shall
use its reasonable best efforts for the Company to obtain a written opinion of LW, reasonably satisfactory in form and substance to the Company (the &#147;<U>Company Distribution Tax Opinion</U>&#148;), dated as of the Closing Date, to the effect
that, on the basis of the facts, customary representations and assumptions set forth or referred to in such opinion, (i)&nbsp;the Contribution and Distribution, taken together, will qualify as a &#147;reorganization&#148; within the meaning of
Sections 368(a)(1)(D) and 355(a) of the Code and (ii)&nbsp;the Merger will not cause Section&nbsp;355(e) of the Code to apply to the Distribution. In delivering the Company Distribution Tax Opinion, LW shall be entitled to receive and rely upon the
Parent Distribution Tax Representations and the Company Distribution Tax Representations. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Company and SpinCo, on the one hand, and
Parent, on the other hand, shall cooperate with one another in obtaining, and shall use their respective reasonable best efforts to obtain, a written opinion of LW (the &#147;<U>Company Merger Tax Opinion</U>&#148;), in the case of Company and
SpinCo, and a written opinion of Weil (the &#147;<U>Parent Merger Tax Opinion</U>&#148;), in the case of Parent, reasonably satisfactory in form and substance to the Company and Parent, respectively, dated as of the Closing Date, to the effect that,
on the basis of the facts, customary representations and assumptions set forth or referred to in such opinion, the Merger will be treated as a &#147;reorganization&#148; within the meaning of Section&nbsp;368(a) of the Code. In delivering the
Company Merger Tax Opinion and the Parent Merger Tax Opinion, LW and Weil shall both be entitled to receive and rely upon the SpinCo Merger Tax Representations and the Parent Merger Tax Representations. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-75- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) Company and SpinCo, on the one hand, and Parent, on the other hand, shall cooperate with
one another in obtaining, and Parent shall use its reasonable best efforts to obtain a written opinion of Weil (the &#147;<U>Parent Domestication Tax Opinion</U>&#148;) reasonably satisfactory in form and substance to Parent, dated as of the Closing
Date, to the effect that, on the basis of the facts, customary representations and assumptions set forth or referred to in such opinion, the Domestication will qualify as a &#147;reorganization&#148; under Section&nbsp;368(a)(1)(F) of the Code. In
delivering the Parent Domestication Tax Opinion, Weil shall be entitled to receive and rely upon representations, as necessary, of an officer of each of the Company, SpinCo and Parent dated as of the Closing Date, in form and substance reasonably
satisfactory to Weil and delivered to Weil in connection with the Domestication. For the avoidance of doubt, the receipt of the Parent Domestication Tax Opinion is not a condition to closing under <U>Article</U><U></U><U>&nbsp;VIII</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) The Company and SpinCo, on the one hand, and Parent, on the other hand, shall cooperate with each other in obtaining, and shall use their
respective reasonable best efforts to obtain, any Tax opinions required to be filed with the SEC in connection with the filing of the Parent Registration Statement and shall each use its respective reasonable best efforts to cause such opinions to
be timely filed. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) Parent will promptly notify the Company if, before the Effective Time, it knows or has reason to believe that Parent
is not reasonably expected to be able to obtain the Parent Merger Tax Opinion. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) The Company will promptly notify Parent if, before the
Effective Time, it knows or has reason to believe that the Company is not reasonably expected to be able to obtain any of the Company Tax Opinions. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.4 <U>Preparation of the Registration Statements and Prospectus; Parent Shareholders Meeting</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) As promptly as practicable after the execution of this Agreement, to the extent such filings are required by Law in connection with the
transactions contemplated by this Agreement: (i)&nbsp;Parent, the Company and SpinCo shall jointly prepare and Parent shall file with the SEC the Parent Registration Statement; (ii)&nbsp;Parent, the Company and SpinCo shall jointly prepare and
SpinCo shall file with the SEC the SpinCo Registration Statement; (iii)&nbsp;Parent, the Company and SpinCo shall jointly prepare and Parent shall file with the SEC the Proxy Statement (which Proxy Statement may form a part of the Parent
Registration Statement); and (iv)&nbsp;the Parties shall jointly prepare and cause to be filed such other filings required under applicable securities Laws in connection with the Transactions. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-76- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Each of Parent, the Company and SpinCo shall use its reasonable best efforts to have the
Parent Registration Statement and the SpinCo Registration Statement declared effective as promptly as practicable after such filing (including by responding to comments of the SEC) and to keep such registration statements effective for as long as is
necessary to consummate the Transactions, and, prior to the effective date of the Parent Registration Statement and the SpinCo Registration Statement, each of Parent, the Company and SpinCo shall take all action reasonably required (other than
qualifying to do business in any jurisdiction in which it is not now so qualified or filing a general consent to service of process in any such jurisdiction) to be taken under any applicable securities Laws in connection with the Parent Share
Issuance and the Distribution. As promptly as practicable after the Parent Registration Statement and the SpinCo Registration Statement shall have become effective, each of the Company and Parent, as applicable, shall cause the Distribution
Documents or the Parent Registration Statement (which shall include the Proxy Statement), as applicable, to be mailed or made available to the Company&#146;s stockholders or the Parent&#146;s stockholders, as applicable, in each case, pursuant to
applicable Law. No filing of, or amendment or supplement to, the Parent Registration Statement or the Proxy Statement will be made by Parent without providing the Company and SpinCo with a reasonable opportunity to review and comment thereon (and
such comments shall be reasonably considered by Parent in good faith). No filing of, or amendment or supplement to, the SpinCo Registration Statement will be made by the Company or SpinCo without providing Parent with a reasonable opportunity to
review and comment thereon (and such comments shall be reasonably considered by the Company in good faith). Each Party (as applicable) will use its reasonable best efforts to cause the Distribution Documents and the Parent Registration Statement to
comply in all material respects with the applicable requirements of U.S. federal securities Laws. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Each of Parent, the Company and
SpinCo shall ensure that none of the information supplied by or on its behalf for inclusion or incorporation by reference in (A)&nbsp;the Parent Registration Statement or SpinCo Registration Statement will, at the time filed with the SEC, at each
time at which it is amended and at the time it becomes effective under the Securities Act, contain any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary to make the statements therein,
not misleading, (B)&nbsp;the Proxy Statement will, at the date it is first mailed or made available to the Parent&#146;s shareholders and at the time of the Parent Shareholders&#146; Meeting, contain any untrue statement of a material fact or omit
to state any material fact required to be stated therein or necessary in order to make the statements therein, in light of the circumstances under which they are made, not misleading or (C)&nbsp;the Distribution Documents will, at the date they are
mailed or made available to the Company&#146;s stockholders, contain any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary in order to make the statements therein, in light of the
circumstances under which they are made, not misleading. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) If, at any time prior to the Effective Time, any information relating to
Parent, the Company or SpinCo, or any of their respective Affiliates, directors or officers, should be discovered by Parent, the Company or SpinCo, which should be set forth in an amendment or supplement to the Parent Registration Statement, the
Proxy Statement or the SpinCo Registration Statement, so that any such document would not include any misstatement of a material fact or omit to state any material fact necessary to make the statements therein, in light of the circumstances under
which they were made, not misleading, the Party that discovers such information shall promptly notify the other Party and an appropriate amendment or supplement describing such information shall be promptly filed with the SEC, and, to the extent
required by Law, disseminated to the shareholders of Parent or the Company, as applicable. Each Party shall </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-77- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
notify the other Party promptly of the time when the Parent Registration Statement or the SpinCo Registration Statement has become effective and of the issuance of any stop order or suspension of
the qualification of the shares of Domesticated Parent Stock issuable pursuant to the Merger or shares of SpinCo Common Stock issuable in the Distribution for offering or sale in any jurisdiction. In addition, each Party agrees to provide the other
Party and their respective counsel promptly with copies of any written comments or requests for amendments or supplements, and shall promptly inform the other Party of any oral comments or requests for amendments or supplements, that such Party or
its counsel may receive from time to time from the SEC with respect to the Parent Registration Statement, the Proxy Statement or the SpinCo Registration Statement promptly after receipt of such comments, and shall provide the other Party with copies
of any written or oral responses or correspondence between it or its Affiliates and the SEC related thereto. Each Party and their respective counsel shall be given a reasonable opportunity to review in advance any such written responses and to
participate in any discussions or oral material communications with the SEC, and each Party shall reasonably consider in good faith the additions, deletions, comments or changes suggested thereto by the other Party and its counsel. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) <I>Parent Shareholders Meeting</I>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) Parent shall call, give notice of, convene and hold a general meeting (the &#147;<U>Parent Shareholders Meeting</U>&#148;)
as promptly as reasonably practicable following the date on which the Parent Registration Statement is declared effective, and in any case, no later than thirty (30)&nbsp;Business Days thereafter, for the purpose of obtaining the Parent Shareholder
Approval; <U>provided</U>, that subject to the requirements of any applicable Law, Parent may (and, in the case of clause (C)&nbsp;on up to two (2)&nbsp;occasions upon the reasonable request of the Company (and for no more than five
(5)&nbsp;Business Days each) shall) postpone or adjourn the Parent Shareholders Meeting (A)&nbsp;if a quorum has not been established; (B)&nbsp;after consultation with the Company, to allow reasonable additional time for the filing and mailing of
any supplement or amendment to the Proxy Statement as may be required under applicable Law and for such supplement or amendment to be disseminated and reviewed by Parent&#146;s shareholders sufficiently in advance of the Parent Shareholders Meeting;
(C)&nbsp;to allow reasonable additional time to solicit additional proxies, if and to the extent the requisite Parent Shareholder Approval would not otherwise be obtained; (D)&nbsp;after consultation with the Company, if otherwise required by
applicable Law; or (E)&nbsp;with the prior written consent of the Company; <U>provided</U>, that the Parent Shareholders&#146; Meeting will not be adjourned to a date that is more than thirty (30)&nbsp;days after the date for which the Parent
Shareholders&#146; Meeting was originally scheduled (excluding any adjournments required by applicable Law). Parent shall advise the Company upon request on a daily basis during each of the last five&nbsp;(5) Business Days prior to the date of the
Parent Shareholders Meeting as to the aggregate tally of proxies received by Parent with respect to the Parent Shareholder Approval and at additional times upon the reasonable request of the Company. Parent agrees that it shall provide the holders
of shares of Parent Class&nbsp;A Common Stock the opportunity to elect redemption of such shares of Parent Class&nbsp;A Common Stock in connection with the Parent Shareholders&#146; Meeting, as required by Parent&#146;s Governing Documents. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-78- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) Parent shall, through the Parent Board, unanimously recommend to its
shareholders (A)&nbsp;adoption and approval of the Domestication and change in the jurisdiction of incorporation of Parent from the Cayman Islands to the State of Delaware, (B)&nbsp;amendment and restatement of Parent&#146;s existing Governing
Documents in connection with the Domestication, including any separate or unbundled proposals as are required to implement the foregoing and the change of Parent&#146;s name to OmniAb, Inc. as set forth in the Parent Charter, (C)&nbsp;adoption and
approval of this Agreement, the Transaction Documents and the Transactions contemplated hereby and thereby, in each case, in accordance with applicable Law and exchange rules and regulations, (D)&nbsp;approval of the issuance of shares of
Domesticated Parent Stock in connection with the Domestication, the PIPE Investment, the Redemption Backstop and the Merger, (E)&nbsp;approval of the adoption by Parent of the Parent Equity Plan and Parent ESPP, each as described in the Employee
Matters Agreement, (F)&nbsp;election of directors to the Parent Board effective as of the Closing as contemplated by this Agreement, (G)&nbsp;adoption and approval of any other proposals as the SEC (or staff thereof) may indicate are necessary in
its comments to the Proxy Statement or the Parent Registration Statement or correspondence related thereto, (H)&nbsp;adoption and approval of any other proposals as reasonably agreed by Parent and the Company to be necessary or appropriate in
connection with the Transactions and (I)&nbsp;adjournment of the Parent Shareholders Meeting, if necessary, to permit further solicitation of proxies because there are not sufficient votes to constitute a quorum or approve and adopt any of the
foregoing (such proposals in (A)&nbsp;through (I), together, the &#147;<U>Transaction Proposals</U>&#148;), and include such Parent Board Recommendation in the Proxy Statement (subject to <U>Section</U><U></U><U>&nbsp;7.5)</U> and, provided there
has been no Modification in Recommendation in response to an Intervening Event in accordance with <U>Section</U><U></U><U>&nbsp;7.5</U>, use its reasonable best efforts to (1)&nbsp;solicit from its shareholders proxies in favor of the approval of
the proposals required under the Parent Shareholder Approval, and (2)&nbsp;take all other action necessary or advisable to secure the Parent Shareholder Approval. Except as expressly permitted by <U>Section</U><U></U><U>&nbsp;7.5</U>, neither the
Parent Board nor any committee thereof shall effect a Modification in Recommendation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.5 <U>Modification in
Recommendation</U>. The Parent Board shall not withdraw, amend, qualify or modify its recommendation to the Parent Shareholders that they vote in favor of the Transaction Proposals (together with any withdrawal, amendment, qualification or
modification of its recommendation to the Parent Shareholders, a &#147;<U>Modification in Recommendation</U>&#148;); <U>provided</U>, that the Parent Board may make a Modification in Recommendation if it determines in good faith, after consultation
with its outside legal counsel, in response to an Intervening Event, that a failure to make a Modification in Recommendation would be inconsistent with its fiduciary obligations to the Parent Shareholders under applicable Law; <U>provided</U>,
<U>further</U>, that: (i)&nbsp;Parent shall have delivered written notice to the Company of its intention to make a Modification in Recommendation at least five (5)&nbsp;Business Days prior to the taking of such action by Parent, (ii)&nbsp;during
such period and prior to making a Modification in Recommendation, if requested by the Company, Parent shall have negotiated in good faith with the Company regarding any revisions or adjustments proposed by the Company to the terms and conditions of
this Agreement as would enable the Parent Board to reaffirm its recommendation and not make such Modification in Recommendation and (iii)&nbsp;if the Company requested negotiations in accordance with clause (ii), Parent may make a Modification in
Recommendation </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-79- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
only if the Parent Board, after considering in good faith any revisions or adjustments to the terms and conditions of this Agreement that the Company shall have, prior to the expiration of the
five (5)&nbsp;Business Day period, offered in writing to Parent, continues to determine in good faith that failure to make a Modification in Recommendation would be inconsistent with its fiduciary duties to the Parent Shareholders under applicable
Law. To the fullest extent permitted by applicable Law, Parent&#146;s obligations to establish a record date for, duly call, give notice of, convene and hold the Parent Shareholders Meeting shall not be affected by any Modification in Recommendation
and Parent agrees to establish a record date for, duly call, give notice of, convene and hold the Parent Shareholders Meeting and submit for approval the Transaction Proposals irrespective of whether a Modification in Recommendation has occurred.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.6 <U>Reasonable Best Efforts</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Subject to the terms of <U>Section</U><U></U><U>&nbsp;7.20</U>, which shall govern with respect to the subject matter thereof, each of
Parent, the Company and their respective Subsidiaries shall use its reasonable best efforts to promptly take, or cause to be taken, all actions, and to promptly do, or cause to be done, and to assist and cooperate with the other in doing, all things
reasonably necessary, proper or advisable under applicable Laws to consummate and make effective the Merger and the other transactions contemplated by this Agreement and the other Transaction Documents, as promptly as practicable and in any event
prior to the Outside Date, including (i)&nbsp;the obtaining of all necessary actions or nonactions, waivers, consents, clearances, approvals, and expirations or terminations of waiting periods, from Governmental Authorities and the making of all
necessary registrations and filings in connection therewith, and (ii)&nbsp;using its commercially reasonable efforts to obtain all necessary consents, approvals or waivers from third parties; <U>provided</U>, that in no event shall the Company,
Parent or their respective Subsidiaries be required to pay any fee, penalty or other consideration to any third party for any consent or approval required for the consummation of the transactions contemplated by this Agreement under any Contract.
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) The Company and Parent shall (i)&nbsp;promptly, but in no event later than ten&nbsp;(10)&nbsp;Business Days after the date hereof,
file (or cause to be filed) any and all required <FONT STYLE="white-space:nowrap">pre-merger</FONT> notification and report forms under the HSR Act with respect to the Merger, and (ii)&nbsp;make, as promptly as practicable and advisable, any
appropriate filings with other Governmental Authorities, if necessary or advisable, pursuant to any other Antitrust Law. The Company and Parent shall (and, to the extent required, shall cause its Affiliates to) request early termination of any
applicable waiting periods under the Antitrust Laws (if available) and shall respectively use their reasonable best efforts to cause the expiration or termination of such waiting periods, and shall supply to the Antitrust Division of the United
States Department of Justice (the &#147;<U>Antitrust Division</U>&#148;) or the United States Federal Trade Commission (the &#147;<U>FTC</U>&#148;) as promptly as reasonably practicable and advisable any additional information or documents that may
be requested pursuant to any Law or by any of them. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) In furtherance of the covenants of the parties contained in this
<U>Section</U><U></U><U>&nbsp;7.6</U> (i)&nbsp;if any administrative or judicial action or proceeding, including any proceeding by a private party, is instituted (or threatened to be instituted) challenging the Merger as violative of any Antitrust
Law, each of the parties hereto shall take all action required to contest and resist any such action or proceeding and to have vacated, lifted, reversed or overturned any decree, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-80- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
judgment, injunction, or other order, whether temporary, preliminary or permanent, that results from such action or proceeding and that prohibits, prevents or restricts consummation of the Merger
on or before the Outside Date and (ii)&nbsp;Parent and the Company each shall take all such further action as may be necessary to avoid or eliminate each and every impediment under any Antitrust Law so as to enable the Closing to occur as promptly
as practicable (and in any event no later than the Outside Date), including proposing, negotiating, committing and effecting, by consent decree, hold separate order, or otherwise, to (x)&nbsp;sell, divest, license, dispose of or otherwise hold
separate (including by establishing a trust or otherwise), any of the businesses, assets or properties of Parent, the SpinCo Entities or any of their respective Subsidiaries (other than the Company and its Subsidiaries following the Closing),
including the SpinCo Business and the SpinCo Assets, (y)&nbsp;terminate, amend or assign any existing Contracts or relationships of Parent, the SpinCo Entities or any of their respective Subsidiaries (other than the Company and its Subsidiaries
following the Closing), including the SpinCo Business and the SpinCo Assets, and (z)&nbsp;otherwise take or commit to take actions that after the Closing would limit such Party&#146;s freedom of action with respect to, or its ability to operate
and/or retain any of the businesses, assets or properties of Parent, the SpinCo Entities or any of their respective Subsidiaries (other than the Company and its Subsidiaries following the Closing), including the SpinCo Business and the SpinCo
Assets; <U>provided</U>, that neither Parent nor the Company shall be required to take any action under this <U>Section</U><U></U><U>&nbsp;7.6</U> that would materially impact Parent&#146;s or the Company&#146;s expected benefits resulting from the
Transactions. Notwithstanding anything in this Agreement to the contrary, the Company and its Subsidiaries shall not be obligated to take or agree or commit to take any action (A)&nbsp;that is not conditioned on the Closing or (B)&nbsp;that relates
to any Ligand Retained Assets or the Ligand Retained Business. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) Parent and the Company shall cooperate and consult with each other in
connection with the making of all filings, notifications, communications, submissions, and any other actions pursuant to this <U>Section</U><U></U><U>&nbsp;7.6</U>, and, subject to applicable legal limitations and the instructions of any
Governmental Authority, Parent and the Company shall keep each other apprised on a current basis of the status of matters relating to the completion of the Transactions, including promptly furnishing the other with copies of notices or other
communications received by Parent and the Company, as the case may be, or any of their respective Subsidiaries or Affiliates, from any third party and/or any Governmental Authority with respect to such Transactions. Subject to applicable Law
relating to the exchange of information, Parent and the Company shall permit counsel for the other party reasonable opportunity to review in advance, and consider in good faith the views of the other party in connection with, any proposed
notifications or filings and any substantive written communications or submissions to any Governmental Authority; <U>provided</U>, that materials may be redacted (i)&nbsp;to remove references concerning the valuation of the SpinCo Business and the
SpinCo Assets or information concerning the Transaction Process, or proposals from third parties with respect thereto, (ii)&nbsp;as necessary to comply with contractual agreements, and (iii)&nbsp;as necessary to address reasonable privilege or
confidentiality concerns. Parent and the Company agree not to participate in any <FONT STYLE="white-space:nowrap">pre-scheduled</FONT> meeting or discussion, either in person, by video conference, or by telephone, with any Governmental Authority in
connection with the Transactions unless it consults with the other party in advance and, to the extent not prohibited by such Governmental Authority, gives the other party a reasonable opportunity to attend and participate. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.7 [Intentionally Omitted]. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-81- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.8 <U>Access to Information</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) The Company shall, and shall cause its Subsidiaries, on the one hand, and Parent shall, and shall cause its Subsidiaries, on the other
hand, to afford to the other Party and to its respective Representatives, reasonable access, during normal business hours and subject to bona fide policies and procedures established by the other Party (including in response to <FONT
STYLE="white-space:nowrap">COVID-19),</FONT> during the Interim Period, in such manner as to not interfere with Parent&#146;s and its Subsidiaries&#146; business&#146;s or the SpinCo Business&#146;s (as applicable) normal operations, the properties,
books and records and appropriate senior-level officers and employees of Parent and its Subsidiaries or the Company and its Subsidiaries (including the SpinCo Entities) that are related to the SpinCo Business (as applicable), and shall furnish such
Party and its Representatives with such accounting (including accountants&#146; work papers), financial and operating data and other information concerning the affairs of Parent and its Subsidiaries or the SpinCo Business or the SpinCo Entities (as
applicable), in each case, as such Party and its Representatives may reasonably request for the purposes of furthering the Transactions or for purposes of preparing for the operation of Parent and the Surviving Corporation post-Closing;
<U>provided</U>, that (x)&nbsp;such investigation shall only be upon reasonable notice and at the sole cost and expense of the investigating Party; and (y)&nbsp;nothing in this Agreement shall require any Party to permit any inspection or disclose
any information to any other Party that (i)&nbsp;would unreasonably interfere with the conduct of such Party&#146;s business or result in damage to property (other than immaterial damage), except with such other Party&#146;s prior written consent
(which may be withheld or denied at its sole discretion), (ii)&nbsp;would cause a violation of any Law, privacy policy or any confidentiality obligations and similar restrictions that may be applicable to such information, or (iii)&nbsp;would
jeopardize the attorney-client privilege or other disclosure privilege or protection to such Party; <U>provided</U>, that the Party that would otherwise be required to disclose information to the other shall take any and all reasonable action
necessary to permit such disclosure without such loss of privilege or violation of agreement, policy, Law or other restriction, including through the use of commercially reasonable efforts to obtain any required consent or waiver to the disclosure
of such information from any third party and through the implementation of appropriate and mutually agreeable &#147;clean room&#148; or other similar procedures designed to limit any such adverse effect of sharing such information by each Party).
Notwithstanding anything in this <U>Section</U><U></U><U>&nbsp;7.8</U> to the contrary, (but without limiting the Company&#146;s obligations under this Agreement, including <U>Section</U><U></U><U>&nbsp;7.4)</U>, the Company and SpinCo shall not be
required to provide access to, or make any disclosure with respect to, any information of or relating to the Company, any of its Affiliates or any of their respective businesses, other than information relating to the SpinCo Business, the SpinCo
Entities, the SpinCo Assets or the SpinCo Liabilities. All requests for such access to any Party shall be made to such Party or its designated Representative. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) The Parties hereby agree that the provisions of the Confidentiality Agreement shall apply to all information and material furnished by any
Party or its Representatives thereunder and hereunder. The Confidentiality Agreement shall survive any termination of this Agreement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-82- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.9 <U>Exclusivity</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) The Company shall immediately cease, and shall cause its Subsidiaries and shall use reasonable best efforts to cause its Representatives to
immediately cease, any discussions or negotiations with any Person (other than Parent or its Affiliates) that may be ongoing with respect to a SpinCo Proposal, or any inquiry, proposal or offer that would reasonably be expected to lead to a SpinCo
Proposal, and shall promptly request that each Person that has been provided with any confidential information in connection with any SpinCo Proposal prior to the date of this Agreement promptly return or destroy such information, including promptly
terminating any access by any Person to any physical or electronic data room relating to any SpinCo Proposal (as defined below). From the date hereof until the earlier to occur of (a)&nbsp;the termination of this Agreement pursuant to
<U>Article</U><U></U><U>&nbsp;IX</U> and (b)&nbsp;the Effective Time, the Company shall not, and shall cause its Subsidiaries and shall use reasonable best efforts to cause its Representatives not to: (i)&nbsp;solicit, initiate, knowingly encourage
or knowingly facilitate (including by way of furnishing information that has not been previously publicly disseminated) any proposal from or on behalf of a third party relating to, directly or indirectly, any acquisition (whether by merger, purchase
of Interests, purchase of assets or otherwise), exclusive license, joint venture, partnership, recapitalization, liquidation, dissolution or other transaction involving any portion of the business or assets of the Company and its Subsidiaries that,
individually or in the aggregate, constitutes 15% or more of the net revenues, net income or assets of the SpinCo Business (taken as a whole) (any of the foregoing, a &#147;<U>SpinCo Proposal</U>&#148;), or any inquiry, proposal or offer which would
reasonably be expected to lead to a SpinCo Proposal, (ii)&nbsp;engage in any discussions or negotiations regarding, or furnish to any Person any nonpublic information relating to the SpinCo Business, SpinCo Assets or SpinCo Entities in connection
with, any SpinCo Proposal or any inquiry, proposal, effort or attempt related to or that would reasonably be expected to lead to, a SpinCo Proposal, (iii)&nbsp;adopt, approve or recommend, or publicly propose to adopt, approve or recommend, any
SpinCo Proposal or (iv)&nbsp;approve or authorize, or cause or permit the Company or any Company Subsidiary to enter into, any merger agreement, acquisition agreement, reorganization agreement, letter of intent, memorandum of understanding,
agreement in principle, option agreement, joint venture agreement, partnership agreement or similar agreement or document relating to, or providing for, any SpinCo Proposal; <U>provided</U>, that nothing in this <U>Section</U><U></U><U>&nbsp;7.9</U>
shall limit the Company&#146;s ability to pursue or engage in any transaction relating to substantially all of the business of the Company and its Subsidiaries, taken as a whole (as opposed to solely the SpinCo Business), so long as such transaction
would not prevent or materially impair or materially delay the Company&#146;s ability to comply with its obligations hereunder and under the Separation and Distribution Agreement or to consummate the Transactions; <U>provided</U>, <U>further</U>,
that the foregoing shall not affect any of the obligations of the Company and SpinCo or the SpinCo Entities under this Agreement or any other Transaction Document. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Notwithstanding the terms of <U>Section</U><U></U><U>&nbsp;7.9(a)</U>, at any time prior to the earlier of (i) 180 days after the date of
this Agreement or (ii)&nbsp;the Parent Registration Statement being declared effective by the SEC, the Company may: (x)&nbsp;furnish information in response to a request therefor (including nonpublic information regarding the Company or any of its
Subsidiaries) to any Person or its Representatives who makes an unsolicited proposal to acquire all or at least seventy-five percent (75%) of the voting securities of the Company or at least seventy-five (75%) of the assets of the Company and its
Subsidiaries, taken as a whole, that is conditioned on the termination of this Agreement (any such proposal, a &#147;<U>Company Acquisition Proposal</U>&#148;), in each case, <U>provided,</U> that prior to furnishing any such information, the Person
making such Company Acquisition Proposal enters into a confidentiality agreement with the Company at least as restrictive as the Confidentiality Agreement; and (y)&nbsp;engage or participate in any discussions or negotiations with any Person
regarding such Company Acquisition Proposal. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-83- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) The Company shall promptly (and, in any event, within two (2)&nbsp;Business Days) give
notice to Parent if any Company Acquisition Proposal is received by the Company, setting forth in such notice the material terms and conditions of any such proposals or offers. Parent shall keep such information confidential pursuant to the terms of
the Confidentiality Agreement. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) Notwithstanding anything to the contrary set forth in this <U>Section</U><U></U><U>&nbsp;7.9</U>, at
any time prior to the earlier of (i) 180 days after the date of this Agreement or (ii)&nbsp;the Parent Registration Statement being declared effective by the SEC, the Company may elect to terminate this Agreement pursuant to and subject to the terms
of <U>Section</U><U></U><U>&nbsp;9.1(i)</U> and <U>Section</U><U></U><U>&nbsp;9.3</U> in order to enter into a definitive agreement with respect to a Company Acquisition Proposal; <U>provided</U>, that, prior to entering into any such definitive
agreement with respect to a Company Acquisition Proposal, (x)&nbsp;the Company must have delivered notice to the Parent of its intention to enter into such definitive agreement at least five (5)&nbsp;Business Days prior to the taking of such action
by the Company and (y)&nbsp;during such five <FONT STYLE="white-space:nowrap">(5)&nbsp;Business-Day</FONT> period and prior to entering into such definitive agreement, if requested by Parent, the Company shall negotiate in good faith with Parent
regarding any revisions or adjustments proposed by Parent to the terms and conditions of this Agreement. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) Parent shall immediately
cease and shall use reasonable best efforts to cause its Representatives to immediately cease, any discussions or negotiations with any Person (other than the Company or its Affiliates) that may be ongoing with respect to a Parent Business
Combination Proposal, or any inquiry, proposal or offer that would reasonably be expected to lead to a Parent Business Combination Proposal. From the date hereof until the earlier to occur of (i)&nbsp;the termination of this Agreement pursuant to
<U>Article</U><U></U><U>&nbsp;IX</U> and (ii)&nbsp;the Effective Time, Parent shall not and shall use reasonable best efforts to cause its Representatives not to: (w)&nbsp;solicit, initiate, knowingly encourage or knowingly facilitate (including by
way of furnishing information that has not been previously publicly disseminated) any proposal from or on behalf of a third party relating to, directly or indirectly, any Business Combination, or any inquiry, proposal or offer which would reasonably
be expected to lead to a Parent Business Combination Proposal, (x)&nbsp;engage in any discussions or negotiations regarding, or exchange with any Person any nonpublic information in connection with, any Parent Business Combination Proposal or any
inquiry, proposal, effort or attempt related to or that would reasonably be expected to lead to, a Parent Business Combination Proposal, (y)&nbsp;adopt, approve or recommend, or publicly propose to adopt, approve or recommend, any Parent Business
Combination Proposal or (z)&nbsp;approve or authorize, or cause or permit Parent to enter into, any merger agreement, acquisition agreement, reorganization agreement, letter of intent, memorandum of understanding, agreement in principle, option
agreement, joint venture agreement, partnership agreement or similar agreement or document relating to, or providing for, any Parent Business Combination Proposal. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-84- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.10 <U>Public Announcements</U>. Except (a)&nbsp;as otherwise expressly
contemplated by this Agreement, (b)&nbsp;in connection with any press release, public statement or filing to be issued or made by Parent with respect to any Modification in Recommendation, and (c)&nbsp;for the separate or joint press releases to be
issued by the Parties in the forms agreed by the Parties (or any public statement or disclosure that contains or reflects only such information previously disclosed in press releases or other public disclosures made in accordance with this
<U>Section</U><U></U><U>&nbsp;7.10</U>), neither Parent nor the Company will, and each of Parent and the Company will cause its Subsidiaries not to, issue any press release or otherwise make any public statements or disclosure with respect to the
Transactions without the prior written consent of the other Party. Notwithstanding the foregoing, to the extent such disclosure is required by applicable Law or the rules of any stock exchange, the Party seeking to make such disclosure will promptly
notify the other Party thereof and the Party making such statement will use efforts reasonable under the circumstances to consult in good faith with the other Party thereto prior to making such disclosure in order to allow a mutually agreeable
release or announcement to be issued. Notwithstanding the foregoing, any Party may make statements that are consistent with previous public releases made by such Party in compliance with this <U>Section</U><U></U><U>&nbsp;7.10</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.11 <U>Defense of Litigation</U>. Parent and the Company shall provide the other Party prompt notice in writing of any Action
brought by any shareholder or purported shareholder of such Party against it, any of its Subsidiaries or any of their respective directors and officers (including, with respect to the Company, SpinCo) relating to this Agreement, the Transactions,
the Transaction Documents and any of the matters contemplated hereby or thereby (collectively, &#147;<U>Transaction Litigation</U>&#148;), and shall keep the other Party informed on a reasonably current basis with respect to the status thereof and
consider any comments or suggestions made by the other Party with respect to the strategy therefor; <U>provided</U>, that prior to the Effective Time, no Party shall compromise, settle, come to an arrangement regarding or agree to compromise, settle
or come to an arrangement regarding any Action arising or resulting from the Transactions or consent to the same, without the prior written consent of the other Party to the extent (a)&nbsp;such Action includes the other Party or any of its
Subsidiaries, directors or officers as named defendants or (b)&nbsp;such compromise, settlement or arrangement would reasonably be expected to prevent, materially impair, materially delay or otherwise have a material adverse effect on the ability of
the Parties to perform their respective obligations hereunder, or to consummate the Transactions in a timely manner. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.12
<U>Section 16</U><U> Matters</U>. Prior to the Effective Time, each of Parent, the Company and SpinCo shall take all such steps as may be required (to the extent permitted by applicable Law) to cause any dispositions of SpinCo Common Stock
(including derivative securities with respect to SpinCo Common Stock) or acquisitions of Parent Common Stock or Domesticated Parent Stock resulting from the Transactions, including the Distribution, directly or indirectly, by each individual, if
any, who is subject to Section&nbsp;16(a) of the Exchange Act with respect to Parent or SpinCo, as applicable, as an officer or director thereof to be exempt under Rule <FONT STYLE="white-space:nowrap">16b-3</FONT> promulgated under the Exchange
Act, such steps to be taken in accordance with (and to the extent permitted by) applicable SEC rules and regulations and interpretations of the SEC staff. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.13 <U>Control of Other Party</U><U>&#146;</U><U>s Business</U>. Nothing contained in this Agreement shall give the Company or
SpinCo, directly or indirectly, the right to control or direct Parent&#146;s operations prior to the Effective Time. Nothing contained in this Agreement shall give Parent, directly or indirectly, the right to control or direct the operations of the
Company, including the SpinCo Business, prior to the Effective Time. Prior to the Effective Time, each of the Company, SpinCo and Parent shall exercise, consistent with the terms and conditions of this Agreement, complete control and supervision
over its respective operations. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-85- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.14 <U>SpinCo Share Issuance</U>. Prior to the Effective Time, SpinCo will
take all actions necessary to authorize the issuance of a number of, or stock split of, shares of SpinCo Common Stock such that the total number of shares of SpinCo Common Stock outstanding immediately prior to the Effective Time will equal the
number of shares of Company Common Stock entitled to receive the Distribution outstanding immediately prior to the Effective Time in accordance with the terms of the Separation and Distribution Agreement. Each of the Company and SpinCo shall effect
such amendments, filings or other actions with respect to its respective Governing Documents as are necessary to effect the Distribution in accordance with the terms of this Agreement and the Separation and Distribution Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.15 <U>Domestication</U>. Subject to receipt of the Parent Shareholder Approval, no later than the date that is one day prior to
the Effective Time, Parent shall cause the Domestication to become effective, including by (a)&nbsp;filing with the Secretary of State of the State of Delaware a Certificate of Domestication with respect to the Domestication, in form and substance
reasonably acceptable to Parent and the Company, together with the Parent Charter substantially in the form attached as <U>Exhibit G</U> hereto (with such changes as may be agreed in writing by Parent and the Company, the &#147;<U>Parent
Charter</U>&#148;), in each case, in accordance with the provisions thereof and applicable Law, (b)&nbsp;completing, making and procuring all those filings required to be made with the Cayman Registrar in connection with the Domestication and
(c)&nbsp;obtaining a certificate of <FONT STYLE="white-space:nowrap">de-registration</FONT> from the Cayman Registrar. In accordance with applicable Law, the Domestication shall provide that at the effective time of the Domestication, by virtue of
the Domestication, and without any action on the part of any shareholder of Parent, (i)&nbsp;each then issued and outstanding share of Parent Class&nbsp;A Common Stock shall convert automatically, on a <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">one-for-one</FONT></FONT> basis, into a share of Domesticated Parent Common Stock; (ii)&nbsp;each then issued and outstanding share of Parent Class&nbsp;B Common Stock shall convert automatically, on a <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">one-for-one</FONT></FONT> basis, into a share of Domesticated Parent Common Stock; (iii)&nbsp;each then issued and outstanding Parent Warrant shall convert automatically into a Domesticated
Parent Warrant, pursuant to the Warrant Agreement; (iv)&nbsp;each then issued and outstanding Parent Unit shall separate and convert automatically into one share of Domesticated Parent Common Stock and
<FONT STYLE="white-space:nowrap">one-third</FONT> of one Domesticated Parent Warrant; and (v)&nbsp;Parent&#146;s bylaws from and after the effective time of the Domestication shall be substantially in the form attached as <U>Exhibit H</U> hereto
(with such changes as may be agreed in writing by Parent and the Company, the &#147;<U>Parent Bylaws</U>&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.16
<U>Transaction Documents</U>. Parent shall, or shall cause its applicable Subsidiaries to, execute and deliver to the Company at or prior to the Closing each of the Transaction Documents to which it or any such Subsidiary is or will be a party at
the Effective Time. The Company shall, or shall cause its applicable Subsidiaries to, execute and deliver to Parent at or prior to the Closing each of the Transaction Documents to which it or any such Subsidiary is or will be a party at the
Effective Time. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-86- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.17 <U>NASDAQ Listing</U>. From the date hereof through the Effective Time,
Parent shall use its reasonable best efforts to maintain the listing of the Parent Class&nbsp;A Common Stock on NASDAQ, and shall prepare and submit to NASDAQ a listing application, if required under NASDAQ rules, covering the shares of Domesticated
Parent Stock issuable in the Merger and the Domestication, and shall use its reasonable best efforts to cause the shares of Domesticated Parent Stock issuable pursuant to the Transactions to be approved for listing on the NASDAQ, subject to official
notice of issuance, as promptly as practicable after the date of this Agreement, and in any event prior to the Effective Time. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.18 <U>Takeover Statutes</U>. If any &#147;fair price,&#148; &#147;moratorium,&#148; &#147;control share acquisition,&#148;
&#147;business combination&#148; or other form of antitakeover Law shall become applicable to the Transactions, Parent, Merger Sub and their respective boards of directors shall use all reasonable efforts to grant such approvals and take such
actions as are reasonably necessary so that the Transactions may be consummated as promptly as practicable on the terms contemplated hereby and otherwise act to eliminate or minimize the effects of such statute or regulation on the Transactions.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.19 <U>Obligations of Merger Sub and SpinCo</U>. Parent shall take all action necessary to cause Merger Sub to perform its
obligations and take any actions contemplated or required under this Agreement or the Transaction Documents or to consummate the Transactions, including the Merger, upon the terms and subject to the conditions set forth in this Agreement. The
Company shall take all action necessary prior to the Effective Time to cause SpinCo to perform its obligations and to take any actions contemplated or required to be taken by SpinCo under this Agreement or the Transaction Documents to consummate the
Transactions, including the Merger, upon the terms and subject to the conditions set forth in this Agreement and the Separation and Distribution Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.20 <U>Further Assurances</U>. Except as otherwise expressly provided in this Agreement, the Parties shall, and shall cause
their respective Affiliates to, use their respective commercially reasonable efforts to take, or cause to be taken, all appropriate action, to do, or cause to be done, and to assist and cooperate with the other Parties in doing, all things
necessary, proper or advisable under this Agreement, any other Transaction Document or applicable Law as may be required to carry out the provisions of this Agreement or such other Transaction Document, as applicable, and to consummate and make
effective the Merger and the other Transactions (other than with respect to the matters covered in <U>Section</U><U></U><U>&nbsp;7.6</U>, which shall be governed by the provisions of <U>Section</U><U></U><U>&nbsp;7.6</U> and any consents required in
connection with the Separation, which shall solely be governed by the Separation and Distribution Agreement). In furtherance and not in limitation of the foregoing, each Party shall use commercially reasonable efforts to obtain all consents,
approvals or waivers from third parties necessary in connection with the Merger (other than with respect to the matters covered in <U>Section</U><U></U><U>&nbsp;7.6</U>, which shall be governed by the provisions of
<U>Section</U><U></U><U>&nbsp;7.6</U> and any consents required in connection with the Separation, which shall solely be governed by the Separation and Distribution Agreement); <U>provided</U>, that no Party or any of its Affiliates shall be
required to commence any litigation, offer or pay any money, or otherwise grant any accommodation (financial or otherwise) to any third party with respect to the foregoing. The failure to obtain any consents, approvals or waivers from third parties
shall not in and of itself constitute a breach of this Agreement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-87- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.21 <U>Sole Shareholder Approvals</U>. Immediately after the execution of this
Agreement, (a)&nbsp;the Company will deliver the SpinCo Shareholder Approval to Parent, and (b)&nbsp;Parent, as the sole shareholder of Merger Sub, acting by written consent, will adopt this Agreement and approve the consummation of the
Transactions, upon the terms and subject to the conditions stated herein and in accordance with the applicable provisions of the DGCL (the &#147;<U>Merger Sub Shareholder Approval</U>&#148;) and deliver a copy of the Merger Sub Shareholder Approval
to the Company.<SUP STYLE="font-size:85%; vertical-align:top"> </SUP> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.22 <U>Financial Information</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) The Company shall, from the date hereof until the Closing Date, prepare and deliver to Parent, (i)&nbsp;as promptly as reasonably
practicable and no later than seventy-five (75)&nbsp;calendar days after the end of any fiscal quarter, the unaudited combined balance sheet of the SpinCo Business as of the end of such fiscal quarter and the related unaudited combined statements of
income, comprehensive income, equity and cash flows of the SpinCo Business for such fiscal quarter, together with comparable financial statements for the corresponding periods of the prior fiscal years, in each case, to the extent required to be
included or incorporated by reference in the Parent Registration Statement (including the Proxy Statement), SpinCo Registration Statement or Distribution Documents (collectively, the &#147;<U>Subsequent Unaudited SpinCo Financial
Statements</U>&#148;) and (ii)&nbsp;if necessary, as promptly as reasonably practicable and no later than <FONT STYLE="white-space:nowrap">one-hundred</FONT> (100)&nbsp;calendar days after the end of any fiscal year, the audited combined balance
sheet of the SpinCo Business as of the end of such fiscal year of SpinCo and the related audited combined statements of income, comprehensive income, equity and cash flows of the SpinCo Business for such fiscal year, together with comparable
financial statements for the prior fiscal years, in each case, to the extent required to be included or incorporated by reference in the Parent Registration Statement (including the Proxy Statement), SpinCo Registration Statement or Distribution
Documents (collectively, the &#147;<U>Subsequent Audited Annual SpinCo Financial Statements</U>&#148; and, together with the Subsequent Unaudited SpinCo Financial Statements, the &#147;<U>Subsequent Period SpinCo Financial Statements</U>&#148;). The
Subsequent SpinCo Financial Statements shall be prepared from the books and records of the Company and its Subsidiaries and in accordance with GAAP applied on a consistent basis throughout the periods involved (except as may otherwise be required
under GAAP) and the applicable rules and regulations of the SEC, including the requirements of Regulation <FONT STYLE="white-space:nowrap">S-X.</FONT> The Subsequent Unaudited SpinCo Financial Statements shall have been reviewed by the independent
accountant for SpinCo in accordance with the procedures specified by the Public Company Accounting Oversight Board (United States) in AU Section&nbsp;722 and each of the Subsequent Audited Annual SpinCo Financial Statements shall be accompanied by
an audit report, without qualification or exception from the independent accountant for SpinCo. When delivered, the Subsequent Period SpinCo Financial Statements shall present fairly in all material respects the combined financial position and
combined and consolidated results of operations of the SpinCo Business as of the dates and for the periods shown therein. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) The Company
agrees to use reasonable best efforts to provide Parent as promptly as practicable after the date of this Agreement, audited financial statements, including combined balance sheets as of December&nbsp;31, 2021 and December&nbsp;31, 2020 and combined
statements of income and comprehensive income, equity and cash flows of the SpinCo Business for the fiscal years ended December&nbsp;31, 2021, December&nbsp;31, 2020 and December&nbsp;31, 2019, in each case, prepared in accordance with GAAP and
Regulation <FONT STYLE="white-space:nowrap">S-X</FONT> and audited in accordance with the auditing standards of the PCAOB; provided, that such audited financial statements shall not be required to include a signed audit opinion, which signed audit
opinion shall be delivered </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-88- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
immediately prior to the initial filing of the SpinCo Registration Statement with the SEC. During the Interim Period and from and after the Closing, the Company shall use reasonable best efforts,
in connection with the filing of the SpinCo Registration Statement and any other applicable SEC filings, to (i)&nbsp;cooperate with Parent to prepare pro forma financial statements that comply with the rules and regulations of the SEC to the extent
required for SEC filings, including the requirements of Regulation <FONT STYLE="white-space:nowrap">S-X,</FONT> and (ii)&nbsp;provide and make reasonably available upon reasonable notice, the senior management employees of the Company to discuss the
materials prepared and delivered pursuant to this <U>Section</U><U></U><U>&nbsp;7.22(b)</U>. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ARTICLE&nbsp;VIII </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">CONDITIONS TO THE MERGER </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;8.1 <U>Conditions to the Obligations of SpinCo, the Company, Parent and Merger Sub to Effect the Merger</U>. The respective
obligations of each Party to consummate the Merger shall be subject to the fulfillment (or, to the extent permitted by applicable Law, waiver by the Company and Parent) at or prior to the Closing of the following conditions: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) (i) the waiting period (or any extension thereof) under the HSR Act with respect to the Merger shall have expired or been terminated
pursuant to the HSR Act; (ii)&nbsp;all other Requisite Regulatory Approvals shall have been obtained and shall remain in full force and effect and all statutory waiting periods (and any extensions thereof) in respect thereof shall have expired or
been terminated; and (iii)&nbsp;there shall not be in effect any voluntary agreement between the Parent or the Company and any Governmental Authority pursuant to which Parent or the Company has agreed not to consummate the Transactions for any
period of time; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) the Internal Reorganization, the Contribution and the Distribution and the other transactions contemplated by the
Separation and Distribution Agreement shall have been consummated in accordance with the Separation and Distribution Agreement; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) (i)
each of the Parent Registration Statement and the SpinCo Registration Statement shall have become effective in accordance with the Securities Act or the Exchange Act, as applicable, and neither shall be the subject of any stop order by the SEC or
actual or threatened proceedings by a Governmental Authority seeking such a stop order; and (ii)&nbsp;the applicable notice periods required by applicable stock exchange rules or securities Laws in connection with the Distribution, if any, shall
have expired; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) the Parent Shareholder Approval shall have been obtained; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) no Governmental Authority of competent jurisdiction shall have enacted, issued or granted any Law (whether temporary, preliminary or
permanent), in each case that is in effect and which has the effect of restraining, enjoining or prohibiting the consummation of the Transactions; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) Parent shall have at least $5,000,001 of net tangible assets (as determined in accordance with Rule
<FONT STYLE="white-space:nowrap">3a51-1(g)(1)</FONT> of the Exchange Act); and </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-89- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) the shares of Domesticated Parent Stock issuable pursuant to the Transactions shall have
been approved for listing on NASDAQ, subject to official notice of issuance. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;8.2 <U>Additional Conditions to the Obligations
of the Company and </U><U>SpinCo</U>. The obligation of the Company and SpinCo to consummate the Merger shall be subject to the fulfillment (or, to the extent permitted by applicable Law, waiver by the Company) at or prior to the Closing of the
following additional conditions: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Parent and Merger Sub shall each have performed and complied in all material respects with the
obligations, covenants and agreements required by this Agreement to be performed or complied with by it at or prior to the Effective Time; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) all representations and warranties made by Parent and Merger Sub set forth in <U>Article</U><U></U><U>&nbsp;VI</U> (other than the
representations and warranties referenced in the second and third sentences of this <U>Section</U><U></U><U>&nbsp;8.2(b)</U>), without giving effect to materiality, Parent Material Adverse Effect or similar qualifications, shall be true and correct
in all respects at and as of the date hereof and as of the Closing Date as though such representations and warranties were made at and as of the Closing Date (except in the case of any representation or warranty that by its terms addresses matters
only as of another specified date, which shall be so true and correct only as of such specified date), except to the extent the failure of such representations and warranties to be true and correct (without giving effect to materiality, Parent
Material Adverse Effect or similar qualifications) would not have, individually or in the aggregate, a Parent Material Adverse Effect. The representations and warranties made by Parent set forth in <U>Section</U><U></U><U>&nbsp;6.1(a)</U>, the first
and third sentences of <U>Section</U><U></U><U>&nbsp;6.1(b)</U>, the entirety of <U>Section</U><U></U><U>&nbsp;6.2</U>, <U>Section</U><U></U><U>&nbsp;6.3</U> (other than the first two sentences of <U>Section</U><U></U><U>&nbsp;6.3(a)</U> and the
second sentence of <U>Section</U><U></U><U>&nbsp;6.3(b)</U>) and <U>Section</U><U></U><U>&nbsp;6.11</U> shall be true and correct in all material respects at and as of the date hereof and as of the Closing Date as though such representations and
warranties were made at and as of the Closing Date (except in the case of any representation or warranty that by its terms addresses matters only as of another specified date, which shall be so true and correct only as of such specified date). The
representations and warranties made by Parent set forth in <U>Section</U><U></U><U>&nbsp;6.10(a)</U>, the first two (2)&nbsp;sentences of <U>Section</U><U></U><U>&nbsp;6.3(a)</U> and the second sentence of <U>Section</U><U></U><U>&nbsp;6.3(b)</U>
shall be true and correct in all respects at and as of the date hereof and as of the Closing Date as though such representations and warranties were made at and as of the Closing Date (other than for <I>de minimis </I>deviations in the case of the
representations and warranties set forth in the first two (2)&nbsp;sentences of <U>Section</U><U></U><U>&nbsp;6.3(a)</U> and the second sentence of <U>Section</U><U></U><U>&nbsp;6.3(b)</U>, and except in the case of any representation or warranty
that by its terms addresses matters only as of another specified date, which shall be so true and correct only as of such specified date); </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Parent shall have delivered to the Company the certificate referenced in <U>Section</U><U></U><U>&nbsp;2.3(b)(ii)</U> dated as of the
Closing Date signed by an authorized officer of Parent certifying that each of the conditions set forth in <U>Section</U><U></U><U>&nbsp;8.1(f)</U> and <U>Section</U><U></U><U>&nbsp;8.2(a)</U>, <U>(b)</U> and <U>(d)</U>&nbsp;have been satisfied;
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) Parent and Merger Sub shall have executed and delivered the applicable Transaction Documents, and to the extent applicable, performed
and complied with the obligations, covenants and agreements thereunder required to be performed by them prior to the Effective Time in all material respects, and each such agreement shall be in full force and effect; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-90- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) the Domestication shall have been completed as provided in
<U>Section</U><U></U><U>&nbsp;7.15</U> and a time-stamped copy of the certificate issued by the Secretary of State of the State of Delaware in relation thereto shall have been delivered to the Company; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) the PIPE Investment and the Redemption Backstop shall have been consummated in accordance with the terms of the A&amp;R Forward Purchase
Agreement; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) other than those Persons identified as continuing directors on <U>Section</U><U></U><U>&nbsp;8.2(g)</U> of the Company
Disclosure Schedule, all members of the Parent Board and all executive officers of Parent shall have executed and delivered written resignations effective as of the Effective Time; and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h) The Company shall have received the Company Tax Opinions from LW and a copy of the Parent Merger Tax Opinion.<SUP
STYLE="font-size:85%; vertical-align:top"> </SUP> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;8.3 <U>Additional Conditions to the Obligations of Parent and Merger
Sub</U>. The obligation of Parent and Merger Sub to consummate the Merger shall be subject to the fulfillment (or, to the extent permitted by applicable Law, waiver by Parent) at or prior to the Closing of the following additional conditions: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Each of SpinCo and the Company shall each have performed and complied in all material respects with the obligations, covenants and
agreements required by this Agreement to be performed or complied with by it at or prior to the Effective Time; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) all representations
and warranties made by the Company set forth in <U>Article</U><U></U><U>&nbsp;IV</U> and <U>Article</U><U></U><U>&nbsp;V</U> (other than the representations and warranties referenced in the second and third sentences of this
<U>Section</U><U></U><U>&nbsp;8.3(b)</U>), without giving effect to materiality, &#147;Company Material Adverse Effect&#148;, &#147;SpinCo Material Adverse Effect&#148; or similar qualifications, shall be true and correct in all respects at and as
of the date hereof and as of the Closing Date as though such representations and warranties were made at and as of the Closing Date (except in the case of any representation or warranty that by its terms addresses matters only as of another
specified date, which shall be so true and correct only as of such specified date), except to the extent the failure of such representations and warranties to be true and correct (without giving effect to materiality, &#147;Company Material Adverse
Effect&#148;, &#147;SpinCo Material Adverse Effect&#148; or similar qualifications) would not have, individually or in the aggregate, a SpinCo Material Adverse Effect, solely with respect to the representations and warranties set forth in <U>Article
V</U>, or Company Material Adverse Effect, solely with respect to the representations and warranties set forth in <U>Article IV</U>. The representations and warranties made by the Company set forth in the first three (3)&nbsp;sentences of
<U>Section</U><U></U><U>&nbsp;4.1</U>, <U>Section</U><U></U><U>&nbsp;4.2</U>, <U>Section</U><U></U><U>&nbsp;4.6</U>, <U>Section</U><U></U><U>&nbsp;4.7</U>, <U>Section</U><U></U><U>&nbsp;5.1</U>, the entirety of <U>Section</U><U></U><U>&nbsp;5.2</U>,
<U>Section</U><U></U><U>&nbsp;5.3</U> (other than the first sentence of <U>Section</U><U></U><U>&nbsp;5.3(a)</U> and the entirety of each of <U>Section</U><U></U><U>&nbsp;5.3(b)</U> and <U>Section</U><U></U><U>&nbsp;5.3(c)</U>),
<U>Section</U><U></U><U>&nbsp;5.5</U> and <U>Section</U><U></U><U>&nbsp;5.22</U> shall be true and correct in all material respects at and as of the date hereof and as of the Closing Date as though such representations and warranties were made at
and as of the Closing Date (except in the case of any representation or warranty that by its terms addresses matters only as of another specified </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-91- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
date, which shall be so true and correct only as of such specified date). The representations and warranties made by the Company set forth in the first sentence of
<U>Section</U><U></U><U>&nbsp;5.3(a)</U> and the entirety of each of <U>Section</U><U></U><U>&nbsp;5.3(c)</U> and <U>Section</U><U></U><U>&nbsp;5.24</U> shall be true and correct in all respects at and as of the date hereof and as of the Closing
Date as though such representations and warranties were made at and as of the Closing Date (other than for <I>de minimis </I>deviations in the case of the representations and warranties set forth in the first sentence of
<U>Section</U><U></U><U>&nbsp;5.3(a)</U> and <U>Section</U><U></U><U>&nbsp;5.3(c)</U>, and except in the case of other than in the case of any representation or warranty that by its terms addresses matters only as of another specified date, which
shall be so true and correct only as of such specified date); </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) No SpinCo Material Adverse Effect shall have occurred between the date
of this Agreement and the Closing Date that is continuing; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) The Company shall have delivered to Parent the certificate referenced in
<U>Section</U><U></U><U>&nbsp;2.3(a)(i)</U> dated as of the Closing Date signed by an authorized officer of the Company certifying that each of the conditions set forth in <U>Section</U><U></U><U>&nbsp;8.1(b)</U> and
<U>Section</U><U></U><U>&nbsp;8.3(a)</U>, <U>(b)</U>, <U>(c)</U> and <U>(e)</U>&nbsp;have been satisfied; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) SpinCo and the Company (or
such other applicable Subsidiary of the Company) shall have executed and delivered each of the applicable Transaction Documents, and to the extent applicable, performed and complied with the obligations, covenants and agreements to be performed
thereunder by them prior to the Effective Time in all material respects, and each such agreement shall be in full force and effect; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f)
Parent shall have received the Parent Merger Tax Opinion from Weil and a copy of the Company Tax Opinions; and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) The Company shall have,
or shall have caused SpinCo to have, delivered to Parent the certificate and other documents described in <U>Section</U><U></U><U>&nbsp;2.3(a)(iii)</U>. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ARTICLE&nbsp;IX </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">TERMINATION </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.1 <U>Termination</U>. This Agreement may be terminated and the Transactions may be abandoned at any time prior to the Effective
Time, whether before or after the Parent Shareholder Approval: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) by mutual written agreement of the Company and Parent; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) by the Company or Parent, if the Closing shall not have occurred on or prior to the date that is nine (9)&nbsp;months after the date of
this Agreement (the &#147;<U>Outside Date</U>&#148;); <U>provided</U>, that the right to terminate this Agreement pursuant to this <U>Section</U><U></U><U>&nbsp;9.1(b)</U> shall not be available to any Party whose action or failure to comply with
its obligations under this Agreement or any of the other Transaction Documents has been the primary cause of, or has primarily resulted in, the failure of the Closing to occur on or prior to such date; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-92- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) by the Company or Parent, if any Law shall have been promulgated, entered, enforced,
enacted or issued and in effect or shall have been deemed to be applicable to the Merger or the other Transactions, including the Internal Reorganization and the Distribution, by any Governmental Authority of competent jurisdiction which permanently
prohibits, restrains or makes illegal the consummation of the Merger or the other Transactions, and such Law shall have become final and <FONT STYLE="white-space:nowrap">non-appealable;</FONT> <U>provided</U>, that the right to terminate this
Agreement pursuant to this <U>Section</U><U></U><U>&nbsp;9.1(c)</U> shall not be available to any Party whose action or failure to perform any of its obligations under this Agreement or any of the Transaction Documents is the primary cause of, or
primarily resulted in, the enactment or issuance of any such Law; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) by Parent upon written notice to the Company, in the event of a
breach of any representation, warranty, covenant or agreement on the part of the Company or SpinCo, such that the conditions specified in <U>Section</U><U></U><U>&nbsp;8.3(a)</U> or <U>Section</U><U></U><U>&nbsp;8.3(b)</U> would not be satisfied at
the Closing, and which, (i)&nbsp;with respect to any such breach that is capable of being cured, is not cured by the Company or SpinCo by the earlier of: (x)&nbsp;thirty (30) days after receipt of written notice thereof; or (y)&nbsp;the Outside
Date, or (ii)&nbsp;is incapable of being cured prior to the Outside Date; <U>provided</U>, that Parent shall not have the right to terminate this Agreement pursuant to this <U>Section</U><U></U><U>&nbsp;9.1(d)</U> if Parent or Merger Sub is then in
breach of any of its representations, warranties, covenants or agreements set forth in this Agreement to the extent such breach or breaches would give rise to the failure of a condition set forth in <U>Section</U><U></U><U>&nbsp;8.2(a)</U> or
<U>Section</U><U></U><U>&nbsp;8.2(b)</U>; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) by the Company upon written notice to Parent, in the event of a breach of any
representation, warranty, covenant or agreement contained in this Agreement on the part of Parent or Merger Sub such that the conditions specified in <U>Section</U><U></U><U>&nbsp;8.2(a)</U> or <U>Section</U><U></U><U>&nbsp;8.2(b)</U> would not be
satisfied at the Closing, and which, (i)&nbsp;with respect to any such breach that is capable of being cured, is not cured by Parent by the earlier of: (x)&nbsp;thirty (30) days after receipt of written notice thereof; or (y)&nbsp;the Outside Date,
or (ii)&nbsp;is incapable of being cured prior to the Outside Date; <U>provided</U>, that the Company shall not have the right to terminate this Agreement pursuant to this <U>Section</U><U></U><U>&nbsp;9.1(e)</U> if the Company or SpinCo is then in
breach of any of its representations, warranties, covenants or agreements set forth in this Agreement to the extent such breach or breaches would give rise to the failure of a condition set forth in <U>Section</U><U></U><U>&nbsp;8.3(a)</U> or
<U>Section</U><U></U><U>&nbsp;8.3(b)</U>; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) by the Company or Parent, if the Parent Shareholder Approval shall not have been obtained
upon a vote taken thereon at the Parent Shareholders Meeting, duly convened therefor, or at any adjournment or postponement thereof; <U>provided</U>, that the right to terminate this Agreement pursuant to this
<U>Section</U><U></U><U>&nbsp;9.1(f)</U> shall not be available to Parent if Parent&#146;s actions or failure to perform any of its obligations under this Agreement is the primary cause of, or primarily resulted in, the failure to obtain such
approval; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) by the Company, if the Parent Board shall have effected a Parent Adverse Recommendation Change prior to the Parent
Shareholders Meeting; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h) by the Company, if all of the conditions to Closing set forth in <U>Article</U><U></U><U>&nbsp;VIII</U> have
been met (other than those conditions that by their terms are to be satisfied at Closing) other than the condition specified in <U>Section</U><U></U><U>&nbsp;8.2(f)</U>; and </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-93- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) by the Company, prior to the earlier of (i) 180 days after the date of this Agreement or
(ii)&nbsp;the Parent Registration Statement being declared effective by the SEC, in order to accept a Company Acquisition Proposal and enter into, immediately following such termination, a binding and definitive written Contract with respect to such
Company Acquisition Proposal; <U>provided</U>, that (x)&nbsp;the Company has materially complied with its covenants and agreements under <U>Section</U><U></U><U>&nbsp;7.9,</U> (y) the Company pays the Termination Fee to Parent in accordance with
<U>Section</U><U></U><U>&nbsp;9.3(a)</U> and (z)&nbsp;the Company pays the FPA Termination Fee to Sponsor pursuant to the terms of the A&amp;R Forward Purchase Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.2 <U>Effect of Termination</U>. In the event of termination of this Agreement pursuant to
<U>Section</U><U></U><U>&nbsp;9.1</U>, this Agreement shall forthwith become null and void and have no effect, without any Liability on the part of any Party; <U>provided</U>, that no such termination shall relieve any Party of any liability or
damages resulting from Actual Fraud or Willful Breach; <U>provided</U>, <U>further</U>, that <U>Section</U><U></U><U>&nbsp;7.8(b)</U>, this <U>Section</U><U></U><U>&nbsp;9.2</U>, <U>Section</U><U></U><U>&nbsp;9.4</U> and
<U>Article</U><U></U><U>&nbsp;X</U> hereof shall survive any termination of this Agreement. The Confidentiality Agreement shall not be affected by any termination of this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.3 <U>Termination Fee</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) In the event that this Agreement is terminated pursuant to <U>Section</U><U></U><U>&nbsp;9.1(i)</U>, concurrently with such termination,
the Company shall be obligated to pay Parent or its designee(s) a termination fee of (i)&nbsp;if terminated within 60 days of the date of this Agreement, $40,000,000, (ii) if terminated between 61 and 120 days after the date of this Agreement,
$50,000,000, and (iii)&nbsp;if terminated between 121 and 180 days after the date of this Agreement, $70,000,000 (each such amount, the &#147;<U>Termination Fee</U>&#148;), by wire transfer of immediately available funds to an account designated by
Parent in writing. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) In addition to payment of the Termination Fee, in the event that this Agreement is terminated pursuant to
<U>Section</U><U></U><U>&nbsp;9.1(i)</U>, the Company also shall pay the Parent Expenses (the &#147;<U>Parent Expenses Reimbursement</U>&#148;) by wire transfer of immediately available funds to an account designated by Parent in writing no later
than two (2)&nbsp;Business Days after the date on which Parent delivers to the Company a written invoice for the Parent Expenses. As used herein, &#147;<U>Parent Expenses</U>&#148; means the amount of all reasonable and documented <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> fees and expenses, but not to exceed $7,500,000, incurred or paid by Parent and its Affiliates in connection with this Agreement and the Transactions, including
fees and expenses of law firms, accounting firms, financial advisors, outside experts and consultants. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Notwithstanding anything to the
contrary set forth in this Agreement, except in the case of Actual Fraud or Willful Breach, if the Termination Fee and the Parent Expenses Reimbursement are paid pursuant to <U>Section</U><U></U><U>&nbsp;9.3(a)</U> and
<U>Section</U><U></U><U>&nbsp;9.3(b)</U>, respectively, such payment(s) shall constitute the sole and exclusive remedy of Parent, Merger Sub, any of their respective Subsidiaries or any of their respective former, current or future general or
limited partners, shareholders, Representatives or assignees against the Company, SpinCo, any of their respective Subsidiaries and any of their respective former, current or future general or limited partners, shareholders, Representatives or
assignees (together with the Company, collectively, the &#147;<U>Company Related Parties</U>&#148;) for all losses and damages suffered as a result of the failure of the Transactions to be consummated or for a breach or failure to perform hereunder
or otherwise, and none of the Company Related Parties shall have any further liability or obligation relating to or arising out of this Agreement or the Transactions. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-94- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) If the Company fails to pay promptly any amount due under this Section&nbsp;9.3, as
applicable, and in order to obtain such payment, the Parent commences an Action that results in a judgment against the Company for any amount owed thereby under this Section&nbsp;9.3, as applicable, the Company shall reimburse Parent for its
reasonable and documented costs and expenses (including reasonable and documented attorneys&#146; fees) in connection with such Action, together with interest on such amount at a rate equal to (x)&nbsp;the prime rate as published in <I>The Wall
Street Journal</I> in effect on the date such payment was required to be made through the date such payment was actually received, plus (y)&nbsp;five percent (5%). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) Each of the Parties acknowledges that (i)&nbsp;the agreements contained in this <U>Section</U><U></U><U>&nbsp;9.3</U> are an integral part
of the Transactions, (ii)&nbsp;without these agreements, the Parties would not enter into this Agreement and (iii)&nbsp;the Termination Fee does not constitute a penalty, but rather is liquidated damages in a reasonable amount that will compensate
Parent for the efforts and resources expended and opportunities foregone while negotiating this Agreement and in reliance on this Agreement and on the expectation of the consummation of the Transactions, which amount would otherwise be impossible to
calculate with precision. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.4 <U>Fees and Expenses</U>. Except as otherwise provided in the Separation and Distribution
Agreement or this Agreement, including this <U>Section</U><U></U><U>&nbsp;9.4</U>, and except for filing fees payable to any Governmental Authority in connection with the approvals required under <U>Section</U><U></U><U>&nbsp;7.5(b)</U>, which shall
be borne equally by the Company and Parent in the event that this Agreement is terminated in accordance with its terms and by SpinCo in the event that the Closing occurs, all fees and expenses incurred by the Parties shall be borne solely by the
Party that has incurred such fees and expenses, whether or not the Merger is consummated. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ARTICLE&nbsp;X </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">MISCELLANEOUS </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;10.1
<U>Trust Account Waiver</U>. The Company acknowledges that Parent is a blank check company with the powers and privileges to effect a Business Combination. The Company further acknowledges that, as described in the prospectus dated August&nbsp;9,
2021 (the &#147;<U>Prospectus</U>&#148;) available at www.sec.gov, substantially all of Parent&#146;s assets consist of the cash proceeds of Parent&#146;s initial public offering and private placements of its securities and substantially all of
those proceeds have been deposited in a trust account for the benefit of Parent, certain of its public stockholders and the underwriters of Parent&#146;s initial public offering (the &#147;<U>Trust Account</U>&#148;). The Company acknowledges that
it has been advised by Parent that, except with respect to interest earned on the funds held in the Trust Account that may be released to Parent to pay its franchise Tax, income Tax and similar obligations, the Trust Agreement provides that cash in
the Trust Account may be disbursed only (i)&nbsp;if Parent completes one or more transactions that constitute a Business Combination, then to those Persons and in such amounts as described in the Prospectus; (ii)&nbsp;if Parent fails to complete a
Business Combination within the allotted time period and liquidates, subject to the terms of the Trust Agreement, to </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-95- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Parent in limited amounts to permit Parent to pay the costs and expenses of its liquidation and dissolution, and then to Parent&#146;s public stockholders; and (iii)&nbsp;if Parent holds a
shareholder vote to amend Parent&#146;s amended and restated memorandum and articles of association to modify the substance or timing of the obligation to redeem 100% of the shares of Parent Common Stock if Parent fails to complete a Business
Combination within the allotted time period, then for the redemption of any shares of Parent Common Stock properly tendered in connection with such vote. For and in consideration of Parent entering into this Agreement, the receipt and sufficiency of
which are hereby acknowledged, the Company hereby irrevocably waives any right, title, interest or claim of any kind it has or may have in the future in or to any monies in the Trust Account (including any distributions therefrom) and agrees not to
seek recourse against the Trust Account or any funds distributed therefrom as a result of, or arising out of, this Agreement and any negotiations, Contracts or agreements with Parent; <U>provided</U>, (x)&nbsp;that nothing herein shall serve to
limit or prohibit the Company&#146;s right to pursue a claim against Parent for legal relief against monies or other assets held outside the Trust Account, for specific performance or other equitable relief in connection with the consummation of the
Transactions (including a claim for Parent to specifically perform its obligations under this Agreement and cause the disbursement of the balance of the cash remaining in the Trust Account (after giving effect to the Parent Share Redemptions) to
Parent in accordance with the terms of this Agreement and the Trust Agreement) so long as such claim would not affect Parent&#146;s ability to fulfill its obligation to effectuate the Parent Share Redemptions, and (y)&nbsp;nothing herein shall serve
to limit or prohibit any claims the Company may have in the future against Parent&#146;s assets or funds that are not held in the Trust Account (including any funds that have been released from the Trust Account to Parent and any assets that have
been purchased or acquired with any such funds). The Company agrees and acknowledges that such irrevocable waiver is material to this Agreement and specifically relied upon by Parent to induce it to enter in this Agreement, and the Company further
intends and understands such waiver to be valid, binding and enforceable under applicable Law. To the extent the Company commences any Action or proceeding based upon, in connection with, relating to or arising out of any matter relating to Parent,
which proceeding seeks, in whole or in part, monetary relief against Parent, the Company hereby acknowledges and agrees that its sole remedy shall be against funds held outside of the Trust Account and that such claim shall not permit the Company
(or any party claiming on the Company&#146;s behalf or in lieu of the Company) to have any claim against the Trust Account (including any distributions therefrom) or any amounts contained therein. In the event that the Company commences any Action
or proceeding based upon, in connection with, relating to or arising out of any matter relating to Parent, which proceeding seeks, in whole or in part, relief against the Trust Account (including any distributions therefrom) or the holders of Parent
Common Stock, whether in the form of money damages or injunctive relief, the prevailing party shall be entitled to recover from the other party the associated legal fees and costs in connection with any such Action. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;10.2 <U><FONT STYLE="white-space:nowrap">Non-Survival</FONT> of Representations, Warranties and Agreements</U>. The obligations,
covenants and agreements that by their terms are to be performed following the Closing pursuant to any Transaction Document, including the Separation and Distribution Agreement, or this Agreement shall survive the Effective Time in accordance with
their terms and all other obligations, covenants and agreements herein and therein shall terminate and shall not survive the Closing. None of the representations or warranties in this Agreement or in any certificate or instrument delivered pursuant
to this Agreement shall survive the Effective Time. The Confidentiality Agreement shall survive the execution and delivery of this Agreement and </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-96- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
any termination of this Agreement, and the provisions of the Confidentiality Agreement shall apply to all information and material furnished by any Party or its Representatives thereunder or
hereunder; <U>provided</U>, that, following the Effective Time, Parent shall have no obligations under the Confidentiality Agreement with respect to information related solely to the SpinCo Entities, the SpinCo Business or the SpinCo Assets, which
information shall no longer be considered &#147;Evaluation Material&#148; for purposes thereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;10.3 <U>Governing Law;
Jurisdiction</U>. This Agreement, and all claims, disputes, controversies or causes of action (whether in contract, tort, equity or otherwise) that may be based upon, arise out of or relate to this Agreement (including any schedule or exhibit
hereto) or the negotiation, execution or performance of this Agreement (including any claim, dispute, controversy or cause of action based upon, arising out of or related to any representation or warranty made in or in connection with this Agreement
or as an inducement to enter into this Agreement), shall be governed by and construed in accordance with the Laws of the State of Delaware, without regard to any choice or conflict of law provision or rule (whether of the State of Delaware or any
other jurisdiction) that would cause the application of the Laws of any jurisdiction other than the State of Delaware; <U>provided</U>, that the Domestication shall be effected in accordance with both the DGCL and the CICA (as applicable), without
giving effect to principles or rules of conflict of laws to the extent such principles or rules would require or permit the application of Laws of another jurisdiction. Each of the Parties agrees that any Action related to this agreement shall be
brought exclusively in the Court of Chancery of the State of Delaware or, if under applicable Law, exclusive jurisdiction over such matter is vested in the federal courts, any federal court in the State of Delaware and any appellate court from any
thereof (the &#147;<U>Chosen Courts</U>&#148;). By executing and delivering this Agreement, each of the Parties irrevocably: (i)&nbsp;accepts generally and unconditionally submits to the exclusive jurisdiction of the Chosen Courts for any Action
relating to this Agreement, including any Action brought for any remedy contemplated by <U>Section</U><U></U><U>&nbsp;10.9</U>; (ii) waives any objections which such party may now or hereafter have to the laying of venue of any such Action
contemplated by this <U>Section</U><U></U><U>&nbsp;10.3</U> and hereby further irrevocably waives and agrees not to plead or claim that any such Action has been brought in an inconvenient forum; (iii)&nbsp;agrees that it will not attempt to deny or
defeat the personal jurisdiction of the Chosen Courts by motion or other request for leave from any such court; (iv)&nbsp;agrees that it will not bring any Action contemplated by this <U>Section</U><U></U><U>&nbsp;10.3</U> in any court other than
the Chosen Courts; (v)&nbsp;agrees that service of all process, including the summons and complaint, in any Action may be made by registered or certified mail, return receipt requested, to such party at their respective addresses provided in
accordance with <U>Section</U><U></U><U>&nbsp;10.4</U> or in any other manner permitted by Law; and (vi)&nbsp;agrees that service as provided in the preceding clause (v)&nbsp;is sufficient to confer personal jurisdiction over such party in the
Action, and otherwise constitutes effective and binding service in every respect. Each of the parties hereto agrees that a final judgment in any Action in a Chosen Court as provided above may be enforced in other jurisdictions by suit on the
judgment or in any other manner provided by Law, and each party further agrees to the <FONT STYLE="white-space:nowrap">non-exclusive</FONT> jurisdiction of the Chosen Courts for the enforcement or execution of any such judgment. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-97- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;10.4 <U>Notices</U>. All notices and other communications among the Parties
shall be in writing and shall be deemed to have been duly given (a)&nbsp;when delivered in person, (b)&nbsp;when delivered after posting in the national mail having been sent registered or certified mail return receipt requested, postage prepaid,
(c)&nbsp;when delivered by FedEx or other internationally recognized overnight delivery service or (d)&nbsp;when delivered by facsimile (solely if receipt is confirmed) or email (so long as the sender of such email does not receive an automatic
reply from the recipient&#146;s email server indicating that the recipient did not receive such email), addressed as follows: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">if to the
Company or SpinCo, to: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Ligand Pharmaceuticals Incorporated </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">with a copy (which shall not constitute notice) to: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Latham&nbsp;&amp; Watkins, LLP </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">12670 High Bluff Dr. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">San Diego,
CA 92130 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Attention: &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Matthew Bush </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Scott Shean </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Email: &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;matt.bush@lw.com </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
scott.shean@lw.com </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">if to Parent, to: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Avista Public Acquisition Corp. II </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">with a copy (which shall not constitute notice) to: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Weil, Gotshal&nbsp;&amp; Manges LLP </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">767 5<SUP STYLE="font-size:85%; vertical-align:top">th</SUP> Avenue </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">New York, NY 10153 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Attention:
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Jaclyn L. Cohen, Esq. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;Raymond O. Gietz, Esq. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Email: &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;jackie.cohen@weil.com
</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;raymond.gietz@weil.com </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">or to such other address or addresses as the Parties may from time to time designate in writing by like notice. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;10.5 <U>Headings</U>. The headings contained in this Agreement are inserted for convenience only and shall not be considered in
interpreting or construing any of the provisions contained in this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;10.6 <U>Entire Agreement</U>. This Agreement
(including the Exhibits and Schedules hereto), the Confidentiality Agreement and the Transaction Documents constitute the entire agreement between the Parties with respect to the subject matter hereof and supersede all prior agreements and
understandings between the Parties with respect to such subject matter; <U>provided</U>, that for the sake of clarity, it is understood that this Agreement shall not supersede the terms and provisions of the Confidentiality Agreement, which shall
survive and remain in effect until expiration or termination thereof in accordance with its respective terms (subject to <U>Section</U><U></U><U>&nbsp;10.2</U>). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-98- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;10.7 <U>Amendments and Waivers</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Any Party may, at any time prior to the Closing, by action taken by its board of directors, or officers thereunto duly authorized, waive
any of the terms or conditions of this Agreement or (without limiting <U>Section</U><U></U><U>&nbsp;10.7(b)</U>) agree to an amendment or modification to this Agreement by an agreement in writing executed in the same manner (but not necessarily by
the same Persons) as this Agreement. No waiver by any of the Parties of any breach hereunder shall be deemed to extend to any prior or subsequent breach hereunder or affect in any way any rights arising by virtue of any prior or subsequent such
occurrence. No waiver by any of the Parties of any of the provisions hereof shall be effective unless explicitly set forth in writing and executed by the Party sought to be charged with such waiver. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) This Agreement may be amended or modified, in whole or in part, only by a duly authorized agreement in writing executed by the Parties in
the same manner (but not necessarily by the same Persons) as this Agreement, and which makes reference to this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;10.8 <U>Assignment; Parties in Interest; <FONT STYLE="white-space:nowrap">Non-Parties</FONT></U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) No Party may assign its rights or delegate its duties under this Agreement without the prior written consent of the other Parties. Any
attempted assignment or delegation in breach of this <U>Section</U><U></U><U>&nbsp;10.8</U> shall be null and void. This Agreement shall be binding upon and inure to the benefit of the Parties and their respective permitted successors and assigns.
Nothing expressed or implied in this Agreement is intended or shall be construed to confer upon or give any Person, other than the Parties, any rights or remedies under or by reason of this Agreement, except as provided in
<U>Section</U><U></U><U>&nbsp;10.8(b)</U> (which is intended to be for the benefit of the Persons covered thereby and may be enforced by such Persons). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Notwithstanding anything to the contrary in this Agreement, it is hereby agreed and acknowledged that this Agreement may only be enforced
against, and any claims of action that may be based upon, arise out of or relate to this Agreement or the negotiation, execution or performance of this Agreement may only be made against, the Parties hereto, and no former, current or future
Affiliates, officers, directors, managers, employees, equityholders, lenders, financing sources, managers, members, partners, agents or representatives of any Party, in each case, who is not a Party to this Agreement, shall have any liability for
any obligations of the Parties hereto or for any claim based on, in respect of, or by reason of, the Transactions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;10.9
<U>Specific Performance</U>. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) The Parties agree and acknowledge that the failure to perform under this Agreement will cause an actual,
immediate and irreparable harm and injury and that the Parties would not have any adequate remedy at law in the event that any of the provisions of this Agreement were not performed in accordance with their specific terms or were otherwise breached.
Accordingly, it is agreed that, (i)&nbsp;each of the Parties shall be entitled to an injunction or injunctions to prevent breaches or threatened breaches of this Agreement by any other Party and to specifically enforce the terms and provisions of
this Agreement, and (ii)&nbsp;prior to the Closing or any termination of this Agreement in accordance with <U>Section</U><U></U><U>&nbsp;9.1</U>, damages shall be awarded only in a case where a court of competent jurisdiction shall have determined
that, notwithstanding the Parties&#146; intention for specific performance to be the applicable remedy prior to termination or the Closing, such specific performance is not available or otherwise will not be granted as a remedy. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-99- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) The Parties further agree that (i)&nbsp;by seeking the remedies provided for in this
<U>Section</U><U></U><U>&nbsp;10.9</U>, a Party shall not in any respect waive its right to seek any other form of relief that may be available to a party under this Agreement, including monetary damages, subject to the terms hereof,
(ii)&nbsp;nothing contained in this <U>Section</U><U></U><U>&nbsp;10.9</U> shall require any Party to institute any proceeding for (or limit any Party&#146;s right to institute any proceeding for) specific performance under this
<U>Section</U><U></U><U>&nbsp;10.9</U> before exercising any termination right under <U>Section</U><U></U><U>&nbsp;9.1</U> (and pursuing damages after such termination), nor shall the commencement of any Action pursuant to this
<U>Section</U><U></U><U>&nbsp;10.9</U> or anything contained in this <U>Section</U><U></U><U>&nbsp;10.9</U> restrict or limit any Party&#146;s right to terminate this Agreement in accordance with the terms of <U>Section</U><U></U><U>&nbsp;9.1</U> or
to pursue any other remedies under this Agreement that may be available then or thereafter and (iii)&nbsp;no Person shall be required to obtain, furnish or post any bond or similar instrument in connection with or as a condition to obtaining any
remedy referred to in this <U>Section</U><U></U><U>&nbsp;10.9</U>, and each Party irrevocably waives any right it may have to require the obtaining, furnishing or posting of any such bond or similar instrument. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) To the extent either party hereto brings any Action to enforce specifically the performance of the terms and provisions of this Agreement
in accordance with this <U>Section</U><U></U><U>&nbsp;10.9</U>, the Outside Date shall automatically be extended by (i)&nbsp;the amount of time during which such Action is pending, plus twenty (20)&nbsp;Business Days, or (ii)&nbsp;such other time
period established by the court presiding over such Action. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;10.10 <U>WAIVER OF JURY TRIAL</U>. THE PARTIES HEREBY
UNCONDITIONALLY AND IRREVOCABLY WAIVE THEIR RIGHT TO TRIAL BY JURY IN ANY JUDICIAL PROCEEDING IN ANY COURT RELATING TO ANY DISPUTE, CONTROVERSY OR CLAIM ARISING OUT OF, RELATING TO OR IN CONNECTION WITH THIS AGREEMENT OR ANY TRANSACTION DOCUMENT
(INCLUDING ANY SCHEDULE OR EXHIBIT HERETO AND THERETO) OR THE BREACH, TERMINATION OR VALIDITY OF SUCH AGREEMENTS OR THE NEGOTIATION, EXECUTION OR PERFORMANCE OF SUCH AGREEMENTS. NO PARTY TO THIS AGREEMENT SHALL SEEK A JURY TRIAL IN ANY LAWSUIT,
PROCEEDING, COUNTERCLAIM OR ANY OTHER LITIGATION PROCEDURE BASED UPON, OR ARISING OUT OF, THIS AGREEMENT OR ANY RELATED INSTRUMENTS. NO PARTY WILL SEEK TO CONSOLIDATE ANY SUCH ACTION IN WHICH A JURY TRIAL HAS BEEN WAIVED WITH ANY OTHER ACTION IN
WHICH A JURY TRIAL CANNOT BE OR HAS NOT BEEN WAIVED. EACH PARTY TO THIS AGREEMENT CERTIFIES THAT IT HAS BEEN INDUCED TO ENTER INTO THIS AGREEMENT OR INSTRUMENT BY, AMONG OTHER THINGS, THE MUTUAL WAIVERS AND CERTIFICATIONS SET FORTH ABOVE IN THIS
<U>SECTION</U><U></U><U>&nbsp;10.10</U>. NO PARTY HAS IN ANY WAY AGREED WITH OR REPRESENTED TO ANY OTHER PARTY THAT THE PROVISIONS OF THIS <U>SECTION</U><U></U><U>&nbsp;10.10</U> WILL NOT BE FULLY ENFORCED IN ALL INSTANCES. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-100- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;10.11 <U>Severability</U>. If any provision of this Agreement or any
Transaction Document, or the application of any such provision to any Person or circumstance, shall be held invalid, illegal or unenforceable in any respect by a court of competent jurisdiction, such invalidity, illegality or unenforceability shall
not affect any other provision hereof. The Parties further agree that if any provision contained herein is, to any extent, held invalid or unenforceable in any respect under the Laws governing this Agreement, they shall take any actions necessary to
render the remaining provisions of this Agreement valid and enforceable to the fullest extent permitted by Law and, to the extent necessary, shall amend or otherwise modify this Agreement to replace any provision contained herein that is held
invalid or unenforceable with a valid and enforceable provision giving effect to the intent of the Parties. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;10.12
<U>Counterparts</U>. This Agreement may be executed in two or more counterparts (including by electronic or .pdf transmission), each of which shall be deemed an original, but all of which together shall constitute one and the same instrument.
Delivery of any signature page by facsimile, electronic or .pdf transmission shall be binding to the same extent as an original signature page. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;10.13 <U>Disclosure Schedules</U>. The Company Disclosure Schedule, the SpinCo Disclosure Schedule and the Parent Disclosure
Schedule (each, a &#147;<U>Disclosure Schedule</U>&#148; and, collectively, the &#147;<U>Disclosure Schedules</U>&#148;) (including, in each case, any section thereof) referenced herein are a part of this Agreement as if fully set forth herein. All
references herein to the Company Disclosure Schedule, SpinCo Disclosure Schedule and Parent Disclosure Schedule (including, in each case, any section thereof) shall be deemed references to such parts of this Agreement, unless the context shall
otherwise require. Certain information set forth in the Disclosure Schedules is included solely for informational purposes and may not be required to be disclosed pursuant to this Agreement. The disclosure of any information in any Disclosure
Schedule shall not be deemed to constitute in itself an acknowledgment that such information is required to be disclosed in connection with this Agreement, nor shall such information be deemed to establish a standard of materiality. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;10.14 <U>Disclosure Schedules</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Parent, SpinCo and the Company, on behalf of their respective successors and assigns (in the case of Parent, including, after the Closing,
each of the SpinCo Entities), hereby agree that, in the event a dispute with respect to this Agreement or the Transactions arises after the Closing between or among the Sponsor, Parent, the shareholders or holders of other equity interests of Parent
or the Sponsor or any of their respective directors, members, partners, officers, employees or Affiliates of any of the foregoing (including any of the SpinCo Entities) (collectively, the &#147;<U>Parent Group</U>&#148;), on the one hand, and the
Company or any other member of the Company Group (as defined below), on the other hand, any legal counsel (including Weil) that represented Parent or the Sponsor prior to the Closing may represent the Sponsor or any other member of the Parent Group
in such dispute, regardless of whether the interests of any such Persons may be directly adverse to Parent or the applicable member of the Parent Group, and even though such counsel may have represented Parent or another member of the Parent Group
in a matter substantially related to such dispute, or may be handling ongoing matters for Parent, the Sponsor or any other member of the Parent Group. Parent, SpinCo and the Company further agree that, as to all legally privileged communications
prior to the Closing between or among any </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-101- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
legal counsel (including Weil) that represented Parent, the Sponsor or any other member of the Parent Group prior to the Closing, on the one hand, and any one or more of such Persons, on the
other hand, that relate in any way to this Agreement or the Transactions, the attorney/client privilege and the expectation of client confidence belongs to the Parent Group, shall be controlled by the Parent Group, and shall not pass to or be
claimed or controlled by the Company or any of its Subsidiaries (after giving effect to the Closing). Notwithstanding the foregoing, any privileged communications or information shared prior to the Closing by the Company or any of its Subsidiaries
(other than the SpinCo Entities), on the one hand, with Parent, the Sponsor or any other member of the Parent Group (other than the SpinCo Entities) (in any capacity), on the other hand, under a common interest agreement shall remain the privileged
communications or information of the Company Group. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Parent, SpinCo and the Company, on behalf of their respective successors and
assigns (in the case of Parent, including, after the Closing, each of the SpinCo Entities) hereby agree that, in the event a dispute with respect to this Agreement or the Transactions arises after the Closing between or among the Company, any
Subsidiary of the Company (other than any of the SpinCo Entities), the shareholders or holders of other equity interests of the Company, any Subsidiary of the Company (other than any of the SpinCo Entities) or any of their respective directors,
members, partners, officers, employees or Affiliates of any of the foregoing (collectively, the &#147;<U>Company Group</U>&#148;), on the one hand, and the Surviving Corporation or any other member of the Parent Group, on the other hand, any legal
counsel (including LW) that represented the Company or any other member of the Company Group prior to the Closing may represent any member of the Company Group in such dispute, regardless of whether the interests of any such Persons may be directly
adverse to the Surviving Corporation or any other member of the Parent Group, and even though such counsel may have represented Parent or any other member of the Parent Group in a matter substantially related to such dispute, or may be handling
ongoing matters for the Surviving Corporation or any other member of the Parent Group. Parent, SpinCo and the Company further agree that, as to all legally privileged communications prior to the Closing between or among any legal counsel (including
LW) that represented the Company or any other member of the Company Group prior to the Closing, on the one hand, and any one or more of such Persons, on the other hand, that relate in any way to this Agreement or the Transactions, the
attorney/client privilege and the expectation of client confidence belongs to the Company Group, shall be controlled by the Company Group, and shall not pass to or be claimed or controlled by Parent or any other member of the Parent Group.
Notwithstanding the foregoing, any privileged communications or information shared prior to the Closing by Parent or any other member of the Parent Group, on the one hand, with any member of the Company Group, on the other hand, under a common
interest agreement shall remain the privileged communications or information of the SpinCo Entities and, following the Closing, the Parent Group. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[<I>Signature page follows.</I>] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">-102- </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">IN WITNESS WHEREOF, the Parties have caused this Agreement to be duly executed by their
respective authorized officers as of the day and year first above written. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">LIGAND PHARMACEUTICALS INCORPORATED</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Matthew Korenberg</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name: Matthew Korenberg</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title: Executive Vice President, Finance and Chief Financial Officer</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">OMNIAB, INC.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Matthew W. Foehr</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name: Matthew W. Foehr</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title: President and Chief Executive Officer</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">AVISTA PUBLIC ACQUISITION CORP. II</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Benjamin Silbert</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name: Benjamin Silbert</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title: General Counsel</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">ORWELL MERGER SUB INC.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ David Burgstahler</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name: David Burgstahler</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title: President</TD></TR>
</TABLE></DIV>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Exhibit A to the Merger Agreement </B></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Execution Version </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">SEPARATION AND DISTRIBUTION AGREEMENT </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">by and among </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">LIGAND
PHARMACEUTICALS INCORPORATED, </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">OMNIAB, INC. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">AVISTA PUBLIC ACQUISITION
CORP. II </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Dated as of March&nbsp;23, 2022 </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">TABLE OF CONTENTS </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="9%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD WIDTH="85%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>Page</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ARTICLE I DEFINITIONS AND INTERPRETATION</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;1.1</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">General</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;1.2</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">References; Interpretation</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">21</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ARTICLE II THE SEPARATION</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">21</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.1</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">General</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">21</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.2</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Restructuring: Transfer of Assets; Assumption of Liabilities</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">21</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.3</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Treatment of Shared Contracts</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">23</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.4</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Intercompany Accounts, Loans and Agreements</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">24</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.5</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Limitation of Liability; Intercompany Contracts</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">25</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.6</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Transfers Not Effected at or Prior to the Distribution Time; Transfers Deemed Effective as of the Distribution Time</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">25</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.7</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Conveyancing and Assumption Instruments</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">27</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.8</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Further Assurances; Ancillary Agreements</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">28</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.9</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Novation of Liabilities; Indemnification</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">29</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.10</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Guarantees; Credit Support Instruments</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">30</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.11</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Disclaimer of Representations and Warranties</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">32</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.12</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Cash Management; Consideration</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">33</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ARTICLE III</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">34</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">COMPLETION OF THE DISTRIBUTION</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">34</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.1</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Actions Prior to the Distribution</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">34</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.2</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Effecting the Distribution</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">35</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.3</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Conditions to the Distribution</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">36</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ARTICLE IV CERTAIN COVENANTS</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">36</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.1</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Cooperation</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">36</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.2</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Retained Names</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">37</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.3</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Ligand Limited License</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">38</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.4</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">No Restriction on Competition</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">38</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ARTICLE V INDEMNIFICATION</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">39</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.1</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Release of <FONT STYLE="white-space:nowrap">Pre-Distribution</FONT> Claims</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">39</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.2</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Indemnification by Ligand</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">42</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.3</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Indemnification by OmniAb and APAC</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">43</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.4</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Procedures for Indemnification</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">43</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.5</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Cooperation in Defense and Settlement</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">46</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.6</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Indemnification Payments</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">47</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">i </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="9%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD WIDTH="85%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.7</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Indemnification Obligations Net of Insurance Proceeds and Other Amounts</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">47</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.8</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Contribution</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">48</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.9</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Additional Matters; Survival of Indemnities</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">48</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ARTICLE VI PRESERVATION OF RECORDS; ACCESS TO INFORMATION; CONFIDENTIALITY;
PRIVILEGE</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">48</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.1</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Preservation of Corporate Records</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">48</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.2</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Access to Information</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">49</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.3</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Auditors and Audits</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">51</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.4</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Witness Services</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">52</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.5</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Reimbursement; Other Matters</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">52</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.6</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Confidentiality</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">52</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.7</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Privilege Matters</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">54</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.8</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Ownership of Information</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">56</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.9</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Processing of Personal Information</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">56</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.10</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Other Agreements</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">56</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ARTICLE VII DISPUTE RESOLUTION</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">56</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.1</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Negotiation</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">56</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.2</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Relief in Court</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">57</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.3</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Continuity of Service and Performance</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">57</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ARTICLE VIII INSURANCE</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">57</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;8.1</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Insurance Matters</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">57</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ARTICLE IX MISCELLANEOUS</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">59</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.1</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Entire Agreement; Construction</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">59</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.2</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Ancillary Agreements</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">59</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.3</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Counterparts</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">59</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.4</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Survival of Agreements</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">59</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.5</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Expenses</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">59</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.6</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Notices</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">60</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.7</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Consents</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">61</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.8</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Assignment</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">61</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.9</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Successors and Assigns</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">62</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.10</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Termination and Amendment</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">62</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.11</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Payment Terms</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">62</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.12</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Subsidiaries</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">62</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.13</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Third Party Beneficiaries</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">63</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.14</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Title and Headings</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">63</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.15</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Exhibits&nbsp;and Schedules</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">63</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.16</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Governing Law and Venue; Submission to Jurisdiction; Selection of Forum; Waiver of Trial by Jury</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">63</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ii </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="9%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD WIDTH="85%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.17</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Specific Performance</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">64</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.18</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Severability</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">65</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.19</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Interpretation</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">65</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.20</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">No Duplication; No Double Recovery</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">65</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.21</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Tax Treatment of Payments</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">65</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.22</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">No Waiver</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">65</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.23</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">No Admission of Liability</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">65</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">List of Schedules </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="10%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="89%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">1.1(75)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Ligand Retained Liabilities</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">1.1(76)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Ligand Retained Names</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">1.1(86)(ii)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">OmniAb Assets &#150; General</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">1.1(86)(v)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">OmniAb Assets &#150; Leases/Subleases</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">1.1(86)(vi)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">OmniAb Assets &#150; Contracts</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">1.1(86)(vii)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">OmniAb Assets &#150; Intellectual Property</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">1.1(86)(x)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">OmniAb Assets &#150; IT Assets</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">1.1(97)(ii)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">OmniAb Liabilities &#150; General</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">1.1(97)(vii)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">OmniAb Liabilities &#150; Actions</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">2.3(a)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Shared Contracts</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">2.10(a)(i)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Guarantees Provided by OmniAb Group</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">2.10(a)(ii)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Guarantees Provided by Ligand Group</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">2.12(c)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Other Reimbursable Expenses</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">List of Exhibits </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="10%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="89%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Exhibit&nbsp;A</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Reorganization Plan</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Exhibit B</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Illustrative Adjustments pursuant to Section&nbsp;2.12(c)</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">iii </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B><I>Final Form </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">SEPARATION AND DISTRIBUTION AGREEMENT </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This SEPARATION AND DISTRIBUTION AGREEMENT (this &#147;<I>Agreement</I>&#148;), dated as of March&nbsp;23, 2022, is entered into by and among
Ligand Pharmaceuticals Incorporated, a Delaware corporation (&#147;<I>Ligand</I>&#148;), OmniAb, Inc., a Delaware corporation and a wholly owned subsidiary of Ligand (&#147;<I>OmniAb</I>&#148;), and Avista Public Acquisition Corp. II, a Cayman
Islands exempted company (which will migrate to and domesticate as a Delaware corporation prior to the Closing (the &#147;<I>Domestication</I>&#148;)) (&#147;<I>APAC</I>&#148;). &#147;<I>Party</I>&#148; or &#147;<I>Parties</I>&#148; means Ligand or
OmniAb, individually or collectively, as the case may be. Capitalized terms used and not defined herein shall have the meaning set forth in <U>Section</U><U></U><U>&nbsp;1.1</U>. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">W I T N E S S E T H: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS,
Ligand owns 100% of the common stock, par value $0.001 per share, of OmniAb (the &#147;<I>OmniAb Stock</I>&#148;); </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, Ligand,
acting through its direct and indirect Subsidiaries, currently conducts the Ligand Retained Business and the OmniAb Business; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS,
the Board of Directors of Ligand (the &#147;<I>Ligand Board</I>&#148;) has determined that it is appropriate, desirable and in the best interests of Ligand and its stockholders to separate Ligand into two separate companies, one for each of
(i)&nbsp;the Ligand Retained Business, which shall be owned and conducted, directly or indirectly, by Ligand and its Subsidiaries (other than OmniAb and its Subsidiaries) and (ii)&nbsp;the OmniAb Business, which shall be owned and conducted,
directly or indirectly, by OmniAb and its Subsidiaries (the &#147;<I>Separation</I>&#148;); </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, in order to effect the Separation,
the Ligand Board has determined that it is appropriate, desirable and in the best interests of Ligand and its stockholders for Ligand to undertake the Internal Reorganization and, in connection therewith, effect the Contribution to OmniAb; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, the Ligand Board has further determined that it is appropriate and desirable, on the terms and conditions contemplated hereby,
following such separation to make a distribution of the OmniAb Business to the holders of common stock, par value $0.001 per share, of Ligand (the &#147;<I>Ligand Stock</I>&#148;) on the Record Date through the distribution of all of the outstanding
shares of OmniAb Stock to holders of Ligand on the Record Date on a pro rata basis in accordance with a distribution ratio to be determined by the Ligand Board (the &#147;<I>Distribution</I>&#148;), in each case, on the terms and conditions set
forth in this Agreement; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, immediately following the Distribution, Ligand will hold none of the outstanding shares of OmniAb
Stock; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, the Ligand Board has further determined that it is appropriate and desirable, on the terms and conditions contemplated in
the Agreement and Plan of Merger, dated as of the date hereof (the &#147;<I>Merger Agreement</I>&#148;), among Ligand, OmniAb, APAC and Orwell Merger Sub Inc., a Delaware corporation and wholly owned subsidiary of APAC (&#147;<I>Merger
Sub</I>&#148;), following the Domestication, Separation and Distribution, Merger Sub will merge with and into OmniAb, with OmniAb continuing as the surviving corporation (the &#147;<I>Merger</I>&#148;); </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, pursuant to the Merger, shares of OmniAb Stock will be exchanged for shares of
Domesticated Parent Common Stock, on the terms and conditions set forth in the Merger Agreement; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, Ligand and OmniAb will prepare,
and OmniAb will file with the SEC, the Form 10, which will include the Information Statement and will set forth certain disclosure concerning OmniAb, the Separation, the Distribution and the Merger; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, (i)&nbsp;the Ligand Board has (x)&nbsp;determined that the transactions contemplated by this Agreement, the Merger Agreement and the
Ancillary Agreements have a valid business purpose, are in furtherance of and consistent with its business strategy and are in the best interests of Ligand and its stockholders and (y)&nbsp;approved this Agreement, the Merger Agreement and each of
the Ancillary Agreements and (ii)&nbsp;the Board of Directors of OmniAb (the &#147;<I>OmniAb Board</I>&#148;) has approved this Agreement, the Merger Agreement and each of the Ancillary Agreements (to the extent OmniAb is a party thereto); </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, the board of directors of APAC has approved this Agreement and the Merger Agreement; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, the Parties and APAC desire to set forth the principal corporate transactions required to effect the Separation and the Distribution,
and certain other agreements relating to the relationship of Ligand and OmniAb and their respective Subsidiaries following the Distribution; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, it is the intention of the Parties and APAC that the (i)&nbsp;Contribution and Distribution, together with certain related
transactions, will qualify as a &#147;reorganization&#148; under Sections&nbsp;355 and 368(a)(1)(D) of the Internal Revenue Code of 1986, as amended (the &#147;<I>Code;</I>&#148;) and (ii)&nbsp;the Merger will qualify as a &#147;reorganization&#148;
within the meaning of Section&nbsp;368(a) of the Code; and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, this Agreement is intended to be, and is hereby adopted as, a
&#147;plan of reorganization&#148; within the meaning of Treasury <FONT STYLE="white-space:nowrap">Regulations&nbsp;Sections&nbsp;1.368-2(g)</FONT> and <FONT STYLE="white-space:nowrap">1.368-3(a).</FONT> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">NOW, THEREFORE, in consideration of the foregoing and the mutual agreements, provisions and covenants contained in this Agreement, the Parties
and APAC hereby agree as follows: </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE I </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>DEFINITIONS AND INTERPRETATION </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;1.1 <U>General</U>. As used in this Agreement, the following terms shall have the following meanings: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1) &#147;<I>Action</I>&#148; shall mean any demand, action, claim, suit, countersuit, arbitration, inquiry, subpoena, case, litigation,
proceeding or investigation (whether civil, criminal, administrative or investigative) by or before any court or grand jury, any Governmental Entity or any arbitration or mediation tribunal. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2) &#147;<I>Affiliate</I>&#148; shall mean, when used with respect to a specified Person
and at a point in, or with respect to a period of, time, a Person that directly or indirectly, through one or more intermediaries, controls, is controlled by, or is under common control with, such specified Person at such point in or during such
period of time. For the purposes of this definition, &#147;control&#148;, when used with respect to any specified Person shall mean the possession, directly or indirectly, of the power to direct or cause the direction of the management and policies
of such Person, whether through the ownership of voting securities or other interests, by Contract or otherwise. It is expressly agreed that, from and after the Distribution Time, solely for purposes of this Agreement, (i)&nbsp;no member of the
OmniAb Group shall be deemed an Affiliate of any member of the Ligand Group and (ii)&nbsp;no member of the Ligand Group shall be deemed an Affiliate of any member of the OmniAb Group. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(3) &#147;<I>Agent</I>&#148; means Computershare Trust Company, N.A., as the distribution agent appointed by Ligand to distribute to the
stockholders of Ligand all of the outstanding shares of OmniAb Stock pursuant to the Distribution. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(4) &#147;<I>Agreement</I>&#148; shall
have the meaning set forth in in the Preamble. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(5) &#147;<I>Amended Financial Report</I>&#148; shall have the meaning set forth in
Section&nbsp;6.3(b). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(6) &#147;<I>Ancillary Agreements</I>&#148; shall mean the Transition Services Agreements, the Employee Matters
Agreement, the Tax Matters Agreement, any Continuing Arrangements, any and all Conveyancing and Assumption Instruments, and any other agreements to be entered into by and between any member of the Ligand Group, on one hand, and any member of the
OmniAb Group, on the other hand, at, prior to or after the Distribution Time in connection with the Separation, the Distribution and the other transactions contemplated by this Agreement. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(7) &#147;<I>APAC</I>&#148; shall have the meaning set forth in the Preamble. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(8) &#147;<I>APAC Released Liabilities</I>&#148; shall have the meaning set forth in <U>Section</U><U></U><U>&nbsp;5.1(a)(iii)</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(9) &#147;<I>Assets</I>&#148; shall mean all rights (including Intellectual Property), title and ownership interests in and to all properties,
claims, Contracts, businesses, or assets (including goodwill), wherever located (including in the possession of vendors or other third parties or elsewhere), of every kind, character and description, whether real, personal or mixed, tangible or
intangible, whether accrued, contingent or otherwise, in each case, whether or not recorded or reflected on the books and records or financial statements of any Person. Except as otherwise specifically set forth herein, in the Employee Matters
Agreement or in the Tax Matters Agreement, the rights and obligations of the Parties with respect to Taxes shall be governed by the Tax Matters Agreement and, therefore, Tax assets (including any Tax items, attributes or rights to receive any
Refunds (as defined in the Tax Matters Agreement)) shall not be treated as Assets. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(10) &#147;<I>Asset Transferors</I>&#148; shall mean
the entities transferring Assets to OmniAb or one of its Subsidiaries in order to consummate the transactions contemplated hereby. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(11) &#147;<I>Assume</I>&#148; shall have the meaning set forth in
<U>Section</U><U></U><U>&nbsp;2.2(c)</U>; and the terms &#147;<I>Assumed</I>&#148; and &#147;<I>Assumption</I>&#148; shall have their correlative meanings. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(12) &#147;<I>Business</I>&#148; shall mean the Ligand Retained Business or the OmniAb Business, as applicable. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(13) &#147;<I>Business Day</I>&#148; shall mean any day other than Saturday or Sunday and any other day on which commercial banking
institutions located in New York, New York are required, or authorized by Law, to remain closed. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(14) &#147;<I>Business Entity</I>&#148;
shall mean any corporation, partnership, limited liability company, joint venture or other entity which may legally hold title to Assets. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(15) &#147;<I>Cash Equivalents</I>&#148; shall mean (i)&nbsp;cash and (ii)&nbsp;checks, certificates of deposit having a maturity of less than
one year, money orders, marketable securities, money market funds, commercial paper, short-term instruments and other cash equivalents, funds in time and demand deposits or similar accounts, and any evidence of indebtedness issued or guaranteed by
any Governmental Entity, minus the amount of any outbound checks, plus the amount of any deposits in transit. For the purposes of <U>Section</U><U></U><U>&nbsp;2.12</U>, &#147;<I>Cash Equivalents</I>&#148; shall not include any cash in transit at
the Distribution Time. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(16) &#147;<I>Chosen Courts</I>&#148; shall have the meaning set forth in
<U>Section</U><U></U><U>&nbsp;9.16(b)</U>. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(17) &#147;<I>Closing</I>&#148; shall have the meaning set forth in the Merger Agreement. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(18) &#147;<I>Code</I>&#148; shall have the meaning set forth in the Recitals. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(19) &#147;<I>Commission</I>&#148; shall mean the United States Securities and Exchange Commission. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(20) &#147;<I>Confidential Information</I>&#148; shall mean all <FONT STYLE="white-space:nowrap">non-public,</FONT> confidential or proprietary
Information to the extent concerning a Party, its Group and/or its Subsidiaries or with respect to OmniAb, the OmniAb Business, any OmniAb Assets or any OmniAb Liabilities or with respect to Ligand, the Ligand Retained Business, any Ligand Retained
Assets or any Ligand Retained Liabilities, including any such Information that was acquired by any Party after the Distribution Time pursuant to <U>Article</U><U></U><U>&nbsp;VI</U> or otherwise in accordance with this Agreement, or that was
provided to a Party by a third party in confidence, including (a)&nbsp;any and all technical information relating to the design, operation, testing, test results, development, and manufacture of any Party&#146;s products, compounds, technologies or
biological, chemical or other materials or that of a Party&#146;s partners (including specifications and documentation; engineering, design, and manufacturing drawings, diagrams, layouts, maps and illustrations; formulations and material
specifications; laboratory studies and benchmark tests; preclinical and clinical data; quality assurance policies, procedures and specifications; evaluation and validation studies; process control and/or shop-floor control strategy, logic or
algorithms; assembly code, Software, firmware, programming data, databases, and all information referred to in the same); costs, margins and pricing; as well as product marketing studies and strategies; all other methodologies, procedures,
techniques and <FONT STYLE="white-space:nowrap">Know-How</FONT> related to discovery, research, engineering, development and manufacturing; (b)&nbsp;information, documents and materials relating to the Party&#146;s financial
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
condition, management and other business conditions, prospects, plans, procedures, partners, infrastructure, security, information technology procedures and systems, and other business or
operational affairs; (c)&nbsp;pending unpublished patent applications and Trade Secrets; and (d)&nbsp;any other data or documentation resident, existing or otherwise provided in a database or in a storage medium, permanent or temporary, intended for
confidential, proprietary and/or privileged use by a Party; except for any Information that is (i)&nbsp;in the public domain or known to the public through no fault of the receiving Party or its Subsidiaries, (ii)&nbsp;lawfully acquired after the
Distribution Time by such Party or its Subsidiaries from other sources not known to be subject to confidentiality obligations with respect to such Information or (iii)&nbsp;independently developed by the receiving Party after the Distribution Time
without reference to any Confidential Information. As used herein, by example and without limitation, Confidential Information shall include any information of a Party intended or marked as confidential, proprietary and/or privileged. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(21) &#147;<I>Consents</I>&#148; shall mean any consents, waivers, notices, reports or other filings to be obtained from or made, including
with respect to any Contract, or any registrations, licenses, permits, authorizations to be obtained from, or approvals from, or notification requirements to, any third parties, including any third party to a Contract and any Governmental Entity.
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(22) &#147;<I>Continuing Arrangements</I>&#148; shall mean: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) this Agreement and the Ancillary Agreements (and each other Contract expressly contemplated by this Agreement or any Ancillary Agreement to
be entered into or continued by any of the Parties or any of the members of their respective Groups); and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) any Contracts or
intercompany accounts solely between or among members of the OmniAb Group. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(23) &#147;<I>Contract</I>&#148; shall mean any agreement,
contract, subcontract, obligation, binding understanding, note, indenture, instrument, option, lease, promise, arrangement, release, warranty, license, sublicense, insurance policy, benefit plan, purchase order or legally binding commitment or
undertaking of any nature (whether written or oral and whether express or implied). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(24) &#147;<I>Contribution</I>&#148; shall mean
(i)&nbsp;the Transfer, directly or indirectly, of the capital stock of or membership or other equity interests in the Transferred Entities and the other OmniAb Assets from Ligand or its Subsidiaries to OmniAb or its Subsidiaries, (ii)&nbsp;the
contribution by Ligand to OmniAb of $15,000,000 (fifteen million dollars) in cash, decreased by the amount of Reimbursable Transaction-related Expenses and Other Reimbursable Expenses, and increased by the amount of any Specific Milestone Payments,<SUP
STYLE="font-size:85%; vertical-align:top"> </SUP>and (iii)&nbsp;the Assumption of Liabilities, directly or indirectly, by OmniAb or its Subsidiaries pursuant to the Internal Reorganization or otherwise relating to, arising out of or resulting from
the transactions contemplated by this Agreement. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(25) &#147;<I>Conveyancing and Assumption Instruments</I>&#148; shall mean, collectively,
the various Contracts, including the related local asset transfer agreements and local stock transfer agreements, and other documents entered into prior to the Distribution Time and to be entered into to effect the Transfer of Assets and the
Assumption of Liabilities in the manner contemplated by this Agreement, or otherwise relating to, arising out of or resulting from the transactions contemplated by this Agreement, in such form or forms as the applicable Parties thereto agree. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(26) &#147;<I>Covered Matter</I>&#148; shall have the meaning set forth in
<U>Section</U><U></U><U>&nbsp;8.1(i)</U>. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(27) &#147;<I>Credit Support Instruments</I>&#148; shall mean any letters of credit, performance
bonds, surety bonds, bankers acceptances, or other similar arrangements. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(28) &#147;<I>Dispute Notice</I>&#148; shall have the meaning set
forth in <U>Section</U><U></U><U>&nbsp;7.1</U>. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(29) &#147;<I>Disputes</I>&#148; shall have the meaning set forth in
<U>Section</U><U></U><U>&nbsp;7.1</U>. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(30) &#147;<I>Distribution</I>&#148; shall have the meaning set forth in the Recitals. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(31) &#147;<I>Distribution Date</I>&#148; shall mean the date on which Ligand, through the Agent, distributes all of the issued and outstanding
shares of OmniAb Stock to holders of Ligand Stock in the Distribution, and &#147;<I>Distribution Time</I>&#148; shall mean the time at which the Distribution occurs on the Distribution Date, which shall be deemed to be 12:01 a.m., New York time on
the Distribution Date. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(32) &#147;<I>Domesticated Parent Common Stock</I>&#148; shall have the meaning set forth in the Merger Agreement.
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(33) &#147;<I>Domestication</I>&#148; shall have the meaning set forth in the Merger Agreement. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(34) &#147;<I>Effective Time</I>&#148; shall have the meaning set forth in the Merger Agreement. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(35) &#147;<I>Employee Matters Agreement</I>&#148; shall mean that certain Employee Matters Agreement to be entered into between Ligand and
OmniAb or any members of their respective Groups in connection with the Separation, the Distribution, the Merger or the other transactions contemplated by this Agreement, as such agreement may be modified or amended from time to time in accordance
with its terms. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(36) &#147;<I>Environmental Laws</I>&#148; shall mean all Laws relating to pollution or protection of human health or
safety or the environment, including Laws relating to the exposure to, or Release, threatened Release or the presence of Hazardous Substances, or otherwise relating to the manufacture, processing, distribution, use, treatment, storage, transport or
handling of Hazardous Substances and all Laws with regard to recordkeeping, notification, disclosure and reporting requirements respecting Hazardous Substances, and all laws relating to endangered or threatened species of fish, wildlife and plants
and the management or use of natural resources. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(37) &#147;<I>Environmental Liabilities</I>&#148; shall mean Liabilities relating to
Environmental Law or the Release or threatened Release of or exposure to Hazardous Substances, including, without limitation, the following: (i)&nbsp;actual or alleged violations of or <FONT STYLE="white-space:nowrap">non-compliance</FONT> with any
Environmental Law, including a failure to obtain, maintain or comply with any Environmental Permits; (ii)&nbsp;obligations arising under or pursuant to any applicable Environmental Law or </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Environmental Permit; (iii)&nbsp;the presence of Hazardous Substances or the introduction of Hazardous Substances to the environment at, in, on, under or migrating from any of the building,
facility, structure or real property, including Liabilities relating to, resulting from or arising out of the investigation, remediation, or monitoring of such Hazardous Substances; (iv)&nbsp;natural resource damages, property damages, personal or
bodily injury or wrongful death relating to the presence of or exposure to Hazardous Substances (including asbestos-containing materials), at, in, on, under or migrating to or from any building, facility, structure or real property; (v)&nbsp;the
transport, disposal, recycling, reclamation, treatment or storage, Release or threatened Release of Hazardous Substances at <FONT STYLE="white-space:nowrap">Off-Site</FONT> Locations; and (vi)&nbsp;any agreement, decree, judgment, or order relating
to the foregoing. The term &#147;<I>Environmental Liabilities</I>&#148; does not include Liabilities arising in connection with claims for injuries to persons or property from products sold by or services provided by the OmniAb Group, the Ligand
Group or their predecessors. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(38) &#147;<I>Environmental Permit</I>&#148; shall mean any permit, license, approval or other authorization
under any applicable Law or of any Governmental Entity relating to Environmental Laws or Hazardous Substances. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(39) &#147;<I>Exchange
Act</I>&#148; shall mean the United States Securities Exchange Act of 1934, as amended, together with the rules and regulations promulgated thereunder. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(40) &#147;<I>Excluded Environmental Liabilities</I>&#148; shall mean any and all Environmental Liabilities whether arising before, at or after
the Distribution Time, to the extent relating to, resulting from, or arising out of the past, present or future operation, conduct or actions of any Ligand Retained Business. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(41) &#147;<I>Final Determination</I>&#148; shall have the meaning set forth in the Tax Matters Agreement. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(42) &#147;<I>Form 10</I>&#148; means the registration statement on Form 10 filed by OmniAb with the SEC to effect the registration of the
OmniAb Stock pursuant to Section&nbsp;12(b) or 12(g) of the Exchange Act in connection with the Distribution, including any amendments or supplements thereto. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(43) &#147;<I>Former Business</I>&#148; shall mean any corporation, partnership, entity, division, business unit or business (in each case,
including any assets and liabilities comprising the same) that has been sold, conveyed, assigned, transferred, <FONT STYLE="white-space:nowrap">spun-off,</FONT> <FONT STYLE="white-space:nowrap">split-off</FONT> or otherwise disposed of or divested
(in whole or in part) to a Person or Persons that is not a member of the OmniAb Group or the Ligand Group or the operations, activities or production of which has been discontinued, abandoned, completed or otherwise terminated (in whole or in part),
in each case, prior to the Distribution Time. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(44) &#147;<I>Governmental Approvals</I>&#148; shall mean any notices or reports to be
submitted to, or other registrations or filings to be made with, or any consents, approvals, licenses, permits or authorizations to be obtained from, any Governmental Entity. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(45) &#147;<I>Governmental Filing</I>&#148; shall have the meaning set forth in <U>Section</U><U></U><U>&nbsp;5.5(c)</U>. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(46) &#147;<I>Governmental Entity</I>&#148; shall mean any nation or government, any state,
municipality or other political subdivision thereof and any entity, body, agency, commission, department, board, bureau or court, whether domestic, foreign, multinational, or supranational exercising executive, legislative, judicial, regulatory,
self-regulatory or administrative functions of or pertaining to government and any executive official thereof. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(47)
&#147;<I>Group</I>&#148; shall mean (i)&nbsp;with respect to Ligand, the Ligand Group and (ii)&nbsp;with respect to OmniAb, the OmniAb Group. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(48) &#147;<I>Hazardous Substance</I>&#148; shall mean (a)&nbsp;any substances defined, listed, classified or regulated as &#147;hazardous
substances,&#148; &#147;hazardous wastes,&#148; &#147;hazardous materials,&#148; &#147;extremely hazardous wastes,&#148; &#147;restricted hazardous wastes,&#148; &#147;toxic substances,&#148; &#147;toxic pollutants,&#148; &#147;contaminants,&#148;
&#147;pollutants,&#148; &#147;wastes,&#148; &#147;radioactive materials,&#148; &#147;petroleum,&#148; &#147;oils&#148; or designations of similar import under any Environmental Law, or (b)&nbsp;any other chemical, material or substance that is
regulated or for which liability can be imposed under any Environmental Law. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(49) &#147;<I>Indebtedness</I>&#148; shall mean, with respect
to any Person, (i)&nbsp;the principal amount, prepayment and redemption premiums and penalties (if any), unpaid fees and other monetary obligations in respect of any indebtedness for borrowed money, whether short term or long term, and all
obligations evidenced by bonds, debentures, notes, other debt securities or similar instruments, (ii)&nbsp;any indebtedness arising under any capital leases (excluding, for the avoidance of doubt, any real estate leases), whether short term or long
term, (iii)&nbsp;all liabilities secured by any Security Interest on any assets of such Person, (iv)&nbsp;all liabilities under any interest rate, currency, commodity or other swap, collar, cap or other hedging or similar agreements or arrangements,
(v)&nbsp;all liabilities under any interest rate protection agreement, interest rate future agreement, interest rate option agreement, interest rate swap agreement or other similar agreement designed to protect such Person against fluctuations in
interest rates, (vi)&nbsp;all interest bearing indebtedness for the deferred purchase price of property or services, (vii)&nbsp;all liabilities under any Credit Support Instruments, (viii)&nbsp;all interest, fees and other expenses owed with respect
to indebtedness described in the foregoing clauses (i)&nbsp;through (vii), and (ix)&nbsp;without duplication, all guarantees of indebtedness referred to in the foregoing clauses (i)&nbsp;through (viii), excluding in each case any obligations related
to Taxes. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(50) &#147;<I>Indemnifiable Loss</I>&#148; and &#147;<I>Indemnifiable Losses</I>&#148; shall mean any and all damages, losses,
deficiencies, Liabilities, obligations, penalties, judgments, settlements, claims, payments, fines, interest, costs and expenses (including the costs and expenses of any and all Actions and demands, assessments, judgments, settlements and
compromises relating thereto and the costs and expenses of attorneys&#146;, accountants&#146;, consultants&#146; and other professionals&#146; fees and expenses incurred in the investigation or defense thereof or the enforcement of rights
hereunder). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(51) &#147;<I>Indemnifying Party</I>&#148; shall have the meaning set forth in <U>Section</U><U></U><U>&nbsp;5.4(a)</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(52) &#147;<I>Indemnitee</I>&#148; shall have the meaning set forth in <U>Section</U><U></U><U>&nbsp;5.4(a)</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(53) &#147;<I>Indemnity Payment</I>&#148; shall have the meaning set forth in <U>Section</U><U></U><U>&nbsp;5.7(a)</U>. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(54) &#147;<I>Information</I>&#148; shall mean information, content and data (including
Personal Information) in written, oral, electronic, computerized, digital or other tangible or intangible media, including (i)&nbsp;books and records, whether accounting, legal or otherwise, ledgers, studies, reports, surveys, designs,
specifications, drawings, blueprints, diagrams, models, prototypes, samples, flow charts, marketing plans, customer names and information (including prospects), technical information relating to the design, operation, testing, test results,
development, and manufacture of any Party&#146;s or its Group&#146;s, or any of their partners&#146;, products, compounds, technologies or biological, chemical or other materials or facilities (including specifications and documentation;
engineering, design and manufacturing drawings, diagrams, layouts, maps and illustrations; formulations and material specifications; laboratory studies and benchmark tests; preclinical and clinical data; quality assurance policies, procedures and
specifications; evaluation and validation studies; process control and/or shop-floor control strategy, logic or algorithms; assembly code, Software, firmware, programming data, databases, and all information referred to in the same); costs, margins
and pricing; as well as product marketing studies and strategies; all other methodologies, procedures, techniques and <FONT STYLE="white-space:nowrap">Know-How</FONT> related to discovery, research, engineering, development and manufacturing;
communications, correspondence, materials, product literature, artwork, files, documents; and (ii)&nbsp;financial and business information, including earnings reports and forecasts, macro-economic reports and forecasts, all cost information
(including partner and supplier records and lists), sales and pricing data, business plans, market evaluations, surveys, credit-related information, and other such information as may be needed for reasonable compliance with reporting, disclosure,
filing or other requirements, including under applicable securities laws or regulations of securities exchanges. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(55) &#147;<I>Information
Statement</I>&#148; shall mean the Information Statement attached as an exhibit to the Form 10 and any related documents to be provided to the holders of Ligand Stock in connection with the Distribution, including any potential revision of such
Information Statement to be a combined proxy statement, prospectus and/or information statement in connection with the Merger, and including any amendment or supplement thereto. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(56) &#147;<I>Insurance Proceeds</I>&#148; shall mean those monies: (a)&nbsp;received by an insured Person from any insurer, insurance
underwriter, mutual protection and indemnity club or other risk collective; or (b)&nbsp;paid on behalf of an insured Person by any insurer, insurance underwriter, mutual protection and indemnity club or other risk collective, on behalf of the
insured, in either such case net of any costs or expenses incurred in the collection thereof; provided, however, that with respect to a captive insurance arrangement, Insurance Proceeds shall only include net amounts received by the captive insurer
from a Third Party in respect of any captive reinsurance arrangement. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(57) &#147;<I>Intellectual Property</I>&#148; shall mean all U.S.
and foreign rights, title and interest (whether statutory, common law or otherwise) in or relating to any intellectual property, including all: (i)&nbsp;trademarks, trade dress, service marks, certification marks, logos, slogans, design rights,
names, corporate names, trade names, brand names and other similar designations of source or origin, together with the goodwill symbolized by any of the foregoing, and all applications, registrations, renewals and extensions of any of the foregoing
(collectively, &#147;<I>Trademarks</I>&#148;); (ii) patents and patent applications, and all related national or international counterparts thereto, including any divisionals, continuations, <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">continuations-in-part,</FONT></FONT> reissues, reexaminations, substitutions provisionals, renewals, extensions, patents of addition, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
supplementary protection certificates, utility models, inventors&#146; certificates, or the like, and any foreign equivalents of any of the foregoing (including certificates of invention and any
applications therefor) and all rights to claim priority from any of the foregoing (collectively, &#147;<I>Patents</I>&#148;); (iii) copyrights and copyrightable subject matter, whether or not registered or published, and all applications,
registrations, reversions, extensions and renewals of any of the foregoing, and all moral rights, however denominated; (iv)&nbsp;trade secrets, and all other confidential or proprietary information, ideas, technology, Software, compositions,
discoveries, improvements, <FONT STYLE="white-space:nowrap">know-how,</FONT> inventions, designs, processes, techniques, formulae, models, and methodologies, in each case, whether or not patentable or copyrightable, but excluding issued Patents
(collectively, &#147;<I><FONT STYLE="white-space:nowrap">Know-How</FONT></I>,&#148; and trade secrets together with confidential <FONT STYLE="white-space:nowrap">Know-How,</FONT> &#147;<I>Trade Secrets</I>&#148;); (v) Internet domain names and
social media accounts and addresses, and all registrations for any of the foregoing (collectively, &#147;<I>Domain Names</I>&#148;); and (vi)&nbsp;rights and remedies with respect to any past, present, or future infringement, misappropriation, or
other violation of any of the foregoing in clauses (i)&nbsp;through (v). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(58) &#147;<I>Intellectual Property Documentation</I>&#148; shall
mean: (i)&nbsp;all correct and complete physical and electronic copies of all prosecution and maintenance files and dockets, registration certificates, litigation files and related opinions of counsel and correspondence for all issued, registered
and <FONT STYLE="white-space:nowrap">applied-for</FONT> items of OmniAb Intellectual Property; (ii)&nbsp;all litigation files to the extent relating to any Actions brought for the infringement, dilution, misappropriation or other violation of any of
the OmniAb Intellectual Property; (iii)&nbsp;all books, records, files, ledgers or similar documentation used to track, organize or maintain any of the OmniAb Intellectual Property; and (iv)&nbsp;copies of all acquisition agreements relating to the
acquisition of any of the OmniAb Intellectual Property. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(59) &#147;<I>Internal Reorganization</I>&#148; shall mean the allocation and
transfer or assignment of Assets and Liabilities, including by means of the Conveyancing and Assumption Instruments, resulting in (i)&nbsp;the OmniAb Group owning and operating the OmniAb Business, and (ii)&nbsp;the Ligand Group continuing to own
and operate the Ligand Retained Business, as described in the internal reorganization plan attached hereto as Exhibit A (the &#147;<I>Reorganization Plan</I>&#148;), as may be amended prior to the Distribution Date only by written consent of Ligand,
OmniAb and APAC. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(60) &#147;<I>IT Assets</I>&#148; shall mean all information technology, Software, computers, computer systems,
communication systems, telecommunications equipment, databases, internet protocol addresses, data rights and documentation, reference, resource and training materials relating to any of the foregoing, and all Contracts (including Contract rights)
relating to any of the foregoing (including Software license agreements, source code escrow agreements, support and maintenance agreements, electronic database access contracts, Domain Name registration agreements, website hosting agreements,
Software or website development agreements, outsourcing agreements, service provider agreements, interconnection agreements, governmental permits, radio licenses and telecommunications agreements). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(61) &#147;<I>Joint Claim</I>&#148; shall mean any claim or series of related claims under any insurance policy that results or could
reasonably be expected to result in the payment of Insurance Proceeds to or for the benefit of both one or more members of the Ligand Group and one or more members of the OmniAb Group. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(62) &#147;<I>Law</I>&#148; shall mean any applicable U.S. or
<FONT STYLE="white-space:nowrap">non-U.S.</FONT> federal, national, supranational, state, provincial, local or similar statute, law, ordinance, regulation, rule, code, income tax treaty, order, requirement or rule of law (including common law) or
other binding directives promulgated, issued, entered into or taken by any Governmental Entity. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(63) &#147;<I>Liabilities</I>&#148; shall
mean any and all Indebtedness, liabilities, costs, expenses, interest and obligations, whether accrued or fixed, absolute or contingent, matured or unmatured, known or unknown, reserved or unreserved, or determined or determinable, including those
arising under any Law (including Environmental Law), Action, whether asserted or unasserted, or order, writ, judgment, injunction, decree, stipulation, determination or award entered by or with any Governmental Entity and those arising under any
Contract or any fines, damages or equitable relief which may be imposed and including all costs and expenses related thereto. Except as otherwise specifically set forth herein, in the Employee Matters Agreement or in the Tax Matters Agreement, the
rights and obligations of the Parties with respect to Taxes shall be governed by the Tax Matters Agreement and, therefore, Taxes shall not be treated as Liabilities governed by this Agreement other than for purposes of indemnification related to the
<FONT STYLE="white-space:nowrap">Spin-off</FONT> Disclosure Documents. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(64) &#147;<I>Liable Party</I>&#148; shall have the meaning set
forth in <U>Section</U><U></U><U>&nbsp;2.9(b)</U>. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(65) &#147;<I>Ligand</I>&#148; shall have the meaning set forth in the Preamble. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(66) &#147;<I>Ligand Board</I>&#148; shall have the meaning set forth in the Recitals. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(67) &#147;<I>Ligand CSIs</I>&#148; shall have the meaning set forth in <U>Section</U><U></U><U>&nbsp;2.10(d)</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(68) &#147;<I>Ligand Former Business</I>&#148; shall mean any Former Business (other than the OmniAb Business or the OmniAb Former Businesses)
that, at the time of sale, conveyance, assignment, transfer, disposition, divestiture (in whole or in part) or discontinuation, abandonment, completion or termination of the operations, activities or production thereof, was primarily managed by or
associated with the Ligand Retained Business as then conducted. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(69) &#147;<I>Ligand Group</I>&#148; shall mean (i)&nbsp;Ligand, the
Ligand Retained Business and each Person that is a direct or indirect Subsidiary of Ligand as of immediately following the Distribution Time and (ii)&nbsp;each Business Entity that becomes a Subsidiary of Ligand after the Distribution Time. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(70) &#147;<I>Ligand Indemnitees</I>&#148; shall mean each member of the Ligand Group and each of their respective Affiliates from and after
the Distribution Time and each member of the Ligand Group&#146;s and such Affiliates&#146; respective current, former and future directors, officers, employees and agents (solely in their respective capacities as current, former and future
directors, officers, employees or agents of any member of the Ligand Group or their respective Affiliates) and each of the heirs, executors, successors and assigns of any of the foregoing, except, for the avoidance of doubt, the OmniAb Indemnitees.
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(71) &#147;<I>Ligand Released Liabilities</I>&#148; shall have the meaning set forth in <U>Section</U><U></U><U>&nbsp;5.1(a)(i)</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(72) &#147;<I>Ligand Retained Assets</I>&#148; shall mean: </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) any and all Assets that are expressly contemplated by this Agreement or any Ancillary
Agreement as Assets to be retained by Ligand or any other member of the Ligand Group, including for the avoidance of doubt all Ligand Retained IP; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) any and all Assets that are owned, leased or licensed, at or prior to the Distribution Time, by Ligand and/or any of its Subsidiaries,
that are not OmniAb Assets; and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iii) any and all Assets that are acquired or otherwise become an Asset of the Ligand Group after the
Distribution Time. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(73) &#147;<I>Ligand Retained Business</I>&#148; shall mean (i)&nbsp;those businesses operated by the Ligand Group
prior to the Distribution Time other than the OmniAb Business, (ii)&nbsp;those Business Entities or businesses acquired or established by or for any member of the Ligand Group after the Distribution Time, and (iii)&nbsp;any Ligand Former Business;
<U>provided</U> that Ligand Retained Business shall not include any OmniAb Former Business or OmniAb Former Real Property. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(74)
&#147;<I>Ligand Retained IP</I>&#148; shall mean (i)&nbsp;all Intellectual Property owned or controlled by the Ligand Group other than OmniAb Intellectual Property and (ii)&nbsp;the Ligand Retained Names. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(75) &#147;<I>Ligand Retained Liabilities</I>&#148; shall mean: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) any and all Liabilities that are expressly contemplated by this Agreement or any Ancillary Agreement as Liabilities to be retained or
assumed by Ligand or any other member of the Ligand Group, and all agreements, obligations and other Liabilities of Ligand or any member of the Ligand Group under this Agreement or any of the Ancillary Agreements, including as set forth in
Section&nbsp;2.12(c)(ii); </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) any and all Liabilities of a member of the Ligand Group to the extent relating to, arising out of or
resulting from any Ligand Retained Assets (other than Liabilities arising under any Shared Contracts to the extent such Liabilities relate to the OmniAb Business); </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iii) the Liabilities listed on <U>Schedule</U><U></U><U>&nbsp;1.1(75)</U>; and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iv) any and all Liabilities of Ligand and each of its Subsidiaries that are not OmniAb Liabilities. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Notwithstanding the foregoing, the Ligand Retained Liabilities shall not include any Liabilities for Taxes that are governed by the Tax Matters
Agreement or the Employee Matters Agreement. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(76) &#147;<I>Ligand Retained Names</I>&#148; shall mean the names and marks set forth in
<U>Schedule</U><U></U><U>&nbsp;1.1(76)</U>, and any Trademarks containing or comprising any of such names or marks, and any Trademarks derivative thereof or confusingly similar thereto, or any telephone numbers or other alphanumeric addresses or
mnemonics containing any of the foregoing names or marks. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(77) &#147;<I>Ligand Stock</I>&#148; shall have the meaning set forth in the
Recitals. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(78) &#147;<I>Litigation Hold</I>&#148; shall have the meaning set forth in
<U>Section</U><U></U><U>&nbsp;6.1</U>. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(79) &#147;<I>Merger</I>&#148; shall have the meaning set forth in the Recitals. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(80) &#147;<I>Merger Agreement</I>&#148; shall have the meaning set forth in the Recitals. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(81) &#147;<I>Merger Sub</I>&#148; shall have the meaning set forth in the Recitals. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(82) &#147;<I>Negotiation Period</I>&#148; shall have the meaning set forth in <U>Section</U><U></U><U>&nbsp;7.1</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(83) &#147;<I><FONT STYLE="white-space:nowrap">Off-Site</FONT> Location</I>&#148; shall mean any third party location that is not now nor has
ever been owned, leased or operated by the Ligand Group or the OmniAb Group or any of their respective predecessors. &#147;<I><FONT STYLE="white-space:nowrap">Off-Site</FONT> Location</I>&#148; does not include any property that is adjacent to or
neighboring any property formerly, currently or in the future owned, leased or operated by the Ligand Group, the OmniAb Group, or their respective predecessors that has been impacted by any Release of a Hazardous Substance from such properties. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(84) &#147;<I>OmniAb</I>&#148; shall have the meaning set forth in the Preamble. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(85) &#147;<I>OmniAb Asset Transferee</I>&#148; shall mean any Business Entity that is or will be a member of the OmniAb Group or a Subsidiary
of OmniAb to which OmniAb Assets shall be or have been transferred at or prior to the Distribution Time, or which is contemplated by the Internal Reorganization or this Agreement or the Ancillary Agreements to occur after the Distribution Time, by
an Asset Transferor in order to consummate the transactions contemplated hereby. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(86) &#147;<I>OmniAb Assets</I>&#148; shall mean, without
duplication: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) all interests in the capital stock of, or membership or other equity interests in, the members of the OmniAb Group (other
than OmniAb) held, directly or indirectly, by Ligand immediately prior to the Distribution Time; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) the Assets set forth on
<U>Schedule</U><U></U><U>&nbsp;1.1(86)(ii)</U> (which for the avoidance of doubt is not a comprehensive listing of all OmniAb Assets and is not intended to limit other clauses of this definition of OmniAb Assets); </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iii) any and all Assets that are expressly contemplated by this Agreement or any Ancillary Agreement as Assets which have been or are to be
Transferred to or retained by any member of the OmniAb Group; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iv) any and all Assets (other than Cash Equivalents, which shall be
governed solely by <U>Section</U><U></U><U>&nbsp;2.12</U>) reflected on the OmniAb Balance Sheet or the accounting records supporting such balance sheet and any Assets acquired by or for OmniAb or any member of the OmniAb Group subsequent to the
date of the OmniAb Balance Sheet which, had they been so acquired on or before such date and owned as of such date, would have been reflected on the OmniAb Balance Sheet if prepared on a consistent basis, subject to any dispositions of any of such
Assets subsequent to the date of the OmniAb Balance Sheet; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(v) all rights, title and interest in, to and under the leases or subleases of the real
property set forth on <U>Schedule</U><U></U><U>&nbsp;1.1(86)(v)</U> and other leases exclusively related to the OmniAb Business, including, to the extent provided for in such leases or subleases, any land and land improvements, structures, buildings
and building improvements, other improvements and appurtenances (the &#147;<I>OmniAb Leased Real Property</I>&#148;); </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(vi) all Contracts
set forth on <U>Schedule 1.1(86)(vi)</U> and all other Contracts exclusively related to the OmniAb Business or the OmniAb Intellectual Property and any rights or claims arising under any of the foregoing (the &#147;<I>OmniAb Contracts</I>&#148;);
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(vii) all Intellectual Property exclusively used, exclusively practiced, exclusively held for the use or practice, or otherwise
exclusively related to the OmniAb Business, including the Intellectual Property applications, registrations and issuances set forth on <U>Schedule</U><U></U><U>&nbsp;1.1(86)(vii)</U> (the &#147;<I>OmniAb Intellectual Property</I>&#148;), and all
Intellectual Property Documentation relating to any of the foregoing; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(viii) all licenses, permits, registrations, approvals and
authorizations which have been issued by any Governmental Entity and are held by a member of the OmniAb Group, or to the extent transferable, relate exclusively to or, are used exclusively in the OmniAb Business (other than to the extent that any
member of the Ligand Group benefits from such licenses, permits, registrations, approvals and authorizations in connection with the Ligand Retained Business); </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ix) all Information exclusively related to, or exclusively used in, the OmniAb Business; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(x) excluding any OmniAb Intellectual Property (which is addressed in <U>Section</U><U></U><U>&nbsp;1.1(86)(vii)</U> above), all IT Assets
listed on <U>Schedule 1.1(86)(x)</U> and other IT Assets exclusively used or exclusively held for use in the OmniAb Business; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(xi) all
goodwill exclusively related to the OmniAb Business; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(xii) all office equipment and furnishings located at the physical site of which the
ownership or a leasehold or sub leasehold interest is being transferred to or retained by a member of the OmniAb Group, and which as of the Distribution Time is not subject to a lease or sublease back to a member of the Ligand Group (excluding any
office equipment and furnishings owned by persons other than Ligand and its Subsidiaries); </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(xiii) subject to
<U>Article</U><U></U><U>&nbsp;VIII</U>, any rights of any member of the OmniAb Group under any insurance policies held solely by one or more members of the OmniAb Group and which provide coverage solely to one or more members of the OmniAb Group
(excluding any insurance policies issued by any captive insurance company of the Ligand Group); and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(xiv) all other Assets (other than
Assets that are of the type that would be listed in clauses (v), (vii), (viii), (x), (xii) and (xiii)) that are held by the OmniAb Group or the Ligand Group immediately prior to the Distribution Time and that are exclusively used and exclusively
held for use in the OmniAb Business as conducted immediately prior to the Distribution Time (the intention of this clause (xiv)&nbsp;is only to rectify an inadvertent omission of transfer or </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
assignment of any Asset that, had the Parties given specific consideration to such Asset as of the date of this Agreement, would have otherwise been classified as an OmniAb Asset based on the
principles of this <U>Section</U><U></U><U>&nbsp;1.1(86))</U>; <U>provided</U> that no Asset shall be an OmniAb Asset solely as a result of this clause (xiv)&nbsp;unless a written claim with respect thereto is made by OmniAb on or prior to the date
that is twenty-four (24)&nbsp;months after the Distribution Time. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Notwithstanding anything to the contrary herein, the OmniAb Assets shall
not include (i)&nbsp;any Assets that are expressly contemplated by this Agreement or by any Ancillary Agreement (or the Schedules hereto or thereto) as Assets to be retained by or Transferred to any member of the Ligand Group (including all Ligand
Retained Assets), or (ii)&nbsp;any Assets governed by the Tax Matters Agreement or Employee Matters Agreement. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(87) &#147;<I>OmniAb
Balance Sheet</I>&#148; shall mean OmniAb&#146;s unaudited pro forma combined condensed balance sheet, including the notes thereto, as of December&nbsp;31, 2021, as included in the Form 10. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(88) &#147;<I>OmniAb Board</I>&#148; shall have the meaning set forth in the Recitals. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(89) &#147;<I>OmniAb Business</I>&#148; shall mean the businesses comprising the OmniAb Group, including the businesses and operations
conducted prior to the Distribution Time by any member of the OmniAb Group and any other businesses or operations conducted primarily through the use of the OmniAb Assets, as such businesses are described in the Form 10, or established by or for
OmniAb or any of its Subsidiaries after the Distribution Time and shall include the OmniAb Former Businesses; <U>provided</U> that the OmniAb Business shall not include any Ligand Former Business. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(90) &#147;<I>OmniAb Debt Obligations</I>&#148; shall mean all Indebtedness of OmniAb or any other member of the OmniAb Group. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(91) &#147;<I>OmniAb Disclosure</I>&#148; shall mean any form, statement, schedule or other material (other than the <FONT
STYLE="white-space:nowrap">Spin-off</FONT> Disclosure Documents) filed with or furnished to the Commission, including in connection with OmniAb&#146;s obligations under the Securities Act and the Exchange Act, any other Governmental Entity, or
holders of any securities of any member of the OmniAb Group, in each case, on or after the Distribution Time by or on behalf of any member of the OmniAb Group in connection with the registration, sale, or distribution of securities or disclosure
related thereto (including periodic disclosure obligations). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(92) &#147;<I>OmniAb Environmental Liabilities</I>&#148; shall mean any and
all Environmental Liabilities, whether arising before, at or after the Distribution Time, to the extent relating to or resulting from or arising out of (i)&nbsp;the past, present or future operation, conduct or actions of the OmniAb Group, OmniAb
Business or the past, present or future use of the OmniAb Assets or (ii)&nbsp;the OmniAb Former Businesses or OmniAb Former Real Property, including, without limitation, any agreement, decree, judgment, or order relating to the foregoing entered
into by Ligand or any Affiliate of Ligand prior to the Distribution Time, but in any event excluding the Excluded Environmental Liabilities. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(93) &#147;<I>OmniAb Former Businesses</I>&#148; shall mean any Former Business that, at the
time of sale, conveyance, assignment, transfer, disposition, divestiture (in whole or in part) or discontinuation, abandonment, completion or termination of the operations, activities or production thereof, was (a)&nbsp;primarily managed by or
associated with the OmniAb Business as then conducted or (b)&nbsp;part of a business the majority of which as of the Distribution Time is or was transferred to OmniAb. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(94) &#147;<I>OmniAb Former Real Property</I>&#148; shall mean any real property that at the time of sale, conveyance, assignment, transfer,
disposition, divestiture (in whole or in part) or discontinuation, abandonment, completion or termination of the operations, activities or production thereof, was primarily owned, leased or operated in connection with the OmniAb Business or any of
the OmniAb Former Businesses. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(95) &#147;<I>OmniAb Group</I>&#148; shall mean OmniAb and each Person that is a direct or indirect
Subsidiary of OmniAb as of the Distribution Time (but after giving effect to the Internal Reorganization) including the Transferred Entities, and each Person that becomes a Subsidiary of OmniAb after the Distribution Time; provided, however, that
for the avoidance of doubt, no member of the Ligand Group shall be treated as a member of the OmniAb Group. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(96) &#147;<I>OmniAb
Indemnitees</I>&#148; shall mean each member of the OmniAb Group and each of their respective Affiliates from and after the Distribution Time and each member of the OmniAb Group&#146;s and such respective Affiliates&#146; respective current, former
and future directors, officers, employees and agents (solely in their respective capacities as current, former and future directors, officers, employees or agents of any member of the OmniAb Group or their respective Affiliates) and each of the
heirs, administrators, executors, successors and assigns of any of the foregoing, except, for the avoidance of doubt, the Ligand Indemnitees. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(97) &#147;<I>OmniAb Liabilities</I>&#148; shall mean: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) any and all Liabilities to the extent relating to, arising out of or resulting from (a)&nbsp;the operation or conduct of the OmniAb
Business, as conducted at any time prior to, at or after the Distribution Time (including any Liability relating to, arising out of or resulting from any act or failure to act by any director, officer, employee, agent or representative (whether or
not such act or failure to act is or was within such Person&#146;s authority) of the OmniAb Group and any and all Liability relating to, arising out of or resulting from any unclaimed property); (b) the operation or conduct of any business conducted
by any member of the OmniAb Group at any time after the Distribution Time (including any Liability relating to, arising out of or resulting from any act or failure to act by any director, officer, employee, agent or representative (whether or not
such act or failure to act is or was within such Person&#146;s authority) of the OmniAb Group and any and all Liability relating to, arising out of or resulting from any unclaimed property); or (c)&nbsp;any OmniAb Asset, whether arising before, at
or after the Distribution Time (including any Liability relating to, arising out of or resulting from OmniAb Contracts, Shared Contracts (to the extent such Liability relates to the OmniAb Business) and any real property and leasehold interests):
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) the Liabilities set forth on <U>Schedule 1.1(97)(ii)</U> and any and all other Liabilities that are expressly provided by this
Agreement or any of the Ancillary Agreements as Liabilities to be assumed by OmniAb or any other member of the OmniAb Group, and all agreements, obligations and Liabilities of OmniAb or any other member of the OmniAb Group under this Agreement or
any of the Ancillary Agreements; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">16 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iii) any and all Liabilities reflected on the OmniAb Balance Sheet or the accounting
records supporting such balance sheet and any Liabilities incurred by or for OmniAb or any member of the OmniAb Group subsequent to the date of the OmniAb Balance Sheet which, had they been so incurred on or before such date, would have been
reflected on the OmniAb Balance Sheet if prepared on a consistent basis, subject to any discharge of any of such Liabilities subsequent to the date of the OmniAb Balance Sheet; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iv) any and all Liabilities to the extent relating to, arising out of, or resulting from, whether prior to, at or after the Distribution Time,
any infringement, misappropriation or other violation of any Intellectual Property of any other Person related to the conduct of the OmniAb Business; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(v) any and all OmniAb Environmental Liabilities; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(vi) any and all Liabilities (including under applicable federal and state securities Laws) relating to, arising out of or resulting from
(A)&nbsp;the <FONT STYLE="white-space:nowrap">Spin-off</FONT> Disclosure Documents or (B)&nbsp;any OmniAb Disclosure; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(vii) for the
avoidance of doubt, and without limiting any other matters that may constitute OmniAb Liabilities, any Liabilities resulting from any Action to the extent relating to, arising out of or resulting from the OmniAb Business, including all Actions
listed on <U>Schedule</U><U></U><U>&nbsp;1.1(97)(vii)</U>; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(viii) all Liabilities relating to, arising out of or resulting from any
Indebtedness of any member of the OmniAb Group or any Indebtedness secured exclusively by any of the OmniAb Assets; and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ix) any and all
other Liabilities that are held by the OmniAb Group or the Ligand Group immediately prior to the Distribution Time that were inadvertently omitted or assigned that, had the parties given specific consideration to such Liability as of the date of
this Agreement, would have otherwise been classified as an OmniAb Liability based on the principles set forth in this <U>Section</U><U></U><U>&nbsp;1.1(97)</U>; <U>provided</U>, that no Liability shall be an OmniAb Liability solely as a result of
this clause (ix)&nbsp;unless a claim with respect thereto is made by Ligand on or prior to the date that is twenty-four (24)&nbsp;months after the Distribution Time. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Notwithstanding the foregoing, the OmniAb Liabilities shall not include any Liabilities that are (A)&nbsp;expressly contemplated by this
Agreement or by any Ancillary Agreement (or the Schedules hereto or thereto) as Liabilities to be Assumed by any member of the Ligand Group, (B)&nbsp;expressly discharged pursuant to <U>Section</U><U></U><U>&nbsp;2.4</U> of this Agreement,
(C)&nbsp;Ligand Retained Liabilities or (D)&nbsp;for Taxes that are governed by the Tax Matters Agreement or Employee Matters Agreement. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(98) &#147;<I>OmniAb Released Liabilities</I>&#148; shall have the meaning set forth in <U>Section</U><U></U><U>&nbsp;5.1(a)(ii)</U>. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">17 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(99) &#147;<I>OmniAb Stock</I>&#148; shall have the meaning set forth in the Recitals. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(100) &#147;<I>Other Party</I>&#148; shall have the meaning set forth in <U>Section</U><U></U><U>&nbsp;2.9(a)</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(101) &#147;<I>Other Reimbursable Expenses</I>&#148; shall have the meaning set forth in <U>Section</U><U></U><U>&nbsp;2.12(c)</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(102) &#147;<I>Party</I>&#148; and &#147;<I>Parties</I>&#148; shall have the meanings set forth in the Preamble. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(103) &#147;<I>Person</I>&#148; shall mean any natural person, firm, individual, corporation, business trust, joint venture, association, bank,
land trust, trust company, company, limited liability company, partnership, or other organization or entity, whether incorporated or unincorporated, or any Governmental Entity. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(104) &#147;<I>Personal Information</I>&#148; shall mean any data or information that identifies, relates to, describes, is reasonably capable
of being associated with, or could reasonably be linked, directly or indirectly, with a particular natural person or household (including any information related to the health of a person) and any information derived from any of the foregoing, in
addition to any definition for &#147;personal information&#148; or any similar term provided by applicable Law or by the applicable Party&#146;s privacy policies, notices or contracts (e.g., &#147;personal data,&#148; &#147;personally identifiable
information&#148; or &#147;PII&#148;). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(105) &#147;<I>Policies</I>&#148; or &#147;<I>Policy</I>&#148; shall mean insurance policies and
insurance contracts of any kind, including primary, excess and umbrella, comprehensive general liability, fiduciary, directors and officers, automobile, products, workers&#146; compensation, employee dishonesty, property and crime insurance policies
and self-insurance and captive insurance arrangements, and interests in insurance pools and programs held in the name of Ligand or any of its Affiliates, together with the rights, benefits and privileges thereunder. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(106) &#147;<I>Prime Rate</I>&#148; shall mean the rate last quoted as of the time of determination by The Wall Street Journal as the
&#147;Prime Rate&#148; in the United States or, if the Wall Street Journal ceases to quote such rate, the highest per annum interest rate published by the Federal Reserve Board in Federal Reserve Statistical Release H.15 (519) (Selected Interest
Rates) as the &#147;bank prime loan&#148; rate as of such time, or, if such rate is no longer quoted therein, any similar rate quoted therein (as determined by Ligand) or any similar release by the Federal Reserve Board (as determined by Ligand).
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(107) &#147;<I>Privacy </I><I>Laws</I>&#148; shall mean any and all applicable Laws, legal requirements and self-regulatory guidelines
(including of any applicable foreign jurisdiction) relating to the Processing of any Personal Information. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(108) &#147;<I>Privacy
Requirements</I>&#148; shall mean all applicable Privacy Laws and all applicable policies, notices, and contractual obligations relating to the Processing of any Personal Information. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(109) &#147;<I>Privilege</I>&#148; shall have the meaning set forth in <U>Section</U><U></U><U>&nbsp;6.7(a)</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(110) &#147;<I>Privileged Information</I>&#148; shall have the meaning set forth in <U>Section</U><U></U><U>&nbsp;6.7(a)</U>. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">18 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(111) &#147;<I>Processing</I>&#148; shall mean any operation or set of operations which is
performed on any Personal Information or on any sets of any Personal Information, whether or not by automated means, such as, without limitation: receipt; collection; compilation; use; disposal; destruction; disclosure or transfer (including
cross-border); recording; organization; structuring; safeguarding; storage; security (technical, physical and/or administrative); sharing; adaptation or alteration; retrieval; consultation; disclosure by transmission, dissemination or otherwise
making available; alignment or combination; restriction; erasure; and/or destruction. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(112) &#147;<I>Record Date</I>&#148; shall mean 5:00
p.m. New York time on the date to be determined by the Ligand Board as the record date for determining stockholders of Ligand entitled to receive shares of OmniAb Stock in the Distribution. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(113) &#147;<I>Record Holders</I>&#148; shall mean the holders of record of Ligand Stock as of the Record Date. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(114) &#147;<I>Reimbursable Transaction-related Expenses</I>&#148; shall have the meaning set forth in <U>Section</U><U></U><U>&nbsp;9.5</U>.
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(115) &#147;<I>Release</I>&#148; shall mean any release, spill, emission, discharge, leaking, pumping, injection, deposit, disposal,
dispersal, leaching or migration into the indoor or outdoor environment (including ambient air, surface water, groundwater and surface or subsurface strata) or into or out of any property, including the movement of Hazardous Substances through or in
the air, soil, surface water, groundwater or property. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(116) &#147;<I>Securities Act</I>&#148; shall mean the Securities Act of 1933,
together with the rules and regulations promulgated thereunder. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(117) &#147;<I>Security Interest</I>&#148; shall mean any mortgage,
security interest, pledge, lien, charge, claim, option, right to acquire, voting or other restriction, <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">right-of-entry,</FONT></FONT> covenant, condition, easement, encroachment,
restriction on transfer, or other encumbrance of any nature whatsoever, excluding restrictions on transfer under securities Laws. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(118)
&#147;<I>Separation</I>&#148; shall have the meaning set forth in the Recitals. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(119) &#147;<I>Shared Contract</I>&#148; shall have the
meaning set forth in <U>Section</U><U></U><U>&nbsp;2.3(a)</U>. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(120) &#147;<I>Software</I>&#148; shall mean all: (i)&nbsp;computer
programs, including all software implementations of algorithms, models and methodologies, whether in source code, object code, human readable form or other form; (ii)&nbsp;databases and compilations, including all data and collections of data,
whether machine readable or otherwise; (iii)&nbsp;descriptions, flow charts and other work products used to design, plan, organize and develop any of the foregoing, screens, user interfaces, report formats, firmware, development tools, templates,
menus, buttons, icons, web content and links; and (iv)&nbsp;documentation relating to any of the foregoing, including user manuals and other training documentation. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(121) &#147;<I>Specific Milestone Payments</I>&#148; shall have the meaning set forth in <U>Section</U><U></U><U>&nbsp;2.12(c)</U>. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">19 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(122) &#147;<I><FONT STYLE="white-space:nowrap">Spin-off</FONT> Disclosure
Documents</I>&#148; shall mean the Form 10 and all exhibits thereto including the Information Statement, and any current reports on Form <FONT STYLE="white-space:nowrap">8-K,</FONT> in each case as filed or furnished by OmniAb with or to the
Commission in connection with the Distribution or Merger or filed or furnished by Ligand with or to the Commission solely to the extent such documents relate to OmniAb, the Distribution or the Merger. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(123) &#147;<I>Subsidiary</I>&#148; shall mean with respect to any Person (i)&nbsp;a corporation, fifty percent (50%) or more of the voting or
capital stock of which is, as of the time in question, directly or indirectly owned by such Person and (ii)&nbsp;any other Person in which such Person, directly or indirectly, owns fifty percent (50%) or more of the equity or economic interest
thereof or has the power to elect or direct the election of fifty percent (50%) or more of the members of the governing body of such entity. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(124) &#147;<I>Tax</I>&#148; or &#147;<I>Taxes</I>&#148; shall have the meaning set forth in the Tax Matters Agreement. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(125) &#147;<I>Tax Contest</I>&#148; shall have the meaning as set forth in the Tax Matters Agreement. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(126) &#147;<I>Tax Matters Agreement</I>&#148; shall mean that certain Tax Matters Agreement to be entered into between Ligand and OmniAb in
connection with the Separation, the Distribution or the other transactions contemplated by this Agreement, as such agreement may be modified or amended from time to time in accordance with its terms. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(127) &#147;<I>Tax Returns</I>&#148; shall have the meaning set forth in the Tax Matters Agreement. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(128) &#147;<I>Taxing Authority</I>&#148; shall have the meaning set forth in the Tax Matters Agreement. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(129) &#147;<I>Third Party Agreements</I>&#148; shall mean any agreements, arrangements, commitments or understandings between or among a Party
(or any member of its Group) and any other Persons (other than either Party or any member of its respective Groups) (it being understood that to the extent that the rights and obligations of the Parties and the members of their respective Groups
under any such Contracts constitute OmniAb Assets or OmniAb Liabilities, or Ligand Retained Assets or Ligand Retained Liabilities, such Contracts shall be assigned or retained pursuant to <U>Article</U><U></U><U>&nbsp;II</U>). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(130) &#147;<I>Third Party Claim</I>&#148; shall have the meaning set forth in <U>Section</U><U></U><U>&nbsp;5.4(b)</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(131) &#147;<I>Third Party Proceeds</I>&#148; shall have the meaning set forth in <U>Section</U><U></U><U>&nbsp;5.7(a).</U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(132) &#147;<I>Transaction-related Expenses</I>&#148; shall have the meaning set forth in <U>Section</U><U></U><U>&nbsp;9.5</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(133) &#147;<I>Transfer</I>&#148; shall have the meaning set forth in <U>Section</U><U></U><U>&nbsp;2.2(b)(i)</U>; and the term
&#147;<I>Transferred</I>&#148; shall have its correlative meaning. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(134) &#147;<I>Transferred Entities</I>&#148; shall mean Ab Initio
Biotherapeutics, Inc., Crystal Bioscience, Inc., Icagen, LLC, Taurus Biosciences, LLC and xCella Biosciences, Inc. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">20 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(135) &#147;<I>Transition Services Agreements</I>&#148; shall mean either or both, as
applicable, of those certain Transition Services Agreements to be entered into between Ligand and OmniAb or any members of their respective Groups in connection with the Distribution or the other transactions contemplated by this Agreement, as such
agreements may be modified or amended from time to time in accordance with their terms. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;1.2 <U>References;
Interpretation</U>. References in this Agreement to any gender include references to all genders, and references to the singular include references to the plural and vice versa. Unless the context otherwise requires, the words &#147;include&#148;,
&#147;includes&#148; and &#147;including&#148; when used in this Agreement shall be deemed to be followed by the phrase &#147;without limitation&#148;. Unless the context otherwise requires, references in this Agreement to Articles, Sections,
Annexes, Exhibits&nbsp;and Schedules shall be deemed references to Articles and Sections&nbsp;of, and Annexes, Exhibits&nbsp;and Schedules to, this Agreement. Unless the context otherwise requires, the words &#147;hereof&#148;, &#147;hereby&#148;
and &#147;herein&#148; and words of similar meaning when used in this Agreement refer to this Agreement in its entirety and not to any particular Article, Section&nbsp;or provision of this Agreement. The words &#147;written request&#148; when used
in this Agreement shall include email. Reference in this Agreement to any time shall be to New York City, New York time unless otherwise expressly provided herein. Unless the context requires otherwise, references in this Agreement to
&#147;<I>Ligand</I>&#148; shall also be deemed to refer to the applicable member of the Ligand Group, references to &#147;<I>OmniAb</I>&#148; shall also be deemed to refer to the applicable member of the OmniAb Group and, in connection therewith,
any references to actions or omissions to be taken, or refrained from being taken, as the case may be, by Ligand or OmniAb shall be deemed to require Ligand or OmniAb, as the case may be, to cause the applicable members of the Ligand Group or the
OmniAb Group, respectively, to take, or refrain from taking, any such action. In the event of any inconsistency or conflict which may arise in the application or interpretation of any of the definitions set forth in
<U>Section</U><U></U><U>&nbsp;1.1</U>, for the purpose of determining what is and is not included in such definitions, any item explicitly included on a Schedule&nbsp;referred to in any such definition shall take priority over any provision of the
text thereof. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE II </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>THE SEPARATION </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.1 <U>General</U>. Subject to the terms and conditions of this Agreement, the Parties shall use, and shall cause their
respective Affiliates to use, their respective commercially reasonable efforts to consummate the transactions contemplated hereby, including the completion of the Internal Reorganization, a portion of which may have already been implemented prior to
the date hereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.2 <U>Restructuring: Transfer of Assets; Assumption of Liabilities</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <U>Internal Reorganization</U>. Prior to the Distribution Time, except for Transfers contemplated by the Internal Reorganization or this
Agreement or the Ancillary Agreements to occur after the Distribution Time, the Parties shall complete the Internal Reorganization, including by taking the actions referred to in <U>Sections</U><U></U><U>&nbsp;2.2(b)</U> and <U>2.2(c)</U> below.
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">21 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <U>Transfer of Assets</U>. At or prior to the Distribution Time (it being understood
that some of such Transfers may occur following the Distribution Time in accordance with <U>Section</U><U></U><U>&nbsp;2.2(a)</U> and <U>Section</U><U></U><U>&nbsp;2.6</U>), pursuant to the Conveyancing and Assumption Instruments and in connection
with the Contribution: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) Ligand shall, and shall cause the applicable Asset Transferors to, transfer, contribute,
distribute, assign and/or convey or cause to be transferred, contributed, distributed, assigned and/or conveyed (&#147;<I>Transfer</I>&#148;) to OmniAb and/or the respective OmniAb Asset Transferees, all of its and the applicable Asset
Transferors&#146; right, title and interest in and to the OmniAb Assets, and the applicable OmniAb Asset Transferees shall accept from Ligand and the applicable members of the Ligand Group all of Ligand&#146;s and the other members of the Ligand
Group&#146;s respective direct or indirect rights, title and interest in and to the applicable Assets, including all of the outstanding shares of capital stock or other ownership interests, that are included in the OmniAb Assets. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) Any costs and expenses incurred after the Distribution Time to effect any Transfer contemplated by this
<U>Section</U><U></U><U>&nbsp;2.2(b)</U> (including any transfer effected pursuant to <U>Section</U><U></U><U>&nbsp;2.6</U>) shall be paid by the Parties as set forth in <U>Section</U><U></U><U>&nbsp;9.5</U>. Other than costs and expenses incurred
in accordance with the foregoing sentence, nothing in this <U>Section</U><U></U><U>&nbsp;2.2(b)</U> shall require any member of any Group to incur any material obligation or grant any material concession for the benefit of any member of any other
Group in order to effect any transaction contemplated by this <U>Section</U><U></U><U>&nbsp;2.2(b)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For the avoidance of doubt any
OmniAb Assets already held by OmniAb prior to the Internal Reorganization shall not need to be Transferred and shall remain with OmniAb prior to and following the Distribution Time. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) <U>Assumption of Liabilities</U>. Except as pursuant to this Agreement or as otherwise specifically set forth in any Ancillary Agreement,
in connection with the Internal Reorganization and the Contribution or, if applicable, from and after, the Distribution Time (i)&nbsp;pursuant to this Agreement or the applicable Conveyancing and Assumption Instruments, OmniAb shall, or shall cause
a member of the OmniAb Group to accept, assume (or, as applicable, retain) and perform, discharge and fulfill, in accordance with their respective terms (&#147;<I>Assume</I>&#148;), all of the OmniAb Liabilities and (ii)&nbsp;pursuant to this
Agreement or the applicable Conveyancing and Assumption Instruments, Ligand shall, or shall cause a member of the Ligand Group to, Assume all of the Ligand Retained Liabilities, in each case, regardless of (A)&nbsp;when or where such Liabilities
arose or arise, (B)&nbsp;whether the facts upon which they are based occurred prior to, at or subsequent to the Distribution Time, (C)&nbsp;whether accruals for such Liabilities have been transferred to OmniAb or included on a combined balance sheet
of the OmniAb Business or whether any such accruals are sufficient to cover such Liabilities, (D)&nbsp;where or against whom such Liabilities are asserted or determined, (E)&nbsp;whether arising from or alleged to arise from negligence, gross
negligence, recklessness, violation of Law, fraud or misrepresentation by any member of the Ligand Group or the OmniAb Group, as the case may be, or any of their past or present respective directors, officers, employees, agents, Subsidiaries or
Affiliates, (F)&nbsp;which entity is named in any Action associated with any Liability, or (G)&nbsp;any benefits, or lack thereof, that have been or may be obtained by the Ligand Group or the OmniAb Group in respect of such Liabilities. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">22 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) <U>Consents</U>. The Parties shall use their commercially reasonable efforts to obtain
the Consents required to Transfer any Assets, Contracts, licenses, permits and authorizations issued by any Governmental Entity or parts thereof as contemplated by this Agreement. Notwithstanding anything herein to the contrary, no Contract or other
Asset shall be transferred if it would violate applicable Law or, in the case of any Contract, the rights of any third party to such Contract; <U>provided</U> that <U>Section</U><U></U><U>&nbsp;2.6</U>, to the extent provided therein, shall apply
thereto. The foregoing shall not preclude OmniAb or any member of the OmniAb Group from disputing in good faith with any third party (other than Ligand or any member of the Ligand Group) the validity of any OmniAb Liabilities or raising any
available defenses in connection therewith. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) It is understood and agreed by the Parties that certain of the Transfers referenced in
<U>Section</U><U></U><U>&nbsp;2.2(b)</U> or Assumptions referenced in <U>Section</U><U></U><U>&nbsp;2.2(c)</U> have occurred prior to the date hereof and, as a result, no additional Transfers or Assumptions by any member of the Ligand Group or the
OmniAb Group, as applicable, shall be deemed to occur upon the execution of this Agreement with respect thereto. Moreover, to the extent that any member of the Ligand Group or the OmniAb Group, as applicable, is liable for any Ligand Retained
Liability or OmniAb Liability, respectively, by operation of law immediately following any Transfer in accordance with this Agreement or any Conveyancing and Assumption Instruments, there shall be no need for any other member of the Ligand Group or
the OmniAb Group, as applicable, to Assume such Liability in connection with the operation of <U>Section</U><U></U><U>&nbsp;2.2(c)</U> and, accordingly, no other member of such Group shall Assume any such Liability in connection with
<U>Section</U><U></U><U>&nbsp;2.2(c)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.3 <U>Treatment of Shared Contracts</U>. Without limiting the generality of the
obligations set forth in <U>Sections</U><U></U><U>&nbsp;2.2(a)</U> and <U>(b)</U>: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Unless the Parties otherwise agree or the benefits
of any Contract described in this <U>Section</U><U></U><U>&nbsp;2.3</U> are expressly conveyed to the applicable Party pursuant to an Ancillary Agreement, and other than as provided by <U>Article VIII</U>, any Contract that is listed on
<U>Schedule</U><U></U><U>&nbsp;2.3(a)</U> (a &#147;<I>Shared Contract</I>&#148;) shall be assigned in part to the applicable member(s) of the applicable Group, if so assignable, or appropriately amended prior to, at or after the Distribution Time,
so that each Party or the members of their respective Groups as of the Distribution Time shall be entitled to the rights and benefits, and shall Assume the related portion of any Liabilities, inuring to their respective Businesses; <U>provided</U>,
<U>however</U>, that (x)&nbsp;in no event shall any member of any Group be required to assign (or amend) any Shared Contract in its entirety or to assign a portion of any Shared Contract which is not assignable (or cannot be amended) by its terms
(including any terms imposing consents or conditions on an assignment where such consents or conditions have not been obtained or fulfilled, subject to <U>Section</U><U></U><U>&nbsp;2.2(d)</U>), and (y)&nbsp;if any Shared Contract cannot be so
partially assigned by its terms or otherwise, cannot be amended or has not for any other reason been assigned or amended, or if such assignment or amendment would impair the benefit the parties thereto derive from such Shared Contract, (A)&nbsp;at
the reasonable request of the Party (or the member of such Party&#146;s Group) to which the benefit of such Shared Contract inures in part, the Party for which such Shared Contract is, as applicable, a Ligand Retained Asset or OmniAb Asset shall,
and shall cause each of its respective Subsidiaries </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">23 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
to, for a period ending not later than six (6)&nbsp;months after the Distribution Date (unless the term of a Shared Contract (excluding any extensions thereof) ends at a later date, in which case
for a period ending on such date), take such other reasonable and permissible actions to cause such member of the OmniAb Group or the Ligand Group, as the case may be, to receive the benefit of that portion of each Shared Contract that relates to
the OmniAb Business or the Ligand Retained Business, as the case may be (in each case, to the extent so related) as if such Shared Contract had been assigned to (or amended to allow) a member of the applicable Group pursuant to this
<U>Section</U><U></U><U>&nbsp;2.3</U> and to bear the burden of the corresponding Liabilities (including any Liabilities that may arise by reason of such arrangement) as if such Liabilities had been Assumed by a member of the applicable Group
pursuant to this <U>Section</U><U></U><U>&nbsp;2.3</U>; <U>provided</U> that the Party for which such Shared Contract is a Ligand Retained Asset or an OmniAb Asset, as applicable, shall be indemnified for all Indemnifiable Losses or other
Liabilities arising out of any actions (or omissions to act) of such retaining Party taken at the direction of the other Party (or relevant member of its Group) in connection with and relating to such Shared Contract, as the case may be, and
(B)&nbsp;the Party to which the benefit of such Shared Contract inures in part shall use commercially reasonable efforts to enter into a separate contract pursuant to which it procures such rights and obligations as are necessary such that it no
longer needs to avail itself of the arrangements provided pursuant to this <U>Section</U><U></U><U>&nbsp;2.3(a)</U>; <U>provided</U> that, the Party for which such Shared Contract is, as applicable, a Ligand Retained Asset or OmniAb Asset, any such
Party&#146;s applicable Subsidiaries shall not be liable for any actions or omissions taken in accordance with clause (y)&nbsp;of this <U>Section</U><U></U><U>&nbsp;2.3(a)</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Unless the Parties otherwise agree, each of Ligand and OmniAb shall, and shall cause the members of its Group to, (A)&nbsp;treat for all
Tax purposes the portion of each Shared Contract inuring to its respective Businesses as Assets owned by, and/or Liabilities of, as applicable, such Party as of the Distribution Time and (B)&nbsp;neither report nor take any Tax position (on a Tax
Return or otherwise) inconsistent with such treatment (unless required by applicable Law or good faith resolution of a Tax Contest). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.4 <U>Intercompany Accounts, Loans and Agreements</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Except as set forth in <U>Section</U><U></U><U>&nbsp;5.1(b)</U>, all intercompany receivables and payables (other than
(x)&nbsp;intercompany loans (which shall be governed by <U>Section</U><U></U><U>&nbsp;2.4(c)</U>), and (y)&nbsp;payables created or required by this Agreement, any Ancillary Agreement or any Continuing Arrangements) and intercompany balances,
including in respect of any cash balances, any cash balances representing deposited checks or drafts or any cash held in any centralized cash management system between any member of the Ligand Group, on the one hand, and any member of the OmniAb
Group, on the other hand, which exist and are reflected in the accounting records of the relevant Parties immediately prior to the Distribution Time, shall be paid, performed or otherwise settled on or prior to the Distribution Time, and all
arrangements, understandings and agreements relating thereto are hereby terminated. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) As between the Parties (and the members of their
respective Group) all payments and reimbursements received after the Distribution Time by one Party (or member of its Group) that relate to a Business, Asset or Liability of the other Party (or member of its Group), shall be held by such Party in
trust for the use and benefit of the Party entitled thereto (at the expense of the Party entitled thereto) and, promptly upon receipt by such Party of any such </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">24 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
payment or reimbursement, such Party shall pay or shall cause the applicable member of its Group to pay over to the Party entitled thereto the amount of such payment or reimbursement without
right of <FONT STYLE="white-space:nowrap">set-off.</FONT> </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Each of Ligand or any member of the Ligand Group, on the one hand, and
OmniAb or any member of the OmniAb Group, on the other hand, will settle with the other Party, as the case may be, all intercompany loans, including any promissory notes, owned or owed by the other Party on or prior to the Distribution Time, it
being understood and agreed by the Parties that all guarantees and Credit Support Instruments shall be governed by <U>Section</U><U></U><U>&nbsp;2.10</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.5 <U>Limitation of Liability; Intercompany Contracts</U>. No Party nor any Subsidiary thereof shall be liable to the other
Party or any Subsidiary of the other Party based upon, arising out of or resulting from any Contract, arrangement, course of dealing or understanding between or among it and the other Party existing at or prior to the Distribution Time (other than
pursuant to this Agreement, any Ancillary Agreement, any Continuing Arrangements, any Third Party Agreements, or pursuant to any other Contract entered into in connection herewith or in order to consummate the transactions contemplated hereby or
thereby) and each Party hereby terminates any and all Contracts, arrangements, courses of dealing or understandings between or among it and the other Party effective as of the Distribution Time (other than as set forth in this Agreement, any
Ancillary Agreement, any Continuing Arrangements, any Third Party Agreements, or pursuant to any Contract entered into in connection herewith or in order to consummate the transactions contemplated hereby or thereby), provided, however, that with
respect to any Contract, arrangement, course of dealing or understanding between or among the Parties or any Subsidiaries thereof discovered after the Distribution Time, the Parties agree that such Contract, arrangement, course of dealing or
understanding shall nonetheless be deemed terminated as of the Distribution Time with the only liability of the Parties in respect thereof to be the obligations incurred between the Parties pursuant to such Contract, arrangement, course of dealing
or understanding between the Distribution Time and the time of discovery or later termination of any such Contract, arrangement, course of dealing or understanding. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.6 <U>Transfers Not Effected at or Prior to the Distribution Time; Transfers Deemed Effective as of the Distribution Time</U>.
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) To the extent that any Transfers or Assumptions contemplated by this <U>Article</U><U></U><U>&nbsp;II</U> shall not have been
consummated at or prior to the Distribution Time, the Parties shall use commercially reasonable efforts (taking into account any applicable restrictions or considerations, in each case relating to the contemplated Tax treatment of the transactions
contemplated hereby) to effect such Transfers or Assumptions as promptly following the Distribution Time as shall be practicable. Nothing herein shall be deemed to require or constitute the Transfer of any Assets or the Assumption of any Liabilities
which by their terms or operation of Law cannot be Transferred; <U>provided</U>, <U>however</U>, that the Parties and their respective Subsidiaries shall cooperate and use commercially reasonable efforts to seek to obtain, in accordance with
applicable Law, any necessary Consents or Governmental Approvals for the Transfer of all Assets and Assumption of all Liabilities contemplated to be Transferred and Assumed pursuant to this <U>Article</U><U></U><U>&nbsp;II</U> to the fullest extent
permitted by applicable Law. In the event that any such Transfer of Assets or Assumption of Liabilities has not been consummated, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">25 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
from and after the Distribution Time, (i)&nbsp;the Party (or relevant member in its Group) retaining such Asset shall thereafter hold (or shall cause such member in its Group to hold) such Asset
in trust for the use and benefit of the Party entitled thereto (at the expense of the Party entitled thereto) and (ii)&nbsp;the Party intended to Assume such Liability shall, or shall cause the applicable member of its Group to, pay or reimburse the
Party retaining such Liability for all amounts paid or incurred in connection with the retention of such Liability. To the extent the foregoing applies to any Contracts (other than Shared Contracts, which shall be governed solely by
<U>Section</U><U></U><U>&nbsp;2.3</U>) to be assigned for which any necessary Consents or Governmental Approvals are not received prior to the Distribution Time, the treatment of such Contracts shall, for the avoidance of doubt, be subject to
<U>Section</U><U></U><U>&nbsp;2.8</U> and <U>Section</U><U></U><U>&nbsp;2.9</U>, to the extent applicable. In addition, the Party retaining such Asset or Liability (or relevant member of its Group) shall (or shall cause such member in its Group to)
treat, insofar as reasonably possible and to the extent permitted by applicable Law, such Asset or Liability in the ordinary course of business in accordance with past practice and take such other actions as may be reasonably requested by the Party
to which such Asset is to be Transferred or by the Party Assuming such Liability in order to place such Party, insofar as reasonably possible and to the extent permitted by applicable Law, in the same position as if such Asset or Liability had been
Transferred or Assumed as contemplated hereby and so that all the benefits and burdens relating to such Asset or Liability, including possession, use, risk of loss, potential for income and gain, and dominion, control and command over such Asset or
Liability, are to inure from and after the Distribution Time to the relevant member or members of the Ligand Group or the OmniAb Group entitled to the receipt of such Asset or required to Assume such Liability. In furtherance of the foregoing, the
Parties agree that, as of the Distribution Time, subject to <U>Section</U><U></U><U>&nbsp;2.2(c)</U> and <U>Section</U><U></U><U>&nbsp;2.9(b)</U>, each Party shall be deemed to have acquired complete and sole beneficial ownership over all of the
Assets, together with all rights, powers and privileges incident thereto, and shall be deemed to have Assumed in accordance with the terms of this Agreement all of the Liabilities, and all duties, obligations and responsibilities incident thereto,
which such Party is entitled to acquire or required to Assume pursuant to the terms of this Agreement. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) If and when the Consents,
Governmental Approvals and/or conditions, the absence or <FONT STYLE="white-space:nowrap">non-satisfaction</FONT> of which caused the deferral of Transfer of any Asset or deferral of the Assumption of any Liability pursuant to
<U>Section</U><U></U><U>&nbsp;2.6(a)</U>, are obtained or satisfied, the Transfer, assignment, Assumption or novation of the applicable Asset or Liability shall be effected without further consideration in accordance with and subject to the terms of
this Agreement (including <U>Section</U><U></U><U>&nbsp;2.2</U>) and/or the applicable Ancillary Agreement, and shall, to the extent possible without the imposition of any undue cost on any Party, be deemed to have become effective as of the
Distribution Time. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) The Party (or relevant member of its Group) retaining any Asset or Liability due to the deferral of the Transfer of
such Asset or the deferral of the Assumption of such Liability pursuant to <U>Section</U><U></U><U>&nbsp;2.6(a)</U> or otherwise shall (i)&nbsp;not be obligated, in connection with the foregoing, to expend any money unless the necessary funds are
advanced, assumed, or agreed in advance to be reimbursed by the Party (or relevant member of its Group) entitled to such Asset or the Person intended to be subject to such Liability, other than reasonable attorneys&#146; fees and recording or
similar or other incidental fees, all of which shall be promptly reimbursed by the Party (or relevant member of its Group) entitled to such Asset or the Person intended to be subject to such Liability and (ii)&nbsp;be indemnified for all
Indemnifiable Losses or other Liabilities arising out of any actions (or omissions to act) of such retaining Party taken at the direction of the other Party (or relevant member of its Group) in connection with and relating to such retained Asset or
Liability, as the case may be. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">26 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) After the Distribution Time, each Party (or any member of its Group) may receive mail,
packages, electronic mail or other electronic communications and any other written communications properly belonging to another Party (or any member of its Group). Accordingly, at all times after the Distribution Time, each Party is hereby
authorized to receive and, if reasonably necessary to identify the proper recipient in accordance with this <U>Section</U><U></U><U>&nbsp;2.6(d)</U>, open all mail, packages, electronic mail or other electronic communication and any other written
communications received by such Party that belongs to such other Party, and to the extent that they do not relate to the business of the receiving Party, the receiving Party shall promptly deliver such mail, packages, electronic mail or other
electronic communication or any other written communications (or, in case the same also relates to the business of the receiving Party or another Party, copies thereof) to such other Party as provided for in <U>Section</U><U></U><U>&nbsp;9.6</U>; it
being understood that if a Party receives a telephone call that relates to the business of the other Party, then the receiving Party shall inform the person making such telephone call to contact the other Party. The provisions of this
<U>Section</U><U></U><U>&nbsp;2.6(d)</U> are not intended to, and shall not, be deemed to constitute an authorization by any Party to permit the other to accept service of process on its behalf and no Party is or shall be deemed to be the agent of
any other Party for service of process purposes. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) With respect to Assets and Liabilities described in
<U>Section</U><U></U><U>&nbsp;2.6(a)</U>, each of Ligand and OmniAb shall, and shall cause the members of its respective Group to, (i)&nbsp;treat for all Tax purposes (A)&nbsp;the deferred Assets as assets having been Transferred to and owned by the
Party entitled to such Assets not later than the Distribution Time and (B)&nbsp;the deferred Liabilities as liabilities having been Assumed and owned by the Person intended to be subject to such Liabilities not later than the Distribution Time and
(ii)&nbsp;neither report nor take any Tax position (on a Tax Return or otherwise) inconsistent with such treatment (unless required by applicable Law or good faith resolution of a Tax Contest). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.7 <U>Conveyancing and Assumption Instruments</U>. In connection with, and in furtherance of, the Transfers of Assets and the
Assumptions of Liabilities contemplated by this Agreement, the Parties shall execute or cause to be executed, on or after the date hereof by the appropriate entities to the extent not executed prior to the date hereof, any Conveyancing and
Assumption Instruments necessary to evidence the valid Transfer to the applicable Party or member of such Party&#146;s Group of all right, title and interest in and to its accepted Assets and the valid and effective Assumption by the applicable
Party of its Assumed Liabilities for Transfers and Assumptions to be effected pursuant to Delaware Law or the Laws of one of the other states of the United States or, if not appropriate for a given Transfer or Assumption, and for Transfers or
Assumptions to be effected pursuant to <FONT STYLE="white-space:nowrap">non-U.S.</FONT> Laws, in such form as the Parties shall reasonably agree, including the Transfer of real property by mutually acceptable conveyance deeds as may be appropriate
and in form and substance as may be required by the jurisdiction in which the real property is located; <U>provided</U>, that the allocation of Assets and Liabilities provided for in any Conveyancing and Assumption Instruments shall be consistent
with the terms of this Agreement, unless otherwise approved in writing by the Parties and APAC . The Transfer of capital stock shall, to the extent necessary to evidence a valid Transfer, be effected by means of executed stock powers and notation on
the stock record books of the corporation or other legal entities involved, or by such other means as may be required in any <FONT STYLE="white-space:nowrap">non-U.S.</FONT> jurisdiction to Transfer title to stock and, only to the extent required by
applicable Law, by notation on public registries. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">27 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.8 <U>Further Assurances; Ancillary Agreements</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) In addition to and without limiting the actions specifically provided for elsewhere in this Agreement and subject to the limitations
expressly set forth in this Agreement, including <U>Section</U><U></U><U>&nbsp;2.6</U>, each of the Parties shall cooperate with each other and use (and shall cause its respective Subsidiaries and Affiliates to use) commercially reasonable efforts,
at and after the Distribution Time, to take, or to cause to be taken, all actions, and to do, or to cause to be done, all things reasonably necessary on its part under applicable Law or contractual obligations to consummate and make effective the
transactions contemplated by this Agreement and the Ancillary Agreements. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Without limiting the foregoing, at and after the
Distribution Time, each Party shall cooperate with the other Party, and without any further consideration, but at the expense of the requesting Party (except as provided in <U>Sections</U><U></U><U>&nbsp;2.2(b)(ii)</U> and <U>2.6(c)</U>) from and
after the Distribution Time, to execute and deliver, or use commercially reasonable efforts to cause to be executed and delivered, all instruments, including instruments of Transfer or title, and to make all filings with, and to obtain all Consents
and/or Governmental Approvals, any permit, license, Contract, indenture or other instrument (including any Consents or Governmental Approvals), and to take all such other actions as such Party may reasonably be requested to take by any other Party
from time to time, consistent with the terms of this Agreement and the Ancillary Agreements, in order to effectuate the provisions and purposes of this Agreement and the Ancillary Agreements and the Transfers of the applicable Assets and the
assignment and Assumption of the applicable Liabilities and the other transactions contemplated hereby and thereby. Without limiting the foregoing, each Party shall, at the reasonable request, cost and expense of any other Party (except as provided
in <U>Sections</U><U></U><U>&nbsp;2.2(b)(ii)</U> and <U>2.6(c)</U>), take such other actions as may be reasonably necessary to vest in such other Party such title and such rights as possessed by the transferring Party to the Assets allocated to such
other Party under this Agreement or any of the Ancillary Agreements, free and clear of any Security Interest. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Without limiting the
foregoing, in the event that any Party (or member of such Party&#146;s Group) receives or retains any Assets (including the receipt of payments made pursuant to Contracts and proceeds from accounts receivable with respect to such Asset) or is liable
for any Liability that is otherwise allocated to any Person that is a member of the other Group pursuant to this Agreement or the Ancillary Agreements, such Party agrees to promptly Transfer, or cause to be Transferred such Asset or Liability to the
other Party so entitled thereto (or member of such other Party&#146;s Group as designated by such other Party) at such other Party&#146;s expense. Prior to any such Transfer, such Asset or Liability, as the case may be, shall be held in accordance
with the provisions of <U>Section</U><U></U><U>&nbsp;2.6</U>. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">28 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) At or prior to the Distribution Time, each of Ligand and OmniAb shall enter into, and/or
(where applicable) shall cause a member or members of their respective Group to enter into, the Ancillary Agreements and any other Contracts reasonably necessary or appropriate in connection with the transactions contemplated hereby and thereby.
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) On or prior to the Distribution Time, Ligand and OmniAb in their respective capacities as direct or indirect stockholders of their
respective Subsidiaries, shall each ratify any actions that are reasonably necessary or desirable to be taken by any Subsidiary of Ligand or Subsidiary of OmniAb, as the case may be, to effectuate the transactions contemplated by this Agreement and
the Ancillary Agreements. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.9 <U>Novation of Liabilities; Indemnification</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Each Party, at the request of any member of the other Party&#146;s Group (such other Party, the &#147;<I>Other Party</I>&#148;), shall use
commercially reasonable efforts (taking into account any applicable restrictions or considerations, in each case relating to the contemplated Tax treatment of the transactions contemplated hereby) to obtain, or to cause to be obtained, any Consent,
Governmental Approval, substitution or amendment required to novate or assign to the fullest extent permitted by applicable Law all obligations under Contracts (other than Shared Contracts, which shall be governed by
<U>Section</U><U></U><U>&nbsp;2.3</U>) and Liabilities (other than with regard to guarantees or Credit Support Instruments, which shall be governed by <U>Section</U><U></U><U>&nbsp;2.10</U>), but solely to the extent that the Parties are jointly or
each severally liable with regard to any such Contracts or Liabilities and such Contracts or Liabilities have been, in whole, but not in part, allocated to the first Party, or, if permitted by applicable Law, to obtain in writing the unconditional
release of the applicable Other Party so that, in any such case, the members of the applicable Group shall be solely responsible for such Contracts or Liabilities; <U>provided</U>, <U>however</U>, that no Party shall be obligated to pay any
consideration therefor to any third party from whom any such Consent, Governmental Approval, substitution or amendment is requested (unless such Party is fully reimbursed by the requesting Party). In addition, with respect to any Action where any
Party hereto is a defendant, when and if requested by such Party, the Other Party at its own cost will use commercially reasonable efforts to remove the requesting Party as a defendant to the extent that such Action relates solely to Assets or
Liabilities that the Other Party (or any member of such requesting Party&#146;s Group) has been allocated pursuant to this <U>Article</U><U></U><U>&nbsp;II</U>, and the Other Party will cooperate and assist in any required communication with any
plaintiff or other related third party. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) If the Parties are unable to obtain, or to cause to be obtained, any such required Consent,
Governmental Approval, release, substitution or amendment referenced in <U>Section</U><U></U><U>&nbsp;2.9(a)</U>, the Other Party or a member of such Other Party&#146;s Group shall continue to be bound by such Contract, license or other obligation
that does not constitute a Liability of such Other Party and, unless not permitted by Law or the terms thereof, as agent or subcontractor for such Party, the Party or member of such Party&#146;s Group who Assumed or retained such Liability as set
forth in this Agreement (the &#147;<I>Liable Party</I>&#148;) shall, or shall cause a member of its Group to, pay, perform and discharge fully all the obligations or other Liabilities of such Other Party or member of such Other Party&#146;s Group
thereunder from and after the Distribution Time. For the avoidance of doubt, in furtherance of the foregoing, the Liable Party or a member of such Liable Party&#146;s Group, as agent or subcontractor of the Other Party or a member of such Other
Party&#146;s Group, to the extent reasonably necessary to pay, perform and discharge fully any Liabilities, or retain the benefits (including pursuant to <U>Section</U><U></U><U>&nbsp;2.6)</U> associated with such Contract or license, is
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">29 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
hereby granted the right to, among other things, (i)&nbsp;prepare, execute and submit invoices under such Contract or license in the name of the Other Party (or the applicable member of such
Other Party&#146;s Group), (ii) send correspondence relating to matters under such Contract or license in the name of the Other Party (or the applicable member of such Other Party&#146;s Group), (iii) file Actions in the name of the Other Party (or
the applicable member of such Other Party&#146;s Group) in connection with such Contract or license and (iv)&nbsp;otherwise exercise all rights in respect of such Contract or license in the name of the Other Party (or the applicable member of such
Other Party&#146;s Group); provided that (y)&nbsp;such actions shall be taken in the name of the Other Party (or the applicable member of such Other Party&#146;s Group) only to the extent reasonably necessary or advisable in connection with the
foregoing and (z)&nbsp;to the extent that there shall be a conflict between the provisions of this <U>Section</U><U></U><U>&nbsp;2.9(b)</U> and the provisions of any more specific arrangement between a member of such Liable Party&#146;s Group and a
member of such Other Party&#146;s Group, such more specific arrangement shall control. The Liable Party shall indemnify each Other Party and hold each of them harmless against any Liabilities (other than Liabilities of such Other Party) arising in
connection therewith; <U>provided</U>, that the Liable Party shall have no obligation to indemnify the Other Party with respect to any matter to the extent that such Liabilities arise from such Other Party&#146;s willful breach, knowing violation of
Law, fraud, misrepresentation or gross negligence in connection therewith, in which case such Other Party shall be responsible for such Liabilities; it being understood that any exercise of rights under this Agreement by such Other Party shall not
be deemed to be willful breach, knowing violation of Law, fraud, misrepresentation or gross negligence. The Other Party shall, without further consideration, promptly pay and remit, or cause to be promptly paid or remitted, to the Liable Party or,
at the direction of the Liable Party, to another member of the Liable Party&#146;s Group, all money, rights and other consideration received by it or any member of its Group in respect of such performance by the Liable Party (unless any such
consideration is an Asset of such Other Party pursuant to this Agreement). If and when any such Consent, Governmental Approval, release, substitution or amendment shall be obtained or such agreement, lease, license or other rights or obligations
shall otherwise become assignable or able to be novated, the Other Party shall, to the fullest extent permitted by applicable Law, promptly Transfer or cause the Transfer of all rights, obligations and other Liabilities thereunder of such Other
Party or any member of such Other Party&#146;s Group to the Liable Party or to another member of the Liable Party&#146;s Group without payment of any further consideration and the Liable Party, or another member of such Liable Party&#146;s Group,
without the payment of any further consideration, shall Assume such rights and Liabilities to the fullest extent permitted by applicable Law. Each of the applicable Parties shall, and shall cause their respective Subsidiaries to, take all actions
and do all things reasonably necessary on its part, or such Subsidiaries&#146; part, under applicable Law or contractual obligations to consummate and make effective the transactions contemplated by this <U>Section</U><U></U><U>&nbsp;2.9</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.10 <U>Guarantees; Credit Support Instruments</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Except as otherwise specified in any Ancillary Agreement, at or prior to the Distribution Time or as soon as practicable thereafter,
(i)&nbsp;Ligand shall (with the reasonable cooperation of the applicable member of the OmniAb Group) use its commercially reasonable efforts to have each member of the OmniAb Group removed as guarantor of or obligor for any Ligand Retained Liability
to the fullest extent permitted by applicable Law, including in respect of those guarantees set forth on <U>Schedule</U><U></U><U>&nbsp;2.10(a)(i)</U>, to the extent that they relate to Ligand Retained Liabilities and (ii)&nbsp;OmniAb shall (with
the reasonable cooperation of the applicable </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">30 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
member of the Ligand Group) use commercially reasonable efforts to have each member of the Ligand Group removed as guarantor of or obligor for any OmniAb Liability, to the fullest extent
permitted by applicable Law, including in respect of those guarantees set forth on <U>Schedule</U><U></U><U>&nbsp;2.10(a)(ii)</U>, to the extent that they relate to OmniAb Liabilities. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) At or prior to the Distribution Time, to the extent required to obtain a release from a guaranty: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) of any member of the Ligand Group, OmniAb shall execute a guaranty agreement substantially in the form of the existing
guaranty or such other form as is agreed to by the relevant parties to such guaranty agreement, except to the extent that such existing guaranty contains representations, covenants or other terms or provisions either (A)&nbsp;with which OmniAb would
be reasonably unable to comply or (B)&nbsp;which would be reasonably expected to be breached; and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) of any member of
the OmniAb Group, Ligand shall execute a guaranty agreement substantially in the form of the existing guaranty or such other form as is agreed to by the relevant parties to such guaranty agreement, except to the extent that such existing guaranty
contains representations, covenants or other terms or provisions either (A)&nbsp;with which Ligand would be reasonably unable to comply or (B)&nbsp;which would be reasonably expected to be breached. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) If Ligand or OmniAb is unable to obtain, or to cause to be obtained, any such required removal as set forth in clauses (a)&nbsp;and (b) of
this <U>Section</U><U></U><U>&nbsp;2.10</U>, (i) Ligand, to the extent a member of the Ligand Group has assumed the underlying Liability with respect to such guaranty or OmniAb, to the extent a member of the OmniAb Group has assumed the underlying
Liability with respect to such guaranty, as the case may be, shall indemnify and hold harmless the guarantor or obligor for any Indemnifiable Loss arising from or relating thereto (in accordance with the provisions of
<U>Article</U><U></U><U>&nbsp;V</U>) and shall or shall cause one of its Subsidiaries, as agent or subcontractor for such guarantor or obligor to pay, perform and discharge fully all the obligations or other Liabilities of such guarantor or obligor
thereunder, (ii)&nbsp;OmniAb shall reimburse the applicable member of the Ligand Group for all <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> expenses incurred by it arising out of or related to any
such guaranty; and (iii)&nbsp;each of Ligand and OmniAb, on behalf of themselves and the members of their respective Groups, agree not to renew or extend the term of, increase its obligations under, or Transfer to a third party, any loan, guaranty,
lease, contract or other obligation for which another Party or member of such Party&#146;s Group is or may be liable without the prior written consent of such other Party, unless all obligations of such other Party and the other members of such
Party&#146;s Group with respect thereto are thereupon terminated by documentation reasonably satisfactory in form and substance to such Party. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) Ligand and OmniAb shall cooperate and OmniAb shall use commercially reasonable efforts to replace all Credit Support Instruments issued by
Ligand or other members of the Ligand Group on behalf of or in favor of any member of the OmniAb Group or the OmniAb Business (the &#147;<I>Ligand CSIs</I>&#148;) as promptly as practicable with Credit Support Instruments from OmniAb or a member of
the OmniAb Group as of the Distribution Time. With respect to any Ligand CSIs that remain outstanding after the Distribution Time, (i)&nbsp;OmniAb shall, and shall cause the members of the OmniAb Group to, jointly and severally indemnify and
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">31 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
hold harmless the Ligand Indemnitees for any Liabilities arising from or relating to such Credit Support Instruments, including, without limitation, any fees in connection with the issuance and
maintenance thereof and any funds drawn by (or for the benefit of), or disbursements made to, the beneficiaries of such Ligand CSIs in accordance with the terms thereof, (ii)&nbsp;OmniAb shall reimburse the applicable member of the Ligand Group for
all out of pocket expenses incurred by it arising out of or related to any such Credit Support Instrument, and (iii)&nbsp;without the prior written consent of Ligand, OmniAb shall not, and shall not permit any member of the OmniAb Group to, enter
into, renew or extend the term of, increase its obligations under, or transfer to a third party, any loan, lease, Contract or other obligation in connection with which Ligand or any member of the Ligand Group has issued any Credit Support
Instruments which remain outstanding. Neither Ligand nor any member of the Ligand Group will have any obligation to renew any Credit Support Instruments issued on behalf of or in favor of any member of the OmniAb Group or the OmniAb Business after
the expiration of any such Credit Support Instrument. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.11 <U>Disclaimer of Representations and Warranties</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) EACH OF LIGAND (ON BEHALF OF ITSELF AND EACH MEMBER OF THE LIGAND GROUP), OMNIAB (ON BEHALF OF ITSELF AND EACH MEMBER OF THE OMNIAB GROUP)
AND APAC UNDERSTANDS AND AGREES THAT, EXCEPT AS EXPRESSLY SET FORTH HEREIN, IN ANY ANCILLARY AGREEMENT OR IN ANY CONTINUING ARRANGEMENT, NO PARTY TO THIS AGREEMENT, ANY ANCILLARY AGREEMENT OR ANY OTHER AGREEMENT OR DOCUMENT CONTEMPLATED BY THIS
AGREEMENT, ANY ANCILLARY AGREEMENTS OR OTHERWISE, IS REPRESENTING OR WARRANTING IN ANY WAY, AND HEREBY DISCLAIMS ALL REPRESENTATIONS AND WARRANTIES, AS TO THE ASSETS, BUSINESSES OR LIABILITIES CONTRIBUTED, TRANSFERRED OR ASSUMED AS CONTEMPLATED
HEREBY OR THEREBY, AS TO ANY CONSENTS OR GOVERNMENTAL APPROVALS REQUIRED IN CONNECTION HEREWITH OR THEREWITH, AS TO THE VALUE OR FREEDOM FROM ANY SECURITY INTERESTS OF, AS TO NONINFRINGEMENT, VALIDITY OR ENFORCEABILITY OR ANY OTHER MATTER
CONCERNING, ANY ASSETS OR BUSINESS OF SUCH PARTY, OR AS TO THE ABSENCE OF ANY DEFENSES OR RIGHT OF SETOFF OR FREEDOM FROM COUNTERCLAIM WITH RESPECT TO ANY ACTION OR OTHER ASSET, INCLUDING ACCOUNTS RECEIVABLE, OF ANY PARTY, OR AS TO THE LEGAL
SUFFICIENCY OF ANY CONTRIBUTION, ASSIGNMENT, DOCUMENT, CERTIFICATE OR INSTRUMENT DELIVERED HEREUNDER TO CONVEY TITLE TO ANY ASSET OR THING OF VALUE UPON THE EXECUTION, DELIVERY AND FILING HEREOF OR THEREOF. FOR THE AVOIDANCE OF DOUBT, THIS
<U>SECTION 2.11</U> SHALL HAVE NO EFFECT ON ANY REPRESENTATION OR WARRANTY MADE HEREIN, IN THE MERGER AGREEMENT OR IN ANY ANCILLARY AGREEMENT OR ANY OTHER AGREEMENT OR DOCUMENT CONTEMPLATED BY THIS AGREEMENT, THE MERGER AGREEMENT OR ANY ANCILLARY
AGREEMENT. EXCEPT AS MAY EXPRESSLY BE SET FORTH HEREIN OR THEREIN, ALL SUCH ASSETS ARE BEING TRANSFERRED ON AN &#147;<U>AS IS, WHERE IS</U>&#148; BASIS (AND, IN THE CASE OF ANY REAL PROPERTY, BY MEANS OF A QUITCLAIM OR SIMILAR FORM DEED OR
CONVEYANCE) AND THE RESPECTIVE TRANSFEREES SHALL BEAR THE ECONOMIC AND LEGAL RISKS THAT (I)&nbsp;ANY </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">32 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
CONVEYANCE SHALL PROVE TO BE INSUFFICIENT TO VEST IN THE TRANSFEREE GOOD TITLE, FREE AND CLEAR OF ANY SECURITY INTEREST AND (II)&nbsp;ANY NECESSARY CONSENTS OR GOVERNMENTAL APPROVALS ARE NOT
OBTAINED OR THAT ANY REQUIREMENTS OF LAWS OR JUDGMENTS ARE NOT COMPLIED WITH. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Each of Ligand (on behalf of itself and each member of
the Ligand Group), OmniAb (on behalf of itself and each member of the OmniAb Group) and APAC further understands and agrees that if the disclaimer of express or implied representations and warranties contained in
<U>Section</U><U></U><U>&nbsp;2.11(a)</U> is held unenforceable or is unavailable for any reason under the Laws of any jurisdiction outside the United States or if, under the Laws of a jurisdiction outside the United States, both Ligand or any
member of the Ligand Group, on the one hand, and OmniAb or any member of the OmniAb Group, on the other hand, are jointly or severally liable for any Ligand Retained Liability or any OmniAb Liability, respectively, then, the Parties and APAC intend
that, notwithstanding any provision to the contrary under the Laws of such foreign jurisdictions, the provisions of this Agreement, the Merger Agreement and the Ancillary Agreements (including the disclaimer of all representations and warranties
(except as otherwise provided in any such agreements), allocation of Liabilities among the Parties and their respective Subsidiaries, releases, indemnification and contribution of Liabilities) shall prevail for any and all purposes among the Parties
and APAC and their respective Subsidiaries. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) OmniAb hereby waives compliance by Ligand and each and every member of the Ligand Group
with the requirements and provisions of any &#147;bulk-sale&#148; or &#147;bulk transfer&#148; Laws of any jurisdiction that may otherwise be applicable with respect to the transfer or sale of any or all of the OmniAb Assets to OmniAb or any member
of the OmniAb Group. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.12 <U>Cash Management; Consideration</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Except as provided in this <U>Section</U><U></U><U>&nbsp;2.12</U>, all cash and Cash Equivalents held by any member of the OmniAb Group as
of the Distribution Time shall be an OmniAb Asset and all cash and Cash Equivalents held by any member of the Ligand Group as of the Distribution Time shall be a Ligand Retained Asset. To the extent that following the Distribution Time any Cash
Equivalents are required to be transferred from any member of the Ligand Group to any member of the OmniAb Group or from any member of the OmniAb Group to any member of the Ligand Group to make effective the Internal Reorganization or the
Contribution pursuant to this Agreement and the Ancillary Agreements (including if required by Law or regulation to effect the foregoing), the Party receiving such Cash Equivalents shall promptly transfer an amount in cash equal to such transferred
Cash Equivalents back to the transferring Party so as not to override the allocations of Assets, Liabilities and expenses related to the Internal Reorganization and the Contribution contemplated by this Agreement and the Ancillary Agreements. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) In exchange for the Contribution, OmniAb agrees, on or prior to the Distribution Date, to issue to Ligand a number of newly issued, fully
paid and nonassessable shares of OmniAb Stock as is necessary to effect the Distribution and such that immediately following the Distribution Ligand will hold none of the outstanding shares of OmniAb Stock. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">33 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Notwithstanding anything to the contrary in this Agreement, the Merger Agreement or any
Ancillary Document, and except as otherwise provided in Section&nbsp;9.5 (relating to Reimbursable Transaction-related Expenses) or the Tax Matters Agreement (relating to Taxes), (i) Ligand shall have all rights to and shall retain all payments
received or accrued by it, any member of the Ligand Group or any member of the OmniAb Group at any time up to and until the Distribution Time relating to current accounts receivable of any member of the OmniAb Group (such current accounts receivable
being included in Ligand Retained Assets), and (ii)&nbsp;Ligand shall pay all costs and expenses relating to current accounts payable and current accrued liabilities of any member of the OmniAb Group that are outstanding or accrued at any time up to
and until the Distribution Time (such current accounts payable and current accrued liabilities being included in Ligand Retained Liabilities). For illustrative purposes only, an example showing such current accounts receivable, accounts payable and
accrued liabilities being retained by Ligand is attached to this Agreement as <U>Exhibit B</U>. Notwithstanding the foregoing and anything to the contrary in this Agreement, the Merger Agreement or any Ancillary Document, the cash portion of the
Contribution to be made by Ligand in connection with the Separation shall be (i)&nbsp;increased by any amounts received by any member of the Ligand Group or the OmniAb Group that is actually retained by any member of the Ligand Group in respect of a
Commercial Milestone Event (as defined in that certain Platform License Agreement, by and between Open Monoclonal Technologies Inc. and CNA Development LLC, dated as of October&nbsp;4, 2013) (the &#147;<I>Specific Milestone Payments</I>&#148;) (such
amounts being included in OmniAb Assets) and (ii)&nbsp;decreased by those certain costs and expenses relating solely to the OmniAb Business paid by Ligand through and including the Distribution Date that are set forth on Schedule 2.12(c) (the
&#147;<I>Other Reimbursable Expenses</I>&#148;) (such costs and expenses being included in OmniAb Liabilities). </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE III </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>COMPLETION OF THE DISTRIBUTION </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.1 <U>Actions Prior to the Distribution</U>. Prior to the Distribution Time, subject to the terms and conditions set forth
herein, the Parties shall take, or cause to be taken, the following actions in connection with the Distribution:<SUP STYLE="font-size:85%; vertical-align:top"> </SUP> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <U>Notice to Nasdaq</U>. Ligand shall give Nasdaq not less than ten (10)&nbsp;days&#146; advance notice of the Record Date in compliance
with Rule <FONT STYLE="white-space:nowrap">10b-17</FONT> under the Exchange Act. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <U>Securities Law Matters</U>. OmniAb shall file with
the Commission any amendments or supplements to the Form 10 as may be necessary or advisable in order to cause the Form 10 to become and remain effective as required by the Commission or federal, state or other applicable securities Laws. Ligand and
OmniAb shall take all such action as may be necessary or advisable under the securities or &#147;blue sky&#148; Laws of the United States (and any comparable Laws under any <FONT STYLE="white-space:nowrap">non-U.S.</FONT> jurisdiction) in connection
with the transactions contemplated by this Agreement, the Merger Agreement and the Ancillary Agreements. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) <U>Authorized Number of
Shares</U>. Prior to the Distribution, the Parties shall take all necessary action required to file an amendment to the Certificate of Incorporation of OmniAb with the Secretary of State of the State of Delaware to increase the number of authorized
shares of OmniAb Stock so that OmniAb Stock then authorized shall be equal to the number of shares of OmniAb Stock necessary to effect the Distribution. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">34 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) <U>Availability of Information</U>. Ligand shall, as soon as is reasonably practicable
after the Form 10 is declared effective under the Exchange Act and the Ligand Board has approved the Distribution, cause the Information Statement to be mailed to the Record Holders or, in connection with the delivery of a notice of Internet
availability of the Information Statement to such holders, posted on the Internet. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) <U>The Distribution Agent</U>. Ligand shall enter
into a distribution agent agreement with the Agent or otherwise provide instructions to the Agent regarding the Distribution. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f)
<U>Officers and Directors</U>. At or prior to the Distribution Time, the Parties shall take all necessary action so that, as of the Distribution Time, the executive officers and directors of OmniAb will be as set forth in the Information Statement.
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) <U>Satisfying Conditions to the Distribution</U>. Each of Ligand, OmniAb and APAC shall cooperate to cause the conditions to the
Distribution set forth in <U>Section</U><U></U><U>&nbsp;3.3</U> to be satisfied and to effect the Distribution at the Distribution Time. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h) <U>Resignations and Removals</U>. On or prior to the Distribution Date or as soon thereafter as practicable, (i)&nbsp;Ligand shall cause
all its employees and any employees of its Subsidiaries (excluding any employees of any member of the OmniAb Group) to resign or be removed, effective as of the Distribution Time, from all positions as officers or directors of any member of the
OmniAb Group in which they serve, and (ii)&nbsp;OmniAb shall cause all its employees and any employees of its Subsidiaries to resign, effective as of the Distribution Time, from all positions as officers or directors of any members of the Ligand
Group in which they serve. Notwithstanding the foregoing, no Person shall be required by any Party to resign from any position or office with another Party if such Person is disclosed in the Form 10 as a Person who is to hold such position or office
following the Distribution. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) <U>Contribution</U>. On or prior to the Distribution Date, the Contribution shall have been made. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.2 <U>Effecting the Distribution</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <U>Delivery of OmniAb Stock</U>. Upon consummation of the Distribution, Ligand shall deliver to the Agent, a book-entry authorization
representing the OmniAb Stock being distributed in the Distribution for the account of the Record Holders and shall take all such other actions (including delivering any other instruments of transfer required by applicable law) as may be necessary
to effect the Distribution. The Agent shall hold such book-entry shares for the account of the Record Holders pending the Merger, as provided in Section&nbsp;3.2 of the Merger Agreement. Immediately after the Distribution Time and prior to the
Effective Time, the shares of OmniAb Stock shall not be transferable and the transfer agent for the OmniAb Stock shall not transfer any shares of OmniAb Stock; <U>provided</U>, for the avoidance of doubt, that the exchange of such shares of OmniAb
Stock for shares of Domesticated Parent Common Stock pursuant to the Merger shall not be deemed a transfer subject to the foregoing restrictions. The Distribution shall be deemed to be effective at the Distribution Time upon written authorization
from Ligand to the Agent to proceed with the Distribution. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">35 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.3 <U>Conditions to the Distribution</U>. The consummation of the Distribution
shall be subject to the satisfaction or waiver by Ligand in its sole and absolute discretion, of the following conditions (other than the condition set forth in <U>Section</U><U></U><U>&nbsp;3.3(a)</U>, which prior to the termination of the Merger
Agreement may not be waived without APAC&#146;s written consent, which consent shall not be unreasonably withheld, conditioned or delayed): </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <U>Completion of the Separation</U>. The Separation shall have been completed substantially in accordance with the Reorganization Plan,
other than any Transfers and Assumptions or other actions that may occur after the Distribution Time in accordance with the terms of this Agreement. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <U>Execution of Ancillary Agreements</U>. Each of the Ancillary Agreements shall have been duly executed and delivered by the parties
thereto. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) <U>Conditions to Ligand Obligations in Merger Agreement</U>. Each of the conditions in Section&nbsp;8.1 (other than
Section&nbsp;8.1(b)) and Section&nbsp;8.2 of the Merger Agreement to Ligand&#146;s obligations to consummate the Merger shall have been satisfied or waived (other than those conditions that by their nature are to be satisfied contemporaneously with
the Distribution and/or the Merger; <U>provided</U>, that such conditions are capable of being satisfied at such time). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d)
<U>Confirmation of Satisfaction of APAC Conditions in Merger Agreement</U>. APAC shall have irrevocably confirmed to Ligand that each condition in Section&nbsp;8.1 (other than Section&nbsp;8.1(b)) and Section&nbsp;8.3 of the Merger Agreement to
APAC&#146;s obligations to consummate the Merger (i)&nbsp;has been satisfied, (ii)&nbsp;will be satisfied at the time of the Distribution, or (iii)&nbsp;subject to applicable Law, is or has been waived by APAC. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE IV </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>CERTAIN
COVENANTS </U></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.1 <U>Cooperation</U>. From and after the Distribution Time, and subject to the terms of and limitations
contained in this Agreement and the Ancillary Agreements, each Party shall, and shall cause each of its respective Affiliates and employees to, (i)&nbsp;provide reasonable cooperation and assistance to the other Party (and any member of its
respective Group) in connection with the completion of the transactions contemplated herein and in each Ancillary Agreement, (ii)&nbsp;reasonably assist the other Party in the orderly and efficient transition in becoming a separate company to the
extent set forth in the Transition Services Agreements or as otherwise set forth herein (including, but not limited to, complying with <U>Articles V</U>, <U>VI</U> and <U>VIII</U>) and (iii)&nbsp;reasonably assist the other Party to the extent such
Party is providing or has provided services, as applicable, pursuant to the Transition Services Agreements in connection with requests for information from, audits or other examinations of, such other Party by a Governmental Entity; in each case,
except as otherwise set forth in this Agreement or may otherwise be agreed to by the Parties in writing, at no additional cost to the Party requesting such assistance other than for the actual <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> costs (which shall not include the costs of salaries and benefits of employees of such Party or any pro rata portion of overhead or other costs of employing such employees which would have been
incurred by such employees&#146; employer regardless of the employees&#146; service with respect to the foregoing) incurred by any such Party, if applicable. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">36 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.2 <U>Retained Names</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) No later than ninety (90)&nbsp;days following the Distribution Date, OmniAb shall, and shall cause the members of the OmniAb Group, to
change their respective names and cause their certificates of incorporation and bylaws (or equivalent organizational documents), as applicable, to be amended to remove the Ligand Retained Names. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Subject to <U>Section</U><U></U><U>&nbsp;4.2(c),</U> following the Distribution Date, unless otherwise directed by Ligand in writing,
OmniAb shall, and shall cause the members of the OmniAb Group to, as soon as reasonably practicable, but in no event later than six (6)&nbsp;months following the Distribution Date, cease to make any use of any Ligand Retained Names. In furtherance
thereof, as soon as reasonably practicable but in no event later than six (6)&nbsp;months following the Distribution Date, OmniAb shall, and shall cause the members of the OmniAb Group, to remove, strike over, or otherwise obliterate all Ligand
Retained Names from all assets and other materials owned by or in the possession of any member of the OmniAb Group, including any vehicles, business cards, schedules, stationery, packaging materials, displays, signs, promotional materials, manuals,
forms, websites, email, Software and other materials and systems. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Notwithstanding anything to the contrary in this
<U>Section</U><U></U><U>&nbsp;4.2</U>, no member of the OmniAb Group shall (i)&nbsp;be obligated to cease using or displaying any of the Ligand Retained Names on any <FONT STYLE="white-space:nowrap">(A)&nbsp;non-public-facing,</FONT> <FONT
STYLE="white-space:nowrap">non-customer</FONT> facing and <FONT STYLE="white-space:nowrap">non-vendor</FONT> facing documents or materials or (B)&nbsp;executed copies of any Contract, in each case of (A)&nbsp;and (B), in existence, used or
disseminated as of the Distribution Date which bear any of the Ligand Retained Names, or (ii)&nbsp;be in breach of this <U>Section</U><U></U><U>&nbsp;4.2</U> if, after the Distribution Date, it (x)&nbsp;uses any of the Ligand Retained Names in a
nominative manner in textual sentences referencing the historical relationship between Ligand and the Ligand Group, on the one hand, and the OmniAb Group, on the other hand, which references are factually accurate and reasonably necessary to
describe such historical relationship, (y)&nbsp;retains any copies of any books, records or other materials that, as of the Distribution Date, contain or display any of the Ligand Retained Names and such copies are used solely for internal or
archival purposes (and not public display) or (z)&nbsp;uses any of the Ligand Retained Names to comply with applicable Laws or stock exchange regulations or for litigation, regulatory or corporate filings and documents filed by a member of the
OmniAb Group or any of its Affiliates with any Governmental Entity. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) Ligand hereby grants to the OmniAb Group a <FONT
STYLE="white-space:nowrap">non-exclusive,</FONT> royalty-free, <FONT STYLE="white-space:nowrap">non-transferable,</FONT> license to use and display the Ligand Retained Names for the periods set forth in this <U>Section</U><U></U><U>&nbsp;4.2</U> as
permitted by this <U>Section</U><U></U><U>&nbsp;4.2</U> in connection with the transactions contemplated herein. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">37 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) Any and all use of the Ligand Retained Names by the OmniAb Group and the goodwill
afforded thereby shall inure to the sole benefit of Ligand. Any use by the members of the OmniAb Group of any of the Ligand Retained Names as permitted in this <U>Section</U><U></U><U>&nbsp;4.2</U> is subject to their use of the Ligand Retained
Names in a form and manner, and with standards of quality, of that in effect for the Ligand Retained Names as of the Distribution Date. OmniAb and the other members of the OmniAb Group shall not use the Ligand Retained Names in a manner that
reflects negatively on the Ligand Retained Names or on Ligand or any member of the Ligand Group. Upon expiration or termination of the rights granted to the OmniAb Group pursuant to this Section&nbsp;4.2, OmniAb hereby assigns, and shall cause the
other members of the OmniAb Group to assign, to Ligand their respective rights (if any) to any Trademarks forming a part of the Ligand Retained Names. Ligand shall have the right to terminate the foregoing license, effective immediately, if any
member of the OmniAb Group fails to comply with the foregoing terms and conditions in this Section&nbsp;4.2 in any material respect or otherwise fails to comply with any reasonable written direction of Ligand in relation to any member of the OmniAb
Group&#146;s use of the Ligand Retained Names, and, in each case, such member of the OmniAb Group has not cured such failure within thirty (30)&nbsp;days after such member of the OmniAb Group&#146;s receipt of written notice from Ligand of such
failure. OmniAb shall indemnify, defend and hold harmless Ligand and the members of the Ligand Group from and against any and all Indemnifiable Losses arising from or relating to the use by any member of the OmniAb Group of the Ligand Retained Names
pursuant to this <U>Section</U><U></U><U>&nbsp;4.2</U>. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) Each of the Parties acknowledges and agrees that the remedy at Law for any
breach of the requirements of this <U>Section</U><U></U><U>&nbsp;4.2</U> would be inadequate and agrees and consents that without intending to limit any additional remedies that may be available, Ligand and the members of the Ligand Group shall be
entitled to a temporary or permanent injunction, without proof of actual damage or inadequacy of legal remedy, and without posting any bond or other undertaking, in any Action which may be brought to enforce any of the provisions of this
<U>Section</U><U></U><U>&nbsp;4.2</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.3 <U>Ligand Limited License</U><U> Grant</U>. Solely to the extent that any Patents
or <FONT STYLE="white-space:nowrap">Know-How</FONT> owned by any member of the Ligand Group are used, practiced or otherwise exploited in the OmniAb Business immediately prior to the Distribution Time, Ligand hereby grants, on behalf of itself and
each member of the Ligand Group, to each member of the OmniAb Group, a royalty-free, fully <FONT STYLE="white-space:nowrap">paid-up,</FONT> perpetual, irrevocable, <FONT STYLE="white-space:nowrap">non-sublicensable</FONT> (except to subcontractors),
<FONT STYLE="white-space:nowrap">non-transferable</FONT> (except in connection with the transfer of all or substantially all of (i)&nbsp;the assets of the OmniAb Business or (ii)&nbsp;the capital stock of OmniAb), worldwide, <FONT
STYLE="white-space:nowrap">non-exclusive</FONT> license in, to and under such Patents or <FONT STYLE="white-space:nowrap">Know-How</FONT> to use, practice and otherwise exploit such Patents and <FONT STYLE="white-space:nowrap">Know-How</FONT> solely
in or for the conduct of the OmniAb Business as conducted on or prior to the Distribution Time (and natural evolutions thereof). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.4 <U>No Restriction on Competition</U>. It is the explicit intent of each of the Parties that the provisions of this Agreement
shall not include any <FONT STYLE="white-space:nowrap">non-competition</FONT> or other similar restrictive arrangements with respect to the range of business activities which may be conducted by the Parties. Accordingly, each of the Parties
acknowledges and agrees that nothing set forth in this Agreement shall be construed to create any explicit or implied restriction or other limitation on (i)&nbsp;the ability of any party hereto to engage in any business or other activity which
competes with the business of any other Party hereto or (ii)&nbsp;the ability of any party to engage in any specific line of business or engage in any business activity in any specific geographic area. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">38 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE V </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>INDEMNIFICATION </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.1 <U>Release of <FONT STYLE="white-space:nowrap">Pre-Distribution</FONT> Claims</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Except (i)&nbsp;as provided in <U>Section</U><U></U><U>&nbsp;5.1(b)</U>, (ii) as may be otherwise expressly provided in this Agreement or
in any Ancillary Agreement and (iii)&nbsp;for any matter for which any Party is entitled to indemnification pursuant to this <U>Article</U><U></U><U>&nbsp;V</U>: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) Ligand, for itself and each member of the Ligand Group, its Affiliates as of the Distribution Time and, to the extent
permitted by Law, all Persons who at any time prior to the Distribution Time were directors, officers, agents or employees of any member of the Ligand Group (in their respective capacities as such), in each case, together with their respective
heirs, executors, administrators, successors and assigns, does hereby remise, release and forever discharge OmniAb and the other members of the OmniAb Group, its Affiliates and all Persons who at any time prior to the Distribution Time were
stockholders, directors, officers, agents or employees of any member of the OmniAb Group (in their respective capacities as such), in each case, together with their respective heirs, executors, administrators, successors and assigns, from any and
all Ligand Retained Liabilities, whether at Law or in equity (including any right of contribution), whether arising under any Contract, by operation of Law or otherwise, in each case, existing or arising from any acts or events occurring or failing
to occur or alleged to have occurred or to have failed to occur or any conditions existing or alleged to have existed at or before the Distribution Time, including in connection with the Internal Reorganization, the Separation, the Distribution, the
Merger and any of the other transactions contemplated hereunder and under the Merger Agreement and the Ancillary Agreements (such liabilities, the &#147;<I>Ligand Released Liabilities</I>&#148;) and in any event shall not, and shall cause its
respective Subsidiaries not to, bring any Action against any member of the OmniAb Groups in respect of any Ligand Released Liabilities; <U>provided</U>, <U>however</U>, that nothing in this <U>Section</U><U></U><U>&nbsp;5.1(a)(i)</U> shall relieve
any Person released in this <U>Section</U><U></U><U>&nbsp;5.1(a)(i)</U> who, after the Distribution Time, is a director, officer or employee of any member of the OmniAb Group and is no longer a director, officer or employee of any member of the
Ligand Group from Liabilities arising out of, relating to or resulting from his or her service as a director, officer or employee of any member of the OmniAb Group after the Distribution Time. Notwithstanding the foregoing, nothing in this Agreement
shall be deemed to limit Ligand, any member of the Ligand Group, or their respective Affiliates from commencing any Actions against any OmniAb officer, director, agent or employee, or their respective heirs, executors, administrators, successors and
assigns with regard to matters arising from, or relating to, (i)&nbsp;theft of Ligand Trade Secrets or (ii)&nbsp;intentional criminal acts by any such officers, directors, agents or employees. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) OmniAb, for itself and each member of the OmniAb Group, its Affiliates as of the Distribution Time and, to the extent
permitted by Law, all Persons who at any time prior to the Distribution Time were directors, officers, agents or employees of any member of the OmniAb Group (in their respective capacities as such), in each case, together with their respective
heirs, executors, administrators, successors </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">39 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
and assigns, does hereby remise, release and forever discharge Ligand and the other members of the Ligand Group, its Affiliates and all Persons who at any time prior to the Distribution Time were
stockholders, directors, officers, agents or employees of any member of the Ligand Group (in their respective capacities as such), in each case, together with their respective heirs, executors, administrators, successors and assigns, from any and
all OmniAb Liabilities, whether at Law or in equity (including any right of contribution), whether arising under any Contract, by operation of Law or otherwise, in each case, existing or arising from any acts or events occurring or failing to occur
or alleged to have occurred or to have failed to occur or any conditions existing or alleged to have existed at or before the Distribution Time, including in connection with the Internal Reorganization, the Separation, the Distribution, the Merger
and any of the other transactions contemplated hereunder and under the Merger Agreement and the Ancillary Agreements (such liabilities, the &#147;<I>OmniAb Released Liabilities</I>&#148;) and in any event shall not, and shall cause its respective
Subsidiaries not to, bring any Action against any member of the Ligand Group in respect of any OmniAb Released Liabilities; <U>provided</U>, <U>however</U> that for purposes of this <U>Section</U><U></U><U>&nbsp;5.1(a)(ii)</U>, the members of the
OmniAb Group shall also release and discharge any officers or other employees of any member of the Ligand Group, to the extent any such officers or employees served as a director or officer of any members of the OmniAb Group prior to the
Distribution Time, from any and all Liability, obligation or responsibility for any and all past actions or failures to take action, in each case in their capacity as a director or officer of any such member of the OmniAb Group, prior to the
Distribution Time, including actions or failures to take action that may be deemed to have been negligent or grossly negligent. Notwithstanding the foregoing, nothing in this Agreement shall be deemed to limit OmniAb, any member of the OmniAb Group,
or their respective Affiliates from commencing any Actions against any Ligand officer, director, agent or employee, or their respective heirs, executors, administrators, successors and assigns with regard to matters arising from, or relating to,
(i)&nbsp;theft of OmniAb Trade Secrets or (ii)&nbsp;intentional criminal acts by any such officers, directors, agents or employees. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iii) APAC, for itself and each of its Affiliates as of the Distribution Time and, to the extent permitted by Law, all Persons
who at any time prior to the Distribution Time were directors, officers, agents or employees of APAC or any of its Affiliates (in their respective capacities as such), in each case, together with their respective heirs, executors, administrators,
successors and assigns, does hereby remise, release and forever discharge Ligand and the other members of the Ligand Group, its Affiliates and all Persons who at any time prior to the Distribution Time were stockholders, directors, officers, agents
or employees of any member of the Ligand Group (in their respective capacities as such), in each case, together with their respective heirs, executors, administrators, successors and assigns, from any and all OmniAb Liabilities, whether at Law or in
equity (including any right of contribution), whether arising under any Contract, by operation of Law or otherwise, in each case, existing or arising from any acts or events occurring or failing to occur or alleged to have occurred or to have failed
to occur or any conditions existing or alleged to have existed at or before the Distribution Time, including in connection with the Internal Reorganization, the Separation, the Distribution, the Merger and any of the other transactions contemplated
hereunder and under the Merger Agreement and the Ancillary Agreements (such </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">40 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
liabilities, the &#147;<I>APAC Released Liabilities</I>&#148;) and in any event shall not, and shall cause its respective Subsidiaries not to, bring any Action against any member of the Ligand
Group in respect of any APAC Released Liabilities; <U>provided</U>, <U>however</U> that for purposes of this <U>Section</U><U></U><U>&nbsp;5.1(a)(iii)</U>, APAC and each of its Affiliates shall also release and discharge any officers or other
employees of any member of the Ligand Group, to the extent any such officers or employees served as a director or officer of any members of the OmniAb Group prior to the Distribution Time, from any and all Liability, obligation or responsibility for
any and all past actions or failures to take action, in each case in their capacity as a director or officer of any such member of the OmniAb Group, prior to the Distribution Time, including actions or failures to take action that may be deemed to
have been negligent or grossly negligent. Notwithstanding the foregoing, nothing in this Agreement shall be deemed to limit APAC or any of its Affiliates from commencing any Actions against any Ligand officer, director, agent or employee, or their
respective heirs, executors, administrators, successors and assigns with regard to matters arising from, or relating to, (i)&nbsp;theft of OmniAb Trade Secrets or (ii)&nbsp;intentional criminal acts by any such officers, directors, agents or
employees. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Nothing contained in this Agreement, including <U>Section</U><U></U><U>&nbsp;5.1(a)</U> or
<U>Section</U><U></U><U>&nbsp;2.5</U>, shall impair or otherwise affect any right of any Party or APAC and, as applicable, a member of such Party&#146;s Group or any of its Affiliates, as well as their respective heirs, executors, administrators,
successors and assigns, to enforce this Agreement, the Merger Agreement any Ancillary Agreement or any agreements, arrangements, commitments or understandings contemplated in this Agreement, the Merger Agreement or in any Ancillary Agreement to
continue in effect after the Distribution Time. In addition, nothing contained in <U>Section</U><U></U><U>&nbsp;5.1(a)</U> shall release any person from: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) any Liability Assumed, Transferred or allocated to a Party or a member of such Party&#146;s Group pursuant to or as
contemplated by, or any other Liability of any member of such Group under, this Agreement or any Ancillary Agreement, including (A)&nbsp;with respect to Ligand, any Ligand Retained Liability and (B)&nbsp;with respect to OmniAb, any OmniAb Liability;
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) any Liability provided for in or resulting from any other Contract or arrangement that is entered into after the
Distribution Time between any Party (and/or a member of such Party&#146;s or Parties&#146; Group), on the one hand, and any other Party or Parties (and/or a member of such Party&#146;s or Parties&#146; Group), on the other hand; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iii) any Liability with respect to any Continuing Arrangements; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iv) any Liability that the Parties may have with respect to indemnification pursuant to this Agreement or otherwise for
Actions brought against the Parties by third Persons, which Liability shall be governed by the provisions of this Agreement and, in particular, this <U>Article</U><U></U><U>&nbsp;V</U> and, if applicable, the appropriate provisions of the Ancillary
Agreements; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(v) the obligations of Ligand, OmniAb, APAC or the other parties to the Merger Agreement to consummate the
Merger and the other transactions expressly contemplated to occur at the Closing, subject to the terms and conditions of the Merger Agreement; and </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">41 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(vi) any Liability the release of which would result in a release of any
Person other than the Persons released in <U>Section</U><U></U><U>&nbsp;5.1(a)</U>; <U>provided</U> that the Parties and APAC agree not to bring any Action or permit any other member of their respective Group or any of their Affiliates to bring any
Action against a Person released in <U>Section</U><U></U><U>&nbsp;5.1(a)</U> with respect to such Liability. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition, nothing contained in
<U>Section</U><U></U><U>&nbsp;5.1(a)</U> shall release: (i)&nbsp;Ligand from indemnifying any director, officer or employee of the OmniAb Group who was a director, officer or employee of Ligand or any of its Affiliates prior to the Distribution
Time, as the case may be, to the extent such director, officer or employee is or becomes a named defendant in any Action with respect to which he or she was entitled to such indemnification pursuant to then-existing obligations; it being understood
that if the underlying obligation giving rise to such Action is an OmniAb Liability, OmniAb shall indemnify Ligand for such Liability (including Ligand&#146;s costs to indemnify the director, officer or employee) in accordance with the provisions
set forth in this <U>Article</U><U></U><U>&nbsp;V</U>; and (ii)&nbsp;OmniAb from indemnifying any director, officer or employee of the Ligand Group who was a director, officer or employee of OmniAb or any of its Affiliates prior to the Distribution
Time, as the case may be, to the extent such director, officer or employee is or becomes a named defendant in any Action with respect to which he or she was entitled to such indemnification pursuant to then-existing obligations; it being understood
that if the underlying obligation giving rise to such Action is a Ligand Retained Liability, Ligand shall indemnify OmniAb for such Liability (including OmniAb&#146;s costs to indemnify the director, officer or employee) in accordance with the
provisions set forth in this <U>Article</U><U></U><U>&nbsp;V</U>. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Each Party and APAC shall not, and shall not permit any member of
its Group or any of their respective Affiliates to, make any claim for offset, or commence any Action, including any claim of contribution or any indemnification, against any other Party or APAC or any member of any other Party&#146;s Group or their
respective Affiliates, or any other Person released pursuant to <U>Section</U><U></U><U>&nbsp;5.1(a)</U>, with respect to any Liabilities released pursuant to <U>Section</U><U></U><U>&nbsp;5.1(a)</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) If any Person associated with a Party or APAC (including any director, officer or employee of a Party or APAC) initiates any Action with
respect to claims released by this <U>Section</U><U></U><U>&nbsp;5.1</U>, the Party or APAC with which such Person is associated shall be responsible for the fees and expenses of counsel of the other Party or APAC, as the case may be (and/or the
members of such Party&#146;s Group or their Affiliates, as applicable) and such other Party or APAC, as the case may be, shall be indemnified for all Liabilities incurred in connection with such Action in accordance with the provisions set forth in
this <U>Article</U><U></U><U>&nbsp;V</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.2 <U>Indemnification by Ligand</U>. In addition to any other provisions of this
Agreement requiring indemnification and except as otherwise specifically set forth in any provision of this Agreement or of any Ancillary Agreement, following the Distribution Time, Ligand shall indemnify, defend and hold harmless the OmniAb
Indemnitees from and against any and all Indemnifiable Losses of the OmniAb Indemnitees to the extent relating to, arising out of, by reason of or otherwise in connection with (a)&nbsp;the Ligand Retained Liabilities, including the
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">42 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
failure of any member of the Ligand Group or any other Person to pay, perform or otherwise discharge any Ligand Retained Liability in accordance with its respective terms, whether arising prior
to, at or after the Distribution Time, (b)&nbsp;any Ligand Retained Asset or Ligand Retained Business, whether arising prior to, at or after the Distribution Time, or (c)&nbsp;any breach by Ligand of any provision of this Agreement or any Ancillary
Agreement unless such Ancillary Agreement expressly provides for separate indemnification therein, in which case any such indemnification claims shall be made thereunder. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.3 <U>Indemnification by OmniAb and APAC</U>. In addition to any other provisions of this Agreement requiring indemnification
and except as otherwise specifically set forth in any provision of this Agreement or of any Ancillary Agreement, following the Distribution Time, OmniAb shall and shall cause the other members of the OmniAb Group to indemnify, defend and hold
harmless the Ligand Indemnitees from and against any and all Indemnifiable Losses of the Ligand Indemnitees to the extent relating to, arising out of, by reason of or otherwise in connection with (a)&nbsp;the OmniAb Liabilities, including the
failure of any member of the OmniAb Group or any other Person to pay, perform or otherwise discharge any OmniAb Liability in accordance with its respective terms, whether prior to, at or after the Distribution Time, (b)&nbsp;any OmniAb Asset or
OmniAb Business, whether arising prior to, at or after the Distribution Time, or (c)&nbsp;any breach by OmniAb of any provision of this Agreement or any Ancillary Agreement unless such Ancillary Agreement expressly provides for separate
indemnification therein, in which case any such indemnification claims shall be made thereunder. From and following the Closing, APAC shall and shall cause its Subsidiaries to indemnify, defend and hold harmless the Ligand Indemnitees from and
against any and all Indemnifiable Losses of the Ligand Indemnitees pursuant to this <U>Article V</U> to the extent not paid by a member of the OmniAb Group. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.4 <U>Procedures for Indemnification</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <U>Direct Claims</U>. Other than with respect to Third Party Claims, which shall be governed by <U>Section</U><U></U><U>&nbsp;5.4(b)</U>,
each Ligand Indemnitee and OmniAb Indemnitee (each, an &#147;<I>Indemnitee</I>&#148;) shall notify in writing, with respect to any matter that such Indemnitee has determined has given or could give rise to a right of indemnification under this
Agreement or any Ancillary Agreement, the Party which is or may be required pursuant to this <U>Article</U><U></U><U>&nbsp;V</U> or pursuant to any Ancillary Agreement to make such indemnification (the &#147;<I>Indemnifying Party</I>&#148;), within
forty-five (45)&nbsp;days of such determination, stating in such written notice the amount of the Indemnifiable Loss claimed, if known, and, to the extent practicable, method of computation thereof, and referring to the provisions of this Agreement
in respect of which such right of indemnification is claimed by such Indemnitee or arises; <U>provided</U>, <U>however</U>, that the failure to provide such written notice shall not release the Indemnifying Party from any of its obligations except
and solely to the extent the Indemnifying Party shall have been actually materially prejudiced as a result of such failure. The Indemnifying Party will have a period of forty-five (45)&nbsp;days after receipt of a notice under this
<U>Section</U><U></U><U>&nbsp;5.4(a)</U> within which to respond thereto. If the Indemnifying Party fails to respond within such period, the Liability specified in such notice from the Indemnitee shall be conclusively determined to be a Liability of
the Indemnifying Party hereunder. If such Indemnifying Party responds within such period and rejects such claim in whole or in part, the disputed matter shall be resolved in accordance with <U>Article</U><U></U><U>&nbsp;VII</U>. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">43 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <U>Third Party Claims</U>. If a claim or demand is made against an Indemnitee by any
Person who is not a member of the Ligand Group or the OmniAb Group or APAC or their respective Affiliates (a &#147;<I>Third Party Claim</I>&#148;) as to which such Indemnitee is or may be entitled to indemnification pursuant to this Agreement or any
Ancillary Agreement, such Indemnitee shall notify the Indemnifying Party in writing (which notice obligation may be satisfied by providing copies of all notices and documents received by the Indemnitee relating to the Third Party Claim), and in
reasonable detail, of the Third Party Claim promptly (and in any event within the earlier of (x)&nbsp;forty-five (45)&nbsp;days or (y)&nbsp;two (2) Business Days prior to the final date of the applicable response period under such Third Party Claim)
after receipt by such Indemnitee of written notice of the Third Party Claim; <U>provided</U>, <U>however</U>, that the failure to provide notice of any such Third Party Claim pursuant to this or the preceding sentence shall not release the
Indemnifying Party from any of its obligations except and solely to the extent the Indemnifying Party shall have been actually materially prejudiced as a result of such failure. Thereafter, the Indemnitee shall deliver to the Indemnifying Party,
promptly (and in any event within ten (10)&nbsp;Business Days) after the Indemnitee&#146;s receipt thereof, copies of all notices and documents (including court papers) received by the Indemnitee relating to the Third Party Claim. For all purposes
of this <U>Section</U><U></U><U>&nbsp;5.4(b)</U>, each Party shall be deemed to have notice of the matters set forth on <U>Schedule</U><U></U><U>&nbsp;1.1(97)(vii)</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Other than in the case of (i)&nbsp;Taxes addressed in the Tax Matters Agreement or Employee Matters Agreement, which shall be addressed as
set forth therein or (ii)&nbsp;indemnification by a beneficiary Party of a guarantor Party pursuant to <U>Section</U><U></U><U>&nbsp;2.10(c)</U> (the defense of which shall be controlled by the beneficiary Party), the Indemnifying Party shall be
entitled, if it so chooses, to assume the defense thereof, and if it does not assume the defense of such Third Party Claim, to participate in the defense of any Third Party Claim in accordance with the terms of <U>Section</U><U></U><U>&nbsp;5.5</U>
at such Indemnifying Party&#146;s own cost and expense and by such Indemnifying Party&#146;s own counsel, that is reasonably acceptable to the Indemnitee, within thirty (30)&nbsp;days of the receipt of an indemnification notice from such Indemnitee;
<U>provided</U>, <U>however</U>, that the Indemnifying Party shall not be entitled to assume the defense of any Third Party Claim to the extent such Third Party Claim (x)&nbsp;is an Action by a Governmental Entity, (y)&nbsp;involves an allegation of
a criminal violation or (z)&nbsp;seeks injunctive relief against the Indemnitee. In connection with the Indemnifying Party&#146;s defense of a Third Party Claim, such Indemnitee shall have the right to employ separate counsel and to participate in
(but not control) the defense, compromise, or settlement thereof, at its own expense and, in any event, shall cooperate with the Indemnifying Party in such defense and make available to the Indemnifying Party, at the Indemnifying Party&#146;s
expense, all witnesses, pertinent Information, materials and information in such Indemnitee&#146;s possession or under such Indemnitee&#146;s control relating thereto as are reasonably required by the Indemnifying Party; <U>provided</U>,
<U>however</U>, that in the event of a conflict of interest between the Indemnifying Party and the applicable Indemnitee(s), or in the event that any Third Party Claim seeks equitable relief which would restrict or limit the future conduct of the
Indemnitee&#146;s business or operations, such Indemnitee(s) shall be entitled to retain, at the Indemnifying Party&#146;s expense, separate counsel as required by the applicable rules of professional conduct with respect to such matter;
<U>provided</U> <U>further</U>, that if the Indemnifying Party has assumed the defense of the Third Party Claim but has specified, and continues to assert, any reservations or exceptions to such defense or to its liability therefor, then, in any
such case, the reasonable fees and expenses of one separate counsel for all Indemnitees shall be borne by the Indemnifying Party. The Indemnifying Party shall have the right to compromise or settle a Third
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">44 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Party Claim the defense of which it shall have assumed pursuant to this <U>Section</U><U></U><U>&nbsp;5.4(c)</U> and any such settlement or compromise made or caused to be made of a Third Party
Claim in accordance with this <U>Article</U><U></U><U>&nbsp;V</U> shall be binding on the Indemnitee, in the same manner as if a final judgment or decree had been entered by a court of competent jurisdiction in the amount of such settlement or
compromise. Notwithstanding the foregoing sentence, the Indemnifying Party shall not settle any such Third Party Claim without the written consent of the Indemnitee unless such settlement (A)&nbsp;completely and unconditionally releases the
Indemnitee in connection with such matter, (B)&nbsp;provides relief consisting solely of money damages borne by the Indemnifying Party and (C)&nbsp;does not involve any admission by the Indemnitee of any wrongdoing or violation of Law. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) If an Indemnifying Party fails for any reason to assume responsibility for defending a Third Party Claim within the period specified in
this <U>Section</U><U></U><U>&nbsp;5.4</U>, such Indemnitee may defend such Third Party Claim at the cost and expense of the Indemnifying Party. If an Indemnifying Party has failed to assume the defense of the Third Party Claim within the time
period specified in clause (c)&nbsp;above, it shall not be a defense to any obligation to pay any amount in respect of such Third Party Claim that the Indemnifying Party was not consulted in the defense thereof, that such Indemnifying Party&#146;s
views or opinions as to the conduct of such defense were not accepted or adopted, that such Indemnifying Party does not approve of the quality or manner of the defense thereof or that such Third Party Claim was incurred by reason of a settlement
rather than by a judgment or other determination of liability. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) Except as otherwise set forth in <U>Section</U><U></U><U>&nbsp;6.6</U>
and <U>Section</U><U></U><U>&nbsp;7.3</U>, or to the extent set forth in any Ancillary Agreement, absent fraud or willful misconduct by an Indemnifying Party, the indemnification provisions of this <U>Article</U><U></U><U>&nbsp;V</U> shall be the
sole and exclusive remedy of an Indemnitee for any monetary or compensatory damages or losses resulting from any breach of this Agreement or any Ancillary Agreement and each Indemnitee expressly waives and relinquishes any and all rights, claims or
remedies such Person may have with respect to the foregoing other than under this <U>Article</U><U></U><U>&nbsp;V</U> against any Indemnifying Party. For the avoidance of doubt, all disputes in respect of this <U>Article</U><U></U><U>&nbsp;V</U>
shall be resolved in accordance with <U>Article</U><U></U><U>&nbsp;VII</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) Notwithstanding the foregoing, to the extent any
Ancillary Agreement provides procedures for indemnification that differ from the provisions set forth in this <U>Section</U><U></U><U>&nbsp;5.4</U>, the terms of the Ancillary Agreement will govern. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) The provisions of this <U>Article</U><U></U><U>&nbsp;V</U> shall apply to Third Party Claims that are already pending or asserted as well
as Third Party Claims brought or asserted after the date of this Agreement. There shall be no requirement under this <U>Section</U><U></U><U>&nbsp;5.4</U> to give a notice with respect to any Third Party Claim that exists as of the Distribution
Time. The Parties acknowledge that Liabilities for Actions (regardless of the parties to the Actions) may be partly Ligand Liabilities and partly OmniAb Liabilities. If the Parties cannot agree on the allocation of any such Liabilities for Actions,
they shall resolve the matter pursuant to the procedures set forth in <U>Article</U><U></U><U>&nbsp;VII</U>. Neither Party shall, nor shall either Party permit its Subsidiaries to, file Third Party claims or cross-claims against the other Party or
its Subsidiaries in an Action in which a Third Party Claim is being resolved. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">45 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.5 <U>Cooperation in Defense and Settlement</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) With respect to any Third Party Claim that implicates both the OmniAb Group (or APAC and its Subsidiaries, as applicable) and the Ligand
Group in any material respect due to the allocation of Liabilities, responsibilities for management of defense and related indemnities pursuant to this Agreement or any of the Ancillary Agreements, OmniAb (or APAC, as applicable) and Ligand agree to
use commercially reasonable efforts to cooperate fully and maintain a joint defense (in a manner that, to the extent reasonably practicable, will preserve for all Parties any Privilege with respect thereto). The Party that is not responsible for
managing the defense of any such Third Party Claim shall, upon reasonable request, be consulted with respect to significant matters relating thereto and may, if necessary or helpful, retain counsel to assist in the defense of such claims.
Notwithstanding the foregoing, nothing in this <U>Section</U><U></U><U>&nbsp;5.5(a)</U> shall derogate from any Party&#146;s rights to control the defense of any Action in accordance with <U>Section</U><U></U><U>&nbsp;5.4</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Notwithstanding anything to the contrary in this Agreement, with respect to any Action (i)&nbsp;by a Governmental Entity against OmniAb
relating to matters involving anti-bribery, anti-corruption, anti-money laundering, export control and similar laws, where the facts and circumstances giving rise to the Action occurred prior to the Distribution Time and (ii)&nbsp;where the
resolution of such Action by order, judgment, settlement or otherwise, would reasonably be expected to include any condition, limitation or other stipulation that adversely impacts the conduct of the Ligand Retained Businesses, Ligand shall have, at
Ligand&#146;s expense, the reasonable opportunity to consult, advise and comment on preparation regarding any such Action, including with regard to any drafts of notices and other conferences and communications to be provided or submitted by OmniAb
to any third party involved in such Action (including any Governmental Entity), to the extent that Ligand&#146;s participation does not affect the defense of any such Action or any privilege in an adverse manner; <U>provided</U> that to the extent
that any such action requires the submission by OmniAb of any content relating to any current or former officer or director of Ligand, such content will only be submitted in a form approved by Ligand in its reasonable discretion. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Notwithstanding anything to the contrary in this Agreement, with respect to any notices or reports to be submitted to, or reporting,
disclosure, filing or other requirements to be made with, any Governmental Entity by OmniAb or its Subsidiaries (&#147;<I>Governmental Filing</I>&#148;) where the Governmental Filing requires disclosure of facts, information or data that relate, in
whole or in part, to periods prior to the Distribution Time, Ligand shall have the reasonable opportunity to consult, advise and comment on the preparation and content of any such Governmental Filing in advance of its submission to a Governmental
Entity, and OmniAb shall in good faith consider and take into account any comments so provided by Ligand with respect to such Governmental Filing. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) Each of Ligand and OmniAb agrees that at all times from and after the Distribution Time, if an Action is commenced by a third party naming
two (2)&nbsp;or more Parties (or any member of such Parties&#146; respective Groups) as defendants and with respect to which one or more named Parties (or any member of such Party&#146;s respective Group) is a nominal defendant and/or such Action is
otherwise not a Liability allocated to such named Party under this Agreement or any Ancillary Agreement, then the other Party or Parties shall use commercially reasonable efforts at its own expense to cause such nominal defendant to be removed from
such Action, as soon as reasonably practicable. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">46 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.6 <U>Indemnification Payments</U>. Indemnification required by this
<U>Article</U><U></U><U>&nbsp;V</U> shall be made by periodic payments of the amount of Indemnifiable Losses in a timely fashion during the course of the investigation or defense, as and when bills are received or an Indemnifiable Loss incurred.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.7 <U>Indemnification Obligations Net of Insurance Proceeds and Other Amounts</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Any recovery by any Indemnitee for any Indemnifiable Loss subject to indemnification pursuant to this <U>Article</U><U></U><U>&nbsp;V</U>
shall be calculated (i)&nbsp;net of Insurance Proceeds actually received by such Indemnitee with respect to any Indemnifiable Loss (which such proceeds shall be reduced by the present value, based on that Party&#146;s then cost of short-term
borrowing, of future premium increases known at such time) and (ii)&nbsp;net of any proceeds actually received by the Indemnitee from any unaffiliated third party with respect to any such Liability corresponding to the Indemnifiable Loss
(&#147;<I>Third Party Proceeds</I>&#148;). Accordingly, the amount which any Indemnifying Party is required to pay pursuant to this <U>Article</U><U></U><U>&nbsp;V</U> to any Indemnitee pursuant to this <U>Article</U><U></U><U>&nbsp;V</U> shall be
reduced by any Insurance Proceeds or Third Party Proceeds theretofore actually recovered by or on behalf of the Indemnitee corresponding to the related Indemnifiable Loss. If an Indemnitee receives a payment required by this Agreement from an
Indemnifying Party corresponding to any Indemnifiable Loss (an &#147;<I>Indemnity Payment</I>&#148;) and subsequently receives Insurance Proceeds or Third Party Proceeds, then the Indemnitee shall pay to the Indemnifying Party an amount equal to the
excess of the Indemnity Payment received over the amount of the Indemnity Payment that would have been due if the Insurance Proceeds or Third Party Proceeds had been received, realized or recovered before the Indemnity Payment was made. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Any Indemnity Payment shall be increased as necessary so that after making all payments corresponding to Taxes imposed on or attributable
to such Indemnity Payment, the Indemnitee receives an amount equal to the sum it would have received had no such Taxes been imposed. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c)
The Parties hereby agree that an insurer or other third party that would otherwise be obligated to pay any amount shall not be relieved of the responsibility with respect thereto or have any subrogation rights with respect thereto by virtue of any
provision contained in this Agreement or any Ancillary Agreement, and that no insurer or any other third party shall be entitled to a &#147;windfall&#148; (<I>e.g.</I>, a benefit they would not otherwise be entitled to receive, or the reduction or
elimination of an insurance coverage obligation that they would otherwise have, in the absence of the indemnification or release provisions) by virtue of any provision contained in this Agreement or any Ancillary Agreement. Each Party shall, and
shall cause its Subsidiaries to, use commercially reasonable efforts to collect or recover, or allow the Indemnifying Party to collect or recover, or cooperate with each other in collecting or recovering, any Insurance Proceeds that may be
collectible or recoverable respecting the Liabilities for which indemnification may be available under this <U>Article</U><U></U><U>&nbsp;V</U>. Notwithstanding the foregoing, an Indemnifying Party may not delay making any indemnification payment
required under the terms of this Agreement, or otherwise satisfying any indemnification obligation, pending the outcome of any Actions to collect or recover Insurance Proceeds, and an Indemnitee need not attempt to collect any Insurance Proceeds
prior to making a claim for indemnification or receiving any Indemnity Payment otherwise owed to it under this Agreement or any Ancillary Agreement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">47 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.8 <U>Contribution</U>. If the indemnification provided for in this
<U>Article</U><U></U><U>&nbsp;V</U> is unavailable for any reason to an Indemnitee (other than failure to provide notice with respect to any Third Party Claims in accordance with <U>Section</U><U></U><U>&nbsp;5.4(b)</U>) in respect of any
Indemnifiable Loss, then the Indemnifying Party shall, in accordance with this <U>Section</U><U></U><U>&nbsp;5.8</U>, contribute to the Indemnifiable Losses incurred, paid or payable by such Indemnitee as a result of such Indemnifiable Loss in such
proportion as is appropriate to reflect the relative fault of OmniAb and each other member of the OmniAb Group, on the one hand, and Ligand and each other member of the Ligand Group, on the other hand, in connection with the circumstances which
resulted in such Indemnifiable Loss. With respect to any Indemnifiable Losses arising out of or related to information contained in the <FONT STYLE="white-space:nowrap">Spin-off</FONT> Disclosure Documents or other securities law filing, the
relative fault shall be determined by reference to, among other things, whether the untrue or alleged untrue statement of a material fact or omission or alleged omission of a material fact relates to information regarding the OmniAb Business
supplied by a member of the OmniAb Group, on the one hand, or regarding the Ligand Retained Business supplied by a member of the Ligand Group, on the other hand. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.9 <U>Additional Matters; Survival of Indemnities</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) The indemnity agreements contained in this <U>Article</U><U></U><U>&nbsp;V</U> shall remain operative and in full force and effect,
regardless of (i)&nbsp;any investigation made by or on behalf of any Indemnitee; and (ii)&nbsp;the knowledge by the Indemnitee of Indemnifiable Losses for which it might be entitled to indemnification hereunder. The indemnity agreements contained in
this <U>Article</U><U></U><U>&nbsp;V</U> shall survive the Distribution. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) The rights and obligations of any member of the Ligand
Group, any member of the OmniAb Group or APAC, in each case, under this <U>Article</U><U></U><U>&nbsp;V</U> shall survive (i)&nbsp;the sale or other Transfer by any Party or its Affiliates of any Assets or businesses or the assignment by it of any
Liabilities and (ii)&nbsp;any merger, consolidation, business combination, restructuring, recapitalization, reorganization or similar transaction involving either Party or any of its Subsidiaries. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE VI </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>PRESERVATION OF RECORDS; ACCESS TO INFORMATION; </U></B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>CONFIDENTIALITY; PRIVILEGE </U></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.1 <U>Preservation of Corporate Records</U>. Except as otherwise required or agreed in writing, or as otherwise provided in any
Ancillary Agreement, with regard to any Information referenced in <U>Section</U><U></U><U>&nbsp;6.2</U>, each Party shall use its commercially reasonable efforts, at such Party&#146;s sole cost and expense, to retain, until the latest of, as
applicable, (i)&nbsp;the date on which such Information is no longer required to be retained pursuant to the applicable record retention policy of Ligand or such other member of the Ligand Group, respectively, as in effect immediately prior to the
Distribution Time, including, without limitation, pursuant to any &#147;<I>Litigation Hold</I>&#148; issued by Ligand or any of its Subsidiaries prior to the Distribution Time, (ii)&nbsp;the concluding date of any period as may be required by any
applicable Law, (iii)&nbsp;the concluding </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">48 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
date of any period during which such Information relates to a pending or threatened Action which is known to the members of the Ligand Group or the OmniAb Group, as applicable, in possession of
such Information at the time any retention obligation with regard to such Information would otherwise expire, and (iv)&nbsp;the concluding date of any period during which the destruction of such Information could interfere with a pending or
threatened investigation by a Governmental Entity which is known to the members of the Ligand Group or the OmniAb Group, as applicable, in possession of such Information at the time any retention obligation with regard to such Information would
otherwise expire; provided that with respect to any pending or threatened Action arising after the Distribution Time, clause (iii)&nbsp;of this sentence applies only to the extent that whichever member of the Ligand Group or the OmniAb Group, as
applicable, is in possession of such Information has been notified in writing pursuant to a &#147;<I>Litigation Hold</I>&#148; by the other Party of the relevant pending or threatened Action. The Parties agree that upon written request from the
other that certain Information relating to the OmniAb Business, the Ligand Retained Businesses or the transactions contemplated hereby be retained in connection with an Action, the Parties shall use reasonable efforts to preserve and not to destroy
or dispose of such Information without the consent of the requesting Party. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.2 <U>Access to Information</U>. Other than in
circumstances in which indemnification is sought pursuant to <U>Article</U><U></U><U>&nbsp;V</U> (in which event the provisions of such <U>Article</U><U></U><U>&nbsp;V</U> shall govern) or for matters related to provision of Tax records (in which
event the provisions of the Tax Matters Agreement and Employee Matters Agreement shall govern) and subject to appropriate restrictions for Privileged Information or Confidential Information: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) After the Distribution Time, and subject to compliance with the terms of the Ancillary Agreements, upon the prior written reasonable
request by, and at the expense of, OmniAb for specific and identified Information: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) that (x)&nbsp;relates to OmniAb or
the OmniAb Business, as the case may be, prior to the Distribution Time or (y)&nbsp;is necessary for OmniAb to comply with the terms of, or otherwise perform under, any Ancillary Agreement to which Ligand and/or OmniAb are parties, Ligand shall
provide, as soon as reasonably practicable following the receipt of such request, appropriate copies of such Information (or the originals thereof if OmniAb has a reasonable need for such originals) in the possession or control of Ligand or any of
its Affiliates or Subsidiaries, but only to the extent such items so relate and are not already in the possession or control of OmniAb; <U>provided</U> that, to the extent any originals are delivered to OmniAb pursuant to this Agreement or the
Ancillary Agreements, OmniAb shall, at its own expense, return them to Ligand within a reasonable time after the need to retain such originals has ceased; <U>provided</U> <U>further</U> that, such obligation to provide any requested Information
shall terminate and be of no further force and effect on the date that is the first anniversary of the date of this Agreement; <U>provided</U> <U>further</U> that, in the event that Ligand, in its sole discretion, determines that any such access or
the provision of any such Information (including information requested under <U>Section</U><U></U><U>&nbsp;6.3</U>) would violate any Law or Contract with a third party or could reasonably result in the waiver of any Privilege, Ligand shall not be
obligated to provide such Information requested by OmniAb; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">49 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) that (x)&nbsp;is required by OmniAb with regard to reasonable
compliance with reporting, disclosure, filing or other requirements imposed on OmniAb (including under applicable securities laws) by a Governmental Entity having jurisdiction over OmniAb, or (y)&nbsp;is for use in any other judicial, regulatory,
administrative or other proceeding or in order to satisfy audit, accounting, claims, regulatory, litigation, Action or other similar requirements, as applicable, Ligand shall provide, as soon as reasonably practicable following the receipt of such
request, appropriate copies of such Information (or the originals thereof if OmniAb has a reasonable need for such originals) in the possession or control of Ligand or any of its Affiliates or Subsidiaries, but only to the extent such items so
relate and are not already in the possession or control of OmniAb; <U>provided</U> that, to the extent any originals are delivered to OmniAb pursuant to this Agreement or the Ancillary Agreements, OmniAb shall, at its own expense, return them to
Ligand within a reasonable time after the need to retain such originals has ceased; <U>provided</U> <U>further</U> that, in the event that Ligand, in its sole discretion, determines that any such access or the provision of any such Information
(including information requested under <U>Section</U><U></U><U>&nbsp;6.3</U>) would violate any Law or Contract with a third party or waive any Privilege, Ligand shall not be obligated to provide such Information requested by OmniAb; or </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) After the Distribution Time, and subject to compliance with the terms of the Ancillary Agreements, upon the prior written reasonable
request by, and at the expense of, Ligand for specific and identified Information: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) that (x)&nbsp;relates to matters
prior to the Distribution Time or (y)&nbsp;is necessary for Ligand to comply with the terms of, or otherwise perform under, any Ancillary Agreement to which Ligand and/or OmniAb are parties, OmniAb shall provide, as soon as reasonably practicable
following the receipt of such request, appropriate copies of such Information (or the originals thereof if Ligand has a reasonable need for such originals) in the possession or control of OmniAb or any of its Affiliates or Subsidiaries, but only to
the extent such items so relate and are not already in the possession or control of Ligand; <U>provided</U> that, to the extent any originals are delivered to Ligand pursuant to this Agreement or the Ancillary Agreements, Ligand shall, at its own
expense, return them to OmniAb within a reasonable time after the need to retain such originals has ceased; <U>provided</U> <U>further</U> that, in the event any such access or the provision of any such Information (including information requested
under <U>Section</U><U></U><U>&nbsp;6.3</U>) would violate any Law or Contract with a third party or waive any Privilege, OmniAb shall not be obligated to provide such Information requested by Ligand. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) that (x)&nbsp;is required by Ligand with regard to reasonable compliance with reporting, disclosure, filing or other
requirements imposed on Ligand (including under applicable securities laws) by a Governmental Entity having jurisdiction over Ligand, or (y)&nbsp;is for use in any other judicial, regulatory, administrative or other proceeding or in order to satisfy
audit, accounting, claims, regulatory, litigation, Action or other similar requirements, as applicable, OmniAb shall provide, as soon as reasonably practicable following the receipt of such request, appropriate copies of such Information (or the
originals thereof if Ligand has a reasonable need for such originals) in the possession or control of OmniAb or any of its Affiliates or Subsidiaries, but only to the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">50 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
extent such items so relate and are not already in the possession or control of Ligand; <U>provided</U> that, to the extent any originals are delivered to Ligand pursuant to this Agreement or the
Ancillary Agreements, Ligand shall, at its own expense, return them to OmniAb within a reasonable time after the need to retain such originals has ceased. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Each of Ligand and OmniAb shall inform their respective officers, employees, agents, consultants, advisors, authorized accountants,
counsel and other designated representatives who have or have access to the other Party&#146;s Confidential Information or other information provided pursuant to this <U>Article</U><U></U><U>&nbsp;VI</U> of their obligation to hold such information
confidential in accordance with the provisions of this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.3 <U>Auditors and Audits</U>.<U> </U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Until the first OmniAb fiscal year end occurring after the Distribution Time and for a reasonable period of time afterwards as required
for each Party to prepare consolidated financial statements or complete a financial statement audit for the fiscal year during which the Distribution Date occurs, each Party shall provide or provide access to the other Party on a timely basis, all
information reasonably required to meet its schedule for the preparation, printing, filing, and public dissemination of its annual financial statements and for management&#146;s assessment of the effectiveness of its disclosure controls and
procedures and its internal control over financial reporting in accordance with Items 307 and 308, respectively, of Regulation <FONT STYLE="white-space:nowrap">S-K</FONT> promulgated by the Commission and, to the extent applicable to such Party, its
auditor&#146;s audit of its internal control over financial reporting and management&#146;s assessment thereof in accordance with Section&nbsp;404 of the Sarbanes-Oxley Act of 2002 and the Commission&#146;s and Public Company Accounting Oversight
Board&#146;s rules and auditing standards thereunder. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) In the event a Party restates any of its financial statements that include such
Party&#146;s audited or unaudited financial statements with respect to any balance sheet date or period of operation as of the end of and for the 2021 fiscal year and the five (5)&nbsp;year period ending December&nbsp;31, 2021, such Party will
deliver to the other Party a substantially final draft, as soon as the same is prepared, of any report to be filed by such first Party with the Commission that includes such restated audited or unaudited financial statements (the &#147;<I>Amended
Financial Report</I>&#148;); provided, however, that such first Party may continue to revise its Amended Financial Report prior to its filing thereof with the Commission, which changes will be delivered to the other Party as soon as reasonably
practicable; provided, further, however, that such first Party&#146;s financial personnel will actively consult with the other Party&#146;s financial personnel regarding any changes which such first Party may consider making to its Amended Financial
Report and related disclosures prior to the anticipated filing of such report with the Commission, with particular focus on any changes which would have an effect upon the other Party&#146;s financial statements or related disclosures. Each Party
will reasonably cooperate with, and permit and make any necessary employees available to, the other Party, in connection with the other Party&#146;s preparation of any Amended Financial Reports. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">51 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.4 <U>Witness Services</U>. At all times from and after the Distribution Time,
each of Ligand and OmniAb shall use its commercially reasonable efforts to make available to the other, upon reasonable written request, its and its Subsidiaries&#146; officers, directors, employees and agents (taking into account the business
demands of such individuals) as witnesses to the extent that (i)&nbsp;such Persons may reasonably be required to testify in connection with the prosecution or defense of any Action in which the requesting Party may from time to time be involved
(except for claims, demands or Actions in which one or more members of one Group is adverse to one or more members of the other Group) and (ii)&nbsp;there is no conflict in the Action between the requesting Party and the other Party. A Party
providing a witness to the other Party under this <U>Section</U><U></U><U>&nbsp;6.4</U> shall be entitled to receive from the recipient of such witness services, upon the presentation of invoices therefor, payments for such amounts, relating to
supplies, disbursements and other <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> expenses (which shall not include the costs of salaries and benefits of employees who are witnesses or any pro rata
portion of overhead or other costs of employing such employees which would have been incurred by such employees&#146; employer regardless of the employees&#146; service as witnesses), as may be reasonably incurred and properly paid under applicable
Law. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.5 <U>Reimbursement; Other Matters</U>. Except to the extent otherwise contemplated by this Agreement or any Ancillary
Agreement, a Party providing Information or access to Information to the other Party under this <U>Article</U><U></U><U>&nbsp;VI</U> shall be entitled to receive from the recipient, upon the presentation of invoices therefor, payments for such
amounts, relating to supplies, disbursements and other <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> expenses (which shall not include the costs of salaries and benefits of employees of such Party or
any pro rata portion of overhead or other costs of employing such employees which would have been incurred by such employees&#146; employer regardless of the employees&#146; service with respect to the foregoing), as may be reasonably incurred in
providing such Information or access to such Information. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.6 <U>Confidentiality</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Notwithstanding any termination of this Agreement, and except as otherwise provided in the Ancillary Agreements, each of Ligand and OmniAb
shall hold, and shall cause their respective Affiliates and their officers, employees, agents, consultants and advisors to hold, in strict confidence (and not to disclose or release or, except as otherwise permitted by this Agreement or any
Ancillary Agreement, use, including for any ongoing or future commercial purpose, without the prior written consent of the Party to whom the Confidential Information relates (which may be withheld in such Party&#146;s sole and absolute discretion,
except where disclosure is required by applicable Law)), any and all Confidential Information concerning or belonging to the other Party or its Affiliates; <U>provided</U> that each Party may disclose, or may permit disclosure of, Confidential
Information (i)&nbsp;to its respective auditors, attorneys, financial advisors, bankers and other appropriate consultants and advisors who have a need to know such Information for auditing and other
<FONT STYLE="white-space:nowrap">non-commercial</FONT> purposes and are informed of the obligation to hold such Information confidential and in respect of whose failure to comply with such obligations, the applicable Party will be responsible,
(ii)&nbsp;if any Party or any of its respective Subsidiaries is required or compelled to disclose any such Confidential Information by judicial or administrative process or by other requirements of Law or stock exchange rule or is advised by outside
counsel in connection with a proceeding brought by a Governmental Entity that it is advisable to do so, (iii)&nbsp;as required in connection with any legal or other proceeding by one Party against the other Party or in respect of claims by one Party
against the other Party brought in a proceeding, (iv)&nbsp;as necessary in order to permit a Party to prepare and disclose its financial statements in connection with any regulatory filings or Tax Returns, (v)
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">52 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
as necessary for a Party to enforce its rights or perform its obligations under this Agreement (including pursuant to <U>Section</U><U></U><U>&nbsp;2.3</U>) or an Ancillary Agreement,
(vi)&nbsp;to Governmental Entities in accordance with applicable procurement regulations and contract requirements or (vii)&nbsp;to other Persons in connection with their evaluation of, and negotiating and consummating, a potential strategic
transaction, to the extent reasonably necessary in connection therewith, provided an appropriate and customary confidentiality agreement has been entered into with the Person receiving such Confidential Information. Notwithstanding the foregoing, in
the event that any demand or request for disclosure of Confidential Information is made by a third party pursuant to clause (ii), (iii), (v) or (vi)&nbsp;above, each Party, as applicable, shall promptly notify (to the extent permissible by Law) the
Party to whom the Confidential Information relates of the existence of such request, demand or disclosure requirement and shall provide such affected Party a reasonable opportunity to seek an appropriate protective order or other remedy, which such
Party will cooperate in obtaining to the extent reasonably practicable. In the event that such appropriate protective order or other remedy is not obtained, the Party which faces the disclosure requirement shall furnish only that portion of the
Confidential Information that is required to be disclosed and shall take commercially reasonable steps to ensure that confidential treatment is accorded such Confidential Information. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Each Party acknowledges that it and the other members of its Group may have in its or their possession confidential or proprietary
Information of third parties that was received under confidentiality or <FONT STYLE="white-space:nowrap">non-disclosure</FONT> agreements with such third party while such Party and/or members of its Group were part of the Ligand Group. Each Party
shall comply, and shall cause the other members of its Group to comply, and shall cause its and their respective officers, employees, agents, consultants and advisors (or potential buyers) to comply, with all terms and conditions of any such
third-party agreements entered into prior to the Distribution Time, with respect to any confidential and proprietary Information of third parties to which it or any other member of its Group has had access. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Notwithstanding anything to the contrary set forth herein, (i)&nbsp;the Parties shall be deemed to have satisfied their obligations
hereunder with respect to Confidential Information if they exercise at least the same degree of care that applies to Ligand&#146;s confidential and proprietary information pursuant to policies in effect as of the Distribution Time and
(ii)&nbsp;confidentiality obligations provided for in any Contract between each Party or its Subsidiaries and their respective employees shall remain in full force and effect. Notwithstanding anything to the contrary set forth herein, Confidential
Information of any Party in the possession of and used by any other Party as of the Distribution Time may continue to be used by such Party in possession of the Confidential Information in and only in the operation of the OmniAb Business (in the
case of the OmniAb Group) or the Ligand Retained Business (in the case of the Ligand Group); <U>provided</U> that such Confidential Information may only be used by such Party and its officers, employees, agents, consultants and advisors in the
specific manner and for the specific purposes for which it is used as of the date of this Agreement, and may only be shared with additional officers, employees, agents, consultants and advisors of such Party on a <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">need-to-know</FONT></FONT> basis exclusively with regard to such specified use; <U>provided</U> <U>further</U> that such Confidential Information may be used only so long as the Confidential Information is maintained in
confidence and not disclosed in violation of <U>Section</U><U></U><U>&nbsp;6.6(a)</U>. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">53 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) The Parties agree that irreparable damage may occur in the event that the provisions of
this <U>Section</U><U></U><U>&nbsp;6.6</U> were not performed in accordance with their specific terms. Accordingly, it is hereby agreed that the Parties shall be entitled to seek an injunction or injunctions to enforce specifically the terms and
provisions hereof in any court having jurisdiction, this being in addition to any other remedy to which they are entitled at law or in equity. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) For the avoidance of doubt and notwithstanding any other provision of this <U>Section</U><U></U><U>&nbsp;6.6</U>, (i) the disclosure and
sharing of Privileged Information shall be governed solely by <U>Section</U><U></U><U>&nbsp;6.7</U>, and (ii)&nbsp;Information that is subject to any confidentiality provision or other disclosure restriction in any Ancillary Agreement shall be
governed by the terms of such Ancillary Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) For the avoidance of doubt and notwithstanding any other provision of this
<U>Section</U><U></U><U>&nbsp;6.6</U>, following the Distribution Time, the confidentiality obligations under this Agreement shall continue to apply to any and all Confidential Information concerning or belonging to each Party or its Affiliates that
is shared or disclosed with the other Party or its Affiliates, whether or not such Confidential Information is shared pursuant to this Agreement, any Ancillary Agreement or otherwise. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.7 <U>Privilege Matters</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <U><FONT STYLE="white-space:nowrap">Pre-Distribution</FONT> Services</U>. The Parties recognize that legal and other professional services
that have been and will be provided prior to the Distribution Time have been and will be rendered for the collective benefit of each of the members of the Ligand Group and the OmniAb Group, and that each of the members of the Ligand Group and the
OmniAb Group should be deemed to be the client with respect to such <FONT STYLE="white-space:nowrap">pre-Distribution</FONT> services for the purposes of asserting all privileges, immunities, or other protections from disclosure which may be
asserted under applicable Law, including, but not limited to, the attorney-client privilege, business strategy privilege, joint defense privilege, common interest privilege, and protection under the work-product doctrine
(&#147;<I>Privilege</I>&#148;). The Parties shall have a shared Privilege with respect to all Information subject to Privilege (&#147;<I>Privileged Information</I>&#148;) which relates to such <FONT STYLE="white-space:nowrap">pre-Distribution</FONT>
services. For the avoidance of doubt, Privileged Information within the scope of this <U>Section</U><U></U><U>&nbsp;6.7</U> includes, but is not limited to, services rendered by legal counsel retained or employed by any Party (or any member of such
Party&#146;s respective Group), including outside counsel and <FONT STYLE="white-space:nowrap">in-house</FONT> counsel. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b)
<U>Post-Distribution Services</U>. The Parties recognize that legal and other professional services will be provided following the Distribution Time to each of Ligand and OmniAb. The Parties further recognize that certain of such post-Distribution
services will be rendered solely for the benefit of Ligand or OmniAb, as the case may be, while other such post-Distribution services may be rendered with respect to claims, proceedings, litigation, disputes, or other matters which involve both
Ligand and OmniAb. With respect to such post-Distribution services and related Privileged Information, the Parties agree as follows: </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">54 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) All Privileged Information relating to any claims, proceedings,
litigation, disputes or other matters which involve both Ligand and OmniAb shall be subject to a shared Privilege among the Parties involved in the claims, proceedings, litigation, disputes, or other matters at issue; and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) Except as otherwise provided in <U>Section</U><U></U><U>&nbsp;6.7(c)(i)</U>, Privileged Information relating to
post-Distribution services provided solely to one of Ligand or OmniAb shall not be deemed shared between the Parties, <U>provided</U>, that the foregoing shall not be construed or interpreted to restrict the right or authority of the Parties
(x)&nbsp;to enter into any further agreement, not otherwise inconsistent with the terms of this Agreement, concerning the sharing of Privileged Information or (y)&nbsp;otherwise to share Privileged Information without waiving any Privilege which
could be asserted under applicable Law. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) The Parties agree as follows regarding all Privileged Information with respect to which the
Parties shall have a shared Privilege under <U>Section</U><U></U><U>&nbsp;6.7(a) or (b)</U>: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) Subject to
<U>Section</U><U></U><U>&nbsp;6.7(c)(iii)</U>, neither Party may waive, allege or purport to waive, any Privilege which could be asserted under any applicable Law, and in which the other Party has a shared Privilege, without the written consent of
the other Party, which shall not be unreasonably withheld or delayed; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) If a dispute arises between or among the
Parties or their respective Subsidiaries regarding whether a Privilege should be waived to protect or advance the interest of any Party, each Party agrees that it shall negotiate in good faith, and shall endeavor to minimize any prejudice to the
rights of the other Party. Neither party shall unreasonably withhold consent to any request for waiver by the other Party, and each Party specifically agrees that it shall not withhold consent to waive for any purpose except to protect its own
legitimate interests; and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iii) In the event of any litigation or dispute between the Parties, or any members of their
respective Groups, either such Party may waive a Privilege in which the other Party or member of such Group has a shared Privilege, without obtaining the consent of the other Party; <U>provided</U> that such waiver of a shared Privilege shall be
effective only as to the use of Privileged Information with respect to the litigation or dispute between the Parties and/or the applicable members of their respective Groups, and shall not operate as a waiver of the shared Privilege with respect to
third parties. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) The transfer of all Information pursuant to this Agreement is made in reliance on the agreement of Ligand and OmniAb
as set forth in <U>Section</U><U></U><U>&nbsp;6.6</U> and this <U>Section</U><U></U><U>&nbsp;6.7</U>, to maintain the confidentiality of Privileged Information and to assert and maintain any applicable Privilege. The access to Information being
granted pursuant to <U>Section</U><U></U><U>&nbsp;5.5</U>, <U>Section</U><U></U><U>&nbsp;6.1</U>, <U>Section</U><U></U><U>&nbsp;6.2</U> and <U>Section</U><U></U><U>&nbsp;6.3 </U>, the agreement to provide witnesses and individuals pursuant to
<U>Section</U><U></U><U>&nbsp;5.5</U> and <U>Section</U><U></U><U>&nbsp;6.4</U>, the furnishing of notices and documents and other cooperative efforts contemplated by <U>Section</U><U></U><U>&nbsp;5.5</U>, and the transfer of Privileged Information
between the Parties and their respective Subsidiaries pursuant to this Agreement shall not be deemed a waiver of any Privilege that has been or may be asserted under this Agreement or otherwise. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">55 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.8 <U>Ownership of Information</U>. Any Information owned by one Party or any
of its Subsidiaries that is provided to a requesting Party pursuant to this <U>Article</U><U></U><U>&nbsp;VI</U> shall be deemed to remain the property of the providing Party. Unless expressly set forth herein, or unless expressly agreed in a
subsequent and separate agreement, nothing contained in this Agreement shall be construed as granting a license or other rights to any Party with respect to any such Information, whether by implication, estoppel or otherwise. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.9 <U>Processing of Personal Information</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Both Parties shall cooperate to ensure that their respective Processing of Personal Information hereunder does and will materially comply
with all applicable Privacy Requirements and take all reasonable precautions to avoid acts that place the other Party in breach of its obligations under any applicable Privacy Requirements. Nothing in this <U>Section</U><U></U><U>&nbsp;6.9</U> shall
be deemed to prevent any Party from taking the steps it reasonably deems necessary to comply with any applicable Privacy Laws. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) To the
extent required to do so by applicable Privacy Requirements as a result of or in connection with the transactions contemplated hereby, including the completion of the Internal Reorganization, the Parties agree to enter into such data processing
agreements as required to comply with applicable Privacy Laws and shall act reasonably and in good faith in doing so. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) It is
understood and agreed by the Parties that the transfer of Personal Information in connection with the Transfer of Assets will not violate any Privacy Requirements in any material respect. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.10 <U>Other Agreements</U>. The rights and obligations granted under this <U>Article</U><U></U><U>&nbsp;VI</U> are subject to
any specific limitations, qualifications or additional provisions on the sharing, exchange or confidential treatment of Information set forth in any Ancillary Agreement. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE VII </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>DISPUTE
RESOLUTION </U></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.1 <U>Negotiation</U>. Except as otherwise provided in any Ancillary Agreement, in the event of a
controversy, dispute or Action arising out of, in connection with, or in relation to the interpretation, performance, nonperformance, validity or breach of this Agreement or the Ancillary Agreements or otherwise arising out of, or in any way related
to, this Agreement or the Ancillary Agreements or the transactions contemplated hereby, including any Action based on contract, tort, statute or constitution (collectively, &#147;<I>Disputes</I>&#148;), where such Dispute is between the Parties or
between Ligand and APAC, the general counsels or chief legal officers of the parties to the Dispute (or such other individuals designated by the respective general counsels or chief legal officers) and/or the executive officers designated by the
parties to the Dispute shall negotiate for a reasonable period of time to settle such Dispute; provided, that such reasonable period shall not, unless otherwise agreed by the parties to such Dispute in writing, exceed sixty (60)&nbsp;days (the
&#147;<I>Negotiation Period</I>&#148;) from the time of receipt by a party to such Dispute of written notice of such Dispute (&#147;<I>Dispute Notice</I>&#148;) and settlement of such Dispute pursuant to this <U>Section</U><U></U><U>&nbsp;7.1</U>
shall be confidential, and no written or oral statements or offers made by the parties to the Dispute during such settlement negotiations shall be admissible for any purpose in any subsequent proceedings. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">56 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.2 <U>Relief in Court</U>. If the Dispute has not been resolved for any reason
after the Negotiation Period, each party to such Dispute shall be entitled to seek relief in a court of competent jurisdiction pursuant to <U>Section</U><U></U><U>&nbsp;9.16</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.3 <U>Continuity of Service and Performance</U>. Unless otherwise agreed in writing, the Parties shall continue to provide
service and honor all other commitments under this Agreement and each Ancillary Agreement during the course of dispute resolution pursuant to the provisions of this <U>Article</U><U></U><U>&nbsp;VII</U> with respect to all matters not subject to
such dispute resolution. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE VIII </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>INSURANCE </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;8.1 <U>Insurance Matters</U>. The provisions of this <U>Section</U><U></U><U>&nbsp;8.1</U> shall apply only to the extent not
otherwise provided for in the Employee Matters Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) The Parties intend by this Agreement that, to the extent permitted under
the terms of any applicable insurance policy, OmniAb, each other member of the OmniAb Group and each of their respective directors, officers and employees will be successors in interest and/or additional insureds and will have and be fully entitled
to continue to exercise all rights that any of them may have as of the Distribution Time (with respect to events occurring or claimed to have occurred before the Distribution Time) as a Subsidiary, Affiliate, division, director, officer or employee
of Ligand before the Distribution Time under any insurance policy, including any rights that OmniAb, any other member of the OmniAb Group or any of its or their respective directors, officers, or employees may have as an insured or additional named
insured, Subsidiary, Affiliate, division, director, officer or employee to avail itself, himself or herself of any policy of insurance or any agreements related to the policies in effect before the Distribution Time, with respect to events occurring
before the Distribution Time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) After the Distribution Time, Ligand (and each other member of the Ligand Group) and OmniAb (and each
other member of the OmniAb Group) shall not, without the consent of OmniAb or Ligand, respectively (such consent not to be unreasonably withheld, conditioned or delayed), provide any insurance carrier with a release or amend, modify or waive any
rights under any insurance policy if such release, amendment, modification or waiver thereunder would materially adversely affect any rights of any member of the Group of the other Party with respect to insurance coverage otherwise afforded to such
other Party for <FONT STYLE="white-space:nowrap">pre-Distribution</FONT> claims; provided, however, that the foregoing shall not (i)&nbsp;preclude any member of any Group from presenting any claim or from exhausting any policy limit,
(ii)&nbsp;require any member of any Group to pay any premium or other amount or to incur any Liability or (iii)&nbsp;require any member of any Group to renew, extend or continue any policy in force. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) The provisions of this Agreement are not intended to relieve any insurer of any Liability under any policy. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">57 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) No member of the Ligand Group or any Ligand Indemnitee will have any Liabilities
whatsoever as a result of the insurance policies as in effect at any time before the Distribution Time, including as a result of (i)&nbsp;the level or scope of any insurance, (ii)&nbsp;the creditworthiness of any insurance carrier, (iii)&nbsp;the
terms and conditions of any policy, or (iv)&nbsp;the adequacy or timeliness of any notice to any insurance carrier with respect to any claim or potential claim. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) Except to the extent otherwise provided in <U>Section</U><U></U><U>&nbsp;8.1(b)</U>, in no event will Ligand, any other member of the
Ligand Group or any Ligand Indemnitee have any Liability or obligation whatsoever to any member of the OmniAb Group if any insurance policy is terminated or otherwise ceases to be in effect for any reason, is unavailable or inadequate to cover any
Liability of any member of the OmniAb Group for any reason whatsoever or is not renewed or extended beyond the current expiration date of any such insurance policy. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) This Agreement shall not be considered as an attempted assignment of any policy of insurance or as a contract of insurance and shall not
be construed to waive any right or remedy of any members of the Ligand Group in respect of any insurance policy or any other contract or policy of insurance. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) Nothing in this Agreement will be deemed to restrict any member of the OmniAb Group from acquiring at its own expense any other insurance
policy in respect of any Liabilities or covering any period. After the Distribution Time, OmniAb will acquire its own insurance policies covering the OmniAb Group and each of their respective directors, officers and employees. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h) To the extent that any insurance policy provides for the reinstatement of policy limits, and both Ligand and OmniAb desire to reinstate
such limits, the cost of reinstatement will be shared by Ligand and OmniAb as the Parties may agree. If either Party, in its sole discretion, determines that such reinstatement would not be beneficial, that Party shall not contribute to the cost of
reinstatement and will not make any claim thereunder nor otherwise seek to benefit from the reinstated policy limits. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) For purposes of
this Agreement, &#147;<I>Covered Matter</I>&#148; shall mean any matter, whether arising before or after the Distribution Time, with respect to which any OmniAb Indemnitee may seek to exercise any right under any insurance policy pursuant to this
<U>Section</U><U></U><U>&nbsp;8.1</U>. If OmniAb receives notice or otherwise learns of any Covered Matter, OmniAb shall promptly give Ligand written notice thereof. Any such notice shall describe the Covered Matter in reasonable detail. With
respect to each Covered Matter and any Joint Claim, OmniAb shall have sole responsibility for reporting the claim to the insurance carrier and will provide a copy of such report to OmniAb. If Ligand or another member of the Ligand Group fails to
notify OmniAb within fifteen (15)&nbsp;days that it has submitted an insurance claim with respect to a Covered Matter or Joint Claim, OmniAb shall be permitted to submit (on behalf of the applicable OmniAb Indemnitee) such insurance claim. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(j) Each of OmniAb and Ligand will share such information as is reasonably necessary in order to permit the other Party to manage and conduct
its insurance matters in an orderly fashion and provide the other Party with any assistance that is reasonably necessary or beneficial in connection with such Party&#146;s insurance matters. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">58 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE IX </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>MISCELLANEOUS </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.1 <U>Entire Agreement; Construction</U>. This Agreement, including the Exhibits&nbsp;and Schedules, and the Ancillary
Agreements shall constitute the entire agreement among the Parties and APAC with respect to the subject matter hereof and shall supersede all previous negotiations, commitments, course of dealings and writings with respect to such subject matter. In
the event of any inconsistency between this Agreement and any Schedule&nbsp;hereto, the Schedule&nbsp;shall prevail. In the event and to the extent that there shall be a conflict between the provisions of (a)&nbsp;this Agreement and the provisions
of any Ancillary Agreement or Continuing Arrangement, such Ancillary Agreement or Continuing Arrangement shall control (except with respect to any Conveyancing and Assumption Instruments, in which case this Agreement shall control) and (b)&nbsp;this
Agreement and any agreement which is not an Ancillary Agreement, this Agreement shall control unless specifically stated otherwise in such agreement. For the avoidance of doubt, the Conveyancing and Assumption Instruments are intended to be
ministerial in nature and only to effect the transactions contemplated by this Agreement with respect to the applicable local jurisdiction and shall not expand or modify the rights and obligations of the Parties, APAC or their respective Affiliates
under this Agreement or any of the Ancillary Agreements that are not Conveyancing and Assumption Instruments. Except as expressly set forth in this Agreement or any Ancillary Agreement: (i)&nbsp;all matters relating to Taxes and Tax Returns of the
Parties and their respective Subsidiaries shall be governed exclusively by the Tax Matters Agreement; and (ii)&nbsp;for the avoidance of doubt, in the event of any conflict between this Agreement or any Ancillary Agreement (other than the Tax
Matters Agreement), on the one hand, and the Tax Matters Agreement, on the other hand, with respect to such matters, the terms and conditions of the Tax Matters Agreement shall govern, except as otherwise provided in the Tax Matters Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.2 <U>Ancillary Agreements</U>. Except as expressly set forth herein, this Agreement is not intended to address, and should not
be interpreted to address, the matters specifically and expressly covered by the Ancillary Agreements. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.3
<U>Counterparts</U>. This Agreement may be executed in more than one counterpart, all of which shall be considered one and the same agreement, and shall become effective when one or more such counterparts have been signed by each of the Parties and
APAC and delivered to each of the Parties and APAC. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.4 <U>Survival of Agreements</U>. Except as otherwise contemplated by
this Agreement or any Ancillary Agreement, all covenants and agreements of the Parties and APAC contained in this Agreement and each Ancillary Agreement shall survive the Distribution Time and remain in full force and effect in accordance with their
applicable terms. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.5 <U>Expenses</U>. Except as otherwise specified in this Agreement or the Ancillary Agreements, or as
otherwise agreed in writing among Ligand, OmniAb and APAC, Ligand and OmniAb shall each be responsible for its own fees, costs and expenses paid or incurred in connection with this Agreement, any Ancillary Agreement and the Form 10 and the
consummation of the Internal Reorganization, the Contribution, the Distribution and the Merger (the &#147;<I>Transaction-related Expenses</I>&#148;). OmniAb shall reimburse Ligand for all documented,
out-</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">59 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
<FONT STYLE="white-space:nowrap">of-pocket</FONT> Transaction-related Expenses of OmniAb that have been paid by Ligand through and including the Distribution Date (the &#147;<I>Reimbursable
Transaction-related Expenses</I>&#148;) by Ligand&#146;s deducting such amount from the cash portion of the Contribution to be made by it in connection with the Separation. On or prior to the date that is three (3)&nbsp;Business Days prior to the
Distribution Date, Ligand shall furnish to APAC a schedule of the Reimbursable Transaction-related Expenses, together with supporting documentation. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.6 <U>Notices</U>. All notices, requests, claims, demands and other communications under this Agreement and, to the extent
applicable and unless otherwise provided therein, under each of the Ancillary Agreements shall be in English, shall be in writing and shall be given or made (and shall be deemed to have been duly given or made upon receipt) by delivery in person, by
overnight courier service, by registered or certified mail (return receipt requested), or by email (provided confirmation of transmission is electronically generated and kept on file by the sending party and so long as the sender of such email does
not receive an automatic reply from the recipient&#146;s email server indicating that the recipient did not receive such email), to the respective Parties or APAC at the following addresses (or at such other address for a Party or APAC as shall be
specified in a notice given in accordance with this Section&nbsp;9.6): </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">To Ligand: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Ligand Pharmaceuticals Incorporated </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">3911 Sorrento Valley Blvd., Suite 110 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">San Diego, CA 92121 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Attn: Chief
Financial Officer </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Email: tespinoza@ligand.com </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">With a copy (which shall not constitute notice) to: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">Latham&nbsp;&amp; Watkins, LLP </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">12670 High Bluff Dr. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">San
Diego, California 92130 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">Attn: &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Matthew
Bush </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Scott
Shean </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">Email: &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;matt.bush@lw.com </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;scott.shean@lw.com
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">To OmniAb: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">OmniAb, Inc.
</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">5980 Horton Street, Suite 405 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Emeryville, CA 94608 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Attn: Chief
Legal Officer </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Email: cberkman@omniab.com </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">With a copy (which shall not constitute notice) to: </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">60 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">Latham&nbsp;&amp; Watkins, LLP </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">12670 High Bluff Dr. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">San
Diego, California 92130 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">Attn: &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Matthew Bush </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Scott Shean </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">Email: &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;matt.bush@lw.com </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;scott.shean@lw.com </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">To APAC: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Avista Public
Acquisition Corp. II </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">65 East 55th Street, 18th Floor New York, New York 10022 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Attn: Benjamin Silbert, General Counsel </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Email: Silbert@avistacap.com </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">with a copy (which shall not constitute notice) to: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">Weil, Gotshal&nbsp;&amp; Manges LLP </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">767 5<SUP STYLE="font-size:85%; vertical-align:top">th</SUP> Avenue </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">New York, NY 10153 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">Attn:
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Jaclyn L. Cohen, Esq. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;Raymond O. Gietz, Esq. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">Email: &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;jackie.cohen@weil.com </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;raymond.gietz@weil.com </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.7 <U>Consents</U>. Any consent required or permitted to be given by any Party or APAC to the
other Party or APAC under this Agreement shall be in writing and signed by the Party or APAC, as the case may be, giving such consent and shall be effective only against such Party (and its Group) or APAC (and its Affiliates), as the case may be.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.8 <U>Assignment</U>. This Agreement shall not be assignable, in whole or in part, directly or indirectly, by any Party or
APAC without the prior written consent of the other Party and APAC, and any attempt to assign any rights or obligations arising under this Agreement without such consents shall be void. Notwithstanding the foregoing, and subject to any restrictions
on assignment pursuant to Article IV of the Tax Matters Agreement, this Agreement shall be assignable to a bona fide third party in connection with a merger, reorganization, consolidation or the sale of all or substantially all the assets of a party
hereto so long as the resulting, surviving or transferee entity assumes all the obligations of the relevant party hereto by operation of law or pursuant to an agreement in form and substance reasonably satisfactory to the other parties to this
Agreement; <U>provided,</U> <U>however,</U> that no assignment permitted by this <U>Section</U><U></U><U>&nbsp;9.8</U> shall release the assigning Party or APAC, as the case may be, from liability for the full performance of its obligations under
this Agreement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">61 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.9 <U>Successors and Assigns</U>. The provisions of this Agreement and the
obligations and rights hereunder shall be binding upon, inure to the benefit of and be enforceable by (and against) the Parties, APAC and their respective successors and permitted assigns. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.10 <U>Termination and Amendment</U>. This Agreement may not be terminated, modified or amended except by an agreement in
writing signed by each of Ligand, OmniAb and APAC; <U>provided</U>, <U>however</U>, that this Agreement shall terminate immediately upon termination of the Merger Agreement if the Merger Agreement is terminated in accordance with its terms prior to
the Distribution. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.11 <U>Payment Terms</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Except as set forth in <U>Article</U><U></U><U>&nbsp;V</U> or as otherwise expressly provided to the contrary in this Agreement or in any
Ancillary Agreement, any amount to be paid or reimbursed by a Party or APAC (and/or a member of such Party&#146;s Group or its Affiliates), on the one hand, to the other Party or APAC (and/or a member of such Party&#146;s Group or its Affiliate), on
the other hand, under this Agreement shall be paid or reimbursed hereunder within forty-five (45)&nbsp;days after presentation of an invoice or a written demand therefor and setting forth, or accompanied by, reasonable documentation or other
reasonable explanation supporting such amount. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Except as set forth in <U>Article</U><U></U><U>&nbsp;V</U> or as expressly provided to
the contrary in this Agreement or in any Ancillary Agreement, any amount not paid when due pursuant to this Agreement (and any amount billed or otherwise invoiced or demanded and properly payable that is not paid within forty-five (45)&nbsp;days of
such bill, invoice or other demand) shall bear interest at a rate per annum equal to the Prime Rate, from time to time in effect, calculated for the actual number of days elapsed, accrued from the date on which such payment was due up to the date of
the actual receipt of payment. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Without the consent of the Party or APAC, as the case may be, receiving any payment under this
Agreement specifying otherwise, all payments to be made by either Party or APAC under this Agreement shall be made in US Dollars. Except as expressly provided herein, any amount which is not expressed in US Dollars shall be converted into US Dollars
by using the exchange rate published on Bloomberg at 5:00 pm Eastern Standard time (EST) on the day before the relevant date or in the Wall Street Journal on such date if not so published on Bloomberg. Except as expressly provided herein, in the
event that any indemnification payment required to be made hereunder or under any Ancillary Agreement may be denominated in a currency other than US Dollars, the amount of such payment shall be converted into US Dollars on the date in which notice
of the claim is given to the Indemnifying Party. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.12 <U>Subsidiaries</U>. Each of the Parties and APAC shall cause to be
performed, and hereby guarantees the performance of, all actions, agreements and obligations set forth herein to be performed by any Subsidiary of such Party or APAC, as the case may be, or by any entity that becomes a Subsidiary of such Party or
APAC, as the case may be, at and after the Distribution Time, to the extent such Subsidiary remains a Subsidiary of the applicable Party or APAC, as the case may be. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">62 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.13 <U>Third Party Beneficiaries</U>. Except (i)&nbsp;as provided in
<U>Article</U><U></U><U>&nbsp;V</U> relating to Indemnitees and for the release under <U>Section</U><U></U><U>&nbsp;5.1</U> of any Person provided therein and (ii)&nbsp;as specifically provided in any Ancillary Agreement, this Agreement is solely
for the benefit of the Parties and APAC and should not be deemed to confer upon third parties any remedy, claim, liability, reimbursement, claim of Action or other right in excess of those existing without reference to this Agreement. For the
avoidance of doubt, no stockholder of Ligand, OmniAb or APAC shall be third-party beneficiaries for any purpose prior to the Distribution, and no stockholder (or Party or APAC on behalf of their respective stockholders) shall be entitled to bring
any claim for damages prior to the Distribution based on a decrease in share value or lost premiums. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.14 <U>Title and
Headings</U>. Titles and headings to sections&nbsp;herein are inserted for the convenience of reference only and are not intended to be a part of or to affect the meaning or interpretation of this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.15 <U>Exhibits</U><U></U><U>&nbsp;and Schedules</U>. The Exhibits&nbsp;and Schedules shall be construed with and as an integral
part of this Agreement to the same extent as if the same had been set forth verbatim herein. Nothing in the Exhibits&nbsp;or Schedules constitutes an admission of any liability or obligation of any member of the Ligand Group or the OmniAb Group or
any of their respective Affiliates to any third party, nor, with respect to any third party, an admission against the interests of any member of the Ligand Group or the OmniAb Group or any of their respective Affiliates. The inclusion of any item or
liability or category of item or liability on any Exhibit&nbsp;or Schedule&nbsp;is made solely for purposes of allocating potential liabilities among the Parties and shall not be deemed as or construed to be an admission that any such liability
exists. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.16 <U>Governing Law and Venue; Submission to Jurisdiction; Selection of Forum; Waiver of Trial by Jury</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) This Agreement and any dispute arising out of, in connection with or relating to this Agreement shall be governed by and construed in
accordance with the Laws of the State of Delaware, without giving effect to the conflicts of laws principles thereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Each of the
Parties and APAC agrees that any Action related to this agreement shall be brought exclusively in the Court of Chancery of the State of Delaware or, if under applicable Law, exclusive jurisdiction over such matter is vested in the federal courts,
any federal court in the State of Delaware and any appellate court from any thereof (the &#147;<I>Chosen Courts</I>&#148;). By executing and delivering this Agreement, each of the Parties and APAC irrevocably: (i)&nbsp;accepts generally and
unconditionally submits to the exclusive jurisdiction of the Chosen Courts for any Action relating to this Agreement, including any Action brought for any remedy contemplated by <U>Section</U><U></U><U>&nbsp;9.17</U>; (ii) waives any objections
which such Party or APAC, as the case may be, may now or hereafter have to the laying of venue of any such Action contemplated by this <U>Section</U><U></U><U>&nbsp;9.16(b)</U> and hereby further irrevocably waives and agrees not to plead or claim
that any such Action has been brought in an inconvenient forum; (iii)&nbsp;agrees that it will not attempt to deny or defeat the personal jurisdiction of the Chosen Courts by motion or other request for leave from any such court; (iv)&nbsp;agrees
that it will not bring any Action contemplated by this <U>Section</U><U></U><U>&nbsp;9.16(b)</U> in any court other than the Chosen Courts; (v)&nbsp;agrees that service of all process, including the summons and complaint, in any Action may be made
by </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">63 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
registered or certified mail, return receipt requested, to such party at their respective addresses provided in accordance with <U>Section</U><U></U><U>&nbsp;9.6</U> or in any other manner
permitted by Law; and (vi)&nbsp;agrees that service as provided in the preceding clause (v)&nbsp;is sufficient to confer personal jurisdiction over such Party or APAC in the Action, and otherwise constitutes effective and binding service in every
respect. Each of the Parties and APAC agrees that a final judgment in any Action in a Chosen Court as provided above may be enforced in other jurisdictions by suit on the judgment or in any other manner provided by Law, and each Party and APAC
further agrees to the <FONT STYLE="white-space:nowrap">non-exclusive</FONT> jurisdiction of the Chosen Courts for the enforcement or execution of any such judgment. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) EACH OF LIGAND, OMNIAB AND APAC HEREBY UNCONDITIONALLY AND IRREVOCABLY WAIVE THEIR RIGHT TO TRIAL BY JURY IN ANY JUDICIAL PROCEEDING IN
ANY COURT RELATING TO ANY DISPUTE, CONTROVERSY OR CLAIM ARISING OUT OF, RELATING TO OR IN CONNECTION WITH THIS AGREEMENT OR ANY INSTRUMENT OR DOCUMENT DELIVERED PURSUANT TO THIS AGREEMENT (INCLUDING ANY SCHEDULE OR EXHIBIT HERETO AND THERETO) OR THE
BREACH, TERMINATION OR VALIDITY OF SUCH AGREEMENT, INSTRUMENTS OR DOCUMENTS OR THE NEGOTIATION, EXECUTION OR PERFORMANCE OF SUCH AGREEMENTS, INSTRUMENTS OR DOCUMENTS. NEITHER LIGAND, OMNIAB NOR APAC SHALL SEEK A JURY TRIAL IN ANY LAWSUIT,
PROCEEDING, COUNTERCLAIM OR ANY OTHER LITIGATION PROCEDURE BASED UPON, OR ARISING OUT OF, THIS AGREEMENT OR ANY RELATED INSTRUMENTS OR DOCUMENTS. NEITHER LIGAND, OMNIAB NOR APAC WILL SEEK TO CONSOLIDATE ANY SUCH ACTION IN WHICH A JURY TRIAL HAS BEEN
WAIVED WITH ANY OTHER ACTION IN WHICH A JURY TRIAL CANNOT BE OR HAS NOT BEEN WAIVED. EACH OF LIGAND, OMNIAB AND APAC CERTIFIES THAT IT HAS BEEN INDUCED TO ENTER INTO THIS AGREEMENT, INSTRUMENT OR DOCUMENT BY, AMONG OTHER THINGS, THE MUTUAL WAIVERS
AND CERTIFICATIONS SET FORTH ABOVE IN THIS <U>SECTION 9.16(c)</U>. NONE OF LIGAND, OMNIAB OR APAC HAS IN ANY WAY AGREED WITH OR REPRESENTED TO ANY OF THE OTHERS THAT THE PROVISIONS OF THIS <U>SECTION 9.16(c)</U> WILL NOT BE FULLY ENFORCED IN ALL
INSTANCES. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.17 <U>Specific Performance</U>. From and after the Distribution Time, in the event of any actual or threatened
default in, or breach of, any of the terms, conditions and provisions of this Agreement or any Ancillary Agreement, the Parties and APAC agree that APAC and the Party or Parties to this Agreement or such Ancillary Agreement who are or are to be
thereby aggrieved shall have the right to specific performance and injunctive or other equitable relief of its or their rights under this Agreement or such Ancillary Agreement, in addition to any and all other rights and remedies at law or in
equity, and all such rights and remedies shall be cumulative. The Parties and APAC agree that, from and after the Distribution Time, the remedies at law for any breach or threatened breach of this Agreement or any Ancillary Agreement, including
monetary damages, are inadequate compensation for any Indemnifiable Loss, that any defense in any action for specific performance that a remedy at law would be adequate is hereby waived, and that any requirements for the securing or posting of any
bond with such remedy are hereby waived. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">64 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.18 <U>Severability</U>. In the event any one or more of the provisions
contained in this Agreement should be held invalid, illegal or unenforceable in any respect, the validity, legality and enforceability of the remaining provisions contained herein and therein shall not in any way be affected or impaired thereby. The
Parties and APAC shall endeavor in good-faith negotiations to replace the invalid, illegal or unenforceable provisions with valid provisions, the economic effect of which comes as close as possible to that of the invalid, illegal or unenforceable
provisions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.19 <U>Interpretation</U>. The Parties and APAC have participated jointly in the negotiation and drafting of
this Agreement. This Agreement shall be construed without regard to any presumption or rule requiring construction or interpretation against the Party or APAC, as the case may be, drafting or causing any instrument to be drafted. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.20 <U>No Duplication; No Double Recovery</U>. Nothing in this Agreement is intended to confer to or impose upon any Party or
APAC a duplicative right, entitlement, obligation or recovery with respect to any matter arising out of the same facts and circumstances (including with respect to the rights, entitlements, obligations and recoveries that may arise out of one or
more of the following Sections: <U>Section</U><U></U><U>&nbsp;5.2</U>; <U>Section</U><U></U><U>&nbsp;5.3</U>; and <U>Section</U><U></U><U>&nbsp;5.4</U>). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.21 <U>Tax Treatment of Payments</U>. Unless otherwise required by a Final Determination, this Agreement or the Tax Matters
Agreement or otherwise agreed to among the Parties and APAC, for U.S. federal Tax purposes, any payment made pursuant to this Agreement (other than any payment of interest pursuant to <U>Section</U><U></U><U>&nbsp;9.11</U>) by: (i)&nbsp;OmniAb to
Ligand shall be treated for all Tax purposes as a distribution by OmniAb to Ligand with respect to stock of OmniAb occurring on or immediately before the Distribution Time; or (ii)&nbsp;Ligand to OmniAb shall be treated for all Tax purposes as a <FONT
STYLE="white-space:nowrap">tax-free</FONT> contribution by Ligand to OmniAb with respect to its stock occurring on or immediately before the Distribution Time; and in each case, no Party or APAC shall take any position inconsistent with such
treatment. In the event that a Taxing Authority asserts that a Party&#146;s treatment of a payment pursuant to this Agreement should be other than as set forth in the preceding sentence, such Party shall use its commercially reasonable efforts to
contest such challenge. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.22 <U>No Waiver</U>. No failure to exercise and no delay in exercising, on the part of any Party,
any right, remedy, power or privilege hereunder or under the other Ancillary Agreements shall operate as a waiver hereof or thereof; nor shall any single or partial exercise of any right, remedy, power or privilege hereunder or thereunder preclude
any other or further exercise thereof or the exercise of any other right, remedy, power or privilege. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.23 <U>No Admission
of Liability</U>. The allocation of Assets and Liabilities herein (including on the Schedules hereto) is solely for the purpose of allocating such Assets and Liabilities between Ligand and OmniAb and is not intended as an admission of liability or
responsibility for any alleged Liabilities <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">vis-&agrave;-vis</FONT></FONT> any third party, including with respect to the Liabilities of any
<FONT STYLE="white-space:nowrap">non-wholly</FONT> owned Subsidiary of Ligand or OmniAb. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[<I>Signature Page Follows</I>] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">65 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">IN WITNESS WHEREOF, each of Ligand, OmniAb and APAC have caused this Agreement to be duly executed as of the
day and year first above written. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">LIGAND PHARMACEUTICALS INCORPORATED</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name:</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title:</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">OMNIAB, INC.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name:</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title:</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">AVISTA PUBLIC ACQUISITION CORP. II</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name:</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title:</TD></TR>
</TABLE></DIV>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Exhibit B to the Merger Agreement </B></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">TAX MATTERS AGREEMENT </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">by and among </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">AVISTA PUBLIC
ACQUISITION CORP. II<SUP STYLE="font-size:85%; vertical-align:top">1</SUP> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">LIGAND PHARMACEUTICALS INCORPORATED </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">OMNIAB, INC. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Dated as of March&nbsp;23, 2022 </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">1</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Note to Draft: To update to Avista&#146;s name post-domestication. </P></TD></TR></TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">TABLE OF CONTENTS </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="8%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="88%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Page</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ARTICLE I</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">DEFINITIONS</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">1.1</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">General</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ARTICLE II</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">PAYMENTS AND TAX REFUNDS</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2.1</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Allocation of Federal Taxes</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2.2</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Allocation of State Taxes</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2.3</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Allocation of Foreign Taxes</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2.4</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Certain Transaction Taxes</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">13</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2.5</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Determinations Regarding the Allocation and Attribution of Taxes</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">13</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2.6</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Allocation of Employment Taxes</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">13</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2.7</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Tax Refunds</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">13</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2.8</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Tax Benefits</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2.9</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Prior Agreements</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ARTICLE III</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">PREPARATION AND FILING OF TAX RETURNS</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3.1</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Remainco&#146;s Responsibility</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3.2</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Spinco&#146;s Responsibility</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">15</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3.3</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Right To Review Tax Returns</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">15</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3.4</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Cooperation</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">15</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3.5</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Tax Reporting Practices</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">15</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3.6</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Reporting of Reorganization</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">16</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3.7</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Payment of Taxes</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">17</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3.8</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Amended Returns and Carrybacks</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">17</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3.9</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Tax Attributes</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">18</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ARTICLE IV</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">TAX-FREE</FONT> STATUS OF THE DISTRIBUTION</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">4.1</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Representations and Warranties</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">18</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">4.2</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Restrictions Relating to the Distribution</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">19</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ARTICLE V</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">INDEMNITY OBLIGATIONS</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">5.1</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Indemnity Obligations</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">22</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">5.2</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Indemnification Payments</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">23</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">5.3</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Payment Mechanics</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">23</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">5.4</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Treatment of Payments</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">24</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">i </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="8%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="88%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ARTICLE VI</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">TAX CONTESTS</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">6.1</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Notice</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">24</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">6.2</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Separate Returns</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">24</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">6.3</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Joint Return</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">24</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">6.4</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Obligation of Continued Notice</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">25</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">6.5</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Settlement Rights</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">25</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">6.6</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Tax Contest Participation</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">25</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ARTICLE VII</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">COOPERATION</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">7.1</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">General</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">26</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">7.2</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Consistent Treatment</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">26</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ARTICLE VIII</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">RETENTION OF RECORDS; ACCESS</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">8.1</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Retention of Records</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">26</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">8.2</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Access to Tax Records</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">26</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ARTICLE IX</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">DISPUTE RESOLUTION</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">9.1</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Dispute Resolution</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">27</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ARTICLE X</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">MISCELLANEOUS PROVISIONS</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">10.1</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Entire Agreement; Construction</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">28</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">10.2</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Interest on Late Payments</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">28</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">10.3</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Successors and Assigns</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">28</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">10.4</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Subsidiaries</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">28</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">10.5</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Assignability</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">28</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">10.6</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">No Fiduciary Relationship</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">28</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">10.7</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Further Assurances</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">29</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">10.8</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Survival</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">29</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">10.9</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Notices</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">29</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">10.10</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; font-size:10pt; font-family:Times New Roman">Counterparts</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">30</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">10.11</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; font-size:10pt; font-family:Times New Roman">Consents</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">30</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">10.12</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; font-size:10pt; font-family:Times New Roman">Expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">30</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">10.13</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; font-size:10pt; font-family:Times New Roman">Termination and Amendment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">30</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">10.14</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; font-size:10pt; font-family:Times New Roman">Titles and Headings</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">30</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">10.15</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; font-size:10pt; font-family:Times New Roman">Severability</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">30</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">10.16</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; font-size:10pt; font-family:Times New Roman">Interpretation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">30</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">10.17</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; font-size:10pt; font-family:Times New Roman">No Duplication; No Double Recovery</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">30</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">10.18</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; font-size:10pt; font-family:Times New Roman">No Waiver</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">30</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">10.19</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; font-size:10pt; font-family:Times New Roman">Governing Law</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">30</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">10.20</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; font-size:10pt; font-family:Times New Roman">Distribution Time</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">31</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ii </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">TAX MATTERS AGREEMENT </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This TAX MATTERS AGREEMENT (this &#147;<U>Agreement</U>&#148;), is entered into as of March&nbsp;23, 2022 by and among Avista Public
Acquisition Corp. II, a Delaware corporation<SUP STYLE="font-size:85%; vertical-align:top">2</SUP> (&#147;<U>Parent</U>&#148;), Ligand Pharmaceuticals Incorporated, a Delaware corporation (&#147;<U>Remainco</U>&#148;), and OmniAb, Inc., a Delaware
corporation (&#147;<U>Spinco</U>&#148; and, together with Parent and Remainco, the &#147;<U>Parties</U>&#148;). Capitalized terms used in this Agreement and not otherwise defined herein shall have the meanings ascribed to such terms in the
Separation and Distribution Agreement, dated as of the date hereof, by and between the Parties (the &#147;<U>Separation Agreement</U>&#148;). </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">R E C I T A L S </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, the
board of directors of Remainco has determined that it is in the best interests of Remainco to separate Remainco&#146;s business from Spinco&#146;s business pursuant to the Separation Agreement (the &#147;<U>Separation</U>&#148;) and, following the
Separation, to undertake the Distribution; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, Remainco will effect certain restructuring transactions for the purpose of
aggregating Spinco&#146;s business in the Spinco Group (as defined below) prior to the Distribution (the &#147;<U>Reorganization</U>&#148;) and in connection therewith, undertake the Contribution to Spinco which, in exchange therefor, Spinco shall
issue to Remainco shares of Spinco Common Stock; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, Remainco intends to effect the Distribution in a transaction that, together
with the Contribution, is intended to qualify as a &#147;reorganization&#148; under Sections 355 and 368(a)(1)(D) of the Code; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS,
pursuant to that Merger Agreement entered into as of March&nbsp;23, 2022 by and among Remainco, Spinco, Parent, and Merger Sub (the &#147;<U>Merger Agreement</U>&#148;), following the completion of the Distribution, Merger Sub will be merged with
and into Spinco, with Spinco continuing as the surviving corporation; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, the Parties intend that the Merger (as defined below) will
qualify as a &#147;reorganization&#148; within the meaning of Section&nbsp;368(a) of the Code; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, certain members of the Remainco
Group (as defined below), on the one hand, and certain members of the Spinco Group, on the other hand, file certain Tax Returns on a consolidated, combined or unitary basis for certain federal, state, local and foreign Tax purposes; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, the Parties desire to (a)&nbsp;provide for the payment of Tax liabilities and entitlement to refunds thereof, allocate responsibility
for, and cooperation in, the filing of Tax Returns, and provide for certain other matters relating to Taxes and (b)&nbsp;set forth certain covenants and indemnities relating to the preservation of the <FONT STYLE="white-space:nowrap">tax-free</FONT>
status of the Distribution combined with certain steps in the Reorganization. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">2</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Note to Draft: To update to Avista&#146;s name post-domestication. </P></TD></TR></TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">NOW, THEREFORE, in consideration of the mutual agreements, provisions and covenants
contained in this Agreement, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Parties, intending to be legally bound, hereby agree as follows: </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE X </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>DEFINITIONS </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;10.1 <U>General</U>. As used in this Agreement, the following terms shall have the following meanings: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(136) &#147;<U>Adjustment</U>&#148; shall mean an adjustment of any item of income, gain, loss, deduction, credit or any other item affecting
Taxes of a taxpayer pursuant to a Final Determination. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(137) &#147;<U>Affiliate</U>&#148; shall mean, with respect to a Person, any other
Person that directly or indirectly, through one or more intermediaries, controls, is controlled by, or is under common control with, the specified Person. For this purpose, &#147;control&#148; of a Person means the possession, directly or
indirectly, of the power to direct or cause the direction of the management or policies of such Person, whether through ownership of voting securities, by contract or otherwise. The term &#147;Affiliate&#148; shall refer to Affiliates of a Person as
determined immediately after the Merger. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(138) &#147;<U>Agreement</U>&#148; shall have the meaning set forth in the preamble hereto. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(139) &#147;<U>Ancillary Agreements</U>&#148; shall have the meaning set forth in the Separation Agreement; provided, however, this Agreement
shall not be considered an &#147;Ancillary Agreement.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(140) &#147;<U>Business Day</U>&#148; shall have the meaning set forth in the
Separation Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(141) &#147;<U>Controlling Party</U>&#148; shall mean, with respect to a Tax Contest, the Party entitled to control
such Tax Contest pursuant to <U>Sections 6.2</U> and <U>6.3</U> of this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(142) &#147;<U>Code</U>&#148; shall mean the Internal
Revenue Code of 1986, as amended. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(143) &#147;<U>Contribution</U>&#148; shall have the meaning set forth in the Separation Agreement.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(144) &#147;<U>Distribution</U>&#148; shall have the meaning set forth in the Separation Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(145) &#147;<U>Distribution Date</U>&#148; shall mean the date on which the Distribution is completed. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(146) &#147;<U>Distribution Taxes</U>&#148; means any Taxes incurred solely as a result of the failure of the
<FONT STYLE="white-space:nowrap">Tax-Free</FONT> Status of the Internal Transactions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(147) &#147;<U>Distribution Time</U>&#148; shall
have the meaning set forth in the Separation Agreement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(148) &#147;<U>Employee Matters Agreement</U>&#148; shall have the meaning set forth in the
Separation Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(149) &#147;<U>Employment Tax</U>&#148; shall mean those Liabilities (as defined in the Separation Agreement) for
Taxes which are allocable pursuant to the provisions of the Employee Matters Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(150) &#147;<U>Equity Awards</U>&#148; means
options, share appreciation rights, restricted shares, share units or other compensatory rights with respect to Spinco Common Stock or Parent stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(151) &#147;<U>Federal Income Tax</U>&#148; shall mean any Tax imposed by Subtitle A of the Code other than an Employment Tax, and any
interest, penalties, additions to tax, or additional amounts in respect of the foregoing. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(152) &#147;<U>Federal Other Tax</U>&#148; any
Tax imposed by the federal government of the United States other than any Federal Income Tax and any interest, penalties, additions to Tax, or additional amounts in respect of the foregoing. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(153) &#147;<U>Federal Tax</U>&#148; means any Federal Income Tax or Federal Other Tax. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(154) &#147;<U>Final Determination</U>&#148; shall mean the final resolution of liability for any Tax for any Tax Period, by or as a result of
(a)&nbsp;a final decision, judgment, decree or other order by any court of competent jurisdiction that can no longer be appealed, (b)&nbsp;a final settlement with the IRS, a closing agreement or accepted offer in compromise under Sections 7121 or
7122 of the Code, or a comparable agreement under the Laws of other jurisdictions, which resolves the entire Tax liability for any Tax Period, (c)&nbsp;any allowance of a refund or credit in respect of an overpayment of Tax, but only after the
expiration of all periods during which such refund or credit may be recovered by the jurisdiction imposing the Tax, or (d)&nbsp;any other final resolution, including by reason of the expiration of the applicable statute of limitations or the
execution of a <FONT STYLE="white-space:nowrap">pre-filing</FONT> agreement with the IRS or other Taxing Authority. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(155)
&#147;<U>Foreign Income Tax</U>&#148; shall mean any Tax imposed by any foreign country or any possession of the United States, or by any political subdivision of any foreign country or United States possession, which is an income Tax as defined in
Treasury Regulations &#167; <FONT STYLE="white-space:nowrap">1.901-2,</FONT> and any interest, penalties, additions to tax, or additional amounts in respect of the foregoing. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(156) &#147;<U>Foreign Other Tax</U>&#148; shall mean any Tax imposed by any foreign country or any possession of the United States, or by any
political subdivision of any foreign country or United States possession, other than any Foreign Income Taxes, and any interest, penalties, additions to tax or additional amounts in respect of the foregoing. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(157) &#147;<U>Foreign Tax</U>&#148; shall mean any Foreign Income Taxes or Foreign Other Taxes. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(158) &#147;<U>Governmental Entity</U>&#148; shall have the meaning set forth in the Separation Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(159) &#147;<U>Group</U>&#148; shall mean the Remainco Group, the Spinco Group or the Parent Group, as the context requires. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(160) &#147;<U>Indemnifying Party</U>&#148; shall have the meaning set forth in
<U>Section</U><U></U><U>&nbsp;5.2</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(161) &#147;<U>Indemnitee</U>&#148; shall have the meaning set forth in
<U>Section</U><U></U><U>&nbsp;5.2</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(162) &#147;<U>IRS</U>&#148; shall mean the United States Internal Revenue Service or any
successor thereto, including, but not limited to its agents, representatives, and attorneys. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(163) &#147;<U>Joint Return</U>&#148; shall
mean any Tax Return that actually includes, by election or otherwise, or is required to include under applicable Law, one or more members of the Remainco Group together with one or more members of the Spinco Group. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(164) &#147;<U>Law</U>&#148; shall have the meaning set forth in the Separation Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(165) &#147;<U>Merger</U>&#148; shall have the meaning set forth in the Merger Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(166) &#147;<U>Merger Sub</U>&#148; shall have the meaning set forth in the Merger Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(167) &#147;<U><FONT STYLE="white-space:nowrap">Non-Controlling</FONT> Party</U>&#148; shall mean, with respect to a Tax Contest, the Party
that is not entitled to control such Tax Contest pursuant to <U>Sections 6.2</U> and <U>6.3</U> of this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(168)
&#147;<U>Parent</U>&#148; shall have the meaning set forth in the preamble hereto. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(169) &#147;<U>Parent Group</U>&#148; shall mean
Parent and each of its direct and indirect Subsidiaries after the Merger. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(170) &#147;<U>Parties</U>&#148; shall mean the parties to this
Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(171) &#147;<U>Past Practices</U>&#148; shall have the meaning set forth in <U>Section</U><U></U><U>&nbsp;3.5</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(172) &#147;<U>Person</U>&#148; shall have the meaning set forth in the Separation Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(173) &#147;<U>Post-Distribution Period</U>&#148; shall mean any Tax Period (or portion thereof) beginning after the Distribution Date,
including for the avoidance of doubt, the portion of any Straddle Period beginning after the Distribution Date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(174)
&#147;<U>Post-Distribution Ruling</U>&#148; shall have the meaning set forth in <U>Section</U><U></U><U>&nbsp;4.2(c)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(175) &#147;<U><FONT
STYLE="white-space:nowrap">Pre-Distribution</FONT> Period</U>&#148; shall mean any Tax Period (or portion thereof) ending on or before the Distribution Date, including for the avoidance of doubt, the portion of any Straddle Period ending at the end
of the day on the Distribution Date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(176) &#147;<U>Prohibited Acts</U>&#148; shall have the meaning set forth in
<U>Section</U><U></U><U>&nbsp;4.2</U>. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(177) &#147;<U>Proposed Acquisition Transaction</U>&#148; shall mean a transaction or series
of transactions (or any agreement, understanding or arrangement, within the meaning of Section&nbsp;355(e) of the Code and Treasury Regulations &#167; <FONT STYLE="white-space:nowrap">1.355-7,</FONT> or any other regulations promulgated thereunder,
to enter into a transaction or series of transactions), whether such transaction is supported by Spinco or Parent management or shareholders, is a hostile acquisition, or otherwise, as a result of which Spinco (or any successor thereto) or Parent
would merge or consolidate with any other Person or as a result of which one or more Persons would (directly or indirectly) acquire, or have the right to acquire, an amount of stock of Spinco or Parent that would, when combined with any other
changes in ownership of Spinco stock or Parent stock pertinent for purposes of Section&nbsp;355(e) of the Code (including the Merger), comprise 45% or more of (a)&nbsp;the value of all outstanding shares of stock of Spinco or Parent, as applicable,
as of the date of such transaction, or in the case of a series of transactions, the date of the last transaction of such series, or (b)&nbsp;the total combined voting power of all outstanding shares of voting stock of Spinco or Parent, as
applicable, as of the date of such transaction, or in the case of a series of transactions, the date of the last transaction of such series. Notwithstanding the foregoing, a Proposed Acquisition Transaction shall not include (i)&nbsp;the adoption by
Spinco or Parent of a shareholder rights plan, (ii)&nbsp;issuances by Spinco or Parent that satisfy Safe Harbor VIII (relating to acquisitions in connection with a person&#146;s performance of services) or Safe Harbor IX (relating to acquisitions by
a retirement plan of an employer) of Treasury Regulations &#167; <FONT STYLE="white-space:nowrap">1.355-7(d),</FONT> including such issuances net of exercise price and/or tax withholding (provided, however, that any sale of such stock in connection
with a net exercise or tax withholding is not exempt under this clause (ii)&nbsp;unless it satisfies the requirements of Safe Harbor VII of Treasury Regulations &#167; <FONT STYLE="white-space:nowrap">1.355-7(d))</FONT> or (iii)&nbsp;acquisitions
that satisfy Safe Harbor VII of Treasury Regulations &#167; <FONT STYLE="white-space:nowrap">1.355-7(d).</FONT> For purposes of determining whether a transaction constitutes an indirect acquisition, any recapitalization resulting in a shift of
voting power or any redemption of shares of stock shall be treated as an indirect acquisition of shares of stock by the <FONT STYLE="white-space:nowrap">non-exchanging</FONT> shareholders. For purposes of this definition, each reference to Spinco
shall include a reference to any entity treated as a successor thereto. This definition and the application thereof is intended to monitor compliance with Section&nbsp;355(e) of the Code and the Treasury Regulations promulgated thereunder and shall
be interpreted accordingly. Any clarification of, or change in, the statute or regulations promulgated under Section&nbsp;355(e) of the Code shall be incorporated in this definition and its interpretation. For the avoidance of doubt, the Merger
shall not constitute a proposed Acquisition Transaction. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(178) &#147;<U>Protective Section</U><U></U><U>&nbsp;336(e) Elections</U>&#148;
shall have the meaning set forth in <U>Section</U><U></U><U>&nbsp;3.6(b)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(179) &#147;<U>Reasonable Basis</U>&#148; shall mean
reasonable basis within the meaning of Section&nbsp;6662(d)(2)(B)(ii)(II) of the Code and the Treasury Regulations promulgated thereunder (or such other level of confidence required by the Code at that time to avoid the imposition of penalties).
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(180) &#147;<U>Refund</U>&#148; shall mean any refund, reimbursement, offset, credit, or other similar benefit in respect of Taxes
(including any overpayment of Taxes that can be refunded or, alternatively, applied against other Taxes payable), including any interest paid on or with respect to such refund of Taxes; <U>provided</U>, <U>however</U>, that the amount of any refund
of Taxes shall be net of any Taxes imposed on, related to, or attributable to, the receipt of or accrual of such refund, including any Taxes imposed by way of withholding or offset. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(181) &#147;<U>Remainco</U>&#148; shall have the meaning set forth in the preamble hereto. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(182) &#147;<U>Remainco Affiliated Group</U>&#148; shall mean an affiliated group (as that term is defined in Section&nbsp;1504 of the Code
and the regulations thereunder) of which a member of the Remainco Group is a member. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(183) &#147;<U>Remainco Common Stock</U>&#148; shall mean the common stock of Remainco, par
value $0.001 per share. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(184) &#147;<U>Remainco Disqualifying Action</U>&#148; means, with respect to any Distribution Taxes,
(a)&nbsp;any act, or failure or omission to act, including, without limitation, the breach of any covenant contained herein or in the Tax Materials, by any member of the Remainco Group that results in any Party (or any of its Affiliates) being
liable for such Distribution Taxes pursuant to a Final Determination, (b)&nbsp;any event (or series of events) involving capital stock of Remainco or any assets of any member of the Remainco Group or (c)&nbsp;any failure to be true, inaccuracy in,
or breach of any of the representations or statements contained in the Tax Materials; <I>provided, however</I>, a Remainco Disqualifying Action shall not include any failure to be true, inaccuracy in, or breach of any of the representations,
warranties, statements or covenants contained in the Tax Materials that is a failure to be true, inaccuracy in, or breach of the representations, warranties, statements or covenants contained in <U>Section</U><U></U><U>&nbsp;4.1(c)</U> that Parent
or Spinco is responsible for pursuant to<U> Section</U><U></U><U>&nbsp;4.1(c)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(185) &#147;<U>Remainco Federal Consolidated Income
Tax Return</U>&#148; shall mean any U.S. federal income Tax Return for a Remainco Affiliated Group. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(186) &#147;<U>Remainco
Group</U>&#148; shall mean Remainco and each Person that is a Subsidiary of Remainco; provided, however, that no member of the Spinco Group shall be a member of the Remainco Group. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(187) &#147;<U>Remainco Retained Business</U>&#148; shall have the meaning given to the term &#147;Ligand Retained Business&#148; in the
Separation Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(188) &#147;<U>Remainco Separate Return</U>&#148; shall mean any Tax Return of or including any member of the
Remainco Group (including any consolidated, combined, or unitary return) that does not include any member of the Spinco Group. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(189)
&#147;<U>Reorganization</U>&#148; shall have the meaning set forth in the recitals. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(190) &#147;<U>Responsible Party</U>&#148; shall
mean, with respect to any Tax Return, the Party having responsibility for preparing and filing such Tax Return pursuant to this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(191) &#147;<U>Restricted Period</U>&#148; shall mean the period which begins with the Distribution Date and ends two (2)&nbsp;years
thereafter. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(192) &#147;<U>Section</U><U></U><U>&nbsp;336(e) Allocation Statement</U>&#148; shall have the meaning set forth in
<U>Section</U><U></U><U>&nbsp;3.6(c)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(193) &#147;<U>Section</U><U></U><U>&nbsp;336(e) Tax Benefit Percentage</U>&#148; means, with
respect to any Distribution Taxes and <FONT STYLE="white-space:nowrap">Tax-Related</FONT> Losses attributable thereto, the percentage equal to one hundred percent (100%) minus the percentage of such Distribution Taxes and <FONT
STYLE="white-space:nowrap">Tax-Related</FONT> Losses for which Remainco is entitled to indemnification under this Agreement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(194) &#147;<U>Separate Return</U>&#148; shall mean a Remainco Separate Return or a Spinco
Separate Return, as the case may be. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(195) &#147;<U>Separation</U>&#148; shall have the meaning set forth in the recitals. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(196) &#147;<U>Separation Agreement</U>&#148; shall have the meaning set forth in the preamble hereto. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(197) &#147;<U>Spinco</U>&#148; shall have the meaning set forth in the preamble hereto. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(198) &#147;<U>Spinco Business</U>&#148; shall have the meaning given to the term &#147;OmniAb Business&#148; in the Separation Agreement.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(199) &#147;<U>Spinco Common Stock</U>&#148; shall mean the Common Stock, par value $0.001 per share, of Spinco. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(200) &#147;<U>Spinco Disqualifying Action</U>&#148; means, with respect to any Distribution Taxes, (a)&nbsp;any act, or failure or omission
to act, including, without limitation, the breach of any covenant contained herein or in the Tax Materials, by Parent or any member of the Spinco Group that results in any Party (or any of its Affiliates) being liable for such Distribution Taxes
pursuant to a Final Determination, regardless of whether such act or failure to act is covered by a Post-Distribution Ruling or Unqualified Tax Opinion, (b)&nbsp;any event (or series of events) involving capital stock of Parent or Spinco or any
assets of any member of the Parent Group or Spinco Group, or (c)&nbsp;any failure to be true, inaccuracy in, or breach of any of the representations or statements contained herein; <I>provided</I> <I>however</I>, that a Spinco Disqualifying Action
shall not include a failure to be true, inaccuracy in, or breach of the representations, warranties, statements or covenants in <U>Section</U><U></U><U>&nbsp;4.1(c)</U> that is the responsibility of Remainco pursuant to
<U>Section</U><U></U><U>&nbsp;4.1(c)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(201) &#147;<U>Spinco Group</U>&#148; shall mean Spinco and each Person that will be a
Subsidiary of Spinco as of immediately after the Distribution Time; provided, that, for the avoidance of doubt, no member of the Remainco Group shall be a member of the Spinco Group. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(202) &#147;<U>Spinco Separate Return</U>&#148; shall mean any Tax Return of or including any member of the Spinco Group (including any
consolidated, combined, or unitary return) that does not include any member of the Remainco Group. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(203) &#147;<U>Straddle
Period</U>&#148; shall mean any taxable year or other Tax Period that begins on or before the Distribution Date and ends after the Distribution Date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(204) &#147;<U>State Income Tax</U>&#148; means any Tax imposed by any State of the United States or by any political subdivision of any such
State that is imposed on or measured by income, including state or local franchise or similar Taxes measured by income, as well as any state or local franchise or similar Taxes imposed in lieu of or in addition to a tax imposed on or measured by
income and any interest, penalties, additions to tax, or additional amounts in respect of the foregoing. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(205) &#147;<U>State Other Tax</U>&#148; means any Tax imposed by any state of the United
States or by any political subdivision of any such state or the District of Columbia, other than any State Income Tax, and any interest, penalties, additions to tax, or additional amounts in respect of the foregoing </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(206) &#147;<U>State Taxes</U>&#148; means any State Income Tax or any State Other Tax. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(207) &#147;<U>Subsidiary</U>&#148; shall have the meaning set forth in the Separation Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(208) &#147;<U>Tax</U>&#148; or &#147;<U>Taxes</U>&#148; shall mean (i)&nbsp;all taxes, charges, fees, duties, levies, imposts, rates or other
assessments or governmental charges of any kind imposed by any federal, state, local or <FONT STYLE="white-space:nowrap">non-U.S.</FONT> Governmental Entity or political subdivision thereof, including, without limitation, income, gross receipts,
employment, estimated, excise, severance, stamp, occupation, premium, windfall profits, environmental, custom duties, property, sales, use, license, capital stock, transfer, franchise, registration, payroll, withholding, social security,
unemployment, disability, value added, alternative or <FONT STYLE="white-space:nowrap">add-on</FONT> minimum or other taxes, whether disputed or not, and including any interest, penalties, charges or additions attributable thereto,
(ii)&nbsp;liability for the payment of any amount of the type described in clause (i)&nbsp;above arising as a result of being (or having been) a member of any group or being (or having been) included or required to be included in any Tax Return
related thereto, and (iii)&nbsp;liability for the payment of any amount of the type described in clauses (i)&nbsp;or (ii) above as a result of any express or implied obligation to indemnify or otherwise assume or succeed to the liability of any
other Person. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(209) &#147;<U>Tax Attribute</U>&#148; shall mean net operating losses, capital losses, research and experimentation credit
carryovers, investment tax credit carryovers, earnings and profits, foreign tax credit carryovers, overall foreign losses, overall domestic losses, previously taxed income, separate limitation losses and any other losses, deductions, credits or
other comparable items that could affect a Tax liability for a past or future Tax Period. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(210) &#147;<U>Tax Benefit</U>&#148; shall have
the meaning set forth in <U>Section</U><U></U><U>&nbsp;2.8</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(211) &#147;<U>Tax Certificates</U>&#148; shall mean any certificates of
officers of Parent, Remainco and Spinco, provided to Latham&nbsp;&amp; Watkins LLP, Weil, Gotshal&nbsp;&amp; Manges LLP or any other law or accounting firm in connection with any Tax Opinion issued in connection with the Reorganization,
Distribution, or Merger. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(212) &#147;<U>Tax Contest</U>&#148; shall have the meaning set forth in <U>Section</U><U></U><U>&nbsp;6.1</U>.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(213) <U><FONT STYLE="white-space:nowrap">&#147;Tax-Free</FONT> Status of the Internal Transactions</U>&#148; shall mean the
qualification of the Contribution and the Distribution, taken together, (A)&nbsp;as a reorganization under Sections 355 and 368(a)(1)(D) of the Code, (B)&nbsp;as a transaction in which the stock distributed thereby is &#147;qualified property&#148;
for purposes of Sections 355(c) and 361(c) of the Code and (C)&nbsp;as a transaction in which Remainco, Spinco and the holders of Remainco Common Stock recognize no income or gain for U.S. federal income tax purposes pursuant to Sections 355, 361
and 1032 of the Code, other than, in the case of the holders of Remainco Common Stock for cash in lieu of fractional shares of Spinco Common Stock and in the case of Remainco and Spinco, amounts subject to Section&nbsp;356 of the Code and
intercompany items or excess loss accounts taken into account pursuant to the Treasury Regulations promulgated pursuant to Section&nbsp;1502 of the Code. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(214) &#147;<U><FONT STYLE="white-space:nowrap">Tax-Free</FONT> Status of the
Merger</U>&#148; shall mean the qualification of the Merger as a reorganization under 368(a) of the Code and as a transaction in which the shareholders of Spinco recognize no income or gain pursuant to Section&nbsp;354(a) of the Code (except to the
extent of any cash received in lieu of fractional shares of Parent stock). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(215)
&#147;<U><FONT STYLE="white-space:nowrap">Tax-Free</FONT> Status of the Transactions</U>&#148; shall mean both the <FONT STYLE="white-space:nowrap">Tax-Free</FONT> Status of the Internal Transactions and the
<FONT STYLE="white-space:nowrap">Tax-Free</FONT> Status of the Merger. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(216) &#147;<U>Tax Item</U>&#148; shall mean any item of income,
gain, loss, deduction, or credit. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(217) &#147;<U>Tax Law</U>&#148; shall mean the law of any Taxing Authority or political subdivision
thereof relating to any Tax. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(218) &#147;<U>Tax Materials</U>&#148; shall have the meaning set forth in
<U>Section</U><U></U><U>&nbsp;4.1(a)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(219) &#147;<U>Tax Opinion</U>&#148; shall mean any written opinion of Latham&nbsp;&amp;
Watkins LLP, Weil, Gotshal&nbsp;&amp; Manges LLP or any other Law or accounting firm, regarding certain tax consequences of certain transactions executed as part of the Separation, the Reorganization, the Contribution, the Distribution or the
Merger, as applicable. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(220) &#147;<U>Tax Period</U>&#148; means, with respect to any Tax, the period for which such Tax is reported as
provided under the Code or other applicable Tax Law. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(221) &#147;<U>Tax Records</U>&#148; shall have the meaning set forth in
<U>Section</U><U></U><U>&nbsp;8.1</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(222) &#147;<U><FONT STYLE="white-space:nowrap">Tax-Related</FONT> Losses</U>&#148; shall mean
with respect to any Taxes, (i)&nbsp;all accounting, legal and other professional fees, and court costs incurred in connection with such Taxes, as well as any other
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> costs incurred in connection with such Taxes; and (ii)&nbsp;all costs, expenses and damages associated with stockholder litigation or controversies and any
amount paid by Remainco (or any of its Affiliates) or Spinco (or any of its Affiliates) in respect of the liability of shareholders, whether paid to shareholders or to the IRS or any other Taxing Authority, in each case, resulting from the failure
of the <FONT STYLE="white-space:nowrap">Tax-Free</FONT> Status of the Transactions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(223) &#147;<U>Tax Return</U>&#148; shall mean any
return, report, certificate, form or similar statement or document (including any related supporting information or schedule attached thereto and any information return, amended tax return, claim for refund or declaration of estimated tax) supplied
to or filed with, or required to be supplied to or filed with, a Taxing Authority, in each case, in connection with the determination, assessment or collection of any Tax or the administration of any laws, regulations or administrative requirements
relating to any Tax. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(224) &#147;<U>Taxing Authority</U>&#148; shall mean any Governmental Entity or any subdivision, agency, commission
or entity thereof or any quasi-governmental or private body having jurisdiction over the assessment, determination, collection or imposition of any Tax (including the IRS). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(225) &#147;<U>Transactions</U>&#148; shall mean the Contribution, Distribution and Merger.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(226) &#147;<U>Transaction Taxes</U>&#148; shall mean all Taxes imposed on the Remainco Group or the Spinco Group in connection with the
Separation, the Reorganization, the Contribution or the Distribution other than Distribution Taxes. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(227) &#147;<U>Treasury
Regulations</U>&#148; shall mean the regulations promulgated from time to time under the Code as in effect for the relevant Tax Period. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(228) &#147;<U>Unqualified Tax Opinion</U>&#148; shall mean a &#147;will&#148; opinion, without substantive qualifications, of a nationally
recognized law firm or accounting firm, to the effect that a transaction will not affect the <FONT STYLE="white-space:nowrap">Tax-Free</FONT> Status of the Transactions. Any such opinion may assume that the
<FONT STYLE="white-space:nowrap">Tax-Free</FONT> Status of the Transactions would apply if not for the occurrence of the transaction in question. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE XI </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>PAYMENTS
AND TAX REFUNDS </U></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;11.1 <U>Allocation of Federal Taxes</U>. Except as otherwise provided in
<U>Section</U><U></U><U>&nbsp;2.4</U>, Federal Taxes shall be allocated as follows: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <U>Federal Income Taxes</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) Remainco shall be responsible for any and all Federal Income Taxes (including any increase in such Taxes as a result of a
Final Determination) due with respect to or required to be reported on (A)&nbsp;any Joint Return<I>; provided, however</I>, that Parent and Spinco shall be responsible for any and all such Taxes that are attributable to the Spinco Business with
respect to any Post-Distribution Period, (B)&nbsp;any Remainco Separate Return, or (C)&nbsp;any Spinco Separate Return with respect to any <FONT STYLE="white-space:nowrap">Pre-Distribution</FONT> Period. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) Parent and Spinco shall be responsible for any and all Federal Income Taxes (including any increase in such Taxes as a
result of a Final Determination) required to be reported on any Spinco Separate Return with respect to any Post-Distribution Period. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b)
<U>Federal Other Taxes Relating to Joint Returns</U>. Remainco shall be responsible for any and all Federal Other Taxes (including any increase in such Taxes as a result of a Final Determination) required to be reported on any Joint Return<I>;
provided, however</I>, that Parent and Spinco shall be responsible for any and all such Taxes that are attributable to the Spinco Business with respect to any Post-Distribution Period. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) <U>Federal Other Taxes Relating to Separate Returns</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) Remainco shall be responsible for any and all Federal Other Taxes (including any increase in such Taxes as a result of a
Final Determination) required to be reported on (A)&nbsp;any Remainco Separate Return or (B)&nbsp;any Spinco Separate Return with respect to any <FONT STYLE="white-space:nowrap">Pre-Distribution</FONT> Period. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) Parent and Spinco shall be responsible for any and all Federal Other
Taxes (including any increase in such Taxes as a result of a Final Determination) required to be reported on any Spinco Separate Return with respect to any Post-Distribution Period. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;11.2 <U>Allocation of State Taxes</U><U>.</U> Except as otherwise provided in <U>Section</U><U></U><U>&nbsp;2.4</U>, State Taxes
shall be allocated as follows. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <U>State Income Taxes Relating to Joint Returns</U>. Remainco shall be responsible for any and all
State Income Taxes (including any increase in such Taxes as a result of a Final Determination) required to be reported on any Joint Return<I>; provided, however</I>, that Parent and Spinco shall be responsible for any and all such Taxes that are
attributable to the Spinco Business with respect to any Post-Distribution Period. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <U>State Income Taxes Relating to Separate
Returns.</U> </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) Remainco shall be responsible for any and all State Income Taxes (including any increase in such Taxes as
a result of a Final Determination) required to be reported on (A)&nbsp;any Remainco Separate Return or (B)&nbsp;any Spinco Separate Return with respect to any <FONT STYLE="white-space:nowrap">Pre-Distribution</FONT> Period. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) Parent and Spinco shall be responsible for any and all State Income Taxes (including any increase in such Taxes as a
result of a Final Determination) required to be reported on any Spinco Separate Return with respect to any Post-Distribution Period. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c)
<U>State Other Taxes Relating to Joint Returns</U>. Remainco shall be responsible for any and all State Other Taxes (including any increase in such Taxes as a result of a Final Determination) required to be reported on any Joint Return<I>; provided,
however</I>, that Parent and Spinco shall be responsible for any and all such Taxes that are attributable to the Spinco Business with respect to any Post-Distribution Period. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) <U>State Other Taxes Relating to Separate Returns</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) Remainco shall be responsible for any and all State Other Taxes (including any increase in such Taxes as a result of a
Final Determination) required to be reported on (A)&nbsp;any Remainco Separate Return or (B)&nbsp;any Spinco Separate Return with respect to any <FONT STYLE="white-space:nowrap">Pre-Distribution</FONT> Period. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) Parent and Spinco shall be responsible for any and all State Other Taxes (including any increase in such Taxes as a result
of a Final Determination) required to be reported on any Spinco Separate Return for any Post-Distribution Period. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;11.3 <U>Allocation of Foreign Taxes</U><U> </U>. Except as otherwise provided
in <U>Section</U><U></U><U>&nbsp;2.4</U>, Foreign Taxes shall be allocated as follows: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <U>Foreign Income Taxes Relating to Joint
Returns.</U> Remainco shall be responsible for any and all Foreign Income Taxes (including any increase in such Taxes as a result of a Final Determination) required to be reported on any Joint Return<I>; provided, however</I>, that Parent and Spinco
shall be responsible for any and all such Taxes that are attributable to the Spinco Business with respect to any Post-Distribution Period. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <U>Foreign Income Taxes Relating to Separate Returns. </U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) Remainco shall be responsible for any and all Foreign Income Taxes (including any increase in such Taxes as a result of a
Final Determination) required to be reported on (A)&nbsp;any Remainco Separate Return or (B)&nbsp;any Spinco Separate Return with respect to any <FONT STYLE="white-space:nowrap">Pre-Distribution</FONT> Period. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) Parent and Spinco shall be responsible for any and all Foreign Income Taxes (including any increase in such Taxes as a
result of a Final Determination) required to be reported on any Spinco Separate Return with respect to any Post-Distribution Period. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c)
<U>Foreign Other Tax Relating to Joint Returns</U>. Remainco shall be responsible for any and all Foreign Other Taxes (including any increase in such Taxes as a result of a Final Determination) required to be reported on any Joint Return<I>;
provided, however</I>, that Parent and Spinco shall be responsible for any and all such Taxes that are attributable to the Spinco Business with respect to any Post-Distribution Period. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) <U>Foreign Other Tax Relating to Separate Returns. </U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) Remainco shall be responsible for any and all Foreign Other Taxes (including any increase in such Taxes as a result of a
Final Determination) required to be reported on (A)&nbsp;any Remainco Separate Return or (B)&nbsp;any Spinco Separate Return with respect to any <FONT STYLE="white-space:nowrap">Pre-Distribution</FONT> Period. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) Parent and Spinco shall be responsible for any and all Foreign Other Taxes (including any increase in such Taxes as a
result of a Final Determination) required to be reported on any Spinco Separate Return with respect to any Post-Distribution Period. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;11.4 <U>Certain Transaction Taxes</U>. Notwithstanding the provisions set forth
in <U>Sections</U><U></U><U>&nbsp;2.1</U>, <U>2.2</U>, and <U>2.3</U>: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Parent and Spinco shall pay and be responsible for any
Transaction Taxes in excess of the Transaction Taxes that would have been imposed on the Separation, the Reorganization, the Contribution, or the Distribution had such transactions been consummated but the Merger was not consummated; and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Remainco shall pay and be responsible for any and all Transaction Taxes other than those Transaction Taxes described in
<U>Section</U><U></U><U>&nbsp;2.4(a)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;11.5 <U>Determinations Regarding the Allocation and Attribution of Taxes</U>. For
purposes of <U>Sections</U><U></U><U>&nbsp;2.1</U>, <U>2.2</U>, and <U>2.3</U>, Taxes shall be allocated, to the extent relevant, in accordance with the following: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) With respect to the Remainco Federal Consolidated Income Tax Return for the taxable year that includes the Distribution Date, Remainco
shall use the closing of the books method under Treasury Regulations &#167; <FONT STYLE="white-space:nowrap">1.1502-76,</FONT> unless otherwise agreed by Remainco and Parent. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Remainco, Parent, and Spinco shall take all actions necessary or appropriate to close the taxable year of each member of the Spinco Group
for all Tax purposes as of the close of the Distribution Date to the extent permitted by applicable Law. With respect to Taxes for any Straddle Period, (a)&nbsp;if applicable Law does not permit a member of the Spinco Group to close its taxable year
on the Distribution Date, then the allocation of income or deductions required to determine any Taxes or other amounts attributable to the portion of the Straddle Period ending on, or beginning after, the Distribution Date shall be made by means of
a closing of the books and records of such member as of the close of the Distribution Date; provided that exemptions, allowances, or deductions that are calculated on an annual or periodic basis shall be allocated between such portions in proportion
to the number of days in each such portion, and (b)&nbsp;any other Taxes, including property Taxes, that are calculated on an annual or periodic basis and not assessed with respect to a transaction or series of transactions shall be allocated to the
portion of the Straddle Period ending on the Distribution Date and the portion of the Straddle Period beginning after the Distribution Date in proportion to the number of days in each such portion. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;11.6 <U>Allocation of Employment Taxes</U>. Liability for Employment Taxes shall be determined pursuant to the Employee Matters
Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;11.7 <U>Tax Refunds</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Remainco shall be entitled to all Refunds related to Taxes the liability for which is allocated to Remainco pursuant to this Agreement.
Spinco shall be entitled to all Refunds related to Taxes the liability for which is allocated to Spinco pursuant to this Agreement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Parent or Spinco shall pay to Remainco any Refund received by Parent or Spinco or any
member of the Spinco Group or Parent Group that is allocable to Remainco pursuant to this <U>Section</U><U></U><U>&nbsp;2.7</U> no later than thirty (30)&nbsp;Business Days after the receipt of such Refund. Remainco shall pay to Spinco any Refund
received by Remainco or any member of the Remainco Group that is allocable to Spinco pursuant to this <U>Section</U><U></U><U>&nbsp;2.7</U> no later than thirty (30)&nbsp;Business Days after the receipt of such Refund. For purposes of this
<U>Section</U><U></U><U>&nbsp;2.7</U>, any Refund that arises as a result of an offset, credit, or other similar benefit in respect of Taxes other than a receipt of cash shall be deemed to be received on the earlier of (i)&nbsp;the date on which a
Tax Return is filed claiming such offset, credit, or other similar benefit and (ii)&nbsp;the date on which payment of the Tax which would have otherwise been paid absent such offset, credit, or other similar benefit is due (determined without taking
into account any applicable extensions). To the extent that the amount of any Refund in respect of which a payment was made under this <U>Section</U><U></U><U>&nbsp;2.7</U> is later reduced by a Taxing Authority or in a Tax Contest, such reduction
shall be allocated to the Party to which such Refund was allocated pursuant to this <U>Section</U><U></U><U>&nbsp;2.7</U> and an appropriate adjusting payment shall be made. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;11.8 <U>Tax Benefits</U>. Except with respect to any Tax Benefit arising as a result of the Protective 336(e) Elections, if
(a)&nbsp;one Party is responsible for a Tax pursuant to this Agreement and (b)&nbsp;the other Party is entitled to a deduction, credit or other Tax benefit relating to such Tax (a &#147;<U>Tax Benefit</U>&#148;), then the Party entitled to such Tax
Benefit shall pay to the Party responsible for such Tax the amount of any cash Tax savings realized by the entitled Party as a result of such Tax Benefit, net of any Taxes imposed by any Taxing Authority on, related to, or attributable to, the
receipt of or accrual of such Tax Benefit, including any Taxes imposed by way of withholding or offset, no later than thirty (30)&nbsp;Business Days after such cash Tax savings are realized. To the extent that the amount of any Tax Benefit in
respect of which a payment was made under this <U>Section</U><U></U><U>&nbsp;2.8</U> is later reduced by a Taxing Authority or in a Tax Contest, the Party that received such payment shall refund such payment to the Party that made such payment to
the extent of such reduction. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;11.9 <U>Prior Agreements</U>. Except as set forth in this Agreement and in consideration of
the mutual indemnities and other obligations of this Agreement, any and all prior Tax sharing or allocation agreements or practices between any member of the Remainco Group and any member of the Spinco Group shall be terminated with respect to the
Spinco Group and the Remainco Group as of the Distribution Date. No member of either the Spinco Group or the Remainco Group shall have any continuing rights or obligations under any such agreement. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE XII </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>PREPARATION AND FILING OF TAX RETURNS </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;12.1 <U>Remainco</U><U>&#146;</U><U>s Responsibility</U>. Remainco shall prepare and file, or shall cause to be prepared and
filed, when due (taking into account any applicable extensions) all Joint Returns, and all Remainco Separate Returns, including any such amended Joint Returns or Separate Returns. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;12.2 <U>Spinco</U><U>&#146;</U><U>s Responsibility</U>. Parent or Spinco shall
prepare and file, or shall cause to be prepared and filed, when due (taking into account any applicable extensions) all Spinco Separate Returns, including any such amended Spinco Separate Returns. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;12.3 <U>Right To Review Tax Returns</U>. To the extent that a Party (the &#147;<U>Reviewing Party</U>&#148;) would reasonably be
expected to be adversely affected by the positions taken on any Tax Return or could reasonably be required by the terms of this Agreement to provide an indemnity or make a payment for any Taxes reported or required to be reported on any Tax Return
is not the Responsible Party, the Responsible Party shall prepare the portions of such Tax Return that could affect or result in indemnification by the Reviewing Party, shall provide a draft of such portions of such Tax Return to the Reviewing Party
for its review and comment at least thirty (30)&nbsp;days prior to the due date for such Tax Return, and shall modify such portions of such Tax Return before filing to include the Reviewing Party&#146;s reasonable comments. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;12.4 <U>Cooperation</U>. The Parties shall provide, and shall cause their Affiliates to provide, assistance and cooperation to
one another in accordance with <U>Article VII</U> with respect to the preparation and filing of Tax Returns, including providing information required to be provided under <U>Article VIII</U>. Notwithstanding anything to the contrary in this
Agreement, Remainco shall not be required to disclose to Parent or Spinco any consolidated, combined, unitary, or other similar Joint Return of which a member of the Remainco Group is the common parent or any information related to such a Joint
Return other than information relating solely to the Spinco Group; <U>provided</U>, <U>that</U> Remainco shall provide such additional information that is reasonably required in order for Spinco to determine the Taxes attributable to the Spinco
Business. If an amended Separate Return for which Parent or Spinco is responsible under this <U>Article III</U> is required to be filed as a result of an amendment made to a Joint Return pursuant to an audit adjustment, then the Parties shall use
their respective commercially reasonable efforts to ensure that such amended Separate Return can be prepared and filed in a manner that preserves confidential information including through the use of confidentiality agreements or third party
preparers. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;12.5 <U>Tax Reporting Practices</U>. Except as provided in <U>Section</U><U></U><U>&nbsp;3.6</U>, with respect to
any Tax Return for any Tax Period that begins on or before the second anniversary of the Distribution Date with respect to which Parent or Spinco is the Responsible Party, such Tax Return shall be prepared in a manner (i)&nbsp;consistent with past
practices, accounting methods, elections and conventions (&#147;<U>Past Practices</U>&#148;) used with respect to the Tax Returns in question (unless there is no Reasonable Basis for the use of such Past Practices), and to the extent any items are
not covered by Past Practices (or in the event that there is no Reasonable Basis for the use of such Past Practices), in accordance with reasonable Tax accounting practices selected by Spinco; and (ii)&nbsp;that, to the extent consistent with clause
(i), minimizes the overall amount of Taxes due and payable on such Tax Return for all of the Parties by cooperating in making such elections or applications for group or other relief or allowances available in the taxing jurisdiction in which such
Tax Return is filed. Neither Parent nor Spinco shall take any action inconsistent with the assumptions (including with respect to any Tax Item) made in determining all estimated or advance payments of Taxes on or prior to the Distribution Date. In
addition, neither Parent nor Spinco shall be permitted, and shall not permit any member of the Spinco Group or Parent Group, without Remainco&#146;s prior written consent (not to be unreasonably withheld, conditioned or delayed), to make a change in
any of its methods of accounting for Tax purposes until all applicable statutes of limitations for all <FONT STYLE="white-space:nowrap">Pre-Distribution</FONT> Periods have expired. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;12.6 <U>Reporting of Reorganization</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) The Tax treatment of any step in or portion of the Separation, the Reorganization, the Contribution and the Distribution shall be reported
on each applicable Tax Return consistently with the <FONT STYLE="white-space:nowrap">Tax-Free</FONT> Status of the Transactions, taking into account the jurisdiction in which such Tax Returns are filed, unless there is no Reasonable Basis for such
Tax treatment. In the event that a Party shall determine that there is no Reasonable Basis for such Tax treatment, such Party shall notify the other Party no later than twenty (20)&nbsp;Business Days prior to filing the relevant Tax Return and the
Parties shall attempt in good faith to agree on the manner in which the relevant portion of the Separation, the Reorganization, the Contribution or the Distribution (as applicable) shall be reported. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) If Remainco determines, in its reasonable discretion, that protective elections under Section&nbsp;336(e) of the Code (and any applicable
state or local Tax Law) shall be made with respect to the Distribution for Spinco and each member of the Spinco Group that is a domestic corporation for Federal Income Tax purposes (the &#147;<U>Protective Section</U><U></U><U>&nbsp;336(e)
Elections</U>&#148;), then Remainco and Spinco shall enter into a written, binding agreement to make the Protective Section&nbsp;336(e) Elections, and Remainco and Spinco shall timely make the Protective Section&nbsp;336(e) Elections in accordance
with Treasury Regulations &#167; <FONT STYLE="white-space:nowrap">1.336-2(h).</FONT> For the avoidance of doubt, such agreement is intended to constitute a &#147;written, binding agreement&#148; to make the Protective Section&nbsp;336(e) Elections
within the meaning of Treasury Regulations &#167; <FONT STYLE="white-space:nowrap">1.336-2(h)(1)(i).</FONT> </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Remainco, Parent and
Spinco shall cooperate in making the Protective Section&nbsp;336(e) Elections, if any, including filing any statements, amending any Tax Returns or undertaking such other actions reasonably necessary to carry out the Protective Section&nbsp;336(e)
Elections. Remainco shall determine the &#147;aggregate deemed asset disposition price&#148; and the &#147;adjusted <FONT STYLE="white-space:nowrap">grossed-up</FONT> basis&#148; (each as defined under applicable Treasury Regulations) and the
allocation of such aggregate deemed asset disposition price and adjusted <FONT STYLE="white-space:nowrap">grossed-up</FONT> basis among the assets of the applicable member or members of the Remainco Group or Spinco Group, each in accordance with the
applicable provisions of Section&nbsp;336(e) of the Code and applicable Treasury Regulations (the &#147;<U>Section</U><U></U><U>&nbsp;336(e) Allocation Statement</U>&#148;). Each Party agrees not to take any position (and to cause each of its
Affiliates not to take any position) that is inconsistent with the Protective Section&nbsp;336(e) Elections, including the Section&nbsp;336(e) Allocation Statement, on any Tax Return, in connection with any Tax Contest or for any other Tax purposes
(in each case, excluding any position taken for financial accounting purposes), except as may be required by a Final Determination. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) In
the event of a failure of the <FONT STYLE="white-space:nowrap">Tax-Free</FONT> Status of the Transactions, if Remainco is not entitled to indemnification for one hundred percent (100%) of any Distribution Taxes and
<FONT STYLE="white-space:nowrap">Tax-Related</FONT> Losses attributable thereto arising from such failure, Remainco shall be entitled to quarterly payments from Parent or Spinco equal to the Section&nbsp;336(e) Tax Benefit Percentage of the actual
Tax savings if, as and when realized by the Spinco Group arising from the increase in Tax basis (including, for the avoidance of doubt, any such increase in Tax basis </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">16 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
attributable to payments made pursuant to this <U>Section</U><U></U><U>&nbsp;3.6(d)</U>) resulting from the Protective Section&nbsp;336(e) Election, determined on a &#147;with and without&#148;
basis (treating any deductions or amortization attributable to the increase in Tax basis resulting from the Protective 336(e) Election, or any other recovery of such increase in Tax basis, as the last items claimed for any taxable year, including
after the utilization of any available net operating loss carryforwards); provided, however, that such payments: (i)&nbsp;shall be reduced by all reasonable costs incurred by any member of the Spinco Group to amend any Tax Returns or other
governmental filings related to such Protective Section&nbsp;336(e) Election and (ii)&nbsp;shall not exceed the amount of any Distribution Taxes and <FONT STYLE="white-space:nowrap">Tax-Related</FONT> Losses attributable thereto of the Remainco
Group (not taking into account this <U>Section</U><U></U><U>&nbsp;3.6(d)</U>) arising from such failure of the <FONT STYLE="white-space:nowrap">Tax-Free</FONT> Status of the Transactions and for which Remainco is not entitled to indemnification
under this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;12.7 <U>Payment of Taxes</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) With respect to any Tax Return required to be filed pursuant to this Agreement, the Responsible Party shall remit or cause to be remitted
to the applicable Taxing Authority in a timely manner any Taxes due in respect of any such Tax Return. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) In the case of any Tax Return
for which the Party that is not the Responsible Party is obligated pursuant to this Agreement to pay all or a portion of the Taxes reported as due on such Tax Return, the Responsible Party shall notify the other Party, in writing, of its obligation
to pay such Taxes and, in reasonably sufficient detail, its calculation of the amount due by such other Party and the Party receiving such notice shall pay such amount to the Responsible Party upon the later of five (5)&nbsp;Business Days prior to
the date on which such payment is due and thirty (30)&nbsp;Business Days after the receipt of such notice. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) For the avoidance of doubt,
with respect to any Taxes that are estimated Taxes, (i)&nbsp;the Party that is or will be the Responsible Party with respect to any Tax Return that will reflect (or otherwise give credit for) such estimated Taxes shall remit or cause to be remitted
to the applicable Taxing Authority in a timely manner any estimated Taxes due, and (ii)&nbsp;in the case of any estimated Taxes for which the Party that is not the Responsible Party is obligated pursuant to this Agreement to pay all or a portion of
the Taxes that will be reported as due on any Tax Return that will reflect (or otherwise give credit for) such estimated Taxes, the Responsible Party shall notify the other Party, in writing, of its obligation to pay such estimated Taxes and, in
reasonably sufficient detail, its calculation of the amount due by such other Party and the Party receiving such notice shall pay such amount to the Responsible Party upon the later of five (5)&nbsp;Business Days prior to the date on which such
payment is due and thirty (30)&nbsp;Business Days after the receipt of such notice. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;12.8 <U>Amended Returns and
Carrybacks</U>. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Parent and Spinco shall not, and shall not permit any member of the Spinco Group to, file or allow to be filed any
request for an Adjustment for any <FONT STYLE="white-space:nowrap">Pre-Distribution</FONT> Period without the prior written consent of Remainco, such consent not to be unreasonably withheld, conditioned or delayed. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">17 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Except as required by applicable Law, Remainco shall not, and shall not permit any
member of the Remainco Group to, file or allow to be filed any amended Tax Return or request for an Adjustment for any <FONT STYLE="white-space:nowrap">Pre-Distribution</FONT> Period or Straddle Period if the result would be to materially increase
any liability of Spinco or any member of the Spinco Group (other than any such increase to the extent attributable to an adjustment to a Tax Attribute) either (i)&nbsp;under this Agreement or (ii)&nbsp;for a Post-Distribution Period, in each case
without the prior written consent of Spinco, such consent not to be unreasonably withheld, conditioned or delayed. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Except as
prohibited by applicable Law, Parent and Spinco shall, and shall cause each member of the Spinco Group to, make any available elections to waive the right to carry back any Tax Attribute from a Post-Distribution Period to a <FONT
STYLE="white-space:nowrap">Pre-Distribution</FONT> Period. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) Parent and Spinco shall not, and shall cause each member of the Spinco
Group not to, without the prior written consent of Remainco, make any affirmative election to carry back any Tax Attribute from a Post-Distribution Period to a <FONT STYLE="white-space:nowrap">Pre-Distribution</FONT> Period, such consent to be
exercised in Remainco&#146;s sole discretion. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) Receipt of consent by Parent, Spinco, or a member of the Spinco Group from Remainco
pursuant to the provisions of this <U>Section</U><U></U><U>&nbsp;3.8</U> shall not limit or modify Parent&#146;s or Spinco&#146;s continuing indemnification obligation pursuant to <U>Article V</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;12.9 <U>Tax Attributes</U>. Remainco shall in good faith advise Spinco in writing of the amount, if any, of any Tax Attributes,
which Remainco determines, in its good faith discretion, shall be allocated or apportioned to the Spinco Group under applicable Law. Parent, Spinco and all members of the Parent Group shall prepare all Tax Returns in accordance with such written
notice. For the avoidance of doubt, Remainco may elect in its reasonable discretion, in order to comply with this <U>Section</U><U></U><U>&nbsp;3.9</U>, to create or cause to be created books and records or reports or other documents based thereon
(including, without limitation, &#147;earnings&nbsp;&amp; profits studies,&#148; &#147;basis studies&#148; or similar determinations) that it does not typically maintain or prepare in the ordinary course of business. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE XIII </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U><FONT
STYLE="white-space:nowrap">TAX-FREE</FONT> STATUS OF THE DISTRIBUTION </U></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;13.1 <U>Representations and Warranties</U>.
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Remainco, on behalf of itself and all other members of the Remainco Group, hereby represents and warrants that (i)&nbsp;it has
examined any and all Tax Opinions all materials delivered or deliverable in connection with the Tax Certificates or the rendering of any Tax Opinions (collectively, the &#147;<U>Tax Materials</U>&#148;), (ii) the facts presented and representations
that have been or will be made therein, to the extent descriptive of or otherwise relating to Remainco or any member of the Remainco Group or the Remainco Retained Business, were or will be at the time presented or represented and from such time
until and including the Distribution Time true, correct and complete in all material respects, and (iii)&nbsp;it has delivered copies of the Tax Materials to Parent. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">18 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Remainco, on behalf of itself and all other members of the Remainco Group, hereby
confirms and agrees to comply with any and all covenants and agreements in the Tax Materials applicable to Remainco or any member of the Remainco Group or the Remainco Retained Business. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Spinco, on behalf of itself and all other members of the Spinco Group, hereby represents and warrants or covenants and agrees, as
appropriate, that it has examined the Tax Materials and the facts presented and representations that have been or will be made therein, to the extent descriptive of or otherwise relating to (i)&nbsp;the Spinco Group or Parent Group (including the
business purposes for the Distribution) and the plans, proposals, intentions and policies of the Spinco Group or Parent Group after the Distribution Time, and (ii)&nbsp;the actions or <FONT STYLE="white-space:nowrap">non-actions</FONT> of the Spinco
Group or Parent Group to be taken (or not taken, as the case may be) after the Distribution Time, are, or will be from the time presented or made through and including the Distribution Time (and thereafter as relevant) true, correct and complete in
all material respects, <I>provided that</I>, for the avoidance of doubt, notwithstanding anything to the contrary in this Agreement, Remainco rather than Spinco or Parent shall be responsible for the accuracy of, or compliance with, any such
representation, warranty, statement, or covenant with respect to the Spinco Group or the Spinco Business at the time presented or made (and, if applicable, through and including the Distribution Time). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) Parent and Spinco, on behalf of themselves and all other members of their respective Groups, hereby confirm and agree to comply with any
and all covenants and agreements in the Tax Materials applicable to Parent, Spinco or any member of their respective Groups or the Spinco Business. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) Each of Remainco, on behalf of itself and all other members of the Remainco Group, Spinco, on behalf of itself and all other members of the
Spinco Group, and Parent, represents and warrants that it knows of no fact (after due inquiry) that may cause the failure of the <FONT STYLE="white-space:nowrap">Tax-Free</FONT> Status of the Transactions. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) Each of Remainco, on behalf of itself and all other members of the Remainco Group, Spinco, on behalf of itself and all other members of the
Spinco Group, and Parent represents and warrants that it has no plan or intent to take any action which is inconsistent with any statements or representations made in the Tax Materials. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;13.2 <U>Restrictions Relating to the Distribution</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Remainco, on behalf of itself and all other members of the Remainco Group, hereby covenants and agrees that no member of the Remainco Group
will take, fail to take, or to permit to be taken: (i)&nbsp;any action where such action or failure to act would be inconsistent with or cause to be untrue any statement, information, covenant or representation in the Tax Materials, (ii)&nbsp;any
action where such action or failure to act would adversely affect, or could reasonably be expected to adversely affect, the <FONT STYLE="white-space:nowrap">Tax-Free</FONT> Status of the Transactions or (iii)&nbsp;any action which constitutes a
Remainco Disqualifying Action. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">19 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Each of Spinco and Parent, on behalf of itself and all other members of their respective
Groups, hereby covenants and agrees that no member of their Group will take, fail to take, or permit to be taken: (i)&nbsp;any action where such action or failure to act would be inconsistent with or cause to be untrue any statement, information,
covenant or representation in the Tax Materials, (ii)&nbsp;any action where such action or failure to act would reasonably be expected to adversely affect the <FONT STYLE="white-space:nowrap">Tax-Free</FONT> Status of the Transactions or
(iii)&nbsp;any action which constitutes a Spinco Disqualifying Action. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) During the Restricted Period, Parent and Spinco: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) shall continue and cause to be continued the active conduct of the Spinco Business for purposes of Section&nbsp;355(b)(2)
of the Code, taking into account Section&nbsp;355(b)(3) of the Code, as conducted immediately prior to the Distribution, </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) shall not voluntarily dissolve or liquidate themselves or any member of the Spinco Group (including any action that is a
liquidation for U.S. federal income tax purposes), </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iii) shall not (1)&nbsp;enter into any Proposed Acquisition
Transaction or, to the extent Spinco or Parent has the right to prohibit any Proposed Acquisition Transaction, permit any Proposed Acquisition Transaction to occur (whether by (A)&nbsp;redeeming rights under a shareholder rights plan,
(B)&nbsp;finding a tender offer to be a &#147;permitted offer&#148; under any such plan or otherwise causing any such plan to be inapplicable or neutralized with respect to any Proposed Acquisition Transaction, (C)&nbsp;approving any Proposed
Acquisition Transaction, whether for purposes of Section&nbsp;203 of the General Corporation Law of the State of Delaware or any similar corporate statute, any &#147;fair price&#148; or other provision of the charter or bylaws of Parent or Spinco,
(D)&nbsp;amending its certificate of incorporation to declassify its board of directors or approving any such amendment, or (E)&nbsp;otherwise), (2) redeem or otherwise repurchase (directly or through an Affiliate) any stock, or rights to acquire
stock except (A)&nbsp;to the extent such repurchases satisfy Section&nbsp;4.05(1)(b) of Revenue Procedure <FONT STYLE="white-space:nowrap">96-30</FONT> (as in effect prior to the amendment of such Revenue Procedure by Revenue Procedure <FONT
STYLE="white-space:nowrap">2003-48),</FONT> (B) to the extent reasonably necessary to pay the total tax liability arising from the vesting of an Equity Award, or (C)&nbsp;through a net exercise of an Equity Award, (3)&nbsp;amend its certificate of
incorporation (or other organizational documents), or take any other action, whether through a stockholder vote or otherwise, affecting the relative voting rights of its capital stock (including through the conversion of any capital stock into
another class of capital stock), (4) merge or consolidate, or agree to merge or consolidate, Parent or Spinco with any other Person (other than pursuant to the Merger) unless, in the case of a merger or consolidation, Parent or Spinco (as
applicable) is the survivor of such merger or consolidation or (5)&nbsp;take any other action or actions (including any action or transaction that would be reasonably likely to be inconsistent with any representation made in the Tax Materials) which
in the aggregate (and taking into account the Merger) would, when combined with any other direct or indirect changes in ownership of Parent or Spinco capital stock pertinent for purposes of Section&nbsp;355(e) of the Code, have the effect of causing
or permitting one or more Persons (whether or not acting in concert) to acquire directly or indirectly stock representing a fifty percent (50%) or greater interest in Parent or Spinco or would reasonably be expected to result in a failure to
preserve the <FONT STYLE="white-space:nowrap">Tax-Free</FONT> Status of the Transactions; and </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">20 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iv) shall not and shall not permit any member of the Spinco Group, to sell,
transfer, or otherwise dispose of or agree to, sell, transfer or otherwise dispose (including in any transaction treated for U.S. federal income tax purposes as a sale, transfer or disposition) of assets (including, any shares of capital stock of a
Subsidiary) that, in the aggregate, constitute more than thirty percent (30%) of the consolidated gross assets of Spinco or the Spinco Group; provided, that this clause (iv)&nbsp;shall not apply to (1)&nbsp;sales, transfers, or dispositions of
assets in the ordinary course of business, (2)&nbsp;any cash paid to acquire assets from an unrelated Person in an <FONT STYLE="white-space:nowrap">arm&#146;s-length</FONT> transaction, (3)&nbsp;any assets transferred to a Person that is disregarded
as an entity separate from the transferor for U.S. federal income tax purposes or (4)&nbsp;any mandatory or optional repayment (or <FONT STYLE="white-space:nowrap">pre-payment)</FONT> of any indebtedness of Spinco or any member of the Spinco Group;
provided, further that the percentages of gross assets or consolidated gross assets of Spinco or the Spinco Group, as the case may be, sold, transferred, or otherwise disposed of, shall be based on the fair market value of the gross assets of Spinco
and the members of the Spinco Group as of the Distribution Date. For purposes of this <U>Section</U><U></U><U>&nbsp;4.2(c)(iv),</U> a merger of Spinco or one of its Subsidiaries with and into any Person that is not a wholly owned Subsidiary of
Spinco shall constitute a disposition of all of the assets of Spinco or such Subsidiary. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) Notwithstanding the restrictions imposed by
<U>Sections 4.2(b)</U> and <U>4.2(c)</U>, Parent, Spinco or a member of the Spinco Group may take any of the actions or transactions described therein if Spinco either (i)&nbsp;obtains an Unqualified Tax Opinion in form and substance reasonably
satisfactory to Remainco, (ii)&nbsp;obtains a ruling from the IRS to the effect that such actions or transactions will not affect the <FONT STYLE="white-space:nowrap">Tax-Free</FONT> Status of the Transactions (a &#147;<U>Post-Distribution
Ruling</U>&#148;) or (iii)&nbsp;obtains the prior written consent of Remainco waiving the requirement that Spinco obtain an Unqualified Tax Opinion or Post-Distribution Ruling, such waiver to be provided in Remainco&#146;s sole and absolute
discretion. Remainco shall cooperate in good faith with any reasonable requests of Spinco in connection with securing any Post-Distribution Ruling or Unqualified Tax Opinion. Remainco&#146;s evaluation of an Unqualified Tax Opinion may consider,
among other factors, the appropriateness of any underlying assumptions, representations, and covenants made in connection with such opinion. Spinco shall bear all costs and expenses of securing any such Unqualified Tax Opinion or Post-Distribution
Ruling and shall reimburse Remainco for all reasonable <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> expenses that Remainco or any of its Affiliates may incur in good faith in connection with obtaining
or evaluating any such Unqualified Tax Opinion or Post-Distribution Ruling. Except as otherwise provided in <U>Section</U><U></U><U>&nbsp;5.1(d)</U>, neither the delivery of an Unqualified Tax Opinion, receipt of a Post-Distribution Ruling nor
Remainco&#146;s waiver of Spinco&#146;s obligation to deliver an Unqualified Tax Opinion or obtain a Post-Distribution Ruling shall limit or modify Parent&#146;s or Spinco&#146;s continuing indemnification obligation Pursuant to <U>Article V</U>.
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">21 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE XIV </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>INDEMNITY OBLIGATIONS </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;14.1 <U>Indemnity Obligations</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Remainco shall indemnify and hold harmless Spinco from and against, and will reimburse Spinco for, (i)&nbsp;all liability for Taxes
allocated to Remainco pursuant to <U>Article II</U>, (ii)&nbsp;all Taxes and <FONT STYLE="white-space:nowrap">Tax-Related</FONT> Losses attributable thereto arising out of, based upon, or relating or attributable to any breach of or inaccuracy in,
or failure to perform, as applicable, any representation, covenant, or obligation of any member of the Remainco Group pursuant to this Agreement, (iii)&nbsp;the amount of any Refund received by any member of the Remainco Group that is allocated to
Spinco pursuant to <U>Section</U><U></U><U>&nbsp;2.7(a)</U> and (iv)&nbsp;any Distribution Taxes and <FONT STYLE="white-space:nowrap">Tax-Related</FONT> Losses attributable to a Remainco Disqualifying Action. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Except as otherwise provided in <U>Section </U><U>Error! Reference source not found.</U>, without regard to whether an Unqualified Tax
Opinion may have been provided, any Post-Distribution Ruling obtained or whether any action is permitted or consented to hereunder and notwithstanding anything else to the contrary contained herein, in the Separation Agreement, the Merger Agreement
or other Ancillary Agreement, Parent and Spinco shall indemnify and hold harmless Remainco from and against, and will reimburse Remainco for, (i)&nbsp;all liability for Taxes allocated to Spinco pursuant to<U> Article II</U>, (ii)&nbsp;all Taxes and
<FONT STYLE="white-space:nowrap">Tax-Related</FONT> Losses attributable thereto arising out of, based upon, or relating or attributable to any breach of or inaccuracy in, or failure to perform, as applicable, any representation, covenant, or
obligation of any member of the Spinco Group pursuant to this Agreement, (iii)&nbsp;the amount of any Refund received by any member of the Spinco Group that is allocated to Remainco pursuant to <U>Section</U><U></U><U>&nbsp;2.7(a)</U> and
(iv)&nbsp;any Distribution Taxes and <FONT STYLE="white-space:nowrap">Tax-Related</FONT> Losses attributable to a Spinco Disqualifying Action . </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Except as otherwise provided in <U>Section </U><U>Error! Reference source not found.</U>, if any Distribution Taxes are (i)&nbsp;not
attributable to either a Remainco Disqualifying Action or a Spinco Disqualifying Action or (ii)&nbsp;attributable to both a Remainco Disqualifying Action and a Spinco Disqualifying Action, then Remainco shall bear fifty percent (50%) and Parent and
Spinco shall bear fifty percent (50%) of such Distribution Taxes and corresponding <FONT STYLE="white-space:nowrap">Tax-Related</FONT> Losses. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) If any Distribution Taxes or <FONT STYLE="white-space:nowrap">Tax-Related</FONT> Losses attributable thereto are attributable to any action
or transaction constituting a Spinco Disqualifying Action with respect to which Spinco obtains both (i)&nbsp;the prior written consent of Remainco in satisfaction of <U>Section</U><U></U><U>&nbsp;4.2(d)(iii)</U> and (ii)&nbsp;either an Unqualified
Tax Opinion in form and substance reasonably satisfactory to Remainco in satisfaction of <U>Section</U><U></U><U>&nbsp;4.2(d)(i)</U> or a Post-Distribution Ruling in satisfaction of <U>Section</U><U></U><U>&nbsp;4.2(d)(ii)</U>, then Remainco shall
bear fifty percent (50%) and Parent and Spinco shall bear fifty percent (50%) of such Distribution Taxes and corresponding <FONT STYLE="white-space:nowrap">Tax-Related</FONT> Losses. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">22 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;14.2 <U>Indemnification Payments</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Except as otherwise provided in this Agreement, if either Party (the &#147;<U>Indemnitee</U>&#148;) is required to pay to a Taxing
Authority a Tax or to another Person a payment in respect of a Tax that the other Party (the &#147;<U>Indemnifying Party</U>&#148;) is liable for under this Agreement, including as the result of a Final Determination, the Indemnitee shall notify the
Indemnifying Party, in writing, of its obligation to pay such Tax and, in reasonably sufficient detail, its calculation of the amount due by such Indemnifying Party to the Indemnitee, including any <FONT STYLE="white-space:nowrap">Tax-Related</FONT>
Losses attributable thereto. The Indemnifying Party shall pay such amount, including any <FONT STYLE="white-space:nowrap">Tax-Related</FONT> Losses attributable thereto, to the Indemnitee no later than the later of (i)&nbsp;five (5) Business Days
prior to the date on which such payment is due to the applicable Taxing Authority or (ii)&nbsp;thirty (30) Business Days after the receipt of notice from the other Party. Any Tax indemnity payment required to be made pursuant to this Agreement shall
be reduced by any corresponding Tax Benefit payment required to be made to the Indemnifying Party by the Indemnitee pursuant to <U>Section</U><U></U><U>&nbsp;2.8</U>. For the avoidance of doubt, a Tax Benefit payment is treated as corresponding to a
Tax indemnity payment to the extent the Tax Benefit realized is directly attributable to the same Tax item (or adjustment of such Tax item pursuant to a Final Determination) that gave rise to the Tax indemnity payment. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) If, as a result of any change or redetermination, any amount previously allocated to and borne by one Party pursuant to the provisions of
<U>Article II</U> is thereafter allocated to the other Party, then, no later than thirty (30)&nbsp;Business Days after such change or redetermination, such other Party shall pay to such Party the amount previously borne by such Party which is
allocated to such other Party as a result of such change or redetermination. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) If an Indemnitee receives a Refund with respect to a Tax
Contest for which the Indemnifying Party made an indemnity payment to the Indemnitee pursuant to <U>Section</U><U></U><U>&nbsp;5.2(a)</U>, the Indemnitee shall pay the amount of such Refund to the Indemnifying Party, such payment to the Indemnifying
Party not to exceed such indemnity payment, no later than thirty (30)&nbsp;Business Days after the receipt of such Refund. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;14.3 <U>Payment Mechanics</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) All payments under this Agreement shall be made by Remainco directly to Spinco and by Spinco directly to Remainco; <U>provided</U>,
<U>however</U>, that if the Parties mutually agree with respect to any such indemnification payment, any member of the Remainco Group, on the one hand, may make such indemnification payment to any member of the Spinco Group, on the other hand, and
vice versa. All indemnification payments shall be treated in the manner described in <U>Section</U><U></U><U>&nbsp;5.4</U>. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) In the
case of any payment of Taxes made by a Responsible Party or Indemnitee pursuant to this Agreement for which such Responsible Party or Indemnitee, as the case may be, has received a payment from the other Party, such Responsible Party or Indemnitee
shall provide to the other Party a copy of any official government receipt received with respect to the payment of such Taxes to the applicable Taxing Authority (or, if no such official governmental receipts are available, executed bank payment
forms or other reasonable evidence of payment). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">23 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;14.4 <U>Treatment of Payments</U>. The Parties agree that any payment made
among the Parties pursuant to this Agreement (other than any payment of interest accruing after the Distribution Date) shall be treated, to the extent permitted by Law, for all U.S. federal income tax purposes as either (i)&nbsp;a <FONT
STYLE="white-space:nowrap">non-taxable</FONT> contribution by Remainco to Spinco or (ii)&nbsp;a distribution by Spinco to Remainco, and, with respect to any payment made among the Parties pursuant to this Agreement after the Distribution, such
payment shall be treated as having been made immediately prior to the Distribution. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE XV </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>TAX CONTESTS </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;15.1 <U>Notice</U>. Each Party shall notify the other Party in writing within ten (10)&nbsp;Business Days after receipt by such
Party or any member of its Group of a written communication from any Taxing Authority with respect to any pending or threatened audit, claim, dispute, suit, action, proposed assessment or other proceeding (a &#147;<U>Tax Contest</U>&#148;)
concerning any Taxes for which the other Party may be liable pursuant to this Agreement, and thereafter shall promptly forward or make available to such Party copies of notices and communications relating to such Tax Contest. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;15.2 <U>Separate Returns</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) If, pursuant to <U>Article II</U> hereof, Spinco has sole liability for the Taxes that are the subject of a Tax Contest with respect to any
Separate Return, then subject to <U>Section</U><U></U><U>&nbsp;6.5 </U>and <U>Section</U><U></U><U>&nbsp;6.6</U>, Spinco shall have the sole responsibility and right to control the prosecution of such Tax Contest, including the exclusive right to
communicate with agents of the applicable Taxing Authority and to control, resolve, settle, or agree to any deficiency, claim or adjustment proposed, asserted or assessed in connection with or as a result of such Tax Contest. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) With respect to any Tax Contest other than those described in <U>Section</U><U></U><U>&nbsp;6.2(a)</U>, subject to
<U>Section</U><U></U><U>&nbsp;6.5</U> or <U>Section</U><U></U><U>&nbsp;6.6</U>, Remainco shall have the sole responsibility and right to control the prosecution of such Tax Contest, including the exclusive right to communicate with agents of the
applicable Taxing Authority and to control, resolve, settle, or agree to any deficiency, claim or adjustment proposed, asserted or assessed in connection with or as a result of such Tax Contest. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;15.3 <U>Joint Return</U>. In the case of any Tax Contest with respect to any Joint Return, Remainco shall, subject to
<U>Section</U><U></U><U>&nbsp;6.5</U> and <U>Section</U><U></U><U>&nbsp;6.6</U>, have the sole responsibility and right to control the prosecution of such Tax Contest, including the exclusive right to communicate with agents of the applicable Taxing
Authority and to control, resolve, settle or agree to any deficiency, claim or adjustment proposed, asserted, or assessed in connection with or as a result of such Tax Contest. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">24 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;15.4 <U>Obligation of Continued Notice</U>. During the pendency of any Tax
Contest or threatened Tax Contest, each of the Parties shall provide prompt notice to the other Party of any written communication received by it or a member of its respective Group from a Taxing Authority regarding any Tax Contest for which it is
indemnified by the other Party hereunder or for which it may be required to indemnify the other Party hereunder. Such notice shall attach copies of the pertinent portion of any written communication from a Taxing Authority and contain factual
information (to the extent known) describing any asserted Tax liability in reasonable detail and shall be accompanied by copies of any notice and other documents received from any Taxing Authority in respect of any such matters. Such notice shall be
provided in a reasonably timely fashion; <U>provided</U>,<U> however</U>, that in the event that timely notice is not provided, a Party shall be relieved of its obligation to indemnify the other Party only to the extent that such delay results in
actual increased costs or actual prejudice to such other Party. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;15.5 <U>Settlement Rights</U>. Unless waived by the Parties
in writing, in connection with any potential adjustment in a Tax Contest as a result of which adjustment the <FONT STYLE="white-space:nowrap">Non-Controlling</FONT> Party may reasonably be expected to become liable to make any indemnification
payment to the Controlling Party under this Agreement: (i)&nbsp;the Controlling Party shall keep the <FONT STYLE="white-space:nowrap">Non-Controlling</FONT> Party informed in a timely manner of all actions taken or proposed to be taken by the
Controlling Party with respect to such potential adjustment in such Tax Contest; (ii)&nbsp;the Controlling Party shall timely provide the <FONT STYLE="white-space:nowrap">Non-Controlling</FONT> Party with copies of any correspondence or filings
submitted to any Taxing Authority or judicial authority in connection with such potential adjustment in such Tax Contest; (iii)&nbsp;the Controlling Party shall defend such Tax Contest diligently and in good faith; and (iv)&nbsp;the Controlling
Party shall not settle or agree to any deficiency, claim or adjustment proposed, asserted or assessed without the prior written consent of the <FONT STYLE="white-space:nowrap">Non-Controlling</FONT> Party (not to be unreasonably withheld,
conditioned or delayed). The failure of the Controlling Party to take any action specified in the preceding sentence with respect to the <FONT STYLE="white-space:nowrap">Non-Controlling</FONT> Party shall not relieve the <FONT
STYLE="white-space:nowrap">Non-Controlling</FONT> Party of any liability and/or obligation which it may have to the Controlling Party under this Agreement, except to the extent the <FONT STYLE="white-space:nowrap">Non-Controlling</FONT> Party is
actually harmed thereby, and in no event shall such failure relieve the <FONT STYLE="white-space:nowrap">Non-Controlling</FONT> Party from any other liability or obligation which it may have to the Controlling Party. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;15.6 <U>Tax Contest Participation</U>. Unless waived by the Parties in writing, the Controlling Party shall provide the <FONT
STYLE="white-space:nowrap">Non-Controlling</FONT> Party with written notice reasonably in advance of, and the <FONT STYLE="white-space:nowrap">Non-Controlling</FONT> Party shall have the right to attend and participate in, any formally scheduled
meetings with Taxing Authorities or hearings or proceedings before any judicial authorities in connection with any potential adjustment in a Tax Contest pursuant to which the <FONT STYLE="white-space:nowrap">Non-Controlling</FONT> Party may
reasonably be expected to become liable to make any indemnification payment to the Controlling Party under this Agreement (including any Tax Contest related to the <FONT STYLE="white-space:nowrap">Tax-Free</FONT> Status of the Transactions) or may
reasonably be expected to give rise to Tax liabilities of the <FONT STYLE="white-space:nowrap">Non-Controlling</FONT> Party for any Post-Distribution Period. The failure of the Controlling Party to provide any notice specified in this
<U>Section</U><U></U><U>&nbsp;6.6</U> to the <FONT STYLE="white-space:nowrap">Non-Controlling</FONT> Party shall not relieve the <FONT STYLE="white-space:nowrap">Non-Controlling</FONT> Party of any liability and/or obligation which it may have to
the Controlling Party under this Agreement except to the extent that the <FONT STYLE="white-space:nowrap">Non-Controlling</FONT> Party was actually harmed by such failure, and in no event shall such failure relieve the
<FONT STYLE="white-space:nowrap">Non-Controlling</FONT> Party from any other liability or obligation which it may have to the Controlling Party. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">25 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE XVI </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>COOPERATION </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;16.1 <U>General</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Each Party shall fully cooperate, and shall cause all members of such Party&#146;s Group to fully cooperate, with all reasonable requests
in writing from the other Party, or from an agent, representative or advisor to such Party, in connection with the preparation and filing of any Tax Return, claims for Refunds, the conduct of any Tax Contest, and calculations of amounts required to
be paid pursuant to this Agreement, in each case, related or attributable to or arising in connection with Taxes of either Party or any member of either Party&#146;s Group covered by this Agreement and the establishment of any reserve required in
connection with any financial reporting (a &#147;<U>Tax Matter</U>&#148;). Such cooperation shall include the provision of any information reasonably necessary or helpful in connection with a Tax Matter and shall include, without limitation, at each
Party&#146;s own cost: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) the provision of any Tax Returns of either Party or any member of either Party&#146;s Group,
books, records (including information regarding ownership and Tax basis of property), documentation and other information relating to such Tax Returns, including accompanying schedules, related work papers, and documents relating to rulings or other
determinations by Taxing Authorities; and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) the execution of any document (including any power of attorney) in
connection with any Tax Contest of either Party or any member of either Party&#146;s Group, or the filing of a Tax Return or a Refund claim of either Party or any member of either Party&#146;s Group. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Each Party shall make its employees and facilities available, without charge, on a mutually convenient basis to facilitate such cooperation.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;16.2 <U>Consistent Treatment</U>. Unless and until there has been a Final Determination to the contrary, each Party agrees
not to take any position on any Tax Return, in connection with any Tax Contest or otherwise that is inconsistent with (a)&nbsp;the treatment of payments between the Remainco Group and the Spinco Group as set forth in
<U>Section</U><U></U><U>&nbsp;5.4</U>, (b) the Tax Materials or (c)&nbsp;the <FONT STYLE="white-space:nowrap">Tax-Free</FONT> Status of the Transactions. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE XVII </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>RETENTION OF RECORDS; ACCESS </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;17.1 <U>Retention of Records</U>. For so long as the contents thereof may become material in the administration of any matter
under applicable Tax Law, but in any event until the later of (i)&nbsp;sixty (60) days after the expiration of any applicable statutes of limitation (including any waivers or extensions thereof) and (ii)&nbsp;seven (7) years after the Distribution
Date, the Parties shall retain records, documents, accounting data and other information (including computer data) </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">26 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
necessary for the preparation and filing of all Tax Returns (collectively, &#147;<U>Tax Records</U>&#148;) in respect of Taxes of any member of either the Remainco Group or the Spinco Group for
any <FONT STYLE="white-space:nowrap">Pre-Distribution</FONT> Period or Post-Distribution Period or for any Tax Contests relating to such Tax Returns. At any time after the Distribution Date when the Remainco Group proposes to destroy any Tax
Records, the Remainco Group shall first notify the Parent Group in writing, and the Parent Group shall be entitled to receive such records or documents proposed to be destroyed. At any time after the Distribution Date when the Spinco Group or Parent
Group proposes to destroy any Tax Records, Spinco or Parent, as appropriate, shall first notify Remainco in writing and the Remainco Group shall be entitled to receive such records or documents proposed to be destroyed. The Parties will notify each
other in writing of any waivers or extensions of the applicable statute of limitations that may affect the period for which the foregoing records or other documents must be retained. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;17.2 <U>Access to Tax Records</U>. The Parties and their respective Affiliates shall make available to each other for inspection
and copying during normal business hours upon reasonable notice all Tax Records (including, for the avoidance of doubt, any pertinent underlying data accessed or stored on any computer program or information technology system) in their possession
and shall permit the other Party and its Affiliates, authorized agents and representatives and any representative of a Taxing Authority or other Tax auditor direct access, during normal business hours upon reasonable notice to any computer program
or information technology system used to access or store any Tax Records, in each case to the extent reasonably required by the other Party in connection with the preparation of Tax Returns or financial accounting statements, audits, litigation, or
the resolution of items pursuant to this Agreement. The Party seeking access to the records of the other Party shall bear all costs and expenses associated with such access, including any professional fees. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE XVIII </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>DISPUTE RESOLUTION </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;18.1 <U>Dispute Resolution</U>. In the event of any dispute between the Parties as to any financial matter covered by this
Agreement, the Parties shall appoint a nationally recognized independent public accounting firm (the &#147;<U>Accounting Firm</U>&#148;) to resolve such dispute. In this regard, the Accounting Firm shall make determinations with respect to the
disputed items based solely on representations made by Remainco, Spinco, Parent, and their respective representatives, and not by independent review, and shall function only as an expert and not as an arbitrator and shall be required to make a
determination in favor of one Party only. The Parties shall require the Accounting Firm to resolve all disputes no later than ninety (90)&nbsp;days after the submission of such dispute to the Accounting Firm, but in no event later than the due date
for the payment of Taxes or the filing of the applicable Tax Return, if applicable, and agree that all decisions by the Accounting Firm with respect thereto shall be final and conclusive and binding on the Parties. The Accounting Firm shall resolve
all disputes in a manner consistent with this Agreement and, to the extent not inconsistent with this Agreement, in a manner consistent with the Past Practices of Remainco and its Subsidiaries, except as otherwise required by applicable Law. The
Parties shall require the Accounting Firm to render all determinations in writing and to set forth, in reasonable detail, the basis for such determination. The fees and expenses of the Accounting Firm shall be borne equally by Remainco, on the one
hand, and Parent and Spinco, on the other hand. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">27 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE XIX </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>MISCELLANEOUS PROVISIONS </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;19.1 <U>Entire Agreement; Construction</U>. This Agreement shall constitute the entire agreement between the Parties with respect
to the subject matter hereof and shall supersede all previous negotiations, commitments, course of dealings and writings with respect to such subject matter. Except as expressly set forth in this Agreement, the Separation Agreement or any Ancillary
Agreement: (i)&nbsp;all matters relating to Taxes and Tax Returns of the Parties and their respective Subsidiaries shall be governed exclusively by this Agreement and (ii)&nbsp;for the avoidance of doubt, in the event of any conflict between this
Agreement, on the one hand, and the Separation Agreement or any Ancillary Agreement, on the other hand, with respect to such matters, the terms and conditions of this Agreement shall govern. Notwithstanding the foregoing, in the event of any
conflict between this Agreement and the Employee Matters Agreement with respect to the Ligand Equity Awards, the OmniAb Equity Awards (as such terms are defined in the Employee Matters Agreement), payroll Taxes, or Code Section&nbsp;409A, the
Employee Matters Agreement shall govern. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;19.2 <U>Interest on Late Payments</U>. With respect to any payment between the
Parties pursuant to this Agreement not made by the due date set forth in this Agreement for such payment, the outstanding amount will accrue interest at a rate per annum equal to the rate in effect for underpayments under Section&nbsp;6621 of the
Code from such due date to and including the payment date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;19.3 <U>Successors and Assigns</U>. The provisions of this
Agreement and the obligations and rights hereunder shall be binding upon, inure to the benefit of and be enforceable by (and against) the Parties and their respective successors and permitted assigns. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;19.4 <U>Subsidiaries</U>. Each of the Parties shall cause to be performed, and hereby guarantees the performance of, all actions,
agreements and obligations set forth herein to be performed by any Subsidiary of such Party or by any entity that becomes a Subsidiary of such Party at and after the Distribution Time, to the extent such Subsidiary remains a Subsidiary of the
applicable Party. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;19.5 <U>Assignability</U>. This Agreement shall not be assignable, in whole or in part, directly or
indirectly, by any party hereto without the prior written consent of the other Party, and any attempt to assign any rights or obligations arising under this Agreement without such consent shall be void. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;19.6 <U>No Fiduciary Relationship</U>. The duties and obligations of the Parties, and their respective successors and permitted
assigns, contained herein are the extent of the duties and obligations contemplated by this Agreement; nothing in this Agreement is intended to create a fiduciary relationship between the Parties hereto, or any of their successors and permitted
assigns, or create any relationship or obligations other than those explicitly described. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">28 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;19.7 <U>Further Assurances</U>. Subject to the provisions hereof, the Parties
hereto shall make, execute, acknowledge and deliver such other instruments and documents, and take all such other actions, as may be reasonably required in order to effectuate the purposes of this Agreement and to consummate the transactions
contemplated hereby. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;19.8 <U>Survival</U>. Notwithstanding any other provision of this Agreement to the contrary, all
representations, covenants and obligations contained in this Agreement shall survive until the expiration of the applicable statute of limitations with respect to any such matter (including extensions thereof). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;19.9 <U>Notices</U>. All notices, requests, claims, demands and other communications under this Agreement and, to the extent
applicable shall be in English, shall be in writing and shall be given or made (and shall be deemed to have been duly given or made upon receipt) by delivery in person, by overnight courier service, by registered or certified mail (return receipt
requested), or by <FONT STYLE="white-space:nowrap">e-mail</FONT> (provided confirmation of transmission is electronically generated and kept on file by the sending party), to the respective Parties at the following addresses (or at such other
address for a Party as shall be specified in a notice given in accordance with this <U>Section</U><U></U><U>&nbsp;10.9</U>): </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">If to
Remainco, to: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Ligand Pharmaceuticals Incorporated </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">3911 Sorrento Valley Blvd., Suite 110 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">San Diego, CA 92121 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Attn: Chief
Financial Officer </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">E-mail:</FONT> tespinoza@ligand.com </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">If to Spinco, to: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">OmniAb, Inc.
</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">5980 Horton Street, Suite 405 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Emeryville, CA 94608 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Attn: Chief
Legal Officer </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">E-mail:</FONT> cberkman@omniab.com </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">If to Parent, to: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Avista Public
Acquisition Corp. II </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">65 East 55th Street, 18th Floor </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">New York, New York 10022 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Attn:
Benjamin Silbert, General Counsel </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Email: Silbert@avistacap.com </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">29 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;19.10 <U>Counterparts</U>. This Agreement may be executed in more than one
counterpart, all of which shall be considered one and the same agreement, and shall become effective when one or more such counterparts have been signed by each of the Parties and delivered to each of the Parties. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;19.11 <U>Consents</U>. Any consent required or permitted to be given by any Party to the other Party under this Agreement shall
be in writing and signed by the Party giving such consent and shall be effective only against such Party (and its Group). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;19.12 <U>Expenses</U>. Except as otherwise specified in this Agreement, or as otherwise agreed in writing between Remainco,
Parent, and Spinco, Remainco, Parent, and Spinco shall each be responsible for its own fees, costs and expenses paid or incurred in connection with this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;19.13 <U>Termination and Amendment</U>. This Agreement may not be terminated, modified or amended except by an agreement in
writing signed by Remainco, Parent, and Spinco. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;19.14 <U>Titles and Headings</U>. Titles and headings to
articles&nbsp;herein are inserted for the convenience of reference only and are not intended to be a part of or to affect the meaning or interpretation of this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;19.15 <U>Severability</U>. In the event any one or more of the provisions contained in this Agreement should be held invalid,
illegal or unenforceable in any respect, the validity, legality and enforceability of the remaining provisions contained herein shall not in any way be affected or impaired thereby. The Parties shall endeavor in good-faith negotiations to replace
the invalid, illegal or unenforceable provisions with valid provisions, the economic effect of which comes as close as possible to that of the invalid, illegal or unenforceable provisions. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;19.16 <U>Interpretation</U>. The Parties have participated jointly in the negotiation and drafting of this Agreement. This
Agreement shall be construed without regard to any presumption or rule requiring construction or interpretation against the Party drafting or causing any instrument to be drafted. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;19.17 <U>No Duplication; No Double Recovery</U>. Nothing in this Agreement is intended to confer to or impose upon any Party a
duplicative right, entitlement, obligation or recovery with respect to any matter arising out of the same facts and circumstances. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;19.18 <U>No Waiver</U>. No failure to exercise and no delay in exercising, on the part of any Party, any right, remedy, power or
privilege hereunder shall operate as a waiver hereof; nor shall any single or partial exercise of any right, remedy, power or privilege hereunder preclude any other or further exercise thereof or the exercise of any other right, remedy, power or
privilege. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;19.19 <U>Governing Law</U>. This Agreement and any dispute arising out of, in connection with or relating to this
Agreement shall be governed by and construed in accordance with the Laws of the State of Delaware, without giving effect to the conflicts of laws principles thereof. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">30 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;19.20 <U>Distribution Time</U>. This Agreement shall become effective only upon
the Distribution Time on the Distribution Date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[<I>Signature Page Follows</I>] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">31 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">IN WITNESS WHEREOF, the Parties hereto have duly executed this Agreement as of the day and
year first above written. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="99%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">AVISTA PUBLIC ACQUISITION CORP. II<SUP STYLE="font-size:85%; vertical-align:top">3</SUP></TD></TR></TABLE></DIV> <DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR></TABLE></DIV> <DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="99%"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Name: [&nbsp;&#9679;&nbsp;]</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Title: [&nbsp;&#9679;&nbsp;]</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">LIGAND PHARMACEUTICALS INCORPORATED</TD></TR></TABLE></DIV> <DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR></TABLE></DIV> <DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="99%"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Name: [&nbsp;&#9679;&nbsp;]</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Title: [&nbsp;&#9679;&nbsp;]</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">OMNIAB, INC.</TD></TR></TABLE></DIV> <DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR></TABLE></DIV> <DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="99%"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Name: [&nbsp;&#9679;&nbsp;]</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Title: [&nbsp;&#9679;&nbsp;]</TD></TR>
</TABLE></DIV> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">3</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Note to Draft: To update to Avista&#146;s name post-domestication. </P></TD></TR></TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Exhibit C to the Merger Agreement </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>EMPLOYEE MATTERS AGREEMENT </U></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This EMPLOYEE MATTERS AGREEMENT (this &#147;<U>Agreement</U>&#148;), dated as of March&nbsp;23, 2022, is entered into by and among Ligand
Pharmaceuticals Incorporated, a Delaware corporation (the &#147;<U>Company</U>&#148;), OmniAb, Inc., a Delaware corporation and a wholly owned subsidiary of the Company (&#147;<U>SpinCo</U>&#148;), Avista Public Acquisition Corp. II, a Cayman
Islands exempted company (which will migrate to and domesticate as a Delaware corporation) (&#147;<U>Parent</U>&#148;), and Orwell Merger Sub Inc., a Delaware corporation and wholly owned Subsidiary of Parent (&#147;<U>Merger Sub</U>&#148;).
&#147;<U>Party</U>&#148; or &#147;<U>Parties</U>&#148; means the Company, SpinCo, Parent or Merger Sub, individually or collectively, as the case may be. Capitalized terms used in this Agreement, but not otherwise defined in this Agreement, the
Separation Agreement or the Merger Agreement, shall have the meaning set forth in Section&nbsp;1.1. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">W I T N E S S E T H: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, the Company, acting through its direct and indirect Subsidiaries, currently conducts the Company Retained Business and the SpinCo
Business; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, the Company Board has determined that it is appropriate, desirable and in the best interests of the Company and its
stockholders to separate the Company into two separate companies, one for each of (i)&nbsp;the Company Retained Business, which shall be owned and conducted, directly or indirectly, by the Company and its Subsidiaries (other than SpinCo and its
Subsidiaries) and (ii)&nbsp;the SpinCo Business, which shall be owned and conducted, directly or indirectly, by SpinCo and its Subsidiaries, in the manner contemplated by the Separation and Distribution Agreement by and among the Parties, dated as
of the date hereof (the &#147;<U>Separation Agreement</U>&#148;) and the other Transaction Documents; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, following the
Domestication and the Separation and pursuant to the Merger Agreement, Merger Sub shall merge with and into SpinCo and SpinCo will be the surviving corporation and a wholly owned Subsidiary of Parent; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, in connection with the transactions contemplated by the Separation Agreement and the Merger Agreement, the Parties have agreed to
enter into this Agreement for the purpose of allocating assets, Liabilities and responsibilities with respect to certain employee matters and employee compensation and benefit plans and programs among them and to address certain other
employment-related matters. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">NOW, THEREFORE, in consideration of the foregoing and the mutual agreements, provisions and covenants
contained in this Agreement, the Parties hereby agree as follows: </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE I </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>DEFINITIONS AND INTERPRETATION </U></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.1 <U>General</U>. As used in this Agreement, the following terms shall have the following meanings: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) &#147;<U>401(k) Plan Transition Date</U>&#148; shall mean (i)&nbsp;December&nbsp;31 of the calendar year in which the Distribution Time
occurs, or (ii)&nbsp;such earlier date as mutually agreed by the Parties. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) &#147;<U>Adjusted Parent Equity Award</U>&#148; shall mean an Adjusted Parent Option,
Adjusted Parent RSU Award or Adjusted Parent PSU Award. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) &#147;<U>Adjusted Parent Option</U>&#148; shall have the meaning set forth
in&nbsp;Section 4.2(d). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) &#147;<U>Adjusted Parent PSU Award</U>&#148; shall have the meaning set forth in&nbsp;Section 4.4(f). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) &#147;<U>Adjusted Parent RSU Award</U>&#148; shall have the meaning set forth in&nbsp;Section 4.3(d). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) &#147;<U>Agreement</U>&#148; shall have the meaning set forth in the Preamble. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) &#147;<U>Benefit Plan</U>&#148; shall mean an &#147;employee benefit plan&#148; (within the meaning of Section&nbsp;3(3) of ERISA but
regardless of whether such plan is subject to ERISA) and each compensation plan, program, agreement or arrangement, including each pension, retirement, profit sharing, 401(k), severance, health and welfare, disability, deferred compensation,
employment, termination, <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">change-in-control,</FONT></FONT> retention, fringe benefit, stock purchase, cash bonus or equity-based incentive or other benefit plan, program, agreement,
policy or other arrangement, in each case, that is or was maintained for the benefit of current and/or former directors, officers, consultants or employees. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h) &#147;<U>Code</U>&#148; means the Internal Revenue Code of 1986, as amended, or any successor federal income tax law. Reference to a
specific Code provision also includes any proposed, temporary or final regulation in force under that provision. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i)
&#147;<U>Company</U>&#148; shall have the meaning set forth in the Preamble. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(j) &#147;<U>Company 2021 TSR PSU Award</U>&#148; shall mean
a Company PSU Award granted in 2021 (or portion thereof) the vesting of which is tied to the Company&#146;s total shareholder return for the three-year performance period ending December&nbsp;31, 2023. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(k) &#147;<U>Company 401(k) Plan</U>&#148; shall mean the Company&#146;s Section&nbsp;401(k) Savings/Retirement Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(l) &#147;<U>Company Allocation Factor</U>&#148; shall mean the quotient obtained by dividing (i)&nbsp;the Company Post-Adjustment Stock
Value, by (ii)&nbsp;the sum of (A)&nbsp;the Company Post-Adjustment Stock Value, plus (B)&nbsp;the product of (x)&nbsp;the SpinCo Stock Value times (y)&nbsp;the Distribution Ratio. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(m) &#147;<U>Company Benefit Plan</U>&#148; shall mean any Benefit Plan sponsored, maintained or contributed to (or required to be contributed
to) by any member of the Company Group that (i)&nbsp;is or has been maintained, sponsored, contributed to or entered into by any member of the Company Group for the benefit of any SpinCo Employee or SpinCo Independent Contractor or for which any
member of the SpinCo Group could have any Liability and (ii)&nbsp;that is not a SpinCo Benefit Plan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(n) &#147;<U>Company
Employee</U>&#148; shall mean each employee of the Company or any of its Subsidiaries or Affiliates who does not qualify as a SpinCo Employee. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(o) &#147;<U>Company Employee List</U>&#148; shall have the meaning set forth in Section&nbsp;2.2(d). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(p) &#147;<U>Company Equity Award</U>&#148; shall mean a Company Option, Company RSU Award or a Company PSU Award. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(q) &#147;<U>Company Equity Plan</U>&#148; shall mean the Company&#146;s 2002 Stock
Incentive Plan, as amended from time to time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(r) &#147;<U>Company ESPP</U>&#148; shall mean the Company&#146;s 2002 Employee Stock
Purchase Plan, as amended from time to time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(s) &#147;<U>Company Group</U>&#148; shall mean (i)&nbsp;the Company, the Company Retained
Business and each Person that is a direct or indirect Subsidiary of the Company as of immediately following the Distribution Time and (ii)&nbsp;each Business Entity that becomes a Subsidiary of the Company after the Distribution Time. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(t) &#147;<U>Company Independent Contractor</U>&#148; shall mean each individual who is engaged as an independent contractor or consultant by
the Company or any of its Subsidiaries or Affiliates who does not qualify as a SpinCo Independent Contractor. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(u) &#147;<U>Company
Individual Agreement</U>&#148; shall mean each Benefit Plan sponsored, maintained entered into or contributed to by the Company under which no more than one service provider is eligible to receive compensation and/or benefits. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(v) &#147;<U>Company Option</U>&#148; shall mean an option to purchase shares of Company Common Stock granted pursuant to the Company Equity
Plan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(w) &#147;<U>Company Post-Adjustment Stock Value</U>&#148; shall mean the average closing price per share of Company Common Stock
trading on an <FONT STYLE="white-space:nowrap">ex-dividend</FONT> basis on the Nasdaq Stock Market during regular trading hours for the five (5)&nbsp;trading days ending on the date on which the Distribution Time occurs (or, if the Distribution Time
occurs prior to regular trading hours, for the five (5)&nbsp;trading days ending on the date prior to the date on which the Distribution Time occurs). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(x) &#147;<U>Company <FONT STYLE="white-space:nowrap">Pre-Adjustment</FONT> Stock Value</U>&#148; shall mean the average closing price per
share of Company Common Stock trading &#147;regular way with due bills&#148; (if applicable) on the Nasdaq Stock Market during regular trading hours for the five (5)&nbsp;trading days ending on the date on which the Distribution Time occurs (or, if
the Distribution Time occurs prior to regular trading hours, for the five (5)&nbsp;trading days ending on the date prior to the date on which the Distribution Time occurs). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(y) &#147;<U>Company PSU Award</U>&#148; shall mean a performance stock unit award granted pursuant to the Company Equity Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(z) &#147;<U>Company Ratio</U>&#148; shall mean the quotient obtained by dividing the Company
<FONT STYLE="white-space:nowrap">Pre-Adjustment</FONT> Stock Value by the Company Post-Adjustment Stock Value. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(aa) &#147;<U>Company RSU
Award</U>&#148; shall mean a restricted stock unit award granted pursuant to the Company Equity Plan that vests solely based on the continued employment or service of the recipient. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(bb) &#147;<U>Company Service Provider</U>&#148; shall mean a Company Employee, a Company Independent Contractor or a member of the Company
Board. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(cc) &#147;<U>Company Severance Plan</U>&#148; shall mean the Company&#146;s Amended and Restated Severance Plan, as amended from
time to time. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(dd) &#147;<U>Distribution Ratio</U>&#148; shall mean the number of shares (and/or fraction
of a share, expressed as a decimal) of SpinCo Common Stock to be distributed in respect of one share of Company Common Stock in the Distribution, as determined by the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ee) &#147;<U>Distribution Time</U>&#148; shall mean the effective time of the Distribution pursuant to the Separation Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ff) &#147;<U>Effective Time</U>&#148; shall mean the &#147;Effective Time&#148; as defined in the Merger Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(gg) &#147;<U>ERISA</U>&#148; shall mean the Employee Retirement Income Security Act of 1974, as amended. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(hh) &#147;<U>Former Company Service Provider</U>&#148; means (i)&nbsp;any individual (other than a SpinCo Employee or SpinCo Independent
Contractor) who, as of the Distribution Time is a former employee or independent contractor of the Company or any of its Subsidiaries, or (ii)&nbsp;any individual who is a Company Employee or Company Independent Contractor as of the Distribution
Time or thereafter who ceases to be an employee or independent contractor of the Company or any of its Subsidiaries following the Distribution Time. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) &#147;<U>Former SpinCo Service Provider</U>&#148; shall mean any individual who is a SpinCo Employee or SpinCo Independent Contractor as
of the Distribution Time and thereafter ceases to be an employee or independent contractor of the SpinCo Group following the Distribution Time. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(jj) &#147;<U>Merger Agreement</U>&#148; shall mean the Agreement and Plan of Merger, dated as of March&nbsp;23, 2022, by and among the
Company, SpinCo, Parent, and Merger Sub. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(kk) &#147;<U>Parent</U>&#148; shall have the meaning set forth in the Preamble. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ll) &#147;<U>Parent Equity Plan</U>&#148; shall have the meaning set forth in Section&nbsp;4.6. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(mm) &#147;<U>Parent Equity Plan Share Reserve</U>&#148; shall have the meaning set forth in Section&nbsp;4.6. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(nn) &#147;<U>Parent ESPP</U>&#148; shall have the meaning set forth in Section&nbsp;4.6. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(oo) &#147;<U>Parent ESPP Share Reserve</U>&#148; shall have the meaning set forth in Section&nbsp;4.6. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(pp) &#147;<U>Party</U>&#148; and &#147;<U>Parties</U>&#148; shall have the meanings set forth in the Preamble. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(qq) &#147;<U>Plan Transition Date</U>&#148; shall mean the date that is the earlier to occur of (i)&nbsp;January&nbsp;1, 2023 or
(ii)&nbsp;such earlier date as agreed among the Parties. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(rr) &#147;<U>SpinCo</U>&#148; shall have the meaning set forth in the Preamble.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ss) &#147;<U>SpinCo 401(k) Plan</U>&#148; shall have the meaning set forth in&nbsp;Section 3.3(b). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(tt) &#147;<U>SpinCo Allocation Factor</U>&#148; shall mean the quotient obtained by dividing (i)&nbsp;the product of (A)&nbsp;the SpinCo
Stock Value times (B)&nbsp;the Distribution Ratio, by (ii)&nbsp;the sum of (A)&nbsp;the Company Post-Adjustment Stock Value, plus (B)&nbsp;the product of (x)&nbsp;the SpinCo Stock Value times (y)&nbsp;the Distribution Ratio. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(uu) &#147;<U>SpinCo Benefit Plan</U>&#148; shall mean any Benefit Plan sponsored,
maintained or contributed to exclusively by any member of the SpinCo Group. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(vv) &#147;<U>SpinCo Common Stock</U>&#148; shall mean the
common stock, par value $0.001 per share, of SpinCo. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ww) &#147;<U>SpinCo Employee</U>&#148; shall mean each individual listed on the
SpinCo Employee List. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(xx) &#147;<U>SpinCo Employee List</U>&#148; shall have the meaning set forth in Section&nbsp;2.2(d). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(yy) &#147;<U>SpinCo Equity Award</U>&#148; shall mean a SpinCo Option, SpinCo RSU Award or SpinCo PSU Award. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(zz) &#147;<U>SpinCo Equity Plans</U>&#148; shall have the meaning set forth in&nbsp;Section 4.5. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(aaa) &#147;<U>SpinCo Group</U>&#148; shall mean SpinCo and each SpinCo Entity as of the Distribution Time (but after giving effect to the
Separation), and, following the Effective Time, Parent and each Person that becomes a Subsidiary of Parent or SpinCo thereafter, provided, however, that for the avoidance of doubt, no member of the Company Group shall be treated as a member of the
SpinCo Group. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(bbb) &#147;<U>SpinCo Independent Contractor</U>&#148; shall mean each individual engaged as an independent contractor or
consultant by the SpinCo Group as of the Distribution Time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ccc) &#147;<U>SpinCo Individual Agreement</U>&#148; shall mean each Benefit
Plan sponsored, maintained entered into or contributed to by SpinCo under which no more than one service provider is eligible to receive compensation and/or benefits. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ddd) &#147;<U>SpinCo Option</U>&#148; shall mean an option to purchase shares of SpinCo Common Stock issued pursuant to the SpinCo Equity
Plans as part of an equitable adjustment to a Company Option made in connection with the Distribution. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(eee) &#147;<U>SpinCo PSU
Award</U>&#148; shall mean an award of restricted stock units covering SpinCo Common Stock issued pursuant to the SpinCo Equity Plans as part of an equitable adjustment to a Company PSU Award made in connection with the Distribution. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(fff) &#147;<U>SpinCo Ratio</U>&#148; shall mean the quotient obtained by dividing the Company
<FONT STYLE="white-space:nowrap">Pre-Adjustment</FONT> Stock Value by the SpinCo Stock Value. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ggg) &#147;<U>SpinCo RSU Award</U>&#148;
shall mean an award of restricted stock units covering SpinCo Common Stock that vests solely based on the continued employment or service of the recipient issued pursuant to the SpinCo Equity Plans as part of an equitable adjustment to a Company RSU
Award made in connection with the Distribution. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(hhh) &#147;<U>SpinCo Service Provider</U>&#148; shall mean a SpinCo Employee, a SpinCo
Independent Contractor or a member of the board of directors of SpinCo, or any individual independent contractor, consultant or director who is reasonably expected to become a SpinCo Service Provider prior to the Distribution Time. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iii) &#147;<U>SpinCo Severance Plan</U>&#148; shall have the meaning set forth in&nbsp;Section 5.2(a). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(jjj) &#147;<U>SpinCo Stock Value</U>&#148; shall mean (i)&nbsp;the Base Exchange Ratio,
multiplied by (ii) $10 per share. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(kkk) &#147;<U>Separation Agreement</U>&#148; shall have the meaning set forth in the Recitals. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(lll) &#147;<U>Specified Service Provider</U>&#148; shall mean a Company Service Provider or SpinCo Service Provider who, in either case, is
set forth on <U>Schedule C</U> attached hereto. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.2 <U>References; Interpretation</U>. References in this Agreement to any gender include
references to all genders, and references to the singular include references to the plural and vice versa. Unless the context otherwise requires, the words &#147;include&#148;, &#147;includes&#148; and &#147;including&#148; when used in this
Agreement shall be deemed to be followed by the phrase &#147;without limitation&#148;. Unless the context otherwise requires, references in this Agreement to Articles, Sections, Annexes, Exhibits and Schedules shall be deemed references to Articles
and Sections of, and Annexes, Exhibits and Schedules to, this Agreement. Unless the context otherwise requires, the words &#147;hereof&#148;, &#147;hereby&#148; and &#147;herein&#148; and words of similar meaning when used in this Agreement refer to
this Agreement in its entirety and not to any particular Article, Section or provision of this Agreement. The words &#147;written request&#148; when used in this Agreement shall include email. Reference in this Agreement to any time shall be to New
York City, New York time unless otherwise expressly provided herein. Unless the context requires otherwise, references in this Agreement to the &#147;Company&#148; shall also be deemed to refer to the applicable member of the Company Group,
references to &#147;SpinCo&#148; shall also be deemed to refer to the applicable member of the SpinCo Group (including, with respect to periods of time following the Effective Time, Parent), and, in connection therewith, any references to actions or
omissions to be taken, or refrained from being taken, as the case may be, by the Company or SpinCo shall be deemed to require the Company, SpinCo or Parent, as the case may be, to cause the applicable members of the Company Group or the SpinCo
Group, respectively, to take, or refrain from taking, any such action. In the event of any inconsistency or conflict which may arise in the application or interpretation of any of the definitions set forth in&nbsp;Section 1.1, for the purpose of
determining what is and is not included in such definitions, any item explicitly included on a Schedule referred to in any such definition shall take priority over any provision of the text thereof. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE II </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>GENERAL
PRINCIPLES </U></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.1 <U>Nature of Liabilities</U>. All Liabilities assumed or retained by a member of the Company Group under this
Agreement shall be &#147;Ligand Retained Liabilities&#148; for purposes of the Separation Agreement. All Liabilities assumed or retained by a member of the SpinCo Group under this Agreement shall be &#147;OmniAb Liabilities&#148; for purposes of the
Separation Agreement.<SUP STYLE="font-size:85%; vertical-align:top"> </SUP> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.2 <U>Transfers of Employees and Independent Contractors
Generally</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <U>Schedule A</U> attached hereto sets forth a complete list of each Company Employee as of the date hereof (the
&#147;<U>Company Employee List</U>&#148;), and <U>Schedule B</U> attached hereto sets forth a complete list of each employee of the Company Group whose employment will be transferred to SpinCo prior to the Distribution Time (the &#147;<U>SpinCo
Employee List</U>&#148;). The Company and SpinCo shall mutually update the Company Employee List and the SpinCo Employee List from time to time between the date hereof and the Distribution Time to remove terminated employees and to add any new
Company Employees or SpinCo Employees hired following the date hereof. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) All SpinCo Employees who are employed by the SpinCo Group as of the Distribution Time
shall continue to be employees of the SpinCo Group immediately after the Distribution Time. The Company and SpinCo will cooperate to cause each of the SpinCo Employees to be employed by a member of the SpinCo Group prior to the Distribution Time.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) The Company and SpinCo will cooperate to cause the contract of any individual who is engaged as an independent contractor or
consultant and who provides services on behalf of the SpinCo Business to the extent of such service, to be transferred to a member of the SpinCo Group prior to the Distribution Time. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) The Company Group and SpinCo Group agree to execute, and to seek to have the applicable SpinCo Employees execute, such documentation, if
any, as may be necessary to reflect the transfers described in this&nbsp;Section 2.2. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.3 <U>Assumption and Retention of Liabilities
Generally</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Except as pursuant to this Agreement, from and after the Distribution Time, the Company shall, or shall cause one or
more members of the Company Group to, accept, assume (or, as applicable, retain) and perform, discharge and fulfill (i)&nbsp;all Liabilities under all Company Benefit Plans with respect to Company Employees, Former Company Service Providers and
their respective dependents and beneficiaries (and any alternate payees in respect thereof), whenever incurred, unless this Agreement expressly provides for such Liabilities to be assumed by the SpinCo Group or subject to reimbursement by the SpinCo
Group; (ii)&nbsp;all Liabilities with respect to the employment, service, termination of employment or termination of service of all Company Employees, Former Company Service Providers and their respective dependents and beneficiaries (and any
alternate payees in respect thereof), in each case to the extent arising in connection with or as a result of employment with or the performance of services to any member of the Company Group; and (iii)&nbsp;all other Liabilities or obligations
expressly assigned to or assumed by a member of the Company Group under this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Except as pursuant to this Agreement, from
and after the Distribution Time, SpinCo shall, or shall cause one or more members of the SpinCo Group to, accept, assume (or, as applicable, retain) and perform, discharge and fulfill (i)&nbsp;all Liabilities under all SpinCo Benefit Plans, whenever
incurred; (ii)&nbsp;all Liabilities with respect to the employment, service, termination of employment or termination of service of all SpinCo Employees, Former SpinCo Service Providers and SpinCo Independent Contractors and their respective
dependents and beneficiaries (and any alternate payees in respect thereof), in each case to the extent arising in connection with or as a result of employment with or the performance of services to any member of the SpinCo Group or the Company
Group; and (iii)&nbsp;all other Liabilities or obligations expressly assigned to or assumed by a member of the SpinCo Group under this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) The Parties shall promptly reimburse one another, upon reasonable request of the Party requesting reimbursement and the presentation by
such Party of such substantiating documentation as the other Party shall reasonably request, for the cost of any obligations or Liabilities satisfied or assumed by the Party requesting reimbursement or its Affiliates that are, or that have been made
pursuant to this Agreement, the responsibility of the other Parties or any of its Affiliates. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) Notwithstanding any provision of this
Agreement or the Separation Agreement to the contrary, SpinCo shall, or shall cause one or more members of the SpinCo Group to, accept, assume (or, as applicable, retain) and perform, discharge and fulfill all Liabilities that have been accepted,
assumed or retained under this Agreement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.4 <U>Treatment of Compensation and Benefit Plans; Terms of Employment</U>. Except as
otherwise (i)&nbsp;required by applicable Law, or (ii)&nbsp;expressly provided for in this Agreement, for a period of twelve (12)&nbsp;months following the Distribution Time (or if shorter, during the period of employment), SpinCo shall, or shall
cause a member of the SpinCo Group to provide or cause to be provided to each SpinCo Employee (A)&nbsp;a base salary or hourly wage rate, as applicable, that is at least equal to the base salary or hourly wage rate provided to such SpinCo Employee
immediately prior to the Distribution Time, (B)&nbsp;subject to&nbsp;Section 5.1, a cash incentive or sales commission opportunity no less favorable than the cash incentive or sales commission opportunity in effect for such SpinCo Employee, if any,
immediately prior to the Distribution Time, (C)&nbsp;health, welfare and retirement benefits that are substantially similar in the aggregate to those provided to such SpinCo Employee immediately prior to the Distribution Time, and (D)&nbsp;severance
benefits (including severance payments, transition payments and continued health coverage) that are substantially similar to those provided to such SpinCo Employee immediately prior to the Distribution Time. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.5 <U>Participation in Company Benefit Plans</U>. Except as otherwise provided pursuant to this Agreement or as required by Applicable Law,
effective no later than the Plan Transition Date, (i)&nbsp;SpinCo and each member of the SpinCo Group, to the extent applicable, shall cease to be a participating company in any Company Benefit Plan and (ii)&nbsp;each then active SpinCo Employee
shall cease to participate in, be covered by, accrue benefits under, be eligible to contribute to or have any rights under any Company Benefit Plan (except to the extent of previously accrued obligations that remain a Liability of any member of the
Company Group pursuant to this Agreement). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.6 <U>Service Recognition</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) From and after the Distribution Time, and in addition to any applicable obligations under applicable Law, SpinCo shall, and shall cause
each member of the SpinCo Group to, give each SpinCo Employee full credit for purposes of eligibility, vesting, and determination of level of benefits under any SpinCo Benefit Plan for such SpinCo Employee&#146;s prior service with any member of the
Company Group or SpinCo Group or any predecessor thereto, to the same extent such service was recognized by the applicable Company Benefit Plan;&nbsp;provided, that, such service shall not be recognized to the extent it would result in the
duplication of benefits or accruals under any defined benefit pension plan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Except to the extent prohibited by applicable Law, as
soon as administratively practicable on or after the Plan Transition Date with respect to any applicable SpinCo Benefit Plan that is a health or welfare benefit plan: (i)&nbsp;SpinCo shall waive or cause to be waived all limitations as to
preexisting conditions or waiting periods with respect to participation and coverage requirements applicable to each SpinCo Employee under any SpinCo Benefit Plan in which SpinCo Employees participate (or are eligible to participate) to the same
extent that such conditions and waiting periods were satisfied or waived under an analogous Company Benefit Plan, and (ii)&nbsp;SpinCo shall use commercially reasonable efforts to provide or cause each SpinCo Employee to be provided with credit for
any <FONT STYLE="white-space:nowrap">co-payments,</FONT> deductibles or other <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> amounts paid during the plan year in which the SpinCo Employees become
eligible to participate in the SpinCo Benefit Plans in satisfying any applicable <FONT STYLE="white-space:nowrap">co-payments,</FONT> deductibles or other <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT>
requirements under any such plans for such plan year. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.7 <U>WARN</U>. Notwithstanding anything set forth in this Agreement to the
contrary, none of the transactions contemplated by or undertaken by this Agreement is intended to and shall not constitute or give rise to an &#147;employment loss&#148; or employment separation within the meaning of the federal Worker Adjustment
and Retraining Notification (WARN) Act, or any other federal, state, or local law or legal requirement addressing mass employment separations. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.8 <U>No Termination; No Change in Control</U>. No Company Employee or SpinCo Employee
shall be deemed to (a)&nbsp;terminate employment or service solely by virtue of the consummation of the Distribution, any transfer of employment or other service relationship contemplated hereby, or any related transactions or events contemplated by
the Separation Agreement, this Agreement, the Merger Agreement, or any other Transaction Document, or (b)&nbsp;become entitled to any severance, termination, separation or similar rights, payments or benefits, whether under any Benefit Plan, the
Company Equity Plan, the SpinCo Equity Plans, the Company Severance Plan, any Company Individual Agreement or any other compensatory agreement or arrangement maintained by the Company or SpinCo or otherwise, in connection with any of the foregoing.
The Parties hereto agree that none of the transactions contemplated by the Separation Agreement, the Merger Agreement, or this Agreement, constitutes a &#147;change in control,&#148; &#147;change of control&#148; or similar term, as applicable,
within the meaning of any Benefit Plan, the Company Equity Plan, the SpinCo Equity Plans, the Company Severance Plan, any Company Individual Agreement or any other compensatory agreement or arrangement maintained by the Company or SpinCo. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE III </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>CERTAIN
BENEFIT PLAN PROVISIONS </U></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.1 <U>Health and Welfare Benefit Plans</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) (i) Effective as of the Plan Transition Date, the participation of each then-active SpinCo Employee who is a participant in a Company
Benefit Plan shall automatically cease and (ii)&nbsp;SpinCo shall or shall cause a member of the SpinCo Group to (A)&nbsp;have in effect, no later than the Business Day immediately prior to the Plan Transition Date, SpinCo Benefit Plans providing
health and welfare benefits for the benefit of each such SpinCo Employee with terms that are substantially similar to those provided to the applicable SpinCo Employee immediately prior to the date on which such SpinCo Benefit Plans become effective;
and (B)&nbsp;effective on and after the Plan Transition Date, fully perform, pay and discharge all claims of SpinCo Employees or Former SpinCo Service Providers, including but not limited to any claims incurred under any Company Benefit Plan (to the
extent not fully covered by insurance) on or prior to the date on which such SpinCo Benefit Plans become effective, that remain unpaid as of the date on which such SpinCo Benefit Plans become effective, regardless of whether any such claim was
presented for payment prior to, on or after such date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Without duplication of amounts otherwise already covered in this Agreement or
the Transition Services Agreement, the applicable member of the SpinCo Group shall reimburse the Company or the applicable Company Benefit Plan in the ordinary course of business consistent with past practice for any premiums and its proportionate
share of any administrative or services costs related to SpinCo Employees or Former SpinCo Service Providers paid by a Company Benefit Plan (whether prior to or after the Distribution Time) and not charged back to the appropriate and applicable
member of the SpinCo Group prior to the Plan Transition Date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Notwithstanding anything to the contrary in this Section&nbsp;3.1,
SpinCo Employees will continue to be considered to be &#147;participants&#148; in any Company Benefit Plan that is either a health care flexible spending account program or a dependent-care flexible spending account program for the duration of any
grace period and/or claims <FONT STYLE="white-space:nowrap">run-out</FONT> period following the calendar year in which the Plan Transition Date occurs (in either case, solely as provided under the terms of such Company Benefit Plans), provided that
such SpinCo Employees will be considered to be participants solely for purposes of utilizing such grace period and/or claims <FONT STYLE="white-space:nowrap">run-out</FONT> period; will not be allowed to make any deferral or contribution elections
under such Company Benefit Plans beyond the Plan Transition Date; and will cease to be participants in such Company Benefit Plans upon the expiration of any grace period and/or claims <FONT STYLE="white-space:nowrap">run-out</FONT> period. Effective
as of the Plan Transition Date, SpinCo shall establish a health care flexible spending account program or a dependent-care flexible spending account program for SpinCo Employees. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.2 <U>Disability</U>. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) To the extent any SpinCo Employee is, as of the Plan Transition Date, receiving payments
as part of any short-term disability program that is part of a Company Benefit Plan, such SpinCo Employee&#146;s rights to continued short-term disability benefits (a)&nbsp;will end under any Company Benefit Plan as of the Plan Transition Date; and
(b)&nbsp;all remaining rights will be recognized under a SpinCo Benefit Plan as of the Plan Transition Date, and the remainder (if any) of such SpinCo Employee&#146;s short-term disability benefits will be paid by a SpinCo Benefit Plan. In the event
that any SpinCo Employee described above shall have any dispute with the short-term disability benefits they are receiving under a SpinCo Benefit Plan, any and all appeal rights of such employees shall be realized through the SpinCo Benefit Plan
(and any appeal rights such SpinCo Employee may have under any Company Benefit Plan will be limited to benefits received and time periods occurring prior to the Plan Transition Date). Any SpinCo Employee or Former SpinCo Service Provider who is
receiving short-term disability benefits under a Company Benefit Plan as of the Plan Transition Date and thereafter becomes entitled to long-term disability benefits upon the expiration of such short-term disability period (whether under a Company
Benefit Plan or SpinCo Benefit Plan), shall be provided long-term disability benefits under the long-term disability plan which is a Company Benefit Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) For any Former SpinCo Service Provider who is, as of the Distribution Time, receiving payments as part of any long-term disability program
that is part of a Company Benefit Plan, and has been receiving payments from such plan for twelve (12)&nbsp;months or fewer before the Distribution Time, to the extent such Former SpinCo Service Provider may have any &#147;return to work&#148;
rights under the terms of such Company Benefit Plan, such Former SpinCo Service Provider&#146;s eligibility for <FONT STYLE="white-space:nowrap">re-employment</FONT> shall be with SpinCo or a member of the SpinCo Group, subject to availability of a
suitable position (with such availability to be determined in the sole discretion by SpinCo or the applicable member of the SpinCo Group),&nbsp;provided&nbsp;however&nbsp;that, notwithstanding the foregoing, no Former SpinCo Service Provider
described in this subsection will be eligible for <FONT STYLE="white-space:nowrap">re-employment</FONT> as described in this subsection after the first anniversary of the Distribution Time. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.3 <U>401(k) Plans</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a)
From the Distribution Time and continuing until the 401(k) Plan Transition Date, SpinCo shall become an &#147;adopting employer&#148; (as defined in the Company 401(k) Plan) and the Company 401(k) Plan shall provide for the SpinCo Group to
participate in the Company 401(k) Plan for the benefit of SpinCo Employees and Former SpinCo Service Providers, and the Company consents to such adoption and maintenance, in accordance with the terms of the Company 401(k) Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) (i) Effective no later than the 401(k) Plan Transition Date, SpinCo shall establish a defined contribution savings plan and related trust
that satisfies the requirements of Sections 401(a) and 401(k) of the Code in which each SpinCo Employee who participated in the Company 401(k) Plan immediately prior thereto shall be eligible to participate (the &#147;<U>SpinCo 401(k)
Plan</U>&#148;), with terms that are substantially similar to those provided by the Company 401(k) Plan immediately prior to the date on which such SpinCo 401(k) Plan become effective, (ii)&nbsp;the <U>active</U> participation of each SpinCo
Employee who is a participant in the Company 401(k) Plan shall automatically cease effective upon the date on which the SpinCo 401(k) Plan becomes effective, <U>and</U> (iii)&nbsp;as soon as practicable after the SpinCo 401(k) Plan becomes
effective, subject to the consent of the SpinCo 401(k) Plan administrator and reasonable proof of qualification of the Company 401(k) Plan, the Company shall cause the accounts (including any outstanding participant loan balances) in the Company
401(k) Plan attributable to SpinCo Employees and all of the assets in the Company 401(k) Plan related thereto to be transferred <FONT STYLE="white-space:nowrap">in-kind</FONT> to the SpinCo 401(k) Plan. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) The Company shall retain all accounts and all assets and Liabilities relating to the
Company 401(k) Plan in respect of each Former SpinCo Service Provider whose employment terminated prior to the 401(k) Plan Transition Date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.4 <U>Chargeback of Certain Costs</U>. Without duplication of amounts otherwise already covered in this Agreement or the Transition Services
Agreement, nothing contained in this Agreement shall limit the Company&#146;s ability to charge back any Liabilities that it incurs in respect of any SpinCo Service Provider under a Company Benefit Plan which is a retirement plan or health or
welfare benefit plan to any of its operating companies in the ordinary course of business consistent with its past practices. Subject, and in addition, to the foregoing, the Company shall allocate and charge back to SpinCo or a member of the SpinCo
Group (without duplication) its proportionate share of Liabilities (other than those arising from the Company&#146;s or its agent&#146;s gross misconduct or negligence) that the Company incurs by reason of the continued participation of SpinCo
Employees, SpinCo Independent Contractors and Former SpinCo Service Providers in <U>such</U> Company Benefit Plans following the Distribution Time (which Liabilities shall, for the avoidance of doubt, be subject to reimbursement under
Section&nbsp;2.3(c) of this Agreement). </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE IV </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>EQUITY INCENTIVE AWARDS </U></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.1 <U>Equity Awards</U>. The Parties shall use commercially reasonable efforts to take all actions necessary or appropriate so that each
outstanding Company Equity Award and SpinCo Equity Award held by any individual shall be adjusted as set forth in this Article IV and in accordance with applicable Law, the applicable equity plan and the applicable award agreement. The adjustments
set forth below shall be the sole adjustments made with respect to Company Equity Awards in connection with the Distribution. The adjustments set forth below shall be the sole adjustments made with respect to SpinCo Equity Awards in connection with
the Merger and are subject to the terms and conditions of the Merger Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.2 <U>Treatment of Company Options</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <U>Company Options Other than (i)</U><U></U><U>&nbsp;Company Options Held by Former Company Service Providers or
(ii)</U><U></U><U>&nbsp;SpinCo Service Providers who are Specified Service Providers</U>. As determined by the Compensation Committee of the Company Board (the &#147;<U>Company Compensation Committee</U>&#148;) pursuant to its authority under the
Company Equity Plan, each Company Option outstanding as of immediately prior to the Distribution Time, other than (x)&nbsp;any Company Option held by a Former Company Service Provider and (y)&nbsp;any Company Option held by a Specified Service
Provider, shall, immediately prior to the Distribution Time, be converted into both a SpinCo Option and a Company Option and shall otherwise be, subject to Section&nbsp;4.2(d) below, subject to the same terms and conditions after the Distribution
Time as the terms and conditions applicable to such Company Option immediately prior to the Distribution Time; <U>provided</U>, <U>however</U>, that from and after the Distribution Time: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) <U>Shares Subject to Post-Distribution Company Option</U>. The number of shares of Company Common Stock subject to such
Company Option shall be equal to the product obtained by multiplying (I)&nbsp;the number of shares of Company Common Stock subject to such Company Option immediately prior to the Distribution Time by (II)&nbsp;the Company Ratio by (III)&nbsp;the
Company Allocation Factor, and rounding such result down to the nearest whole share. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) <U>Shares Subject to
Post-Distribution SpinCo Option</U>. The number of shares of SpinCo Common Stock subject to such SpinCo Option shall be equal to the product obtained by multiplying (I)&nbsp;the number of shares of Company Common Stock subject to the Company Option
immediately prior to the Distribution Time by (II)&nbsp;the SpinCo Ratio by (III)&nbsp;the SpinCo Allocation Factor, and rounding such result down to the nearest whole share. Each SpinCo Option that is outstanding as of the Effective Time will be
further adjusted to reflect the Transactions as set forth in Section&nbsp;4.2(d) below. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iii) <U>Exercise Price of Post-Distribution Company Option</U>. The per
share exercise price of such Company Option shall be equal to the quotient obtained by dividing (I)&nbsp;the per share exercise price of such Company Option immediately prior to the Distribution Time by (II)&nbsp;the Company Ratio, and rounding such
quotient up to the nearest whole cent. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iv) <U>Exercise Price of Post-Distribution SpinCo Option</U>. The per share
exercise price of such SpinCo Option shall be equal to the quotient obtained by dividing (I)&nbsp;the per share exercise price of the Company Option immediately prior to the Distribution Time by (II)&nbsp;the SpinCo Ratio, and rounding such quotient
up to the nearest whole cent. Each SpinCo Option that is outstanding as of the Effective Time will be further adjusted to reflect the Transactions as set forth in Section&nbsp;4.2(d) below. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <U>Company Options Held by (i)</U><U></U><U>&nbsp;Former Company Service Providers and (ii)</U><U></U><U>&nbsp;Specified Service Providers
who are Company Service Providers</U>. As determined by the Company Compensation Committee pursuant to its authority under the Company Equity Plan, each Company Option outstanding as of immediately prior to the Distribution Time (x)&nbsp;that is
held by a Former Company Service Provider or (y)&nbsp;that is held by a Specified Service Provider who is a Company Service Provider, shall be subject to the same terms and conditions after the Distribution Time as the terms and conditions
applicable to such Company Option immediately prior to the Distribution Time; <U>provided</U>, <U>however</U>, that from and after the Distribution Time: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) <U>Shares Subject to Post-Distribution Company Option</U>. The number of shares of Company Common Stock subject to such
Company Option shall be equal to the product obtained by multiplying (A)&nbsp;the number of shares of Company Common Stock subject to such Company Option immediately prior to the Distribution Time by (B)&nbsp;the Company Ratio, and rounding such
product down to the nearest whole share. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) <U>Exercise Price of Post-Distribution Company Option</U>. The per share
exercise price of such Company Option shall be equal to the quotient obtained by dividing (A)&nbsp;the per share exercise price of such Company Option immediately prior to the Distribution Time by (B)&nbsp;the Company Ratio, and rounding such
quotient up to the nearest whole cent. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) <U>Company Options Held by Specified Service Providers who are SpinCo Service Providers</U>.
As determined by the Company Compensation Committee pursuant to its authority under the Company Equity Plan, each Company Option outstanding as of immediately prior to the Distribution Time that is held by a Specified Service Provider who is an
SpinCo Service Provider, shall, immediately prior to the Distribution Time, be converted solely into an SpinCo Option and shall otherwise be, subject to Section&nbsp;4.2(d) below, subject to the same terms and conditions after the Distribution Time
as the terms and conditions applicable to such Company Option immediately prior to the Distribution Time; <U>provided</U>, <U>however</U>, that from and after the Distribution Time: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) <U>Shares Subject to Post-Distribution SpinCo Option</U>. The number of shares of Company Common Stock subject to such
SpinCo Option shall be equal to the product obtained by multiplying (A)&nbsp;the number of shares of Company Common Stock subject to such Company Option immediately prior to the Distribution Time by (B)&nbsp;the SpinCo Ratio, and rounding such
product down to the nearest whole share. Each SpinCo Option that is outstanding as of the Effective Time will be further adjusted to reflect the Transactions as set forth in Section&nbsp;4.2(d) below. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) <U>Exercise Price of Post-Distribution SpinCo Option</U>. The per share
exercise price of such Company Option shall be equal to the quotient obtained by dividing (A)&nbsp;the per share exercise price of such Company Option immediately prior to the Distribution Time by (B)&nbsp;the SpinCo Ratio, and rounding such
quotient up to the nearest whole cent. Each SpinCo Option that is outstanding as of the Effective Time will be further adjusted to reflect the Transactions as set forth in Section&nbsp;4.2(d) below. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) <U>SpinCo Options Outstanding as of Immediately Prior to the Effective Time.</U> As of the Effective Time, each SpinCo Option that is then
outstanding and unexercised shall be converted into the right to receive an option relating to shares of Domesticated Parent Common Stock upon substantially the same terms and conditions as are in effect with respect to such option immediately prior
to the Effective Time (other than terms that have been rendered inoperative by the Transactions), including with respect to vesting and termination-related provisions (each, an &#147;<U>Adjusted Parent Option</U>&#148;), except that (A)&nbsp;such
Adjusted Parent Option shall relate to that whole number of shares of Domesticated Parent Common Stock (rounded down to the nearest whole share) equal to the number of shares of SpinCo Common Stock subject to such SpinCo Option, multiplied by the
Base Exchange Ratio, and (B)&nbsp;the exercise price per share for each such Adjusted Parent Option shall be equal to the exercise price per share of such SpinCo Option in effect immediately prior to the Effective Time, divided by the Base Exchange
Ratio (the exercise price per share, as so determined, being rounded up to the nearest full cent). In addition, at the Effective Time, Parent will issue to each holder of a SpinCo Option a number of Earnout Shares equal to the product of
(A)&nbsp;the number of shares of SpinCo Common Stock subject to the SpinCo Option, multiplied by (B)&nbsp;the Earnout Exchange Ratio, which Earnout Shares will be subject to the restrictions set forth in the Merger Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.3 <U>Treatment of Company RSU Awards</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <U>Company RSU Awards Other than (i)</U><U></U><U>&nbsp;Company RSU Awards Held by Former Company Service Providers and
(ii)</U><U></U><U>&nbsp;Company RSU Awards Held by Specified Service Providers</U>. As determined by the Company Compensation Committee pursuant to its authority under the Company Equity Plan, each Company RSU Award outstanding as of immediately
prior to the Distribution Time, other than (x)&nbsp;any Company RSU Award held by a Specified Service Provider and (y)&nbsp;any Company RSU Award held by a Former Company Service Provider, shall, immediately prior to the Distribution Time, be
converted into both a SpinCo RSU Award and a Company RSU Award and shall otherwise be, subject to Section&nbsp;4.3(d) below, subject to the same terms and conditions after the Distribution Time as the terms and conditions applicable to such Company
RSU Award immediately prior to the Distribution Time;<U>&nbsp;provided</U>,<U>&nbsp;however</U>, that from and after the Distribution Time: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) <U>Shares Subject to Post-Distribution Company RSU</U>. The number of shares of Company Common Stock subject to such
Company RSU Award shall be equal to the number of shares of Company Common Stock subject to such Company RSU Award immediately prior to the Distribution Time, and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) <U>Shares Subject to Post-Distribution SpinCo RSU.</U> The number of shares of SpinCo Common Stock subject to such SpinCo
RSU Award shall be equal to the product obtained by multiplying (A)&nbsp;the number of shares of Company Common Stock subject to the Company RSU Award immediately prior to the Distribution Time by (B)&nbsp;the Distribution Ratio, and rounding such
product down to the nearest whole share. Each SpinCo RSU Award that is outstanding as of the Effective Time will be further adjusted to reflect the Transactions as set forth in Section&nbsp;4.3(d) below. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;<U>Company RSU Awards Held by (i)</U><U></U><U>&nbsp;Former Company Service
Providers or Former SpinCo Service Providers and (ii)</U><U></U><U>&nbsp;Specified Service Providers who are Company Service Providers</U>. As determined by the Company Compensation Committee pursuant to its authority under the Company Equity Plan,
each Company RSU Award that is outstanding as of immediately prior to the Distribution Time (x)&nbsp;that is held by a Former Company Service Provider or a Former SpinCo Service Provider or (y)&nbsp;that is held by a Specified Service Provider who
is a Company Service Provider, shall be subject to the same terms and conditions after the Distribution Time as the terms and conditions applicable to such Company RSU Award immediately prior to the Distribution Time; <U>provided</U>,
<U>however</U>, that from and after the Distribution Time, the number of shares of Company Common Stock covered by such Company RSU Award held by the participant, as applicable, rounded to the nearest whole share, shall be equal to the product
obtained by multiplying (i)&nbsp;the number of shares of Company Common Stock covered by such Company RSU Award immediately prior to the Distribution Time by (ii)&nbsp;the Company Ratio. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;<U>Company RSU Awards Held by Specified Service Providers who are SpinCo Service Providers</U>. As determined by the Company
Compensation Committee pursuant to its authority under the Company Equity Plan, each Company RSU Award that is outstanding as of immediately prior to the Distribution Time that is held by a Specified Service Provider who is <U>a</U> SpinCo Service
Provider shall, immediately prior to the Distribution Time, be converted solely into <U>a</U> SpinCo RSU Award and shall otherwise be, subject to Section&nbsp;4.3(d) below, subject to the same terms and conditions after the Distribution Time as the
terms and conditions applicable to such Company RSU Award immediately prior to the Distribution Time;<U>&nbsp;provided</U>,<U>&nbsp;however</U>, that from and after the Distribution Time the number of shares of SpinCo Common Stock subject to such
SpinCo RSU Award shall be equal to the product obtained by multiplying (x)&nbsp;the number of shares of Company Common Stock subject to the Company RSU Award immediately prior to the Distribution Time by (y)&nbsp;the SpinCo Ratio, and rounding down
to the nearest whole share. Each SpinCo RSU Award that is outstanding as of the Effective Time will be further adjusted to reflect the Transactions as set forth in Section&nbsp;4.3(d) below. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) <U>SpinCo RSU Awards Outstanding as of the Effective Time</U>. As of the Effective Time, each SpinCo RSU Award that is outstanding
immediately prior to the Effective Time shall be converted into the right to receive restricted stock units relating to shares of Domesticated Parent Common Stock (each, an &#147;<U>Adjusted Parent RSU Award</U>&#148;) with substantially the same
terms and conditions as were applicable to such SpinCo RSU Award immediately prior to the Effective Time (other than terms that have been rendered inoperative by the Transactions), including with respect to vesting and termination-related
provisions, except that such Adjusted Parent RSU Award shall relate to that whole number of shares of Domesticated Parent Common Stock as is equal to the product of (B)&nbsp;the number of shares of SpinCo Common Stock subject to such SpinCo RSU
Awards immediately prior to the Effective Time, multiplied by (B)&nbsp;the Base Exchange Ratio, with any fractional shares rounded down to the nearest whole share. In addition, at the Effective Time, Parent will issue to each holder of a SpinCo RSU
Award a number of Earnout Shares equal to the product of (A)&nbsp;the number of shares of SpinCo Common Stock subject to the SpinCo RSU Award, multiplied by (B)&nbsp;the Earnout Exchange Ratio, which Earnout Shares will be subject to the
restrictions set forth in the Merger Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.4 <U>Treatment of Company PSU Awards</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <U>Company PSU Awards (Other than Company 2021 TSR PSU Awards) Not Held by Former Company Service Providers</U>. As determined by the
Company Compensation Committee pursuant to its authority under the Company Equity Plan, each Company PSU Award outstanding as of immediately prior to the Distribution Time, other than (x)&nbsp;any Company PSU Award held by a Former Company Service
Provider and (y)&nbsp;any Company PSU Award that is a Company 2021 TSR PSU Award, shall, immediately prior to the Distribution Time, be converted into both a SpinCo PSU Award and a </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">16 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Company PSU Award and shall, subject to Sections 4.4(e) and (f)&nbsp;below, otherwise be subject to the same terms and conditions after the Distribution Time as the terms and conditions
applicable to such Company PSU Award immediately prior to the Distribution Time;<U>&nbsp;provided</U>,<U>&nbsp;however</U>, that from and after the Distribution Time: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) <U>Shares Subject to Post-Distribution Company PSU.</U> The number of shares of Company Common Stock subject to such
Company PSU Award shall be equal to the number of shares of Company Common Stock subject to such Company PSU Award immediately prior to the Distribution Time, and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) <U>Shares Subject to Post-Distribution SpinCo PSU.</U> The number of shares of SpinCo Common Stock subject to such SpinCo
PSU Award shall be equal to the product obtained by multiplying (A)&nbsp;the number of shares of Company Common Stock subject to the Company PSU Award immediately prior to the Distribution Time by (B)&nbsp;the Distribution Ratio, and rounding such
product down to the nearest whole share. Each SpinCo PSU Award that is outstanding as of the Effective Time will be further adjusted to reflect the Transactions as set forth in Section&nbsp;4.4(f) below. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <U>Company 2021 TSR PSU Awards </U><U>Not</U><U> </U><U>Held by Former Company Service Providers</U>. As determined by the Company
Compensation Committee pursuant to its authority under the Company Equity Plan, each Company 2021 TSR PSU Award outstanding as of immediately prior to the Distribution Time, other than any 2021 TSR PSU Award that is held by a Former Company Service
Provider, shall, immediately prior to the Distribution Time, be converted into both an SpinCo PSU Award and a Company PSU Award and shall, subject to Sections 4.4(e) and (f)&nbsp;below, otherwise be subject to the same terms and conditions after the
Distribution Time as the terms and conditions applicable to such Company PSU Award immediately prior to the Distribution Time;<U>&nbsp;provided</U>,<U>&nbsp;however</U>, that from and after the Distribution Time: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) <U>Shares Subject to Post-Distribution Company PSU.</U> The number of shares of Company Common Stock subject to such
Company PSU Award shall be equal to (x)&nbsp;the number of shares of Company Common Stock subject to such Company 2021 TSR PSU Award immediately prior to the Distribution Time, multiplied by (y)&nbsp;such percentage (not to exceed 200%) as is
mutually determined by the Company and SpinCo prior to the Distribution Time, and rounding such product down to the nearest whole share, and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) <U>Shares Subject to Post-Distribution SpinCo PSU.</U> The number of shares of SpinCo Common Stock subject to such SpinCo
PSU Award shall be equal to the product obtained by multiplying (A) (x)&nbsp;the number of shares of Company Common Stock subject to the Company PSU Award immediately prior to the Distribution Time, multiplied by (y)&nbsp;such percentage (not to
exceed 200%) as is mutually determined by the Company and SpinCo prior to the Distribution Time by (B)&nbsp;the Distribution Ratio, and rounding such product down to the nearest whole share; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">provided, further, that from and after the Distribution Time, such Company 2021 TSR PSU Award shall no longer vest based on the performance objectives
applicable to such Company 2021 TSR PSU Award immediately prior to the Distribution Time and shall instead be amended to vest solely based on continuous employment or service on December&nbsp;31, 2023. Each SpinCo PSU Award that is outstanding as of
the Effective Time will be further adjusted to reflect the Transactions as set forth in Section&nbsp;4.4(f) below. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">17 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;<U>Company PSU Awards (Other than Company 2021 TSR PSU Awards) Held by Former
Company Service Providers</U>. As determined by the Company Compensation Committee pursuant to its authority under the Company Equity Plan, each Company PSU Award that is not a Company 2021 TSR PSU Award and is held by a Former Company Service
Provider outstanding as of immediately prior to the Distribution Time shall be, subject to Sections 4.4(e) and (f)&nbsp;below, subject to the same terms and conditions after the Distribution Time as the terms and conditions applicable to such
Company PSU Award immediately prior to the Distribution Time;<U>&nbsp;provided</U>,<U>&nbsp;however</U>, that from and after the Distribution Time, the number of shares of Company Common Stock covered by such Company PSU Award held by the
participant, as applicable, rounded to the nearest whole share, shall be equal to the product obtained by multiplying (i)&nbsp;the number of shares of Company Common Stock covered by such Company PSU Award immediately prior to the Distribution Time
by (ii)&nbsp;the Company Ratio. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) <U>Company 2021 TSR PSU Awards Held by Former Company Service Providers</U>. As determined by the
Company Compensation Committee pursuant to its authority under the Company Equity Plan, each Company 2021 TSR PSU Award held by a Former Company Service Provider that is outstanding as of immediately prior to the Distribution Time shall be, subject
to Sections 4.4(e) and (f)&nbsp;below, subject to the same terms and conditions after the Distribution Time as the terms and conditions applicable to such Company 2021 TSR PSU Award immediately prior to the Distribution
Time;<U>&nbsp;provided</U>,<U>&nbsp;however</U>, that from and after the Distribution Time, the number of shares of Company Common Stock covered by such Company 2021 TSR PSU Award held by the participant, as applicable, rounded to the nearest whole
share, shall be equal to the product obtained by multiplying (i)&nbsp;the number of shares of Company Common Stock covered by such Company 2021 TSR PSU Award immediately prior to the Distribution Time by (ii)&nbsp;such percentage (not to exceed
200%) as is mutually determined by the Company and SpinCo prior to the Distribution Time by (iii)&nbsp;the Company Ratio; provided, further, that from and after the Distribution Time, such Company 2021 TSR PSU Award shall no longer vest based on the
performance objectives applicable to such Company 2021 TSR PSU Award immediately prior to the Distribution Time and shall instead be amended to vest solely based on continuous employment or service on December&nbsp;31, 2023. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) <U>Amendment to Vesting Terms</U>. Prior to the Distribution Time, the Company and SpinCo may mutually agree to amend the vesting terms of
any or all outstanding Company PSU Awards. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) <U>SpinCo PSU Awards Outstanding as of the Effective Time</U>. As of the Effective Time,
each SpinCo PSU Award that is outstanding immediately prior to the Effective Time shall be converted into the right to receive (i)&nbsp;performance-vesting restricted stock units relating to shares of Domesticated Parent Common Stock (each, an
&#147;<U>Adjusted Parent PSU Award</U>&#148;) with substantially the same terms and conditions as were applicable to such SpinCo PSU Award immediately prior to the Effective Time (other than terms that have been rendered inoperative by the
Transactions), including with respect to vesting and termination-related provisions, except that such Adjusted Parent PSU Award shall relate to that whole number of shares of Domesticated Parent Common Stock as is equal to the product of
(A)&nbsp;the number of shares of SpinCo Common Stock subject to such SpinCo PSU Awards immediately prior to the Effective Time, multiplied by (B)&nbsp;the Base Exchange Ratio, with any fractional shares rounded down to the nearest whole share. Any
performance targets to which an Adjusted Parent PSU Awards are subject will be adjusted to reflect the Transactions contemplated hereby. In addition, at the Effective Time, Parent will issue to each holder of a SpinCo PSU Award a number of Earnout
Shares equal to the product of (A)&nbsp;the number of shares of SpinCo Common Stock subject to the SpinCo PSU Award, multiplied by (B)&nbsp;the Earnout Exchange Ratio, which Earnout Shares will be subject to the restrictions set forth in the Merger
Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.5 <U>SpinCo Equity Plans</U>. Effective as of immediately prior to the Distribution Time, SpinCo shall have adopted the
SpinCo 2022 Incentive Award Plan (Company Service Provider Awards) and the SpinCo 2022 Incentive Award Plan (SpinCo Service Provider Awards) (the &#147;<U>SpinCo Equity Plans</U>&#148;), which shall permit the grant and issuance of equity incentive
awards denominated in SpinCo Common Stock as described in this Article IV. In addition, prior to the Distribution Time, the Company shall approve the SpinCo Equity Plans as the sole stockholder of SpinCo. As of the Effective Time, Parent will assume
the SpinCo Equity Plans and all outstanding equity awards thereunder in accordance with the terms of this Article IV. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">18 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.6 <U>Parent Equity Plan and Parent ESPP</U>. Prior to the Effective Time, Parent shall
approve and adopt, subject to receipt of Parent Shareholder Approval: (i)&nbsp;an incentive equity plan (the &#147;<U>Parent Equity Plan</U>&#148;); and (ii)&nbsp;an employee stock purchase plan (the &#147;<U>Parent ESPP</U>&#148;), in each case, in
form and substance reasonably acceptable to the Company and SpinCo in consultation with Parent, and effective as of the Effective Time. The Parent Equity Plan will provide for the grant of awards of Domesticated Parent Common Stock with a total pool
of shares equal to (i) 14% of the aggregate number of Fully Diluted SpinCo Shares as of the Effective Time, plus (ii)&nbsp;any shares which, as of the effective date of the Parent Equity Plan, are subject to Adjusted Parent Equity Awards under the
SpinCo Equity Plans which, on or following such effective date, become available for issuance under the Parent Equity Plan pursuant to its terms, plus (iii)&nbsp;an annual &#147;evergreen&#148; increase of 5% of the shares of Parent Common Stock
outstanding as of the day prior to such increase (the &#147;<U>Parent Equity Plan Share Reserve</U>&#148;). The ESPP will provide for the grant of purchase rights with respect to Domesticated Parent Common Stock with a total pool of shares equal to
1.5% of the aggregate number of Fully Diluted SpinCo Shares as of the Effective Time, plus an annual &#147;evergreen&#148; increase of 1% of the shares of Parent Common Stock outstanding as of the day prior to such increase (the &#147;<U>Parent ESPP
Share Reserve</U>&#148;). <U>As soon as reasonably practicable</U> following the expiration of the sixty (60)&nbsp;day period following the date Parent has filed current Form 10 information with the SEC reflecting its status as an entity that is not
a shell company, Parent shall file an effective registration statement on Form <FONT STYLE="white-space:nowrap">S-8</FONT> (or other applicable form, including Form <FONT STYLE="white-space:nowrap">S-1</FONT> or Form
<FONT STYLE="white-space:nowrap">S-3)</FONT> with respect to the Domesticated Parent Common Stock issuable under the Parent Equity Plan and the Parent ESPP, and Parent shall use commercially reasonable efforts to maintain the effectiveness of such
registration statement(s) (and maintain the current status of the prospectus or prospectuses contained therein) for so long as awards granted pursuant to the Parent Equity Plan and the Parent ESPP remain outstanding. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.7 <U>Vesting; Accelerated Vesting</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) The Distribution Time shall not constitute a termination of employment or service for any SpinCo Service Providers for purposes of any
Company Equity Award and, except as otherwise provided in this Agreement, with respect to grants adjusted pursuant to this Article IV, continued employment with the SpinCo Group shall be treated as continued employment with the Company Group with
respect to Company Equity Awards held by SpinCo Service Providers and continued employment with the Company Group shall be treated as continued employment with the SpinCo Group with respect to SpinCo Equity Awards (or, following the Effective Time,
Adjusted Parent Equity Awards) held by Company Service Providers. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Notwithstanding the foregoing, with respect to any unvested SpinCo
Equity Awards (or, following the Effective Time, Adjusted Parent Equity Awards) granted to a Company Service Provider in accordance with this Agreement, if the original Company Equity Award (that was partially adjusted into the SpinCo Equity Award
(or, following the Effective Time, Adjusted Parent Equity Award)) was subject, as of immediately prior to the Distribution, to accelerated vesting provisions (i)&nbsp;by reference to a termination of employment or service with the Company and/or
(ii)&nbsp;in connection with a &#147;Change in Control&#148; (as defined in the applicable award agreement and/or Company Equity Plan) of the Company, then the SpinCo Equity Awards (or, following the Effective Time, Adjusted Parent Equity Awards)
also shall be subject to such same acceleration provisions upon the Company Service Provider&#146;s termination of employment or service with the Company Group and/or in connection with a &#147;Change in Control&#148; (as defined in the applicable
award agreement and/or Company Equity Plan) of the Company. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">19 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Further notwithstanding the foregoing, with respect to any unvested Company Equity
Awards or unvested SpinCo Equity Awards (or, following the Effective Time, Adjusted Parent Equity Awards) granted to an SpinCo Service Provider in accordance with this Agreement, if the original Company Equity Award (including any Company Equity
Award that was solely or partially adjusted into the SpinCo Equity Award (or, following the Effective Time, Adjusted Parent Equity Award)), was subject, as of immediately prior to the Distribution, to accelerated vesting provisions (i)&nbsp;by
reference to a termination of employment or service with the Company and/or (ii)&nbsp;in connection with a &#147;Change in Control&#148; (as defined in the applicable award agreement and/or Company Equity Plan) of the Company, then the Company
Equity Award or SpinCo Equity Award (or, following the Effective Time, Adjusted Parent Equity Award), as applicable, also shall be subject to such same acceleration provisions upon the SpinCo Service Provider&#146;s termination of employment or
service with the relevant member of the SpinCo Group and/or in connection with a &#147;Change in Control&#148; (as defined in the applicable award agreement and/or SpinCo Equity Plan) of SpinCo. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) In addition, with respect to any unvested SpinCo Equity Awards (or, following the Effective Time, Adjusted Parent Equity Awards) held by a
Company Service Provider following the Distribution Time, notwithstanding anything herein or in the applicable award agreement to the contrary, such SpinCo Equity Awards (or, following the Effective Time, Adjusted Parent Equity Awards) will vest in
full upon a &#147;Change in Control&#148; (as defined in the applicable award agreement and/or SpinCo Equity Plans) of SpinCo (or, following the Effective Time, Parent). Further, with respect to any unvested Company Equity Awards which are adjusted
as of immediately prior to the Distribution Time and continue to be held by a SpinCo Service Provider following the Distribution, in each case, in accordance with this Agreement, notwithstanding anything herein or in the applicable award agreement
to the contrary, such Company Equity Awards will vest in full upon a &#147;Change in Control&#148; (as defined in the applicable award agreement and/or Company Equity Plan) of the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) Additionally, notwithstanding anything herein or in the applicable award agreement to the contrary, if, following the Distribution Time,
the Company Board determines, in its discretion, to accelerate in full the vesting of all Company Equity Awards then held by Company Service Providers and Former Company Service Providers (other than in connection with a &#147;Change in
Control&#148; (as defined in the applicable award agreement and/or Company Equity Plan)), the Company Board shall also accelerate in full the vesting of all outstanding Company Equity Awards which are then held by SpinCo Service Providers and Former
SpinCo Service Providers. Further notwithstanding anything herein or in the applicable award agreement to the contrary, if, following the Distribution Time, the SpinCo Board or Parent Board determines, in its discretion, to accelerate in full the
vesting of all SpinCo Equity Awards (or, following the Effective Time, Adjusted Parent Equity Awards) then held by SpinCo Service Providers and Former SpinCo Service Providers (other than in connection with a &#147;Change in Control&#148; (as
defined in the applicable award agreement and/or SpinCo Equity Plans)), the SpinCo Board or Parent Board shall also accelerate in full the vesting of all outstanding SpinCo Equity Awards (or, following the Effective Time, Adjusted Parent Equity
Awards) which are then held by Company Service Providers and Former Company Service Providers. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) The Parties hereto acknowledge and
agree that in no event shall the vesting of any Company Equity Awards or SpinCo Equity Awards (or, following the Effective Time, Adjusted Parent Equity Awards), in any case, accelerate solely by reason of the transactions or events contemplated by
the Separation Agreement, this Agreement, the Merger Agreement or any other Transaction Document. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">20 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.8 <U>General Terms</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) The adjustments contemplated by this Article IV are all intended to comply in all respects with the requirements of Sections 409A and 424
of the Code, in each case, to the extent applicable, and all such provisions shall be interpreted and implemented in accordance with the foregoing. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) The Parties shall use their commercially reasonable efforts to maintain effective registration statements with the Securities Exchange
Commission with respect to the awards described in this Article IV, to the extent any such registration statement is required by applicable Law. For the avoidance of doubt, Parent shall use commercially reasonable efforts to file an effective
registration statement on Form <FONT STYLE="white-space:nowrap">S-8</FONT> (or other applicable form, including Form <FONT STYLE="white-space:nowrap">S-1</FONT> or Form <FONT STYLE="white-space:nowrap">S-3)</FONT> with respect to the Domesticated
Parent Common Stock issuable under the Adjusted Parent Equity Awards issuable under the SpinCo Equity Plans, and Parent shall use commercially reasonable efforts to maintain the effectiveness of such registration statement(s) (and maintain the
current status of the prospectus or prospectuses contained therein) for so long as such awards remain outstanding. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) The Parties hereby
acknowledge that the provisions of this Article IV are intended to achieve certain tax, legal and accounting objectives and, in the event such objectives are not achieved, the Parties agree to negotiate in good faith regarding such other actions
that may be necessary or appropriate to achieve such objectives. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) After the Distribution Time, Company Equity Awards adjusted pursuant
to this Article IV, regardless of by whom held, shall be settled by the Company pursuant to the terms of the Company Equity Plan, and SpinCo Equity Awards (or, following the Effective Time, Adjusted Parent Equity Awards), regardless of by whom held,
shall be settled by SpinCo or Parent (as applicable) pursuant to the terms of the SpinCo Equity Plan. Accordingly, it is intended that, to the extent of the issuance of such SpinCo Equity Awards (or, following the Effective Time, Adjusted Parent
Equity Awards) and in connection with the adjustment provisions of this Article IV, the SpinCo Equity Plan shall be considered a successor to the Company Equity Plan and to have assumed the obligations of the Company Equity Plan to make the
adjustments of the Company Equity Awards as set forth in this Article IV. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) The Parties acknowledge and agree that each of the
applicable tax deductions for which they may be eligible for federal income tax purposes with regard to the Company Equity Awards and SpinCo Equity Awards (or, following the Effective Time, Adjusted Parent Equity Awards), in any case, shall be
determined in accordance with Revenue Ruling <FONT STYLE="white-space:nowrap">2002-1.</FONT> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) By approving the form, terms and
conditions of, and the entrance by the Parties into, this Agreement, the Company Board, the SpinCo Board and the Parent Board intend to exempt from the short-swing profit recovery provisions of Section&nbsp;16(b) of the Exchange Act, by reason of
the application of Rule 16b&#151;3 thereunder, all acquisitions and dispositions of Company Equity Awards, SpinCo Equity Awards and/or Adjusted Parent Equity Awards by directors and executive officers of each of the Parties contemplated herein, and
the Company Board, the SpinCo Board and the Parent Board also intend to expressly approve, in respect of any Company Equity Awards, SpinCo Equity Awards and/or Adjusted Parent Equity Awards, the use of any method for the payment of an exercise price
and the satisfaction of any applicable tax withholding (specifically including the actual or constructive tendering of shares in payment of an exercise price and the withholding of shares from delivery in satisfaction of applicable tax withholding
requirements) to the extent such method is permitted under the Company Equity Plan or SpinCo Equity Plan (as applicable) and the applicable award agreement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">21 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) Each of the Parties shall establish an appropriate administration system in order to
handle, in an orderly manner that complies with applicable Laws, (i)&nbsp;exercises of Ligand Options and SpinCo Options (or, following the Effective Time, Adjusted Parent Options), (ii) the settlement of other Ligand Equity Awards and SpinCo Equity
Awards (or, following the Effective Time, Adjusted Parent Equity Awards), (iii) the vesting of Ligand Equity Awards and SpinCo Equity Awards (or, following the Effective Time, Adjusted Parent Equity Awards) and (iv)&nbsp;the satisfaction of
applicable withholding taxes with respect to Ligand Equity Awards and SpinCo Equity Awards (or, following the Effective Time, Adjusted Parent Equity Awards). The Parties shall work together to unify and consolidate all indicative data and payroll
and employment information on regular timetables and make certain that each applicable entity&#146;s data and records in respect of such awards are correct and updated on a timely basis. The foregoing shall include employment status and information
required for tax withholding/remittance and reporting, compliance with trading windows and compliance with the requirements of the Exchange Act and other applicable Laws. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE V </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>ADDITIONAL
MATTERS </U></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.1 <U>Cash Incentive Programs</U>. SpinCo shall assume all Liabilities with respect to all cash incentive compensation,
commissions or similar cash payments earned by or payable to SpinCo Employees for the year in which the Distribution Time occurs and thereafter. The Company shall retain all Liabilities with respect to any cash incentive compensation, commissions or
similar cash payments earned by or payable to Company Employees for the year in which the Distribution Time occurs and thereafter. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.2
<U>Severance</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Effective as of the Distribution Time, SpinCo shall have adopted a severance plan (the &#147;<U>SpinCo Severance
Plan</U>&#148;) for the benefit of eligible SpinCo Employees containing terms substantially similar to those set forth in the Company Severance Plan. Following the Distribution Time, the Company shall be responsible for any and all Liabilities and
other obligations with respect to the Company Severance Plan, and SpinCo shall be responsible for any and all Liabilities and other obligations with respect to the SpinCo Severance Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) A SpinCo Employee shall not be deemed to have terminated employment for purposes of determining eligibility for severance benefits in
connection with or in anticipation of the consummation of the transactions contemplated by the Separation Agreement or Merger Agreement. SpinCo shall be solely responsible for all Liabilities in respect of all costs arising out of payments and
benefits relating to the termination or alleged termination of any SpinCo Employee&#146;s employment that occurs on or after the Distribution Time, including as a result of, in connection with or following the consummation of the transactions
contemplated by the Separation Agreement or Merger Agreement, including any amounts required to be paid (including any payroll or other taxes), and the costs of providing benefits, under any applicable severance, separation, redundancy, termination
or similar plan, program, practice, contract, agreement, law or regulation (such benefits to include any medical or other welfare benefits, outplacement benefits, accrued vacation, and taxes). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.3 <U><FONT STYLE="white-space:nowrap">Time-Off</FONT> Benefits</U>. Unless otherwise required under applicable Law (or as would result in
duplication of benefits), SpinCo shall (i)&nbsp;credit each SpinCo Employee with the amount of accrued but unused vacation time, paid <FONT STYLE="white-space:nowrap">time-off</FONT> and other <FONT STYLE="white-space:nowrap">time-off</FONT>
benefits as such SpinCo Employee had with the Company Group as of immediately before the date on which the employment of the SpinCo Employee transfers to SpinCo and (ii)&nbsp;permit each such SpinCo Employee to use such accrued but unused vacation
time, paid time off and other <FONT STYLE="white-space:nowrap">time-off</FONT> benefits in the same manner and upon the same terms and conditions as the SpinCo Employee would have been so permitted under the terms and conditions of the applicable
Company policies in effect for the year in which such transfer of employment occurs, up to and including full exhaustion of such transferred unused vacation time, paid-time off and other <FONT STYLE="white-space:nowrap">time-off</FONT> benefits (if
such full exhaustion would be permitted under the applicable Company policies in effect for that year in which the transfer of employment occurs). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">22 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.4 <U>Workers&#146; Compensation Liabilities</U>. Effective no later than the Distribution
Time, SpinCo shall assume all Liabilities for SpinCo Employees, SpinCo Independent Contractors and Former SpinCo Service Providers related to any and all workers&#146; compensation injuries, incidents, conditions, claims or coverage, whenever
incurred (including claims incurred prior to the Distribution Time but not reported until after the Distribution Time), and SpinCo shall be fully responsible for the administration, management and payment of all such claims and satisfaction of all
such Liabilities. Notwithstanding the foregoing, if SpinCo is unable to assume any such Liability or the administration, management or payment of any such claim solely because of the operation of applicable Law, the Company shall retain such
Liabilities and SpinCo shall reimburse and otherwise fully indemnify the Company for all such Liabilities, including the costs of administering the plans, programs or arrangements under which any such Liabilities have accrued or otherwise arisen.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.5 <U>COBRA Compliance</U>. The Company shall retain responsibility for compliance with the health care continuation requirements of
COBRA with respect to SpinCo Employees or Former SpinCo Service Providers who, as of <U>the Plan Transition Date</U>, were covered under a Company Benefit Plan or who had incurred a COBRA qualifying event and were eligible to elect COBRA under a
Company Benefit Plan. SpinCo shall be responsible for administering compliance with the health care continuation requirements of COBRA, and the corresponding provisions of the SpinCo Benefit Plans with respect to SpinCo Employees and their covered
dependents who incur a COBRA qualifying event or loss of coverage at any time after the Plan Transition Date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.6 <U>Code
Section</U><U></U><U>&nbsp;409A</U>. Notwithstanding anything in this Agreement to the contrary, the Parties shall negotiate in good faith regarding the need for any treatment different from that otherwise provided herein with respect to the payment
of compensation to ensure that the treatment of such compensation does not cause the imposition of a Tax under Section&nbsp;409A of the Code. In no event, however, shall any Party be liable to another in respect of any Taxes imposed under, or any
other costs or Liabilities relating to, Section&nbsp;409A of the Code. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.7 <U>Payroll Taxes and Reporting</U>. The Parties shall, to the
extent practicable, (i)&nbsp;treat SpinCo or a member of the SpinCo Group as a &#147;successor employer&#148; and the Company (or the appropriate member of the Company Group) as a &#147;predecessor,&#148; within the meaning of Sections 3121(a)(1)
and 3306(b)(1) of the Code, with respect to SpinCo Employees for purposes of Taxes imposed under the United States Federal Unemployment Tax Act or the United States Federal Insurance Contributions Act, and (ii)&nbsp;cooperate with each other to
avoid, to the extent <U>reasonably practicable</U>, the filing of more than one IRS Form <FONT STYLE="white-space:nowrap">W-2</FONT> with respect to each SpinCo Employee for the calendar year in which the Distribution Time occurs. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.8 <U>Regulatory Filings</U>. Subject to applicable Law and the Tax Matters Agreement, the Company shall retain responsibility for all
employee-related regulatory filings for reporting periods ending at or prior to the Distribution Time, except for Equal Employment Opportunity Commission <FONT STYLE="white-space:nowrap">EEO-1</FONT> reports and affirmative action program (AAP)
reports and responses to Office of Federal Contract Compliance Programs (OFCCP) submissions, for which the Company shall provide data and information (to the extent permitted by applicable Laws) to SpinCo, which shall be responsible for making such
filings in respect of SpinCo Employees. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">23 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.9 <U>Certain Requirements</U>. Notwithstanding anything in this Agreement to the contrary,
if applicable Law requires that any assets or Liabilities be retained by the Company Group or transferred to or assumed by the SpinCo Group in a manner that is different from that set forth in this Agreement, such retention, transfer or assumption
shall be made in accordance with the terms of such applicable Law and shall not be made as otherwise set forth in this Agreement and the Parties shall reasonably cooperate to adjust for any related economic consequences. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE VI </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>OBLIGATIONS
OF PARENT AND MERGER SUB </U></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6.1 <U>Obligations of Parent</U>. Following the Merger Effective Time, Parent agrees to cause, and to take
all actions to enable, SpinCo and the members of the SpinCo Group to adhere to each provision of this Agreement which requires an act on the part of SpinCo or any member of the SpinCo Group or any of its or their Affiliates, and to cause or enable
SpinCo and the SpinCo Group to comply with their obligations to provide or establish compensation or benefits to SpinCo Service Providers in accordance with this Agreement pursuant to a Benefit Plan sponsored or maintained by Parent or any of its
Subsidiaries. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE VII </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>GENERAL AND ADMINISTRATIVE </U></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7.1 <U>Employer Rights</U>. Nothing in this Agreement shall be deemed to be an amendment to any Company Benefit Plan or SpinCo Benefit Plan or
to prohibit any member of the Company Group or SpinCo Group, as the case may be, from amending, modifying or terminating any Company Benefit Plan or SpinCo Benefit Plan at any time within its sole discretion. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7.2 <U>Effect on Employment</U>. Nothing in this Agreement is intended to or shall confer upon any employee or former employee of the Company,
SpinCo or any of their respective Affiliates any right to continued employment, or any recall or similar rights to any such individual on layoff or any type of approved leave. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7.3 <U>Consent of Third Parties</U>. If any provision of this Agreement is dependent on the consent of any third party and such consent is
withheld, the Parties shall use their reasonable efforts to implement the applicable provisions of this Agreement to the fullest extent practicable. If any provision of this Agreement cannot be implemented due to the failure of such third party to
consent, the Parties hereto shall negotiate in good faith to implement the provision (as applicable) in a mutually satisfactory manner. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7.4 <U>Access to Employees</U>. On and after the Distribution Time, the Parties shall, or shall cause each of their respective Affiliates to,
make available to each other those of their employees who may reasonably be needed in order to defend or prosecute any legal or administrative action (other than a legal action among the Parties) to which any employee or director of the Company
Group or the SpinCo Group or any Company Benefit Plan or SpinCo Benefit Plan is a party and which relates to a Company Benefit Plan or SpinCo Benefit Plan. The Party to whom an employee is made available in accordance with this&nbsp;Section
7.4&nbsp;shall pay or reimburse the other Parties for all reasonable expenses which may be incurred by such employee in connection therewith, including all reasonable travel, lodging, and meal expenses, but excluding any amount for such
employee&#146;s time spent in connection herewith. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7.5 <U>Beneficiary Designation/Release of Information/Right to Reimbursement</U>. To
the extent permitted by applicable Law and except as otherwise provided for in this Agreement, all beneficiary designations, authorizations for the release of information and rights to reimbursement made by or relating to SpinCo Employees under
Company Benefit Plan shall be transferred to and be in full force and effect under the corresponding SpinCo Benefit Plan until such beneficiary designations, authorizations or rights are replaced or revoked by, or no longer apply, to the relevant
SpinCo Employee. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">24 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7.6 <U>No Third Party Beneficiaries</U>. This Agreement is solely for the benefit of the
Parties and, except to the extent otherwise expressly provided herein, nothing in this Agreement, express or implied, is intended to confer any rights, benefits, remedies, obligations or Liabilities under this Agreement upon any Person, including
any SpinCo Employee or other current or former employee, officer, director or contractor of the Company Group or SpinCo Group, other than the Parties and their respective successors and assigns. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7.7 <U>Employee Benefits Administration</U>. At all times following the date hereof, the Parties will cooperate in good faith as necessary to
facilitate the administration of employee benefits and the resolution of related employee benefit claims with respect to SpinCo Employees, Former SpinCo Service Providers and employees and other service providers of the Company, as applicable,
including with respect to the provision of employee level information necessary for the other Parties to manage, administer, finance and file required reports with respect to such administration. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7.8 <U>Audit Rights With Respect to Information Provided</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Each Party, and their duly authorized representatives, shall have the right to conduct reasonable audits with respect to all information
required to be provided to it by the other Parties under this Agreement. The Party conducting the audit (the &#147;<U>Auditing Party</U>&#148;) may adopt reasonable procedures and guidelines for conducting audits and the selection of audit
representatives under this Section&nbsp;7.8. The Auditing Party shall have the right to make copies of any records at its expense, subject to any restrictions imposed by applicable laws and to any confidentiality provisions set forth in the
Separation Agreement, which are incorporated by reference herein. The Party being audited shall provide the Auditing Party&#146;s representatives with reasonable access during normal business hours to its operations, computer systems and paper and
electronic files, and provide workspace to its representatives. After any audit is completed, the Party being audited shall have the right to review a draft of the audit findings and to comment on those findings in writing within thirty business
days after receiving such draft. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) The Auditing Party&#146;s audit rights under this Section&nbsp;7.8 shall include the right to audit,
or participate in an audit facilitated by the Party being audited, of any Subsidiaries and Affiliates of the Party being audited and to require the other Parties to request any benefit providers and third parties with whom the Party being audited
has a relationship, or agents of such Party, to agree to such an audit to the extent any such Persons are affected by or addressed in this Agreement (collectively, the &#147;<U><FONT STYLE="white-space:nowrap">Non-parties</FONT></U>&#148;). The
Party being audited shall, upon written request from the Auditing Party, provide an individual (at the Auditing Party&#146;s expense) to supervise any audit of a <FONT STYLE="white-space:nowrap">Non-party.</FONT> The Auditing Party shall be
responsible for supplying, at the Auditing Party&#146;s expense, additional personnel sufficient to complete the audit in a reasonably timely manner. The responsibility of the Party being audited shall be limited to providing, at the Auditing
Party&#146;s expense, a single individual at each audited site for purposes of facilitating the audit. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7.9 <U>C</U><U>ooperation</U>.
Each of the Parties hereto will use its commercially reasonable efforts to share information and promptly take, or cause to be taken, all actions and to do, or cause to be done, all things necessary, proper or advisable under applicable Laws to
consummate the transactions contemplated by this Agreement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">25 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE VIII </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>MISCELLANEOUS </U></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8.1
<U>Entire Agreement</U>. This Agreement, the Separation Agreement, the Merger Agreement, and the other Transaction Documents, including the Exhibits and Schedules thereto, shall constitute the entire agreement among the Parties with respect to the
subject matter hereof and shall supersede all previous negotiations, commitments, course of dealings and writings with respect to such subject matter. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8.2 <U>Counterparts</U>. This Agreement may be executed in two or more counterparts (including by electronic or .pdf transmission), each of
which shall be deemed an original, but all of which together shall constitute one and the same instrument. Delivery of any signature page by facsimile, electronic or .pdf transmission shall be binding to the same extent as an original signature
page. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8.3 <U>Survival of Agreements</U>. Except as otherwise contemplated by this Agreement, all covenants and agreements of the Parties
contained in this Agreement shall survive the Distribution Time and Merger Effective Time and remain in full force and effect in accordance with their applicable terms. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8.4 <U>Notices</U>. All notices and other communications among the Parties shall be in writing and shall be deemed to have been duly given
(a)&nbsp;when delivered in person, (b)&nbsp;when delivered after posting in the national mail having been sent registered or certified mail return receipt requested, postage prepaid, (c)&nbsp;when delivered by FedEx or other internationally
recognized overnight delivery service or (d)&nbsp;when delivered by facsimile (solely if receipt is confirmed) or email (so long as the sender of such email does not receive an automatic reply from the recipient&#146;s email server indicating that
the recipient did not receive such email), addressed as follows: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">To the Company: </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">Ligand Pharmaceuticals Incorporated </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">3911 Sorrento Valley Boulevard, Suite 110 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">San Diego, California 92121 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">Attn: Chief Financial Officer </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">Email: tespinoza@ligand.com </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">with a copy (which shall not constitute notice) to: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">Latham&nbsp;&amp; Watkins, LLP </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">12670 High Bluff Dr. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">San
Diego, California 92130 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">Attention: Matthew Bush </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:20%; font-size:10pt; font-family:Times New Roman">Scott Shean </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">Email:
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;matt.bush@lw.com </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:20%; font-size:10pt; font-family:Times New Roman">scott.shean@lw.com </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">To SpinCo: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">OmniAb, Inc. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">5980 Horton Street, Suite 405 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">Emeryville, California 94608 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">Attn: Chief Legal Officer </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">Email: cberkman@omniab.com </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">with a copy (which shall not constitute notice) to: </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">Latham&nbsp;&amp; Watkins, LLP </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">12670 High Bluff Dr. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">San
Diego, California 92130 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">Attention: Matthew Bush </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">26 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:20%; font-size:10pt; font-family:Times New Roman">Scott Shean </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">Email: &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;matt.bush@lw.com </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:20%; font-size:10pt; font-family:Times New Roman">scott.shean@lw.com </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">To Parent or
Merger Sub: </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">Avista Public Acquisition Corp. II </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">65 East 55<SUP STYLE="font-size:85%; vertical-align:top">th</SUP> Street, 18<SUP STYLE="font-size:85%; vertical-align:top">th</SUP> Floor </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">New York, New York 10022 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">Attn:
General Counsel </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">Email: Silbert@avistacap.com </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">with a copy (which shall not constitute notice) to: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">Weil, Gotshal&nbsp;&amp; Manges LLP </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">767 5th Avenue </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">New York, New
York 10153 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">Attention: Jaclyn L. Cohen, Esq. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:20%; font-size:10pt; font-family:Times New Roman">Raymond O. Gietz, Esq. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">Email:
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;jackie.cohen@weil.com </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:20%; font-size:10pt; font-family:Times New Roman">Raymond.gietz@weil.com </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">or to such other address or addresses as the Parties may from time to time designate in writing by like notice. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8.5 <U>Consents</U>. Any consent required or permitted to be given by any Party to the other Parties under this Agreement shall be in writing
and signed by the Party giving such consent and shall be effective only against such Party (and its Group). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8.6 <U>Assignment</U>. This
Agreement shall not be assignable, in whole or in part, directly or indirectly, by any Party hereto without the prior written consent of the other Parties, and any attempt to assign any rights or obligations arising under this Agreement without such
consent shall be void. Notwithstanding the foregoing, and subject to any restrictions on assignment by SpinCo pursuant to Article IV of the Tax Matters Agreement, this Agreement shall be assignable to (i)&nbsp;with respect to the Company, an
Affiliate of the Company, and with respect to SpinCo, and Affiliate of SpinCo, or (ii)&nbsp;a bona fide third party in connection with a merger, reorganization, consolidation or the sale of all or substantially all the assets of a party hereto so
long as the resulting, surviving or transferee entity assumes all the obligations of the relevant party hereto by operation of Law or pursuant to an agreement in form and substance reasonably satisfactory to the other Parties to this
Agreement;&nbsp;provided&nbsp;however&nbsp;that in the case of each of the preceding clauses (i)&nbsp;and (ii), no assignment permitted by this&nbsp;Section 8.6&nbsp;shall release the assigning Party from liability for the full performance of its
obligations under this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8.7 <U>Successors and Assigns</U>. The provisions of this Agreement and the obligations and rights
hereunder shall be binding upon, inure to the benefit of and be enforceable by (and against) the Parties and their respective successors and permitted assigns. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8.8 <U>Termination and Amendment</U>. This Agreement may be amended or modified, in whole or in part, only by a duly authorized agreement in
writing executed by the Parties in the same manner (but not necessarily by the same Persons) as this Agreement, and which makes reference to this Agreement. This Agreement shall terminate automatically without any further action of the Parties upon
a termination of the Merger Agreement, and no Party will have any further obligations to the other Parties hereunder. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">27 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8.9 <U>Subsidiaries</U>. Each of the Parties shall cause to be performed, and hereby
guarantees the performance of, all actions, agreements and obligations set forth herein to be performed by any Subsidiary of such Party or by any entity that becomes a Subsidiary of such Party at and after the Distribution Time, to the extent such
Subsidiary remains a Subsidiary of the applicable Party. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8.10 <U>Title and Headings</U>. Titles and headings to sections herein are
inserted for the convenience of reference only and are not intended to be a part of or to affect the meaning or interpretation of this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8.11 <U>Governing Law</U>. This Agreement, and all claims, disputes, controversies or causes of action (whether in contract, tort, equity or
otherwise) that may be based upon, arise out of or relate to this Agreement (including any schedule or exhibit hereto) or the negotiation, execution or performance of this Agreement (including any claim, dispute, controversy or cause of action based
upon, arising out of or related to any representation or warranty made in or in connection with this Agreement or as an inducement to enter into this Agreement), shall be governed by and construed in accordance with the Laws of the State of
Delaware, without regard to any choice or conflict of law provision or rule (whether of the State of Delaware or any other jurisdiction) that would cause the application of the Laws of any jurisdiction other than the State of Delaware. Each of the
Parties agrees that any Action related to this agreement shall be brought exclusively in the <U>Chosen Courts</U>. By executing and delivering this Agreement, each of the Parties irrevocably: (a)&nbsp;accepts generally and unconditionally submits to
the exclusive jurisdiction of the Chosen Courts for any Action relating to this Agreement; (b)&nbsp;waives any objections which such party may now or hereafter have to the laying of venue of any such Action contemplated by this Section&nbsp;8.11 and
hereby further irrevocably waives and agrees not to plead or claim that any such Action has been brought in an inconvenient forum; (c)&nbsp;agrees that it will not attempt to deny or defeat the personal jurisdiction of the Chosen Courts by motion or
other request for leave from any such court; (d)&nbsp;agrees that it will not bring any Action contemplated by this Section&nbsp;8.11 in any court other than the Chosen Courts; (e)&nbsp;agrees that service of all process, including the summons and
complaint, in any Action may be made by registered or certified mail, return receipt requested, to such party at their respective addresses provided in accordance with Section&nbsp;8.4 or in any other manner permitted by Law; and (f)&nbsp;agrees
that service as provided in the preceding clause (e)&nbsp;is sufficient to confer personal jurisdiction over such party in the Action, and otherwise constitutes effective and binding service in every respect. Each of the parties hereto agrees that a
final judgment in any Action in a Chosen Court as provided above may be enforced in other jurisdictions by suit on the judgment or in any other manner provided by Law, and each party further agrees to the
<FONT STYLE="white-space:nowrap">non-exclusive</FONT> jurisdiction of the Chosen Courts for the enforcement or execution of any such judgment. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8.12 WAIVER OF JURY TRIAL. THE PARTIES HEREBY UNCONDITIONALLY AND IRREVOCABLY WAIVE THEIR RIGHT TO TRIAL BY JURY IN ANY JUDICIAL PROCEEDING IN
ANY COURT RELATING TO ANY DISPUTE, CONTROVERSY OR CLAIM ARISING OUT OF, RELATING TO OR IN CONNECTION WITH THIS AGREEMENT (INCLUDING ANY SCHEDULE OR EXHIBIT HERETO) OR THE BREACH, TERMINATION OR VALIDITY OF THIS AGREEMENT OR THE NEGOTIATION,
EXECUTION OR PERFORMANCE OF THIS AGREEMENT. NO PARTY TO THIS AGREEMENT SHALL SEEK A JURY TRIAL IN ANY LAWSUIT, PROCEEDING, COUNTERCLAIM OR ANY OTHER LITIGATION PROCEDURE BASED UPON, OR ARISING OUT OF, THIS AGREEMENT OR ANY RELATED INSTRUMENTS. NO
PARTY WILL SEEK TO CONSOLIDATE ANY SUCH ACTION IN WHICH A JURY TRIAL HAS BEEN WAIVED WITH ANY OTHER ACTION IN WHICH A JURY TRIAL CANNOT BE OR HAS NOT BEEN WAIVED. EACH PARTY TO THIS AGREEMENT CERTIFIES THAT IT HAS BEEN INDUCED TO ENTER INTO THIS
AGREEMENT OR INSTRUMENT BY, AMONG OTHER THINGS, THE MUTUAL WAIVERS AND CERTIFICATIONS SET FORTH ABOVE IN THIS SECTION 8.12. NO PARTY HAS IN ANY WAY AGREED WITH OR REPRESENTED TO ANY OTHER PARTY THAT THE PROVISIONS OF THIS SECTION 8.12 WILL NOT BE
FULLY ENFORCED IN ALL INSTANCES. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">28 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8.13 <U>Severability</U>. If any provision of this Agreement, or the application of any such
provision to any Person or circumstance, shall be held invalid, illegal or unenforceable in any respect by a court of competent jurisdiction, such invalidity, illegality or unenforceability shall not affect any other provision hereof. The Parties
further agree that if any provision contained herein is, to any extent, held invalid or unenforceable in any respect under the Laws governing this Agreement, they shall take any actions necessary to render the remaining provisions of this Agreement
valid and enforceable to the fullest extent permitted by Law and, to the extent necessary, shall amend or otherwise modify this Agreement to replace any provision contained herein that is held invalid or unenforceable with a valid and enforceable
provision giving effect to the intent of the Parties. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8.14 <U>Interpretation</U>. The Parties have participated jointly in the
negotiation and drafting of this Agreement. This Agreement shall be construed without regard to any presumption or rule requiring construction or interpretation against the Party drafting or causing any instrument to be drafted. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8.15 <U>No Duplication; No Double Recovery</U>. Nothing in this Agreement is intended to confer to or impose upon any Party a duplicative
right, entitlement, obligation or recovery with respect to any matter arising out of the same facts and circumstances. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8.16 <U>No
Waiver</U>. No failure to exercise and no delay in exercising, on the part of any Party, any right, remedy, power or privilege hereunder shall operate as a waiver hereof; nor shall any single or partial exercise of any right, remedy, power or
privilege hereunder preclude any other or further exercise thereof or the exercise of any other right, remedy, power or privilege. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8.17
<U>No Admission of Liability</U>. The allocation of Assets and Liabilities herein is solely for the purpose of allocating such Assets and Liabilities among the Parties and is not intended as an admission of liability or responsibility for any
alleged Liabilities <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">vis-&agrave;-vis</FONT></FONT> any third party, including with respect to the Liabilities of any <FONT STYLE="white-space:nowrap">non-wholly</FONT> owned
subsidiary of any Party. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>[Signature Page Follows] </I></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">29 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">IN WITNESS WHEREOF, the Parties have caused this Agreement to be duly executed as of the day
and year first above written. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="13%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="86%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">LIGAND PHARMACEUTICALS INCORPORATED</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Matthew Korenberg</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Executive Vice President, Finance and Chief Financial Officer</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">OMNIAB, INC.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Matthew W. Foehr</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">President and Chief Executive Officer</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">AVISTA PUBLIC ACQUISITION CORP. II</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Benjamin Silbert</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">General Counsel</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">ORWELL MERGER SUB INC.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">David Burgstahler</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">President</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>[Signature Page to Employee Matters Agreement] </I></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">30 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>Schedule A </U></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Company Employee List </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>[see
attached] </I></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">31 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>Schedule B </U></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">SpinCo Employee List </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>[see
attached] </I></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">32 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>Schedule C </U></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Specified Service Providers </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">33 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Exhibit <FONT STYLE="white-space:nowrap">D-1</FONT> to the Merger Agreement </B></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Execution Copy </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">TRANSITION SERVICES AGREEMENT </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This TRANSITION SERVICES AGREEMENT (this &#147;<U>Agreement</U>&#148;), effective as of the Distribution Time of the Separation and
Distribution Agreement (as defined below) (the &#147;<U>Effective Date</U>&#148;), by and between Ligand Pharmaceuticals Incorporated, a Delaware corporation (&#147;<U>Ligand</U>&#148; or &#147;<U>Provider</U>&#148;), and OmniAb, Inc., a Delaware
Corporation (&#147;<U>OmniAb</U>&#148;). Each of Provider and OmniAb may be referred to herein individually as a &#147;<U>Party</U>&#148; and collectively as the &#147;<U>Parties</U>&#148;. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, Ligand and OmniAb are parties to a certain Separation and Distribution Agreement dated as of March&nbsp;23, 2022 (the
&#147;<U>Separation and Distribution Agreement</U>&#148;), pursuant to which Ligand has agreed to perform, and OmniAb has agreed to receive, certain Transition Services (as defined below) with respect to OmniAb&#146;s operation of the OmniAb
Business (as defined in the Separation and Distribution Agreement), subject to, and in accordance with, the terms and conditions contained herein. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">NOW,
THEREFORE, in consideration of the premises and the mutual promises and conditions hereinafter set forth and set forth in the Separation and Distribution Agreement, and other good and valuable consideration, the receipt and sufficiency of which are
hereby acknowledged, the Parties, intending to be legally bound, do hereby agree as set forth herein. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE I </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>DEFINITIONS </U></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.1
<U>Certain Defined Terms</U>. Unless otherwise specifically provided herein, capitalized terms used, but not otherwise defined, herein shall have the meanings ascribed thereto in the Separation and Distribution Agreement. As used herein, the
following terms have the following meanings. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) &#147;<U>Affiliate(s)</U>&#148; means, with respect to a particular entity or Person,
any Person that controls, is controlled by, or is under common control with that Party. For the purpose of this definition, &#147;control&#148; will mean, direct or indirect ownership of more than 50% of the shares of stock entitled to vote for the
election of directors, in the case of a corporation, or more than 50% of the equity interest in the case of any other type of legal entity, status as a general partner in any partnership, or any other arrangement whereby the entity or Person
controls or has the right to control the board of directors or equivalent governing body of a corporation or other entity, or the ability to cause the direction of the management or policies of a corporation or other entity. For purposes of this
Agreement, Ligand and OmniAb shall not be considered Affiliates of each other. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) &#147;<U>Governmental Authority</U>&#148; means
(a)&nbsp;any court, agency, department, authority or other instrumentality of any national, state, county, city or other political subdivision; (b)&nbsp;any public international organization; or (c)&nbsp;any department, agency or instrumentality
thereof, including any company, business, enterprise or other entity owned or controlled, in whole or in part, by any government. </P> <P STYLE="font-size:18pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) &#147;<U>Intellectual Property</U>&#148; means any and all intellectual property and
other proprietary rights throughout the world, including any and all state, United States, international and/or foreign or other territorial or regional rights in, arising out of or associated with any of the following: (a)&nbsp;all patents and
applications therefor, including all related provisionals, continuations, <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">continuations-in-part,</FONT></FONT> divisionals, reissues, renewals and extensions
(&#147;<U>Patents</U>&#148;), (b) all inventions (whether patentable or not), invention disclosures, improvements, trade secrets, proprietary information, know how (including formulations, specifications, formulae, manufacturing and other processes,
operating procedures, methods, techniques and all research and development information), technology, technical data and customer lists, and all documentation relating to any of the foregoing, (c)&nbsp;all copyrights, copyrightable works, copyright
registrations and applications therefor, including all rights of authorship, use, publication, reproduction, distribution, performance and transformation (&#147;<U>Copyrights</U>&#148;), (d) all industrial designs and any registrations and
applications therefor, (e)&nbsp;all domain names, uniform resource locators and other names and locators associated with the internet (&#147;<U>Domain Names</U>&#148;), and all social media accounts and handles and app registrations, (f)&nbsp;all
trade names, logos, common law trademarks and service marks, trademark and service mark registrations and applications therefor and all goodwill associated therewith (&#147;<U>Trademarks</U>&#148;), (g) all rights in databases and data collections,
(h)&nbsp;all moral and economic rights of authors and inventors, however denominated, (i)&nbsp;rights in computer software (including source code, object code, firmware, algorithms, operating systems and specifications) and related technology,
(j)&nbsp;all rights in content (including text, graphics, images, audio, video and data) and computer software included on or used to operate and maintain any websites, including all rights in documentation, files, cgi and other scripts and
programming code, (k)&nbsp;all rights of publicity or privacy, including with respect to name, likeness or persona, and (l)&nbsp;all rights to sue or recover and retain damages and costs and attorneys&#146; fees for the past, present or future
infringement, dilution, misappropriation, or other violation of any of the foregoing anywhere in the world. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) &#147;<U>Law</U>&#148;
means any law (including common law), statute, code, ordinance, rule, regulation, order or charge of any Governmental Authority. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e)
&#147;<U>Person</U>&#148; means any individual, partnership, limited liability company, firm, corporation, association, trust, unincorporated organization or other entity. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f) &#147;<U>Personal Information</U>&#148; means&nbsp;any data or&nbsp;information that identifies,&nbsp;relates to, describes, is reasonably
capable of being associated with, or could reasonably be linked, directly or indirectly, with a particular natural person or household (including any information related to the health of a person) and any information derived from the foregoing. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(g) &#147;<U>Representatives</U>&#148; means, as to any Person, such Person&#146;s Affiliates and its and their successors, owners,
controlling Persons, directors, officers, employees, agents, representatives, subcontractors, or other third party acting for or on its behalf, including, as to Provider, any Vendor providing any Transition Services as permitted in this Agreement.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(h) &#147;<U>Recipient</U>&#148; means, with respect to a particular Transition Service, either OmniAb or the applicable member of the
OmniAb Group (as defined in the Separation and Distribution Agreement) receiving such Transition Service. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE II </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>TRANSITION SERVICES PROVIDED </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.1 <U>Transition Services. </U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) Upon the terms and subject to the conditions set forth in this Agreement, Provider shall provide, or cause one or more of its
Representatives to provide, to Recipient each of the services set forth on Schedule A attached hereto (hereinafter referred to individually as a &#147;<U>Transition Service</U>&#148;, and collectively as the &#147;<U>Transition Services</U>&#148;),
at the corresponding costs set forth on Schedule A, and Recipient agrees to receive the Transition Services and pay the costs therefor during the time period specified for each such Transition Service in such Schedule or for such other time period
as permitted pursuant to this Agreement (hereinafter referred to collectively as the &#147;<U>Service Periods</U>&#148; for all of the Transition Services, and individually a &#147;<U>Service Period</U>&#148; for each Transition Service). The
Parties may amend the scale and scope of the Transition Services from time to time upon mutual agreement by executing a signed amendment to Schedule A. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) If, within three (3)&nbsp;months following the Effective Date, Recipient identifies in good faith any service that was provided by
Provider or one of its Affiliates (excluding the OmniAb Group) to the OmniAb Business during the six (6)&nbsp;month period (or twelve (12)&nbsp;month period solely with respect to activities that are customarily performed on an annual basis) prior
to the Effective Date that is not listed on Schedule A and is necessary to effectuate the Separation (an &#147;<U>Omitted Service</U>&#148;), then Recipient shall notify Provider thereof and Schedule A will be deemed amended to include such Omitted
Service. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.2 <U>Personnel; Affiliates; Vendors</U>. In providing the Transition Services, Provider may, as it deems necessary or
appropriate, (i)&nbsp;use the qualified personnel of Provider or its Affiliates, and (ii)&nbsp;employ the services of qualified third parties (&#147;<U>Vendors</U>&#148;) to the extent that, and subject to the condition that, such Vendor&#146;s
services (A)&nbsp;were utilized by or for the benefit of the OmniAb Business prior to the Effective Date, (B)&nbsp;are routinely utilized to provide similar services to other businesses of Provider or (C)&nbsp;are reasonably necessary for the
efficient performance of such Transition Services. Furthermore, each Party shall, and shall cause its Representatives to, comply, in all material respects, with all Laws which may be applicable to the Transition Services. Each Party shall be
responsible for its Representatives, including for such Representatives adhering to any health, safety, and security regulations and other published policies of the other Party while on the other Party&#146;s premises or when given access to any
equipment, computer, databases, systems, software, network or other files (collectively, &#147;<U>Systems</U>&#148;) owned or controlled by the other Party. If a Party or one or more of its Representatives needs access to the premises or Systems of
the other Party or one or more of its Representatives to provide or receive the Transition Services (as applicable), then (x)&nbsp;the accessing Party shall advise the other Party in writing in advance of such access of the name of each of the
accessing Party&#146;s Representatives who shall require such access, (y)&nbsp;the accessing Party and its Representatives shall not attempt to obtain access to, use or interfere with any of the premises or Systems of the other Party or such other
Party&#146;s Representatives, except to the extent permitted by the other Party or required to do so to provide or receive the Transition Services (as applicable), and (z)&nbsp;the accessing Party and its Representatives shall not intentionally
damage, disrupt or impair the normal operation of any of the premises or Systems of the other Party or such other Party&#146;s Representatives. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.3 <U>Coordinators</U>. Each of Provider and Recipient shall nominate a representative to
act as its primary contact person to coordinate the provision of all Transition Services (collectively, the &#147;<U>Primary Coordinators</U>&#148;). Each Primary Coordinator may designate one or more service coordinators for each specific
Transition Service (the &#147;<U>Service Coordinators</U>&#148;). Each Party may treat an act of a Primary Coordinator or Service Coordinator of another Party as being authorized by such other Party without inquiring behind such act or ascertaining
whether such Primary Coordinator or Service Coordinator had authority to so act, <I>provided</I>, <I>however</I>, that no such Primary Coordinator or Service Coordinator has authority to amend this Agreement. Provider and Recipient shall advise each
other promptly (in any case no more than five (5)&nbsp;business days) in writing of any change in the Primary Coordinators and any Service Coordinator for a particular Transition Service, setting forth the name of the Primary Coordinator or Service
Coordinator to be replaced and the name of the replacement, and certifying that the replacement Primary Coordinator or Service Coordinator is authorized to act for such Party in all matters relating to this Agreement, in the case of a Primary
Coordinator or, in the case of a Service Coordinator, with respect to the Transition Service for which such Service Coordinator has been designated. Provider and Recipient each agrees that all communications relating to the provision of the
Transition Services shall be directed to the Service Coordinators for such Transition Service with copies to the Primary Coordinators. Provider&#146;s initial Primary Coordinator shall be Matthew Korenberg. Recipient&#146;s initial Primary
Coordinator shall be Matt Foehr. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.4 <U>Level of Transition Services</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) Recipient acknowledges and agrees that Provider is not in the business of providing services to third parties and is entering into this
Agreement only in connection with the Separation and Distribution Agreement. Provider shall, and shall cause each of its Representatives to, provide the Transition Services with substantially the same degree of skill, quality and standard of care as
that utilized by Provider (or its Affiliates) to perform similar activities in the six (6)&nbsp;month period (or twelve (12)&nbsp;month period solely with respect to activities that are customarily performed on an annual basis) prior to the
Effective Date, and, in any event, no less than with commercially reasonable care and diligence (collectively, the &#147;<U>Services Standard</U>&#148;). Under no circumstances shall Provider or any of its Representatives be held accountable to a
greater standard of care, efforts or skill than the Services Standard in the performance of the Transition Services. Recipient acknowledges and agrees that (i)&nbsp;the Transition Services do not include the exercise of business judgment or general
management for Provider and (ii)&nbsp;NEITHER PROVIDER NOR ANY OF ITS AFFILIATES MAKES ANY REPRESENTATIONS OR WARRANTIES, EXPRESS OR IMPLIED, INCLUDING ANY WARRANTY OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE, WITH RESPECT TO THE
TRANSITION SERVICES. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) If the Transition Services to be provided to Recipient materially increase in scale or in scope as compared to
the level of the similar services provided in connection with the operation of the OmniAb Business as of the Effective Date, Provider may, at its election, choose to not provide such increased scale or scope of Transition Services, and if Provider
elects to perform such increased scale or scope of Transition Services, all costs incurred in connection therewith shall be mutually agreed upon by Provider and Recipient prior to the time such additional Transition Services are performed, shall be
set forth in an amended Schedule A, and shall be borne by Recipient. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) In addition to being subject to the terms and conditions of this Agreement for the
provision of the Transition Services, Provider and Recipient each agree that the Transition Services provided by any Vendor shall be subject to the terms and conditions of any agreements between Provider and such Vendor, which agreements shall be on
substantially the same conditions as Provider would enter into with such Vendor for its own account, and no such agreements shall be binding on Recipient after the Term hereof without Recipient&#146;s express written consent. Provider shall consult
with Recipient concerning the terms and conditions of any such agreements to be entered into, or proposed to be entered into, or amended, with any Vendors after the Effective Date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) Without relieving Provider of its obligation to perform the Transition Services in accordance with the Services Standard, Provider shall
not be (i)&nbsp;obligated to perform the Transition Services to the extent that such performance would be unlawful or that would require Provider to violate applicable Law; (ii)&nbsp;obligated to perform the Transition Services to the extent that
such performance, in Provider&#146;s reasonable determination, could create deficiencies in Provider&#146;s controls over financial information or adversely affect the maintenance of Provider&#146;s financial books and records or the preparation of
its financial statements; (iii)&nbsp;obligated to hire any additional employees to perform the Transition Services or maintain the employment of any specific employee; (iv)&nbsp;obligated to hire replacements for employees that resign, retire or are
terminated; (v)&nbsp;obligated to enter into retention agreements with employees or otherwise provide any incentive beyond payment of regular salary and benefits; (vi)&nbsp;prevented from transferring after the Effective Date any employees who were
supporting the business operations as of the Effective Date to support other business operations for Provider or its Affiliates or to assume other roles with Provider or its Affiliates to the extent such employees are not required to provide
Transition Services; (vii)&nbsp;prevented from determining, in its sole discretion, the individual employees who will provide Transition Services; or (viii)&nbsp;obligated to purchase, lease or license any additional equipment or software. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.5 <U>Transitional Nature of Services</U>. Recipient acknowledges and agrees that the Transition Services are intended only to be
transitional in nature, and shall be furnished by Provider only during the Service Periods. Recipient shall use commercially reasonable efforts to have sufficient resources available to it at the end of the Service Periods to perform the Transition
Services (or have the Transition Services performed) without the involvement of Provider, its Affiliates or any of its or their respective employees or agents upon the termination or expiration of a Service Period for an applicable Transition
Service. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.6 <U>Location of Services Provided; Travel Expenses</U>. Provider shall provide the Transition Services to Recipient from
locations of Provider&#146;s choice in its sole discretion except to the extent the nature of the Transition Services necessitates performance at a specific location, as mutually agreed upon by the Parties. Subject to Section&nbsp;3.1, should the
provision of the Transition Services require any directors, officers, employees, agents, representatives, or subcontractors of Provider or its Affiliates to travel beyond fifty (50)&nbsp;miles from his or her employment location, Recipient shall
reimburse Provider for all reasonable travel-related <FONT STYLE="white-space:nowrap">out-of-pocket</FONT> costs, consistent with Provider&#146;s travel policy as provided to Recipient in advance in writing. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.7 <U>Limitation of Liability</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Parties hereto acknowledge and agree that the Transition Services are provided by Provider: (a)&nbsp;at the request of Recipient in order
to accommodate it following the closing under the Separation and Distribution Agreement; (b)&nbsp;at the costs set forth on Schedule A hereto and with no expectation of profit being made by Provider thereon; and (c)&nbsp;with the expectation that
Provider is not assuming any financial or operational risks, including those usually assumed by a service provider, except for those risks explicitly set forth herein. Accordingly, each Party agrees that, absent gross negligence or willful
misconduct, and except for breaches of Article V (Confidentiality) and except for a Party&#146;s obligations under Section&nbsp;2.8 (Indemnification), the other Party, its Affiliates and their directors, officers, employees, representatives,
consultants and agents shall not be liable for any indirect, special, incidental or consequential damages, including lost profits or savings, whether or not such damages are foreseeable, or for any third party claims relating to the Transition
Services or each Party&#146;s performance under this Agreement. Notwithstanding anything to the contrary contained herein, in the event Provider commits an error with respect to or incorrectly performs or fails to perform any Transition Service, at
Recipient&#146;s request, Provider shall use commercially reasonable efforts and in good faith attempt to correct such error, <FONT STYLE="white-space:nowrap">re-perform</FONT> or perform such Transition Service at no additional cost to Recipient;
<I>provided </I>that, absent gross negligence or willful misconduct, and assuming that Provider uses commercially reasonable data backup processes, Provider shall have no obligation to recreate any lost or destroyed data to the extent the same
cannot be cured by the <FONT STYLE="white-space:nowrap">re-performance</FONT> of the Transition Service in question. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.8
<U>Indemnification</U>.<U> </U> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) Recipient shall indemnify, defend and hold harmless Provider and its Affiliates and its and their
respective officers, directors, employees, representatives, subcontractors and agents from and against any and all damages, liabilities, losses, taxes, fines, penalties, costs and expenses (including, without limitation, reasonable fees of counsel)
incurred by any of them in connection with any Third Party Claim (as defined below) (each, a &#147;<U>Loss</U>&#148; and, collectively, the &#147;<U>Losses</U>&#148;) relating to, arising out of or resulting from or based on
(i)&nbsp;Recipient&#146;s material breach of this Agreement or (ii)&nbsp;any gross negligence or willful misconduct of Recipient, (iii)&nbsp;Provider&#146;s provision of the Transition Services as directed or requested by Recipient, or
(iv)&nbsp;Recipient&#146;s use or exploitation of any work product provided by Provider in the performance of the Transition Services, except in each case (i), (ii), (iii), and (iv)&nbsp;to the extent such Losses are subject to indemnification
pursuant to Section&nbsp;2.8(b). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) Provider hereby agrees to indemnify, defend and hold harmless Recipient and its Affiliates and its
and their respective officers, directors, employees, representatives, subcontractors and agents from and against any and all Losses relating to, arising out of or resulting from (i)&nbsp;Provider&#146;s material breach of this Agreement or
(ii)&nbsp;any gross negligence or willful misconduct in the performance of its obligations under this Agreement, except in each case of (i)&nbsp;and (ii) to the extent such Losses are subject to indemnification pursuant to Section&nbsp;2.8(a). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) To the maximum extent permitted by applicable Law, each Party&#146;s and its
Affiliates&#146; and each of its and their respective subcontractors&#146; officers&#146;, directors&#146;, employees&#146; and agents&#146; sole and exclusive remedy with respect to any and all claims relating to the Transition Services shall be
pursuant to the indemnification provisions set forth in this Section&nbsp;2.8. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.9 <U>Indemnification Procedures</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) If any claim or demand is made by a third party (including any action or proceeding commenced or threatened to be commenced) with respect
to which a Party seeking indemnification (the &#147;<U>Indemnified Party</U>&#148;) intends to seek indemnity under Section&nbsp;2.8 (a &#147;<U>Third Party Claim</U>&#148;), the Indemnified Party shall promptly give written notice thereof to the
other Party (the &#147;<U>Indemnifying Party</U>&#148;) indicating, with reasonable specificity, the nature of such Third Party Claim, the basis therefor, and a copy of any documentation received from such third party. A failure by the Indemnified
Party to give notice and to tender the defense of any action or proceeding in a timely manner pursuant to this Section&nbsp;2.9(a) shall not limit the obligation of the Indemnifying Party under Section&nbsp;2.8, except to the extent such
Indemnifying Party is actually and materially prejudiced thereby. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) Upon receipt of a notice for indemnity from the Indemnified Party
pursuant to Section&nbsp;2.9(a) with respect to any Third Party Claim, the Indemnifying Party shall have the right to assume the defense of, at its own expense and by its own counsel, any such Third Party Claim. If the Indemnifying Party shall, in
accordance with the immediately preceding sentence, undertake to compromise or defend any such Third Party Claim, it shall notify the Indemnified Party of its intention to do so, and the Indemnified Party shall agree to cooperate with the
Indemnifying Party and its counsel in the compromise of, or defense against, any such Third Party Claim; <I>provided </I>that the Indemnifying Party shall not settle or compromise any such Third Party Claim without the written consent of the
Indemnified Party (not to be unreasonably withheld, conditioned or delayed) unless such settlement or compromise fully and irrevocably releases the Indemnified Party in connection with such Third Party Claim and provides relief consisting solely of
money damages borne by the Indemnifying Party. Notwithstanding an election of the Indemnifying Party to assume the defense of such Third Party Claim, the Indemnified Party shall have the right to employ separate legal counsel, its own cost and
expense, and to participate in the defense thereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.10 <U>Modification of Transition Services Procedures</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) Subject to the procedure set forth in this Section&nbsp;2.10 to the extent applicable, Provider may make changes from time to time in its
standards and procedures for performing the Transition Services, <I>provided</I> that any such change shall not interfere in any material respect with the continued provision or cost of the Transition Services. Notwithstanding the foregoing
sentence, unless required by Law, Provider shall not implement any substantial or material changes to such standards and procedures in a manner affecting the operation of the OmniAb Business unless Recipient agrees in writing to such changes and
Provider gives Recipient ten (10)&nbsp;business days to adapt its operations to accommodate such changes to the extent commercially reasonable. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) During the term of this Agreement, if Recipient intends to make any changes that may
affect the provision of any of the Transition Services, Recipient shall provide Provider with a plan identifying any changes as soon as reasonably practicable, but in any case no less than ten (10)&nbsp;business days before implementing such
changes; <I>provided</I>, <I>however</I>, that Provider shall not be required to alter the method in which it provides any of the Transition Services or increase the level of any such Transition Services in any material manner except as expressly
provided herein; <I>provided, further, however, </I>that the failure of Recipient to provide such notice shall not alter or diminish Provider&#146;s obligations to provide the Transition Services on the terms set forth herein except where the
failure to provide notice has materially increased Provider&#146;s cost or burden to provide such Transition Service. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.11
<U>Cooperation</U>. The Parties will use commercially reasonable efforts to reasonably cooperate and cause each of their respective Representatives to reasonably cooperate in a professional and workmanlike manner with each other to the extent
necessary to assist the other Party in performance of its obligations under this Agreement, including with respect to the provision and receipt of the Transition Services. Such cooperation shall include exchanging information relevant to and
reasonably necessary for the provision or receipt of the Transition Services hereunder and the performance of such other duties and tasks as may be reasonably required for the provision or receipt of the Transition Services. Without limiting the
foregoing: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) Recipient shall permit Provider and its Representatives reasonable access during regular business hours (or otherwise upon
reasonable prior notice) to any data, records and personnel involved in receiving or overseeing the Transition Services as reasonably requested by Provider to facilitate Provider&#146;s performance of this Agreement. Any such data and records shall
be subject to Article V. Before the Parties exchange any Personal Information in connection with the Transition Services, the Parties will enter into a data processing agreement in accordance with applicable Laws. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) Provider shall use commercially reasonable efforts to obtain any consents, licenses, waivers or approvals necessary to permit Provider to
perform its obligations hereunder; <I>provided, however,</I> that under no circumstances shall Provider be obligated to provide the relevant part of any Transition Services to the extent that (i)&nbsp;Provider is unable to obtain necessary third
party consents, licenses, waivers or approvals relating to such part of the Transition Services on commercially reasonable terms, (ii)&nbsp;in order to provide such part of the Transition Services, Provider will have an obligation to make any
payments to any Third Party or incur any obligations in respect of any such consents, licenses, waivers or approvals, which payments are not subject to reimbursement by Recipient or which other obligations are not assumed by Recipient hereunder,
(iii)&nbsp;Provider would be obligated to make any alternative arrangements in the event that any such consents, licenses, waivers or approvals are not obtained (but only to the extent such arrangements would not be commercially reasonable) or
(iv)&nbsp;Provider would be required to seek broader rights or more favorable terms with respect to any consents, licenses, waivers or approvals than those applicable immediately prior to the date hereof where the costs of obtaining the same are not
subject to reimbursement by Recipient. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) Recipient shall obtain all necessary consents, licenses, waivers and approvals necessary for
it to receive the Transition Services and perform its obligations under this Agreement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE III </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>COMPENSATION </U></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.1
<U>Consideration</U>. As consideration for the Transition Services, Recipient shall pay to Provider the amount specified for each such Transition Service as set forth in Schedule A, including any &#147;pass-through costs&#148; expressly identified
as such in Schedule A. The fees set forth on Schedule A will be equitably reduced if any Transition Service is suspended, terminated or removed from the scope of this Agreement and will be equitably prorated for partial months. In addition,
Recipient shall reimburse Provider (upon receipt of applicable receipts and other reasonable supporting documentation if requested by Provider) for all reasonable documented out of pocket costs of Provider in connection with performance of the
Transition Services by Provider, including: (a)&nbsp;shipping and transportation costs (including the cost of any insurance related thereto), duties and other taxes (excluding taxes on Provider&#146;s income); (b) travel-related costs, (c)&nbsp;out
of pocket costs or expenses incurred with third parties by Provider, its Affiliates or subcontractors, including for the extraction, conversion and transfer of data and (d)&nbsp;any other out of pocket costs and expenses incurred with third parties
described herein as reimbursable by Provider (the &#147;<U>Reimbursable Expenses</U>&#148;); <I>provided</I> that if any particular Reimbursable Expense exceeds Ten Thousand Dollars ($10,000), Provider must obtain Recipient&#146;s consent prior to
any obligation of Recipient to reimburse Provider for such Reimbursable Expense; <I><U>provided, further</U></I> that until Recipient consents to such Reimbursable Expenses exceeding Ten Thousand Dollars ($10,000), Provider shall not be required to
provide the relevant part of the Transition Services for which such Reimbursable Expenses exceeding Ten Thousand Dollars ($10,000) is necessary. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.2 <U>Invoices</U>. Provider shall, on a monthly basis on the last day of each calendar month, submit a single itemized invoice to Recipient
for all Transition Services provided to Recipient during such month. All invoices shall be sent to the attention of the Primary Coordinators at the address set forth in Section&nbsp;7.5 hereof or to such other address as Recipient shall have
specified by notice in writing to Provider. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.3 <U>Payment of Invoices</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) Recipient shall pay any undisputed invoice for Transition Services promptly but in no event later than thirty (30)&nbsp;days after the
date of receipt of such invoice and such payment shall be made by wire transfer of immediately available funds to such bank account as shall have been notified in writing to Recipient by Provider. Payment of all invoices in respect of the Transition
Services shall be made by check or electronic funds transmission in U.S. Dollars, without any offset or deduction of any nature whatsoever (except that offset or deduction may be made in regard to other invoiced amounts due under this Agreement or
to the extent of a dispute in good faith concerning amounts due under this Agreement). All payments shall be made to the account designated by Provider to Recipient. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) If any payment is not paid when due (except to the extent disputed in good faith) and Recipient does not make such payment within thirty
(30)&nbsp;days of receiving a <FONT STYLE="white-space:nowrap">past-due</FONT> notice from Provider, Provider shall have the right, without any liability to Recipient, or anyone claiming by or through Recipient, to, upon written notice to Recipient,
immediately cease providing any or all of the Transition Services provided by Provider to Recipient and/or to </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
terminate this Agreement in its entirety, which right may be exercised by Provider in its sole and absolute discretion. Notwithstanding the above, Provider shall not cease providing any
Transition Service or terminate this Agreement if such lack of payment is due to a good faith dispute, the details of which Recipient has indicated to Provider in writing. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE IV </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>OWNERSHIP OF INTELLECTUAL PROPERTY </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.1 <U>Ownership; Delivery</U>. Except as expressly set forth herein, neither Party will obtain, by virtue of this Agreement or the Transition
Services, by implication or otherwise, any rights of ownership or use of any property or Intellectual Property owned by the other. All Intellectual Property conceived, created or made by Provider or any of its Representatives (whether alone or
jointly with Recipient) in the course of Provider&#146;s performance of the Transition Services and other activities under this Agreement that are (a)&nbsp;exclusively related to the OmniAb Business and/or (b)&nbsp;based on, derived from, or
improvements of any of Recipient&#146;s background Intellectual Property (altogether, (a)&nbsp;and (b), the &#147;<U>Assigned IP</U>&#148;) shall be solely owned by Recipient, and Provider hereby assigns to Recipient all of Provider&#146;s right,
title, and interest in and to such Assigned IP. All other Intellectual Property conceived, created or made by Provider or any of its Representatives in the course of Provider&#146;s or such Representative&#146;s performance of any Transition
Services or other activities under this Agreement shall be solely owned by Provider. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.2 <U>Limited Licenses</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) Recipient (on behalf of itself and its controlled Affiliates) hereby grants to Provider a limited,
<FONT STYLE="white-space:nowrap">non-exclusive,</FONT> royalty-free, <FONT STYLE="white-space:nowrap">non-transferable</FONT> license, with the right to grant sublicenses to its Affiliates and its and their subcontractors during the Service Periods,
under the Intellectual Property owned or controlled by Recipient, solely to the extent necessary for Provider and its Affiliates and its and their subcontractors to perform the Transition Services hereunder for the benefit of Recipient during the
applicable Services Period. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) Provider (on behalf of itself and its controlled Affiliates) hereby grants to Recipient and its
Affiliates a limited, <FONT STYLE="white-space:nowrap">non-exclusive,</FONT> royalty-free, <FONT STYLE="white-space:nowrap">non-transferable</FONT> license, with the right to grant sublicenses to its and their Affiliates and subcontractors, under
the Intellectual Property owned or controlled by Provider, solely to the extent necessary for Recipient and its Affiliates and its and their subcontractors to (i)&nbsp;receive the Transition Services during the applicable Service Period and/or
(ii)&nbsp;use or exploit any deliverables provided by Provider to Recipient as part of the Transition Services in the operation of the OmniAb Business. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE V </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>CONFIDENTIALITY </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.1 <U>Confidential Information</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) Each Party recognizes that in the performance of this Agreement, or as a result of the Parties&#146; ongoing relationship, <FONT
STYLE="white-space:nowrap">non-public,</FONT> Confidential Information (as defined in the Separation and Distribution Agreement) belonging to the other Party regarding the Transition Services may be disclosed or become known to the Party or its
Affiliates. Unless otherwise expressed in writing to the other Party, confidential information and confidential materials concerning a Party&#146;s business and products (including information and materials contained in technical data, information
concerning the OmniAb Business, financial information and data, strategies and marketing and customer information), including that expressed orally, that is exchanged between the Parties in connection with the performance of this Agreement shall be
considered to be Confidential Information. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) Notwithstanding any termination of this Agreement, Provider and Recipient shall hold and
shall cause their respective Representatives to hold, in strict confidence (and not to disclose or release or, except as otherwise permitted by this Agreement or the Separation and Distribution Agreement, use, including for any ongoing or future
commercial purpose, without the prior written consent of the Party to whom the Confidential Information relates (which may be withheld in such Party&#146;s sole and absolute discretion, except where disclosure is required by applicable Law), any and
all Confidential Information concerning or belonging to the other Party or its Affiliates; <I>provided</I> that each Party may disclose, or may permit disclosure of, Confidential Information: (i)&nbsp;to its respective auditors, attorneys, financial
advisors, bankers and other appropriate consultants and advisors who have a need to know such Information (as defined in the Separation and Distribution Agreement) for auditing and other <FONT STYLE="white-space:nowrap">non-commercial</FONT>
purposes and are informed of the obligation to hold such Information confidential and in respect of whose failure to comply with such obligations, the applicable Party will be responsible, (ii)&nbsp;if any Party or its Affiliates or any of its
respective Subsidiaries is required or compelled to disclose any such Confidential Information by judicial or administrative process or by other requirements of Law or stock exchange rule or is advised by outside counsel in connection with a
proceeding brought by a Governmental Authority that it is advisable to do so, (iii)&nbsp;as required in connection with any legal or other proceeding by one Party against the other Party or in respect of claims by one Party against the other Party
brought in a proceeding, (iv)&nbsp;as necessary in order to permit a Party to prepare and disclose its financial statements in connection with any regulatory filings or tax returns, (v)&nbsp;as necessary for a Party to enforce its rights or perform
its obligations under this Agreement or the Separation and Distribution Agreement, (vi)&nbsp;to Governmental Authorities in accordance with applicable procurement regulations and contract requirements or (vii)&nbsp;to other Persons in connection
with their evaluation of, and negotiating and consummating, a potential strategic transaction, to the extent reasonably necessary in connection therewith, provided an appropriate and customary confidentiality agreement has been entered into with the
Person receiving such Confidential Information at least as protective of such Confidential Information as this Agreement. Notwithstanding the foregoing, in the event that any demand or request for disclosure of Confidential Information is made by a
third party pursuant to clause (ii), (iii), (v) or (vi)&nbsp;above, each Party, as applicable, shall promptly notify (to the extent permissible by Law) the Party to whom the Confidential Information relates of the existence of such request, demand
or disclosure requirement and shall provide such affected Party a reasonable opportunity to seek an appropriate protective order or other remedy, which such Party will cooperate in obtaining to the extent reasonably practicable. In the event that
such appropriate protective order or other remedy is not obtained, the Party which faces the disclosure requirement shall furnish only that portion of the Confidential Information that is required to be disclosed and shall take commercially
reasonable steps to ensure that confidential treatment is accorded such Confidential Information. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) Each Party acknowledges that it and its Affiliates may have in its or their possession
confidential or proprietary Information of third parties that was received under confidentiality or <FONT STYLE="white-space:nowrap">non-disclosure</FONT> agreements with such third party while such Party and/or its Affiliates were part of the
Ligand Group. Each Party shall comply, shall cause its Affiliates to comply, and shall cause its and their respective officers, employees, agents, consultants and advisors (or potential buyers) to comply, with all terms and conditions of any such
third-party agreements entered into prior to the Effective Date, with respect to any confidential and proprietary Information of third parties to which it or any other member of its Group has had access. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) Notwithstanding anything to the contrary set forth herein, (i)&nbsp;the Parties shall be deemed to have satisfied their obligations
hereunder with respect to Confidential Information if they exercise at least the same degree of care that applies to Ligand&#146;s confidential and proprietary information pursuant to policies in effect as of the Effective Date and
(ii)&nbsp;confidentiality obligations provided for in any Contract between each Party or its Affiliates or Subsidiaries and their respective employees shall remain in full force and effect. Notwithstanding anything to the contrary set forth herein,
Confidential Information of a Party in the possession of and used by the other Party as of the Effective Date may continue to be used by such Party in possession of the Confidential Information in and only in the operation of the OmniAb Business;
<I>provided</I> that such Confidential Information may only be used by such Party and its officers, employees, agents, consultants and advisors in the specific manner and for the specific purposes for which it is used as of the Effective Date, and
may only be shared with additional officers, employees, agents, consultants and advisors of such Party on a <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">need-to-know</FONT></FONT> basis exclusively with regard to such specified
use; <I>provided further</I> that such Confidential Information may be used only so long as the Confidential Information is maintained in confidence and not disclosed in violation of this Section&nbsp;5.1. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) The Parties agree that irreparable damage may occur in the event that the provisions of this Section&nbsp;5.1 were not performed in
accordance with their specific terms. Accordingly, it is hereby agreed that the Parties shall be entitled to seek an injunction or injunctions to enforce specifically the terms and provisions hereof in any court having jurisdiction, this being in
addition to any other remedy to which they are entitled at law or in equity. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f) Upon expiration of the Service Periods or termination of
this Agreement for any reason whatsoever, except for such retention and use as expressly provided for in the Separation and Distribution Agreement, each Party shall not disclose and shall make no further use of the other Party&#146;s Confidential
Information and upon written request shall immediately destroy or, with respect to Confidential Information in written or other tangible form (including all copies thereof), return to the other Party, all such Confidential Information;
<I>provided</I> that (i)&nbsp;each Party shall be entitled to retain one record copy in its legal department solely to determine the extent of its continuing obligations or as otherwise required to comply with applicable Law, and (ii)&nbsp;neither
Party nor its Representatives shall be required to expunge Confidential Information from computer archiving conducted as part of established record retention policies (<I>provided</I> that the foregoing shall not be deemed to permit the accessing,
retrieval or use of any Confidential Information). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE VI </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>TERM </U></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6.1
<U>Term</U>. This Agreement shall commence on the Effective Date and shall continue in full force and effect until the earliest of (a)&nbsp;the date on which this Agreement is terminated in accordance with this Article VI or (b)&nbsp;the expiration
of the last Service Period, such that Provider is no longer obligated to provide any Transition Services pursuant to this Agreement (the &#147;<U>Term</U>&#148;). If no expiration date is provided for any Transition Service, then such Transition
Service will terminate twelve (12)&nbsp;months after the Effective Date, <I>provided</I> that Recipient shall have the right to an extension of each or any Transition Service for up to six (6)&nbsp;months by providing written notice to Provider in
advance of the original termination date for such Transition Service if, prior to such request for extension, Recipient has used commercially reasonable efforts to establish analogous capabilities of its own. The Parties will discuss in good faith
any subsequent requests to further extend the Transition Services. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6.2 <U>Termination of Services</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) Recipient may, at any time prior to the end of the Service Period for any Transition Service(s) and upon thirty (30)&nbsp;days&#146; prior
written notice to Provider, terminate any Transition Service(s) or this Agreement in its entirety, whereupon, from and after the date of termination specified in such written notice, Provider&#146;s obligation to provide such Transition Service(s)
to Recipient shall cease and Recipient shall have no obligation to pay Provider for such Transition Service(s) (other than with respect to those Transition Services for which costs will be incurred by Provider as a result of <FONT
STYLE="white-space:nowrap">non-cancellable</FONT> commitments that Provider incurred in good faith in order to provide such Transition Services); <I>provided</I> that if termination of any Transition Service materially inhibits Provider&#146;s
ability to provide or prevents Provider from providing any other Transition Services (as determined in Provider&#146;s sole discretion), Provider shall promptly notify Recipient of such determination and such other Transition Services shall also
shall be deemed terminated, subject to Recipient&#146;s prior written consent of such termination; and <I>provided further</I> that partial reduction of any specific Transition Service may only be made with the prior written consent of Provider,
which consent shall not be unreasonably withheld, delayed or conditioned. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) Except as set forth in Section&nbsp;3.3(b), in the event
that either Party breaches any of its material obligations under this Agreement (the &#147;<U>Breaching Party</U>&#148;), the other Party may terminate this Agreement in its entirety upon thirty (30)&nbsp;days&#146; prior written notice (such thirty
(30)&nbsp;day period, the &#147;<U>Notice Period</U>&#148;) to the Breaching Party, specifying the breach and its claim of right to terminate; <I>provided</I>, that the termination of this Agreement shall not become effective at the end of the
Notice Period if (i)&nbsp;the Breaching Party cures such breach during the Notice Period or (ii)&nbsp;such breach cannot be cured during the Notice Period and the Breaching Party commences and diligently pursues actions to cure such breach within
the Notice Period, in which case the Breaching Party shall have an additional thirty (30)&nbsp;day period to cure such breach before such termination shall become effective. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) Either Party may terminate this Agreement in its entirety immediately upon written
notice to the other Party if the other Party (i)&nbsp;files in any court or with any other Governmental Authority, pursuant to any Law of any state or country, a petition in bankruptcy or insolvency or for reorganization or for an arrangement or for
the appointment of a receiver or trustee of such other Party or of its assets; (ii)&nbsp;is served with an involuntary petition against it, filed in any insolvency proceeding, and such petition is not dismissed within sixty (60)&nbsp;days after the
filing thereof; (iii)&nbsp;consents to the appointment or taking possession by a receiver, liquidator, assignee, custodian, trustee, sequestrator (or similar official) of such other Party or for any substantial part of its property or makes any
assignment for the benefit of creditors; (iv)&nbsp;admits in writing its inability to pay its debts generally as they become due; or (v)&nbsp;has issued or levied against its property any judgment, writ, warrant of attachment or execution or similar
process that represents a substantial portion of its property. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) Any Transition Service, or this Agreement in its entirety, may be
terminated upon the mutual written agreement of Provider and Recipient at any time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6.3 <U>Termination of Obligations</U><U>.
</U>Recipient specifically agrees and acknowledges that all obligations of Provider to provide each Transition Service shall immediately cease upon the expiration of the Service Period (as may be extended as set forth in this Agreement) for such
Transition Service, and Provider&#146;s obligations to provide all of the Transition Services shall immediately cease upon termination of this Agreement. Recipient shall bear sole responsibility for instituting permanent services, or obtaining
replacement services, in respect of any Transition Service terminated in accordance with the provisions hereof, and, except to the extent provided in the Schedules, Provider shall bear no liability for Recipient&#146;s failure to implement or obtain
such service or for any difficulties in transitioning from the Transition Service to such permanent or replacement service. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6.4
<U>Accrued Rights</U>. Termination or expiration of this Agreement for any reason shall be without prejudice to any rights that shall have accrued to the benefit of a Party prior to such termination or expiration. Such termination or expiration
shall not relieve a Party from obligations that are expressly indicated to survive the termination or expiration of this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6.5
<U>Surviving Obligations</U>. Without limiting the foregoing, Article I, Article V and Article VII and Sections 2.7, 2.8, 2.9, 3.2 (solely with respect to accrued, unpaid fees as of such termination or expiration), 3.3 (solely with respect to
accrued, unpaid fees as of such termination or expiration), 4.1, 4.2(b)(ii), 6.3 and 6.5 shall survive the termination or expiration of this Agreement for any reason. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE VII </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>MISCELLANEOUS </U></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7.1
<U><FONT STYLE="white-space:nowrap">Non-Solicitation</FONT></U>. During the Term of this Agreement and for a period of one (1)&nbsp;month after the Term, neither Party shall, directly or indirectly, in any manner solicit or induce for employment, or
hire or engage the services of, any employee of the other Party without the other Party&#146;s prior written consent. A general advertisement or notice of a job listing or opening or other similar general publication of a job search or availability
of employment positions, including on the internet, shall not be construed as a solicitation or inducement for the purposes of this provision. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7.2 <U>Force Majeure</U>. Provider shall not be liable for any failure to perform or any
delays in performance (other than the payment of money owed and the providing of indemnity and defense), and Provider shall not be deemed to be in breach or default of its obligations set forth in this Agreement, if, to the extent and for so long
as, such failure or delay is due to any causes that are beyond its reasonable control and not to its fault or negligence, including, such causes as acts of God, epidemic, pandemic, natural disasters, fire, flood, severe storm, earthquake, civil
disturbance, strike, lockout, riot, order of any court or administrative body, embargo, acts of government, war (whether or not declared), acts of terrorism, or other similar causes. For clarity, in the event of any such delay, the time for
performance shall be extended for a period equal to the time lost by reason of the delay. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7.3 <U>Complete Agreement: Construction</U>.
This Agreement, including the Schedules hereto, shall constitute the entire agreement between the Parties with respect to the subject matter hereof and shall supersede all previous negotiations, commitments and writings with respect to such subject
matter. In the event of any inconsistency between this Agreement and any Schedule hereto, this Agreement shall prevail. No rule of construction that disfavors the drafting party will apply to this Agreement. As used in this Agreement,
&#147;including&#148; and words of similar import mean &#147;including but not limited to.&#148; The use of &#147;or&#148; will not be deemed to be exclusive<U>.</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7.4 <U>Counterparts</U>. This Agreement may be executed in one or more counterparts, all of which shall be considered one and the same
agreement, and shall become effective when one or more such counterparts have been signed by each of the Parties and delivered to the other Party. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7.5 <U>Notices</U>. All notices and other communications hereunder shall be in writing and hand delivered or mailed by registered or certified
mail (return receipt requested) or sent by any means of electronic message transmission with delivery confirmed (by read receipt, voice or otherwise) to the parties at the following addresses (or at such other addresses for a party as shall be
specified by like notice) and will be deemed given on the date on which such notice is received: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">To Ligand: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Ligand Pharmaceuticals Incorporated </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">3911 Sorrento Valley Blvd., Suite 110 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">San Diego, CA 92121 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Attn: Chief
Financial Officer </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Email: tespinoza@ligand.com </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;To OmniAb: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">OmniAb Incorporated </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">5980 Horton
St., Suite 405 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Emeryville, California 94608 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Attn: Chief Legal Officer </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Email:
cberkman@omniab.com </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7.6 <U>Waivers</U>. The failure of any Party to require strict performance by any other
Party of any provision in this Agreement will not waive or diminish that Party&#146;s right to demand strict performance thereafter of that or any other provision hereof. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7.7 <U>Amendments</U>. This Agreement may not be modified or amended except by an agreement in writing signed by each of the Parties hereto.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7.8 <U>Assignment</U>. This Agreement shall not be assignable, in whole or in part, directly or indirectly; <I>provided, however</I>,
that (a)&nbsp;either Party may assign this Agreement without the other&#146;s consent to any of its controlled Affiliates and (b)&nbsp;either Party may assign this Agreement in its entirety to any successor to its business, whether by merger,
reorganization or otherwise; <I>provided, further</I>, that any such assignment shall not relieve the assignor of its obligations under this Agreement. Any attempt to assign any rights or obligations arising under this Agreement in contravention
with this paragraph shall be null and void <I>ab initio</I>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7.9 <U>Successors and Assigns</U>. The provisions of this Agreement shall be
binding upon, inure to the benefit of and be enforceable by the Parties and their respective successors and permitted assigns. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7.10
<U>Third Party Beneficiaries</U>. This Agreement is solely for the benefit of the Parties hereto and should not be deemed to confer upon third parties any remedy, claim, liability, reimbursement, claim of action or other right in excess of those
existing without reference to this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7.11 <U>Title and Headings</U>. Titles and headings to sections herein are inserted for the
convenience of reference only and are not intended to be a part of or to affect the meaning or interpretation of this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7.12
<U>Schedules</U>. The Schedules to this Agreement shall be construed with and as an integral part of this Agreement to the same extent as if the same had been set forth verbatim herein. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7.13 <U>Governing Law</U>. This Agreement shall be governed by and construed in accordance with the laws of the State of California (without
regard to its conflicts of Law doctrines). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7.14 <U>Severability</U>. In the event any one or more of the provisions contained in this
Agreement should be held invalid, illegal or unenforceable in any respect, the validity, legality and enforceability of the remaining provisions contained herein and therein shall not in any way be affected or impaired thereby. The Parties shall
endeavor in good-faith negotiations to replace the invalid, illegal or unenforceable provisions with valid provisions, the economic effect of which comes as close as possible to that of the invalid, illegal or unenforceable provisions. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7.15 <U>Relationship of Parties</U>. Nothing in this Agreement shall be deemed or construed by the Parties or any third party as creating a
partnership or the relationship of principal and agent or joint venturer between the Parties, it being understood and agreed that no provision contained herein, and no act of the Parties, shall be deemed to create any relationship between the
Parties other than the relationship of Provider and Recipient of the Transition Services nor be deemed to vest any rights, interests or claims in any third parties. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">16 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7.16 <U>Insurance</U>. During the Term, Provider shall carry commercially appropriate and
customary levels of insurance with a reputable insurance provider covering business interruptions and general liability insurance (including errors&nbsp;&amp; omissions and contractual liability) to protect its own business and property interests.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7.17 <U>Audit</U>. During the term of this Agreement and for one (1)&nbsp;year thereafter (or such longer period as may be required by
applicable Law), Provider and Recipient shall each use commercially reasonable efforts to maintain complete and accurate records related to any Transition Service provided, fees invoiced and payments made hereunder (the &#147;<U>Service
Records</U>&#148;). Recipient may request a certified audit of Provider&#146;s Service Records from the date of commencement of the Transition Services to be performed by an independent certified public accountant which (a)&nbsp;is reasonably
acceptable to Provider and (b)&nbsp;may not be compensated on a contingency basis or otherwise have any financial interest in the outcome of such audit. Any such audit shall be at the expense of Recipient. Recipient may not request such an audit
more than one (1)&nbsp;time within any twelve (12)&nbsp;month period with respect to any particular Transition Service. The accountant shall be required to execute a confidentiality and <FONT STYLE="white-space:nowrap">non-disclosure</FONT>
agreement if requested by Provider and shall hold all information confidential. The accountant may reveal to Recipient only the amounts of any underpayment or under reimbursement, or overbilling, as applicable. The accountant shall provide to
Provider a final report of its work, including both overbilling and underpayment information. The audit shall take place during normal business hours and upon reasonable notice and such accountant shall use commercially reasonable efforts to
minimize interference with the normal business activities of Provider. If any audit reveals an overpayment by Recipient, Provider shall promptly refund to Recipient any such overpayment. In addition, if any audit reveals an overpayment by Recipient
exceeding five percent (5%) during the audited period, Provider shall reimburse Recipient for the costs of conducting such audit. If any audit reveals an underpayment by Recipient, Recipient shall promptly pay Provider such underpayment amount. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(Signature Page Follows) </P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">17 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Execution Copy </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">IN WITNESS WHEREOF, the Parties have executed this Agreement as of the Effective Date. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="87%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">LIGAND PHARMACEUTICALS INCORPORATED</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">OMNIAB, INC.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
</TABLE></DIV>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">SCHEDULE 1 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">PROVIDER TRANSITION SERVICES </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Exhibit <FONT STYLE="white-space:nowrap">D-2</FONT> to the Merger Agreement </B></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">TRANSITION SERVICES AGREEMENT </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This TRANSITION SERVICES AGREEMENT (this &#147;<U>Agreement</U>&#148;), effective as of the Distribution Time of the Separation and
Distribution Agreement (as defined below) (the &#147;<U>Effective Date</U>&#148;), by and between OmniAb, Inc., a Delaware corporation (&#147;<U>OmniAb</U>&#148; or &#147;<U>Provider</U>&#148;), and Ligand Pharmaceuticals Incorporated, a Delaware
Corporation (&#147;<U>Ligand</U>&#148;). Each of Provider and Ligand may be referred to herein individually as a &#147;<U>Party</U>&#148; and collectively as the &#147;<U>Parties</U>&#148;. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, OmniAb and Ligand are parties to a certain Separation and Distribution Agreement dated as of March&nbsp;23, 2022 (the
&#147;<U>Separation and Distribution Agreement</U>&#148;), pursuant to which OmniAb has agreed to perform, and Ligand has agreed to receive, certain Transition Services (as defined below) with respect to Ligand&#146;s operation of the Ligand
Retained Business (as defined in the Separation and Distribution Agreement), subject to, and in accordance with, the terms and conditions contained herein. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">NOW, THEREFORE, in consideration of the premises and the mutual promises and conditions hereinafter set forth and set forth in the Separation and Distribution
Agreement, and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Parties, intending to be legally bound, do hereby agree as set forth herein. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE VIII </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>DEFINITIONS </U></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8.1
<U>Certain Defined Terms</U>. Unless otherwise specifically provided herein, capitalized terms used, but not otherwise defined, herein shall have the meanings ascribed thereto in the Separation and Distribution Agreement. As used herein, the
following terms have the following meanings. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) &#147;<U>Affiliate</U><U>(s)</U>&#148; means, with respect to a particular entity or
Person, any Person that controls, is controlled by, or is under common control with that Party. For the purpose of this definition, &#147;control&#148; will mean, direct or indirect ownership of more than 50% of the shares of stock entitled to vote
for the election of directors, in the case of a corporation, or more than 50% of the equity interest in the case of any other type of legal entity, status as a general partner in any partnership, or any other arrangement whereby the entity or Person
controls or has the right to control the board of directors or equivalent governing body of a corporation or other entity, or the ability to cause the direction of the management or policies of a corporation or other entity. For purposes of this
Agreement, OmniAb and Ligand shall not be considered Affiliates of each other. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) &#147;<U>Governmental Authority</U>&#148; means
(a)&nbsp;any court, agency, department, authority or other instrumentality of any national, state, county, city or other political subdivision; (b)&nbsp;any public international organization; or (c)&nbsp;any department, agency or instrumentality
thereof, including any company, business, enterprise or other entity owned or controlled, in whole or in part, by any government. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) &#147;<U>Intellectual Property</U>&#148; means any and all intellectual property and
other proprietary rights throughout the world, including any and all state, United States, international and/or foreign or other territorial or regional rights in, arising out of or associated with any of the following: (a)&nbsp;all patents and
applications therefor, including all related provisionals, continuations, <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">continuations-in-part,</FONT></FONT> divisionals, reissues, renewals and extensions
(&#147;<U>Patents</U>&#148;), (b) all inventions (whether patentable or not), invention disclosures, improvements, trade secrets, proprietary information, know how (including formulations, specifications, formulae, manufacturing and other processes,
operating procedures, methods, techniques and all research and development information), technology, technical data and customer lists, and all documentation relating to any of the foregoing, (c)&nbsp;all copyrights, copyrightable works, copyright
registrations and applications therefor, including all rights of authorship, use, publication, reproduction, distribution, performance and transformation (&#147;<U>Copyrights</U>&#148;), (d) all industrial designs and any registrations and
applications therefor, (e)&nbsp;all domain names, uniform resource locators and other names and locators associated with the internet (&#147;<U>Domain Names</U>&#148;), and all social media accounts and handles and app registrations, (f)&nbsp;all
trade names, logos, common law trademarks and service marks, trademark and service mark registrations and applications therefor and all goodwill associated therewith (&#147;<U>Trademarks</U>&#148;), (g) all rights in databases and data collections,
(h)&nbsp;all moral and economic rights of authors and inventors, however denominated, (i)&nbsp;rights in computer software (including source code, object code, firmware, algorithms, operating systems and specifications) and related technology,
(j)&nbsp;all rights in content (including text, graphics, images, audio, video and data) and computer software included on or used to operate and maintain any websites, including all rights in documentation, files, cgi and other scripts and
programming code, (k)&nbsp;all rights of publicity or privacy, including with respect to name, likeness or persona, and (l)&nbsp;all rights to sue or recover and retain damages and costs and attorneys&#146; fees for the past, present or future
infringement, dilution, misappropriation, or other violation of any of the foregoing anywhere in the world. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) &#147;<U>Law</U>&#148;
means any law (including common law), statute, code, ordinance, rule, regulation, order or charge of any Governmental Authority. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e)
&#147;<U>Person</U>&#148; means any individual, partnership, limited liability company, firm, corporation, association, trust, unincorporated organization or other entity. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f) &#147;<U>Personal </U><U>Information</U>&#148; means&nbsp;any data or&nbsp;information that identifies,&nbsp;relates to, describes, is
reasonably capable of being associated with, or could reasonably be linked, directly or indirectly, with a particular natural person or household (including any information related to the health of a person) and any information derived from the
foregoing. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(g) &#147;<U>Representatives</U>&#148; means, as to any Person, such Person&#146;s Affiliates and its and their successors,
owners, controlling Persons, directors, officers, employees, agents, representatives, subcontractors, or other third party acting for or on its behalf, including, as to Provider, any Vendor providing any Transition Services as permitted in this
Agreement. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(h) &#147;<U>Recipient</U>&#148; means, with respect to a particular Transition Service, either Ligand or the applicable member
of the Ligand Group (as defined in the Separation and Distribution Agreement) receiving such Transition Service. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE IX </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>TRANSITION SERVICES PROVIDED </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9.1 <U>Transition Services</U><U>.</U><U> </U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) Upon the terms and subject to the conditions set forth in this Agreement, Provider shall provide, or cause one or more of its
Representatives to provide, to Recipient each of the services set forth on Schedule A attached hereto (hereinafter referred to individually as a &#147;<U>Transition Service</U>&#148;, and collectively as the &#147;<U>Transition Services</U>&#148;),
at the corresponding costs set forth on Schedule A, and Recipient agrees to receive the Transition Services and pay the costs therefor during the time period specified for each such Transition Service in such Schedule or for such other time period
as permitted pursuant to this Agreement (hereinafter referred to collectively as the &#147;<U>Service Periods</U>&#148; for all of the Transition Services, and individually a &#147;<U>Service Period</U>&#148; for each Transition Service). The
Parties may amend the scale and scope of the Transition Services from time to time upon mutual agreement by executing a signed amendment to Schedule A. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) If, within three (3)&nbsp;months following the Effective Date, Recipient identifies in good faith any service that was provided by Provider
or one of its Affiliates (excluding the Ligand Group) to the Ligand Retained Business during the six (6)&nbsp;month period (or twelve (12)&nbsp;month period solely with respect to activities that are customarily performed on an annual basis) prior
to the Effective Date that is not listed on Schedule A and is necessary to effectuate the Separation (an &#147;<U>Omitted Service</U>&#148;), then Recipient shall notify Provider thereof and Schedule A will be deemed amended to include such Omitted
Service. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9.2 <U>P</U><U>ersonnel; Affiliates; Vendors</U>. In providing the Transition Services, Provider may, as it deems necessary or
appropriate, (i)&nbsp;use the qualified personnel of Provider or its Affiliates, and (ii)&nbsp;employ the services of qualified third parties (&#147;Vendors&#148;) to the extent that, and subject to the condition that, such Vendor&#146;s services
(A)&nbsp;were utilized by or for the benefit of the Ligand Retained Business prior to the Effective Date, (B)&nbsp;are routinely utilized to provide similar services to other businesses of Provider or (C)&nbsp;are reasonably necessary for the
efficient performance of such Transition Services. Furthermore, each Party shall, and shall cause its Representatives to, comply, in all material respects, with all Laws which may be applicable to the Transition Services. Each Party shall be
responsible for its Representatives, including for such Representatives adhering to any health, safety, and security regulations and other published policies of the other Party while on the other Party&#146;s premises or when given access to any
equipment, computer, databases, systems, software, network or other files (collectively, &#147;Systems&#148;) owned or controlled by the other Party. If a Party or one or more of its Representatives needs access to the premises or Systems of the
other Party or one or more of its Representatives to provide or receive the Transition Services (as applicable), then (x)&nbsp;the accessing Party shall advise the other Party in writing in advance of such access of the name of each of the accessing
Party&#146;s Representatives who shall require such access, (y)&nbsp;the accessing Party and its Representatives shall not attempt to obtain access to, use or interfere with any of the premises or Systems of the other Party or such other
Party&#146;s Representatives, except to the extent permitted by the other Party or required to do so to provide or receive the Transition Services (as applicable), and (z)&nbsp;the accessing Party and its Representatives shall not intentionally
damage, disrupt or impair the normal operation of any of the premises or Systems of the other Party or such other Party&#146;s Representatives. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9.3 <U>Coordinators</U>. Each of Provider and Recipient shall nominate a representative to
act as its primary contact person to coordinate the provision of all Transition Services (collectively, the &#147;<U>Primary Coordinators</U>&#148;). Each Primary Coordinator may designate one or more service coordinators for each specific
Transition Service (the &#147;<U>Service Coordinators</U>&#148;). Each Party may treat an act of a Primary Coordinator or Service Coordinator of another Party as being authorized by such other Party without inquiring behind such act or ascertaining
whether such Primary Coordinator or Service Coordinator had authority to so act, <I>provided</I>, <I>however</I>, that no such Primary Coordinator or Service Coordinator has authority to amend this Agreement. Provider and Recipient shall advise each
other promptly (in any case no more than five (5)&nbsp;business days) in writing of any change in the Primary Coordinators and any Service Coordinator for a particular Transition Service, setting forth the name of the Primary Coordinator or Service
Coordinator to be replaced and the name of the replacement, and certifying that the replacement Primary Coordinator or Service Coordinator is authorized to act for such Party in all matters relating to this Agreement, in the case of a Primary
Coordinator or, in the case of a Service Coordinator, with respect to the Transition Service for which such Service Coordinator has been designated. Provider and Recipient each agrees that all communications relating to the provision of the
Transition Services shall be directed to the Service Coordinators for such Transition Service with copies to the Primary Coordinators. Provider&#146;s initial Primary Coordinator shall be Matt Foehr. Recipient&#146;s initial Primary Coordinator
shall be Matthew Korenberg. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9.4 <U>Level of Transition Services</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) Recipient acknowledges and agrees that Provider is not in the business of providing services to third parties and is entering into this
Agreement only in connection with the Separation and Distribution Agreement. Provider shall, and shall cause each of its Representatives to, provide the Transition Services with substantially the same degree of skill, quality and standard of care as
that utilized by Provider (or its Affiliates) to perform similar activities in the six (6)&nbsp;month period (or twelve (12)&nbsp;month period solely with respect to activities that are customarily performed on an annual basis) prior to the
Effective Date, and, in any event, no less than with commercially reasonable care and diligence (collectively, the &#147;<U>Services Standard</U>&#148;). Under no circumstances shall Provider or any of its Representatives be held accountable to a
greater standard of care, efforts or skill than the Services Standard in the performance of the Transition Services. Recipient acknowledges and agrees that (i)&nbsp;the Transition Services do not include the exercise of business judgment or general
management for Provider and (ii)&nbsp;NEITHER PROVIDER NOR ANY OF ITS AFFILIATES MAKES ANY REPRESENTATIONS OR WARRANTIES, EXPRESS OR IMPLIED, INCLUDING ANY WARRANTY OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE, WITH RESPECT TO THE
TRANSITION SERVICES. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) If the Transition Services to be provided to Recipient materially increase in scale or in scope as compared to
the level of the similar services provided in connection with the operation of the Ligand Retained Business as of the Effective Date, Provider may, at its election, choose to not provide such increased scale or scope of Transition Services, and if
Provider elects to perform such increased scale or scope of Transition Services, all costs incurred in connection therewith shall be mutually agreed upon by Provider and Recipient prior to the time such additional Transition Services are performed,
shall be set forth in an amended Schedule A, and shall be borne by Recipient. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) In addition to being subject to the terms and conditions of this Agreement for the
provision of the Transition Services, Provider and Recipient each agree that the Transition Services provided by any Vendor shall be subject to the terms and conditions of any agreements between Provider and such Vendor, which agreements shall be on
substantially the same conditions as Provider would enter into with such Vendor for its own account, and no such agreements shall be binding on Recipient after the Term hereof without Recipient&#146;s express written consent. Provider shall consult
with Recipient concerning the terms and conditions of any such agreements to be entered into, or proposed to be entered into, or amended, with any Vendors after the Effective Date. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) Without relieving Provider of its obligation to perform the Transition Services in accordance with the Services Standard, Provider shall
not be (i)&nbsp;obligated to perform the Transition Services to the extent that such performance would be unlawful or that would require Provider to violate applicable Law; (ii)&nbsp;obligated to perform the Transition Services to the extent that
such performance, in Provider&#146;s reasonable determination, could create deficiencies in Provider&#146;s controls over financial information or adversely affect the maintenance of Provider&#146;s financial books and records or the preparation of
its financial statements; (iii)&nbsp;obligated to hire any additional employees to perform the Transition Services or maintain the employment of any specific employee; (iv)&nbsp;obligated to hire replacements for employees that resign, retire or are
terminated; (v)&nbsp;obligated to enter into retention agreements with employees or otherwise provide any incentive beyond payment of regular salary and benefits; (vi)&nbsp;prevented from transferring after the Effective Date any employees who were
supporting the business operations as of the Effective Date to support other business operations for Provider or its Affiliates or to assume other roles with Provider or its Affiliates to the extent such employees are not required to provide
Transition Services; (vii)&nbsp;prevented from determining, in its sole discretion, the individual employees who will provide Transition Services; or (viii)&nbsp;obligated to purchase, lease or license any additional equipment or software. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9.5 <U>Transitional Nature of Services</U>. Recipient acknowledges and agrees that the Transition Services are intended only to be transitional
in nature, and shall be furnished by Provider only during the Service Periods. Recipient shall use commercially reasonable efforts to have sufficient resources available to it at the end of the Service Periods to perform the Transition Services (or
have the Transition Services performed) without the involvement of Provider, its Affiliates or any of its or their respective employees or agents upon the termination or expiration of a Service Period for an applicable Transition Service. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9.6 <U>Location of Services Provided; Travel Expenses</U>. Provider shall provide the Transition Services to Recipient from locations of
Provider&#146;s choice in its sole discretion except to the extent the nature of the Transition Services necessitates performance at a specific location, as mutually agreed upon by the Parties. Subject to Section&nbsp;3.1, should the provision of
the Transition Services require any directors, officers, employees, agents, representatives, or subcontractors of Provider or its Affiliates to travel beyond fifty (50)&nbsp;miles from his or her employment location, Recipient shall reimburse
Provider for all reasonable travel-related <FONT STYLE="white-space:nowrap">out-of-pocket</FONT> costs, consistent with Provider&#146;s travel policy as provided to Recipient in advance in writing. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9.7 <U>Limitation of Liability</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Parties hereto acknowledge and agree that the Transition Services are provided by Provider: (a)&nbsp;at the request of Recipient in order
to accommodate it following the closing under the Separation and Distribution Agreement; (b)&nbsp;at the costs set forth on Schedule A hereto and with no expectation of profit being made by Provider thereon; and (c)&nbsp;with the expectation that
Provider is not assuming any financial or operational risks, including those usually assumed by a service provider, except for those risks explicitly set forth herein. Accordingly, each Party agrees that, absent gross negligence or willful
misconduct, and except for breaches of Article V (Confidentiality) and except for a Party&#146;s obligations under Section&nbsp;2.8 (Indemnification), the other Party, its Affiliates and their directors, officers, employees, representatives,
consultants and agents shall not be liable for any indirect, special, incidental or consequential damages, including lost profits or savings, whether or not such damages are foreseeable, or for any third party claims relating to the Transition
Services or each Party&#146;s performance under this Agreement. Notwithstanding anything to the contrary contained herein, in the event Provider commits an error with respect to or incorrectly performs or fails to perform any Transition Service, at
Recipient&#146;s request, Provider shall use commercially reasonable efforts and in good faith attempt to correct such error, <FONT STYLE="white-space:nowrap">re-perform</FONT> or perform such Transition Service at no additional cost to Recipient;
<I>provided </I>that, absent gross negligence or willful misconduct, and assuming that Provider uses commercially reasonable data backup processes, Provider shall have no obligation to recreate any lost or destroyed data to the extent the same
cannot be cured by the <FONT STYLE="white-space:nowrap">re-performance</FONT> of the Transition Service in question. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9.8
<U>Indemnification</U>.<U> </U> </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) Recipient shall indemnify, defend and hold harmless Provider and its Affiliates and its and their
respective officers, directors, employees, representatives, subcontractors and agents from and against any and all damages, liabilities, losses, taxes, fines, penalties, costs and expenses (including, without limitation, reasonable fees of counsel)
incurred by any of them in connection with any Third Party Claim (as defined below) (each, a &#147;<U>Loss</U>&#148; and, collectively, the &#147;<U>Losses</U>&#148;) relating to, arising out of or resulting from or based on
(i)&nbsp;Recipient&#146;s material breach of this Agreement or (ii)&nbsp;any gross negligence or willful misconduct of Recipient, (iii)&nbsp;Provider&#146;s provision of the Transition Services as directed or requested by Recipient, or
(iv)&nbsp;Recipient&#146;s use or exploitation of any work product provided by Provider in the performance of the Transition Services, except in each case (i), (ii), (iii), and (iv)&nbsp;to the extent such Losses are subject to indemnification
pursuant to Section&nbsp;2.8(b). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) Provider hereby agrees to indemnify, defend and hold harmless Recipient and its Affiliates and its
and their respective officers, directors, employees, representatives, subcontractors and agents from and against any and all Losses relating to, arising out of or resulting from (i)&nbsp;Provider&#146;s material breach of this Agreement or
(ii)&nbsp;any gross negligence or willful misconduct in the performance of its obligations under this Agreement, except in each case of (i)&nbsp;and (ii) to the extent such Losses are subject to indemnification pursuant to Section&nbsp;2.8(a). </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) To the maximum extent permitted by applicable Law, each Party&#146;s and its
Affiliates&#146; and each of its and their respective subcontractors&#146; officers&#146;, directors&#146;, employees&#146; and agents&#146; sole and exclusive remedy with respect to any and all claims relating to the Transition Services shall be
pursuant to the indemnification provisions set forth in this Section&nbsp;2.8.</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9.9 <U>Indemnification Procedures</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) If any claim or demand is made by a third party (including any action or proceeding commenced or threatened to be commenced) with respect
to which a Party seeking indemnification (the &#147;<U>Indemnified Party</U>&#148;) intends to seek indemnity under Section&nbsp;2.8 (a &#147;<U>Third Party Claim</U>&#148;), the Indemnified Party shall promptly give written notice thereof to the
other Party (the &#147;<U>Indemnifying Party</U>&#148;) indicating, with reasonable specificity, the nature of such Third Party Claim, the basis therefor, and a copy of any documentation received from such third party. A failure by the Indemnified
Party to give notice and to tender the defense of any action or proceeding in a timely manner pursuant to this Section&nbsp;2.9(a) shall not limit the obligation of the Indemnifying Party under Section&nbsp;2.8, except to the extent such
Indemnifying Party is actually and materially prejudiced thereby. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) Upon receipt of a notice for indemnity from the Indemnified Party
pursuant to Section&nbsp;2.9(a) with respect to any Third Party Claim, the Indemnifying Party shall have the right to assume the defense of, at its own expense and by its own counsel, any such Third Party Claim. If the Indemnifying Party shall, in
accordance with the immediately preceding sentence, undertake to compromise or defend any such Third Party Claim, it shall notify the Indemnified Party of its intention to do so, and the Indemnified Party shall agree to cooperate with the
Indemnifying Party and its counsel in the compromise of, or defense against, any such Third Party Claim; <I>provided </I>that the Indemnifying Party shall not settle or compromise any such Third Party Claim without the written consent of the
Indemnified Party (not to be unreasonably withheld, conditioned or delayed) unless such settlement or compromise fully and irrevocably releases the Indemnified Party in connection with such Third Party Claim and provides relief consisting solely of
money damages borne by the Indemnifying Party. Notwithstanding an election of the Indemnifying Party to assume the defense of such Third Party Claim, the Indemnified Party shall have the right to employ separate legal counsel, its own cost and
expense, and to participate in the defense thereof. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9.10 <U>Modification of Transition Services Procedures</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) Subject to the procedure set forth in this Section&nbsp;2.10 to the extent applicable, Provider may make changes from time to time in its
standards and procedures for performing the Transition Services, <I>provided</I> that any such change shall not interfere in any material respect with the continued provision or cost of the Transition Services. Notwithstanding the foregoing
sentence, unless required by Law, Provider shall not implement any substantial or material changes to such standards and procedures in a manner affecting the operation of the Ligand Retained Business unless Recipient agrees in writing to such
changes and Provider gives Recipient ten (10)&nbsp;business days to adapt its operations to accommodate such changes to the extent commercially reasonable. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) During the term of this Agreement, if Recipient intends to make any changes that may
affect the provision of any of the Transition Services, Recipient shall provide Provider with a plan identifying any changes as soon as reasonably practicable, but in any case no less than ten (10)&nbsp;business days before implementing such
changes; <I>provided</I>, <I>however</I>, that Provider shall not be required to alter the method in which it provides any of the Transition Services or increase the level of any such Transition Services in any material manner except as expressly
provided herein; <I>provided, further, however, </I>that the failure of Recipient to provide such notice shall not alter or diminish Provider&#146;s obligations to provide the Transition Services on the terms set forth herein except where the
failure to provide notice has materially increased Provider&#146;s cost or burden to provide such Transition Service. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9.11
<U>Cooperation</U>. The Parties will use commercially reasonable efforts to reasonably cooperate and cause each of their respective Representatives to reasonably cooperate in a professional and workmanlike manner with each other to the extent
necessary to assist the other Party in performance of its obligations under this Agreement, including with respect to the provision and receipt of the Transition Services. Such cooperation shall include exchanging information relevant to and
reasonably necessary for the provision or receipt of the Transition Services hereunder and the performance of such other duties and tasks as may be reasonably required for the provision or receipt of the Transition Services. Without limiting the
foregoing: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) Recipient shall permit Provider and its Representatives reasonable access during regular business hours (or otherwise upon
reasonable prior notice) to any data, records and personnel involved in receiving or overseeing the Transition Services as reasonably requested by Provider to facilitate Provider&#146;s performance of this Agreement. Any such data and records shall
be subject to Article V. Before the Parties exchange any Personal Information in connection with the Transition Services, the Parties will enter into a data processing agreement in accordance with applicable Laws. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) Provider shall use commercially reasonable efforts to obtain any consents, licenses, waivers or approvals necessary to permit Provider to
perform its obligations hereunder; <I>provided, however,</I> that under no circumstances shall Provider be obligated to provide the relevant part of any Transition Services to the extent that (i)&nbsp;Provider is unable to obtain necessary third
party consents, licenses, waivers or approvals relating to such part of the Transition Services on commercially reasonable terms, (ii)&nbsp;in order to provide such part of the Transition Services, Provider will have an obligation to make any
payments to any Third Party or incur any obligations in respect of any such consents, licenses, waivers or approvals, which payments are not subject to reimbursement by Recipient or which other obligations are not assumed by Recipient hereunder,
(iii)&nbsp;Provider would be obligated to make any alternative arrangements in the event that any such consents, licenses, waivers or approvals are not obtained (but only to the extent such arrangements would not be commercially reasonable) or
(iv)&nbsp;Provider would be required to seek broader rights or more favorable terms with respect to any consents, licenses, waivers or approvals than those applicable immediately prior to the date hereof where the costs of obtaining the same are not
subject to reimbursement by Recipient. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) Recipient shall obtain all necessary consents, licenses, waivers and approvals necessary for it
to receive the Transition Services and perform its obligations under this Agreement. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE X </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>COMPENSATION </U></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">10.1
<U>Consideration</U>. As consideration for the Transition Services, Recipient shall pay to Provider the amount specified for each such Transition Service as set forth in Schedule A, including any &#147;pass-through costs&#148; expressly identified
as such in Schedule A. The fees set forth on Schedule A will be equitably reduced if any Transition Service is suspended, terminated or removed from the scope of this Agreement and will be equitably prorated for partial months. In addition,
Recipient shall reimburse Provider (upon receipt of applicable receipts and other reasonable supporting documentation if requested by Provider) for all reasonable documented out of pocket costs of Provider in connection with performance of the
Transition Services by Provider, including: (a)&nbsp;shipping and transportation costs (including the cost of any insurance related thereto), duties and other taxes (excluding taxes on Provider&#146;s income); (b) travel-related costs, (c)&nbsp;out
of pocket costs or expenses incurred with third parties by Provider, its Affiliates or subcontractors, including for the extraction, conversion and transfer of data and (d)&nbsp;any other out of pocket costs and expenses incurred with third parties
described herein as reimbursable by Provider (the &#147;<U>Reimbursable Expenses</U>&#148;); <I>provided</I> that if any particular Reimbursable Expense exceeds Ten Thousand Dollars ($10,000), Provider must obtain Recipient&#146;s consent prior to
any obligation of Recipient to reimburse Provider for such Reimbursable Expense; <I><U>provided, further</U></I> that until Recipient consents to such Reimbursable Expenses exceeding Ten Thousand Dollars ($10,000), Provider shall not be required to
provide the relevant part of the Transition Services for which such Reimbursable Expenses exceeding Ten Thousand Dollars ($10,000) is necessary. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">10.2 <U>Invoices</U>. Provider shall, on a monthly basis on the last day of each calendar month, submit a single itemized invoice to Recipient
for all Transition Services provided to Recipient during such month. All invoices shall be sent to the attention of the Primary Coordinators at the address set forth in Section&nbsp;7.5 hereof or to such other address as Recipient shall have
specified by notice in writing to Provider. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">10.3 <U>Payment of Invoices</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) Recipient shall pay any undisputed invoice for Transition Services promptly but in no event later than thirty (30)&nbsp;days after the date
of receipt of such invoice and such payment shall be made by wire transfer of immediately available funds to such bank account as shall have been notified in writing to Recipient by Provider. Payment of all invoices in respect of the Transition
Services shall be made by check or electronic funds transmission in U.S. Dollars, without any offset or deduction of any nature whatsoever (except that offset or deduction may be made in regard to other invoiced amounts due under this Agreement or
to the extent of a dispute in good faith concerning amounts due under this Agreement). All payments shall be made to the account designated by Provider to Recipient. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) If any payment is not paid when due (except to the extent disputed in good faith) and Recipient does not make such payment within thirty
(30)&nbsp;days of receiving a <FONT STYLE="white-space:nowrap">past-due</FONT> notice from Provider, Provider shall have the right, without any liability to Recipient, or anyone claiming by or through Recipient, to, upon written notice to Recipient,
immediately cease providing any or all of the Transition Services provided by Provider to Recipient and/or to terminate this Agreement in its entirety, which right may be exercised by Provider in its sole and absolute discretion. Notwithstanding the
above, Provider shall not cease providing any Transition Service or terminate this Agreement if such lack of payment is due to a good faith dispute, the details of which Recipient has indicated to Provider in writing. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE XI </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>OWNERSHIP OF INTELLECTUAL PROPERTY </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">11.1 <U>Ownership; Delivery</U>. Except as expressly set forth herein, neither Party will obtain, by virtue of this Agreement or the
Transition Services, by implication or otherwise, any rights of ownership or use of any property or Intellectual Property owned by the other. All Intellectual Property conceived, created or made by Provider or any of its Representatives (whether
alone or jointly with Recipient) in the course of Provider&#146;s performance of the Transition Services and other activities under this Agreement that are (a)&nbsp;exclusively related to the Ligand Retained Business and/or (b)&nbsp;based on,
derived from, or improvements of any of Recipient&#146;s background Intellectual Property (altogether, (a)&nbsp;and (b), the &#147;<U>Assigned IP</U>&#148;) shall be solely owned by Recipient, and Provider hereby assigns to Recipient all of
Provider&#146;s right, title, and interest in and to such Assigned IP. All other Intellectual Property conceived, created or made by Provider or any of its Representatives in the course of Provider&#146;s or such Representative&#146;s performance of
any Transition Services or other activities under this Agreement shall be solely owned by Provider.</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">11.2 <U>Limited Licenses</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) Recipient (on behalf of itself and its controlled Affiliates) hereby grants to Provider a limited,
<FONT STYLE="white-space:nowrap">non-exclusive,</FONT> royalty-free, <FONT STYLE="white-space:nowrap">non-transferable</FONT> license, with the right to grant sublicenses to its Affiliates and its and their subcontractors during the Service Periods,
under the Intellectual Property owned or controlled by Recipient, solely to the extent necessary for Provider and its Affiliates and its and their subcontractors to perform the Transition Services hereunder for the benefit of Recipient during the
applicable Services Period. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) Provider (on behalf of itself and its controlled Affiliates) hereby grants to Recipient and its Affiliates
a limited, <FONT STYLE="white-space:nowrap">non-exclusive,</FONT> royalty-free, <FONT STYLE="white-space:nowrap">non-transferable</FONT> license, with the right to grant sublicenses to its and their Affiliates and subcontractors, under the
Intellectual Property owned or controlled by Provider, solely to the extent necessary for Recipient and its Affiliates and its and their subcontractors to (i)&nbsp;receive the Transition Services during the applicable Service Period and/or
(ii)&nbsp;use or exploit any deliverables provided by Provider to Recipient as part of the Transition Services in the operation of the Ligand Retained Business. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE XII </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>CONFIDENTIALITY </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">12.1 <U>Confidential Information</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) Each Party recognizes that in the performance of this Agreement, or as a result of the Parties&#146; ongoing relationship, <FONT
STYLE="white-space:nowrap">non-public,</FONT> Confidential Information (as defined in the Separation and Distribution Agreement) belonging to the other Party regarding the Transition Services may be disclosed or become known to the Party or its
Affiliates. Unless otherwise expressed in writing to the other Party, confidential information and confidential materials concerning a Party&#146;s business and products (including information and materials contained in technical data, information
concerning the Ligand Retained Business, financial information and data, strategies and marketing and customer information), including that expressed orally, that is exchanged between the Parties in connection with the performance of this Agreement
shall be considered to be Confidential Information. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) Notwithstanding any termination of this Agreement, Provider and Recipient shall
hold and shall cause their respective Representatives to hold, in strict confidence (and not to disclose or release or, except as otherwise permitted by this Agreement or the Separation and Distribution Agreement, use, including for any ongoing or
future commercial purpose, without the prior written consent of the Party to whom the Confidential Information relates (which may be withheld in such Party&#146;s sole and absolute discretion, except where disclosure is required by applicable Law),
any and all Confidential Information concerning or belonging to the other Party or its Affiliates; <I>provided</I> that each Party may disclose, or may permit disclosure of, Confidential Information: (i)&nbsp;to its respective auditors, attorneys,
financial advisors, bankers and other appropriate consultants and advisors who have a need to know such Information (as defined in the Separation and Distribution Agreement) for auditing and other
<FONT STYLE="white-space:nowrap">non-commercial</FONT> purposes and are informed of the obligation to hold such Information confidential and in respect of whose failure to comply with such obligations, the applicable Party will be responsible,
(ii)&nbsp;if any Party or its Affiliates or any of its respective Subsidiaries is required or compelled to disclose any such Confidential Information by judicial or administrative process or by other requirements of Law or stock exchange rule or is
advised by outside counsel in connection with a proceeding brought by a Governmental Authority that it is advisable to do so, (iii)&nbsp;as required in connection with any legal or other proceeding by one Party against the other Party or in respect
of claims by one Party against the other Party brought in a proceeding, (iv)&nbsp;as necessary in order to permit a Party to prepare and disclose its financial statements in connection with any regulatory filings or tax returns, (v)&nbsp;as
necessary for a Party to enforce its rights or perform its obligations under this Agreement or the Separation and Distribution Agreement, (vi)&nbsp;to Governmental Authorities in accordance with applicable procurement regulations and contract
requirements or (vii)&nbsp;to other Persons in connection with their evaluation of, and negotiating and consummating, a potential strategic transaction, to the extent reasonably necessary in connection therewith, provided an appropriate and
customary confidentiality agreement has been entered into with the Person receiving such Confidential Information at least as protective of such Confidential Information as this Agreement. Notwithstanding the foregoing, in the event that any demand
or request for disclosure of Confidential Information is made by a third party pursuant to clause (ii), (iii), (v) or (vi)&nbsp;above, each Party, as applicable, shall promptly notify (to the extent permissible by Law) the Party to whom the
Confidential Information relates of the existence of such request, demand or disclosure requirement and shall provide such affected Party a reasonable opportunity to seek an appropriate protective order or other remedy, which such Party will
cooperate in obtaining to the extent reasonably practicable. In the event that such appropriate protective order or other remedy is not obtained, the Party which faces the disclosure requirement shall furnish only that portion of the Confidential
Information that is required to be disclosed and shall take commercially reasonable steps to ensure that confidential treatment is accorded such Confidential Information. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) Each Party acknowledges that it and its Affiliates may have in its or their possession
confidential or proprietary Information of third parties that was received under confidentiality or <FONT STYLE="white-space:nowrap">non-disclosure</FONT> agreements with such third party while such Party and/or its Affiliates were part of the
Ligand Group. Each Party shall comply, shall cause its Affiliates to comply, and shall cause its and their respective officers, employees, agents, consultants and advisors (or potential buyers) to comply, with all terms and conditions of any such
third-party agreements entered into prior to the Effective Date, with respect to any confidential and proprietary Information of third parties to which it or any other member of its Group has had access. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) Notwithstanding anything to the contrary set forth herein, (i)&nbsp;the Parties shall be deemed to have satisfied their obligations
hereunder with respect to Confidential Information if they exercise at least the same degree of care that applies to Ligand&#146;s confidential and proprietary information pursuant to policies in effect as of the Effective Date and
(ii)&nbsp;confidentiality obligations provided for in any Contract between each Party or its Affiliates or Subsidiaries and their respective employees shall remain in full force and effect. Notwithstanding anything to the contrary set forth herein,
Confidential Information of a Party in the possession of and used by the other Party as of the Effective Date may continue to be used by such Party in possession of the Confidential Information in and only in the operation of the Ligand Retained
Business; <I>provided</I> that such Confidential Information may only be used by such Party and its officers, employees, agents, consultants and advisors in the specific manner and for the specific purposes for which it is used as of the Effective
Date, and may only be shared with additional officers, employees, agents, consultants and advisors of such Party on a <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">need-to-know</FONT></FONT> basis exclusively with regard to such
specified use; <I>provided further</I> that such Confidential Information may be used only so long as the Confidential Information is maintained in confidence and not disclosed in violation of this Section&nbsp;5.1. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) The Parties agree that irreparable damage may occur in the event that the provisions of this Section&nbsp;5.1 were not performed in
accordance with their specific terms. Accordingly, it is hereby agreed that the Parties shall be entitled to seek an injunction or injunctions to enforce specifically the terms and provisions hereof in any court having jurisdiction, this being in
addition to any other remedy to which they are entitled at law or in equity. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f) Upon expiration of the Service Periods or termination of
this Agreement for any reason whatsoever, except for such retention and use as expressly provided for in the Separation and Distribution Agreement, each Party shall not disclose and shall make no further use of the other Party&#146;s Confidential
Information and upon written request shall immediately destroy or, with respect to Confidential Information in written or other tangible form (including all copies thereof), return to the other Party, all such Confidential Information;
<I>provided</I> that (i)&nbsp;each Party shall be entitled to retain one record copy in its legal department solely to determine the extent of its continuing obligations or as otherwise required to comply with applicable Law, and (ii)&nbsp;neither
Party nor its Representatives shall be required to expunge Confidential Information from computer archiving conducted as part of established record retention policies (<I>provided</I> that the foregoing shall not be deemed to permit the accessing,
retrieval or use of any Confidential Information). </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE XIII </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>TERM </U></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">13.1
<U>Term</U>. This Agreement shall commence on the Effective Date and shall continue in full force and effect until the earliest of (a)&nbsp;the date on which this Agreement is terminated in accordance with this Article VI or (b)&nbsp;the expiration
of the last Service Period, such that Provider is no longer obligated to provide any Transition Services pursuant to this Agreement (the &#147;<U>Term</U>&#148;). If no expiration date is provided for any Transition Service, then such Transition
Service will terminate twelve (12)&nbsp;months after the Effective Date, <I>provided</I> that Recipient shall have the right to an extension of each or any Transition Service for up to six (6)&nbsp;months by providing written notice to Provider in
advance of the original termination date for such Transition Service if, prior to such request for extension, Recipient has used commercially reasonable efforts to establish analogous capabilities of its own. The Parties will discuss in good faith
any subsequent requests to further extend the Transition Services. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">13.2 <U>Termination of Services</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) Recipient may, at any time prior to the end of the Service Period for any Transition Service(s) and upon thirty (30)&nbsp;days&#146; prior
written notice to Provider, terminate any Transition Service(s) or this Agreement in its entirety, whereupon, from and after the date of termination specified in such written notice, Provider&#146;s obligation to provide such Transition Service(s)
to Recipient shall cease and Recipient shall have no obligation to pay Provider for such Transition Service(s) (other than with respect to those Transition Services for which costs will be incurred by Provider as a result of <FONT
STYLE="white-space:nowrap">non-cancellable</FONT> commitments that Provider incurred in good faith in order to provide such Transition Services); <I>provided</I> that if termination of any Transition Service materially inhibits Provider&#146;s
ability to provide or prevents Provider from providing any other Transition Services (as determined in Provider&#146;s sole discretion), Provider shall promptly notify Recipient of such determination and such other Transition Services shall also
shall be deemed terminated, subject to Recipient&#146;s prior written consent of such termination; and <I>provided further</I> that partial reduction of any specific Transition Service may only be made with the prior written consent of Provider,
which consent shall not be unreasonably withheld, delayed or conditioned. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) Except as set forth in Section&nbsp;3.3(b), in the event
that either Party breaches any of its material obligations under this Agreement (the &#147;<U>Breaching Party</U>&#148;), the other Party may terminate this Agreement in its entirety upon thirty (30)&nbsp;days&#146; prior written notice (such thirty
(30)&nbsp;day period, the &#147;<U>Notice Period</U>&#148;) to the Breaching Party, specifying the breach and its claim of right to terminate; <I>provided</I>, that the termination of this Agreement shall not become effective at the end of the
Notice Period if (i)&nbsp;the Breaching Party cures such breach during the Notice Period or (ii)&nbsp;such breach cannot be cured during the Notice Period and the Breaching Party commences and diligently pursues actions to cure such breach within
the Notice Period, in which case the Breaching Party shall have an additional thirty (30)&nbsp;day period to cure such breach before such termination shall become effective. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) Either Party may terminate this Agreement in its entirety immediately upon written
notice to the other Party if the other Party (i)&nbsp;files in any court or with any other Governmental Authority, pursuant to any Law of any state or country, a petition in bankruptcy or insolvency or for reorganization or for an arrangement or for
the appointment of a receiver or trustee of such other Party or of its assets; (ii)&nbsp;is served with an involuntary petition against it, filed in any insolvency proceeding, and such petition is not dismissed within sixty (60)&nbsp;days after the
filing thereof; (iii)&nbsp;consents to the appointment or taking possession by a receiver, liquidator, assignee, custodian, trustee, sequestrator (or similar official) of such other Party or for any substantial part of its property or makes any
assignment for the benefit of creditors; (iv)&nbsp;admits in writing its inability to pay its debts generally as they become due; or (v)&nbsp;has issued or levied against its property any judgment, writ, warrant of attachment or execution or similar
process that represents a substantial portion of its property. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) Any Transition Service, or this Agreement in its entirety, may be
terminated upon the mutual written agreement of Provider and Recipient at any time. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">13.3 <U>Termination of Obligations</U><U>.
</U>Recipient specifically agrees and acknowledges that all obligations of Provider to provide each Transition Service shall immediately cease upon the expiration of the Service Period (as may be extended as set forth in this Agreement) for such
Transition Service, and Provider&#146;s obligations to provide all of the Transition Services shall immediately cease upon termination of this Agreement. Recipient shall bear sole responsibility for instituting permanent services, or obtaining
replacement services, in respect of any Transition Service terminated in accordance with the provisions hereof, and, except to the extent provided in the Schedules, Provider shall bear no liability for Recipient&#146;s failure to implement or obtain
such service or for any difficulties in transitioning from the Transition Service to such permanent or replacement service. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">13.4
<U>Accrued Rights</U>. Termination or expiration of this Agreement for any reason shall be without prejudice to any rights that shall have accrued to the benefit of a Party prior to such termination or expiration. Such termination or expiration
shall not relieve a Party from obligations that are expressly indicated to survive the termination or expiration of this Agreement. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">13.5
<U>Surviving Obligations</U>. Without limiting the foregoing, Article I, Article V and Article VII and Sections 2.7, 2.8, 2.9, 3.2 (solely with respect to accrued, unpaid fees as of such termination or expiration), 3.3 (solely with respect to
accrued, unpaid fees as of such termination or expiration), 4.1, 4.2(b)(ii), 6.3 and 6.5 shall survive the termination or expiration of this Agreement for any reason. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE XIV </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>MISCELLANEOUS </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">14.1 <U><FONT STYLE="white-space:nowrap">Non-Solicitation</FONT></U>. During the Term of this Agreement and for a period of one (1)&nbsp;month
after the Term, neither Party shall, directly or indirectly, in any manner solicit or induce for employment, or hire or engage the services of, any employee of the other Party without the other Party&#146;s prior written consent. A general
advertisement or notice of a job listing or opening or other similar general publication of a job search or availability of employment positions, including on the internet, shall not be construed as a solicitation or inducement for the purposes of
this provision. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">14.2 <U>Force Majeure</U>. Provider shall not be liable for any failure to perform or any
delays in performance (other than the payment of money owed and the providing of indemnity and defense), and Provider shall not be deemed to be in breach or default of its obligations set forth in this Agreement, if, to the extent and for so long
as, such failure or delay is due to any causes that are beyond its reasonable control and not to its fault or negligence, including, such causes as acts of God, epidemic, pandemic, natural disasters, fire, flood, severe storm, earthquake, civil
disturbance, strike, lockout, riot, order of any court or administrative body, embargo, acts of government, war (whether or not declared), acts of terrorism, or other similar causes. For clarity, in the event of any such delay, the time for
performance shall be extended for a period equal to the time lost by reason of the delay. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">14.3 <U>Complete Agreement: Construction</U>.
This Agreement, including the Schedules hereto, shall constitute the entire agreement between the Parties with respect to the subject matter hereof and shall supersede all previous negotiations, commitments and writings with respect to such subject
matter. In the event of any inconsistency between this Agreement and any Schedule hereto, this Agreement shall prevail. No rule of construction that disfavors the drafting party will apply to this Agreement. As used in this Agreement,
&#147;including&#148; and words of similar import mean &#147;including but not limited to.&#148; The use of &#147;or&#148; will not be deemed to be exclusive<U>.</U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">14.4 <U>Counterparts</U>. This Agreement may be executed in one or more counterparts, all of which shall be considered one and the same
agreement, and shall become effective when one or more such counterparts have been signed by each of the Parties and delivered to the other Party. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">14.5 <U>Notices</U>. All notices and other communications hereunder shall be in writing and hand delivered or mailed by registered or certified
mail (return receipt requested) or sent by any means of electronic message transmission with delivery confirmed (by read receipt, voice or otherwise) to the parties at the following addresses (or at such other addresses for a party as shall be
specified by like notice) and will be deemed given on the date on which such notice is received: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">To OmniAb: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">OmniAb Incorporated </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">5980 Horton St., Suite 405 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Emeryville, California 94608 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Attn: Chief Legal Officer </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Email: cberkman@omniab.com </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;To Ligand: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Ligand Pharmaceuticals Incorporated </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">3911 Sorrento Valley Blvd.,
Suite 110 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">San Diego, CA 92121 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Attn: Chief Financial Officer
</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Email: tespinoza@ligand.com </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">14.6 <U>Waivers</U>. The failure of any Party to require strict performance by any other
Party of any provision in this Agreement will not waive or diminish that Party&#146;s right to demand strict performance thereafter of that or any other provision hereof. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">14.7 <U>Amendments</U>. This Agreement may not be modified or amended except by an agreement in writing signed by each of the Parties hereto.
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">14.8 <U>Assignment</U>. This Agreement shall not be assignable, in whole or in part, directly or indirectly; <I>provided, however</I>,
that (a)&nbsp;either Party may assign this Agreement without the other&#146;s consent to any of its controlled Affiliates and (b)&nbsp;either Party may assign this Agreement in its entirety to any successor to its business, whether by merger,
reorganization or otherwise; <I>provided, further</I>, that any such assignment shall not relieve the assignor of its obligations under this Agreement. Any attempt to assign any rights or obligations arising under this Agreement in contravention
with this paragraph shall be null and void <I>ab initio</I>. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">14.9 <U>Successors and Assigns</U>. The provisions of this Agreement shall be
binding upon, inure to the benefit of and be enforceable by the Parties and their respective successors and permitted assigns. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">14.10
<U>Third Party Beneficiaries</U>. This Agreement is solely for the benefit of the Parties hereto and should not be deemed to confer upon third parties any remedy, claim, liability, reimbursement, claim of action or other right in excess of those
existing without reference to this Agreement. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">14.11 <U>Title and Headings</U>. Titles and headings to sections herein are inserted for the
convenience of reference only and are not intended to be a part of or to affect the meaning or interpretation of this Agreement. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">14.12
<U>Schedules</U>. The Schedules to this Agreement shall be construed with and as an integral part of this Agreement to the same extent as if the same had been set forth verbatim herein. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">14.13 <U>Governing Law</U>. This Agreement shall be governed by and construed in accordance with the laws of the State of California (without
regard to its conflicts of Law doctrines). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">14.14 <U>Severability</U>. In the event any one or more of the provisions contained in this
Agreement should be held invalid, illegal or unenforceable in any respect, the validity, legality and enforceability of the remaining provisions contained herein and therein shall not in any way be affected or impaired thereby. The Parties shall
endeavor in good-faith negotiations to replace the invalid, illegal or unenforceable provisions with valid provisions, the economic effect of which comes as close as possible to that of the invalid, illegal or unenforceable provisions. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">14.15 <U>Relationship of Parties</U>. Nothing in this Agreement shall be deemed or construed
by the Parties or any third party as creating a partnership or the relationship of principal and agent or joint venturer between the Parties, it being understood and agreed that no provision contained herein, and no act of the Parties, shall be
deemed to create any relationship between the Parties other than the relationship of Provider and Recipient of the Transition Services nor be deemed to vest any rights, interests or claims in any third parties. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">14.16 <U>I</U><U>nsurance</U>. During the Term, Provider shall carry commercially appropriate and customary levels of insurance with a
reputable insurance provider covering business interruptions and general liability insurance (including errors&nbsp;&amp; omissions and contractual liability) to protect its own business and property interests. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">14.17 <U>Audit</U>. During the term of this Agreement and for one (1)&nbsp;year thereafter (or such longer period as may be required by
applicable Law), Provider and Recipient shall each use commercially reasonable efforts to maintain complete and accurate records related to any Transition Service provided, fees invoiced and payments made hereunder (the &#147;<U>Service
Records</U>&#148;). Recipient may request a certified audit of Provider&#146;s Service Records from the date of commencement of the Transition Services to be performed by an independent certified public accountant which (a)&nbsp;is reasonably
acceptable to Provider and (b)&nbsp;may not be compensated on a contingency basis or otherwise have any financial interest in the outcome of such audit. Any such audit shall be at the expense of Recipient. Recipient may not request such an audit
more than one (1)&nbsp;time within any twelve (12)&nbsp;month period with respect to any particular Transition Service. The accountant shall be required to execute a confidentiality and <FONT STYLE="white-space:nowrap">non-disclosure</FONT>
agreement if requested by Provider and shall hold all information confidential. The accountant may reveal to Recipient only the amounts of any underpayment or under reimbursement, or overbilling, as applicable. The accountant shall provide to
Provider a final report of its work, including both overbilling and underpayment information. The audit shall take place during normal business hours and upon reasonable notice and such accountant shall use commercially reasonable efforts to
minimize interference with the normal business activities of Provider. If any audit reveals an overpayment by Recipient, Provider shall promptly refund to Recipient any such overpayment. In addition, if any audit reveals an overpayment by Recipient
exceeding five percent (5%) during the audited period, Provider shall reimburse Recipient for the costs of conducting such audit. If any audit reveals an underpayment by Recipient, Recipient shall promptly pay Provider such underpayment amount. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(Signature Page Follows) </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">IN WITNESS WHEREOF, the Parties have executed this Agreement as of the Effective Date. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="99%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">OMNIAB, INC.</TD></TR></TABLE></DIV> <DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR></TABLE></DIV> <DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="87%"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR></TABLE></DIV> <DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="10%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="89%"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR></TABLE></DIV> <DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="99%"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">LIGAND PHARMACEUTICALS INCORPORATED</TD></TR></TABLE></DIV> <DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR></TABLE></DIV> <DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="87%"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR></TABLE></DIV> <DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="10%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="89%"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
</TABLE></DIV>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Exhibit E to the Merger Agreement </B></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">FORM OF AMENDED AND RESTATED REGISTRATION AND STOCKHOLDER RIGHTS </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">AGREEMENT </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">THIS AMENDED AND
RESTATED REGISTRATION AND STOCKHOLDER RIGHTS AGREEMENT (this &#147;<I>Agreement</I>&#148;), dated as of [__], 2022, is made and entered into by and among OmniAb, Inc., a Delaware corporation, formerly known as Avista Public Acquisition Corp. II, a
Cayman Islands exempted company (the &#147;<I>Company</I>&#148;), Avista Acquisition LP II, a Cayman Islands exempted limited partnership (the &#147;<I>Sponsor</I>&#148;), the undersigned parties listed under Existing Holder on the signature page
hereto (each such party, together with the Sponsor and any person or entity deemed an &#147;Existing Holder&#148; who hereafter becomes a party to this Agreement pursuant to <U>Section</U><U></U><U>&nbsp;6.2</U> of this Agreement, an
&#147;<I>Existing Holder</I>&#148; and, collectively, the &#147;<I>Existing Holders</I>&#148;), the undersigned directors and officers of Ligand (as defined below) and/or OmniAb, as applicable, who are listed as New Holders on the signature pages
hereto (each such party, together with any person or entity deemed a &#147;New Holder&#148; who hereafter becomes a party to this Agreement pursuant to <U>Section</U><U></U><U>&nbsp;6.2</U> of this Agreement<U>,</U> a &#147;<I>New Holder</I>&#148;
and collectively the &#147;<I>New Holders</I>&#148;) and solely with respect to <U>Section</U><U></U><U>&nbsp;2.2.1</U>, <U>Article 4</U> and <U>Section</U><U></U><U>&nbsp;6.14</U>, Ligand Pharmaceuticals Incorporated, a Delaware corporation
(&#147;<I>Ligand</I>&#148;). Capitalized terms used but not otherwise defined in this Agreement shall have the meaning ascribed to such terms in the Merger Agreement (as defined below). </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">RECITALS </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, on
August&nbsp;9, 2021, the Company, the Sponsor and certain other parties thereto entered into that certain Registration Rights and Shareholder Rights Agreement (the &#147;<I>Existing Agreement</I>&#148;), pursuant to which the Company granted the
Existing Holders certain registration rights with respect to certain securities of the Company; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, the Company has entered into
that certain Agreement and Plan of Merger (the &#147;<I>Merger Agreement</I>&#148;), dated as of March&nbsp;23, 2022, by and among the Company, Orwell Merger Sub, Inc., a Delaware corporation, Ligand, and
[&nbsp;<FONT STYLE="FONT-SIZE:70%">&#127761;</FONT>&nbsp;] (formerly known as OmniAb, Inc.), a Delaware corporation; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, in
connection with the closing of the Transactions and subject to the terms and conditions set forth in the Merger Agreement and the other Transaction Documents, the Existing Holders and New Holders were issued shares of common stock, par value $0.0001
per share, of the Company (the &#147;<I>Domesticated Parent Common Stock</I>&#148;), in each case, in such amounts and subject to such terms and conditions set forth in the Merger Agreement; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, in order to finance the Company&#146;s transaction costs in connection with an intended Business Combination (as defined below), the
Sponsor or certain of the Company&#146;s officers or directors may, but are not obligated to, loan the Company funds as the Company may require, of which up to $2,000,000 of such loans may be convertible into an additional 1,333,333 Private
Placement Warrants (as defined below) (the &#147;<I>Working Capital Warrants</I>&#148;); and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, pursuant to Section&nbsp;6.8 of the
Existing Agreement, any of the provisions, covenants and conditions set forth therein may be amended or modified upon the written consent of the Company and the Holders (as defined therein) of at least a <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">majority-in-interest</FONT></FONT> of the Registrable Securities (as defined therein) at the time in question; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, the Company, Sponsor and the other parties to the Existing Agreement desire to amend and restate the Existing Agreement in order to
provide the Existing Holders and the New Holders certain registration rights with respect to certain securities of the Company, as set forth in this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">NOW, THEREFORE, in consideration of the mutual representations, covenants and agreements contained herein, and certain other good and valuable
consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto, intending to be legally bound, hereby agree as follows: </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE 1 </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">DEFINITIONS </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">1.1 <U>Definitions</U>. The terms defined in this <I>Article I</I> shall, for all purposes of this Agreement, have the respective meanings set forth below:
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<I>Adverse Disclosure</I>&#148; shall mean any public disclosure of material <FONT STYLE="white-space:nowrap">non-public</FONT> information, which
disclosure, in the good faith judgment of the Board or the Chairman, Chief Executive Officer or Chief Financial Officer of the Company, after consultation with counsel to the Company, (i)&nbsp;would be required to be made in any Registration
Statement or Prospectus in order for the applicable Registration Statement or Prospectus not to contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements contained therein (in the case of any
prospectus and any preliminary prospectus, in the light of the circumstances under which they were made) not misleading, (ii)&nbsp;would not be required to be made at such time if the Registration Statement were not being filed, declared effective
or used, as the case may be, and (iii)&nbsp;the Company has a bona fide business purpose for not making such information public. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<I>Agreement</I>&#148; shall have the meaning given in the Preamble. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<I>Backstop Shares</I>&#148; shall have the meaning set forth in the A&amp;R Forward Purchase Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<I>Backstop Warrants</I>&#148; shall have the meaning set forth in the A&amp;R Forward Purchase Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<I>Board</I>&#148; shall mean the Board of Directors of the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<I>Commission</I>&#148; shall mean the U.S. Securities and Exchange Commission. </P>
<P STYLE="font-size:18pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<I>Company</I>&#148; shall have the meaning given in the Preamble. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<I>D&amp;O <FONT STYLE="white-space:nowrap">Lock-Up</FONT> Period</I>&#148; shall mean with respect to the shares of Domesticated Parent Common Stock
issued to the New Holders in connection with the consummation of the Merger and held by the New Holders or their Permitted Transferees, the period ending on the earliest of (A)&nbsp;three months after the date hereof and (B)&nbsp;the date on which
the Company completes a liquidation, merger, share exchange, reorganization or other similar transaction that results in all of the Company&#146;s stockholders having the right to exchange their shares of Domesticated Parent Common Stock for cash,
securities or other property. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<I>Domesticated Parent Common Stock</I>&#148; shall have the meaning given in the Recitals. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<I>Exchange Act</I>&#148; shall mean the Securities Exchange Act of 1934, as it may be amended from time to time. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<I>Existing Agreement</I>&#148; shall have the meaning given in the Recitals. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<I>Existing Holders</I>&#148; shall have the meaning given in the Preamble. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<I>Form <FONT STYLE="white-space:nowrap">S-1</FONT></I>&#148; shall mean Form <FONT STYLE="white-space:nowrap">S-1</FONT> or any similar long-form
registration statement that may be available at such time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<I>Form <FONT STYLE="white-space:nowrap">S-3</FONT></I>&#148; shall have the meaning
given in <U>subsection 2.2.1</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<I>Forward Purchase Shares</I>&#148; shall have the meaning set forth in the A&amp;R Forward Purchase Agreement.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<I>Forward Purchase Warrants</I>&#148; shall have the meaning set forth in the A&amp;R Forward Purchase Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<I>Founder Shares</I>&#148; shall mean all shares of Domesticated Parent Common Stock issued to the Existing Holders in respect of the shares of Parent
Class&nbsp;B Common Stock held by the Existing Holders pursuant to the Domestication. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<I>Founder Shares
<FONT STYLE="white-space:nowrap">Lock-Up</FONT> Period</I>&#148; shall mean, with respect to the Founder Shares, the period ending on the earliest of (A)&nbsp;one year after the date hereof and (B)&nbsp;the first date on which, (x)&nbsp;the last
reported sales price of a share of Domesticated Parent Common Stock equals or exceeds $12.00 per share (as adjusted for share splits, share capitalizations, reorganizations, recapitalizations and the like) for any twenty (20)&nbsp;trading days
within any thirty (30)-trading day period commencing at least one hundred fifty (150)&nbsp;days after the date hereof or (y)&nbsp;the Company completes a liquidation, merger, share exchange, reorganization or other similar transaction that results
in all of the Company&#146;s stockholders having the right to exchange their shares of Domesticated Parent Common Stock for cash, securities or other property. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<I>Holder Information</I>&#148; shall have the meaning given in <U>subsection 4.1.2</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<I>Holders</I>&#148; shall mean the Existing Holders, the New Holders, and, solely with respect to <U>Section</U><U></U><U>&nbsp;2.2.1</U> and
<U>Article 4</U>, the [L] Equity Award Holders and any person or entity who hereafter becomes a party to this Agreement pursuant to <U>Section</U><U></U><U>&nbsp;5.2</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<I>Insider Letter</I>&#148; shall mean any of those certain letter agreements, dated as of August&nbsp;9, 2021 (as amended by the Sponsor Insider
Agreement entered into on the Closing Date), by and between the Company, the Sponsor and each of the Company&#146;s officers, directors and director nominees. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<I>Ligand Equity Award Holders</I>&#148; shall mean any Company Service Provider (as defined in the Employee Matters Agreement, dated as of
March&nbsp;23, 2022) who hold Registrable Securities. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<I><FONT STYLE="white-space:nowrap">Lock-Up</FONT> Period</I>&#148; shall mean the Founder
Shares <FONT STYLE="white-space:nowrap">Lock-Up</FONT> Period, the D&amp;O <FONT STYLE="white-space:nowrap">Lock-Up</FONT> Period or the Private Warrant <FONT STYLE="white-space:nowrap">Lock-Up</FONT> Period, as applicable. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<I>Maximum Number of Securities</I>&#148; shall have the meaning given in <U>subsection 2.1.2</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<I>Merger Agreement</I>&#148; shall have the meaning given in the Recitals. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<I>Misstatement</I>&#148; shall mean an untrue statement of a material fact or an omission to state a material fact required to be stated in a
Registration Statement or Prospectus, or necessary to make the statements in a Registration Statement or Prospectus (in the case of a Prospectus, in the light of the circumstances under which they were made) not misleading. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<I>New Holders</I>&#148; shall have the meaning given in the Preamble. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<I>Permitted Transferees</I>&#148; shall mean any person or entity to whom a Holder is permitted to Transfer such securities prior to the expiration of
the applicable <FONT STYLE="white-space:nowrap">Lock-Up</FONT> Period as set forth in <U>subsection 3.6.2</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<I>Piggyback Registration</I>&#148;
shall have the meaning given in <U>subsection 2.1.1</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<I>Private Placement Warrants</I>&#148; shall mean the 8,233,333 Domesticated Parent
Warrants to be issued to holders of Parent Private Placement Warrants pursuant to the Domestication. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<I>Private Warrant <FONT
STYLE="white-space:nowrap">Lock-Up</FONT> Period</I>&#148; shall mean, with respect to Private Placement Warrants, Backstop Warrants and Forward Purchase Warrants that are held by the initial purchasers of such warrants or their Permitted
Transferees, and any of the shares of Domesticated Parent Common Stock issued or issuable upon the exercise or conversion of such warrants and that are held by the initial purchasers of the applicable warrants being converted or their Permitted
Transferees, the period ending thirty (30)&nbsp;days after the date hereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<I>Prospectus</I>&#148; shall mean the prospectus included in any
Registration Statement, as supplemented by any and all prospectus supplements and as amended by any and all post-effective amendments and including all material incorporated by reference in such prospectus. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<I>Registrable Security</I>&#148; shall mean (a)&nbsp;the Founder Shares (including any shares of Domesticated Parent Common Stock or other equivalent
equity security issued or issuable upon the conversion of any such Founder Shares or exercisable for shares of Domesticated Parent Common Stock), (b) the Backstop Shares, (c)&nbsp;the Forward Purchase Shares, (d)&nbsp;the Private Placement Warrants
(including any shares of Domesticated Parent Common Stock issued or issuable upon the exercise of any such Private Placement Warrants), (e) the Working Capital Warrants (including any </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
shares of Domesticated Parent Common Stock issued or issuable upon the exercise of any such Working Capital Warrants), (f) the Backstop Warrants (including any shares of Domesticated Parent
Common Stock issued or issuable upon the conversion of any such Backstop Warrants), (g) the Forward Purchase Warrants (including any shares of Domesticated Parent Common Stock issued or issuable upon the conversion of any such Forward Purchase
Warrants), (h) shares of Domesticated Parent Common Stock issued to a New Holder as consideration pursuant to the Merger, (i)&nbsp;shares of Domesticated Parent Common Stock issuable upon vesting, settlement, or exercise of restricted stock units,
performance stock units, options, warrants, or other rights held by a New Holder; (j)&nbsp;shares of Domesticated Parent Common Stock held by, or issuable upon vesting, settlement, or exercise of restricted stock units, performance stock units,
options, warrants, or other rights held by, a Ligand Equity Award Holder) and (k)&nbsp;any other equity security of the Company issued or issuable with respect to any such Domesticated Parent Common Stock by way of a share capitalization or share
split or in connection with a combination of shares, recapitalization, merger, consolidation or reorganization; <U>provided</U>, <U>however</U>, that, as to any particular Registrable Security, such securities shall cease to be Registrable
Securities when: (i)&nbsp;a Registration Statement with respect to the sale of such securities shall have become effective under the Securities Act and such securities shall have been sold, transferred, disposed of or exchanged in accordance with
such Registration Statement; (ii)&nbsp;such securities shall have been otherwise transferred, new certificates for such securities not bearing a legend restricting further transfer shall have been delivered by the Company and subsequent public
distribution of such securities shall not require registration under the Securities Act; (iii)&nbsp;such securities shall have ceased to be outstanding; (iv)&nbsp;such securities may be sold without registration pursuant to Rule 144 or any successor
rule promulgated under the Securities Act (but with no volume or other restrictions or limitations, including as to manner or timing of sale); or (v)&nbsp;such securities have been sold to, or through, a broker, dealer or underwriter in a public
distribution or other public securities transaction. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<I>Registration</I>&#148; shall mean a registration effected by preparing and filing a
registration statement or similar document in compliance with the requirements of the Securities Act, and the applicable rules and regulations promulgated thereunder, and such registration statement becoming effective. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<I>Registration Expenses</I>&#148; shall mean the <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> expenses
of a Registration, including, without limitation, the following: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(A) all registration and filing fees (including fees with respect to filings required to
be made with the Financial Industry Regulatory Authority, Inc.) and any securities exchange on which the shares of Domesticated Parent Common Stock are then listed; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(B) fees and expenses of compliance with securities or blue sky laws (including reasonable fees and disbursements of counsel for the Underwriters in
connection with blue sky qualifications of Registrable Securities); </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(C) printing, messenger, telephone and delivery expenses; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(D) reasonable fees and disbursements of counsel for the Company; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(E) reasonable fees and disbursements of all independent registered public accountants of the Company incurred specifically in connection with such
Registration; and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(F) in an Underwritten Offering or other offering involving an Underwriter, reasonable fees and expenses of one (1)&nbsp;legal counsel
selected by the <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">majority-in-interest</FONT></FONT> of the Takedown Requesting Holders initiating an Underwritten Shelf Takedown, not to exceed $50,000 without the consent of the
Company (not to be unreasonably withheld, conditioned or delayed). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<I>Registration Statement</I>&#148; shall mean any registration statement that
covers the Registrable Securities pursuant to the provisions of this Agreement, including the Prospectus included in such registration statement, amendments (including post-effective amendments) and supplements to such registration statement, and
all exhibits to and all material incorporated by reference in such registration statement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<I>Restricted Shares</I>&#148; shall have the meaning
given in <U>subsection 3.6.1</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<I>Rule 415</I>&#148; shall have the meaning given in <U>subsection 2.2.1</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<I>Securities Act</I>&#148; shall mean the Securities Act of 1933, as amended from time to time. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<I>Shelf</I>&#148; shall mean a registration statement filed pursuant to <U>subsection 2.2.1</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<I>Sponsor</I>&#148; shall have the meaning given in the Recitals hereto. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<I>Sponsor Director</I>&#148; means an individual elected to the Board that has been nominated by the Sponsor pursuant to this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<I>Subsequent Shelf Registration</I>&#148; shall have the meaning given in <U>subsection 2.2.2</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<I>Takedown Requesting Holder</I>&#148; shall have the meaning given in <U>subsection 2.2.3</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<I>Transfer</I>&#148; shall mean a registration statement filed pursuant to <U>subsection 3.6.1</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<I>Underwriter</I>&#148; shall mean a securities dealer who purchases any Registrable Securities as principal in an Underwritten Offering and not as
part of such dealer&#146;s market-making activities. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<I>Underwritten Registration</I>&#148; or &#147;<I>Underwritten Offering</I>&#148; shall mean
a Registration in which securities of the Company are sold to an Underwriter in a firm commitment underwriting for distribution to the public. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<I>Underwritten Shelf Takedown</I>&#148; shall have the meaning given in <U>subsection 2.2.3</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<I>Working Capital Warrants</I>&#148; shall have the meaning given in the Recitals hereto. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE 2 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">REGISTRATIONS </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">2.1 <U>Piggyback Registration</U>.
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.1.1 <U>Piggyback Rights</U>. If, at any time on or after the date hereof, the Company proposes to file a Registration Statement under
the Securities Act with respect to an offering of equity securities, or securities or other obligations exercisable or exchangeable for, or convertible into equity securities, for its own account or for the account of stockholders of the Company (or
by the Company and by the stockholders of the Company), other than a Registration Statement (i)&nbsp;filed in connection with any employee share option or other benefit plan, (ii)&nbsp;for an exchange offer or offering of securities solely to the
Company&#146;s existing stockholders, (iii)&nbsp;pursuant to a Registration Statement on Form <FONT STYLE="white-space:nowrap">S-4</FONT> (or similar form that relates to a transaction subject to Rule 145 under the Securities Act or any successor
rule thereto), (iv) for an offering of debt that is convertible into equity securities of the Company or (v)&nbsp;for a dividend reinvestment plan, then the Company shall give written notice of such proposed filing to all of the Holders of
Registrable Securities as soon as practicable but not less than seven (7)&nbsp;days before the anticipated filing date of such Registration Statement, which notice shall (A)&nbsp;describe the amount and type of securities to be included in such
offering, the intended method(s) of distribution, and the name of the proposed managing Underwriter or Underwriters, if any, in such offering, and (B)&nbsp;offer to all of the Holders of Registrable Securities the opportunity to register the sale of
such number of Registrable Securities as such Holders may request in writing within three (3)&nbsp;business days after receipt of such written notice (such Registration a &#147;<I>Piggyback Registration</I>&#148;). The Company shall, in good faith,
cause such Registrable Securities to be included in such Piggyback Registration and shall use its commercially reasonable efforts to cause the managing Underwriter or Underwriters of a proposed Underwritten Offering to permit the Registrable
Securities requested by the Holders pursuant to this <U>subsection 2.1.1</U> to be included in a Piggyback Registration on the same terms and conditions as any similar securities of the Company included in such Registration and to permit the sale or
other disposition of such Registrable Securities in accordance with the intended method(s) of distribution thereof. All such Holders proposing to distribute their Registrable Securities through an Underwritten Offering under this <U>subsection
2.1.1</U> shall enter into an underwriting agreement in customary form with the Underwriter(s) selected for such Underwritten Offering by the Company. The notice periods set forth in this <U>subsection 2.1.1</U> shall not apply to an Underwritten
Shelf Takedown conducted in accordance with <U>subsection 2.2.3. </U> </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.1.2 <U>Reduction of Piggyback Registration</U>. If the managing
Underwriter or Underwriters in an Underwritten Registration that is to be a Piggyback Registration (other than Underwritten Shelf Takedown), in good faith, advises the Company and the Holders of Registrable Securities participating in the Piggyback
Registration in writing that the dollar amount or number of the shares of Domesticated Parent Common Stock that the Company desires to sell, taken together with (i)&nbsp;the shares of Domesticated Parent Common Stock, if any, as to which
Registration has been demanded pursuant to separate written contractual arrangements with persons or entities other than the Holders of Registrable Securities hereunder, (ii)&nbsp;the Registrable Securities as to which registration has been
requested pursuant <U>Section</U><U></U><U>&nbsp;2.1</U> hereof, and (iii)&nbsp;the shares of Domesticated Parent Common Stock, if any, as to which Registration has been requested pursuant to separate written contractual piggy-back registration
rights of other stockholders of the Company, exceeds the maximum dollar amount or maximum number of equity securities that can be sold in the Underwritten Offering without adversely affecting the proposed offering price, the timing, the distribution
method, or the probability of success of such offering (such maximum dollar amount or maximum number of such securities, as applicable, the &#147;<I>Maximum Number of Securities</I>&#148;), then: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) If the Registration is undertaken for the Company&#146;s account, the Company shall include in any such Registration
(A)&nbsp;first, the shares of Domesticated Parent Common Stock or other equity securities that the Company desires to sell, which can be sold without exceeding the Maximum Number of Securities; and (B)&nbsp;second, to the extent that the Maximum
Number of Securities has not been reached under the foregoing clause (A), the Registrable Securities of Holders exercising their rights to register their Registrable Securities pursuant to <U>subsection 2.1.1</U> hereof, pro rata based on the
respective number of Registrable Securities that each Holder has requested be included in such Underwritten Registration and the aggregate number of Registrable Securities that the Holders have requested be included in such Underwritten Registration
(such proportion is referred to herein as &#147;<I>Pro Rata</I>&#148;) exercising its rights to register its Registrable Securities pursuant to<U> subsection 2.1.1</U> hereof, which can be sold without exceeding the
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
Maximum Number of Securities; and (C)&nbsp;third, to the extent that the Maximum Number of Securities has not been reached under the foregoing clauses (A)&nbsp;and (B), the shares of Domesticated
Parent Common Stock, if any, as to which Registration has been requested pursuant to written contractual piggy-back registration rights of other stockholders of the Company, which can be sold without exceeding the Maximum Number of Securities; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) If the Registration is pursuant to a request by persons or entities other than the Holders of Registrable Securities, then
the Company shall include in any such Registration (A)&nbsp;first, the shares of Domesticated Parent Common Stock or other equity securities, if any, of such requesting persons or entities, other than the Holders of Registrable Securities, which can
be sold without exceeding the Maximum Number of Securities; (B)&nbsp;second, to the extent that the Maximum Number of Securities has not been reached under the foregoing clause (A), the Registrable Securities of Holders exercising their rights to
register their Registrable Securities pursuant to <U>subsection 2.1.1</U>, Pro Rata, which can be sold without exceeding the Maximum Number of Securities; (C)&nbsp;third, to the extent that the Maximum Number of Securities has not been reached under
the foregoing clauses (A)&nbsp;and (B), the shares of Domesticated Parent Common Stock or other equity securities that the Company desires to sell, which can be sold without exceeding the Maximum Number of Securities; and (D)&nbsp;fourth, to the
extent that the Maximum Number of Securities has not been reached under the foregoing clauses (A), (B) and (C), the shares of Domesticated Parent Common Stock or other equity securities for the account of other persons or entities that the Company
is obligated to register pursuant to separate written contractual arrangements with such persons or entities, which can be sold without exceeding the Maximum Number of Securities. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.1.3 <U>Piggyback Registration Withdrawal</U>. Any Holder of Registrable Securities shall have the right to withdraw from a Piggyback
Registration for any or no reason whatsoever upon written notification to the Company and the Underwriter or Underwriters (if any) of his, her or its intention to withdraw from such Piggyback Registration prior to the effectiveness of the
Registration Statement filed with the Commission with respect to such Piggyback Registration. The Company (whether on its own good faith determination or as the result of a request for withdrawal by persons pursuant to separate written contractual
obligations) may withdraw a Registration Statement filed with the Commission in connection with a Piggyback Registration at any time prior to the effectiveness of such Registration Statement. Notwithstanding anything to the contrary in this
Agreement, the Company shall be responsible for the Registration Expenses incurred in connection with the Piggyback Registration prior to its withdrawal under this <U>subsection 2.1.3</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">2.2 <U>Shelf Registrations</U>. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.2.1 <U>Initial
Registration</U>. The Company shall use commercially reasonable efforts to, within thirty (30)&nbsp;days after the date hereof, file a Registration Statement under the Securities Act to permit the public resale of all the Registrable Securities held
by the Holders from time to time as permitted by Rule 415 under the Securities Act (or any successor or similar provision adopted by the Commission then in effect) (&#147;<I>Rule 415</I>&#148;) on the terms and conditions specified in this
<U>Section</U><U></U><U>&nbsp;2.2.1</U> and shall use its commercially reasonable efforts to cause such Registration Statement to be declared effective as soon as practicable after the filing thereof. The Registration Statement filed with the
Commission pursuant to this <U>Section</U><U></U><U>&nbsp;2.2.1</U> shall be a shelf registration statement on Form <FONT STYLE="white-space:nowrap">S-1</FONT> or such other form of registration statement as is then available to effect a
registration for resale of such Registrable Securities, covering such Registrable Securities, and shall contain a Prospectus in such form as to permit any Holder to sell such Registrable Securities pursuant to Rule 415 at any time beginning on the
effective date for such Registration Statement. A Registration Statement filed pursuant to this <U>Section</U><U></U><U>&nbsp;2.2.1</U> shall provide for the resale pursuant to any method or combination of methods legally available to, and requested
by, the Holders. The Company shall use its commercially reasonable efforts to cause a Registration Statement filed pursuant to this <U>Section</U><U></U><U>&nbsp;2.2.1</U> to remain effective, and to be supplemented and amended to the extent
necessary to ensure that such Registration Statement is available or, if not available, that another Registration Statement is available, for the resale of all the Registrable Securities held by the Holders until all such Registrable Securities have
ceased to be Registrable Securities. As soon as practicable following the effective date of a Registration Statement filed pursuant to this <U>Section</U><U></U><U>&nbsp;2.2.1</U>, the Company shall notify the Holders of the effectiveness of such
Registration Statement. When effective, a Registration Statement filed pursuant to this <U>Section</U><U></U><U>&nbsp;2.3.1</U> (including the documents incorporated therein by reference) will comply as to form in all material respects with all
applicable requirements of the Securities Act and will not contain an untrue statement of a material fact or omit to state a material fact required to be stated therein or </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
necessary to make the statements therein not misleading (in the case of any prospectus contained in such Registration Statement, in the light of the circumstances under which such statement is
made). In the event the Company files a Shelf on Form <FONT STYLE="white-space:nowrap">S-1,</FONT> the Company shall use its commercially reasonable efforts to convert the Form <FONT STYLE="white-space:nowrap">S-1</FONT> to a shelf registration
statement on Form <FONT STYLE="white-space:nowrap">S-3</FONT> (&#147;<I>Form <FONT STYLE="white-space:nowrap">S-3</FONT></I>&#148;) as soon as practicable after the Company is eligible to use Form <FONT STYLE="white-space:nowrap">S-3.</FONT> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.2.2 <U>Subsequent Shelf Registration</U>. If any Shelf ceases to be effective under the Securities Act for any reason at any time while
Registrable Securities included thereon are still outstanding or if the Prospectus included in such Registration Statement, as then in effect, includes a Misstatement<U></U>&nbsp;for any reason at any time while Registrable Securities are still
outstanding, the Company shall, subject to<U>&nbsp;Section</U><U></U><U>&nbsp;3.4</U>,&nbsp;use its commercially reasonable efforts to as promptly as is reasonably practicable cause such Shelf to again become effective under the Securities Act
(including using its commercially reasonable efforts to obtain the prompt withdrawal of any order suspending the effectiveness of such Shelf) and correct any such Misstatement, and shall use its commercially reasonable efforts to as promptly as is
reasonably practicable amend such Shelf in a manner reasonably expected to result in the withdrawal of any order suspending the effectiveness of such Shelf or file an additional registration statement (a &#147;<I>Subsequent Shelf
Registration</I>&#148;) registering the resale of all Registrable Securities including on such Shelf (determined as of two (2)&nbsp;business days prior to such filing), and pursuant to any method or combination of methods legally available to, and
requested by, any Holder. If a Subsequent Shelf Registration is filed, the Company shall use its commercially reasonable efforts to (i)&nbsp;cause such Subsequent Shelf Registration to become effective under the Securities Act as promptly as is
reasonably practicable after the filing thereof and (ii)&nbsp;keep such Subsequent Shelf Registration continuously effective and available for use to permit the Holders named therein to sell their Registrable Securities included therein, and in
compliance with the provisions of the Securities Act&nbsp;until such time as there are no longer any Registrable Securities included thereon. Any such Subsequent Shelf Registration shall be on Form <FONT STYLE="white-space:nowrap">S-3</FONT> to the
extent that the Company is eligible to use such form. Otherwise, such Subsequent Shelf Registration shall be on another appropriate form. In the event that any Holder holds Registrable Securities that are not registered for resale on a delayed or
continuous basis, the Company, upon written request of a Holder shall promptly use its commercially reasonable efforts to cause the resale of such Registrable Securities to be covered by either, at the Company&#146;s option, a Shelf (including by
means of a post-effective amendment) or a Subsequent Shelf Registration and cause the same to become effective as soon as practicable after such filing and such Shelf or Subsequent Shelf Registration shall be subject to the terms hereof;
<U>provided</U>,<U> however</U>, the Company shall only be required to cause such Registrable Securities to be so covered once annually after inquiry of the Holder. The Company&#146;s obligation under
this<U>&nbsp;Section</U><U></U><U>&nbsp;2.2.2</U>, shall, for the avoidance of doubt, be subject to<U>&nbsp;Section</U><U></U><U>&nbsp;3.4</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.2.3 <U>Requests for Underwritten Shelf Takedowns</U>. Subject to <U>Section</U><U></U><U>&nbsp;3.4</U>, following the expiration of the
applicable <FONT STYLE="white-space:nowrap">Lock-Up</FONT> Period, the Sponsor may request to sell all or any portion of its Registrable Securities in an underwritten offering that is registered pursuant to the Shelf (each, an &#147;<I>Underwritten
Shelf Takedown</I>&#148;); <U>provided</U> that the Company shall only be obligated to effect an Underwritten Shelf Takedown if such offering shall include securities with a total offering price (including piggy-back securities and before deduction
of underwriting discounts) reasonably expected to exceed, in the aggregate, $15,000,000. All requests for Underwritten Shelf Takedowns shall be made by giving written notice to the Company at least 48 hours prior to the public announcement of such
Underwritten Shelf Takedown, which shall specify the approximate number of Registrable Securities proposed to be sold in the Underwritten Shelf Takedown and the expected price range (net of underwriting discounts and commissions) of such
Underwritten Shelf Takedown. The Company shall include in any Underwritten Shelf Takedown the securities requested to be included by any Holder (each a &#147;<I>Takedown Requesting Holder</I>&#148;) at least 48 hours prior to the public announcement
of such Underwritten Shelf Takedown pursuant to written contractual piggy-back registration rights of such holder (including to those set forth herein). The Sponsor shall have the right to select the underwriter(s) for such offering (which shall
consist of one or more reputable nationally recognized investment banks), subject to the Company&#146;s prior approval which shall not be unreasonably withheld, conditioned or delayed. The Sponsor may demand not more than one (1)&nbsp;Underwritten
Shelf Takedowns pursuant to this<U>&nbsp;Section</U><U></U><U>&nbsp;2.2.3</U>&nbsp;in any six (6)-month period. Notwithstanding anything to the contrary in this Agreement, the Company may effect any Underwritten Offering pursuant to any then
effective Registration Statement, including a <FONT STYLE="white-space:nowrap">Form&nbsp;S-3,&nbsp;that</FONT> is then available for such offering, subject to the provisions of <U>Section</U><U></U><U>&nbsp;2.1</U>. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.2.4 <U>Reduction of Underwritten Offering</U>. If the managing Underwriter or Underwriters
in an Underwritten Shelf Takedown, in good faith, advises the Company, the Sponsor and the Takedown Requesting Holders (if any) in writing that the dollar amount or number of Registrable Securities that the Sponsor and the Takedown Requesting
Holders (if any) desire to sell, taken together with all other shares of Domesticated Parent Common Stock or other equity securities that the Company desires to sell, exceeds the Maximum Number of Securities, then the Company shall include in such
Underwritten Shelf Takedown, as follows: (i)&nbsp;first, the Registrable Securities of the Sponsor that can be sold without exceeding the Maximum Number of Securities; (ii)&nbsp;second, to the extent that the Maximum Number of Securities has not
been reached under the foregoing clause (i), the shares of Domesticated Parent Common Stock or other equity securities that the Company desires to sell, which can be sold without exceeding the Maximum Number of Securities; and (iii)&nbsp;third, to
the extent that the Maximum Number of Securities has not been reached under the foregoing clauses (i)&nbsp;and (ii), the shares of Domesticated Parent Common Stock or other equity securities of the Takedown Requesting Holders, if any, that can be
sold without exceeding the Maximum Number of Securities, determined Pro Rata based on the respective number of Registrable Securities that each Takedown Requesting Holder has so requested to be included in such Underwritten Shelf Takedown. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.2.5 <U>Withdrawal</U>. The Sponsor shall have the right to withdraw from an Underwritten Shelf Takedown for any or no reason whatsoever upon
written notification to the Company and the Underwriter or Underwriters (if any) of its intention to withdraw from such Underwritten Shelf Takedown prior to the public announcement of such Underwritten Shelf Takedown. If so withdrawn, a demand for
an Underwritten Shelf Takedown shall constitute a demand for an Underwritten Shelf Takedown by the Sponsor for purposes of <U>subsection 2.2.3</U>, unless either (i)&nbsp;the Sponsor has not previously withdrawn any Underwritten Shelf Takedown or
(ii)&nbsp;the Sponsor reimburses the Company for all Registration Expenses with respect to such Underwritten Shelf Takedown (or, if there is more than one Takedown Requesting Holders, a pro rata portion of such Registration Expenses based on the
respective number of Registrable Securities that each Takedown Requesting Holder has requested be included in such Underwritten Shelf Takedown). Notwithstanding anything to the contrary in this Agreement, the Company shall be responsible for the
Registration Expenses incurred in connection with an Underwritten Shelf Takedown prior to and including a withdrawal under this <U>subsection 2.2.5</U>, unless the Sponsor elect to pay such Registration Expenses pursuant to clause (ii)&nbsp;of this
<U>subsection 2.2.5</U>. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">2.3 <U>Market <FONT STYLE="white-space:nowrap">Stand-off</FONT></U>.&nbsp;In connection with any Underwritten Offering of equity
securities of the Company, if requested by the managing Underwriters, each Holder that is an executive officer, director or Holder in excess of five percent (5%) of the outstanding Common Stock agrees that it shall not Transfer any equity securities
of the Company (other than those included in such offering pursuant to this Agreement), without the prior written consent of the Company, during the ninety <FONT STYLE="white-space:nowrap">(90)-day</FONT> period (or such shorter time agreed to by
the managing Underwriters) beginning on the date of pricing of such offering, except as expressly permitted by such <FONT STYLE="white-space:nowrap">lock-up</FONT> agreement or in the event the managing Underwriters otherwise agree by written
consent. Each such Holder that participates and sells Registrable Securities in such Underwritten Offering agrees to execute a customary <FONT STYLE="white-space:nowrap">lock-up</FONT> agreement in favor of the Underwriters to such effect (in each
case on substantially the same terms and conditions as all such Holders that execute a <FONT STYLE="white-space:nowrap">lock-up</FONT> agreement). </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE 3 </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">COMPANY
PROCEDURES </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">3.1 <U>General Procedures</U>. If at any time the Company is required to effect the Registration of Registrable Securities, the Company shall
use its commercially reasonable efforts to effect such Registration to permit the sale of such Registrable Securities in accordance with the intended plan of distribution thereof, and pursuant thereto the Company shall, in a timely manner: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.1.1 prepare and file with the Commission as soon as reasonably practicable a Registration Statement with respect to such Registrable
Securities and use its commercially reasonable efforts to cause such Registration Statement to become effective and remain effective until all Registrable Securities covered by such Registration Statement have ceased to be Registrable Securities;
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.1.2 prepare and file with the Commission such amendments and post-effective amendments to the Registration Statement, and such
supplements to the Prospectus, as may be reasonably requested by the Holders or any Underwriter of Registrable Securities or as may be required by the rules, regulations or instructions applicable to the registration form used by the Company or by
the Securities Act or rules and regulations thereunder to keep the Registration Statement effective until the earlier of (a)&nbsp;all Registrable Securities covered by such Registration Statement are sold in accordance with the intended plan of
distribution set forth in such Registration Statement or supplement to the Prospectus or (b)&nbsp;the termination of this Agreement; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.1.3 prior to filing a Registration Statement or Prospectus, or any amendment or supplement
thereto, furnish without charge to the Underwriters, if any, and the Holders of Registrable Securities included in such Registration, and such Holders&#146; legal counsel, copies of such Registration Statement as proposed to be filed, each amendment
and supplement to such Registration Statement (in each case including all exhibits thereto and documents incorporated by reference therein), the Prospectus included in such Registration Statement (including each preliminary Prospectus), and such
other documents as the Underwriters and the Holders of Registrable Securities included in such Registration or the legal counsel for any such Holders may reasonably request in order to facilitate the disposition of the Registrable Securities owned
by such Holders; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.1.4 prior to any public offering of Registrable Securities, use its commercially reasonable efforts to
(i)&nbsp;register or qualify the Registrable Securities covered by the Registration Statement under such securities or &#147;blue sky&#148; laws of such jurisdictions in the United States as the Holders of Registrable Securities included in such
Registration Statement (in light of their intended plan of distribution) may request and (ii)&nbsp;take such action necessary to cause such Registrable Securities covered by the Registration Statement to be registered with or approved by such other
governmental authorities as may be necessary by virtue of the business and operations of the Company and do any and all other acts and things that may be necessary or advisable to enable the Holders of Registrable Securities included in such
Registration Statement to consummate the disposition of such Registrable Securities in such jurisdictions; <U>provided</U>, <U>however</U>, that the Company shall not be required to qualify generally to do business in any jurisdiction where it would
not otherwise be required to qualify or take any action to which it would be subject to general service of process or taxation in any such jurisdiction where it is not then otherwise so subject; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.1.5 use commercially reasonable efforts to cause all such Registrable Securities to be listed on each national securities exchange on which
similar securities issued by the Company are then listed; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.1.6 provide a transfer agent or warrant agent, as applicable, and registrar
for all such Registrable Securities no later than the effective date of such Registration Statement; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.1.7 advise each seller of such
Registrable Securities, promptly after it shall receive notice or obtain knowledge thereof, of the issuance of any stop order by the Commission suspending the effectiveness of such Registration Statement or the initiation or threatening of any
proceeding for such purpose and promptly use its commercially reasonable efforts to prevent the issuance of any stop order or to obtain its withdrawal if such stop order should be issued; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.1.8 at least five (5)&nbsp;days prior to the filing of any Registration Statement or Prospectus or any amendment or supplement to such
Registration Statement or Prospectus other than by way of a document incorporated by reference (or such shorter period of time as may be (a)&nbsp;necessary in order to comply with the Securities Act, the Exchange Act, and the rules and regulations
promulgated under the Securities Act or Exchange Act, as applicable or (b)&nbsp;advisable in order to reduce the number of days that sales are suspended pursuant to<U>&nbsp;Section</U><U></U><U>&nbsp;3.4</U>) furnish a copy thereof to each seller of
such Registrable Securities or its counsel, excluding any exhibits thereto and any filing made under the Exchange Act that is to be incorporated by reference therein; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.1.9 notify the Holders at any time when a Prospectus relating to such Registration Statement is required to be delivered under the Securities
Act, of the happening of any event as a result of which the Prospectus included in such Registration Statement, as then in effect, includes a Misstatement, and then to correct such Misstatement as set forth in <U>Section</U><U></U><U>&nbsp;3.4</U>
hereof; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.1.10 in the event of an Underwritten Offering or a sale by a placement agent or sales agent pursuant to such Registration,
permit a representative of the Holders, the Underwriters, if any, and any attorney or accountant retained by such Holders, Underwriter, placement agent or sales agent to participate, at each such person&#146;s own expense, in the preparation of the
Registration Statement, and cause the Company&#146;s officers, directors and employees to supply all information reasonably requested by any such representative, Underwriter, placement agent, sales agent attorney or accountant in connection with the
Registration; <U>provided</U>, <U>however</U>, that such representatives, Underwriters, placement agents, sales agents, attorneys or accountant enter into a confidentiality agreement, in form </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
and substance reasonably satisfactory to the Company, prior to the release or disclosure of any such information; and<U>&nbsp;provided</U><U>&nbsp;further</U>, that the Company will not include
the name of any Holder or any information regarding any Holder not participating in such sale pursuant to such Registration unless required by the Commission or any applicable law, rules or regulations; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.1.11 obtain a &#147;cold comfort&#148; letter from the Company&#146;s independent registered public accountants in the event of an
Underwritten Registration, in customary form and covering such matters of the type customarily covered by &#147;cold comfort&#148; letters as the managing Underwriter may reasonably request, and reasonably satisfactory to a <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">majority-in-interest</FONT></FONT> of the participating Holders; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.1.12 in the
event of an Underwritten Offering or a sale by a placement agent or sales agent pursuant to such Registration, on the date the Registrable Securities are delivered for sale pursuant to such Registration, obtain an opinion, dated such date, of
counsel representing the Company for the purposes of such Registration, addressed to the Holders, the placement agent or sales agent, if any, and the Underwriters, if any, covering such legal matters with respect to the Registration in respect of
which such opinion is being given as the Holders, placement agent, sales agent, or Underwriter may reasonably request and as are customarily included in such opinions and negative assurance letters, and reasonably satisfactory to a majority in
interest of the participating Holders; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.1.13 in the event of any Underwritten Offering, enter into and perform its obligations under an
underwriting agreement, in usual and customary form, with the managing Underwriter of such offering; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.1.14 otherwise use its commercially
reasonable efforts to&nbsp;make available to its security holders, as soon as reasonably practicable, an earnings statement covering the period of at least twelve (12)&nbsp;months beginning with the first day of the Company&#146;s first full
calendar quarter after the effective date of the Registration Statement which satisfies the provisions of Section&nbsp;11(a) of the Securities Act and Rule 158 thereunder (or any successor rule promulgated thereafter by the Commission), and which
requirement will be deemed satisfied if the Company timely files complete and accurate information on
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Forms&nbsp;10-Q,&nbsp;10-K&nbsp;and&nbsp;8-K&nbsp;under</FONT></FONT></FONT> the Exchange Act and otherwise complies with Rule 158 under the
Securities Act (or any successor rule promulgated thereafter by the Commission); </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.1.15 with respect to an Underwritten Offering pursuant
to<U>&nbsp;Section</U><U></U><U>&nbsp;2.2.3</U>,&nbsp;if the Registration involves the Registration of Registrable Securities involving gross proceeds in excess of $50,000,000, use its commercially reasonable efforts to make available senior
executives of the Company to participate in customary &#147;road show&#148; presentations that may be reasonably requested by the Underwriter in such Underwritten Offering; and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.1.16 otherwise, in good faith, cooperate reasonably with, and take such customary actions as may reasonably be requested by the participating
Holders, consistent with the terms of this Agreement,&nbsp;in connection with such Registration. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Notwithstanding the foregoing, the Company shall not be
required to provide any documents or information to an Underwriter or other sales agent or placement agent if such Underwriter or other sales agent or placement agent has not then been named with respect to the applicable Underwritten Offering or
other offering involving a Registration and an Underwriter. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">3.2 <U>Registration Expenses</U>. The Registration Expenses of all Registrations shall be
borne by the Company. It is acknowledged by the Holders that the Holders shall bear all incremental selling expenses relating to the sale of Registrable Securities, such as Underwriters&#146; commissions and discounts, brokerage fees, Underwriter
marketing costs and, other than as set forth in the definition of &#147;Registration Expenses,&#148; all reasonable fees and expenses of any legal counsel representing the Holders. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">3.3 <U>Requirements for Participation in Underwritten Offerings</U>. Notwithstanding anything in this Agreement to the contrary, if any Holder does not provide
the Company with its requested Holder Information, the Company may exclude such Holder&#146;s Registrable Securities from the applicable Registration Statement or Prospectus if the Company determines, based on the advice of counsel, that such
information is necessary to effect the Registration. No person may participate in any Underwritten Offering or other offering involving a Registration and an Underwriter for equity securities of the Company pursuant to a Registration initiated by
the Company hereunder </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
unless such person (i)&nbsp;agrees to sell such person&#146;s securities on the basis provided in any arrangements approved by the Company and (ii)&nbsp;completes and executes all customary
questionnaires, powers of attorney, indemnities, <FONT STYLE="white-space:nowrap">lock-up</FONT> agreements, underwriting agreements and other customary documents as may be reasonably required under the terms of such arrangements. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">3.4 <U>Suspension of Sales; Adverse Disclosure; </U><U></U><U>Restrictions on Registration Rights</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.4.1 Upon receipt of written notice from the Company that a Registration Statement or Prospectus contains a Misstatement, or in the opinion of
counsel for the Company it is necessary to supplement or amend such Prospectus to comply with law, each of the Holders shall forthwith discontinue disposition of Registrable Securities until it has received copies of a supplemented or amended
Prospectus correcting the Misstatement (it being understood that the Company hereby covenants to prepare and file such supplement or amendment as soon as practicable after the time of such notice), or until it is advised in writing by the Company
that the use of the Prospectus may be resumed. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.4.2 If the filing, initial effectiveness or continued use of a Registration Statement in
respect of any Registration at any time would (i)&nbsp;require the Company to make an Adverse Disclosure, (ii)&nbsp;would require the inclusion in such Registration Statement of financial statements that are unavailable to the Company for reasons
beyond the Company&#146;s control, (iii)&nbsp;in the good faith judgment of the majority of the Board, be seriously detrimental to the Company and the majority of the Board concludes as a result that it is essential to defer such filing, the Company
may, upon giving prompt written notice of such action to the Holders, delay the filing or initial effectiveness of, or suspend use of, such Registration Statement for the shortest period of time, but in no event more than thirty (30)&nbsp;days,
determined in good faith by the Company to be necessary for such purpose. In the event the Company exercises its rights under the preceding sentence, the Holders agree to suspend, immediately upon their receipt of the notice referred to above, their
use of the Prospectus relating to any Registration in connection with any sale or offer to sell Registrable Securities, and in each case maintain the confidentiality of such notice and its contents. The Company shall immediately notify the Holders
of the expiration of any period during which it exercised its rights under this <U>subsection 3.4.2</U>. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.4.3 Subject to <U>subsection
3.4.4</U>, if (i)&nbsp;during the period starting with the date sixty (60)&nbsp;days prior to the Company&#146;s good faith estimate of the date of the filing of, and ending on a date one hundred twenty (120)&nbsp;days (or such shorter time as the
managing Underwriters may agree) after the effective date of, a Company-initiated Registration and provided that the Company continues to actively employ, in good faith, all reasonable efforts to cause the applicable Registration Statement to become
effective or maintain the effectiveness of the applicable Registration Statement, or (ii)&nbsp;pursuant to <U>subsection 2.2.3</U>, Holders have requested an Underwritten Shelf Takedown and the Company and Holders are unable to obtain the commitment
of underwriters to firmly underwrite such offering, then, in each case, the Company may, upon giving prompt written notice of such action to the Holders, delay any other registered offering pursuant to <U>subsection 2.2.3</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.4.4 The right to delay or suspend any filing, initial effectiveness or continued use of a Registration Statement pursuant to <U>subsection
3.4.2</U> or a registered offering pursuant to <U>subsection 3.4.3</U> shall be exercised by the Company, in either case, for not more than sixty (60)&nbsp;consecutive calendar days or more than one hundred twenty (120)&nbsp;total calendar days
during any twelve (12)-month period. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.4.5 Notwithstanding anything to the contrary set forth herein, the Company shall not be required
provide any Holder with any material, nonpublic information regarding the Company other than to the extent that providing notice to such Holder hereunder constitutes material, nonpublic information regarding the Company. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">3.5 <U>Reporting Obligations</U>. As long as any Holder shall own Registrable Securities, the Company, at all times while it shall be a reporting company under
the Exchange Act, covenants to use commercially reasonable efforts to file timely (or obtain extensions in respect thereof and file within the applicable grace period) all reports required to be filed by the Company after the date hereof pursuant to
Sections 13(a) or 15(d) of the Exchange Act and to promptly furnish the Holders with true and complete copies of all such filings; <U>provided</U>&nbsp;that any documents publicly filed or furnished with the Commission pursuant to the Electronic
Data Gathering, Analysis and Retrieval System shall be deemed to have been furnished or delivered to the Holders pursuant to this<U>&nbsp;Section</U><U></U><U>&nbsp;3.5</U>. The Company further covenants that it shall take such further action as any
Holder may reasonably request, all to the extent required from </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
time to time to enable such Holder to sell shares of Domesticated Parent Common Stock held by such Holder without registration under the Securities Act within the limitation of the exemptions
provided by Rule 144 promulgated under the Securities Act (or any successor rule then in effect), including providing any customary&nbsp;legal opinions. Upon the request of any Holder, the Company shall deliver to such Holder a written certification
of a duly authorized officer as to whether it has complied with such requirements. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">3.6 <U>Transfer Restrictions</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.6.1 Except with respect to a Transfer to a Permitted Transferee, during the applicable <FONT STYLE="white-space:nowrap">Lock-Up</FONT>
Periods, no Existing Holder or New Holder shall, directly or indirectly, (a)&nbsp;offer, sell, contract to sell, pledge, hypothecate, grant any option to purchase, make any short sale or otherwise dispose of or distribute, establish or increase a
put equivalent position or liquidation with respect to or decrease of a call equivalent position within the meaning of Section&nbsp;16 of the Exchange Act with respect to, any security, (b)&nbsp;enter into any swap or other arrangement that
transfers to another, in whole or in part, any of the economic consequences of ownership of any security, whether any such transaction is to be settled by delivery of such securities, in cash or otherwise, or (c)&nbsp;publicly announce any intention
to effect any transaction specified in clause (a)&nbsp;or (b) (each, a &#147;<I>Transfer</I>&#148;) any (i)&nbsp;shares of Domesticated Parent Common Stock or any other shares of the Company&#146;s capital stock, (ii)&nbsp;options or warrants to
purchase any shares of Domesticated Parent Common Stock or any other shares of the Company&#146;s capital stock or (iii)&nbsp;securities convertible into, exercisable for, exchangeable for or that represent the right to receive shares of
Domesticated Parent Common Stock or any other shares of the Company&#146;s capital stock, in each case, whether now owned or hereinafter acquired, that are owned directly by such Existing Holder or New Holder (including securities held as a
custodian) or with respect to which such Existing Holder or New Holder has beneficial ownership within the rules and regulations of the Commission (collectively, the &#147;<I>Restricted Shares</I>&#148;). The foregoing restriction is expressly
agreed to preclude each Existing Holder and New Holder from engaging in any hedging or other transaction which is designed to or which reasonably could be expected to lead to or result in a sale or disposition of the Restricted Shares even if such
Restricted Shares would be disposed of by someone other than such Existing Holder or each New Holder, as applicable. Such prohibited hedging or other transactions include any short sale or any purchase, sale or grant of any right (including any put
or call option) with respect to any of the Restricted Shares of the applicable Existing Holder or New Holder or with respect to any security that includes, relates to, or derives any significant part of its value from such Restricted Shares;
provided, however, that the foregoing restrictions are not intended to cover liens established in the ordinary course in favor of a broker-dealer over property held in an account with such broker-dealer generally. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.6.2 Notwithstanding the provisions set forth in <U>subsection 3.6.1</U>: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) with respect to any Existing Holder, Transfers of Registrable Securities are permitted during the applicable <FONT
STYLE="white-space:nowrap">Lock-Up</FONT> Period: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) to the Company&#146;s officers or directors, any Affiliate or family
member of any of the Company&#146;s officers or directors, </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) to any members or partners of the Sponsor or their
Affiliates, any Affiliates of the Sponsor, or any employees of such Affiliates; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii) in the case of an individual, by
gift to a member of one of the individual&#146;s immediate family or to a trust, the beneficiary of which is a member of the individual&#146;s immediate family, an affiliate of such person or to a charitable organization; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iv) in the case of an individual, by virtue of laws of descent and distribution upon death of the individual; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(v) in the case of an individual, pursuant to a qualified domestic relations order; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(vi) by virtue of the Sponsor&#146;s organizational documents upon liquidation or dissolution of the Sponsor; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(vii) to the Company for no value for cancellation; and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(viii) in connection with a liquidation, merger, amalgamation, stock exchange, reorganization, tender offer approved by the
Board or a duly authorized committee thereof or other similar transactions which results in all of the Company&#146;s stockholders having the right to exchange their shares of common stock for cash, securities or other property;</P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman"><U>provided</U> that in the case of any Transfer pursuant to clauses (a)(i), (ii), (iii), (iv), (v), (vi) and (vii)&nbsp;such
Transfer shall not involve a disposition for value; <U>provided</U>, <U>further</U> that in the case of any Transfer pursuant to clauses (a)(i), (ii), (iii), (iv) and (vi), each donee, devisee, transferee or distributee enters into a written
agreement with the Company agreeing to be bound to the restrictions set forth herein; and <U>provided</U>, <U>further</U>, that in the case of any permitted Transfer no public filing, report or announcement shall be voluntarily made and if any
filing under Section&nbsp;16(a) of the Exchange Act, or other public filing, report or announcement reporting a reduction in beneficial ownership of shares of Domesticated Parent Common Stock in connection with such Transfer shall be legally
required during the applicable <FONT STYLE="white-space:nowrap">Lock-Up</FONT> Period, such filing, report or announcement shall clearly indicate in the footnotes thereto the nature and conditions of such transfer. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) with respect to any New Holder, Transfers of Domesticated Parent Common Stock are permitted during the applicable <FONT
STYLE="white-space:nowrap">Lock-Up</FONT> Period: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) to any New Holder&#146;s Affiliate; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) in the case of an individual, by gift to a member of one of the individual&#146;s immediate family or to a trust, the
beneficiary of which is a member of the individual&#146;s immediate family, an affiliate of such person or to a charitable organization; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii) in the case of an individual, by virtue of laws of descent and distribution upon death of the individual; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iv) in the case of an individual, pursuant to a qualified domestic relations order; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(v) to the Company for no value for cancellation; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(vi) in connection with a liquidation, merger, amalgamation, stock exchange, reorganization, tender offer approved by the Board
or a duly authorized committee thereof or other similar transactions which results in all of the Company&#146;s stockholders having the right to exchange their shares of Domesticated Parent Common Stock for cash, securities or other property;</P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(vii) to the Company from an employee of the Company upon death, disability or termination of employment, in each case, of such
employee; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(viii) to the Company in connection with the vesting, settlement, or exercise of restricted stock units,
performance stock units, options, warrants or other rights to purchase shares of Domesticated Parent Common Stock (including, in each case, by way of &#147;net&#148; or &#147;cashless&#148; exercise), including for the payment of exercise price and
tax and remittance payments due as a result of the vesting, settlement, or exercise of such restricted stock units, performance stock units, options, warrants or rights; provided that any such restricted stock units, performance stock units,
options, warrants or other rights are held by a New Holder pursuant to an agreement or equity awards granted under a stock incentive plan or other equity award plan; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ix) as part of a sale of Domesticated Parent Common Stock to cover the
payment of any exercise price and tax and remittance payment due as the result of the vesting, settlement, or exercise of restricted stock units, performance stock units, options, warrants or other rights to purchase shares of Domesticated Parent
Common Stock; provided that any such restricted stock units, performance stock units, options, warrants or other rights are held by a New Holder pursuant to an agreement or equity awards granted under a stock incentive plan or other equity award
plan; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(x) to the Company in connection with the vesting or settlement of the Earnout Shares received for the payment of
tax and remittance payments due as a result of the vesting of such Earnout Shares; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(xi) as part of a sale of Domesticated
Parent Common Stock to cover the payment of any tax and remittance payment due as the result of the vesting of Earnout Shares; and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(xii) as part of a sale of Domesticated Parent Common Stock acquired in open market transactions after the date hereof; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman"><U>provided</U> that in the case of any Transfer pursuant to clauses (b)(i), (ii), (iii), (iv), (v) and (vii)&nbsp;such
Transfer shall not involve a disposition for value; <U>provided</U>, <U>further</U> that in the case of any Transfer pursuant to clauses (b)(i), (ii) and (iii), each donee, devisee, transferee or distributee enters into a written agreement with the
Company agreeing to be bound to the restrictions set forth herein; and <U>provided</U>, <U>further</U>, that in the case of any permitted Transfer no public filing, report or announcement shall be voluntarily made and if any filing under
Section&nbsp;16(a) of the Exchange Act, or other public filing, report or announcement reporting a reduction in beneficial ownership of shares of Domesticated Parent Common Stock in connection with such Transfer shall be legally required during the
applicable <FONT STYLE="white-space:nowrap">Lock-Up</FONT> Period, such filing, report or announcement shall clearly indicate in the footnotes thereto the nature and conditions of such transfer. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) the Board may, in its sole discretion, determine to waive, amend, or repeal the
<FONT STYLE="white-space:nowrap">lock-up</FONT> obligations set forth in <U>subsection 3.6.1</U>; provided that any such waiver, amendment or repeal shall require, in addition to any other vote of the members of the Board required to take such
action pursuant to these bylaws or applicable law, the affirmative vote of the Sponsor Director. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.6.3 Each Existing Holder and each New
Holder hereby represents and warrants that it now has and, except as contemplated by <U>Section</U><U></U><U>&nbsp;3.6.2</U> for the duration of the applicable <FONT STYLE="white-space:nowrap">Lock-Up</FONT> Period, will have good and marketable
title to its Restricted Shares, free and clear of all liens, encumbrances, and claims that could impact the ability of such Existing Holder or New Holder, as applicable, to comply with the foregoing restrictions. Each Existing Holder and each New
Holder agrees and consents to the entry of stop transfer instructions with the Company&#146;s transfer agent against the Transfer of any Restricted Shares during the applicable <FONT STYLE="white-space:nowrap">Lock-Up</FONT> Period, except in
compliance with the foregoing restrictions. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE 4 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">INDEMNIFICATION AND CONTRIBUTION </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">4.1
<U>Indemnification</U>. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.1.1 The Company agrees to indemnify, to the extent permitted by law, each Holder of Registrable Securities, its
officers and directors and each person who controls such Holder (within the meaning of the Securities Act) against all losses, claims, damages, liabilities and expenses (including attorneys&#146; fees) caused by any untrue or alleged untrue
statement of material fact contained in any Registration Statement, Prospectus or preliminary Prospectus or any amendment thereof or supplement thereto or any omission or alleged omission of a material fact
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
required to be stated therein or necessary to make the statements therein not misleading, except insofar as the same are caused by or contained in any information furnished in writing to the
Company by such Holder expressly for use therein. The Company shall indemnify the Underwriters, their officers and directors and each person who controls such Underwriters (within the meaning of the Securities Act) to the same extent as provided in
the foregoing with respect to the indemnification of the Holder. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.1.2 In connection with any Registration Statement in which a Holder of
Registrable Securities is participating, such Holder shall furnish to the Company in writing such information and affidavits as the Company reasonably requests for use in connection with any such Registration Statement or Prospectus (the
&#147;<I>Holder Information</I>&#148;) and, to the extent permitted by law, shall indemnify the Company, its directors and officers and agents and each person who controls the Company (within the meaning of the Securities Act) against any losses,
claims, damages, liabilities and expenses (including without limitation reasonable attorneys&#146; fees) resulting from any untrue or alleged untrue statement of material fact contained or incorporated by reference in the Registration Statement,
Prospectus or preliminary Prospectus or any amendment thereof or supplement thereto or any omission or alleged omission of a material fact required to be stated therein or necessary to make the statements therein not misleading, but only to the
extent that such untrue statement or omission is contained in (or not contained in, in the case of an omission) any information or affidavit so furnished in writing by or on behalf of such Holder expressly for use therein; <U>provided</U>,
<U>however</U>, that the obligation to indemnify shall be several, not joint and several, among such Holders of Registrable Securities, and the liability of each such Holder of Registrable Securities shall be in proportion to and limited to the net
proceeds received by such Holder from the sale of Registrable Securities pursuant to such Registration Statement. The Holders of Registrable Securities shall indemnify the Underwriters, their officers, directors and each person who controls such
Underwriters (within the meaning of the Securities Act) to the same extent as provided in the foregoing with respect to indemnification of the Company. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.1.3 Any person entitled to indemnification herein shall (i)&nbsp;give prompt written notice to the indemnifying party of any claim with
respect to which it seeks indemnification (provided that the failure to give prompt notice shall not impair any person&#146;s right to indemnification hereunder to the extent such failure has not materially prejudiced the indemnifying party) and
(ii)&nbsp;unless in such indemnified party&#146;s reasonable judgment a conflict of interest between such indemnified and indemnifying parties may exist with respect to such claim, permit such indemnifying party to assume the defense of such claim
with counsel reasonably satisfactory to the indemnified party. If such defense is assumed, the indemnifying party shall not be subject to any liability for any settlement made by the indemnified party without its consent (but such consent shall not
be unreasonably withheld). An indemnifying party who is not entitled to, or elects not to, assume the defense of a claim shall not be obligated to pay the fees and expenses of more than one counsel for all parties indemnified by such indemnifying
party with respect to such claim, unless in the reasonable judgment of any indemnified party a conflict of interest may exist between such indemnified party and any other of such indemnified parties with respect to such claim. No indemnifying party
shall, without the consent of the indemnified party, consent to the entry of any judgment or enter into any settlement, which (a)&nbsp;cannot be settled in all respects by the payment of money (and such money is so paid by the indemnifying party
pursuant to the terms of such settlement), (b) includes a statement or admission of fault and culpability on the part of such indemnified party&nbsp;or (c)&nbsp;does not include as an unconditional term thereof the giving by the claimant or
plaintiff to such indemnified party of a release from all liability in respect to such claim or litigation. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.1.4 The indemnification
provided for under this Agreement shall remain in full force and effect regardless of any investigation made by or on behalf of the indemnified party or any officer, director or controlling person of such indemnified party and shall survive the
Transfer of securities. The Company and each Holder of Registrable Securities participating in an offering also agrees to make such provisions as are reasonably requested by any indemnified party for contribution to such party in the event the
Company&#146;s or such Holder&#146;s indemnification is unavailable for any reason. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.1.5 If the indemnification provided under
<U>Section</U><U></U><U>&nbsp;4.1</U> hereof from the indemnifying party is unavailable or insufficient to hold harmless an indemnified party in respect of any losses, claims, damages, liabilities and expenses referred to herein, then the
indemnifying party, in lieu of indemnifying the indemnified party, shall contribute to the amount paid or payable by the indemnified party as a result of such losses, claims, damages, liabilities and expenses in such proportion as is appropriate to
reflect the relative fault of the indemnifying party and the indemnified party, as well as any other relevant equitable considerations. The relative fault of the indemnifying party and indemnified party shall be determined by reference to, among
other things, whether any action in question, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
including any untrue or alleged untrue statement of a material fact or omission or alleged omission to state a material fact, was made by, or relates to information supplied by, such indemnifying
party or indemnified party, and the indemnifying party&#146;s and indemnified party&#146;s relative intent, knowledge, access to information and opportunity to correct or prevent such action; <U>provided</U>, <U>however</U>, that the liability of
any Holder under this <U>subsection 4.1.5</U> shall be limited to the amount of the net proceeds received by such Holder in such offering giving rise to such liability. The amount paid or payable by a party as a result of the losses or other
liabilities referred to above shall be deemed to include, subject to the limitations set forth in <U>subsections 4.1.1</U>, <U>4.1.2</U> and <U>4.1.3</U> above, any legal or other fees, charges or expenses reasonably incurred by such party in
connection with any investigation or proceeding. The parties hereto agree that it would not be just and equitable if contribution pursuant to this <U>subsection 4.1.5</U> were determined by pro rata allocation or by any other method of allocation,
which does not take account of the equitable considerations referred to in this <U>subsection 4.1.5</U>. No person guilty of fraudulent misrepresentation (within the meaning of Section&nbsp;11(f) of the Securities Act) shall be entitled to
contribution pursuant to this <U>subsection 4.1.5</U> from any person who was not guilty of such fraudulent misrepresentation. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE
5 </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">STOCKHOLDER RIGHTS </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">5.1 <U>Stockholder
Rights</U>. At any time and from time to time on or after the date hereof and until the later of (i)&nbsp;such time as the Sponsor ceases to beneficially own at least ten percent (10%) of the Company&#146;s outstanding voting stock and
(ii)&nbsp;subject to compliance with the rules of The Nasdaq Stock Market, the third anniversary of the date of this Merger Agreement: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.1.1 The Sponsor shall have the right, but not the obligation, to designate one individual to be appointed or nominated, as the case may be,
for election to the Board (including any successor, each, a &#147;<I>Nominee</I>&#148;) as a Class&nbsp;III director by giving written notice to the Company on or before the time such information is reasonably requested by the Board or the
Nominating Committee of the Board, as applicable, for inclusion in a proxy statement for a meeting of stockholders provided to the Sponsor. Any Nominee shall be subject to the consent of the Board (not to be unreasonably withheld, conditioned or
delayed); <U>provided</U>, that the Board&#146;s consent shall not be required if such Nominee is Josh Tamaroff, Garrett Lustig, or any individual who is a director of the Company as of the date of the Merger Agreement. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.1.2 The Company will, as promptly as practicable, use its commercially reasonable efforts to ensure that there is one Sponsor Director
serving on the Board at all times that the Sponsor shall be entitled to nominate a Director. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.1.3 The Company shall, to the fullest
extent permitted by applicable law, use its commercially reasonable efforts to ensure that: (i)&nbsp;the Nominee is included in the Board&#146;s slate of nominees to the stockholders of the Company for each election of the applicable class of
Directors; and (ii)&nbsp;the Nominee is included in the proxy statement prepared by management of the Company in connection with soliciting proxies for such meeting of the stockholders of the Company called with respect to the election of members of
the Board, and at every adjournment or postponement thereof, and on every action or approval by written consent of the stockholders of the Company or the Board with respect to the election of members of the Board. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.1.4 If a vacancy occurs because of the death, disability, disqualification, resignation, or removal (or for any other reason) of a Sponsor
Director, the Sponsor shall be entitled to designate such person&#146;s successor, and the Company will promptly following such designation use its commercially reasonable efforts to ensure that such vacancy shall be filled with such successor
Nominee. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.1.5 If a Nominee is not elected for any reason, the Sponsor shall be entitled to designate promptly another Nominee and the
Company will use its commercially reasonable efforts to ensure that the director position for which such Nominee was nominated shall not be filled pending such designation or that the size of the Board shall be increased by one and such vacancy
shall be filled with such successor Nominee as promptly as practicable following such designation. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.1.6 Promptly following the request of any Sponsor Director, the Company shall enter into
an indemnification agreement with such Sponsor Director, in the form entered into with the other members of the Board. The Company shall pay the reasonable, documented
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> expenses incurred by the Sponsor Director in connection with his or her services provided to or on behalf of the Company, including attending meetings or
events attended explicitly on behalf of the Company at the Company&#146;s request. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.1.7 Any Nominee will be subject to the Company&#146;s
customary due diligence process, including its review of a completed questionnaire and a background check. Based on the foregoing, the Company may object to any Nominee provided (a)&nbsp;it does so in good faith, and (b)&nbsp;such objection is based
upon any of the following: (i)&nbsp;such Nominee was convicted in a criminal proceeding or is a named subject of a pending criminal proceeding (excluding traffic violations and other minor offenses), (ii) such Nominee was the subject of any order,
judgment or decree not subsequently reversed, suspended or vacated of any court of competent jurisdiction, permanently or temporarily enjoining such proposed director from, or otherwise limiting, the following activities: (A)&nbsp;engaging in any
type of business practice, or (B)&nbsp;engaging in any activity in connection with the purchase or sale of any security or in connection with any violation of federal or state securities laws, (iii)&nbsp;such Nominee was the subject of any order,
judgment or decree, not subsequently reversed, suspended or vacated, of any federal or state authority barring, suspending or otherwise limiting the right of such person to engage in any activity described in clause (ii)(B), or to be associated with
persons engaged in such activity, (iv)&nbsp;such proposed director was found by a court of competent jurisdiction in a civil action or by the Commission to have violated any federal or state securities law, and the judgment in such civil action or
finding by the Commission has not been subsequently reversed, suspended or vacated, or (v)&nbsp;such proposed director was the subject of, or a party to any federal or state judicial or administrative order, judgment, decree or finding, not
subsequently reversed, suspended or vacated, relating to a violation of any federal or state securities laws or regulations. In the event the Board reasonably finds the Nominee to be unsuitable based upon one or more of the foregoing clauses
(i)&nbsp;through (v) and reasonably objects to the identified director, the Sponsor shall be entitled to propose a different nominee to the Board within thirty (30)&nbsp;calendar days of the Company&#146;s notice to the Sponsor of its objection to
the Nominee and such replacement Nominee shall be subject to the review process outlined above. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE 6 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">MISCELLANEOUS </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">6.1 <U>Notices</U>. Any notice or
communication under this Agreement must be in writing and given by (i)&nbsp;deposit in the United States mail, addressed to the party to be notified, postage prepaid and registered or certified with return receipt requested, (ii)&nbsp;delivery in
person or by courier service providing evidence of delivery, or (iii)&nbsp;transmission by hand delivery, electronic mail, telecopy, telegram or facsimile. Each notice or communication that is mailed, delivered or transmitted in the manner described
above shall be deemed sufficiently given, served, sent, and received, in the case of mailed notices, on the third business day following the date on which it is mailed and, in the case of notices delivered by courier service, hand delivery,
electronic mail, telecopy, telegram or facsimile, at such time as it is delivered to the addressee (with the delivery receipt or the affidavit of messenger) or at such time as delivery is refused by the addressee upon presentation. Any notice or
communication under this Agreement must be addressed, if to the Company, to: OmniAb, Inc. 5980 Horton Street, Suite 405, Emeryville, CA 94608, Attention: Charles Berkman, with copy to: Latham&nbsp;&amp; Watkins LLP, 12670 High Bluff Drive, San
Diego, California 92130, Attention: Matthew T. Bush, Esq., and, if to any Holder, at such Holder&#146;s address or facsimile number as set forth in the Company&#146;s books and records. Any party may change its address for notice at any time and
from time to time by written notice to the other parties hereto, and such change of address shall become effective thirty (30)&nbsp;days after delivery of such notice as provided in this <U>Section</U><U></U><U>&nbsp;6.1</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">6.2 <U>Assignment; No Third Party Beneficiaries</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6.2.1 This Agreement and the rights, duties and obligations of the Company hereunder may not be assigned or delegated by the Company in whole
or in part. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6.2.2 Prior to the expiration of the applicable <FONT STYLE="white-space:nowrap">Lock-Up</FONT> Period, as the case may be, no
Holder may assign or delegate such Holder&#146;s rights, duties or obligations under this Agreement, in whole or in part, except in connection with a Transfer of Registrable Securities by such Holder to a Permitted Transferee. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6.2.3 This Agreement and the provisions hereof shall be binding upon and shall inure to the benefit of each of the parties and its successors
and the permitted assigns of the Holders, which shall include Permitted Transferees. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">16 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6.2.4 This Agreement shall not confer any rights or benefits on any persons that are not
parties hereto, other than as expressly set forth in this Agreement. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6.2.5 No assignment by any party hereto of such party&#146;s rights,
duties and obligations hereunder shall be binding upon or obligate the Company unless and until the Company shall have received (i)&nbsp;written notice of such assignment as provided in <U>Section</U><U></U><U>&nbsp;6.1</U> hereof and (ii)&nbsp;the
written agreement of the assignee, in a form reasonably satisfactory to the Company, to be bound by the terms and provisions of this Agreement (which may be accomplished by an addendum or certificate of joinder to this Agreement). Any Transfer or
assignment made other than as provided in this <U>Section</U><U></U><U>&nbsp;6.2</U> shall be null and void. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">6.3 <U>Severability</U>. This Agreement shall
be deemed severable, and the invalidity or unenforceability of any term or provision hereof shall not affect the validity or enforceability of this Agreement or of any other term or provision hereof. Furthermore, in lieu of any such invalid or
unenforceable term or provision, the parties hereto intend that there shall be added as a part of this Agreement a provision as similar in terms to such invalid or unenforceable provision as may be possible that is valid and enforceable. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">6.4 <U>Counterparts</U>. This Agreement may be executed in multiple counterparts (including facsimile or PDF counterparts), each of which shall be deemed an
original, and all of which together shall constitute the same instrument, but only one of which need be produced. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">6.5 <U>Entire Agreement</U>. This
Agreement constitutes the entire agreement of the parties with respect to the subject matter hereof and supersedes all prior and contemporaneous agreements (including the Existing Agreement), representations, understandings, negotiations and
discussions between the parties, whether oral or written. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">6.6 <U>Governing Law</U><U>; Venue</U>. NOTWITHSTANDING THE PLACE WHERE THIS AGREEMENT MAY BE
EXECUTED BY ANY OF THE PARTIES HERETO, THE PARTIES EXPRESSLY AGREE THAT (1)&nbsp;THIS AGREEMENT SHALL BE GOVERNED BY AND CONSTRUED UNDER THE LAWS OF THE STATE OF NEW YORK WITHOUT REGARD TO THE CONFLICT OF LAW PROVISIONS OF SUCH JURISDICTION AND
(2)&nbsp;THE VENUE FOR ANY ACTION TAKEN WITH RESPECT TO THIS AGREEMENT SHALL BE ANY STATE OR FEDERAL COURT IN NEW YORK COUNTY IN THE STATE OF NEW YORK. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">6.7 <U>WAIVER OF TRIAL BY JURY</U>. EACH PARTY HEREBY IRREVOCABLY AND UNCONDITIONALLY WAIVES THE RIGHT TO A TRIAL BY JURY IN ANY ACTION, SUIT, COUNTERCLAIM OR
OTHER PROCEEDING (WHETHER BASED ON CONTRACT, TORT OR OTHERWISE) ARISING OUT OF, CONNECTED WITH OR RELATING TO THIS AGREEMENT OR THE TRANSACTIONS CONTEMPLATED HEREBY. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">6.8 <U>Amendments and Modifications</U>. Upon the written consent of the Company and the Holders of at least a <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">majority-in-interest</FONT></FONT> of the Registrable Securities at the time in question, compliance with any of the provisions, covenants and conditions set forth in this Agreement may be waived, or any of such
provisions, covenants or conditions may be amended or modified; <U>provided</U>, <U>however</U>, that notwithstanding the foregoing, any amendment hereto or waiver hereof that adversely affects one Holder, solely in its capacity as a holder of the
shares of the Company, in a manner that is materially different from the other Holders (in such capacity) shall require the consent of the Holder so affected; and provided, further, that the Company may waive the lockup restrictions as set forth in
Section&nbsp;3.6.2. No course of dealing between any Holder or the Company and any other party hereto or any failure or delay on the part of a Holder or the Company in exercising any rights or remedies under this Agreement shall operate as a waiver
of any rights or remedies of any Holder or the Company. No single or partial exercise of any rights or remedies under this Agreement by a party shall operate as a waiver or preclude the exercise of any other rights or remedies hereunder or
thereunder by such party. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">6.9 <U>Titles and Headings</U>. Titles and headings of sections of this Agreement are for convenience only and shall not affect
the construction of any provision of this Agreement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">17 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">6.10 <U>Waivers and Extensions</U>. Any party to this Agreement may waive any right, breach or default which
such party has the right to waive, <U>provided</U> that such waiver will not be effective against the waiving party unless it is in writing, is signed by such party, and specifically refers to this Agreement. Waivers may be made in advance or after
the right waived has arisen or the breach or default waived has occurred. Any waiver may be conditional. No waiver of any breach of any agreement or provision herein contained shall be deemed a waiver of any preceding or succeeding breach thereof
nor of any other agreement or provision herein contained. No waiver or extension of time for performance of any obligations or acts shall be deemed a waiver or extension of the time for performance of any other obligations or acts. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">6.11 <U>Remedies Cumulative</U>. In the event that the Company fails to observe or perform any covenant or agreement to be observed or performed under this
Agreement, the Holders may proceed to protect and enforce its rights by suit in equity or action at law, whether for specific performance of any term contained in this Agreement or for an injunction against the breach of any such term or in aid of
the exercise of any power granted in this Agreement or to enforce any other legal or equitable right, or to take any one or more of such actions, without being required to post a bond. None of the rights, powers or remedies conferred under this
Agreement shall be mutually exclusive, and each such right, power or remedy shall be cumulative and in addition to any other right, power or remedy, whether conferred by this Agreement or now or hereafter available at law, in equity, by statute or
otherwise. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">6.12 <U>Other Registration Rights</U>. The Company represents and warrants that no person, other than a Holder of Registrable Securities, has
any right to require the Company to register any securities of the Company for sale or to include such securities of the Company in any Registration filed by the Company for the sale of securities for its own account or for the account of any other
person. Further, the Company represents and warrants that this Agreement supersedes any other registration rights agreement or agreement with similar terms and conditions and in the event of a conflict between any such agreement or agreements and
this Agreement, the terms of this Agreement shall prevail. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">6.13 <U>Additional Holder Information</U>. Each Holder agrees, if requested in writing, to
represent to the Company the total number of Registrable Securities held by such Holder, to the extent necessary for the Company to make determinations hereunder. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">6.14 <U>No Third-Party Beneficiaries</U>. In Ligand&#146;s sole discretion, Ligand may enforce the provisions of Section&nbsp;1.1 (definition of Holder),
<U>subsection 2.2.1</U> and <U>Article IV</U>, to the extent applicable, on behalf of the Ligand Equity Award Holders. For the avoidance of doubt, none of the Ligand Equity Award Holders is or is intended to be a third-party beneficiary of this
Agreement. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">6.15 <U>Term</U>. This Agreement shall terminate upon the earlier of (i)&nbsp;the fifth anniversary of the date of this Agreement and
(ii)&nbsp;with respect to any Holder, on the date that such Holder no longer holds any Registrable Securities. The provisions of <U>Section</U><U></U><U>&nbsp;3.5</U> and <U>Article IV</U> shall survive any termination. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>[</I>SIGNATURE PAGES FOLLOW<I>]</I> </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">18 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">IN WITNESS WHEREOF, the undersigned have caused this Agreement to be executed as of the date first written
above. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="87%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">COMPANY:</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>OMNIAB, INC.</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[<I>Signature Page to A&amp;R Registration Rights Agreement</I>] </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="87%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">HOLDERS:</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>AVISTA ACQUISITION LP II</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">By: Avista Acquisition GP LLC II, its general partner</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">David Burgstahler</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Manager</TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[<I>Signature Page to A&amp;R Registration Rights Agreement</I>] </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="16%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="83%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">WILLIAM KLITGAARD</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Address:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[<I>Signature Page to A&amp;R Registration Rights Agreement</I>] </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="16%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="83%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">L&Acirc;LE WHITE</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">By:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Address:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[<I>Signature Page to A&amp;R Registration Rights Agreement</I>] </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">WENDEL BARR</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Address:</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">NEW HOLDERS:</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">[__]</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">By: [__]</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">[__]</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">[__]</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Solely with respect to <U>Section&nbsp;2.2.1</U>, <U>Article 4</U> and <U>Section&nbsp;6.14</U></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>LIGAND PHARMACEUTICALS INCORPORATED</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Name:</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Title:</TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[<I>Signature Page to A&amp;R Registration Rights Agreement</I>] </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Exhibit F to the Merger Agreement </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B><I>Execution Version </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">March&nbsp;23, 2022 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Avista Public Acquisition
Corp. II </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">65 East 55th Street, 18th Floor </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">New York, NY 10022
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Re: <U>Letter Agreement</U> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Ladies and Gentlemen: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Reference is made to that certain Agreement and Plan of Merger, dated as of March&nbsp;23, 2022 (the &#147;<I>Merger Agreement</I>&#148;), by
and among Ligand Pharmaceuticals Incorporated (&#147;<I>Ligand</I>&#148;), a Delaware corporation, OmniAb, Inc., a Delaware corporation (&#147;<I>SpinCo</I>&#148;, and together with Ligand, the &#147;<I>Companies</I>&#148;), Avista Public
Acquisition Corp. II, a Cayman Islands exempted company (&#147;<I>Parent</I>&#148;), and Orwell Merger Sub Inc., a Delaware corporation. This letter agreement (this &#147;<I>Letter Agreement</I>&#148;) is being entered into and delivered by Parent,
Avista Acquisition LP II (the &#147;<I>Sponsor</I>&#148;), SpinCo and each of the undersigned, each of whom is a member of Parent&#146;s management team and/or Parent&#146;s Board of Directors (the &#147;<I>Board</I>&#148;) (each, an
&#147;<I>Insider</I>&#148;), in connection with the transactions contemplated by the Merger Agreement (the &#147;<I>Merger</I>&#148;). Capitalized terms used but not otherwise defined herein shall have the respective meanings ascribed to such terms
in the Merger Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In order to induce the Companies to enter into the Merger Agreement and for other good and valuable
consideration, the receipt and sufficiency of which are hereby acknowledged, the Sponsor and each Insider hereby agrees with Parent as follows: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1. <U>Definitions</U>. As used herein, (i) &#147;<I>Earnout Period</I>&#148; shall mean the period from the Closing Date to and including the
fifth (5th) anniversary of the Closing Date; (ii) &#147;<I>Founder Shares</I>&#148; shall mean the 5,750,000 shares of Domesticated Parent Common Stock into which the 5,750,000 Class&nbsp;B ordinary shares of Parent are to be converted in the
Domestication, equitably adjusted for stock splits, reverse stock splits, stock dividends, reorganizations, recapitalizations, reclassifications, combinations, exchanges of shares or other like changes or transactions with respect to such Founder
Shares; (iii) &#147;<I>Post-Transaction VWAP</I>&#148; shall mean the daily volume-weighted average share price for any 20 Trading Days over any consecutive <FONT STYLE="white-space:nowrap">30-day</FONT> period; (iv) &#147;<I>Trading Day</I>&#148;
shall mean any day on which Domesticated Parent Common Stock are actually traded on the principal securities exchange or securities market on which shares of Domesticated Parent Common Stock are then traded; and (v) &#147;<I>Triggering
Event</I>&#148; shall mean, (a)&nbsp;with respect to fifty percent (50%) of the Earnout Founder Shares (as hereinafter defined), the first date during the Earnout Period on which the Post-Transaction VWAP is $12.50 per share or higher, and
(b)&nbsp;with respect any Earnout Founder Shares for which a Triggering Event has not occurred with respect to clause (a), the first date during the Earnout Period on which the Post-Transaction VWAP is $15.00 per share or higher; <U>provided</U>,
that in the event of a Change of Control during the Earnout Period pursuant to which Parent or any of its stockholders have the right to receive, directly or indirectly, cash, securities or other property attributing a value of at least $12.50 (with
respect to fifty percent (50%) of the Earnout Founder Shares) or $15.00 (with respect to all Earnout Founder Shares) per share of Domesticated Parent Common Stock, as agreed in good faith by the Sponsor and the Board), then a Triggering Event shall
be deemed to have occurred immediately prior to such Change of Control. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2. <U>Representations and Warranties</U>. Each Insider hereby
severally represents and warrants to Parent that as of the date hereof such Insider holds the number of issued and outstanding Founder Shares set forth next to such Insider&#146;s name on the signature pages hereto. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3. <U>Business Combination Vote</U>. The Sponsor and each Insider agrees that if Parent seeks shareholder approval of the Merger, then in
connection with the Merger, the Sponsor or such Insider shall vote all of the (a)&nbsp;Parent Class&nbsp;A Common Stock and Founder Shares, in each case owned by such Person (beneficially or of record) as of the date hereof and (b)&nbsp;any
additional Parent Class&nbsp;A Common Stock or </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Founder Shares (or any securities convertible into or exercisable or exchangeable for Parent Class&nbsp;A Common Stock or Founder Shares) of which the Sponsor or such Insider acquires record or
beneficial ownership on or after the date hereof (including by purchase, as a result of stock splits, reverse stock splits, stock dividends, reorganizations, recapitalizations, reclassifications, combinations, exchanges of shares or other like
changes or transactions) (clauses (a)&nbsp;and (b), the &#147;<I>Covered Shares</I>&#148;) held by the Sponsor or such Insider in favor of the Merger (including the Transaction Proposals and any other proposals recommended by the Board in connection
with the Merger) and not elect to redeem any Covered Shares held by the Sponsor and each Insider in connection with such shareholder approval or the Merger (including, without limitation, the Transactions). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4. <U>Founder Shares Earnout</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Upon and subject to the Closing, a number of Founder Shares beneficially owned by Sponsor as of the date hereof equal to (i) 1,916,667
minus (ii) (A) 718,750 multiplied by (B)&nbsp;a number, the numerator of which is the number of shares of Domesticated Parent Common Stock actually purchased pursuant to the Redemption Backstop in connection with the Closing and the denominator of
which is 10,000,000 (the &#147;<I>Earnout Founder Shares</I>&#148;), all or fifty percent (50%) of which shall be automatically forfeited for no consideration if an applicable Triggering Event has not occurred with respect to such Earnout Founder
Shares during the Earnout Period, with such Earnout Founder Shares vesting (and therefore no longer subject to forfeiture), if at all, in accordance with the terms of this Letter Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) The holders of the Earnout Founder Shares shall not (i)&nbsp;sell, transfer, assign, pledge, encumber, hypothecate, or similarly dispose
of, (ii)&nbsp;enter into, establish or increase a put or equivalent position or liquidation with respect to, or increase a call equivalent position with respect to, (iii)&nbsp;enter into any swap or other arrangement that transfers to another, in
whole or in part, any of the economic consequences of ownership of, whether any such transaction is to be settled by delivery of securities, in cash or otherwise, or (iv)&nbsp;announce the intent to take any of the actions set forth in clauses
(i)-(iii) with respect to, any Earnout Founder Shares until the date on which a Triggering Event has occurred; <U>provided</U>, that the Sponsor may distribute the Earnout Founder Shares held by it to its members in accordance with its Governing
Documents and the A&amp;R Registration Rights Agreement, in each case, provided that the recipient of such distribution enters into a joinder to this Letter Agreement substantially in the form attached hereto as <U>Exhibit</U><U></U><U>&nbsp;A</U>.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Any certificates or book entries representing the Earnout Founder Shares shall bear a legend referencing that they are subject to
forfeiture pursuant to the provisions of this Letter Agreement, and any transfer agent for the shares of Domesticated Parent Common Stock will be given appropriate stop transfer orders that will be applicable until the Earnout Founder Shares are
vested; <U>provided</U>, however, that upon the vesting of any Earnout Founder Shares in accordance with the terms herein, Parent shall immediately cause the removal of such legend and direct such transfer agent that such stop transfer orders are no
longer applicable. Holders of the Earnout Founder Shares shall be entitled to vote such Earnout Founder Shares and receive dividends and other distributions in respect thereof prior to the vesting of such Earnout Founder Shares in accordance with
the terms herein; <U>provided</U>, that any such dividends and other distributions in respect of the Earnout Founder Shares that are subject to vesting pursuant to the terms herein shall be set aside by Parent and shall only be paid to the holder of
such Earnout Founder Shares upon the vesting thereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) The Earnout Founder Shares shall immediately become fully vested and no longer
subject to forfeiture upon the occurrence of the applicable Triggering Event during the Earnout Period. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) If Parent at any time combines or subdivides the Domesticated Parent Common Stock (by
any stock split, stock dividend, recapitalization, reorganization, merger, amendment of the applicable Governing Documents, scheme, arrangement or otherwise or extraordinary dividend resulting from an asset sale or leveraged recapitalization), the
number of Earnout Founder Shares and the share prices set forth in the definition of &#147;Triggering Events&#148; shall be equitably adjusted by Parent in good faith to take into account such stock split, stock dividend, recapitalization,
reorganization, merger, amendment of the applicable Governing Documents, scheme, arrangement or extraordinary dividend or other applicable transaction. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5. <U>Amendment to Original Letter Agreements; Effects of Termination</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) The first sentence of paragraph 4(b) of each of the Letter Agreements (collectively, as amended and restated pursuant to this <U>paragraph
5(a)</U>, the &#147;<I>Existing Letter Agreements</I>&#148;), dated August&nbsp;9, 2021, entered into between Parent, on the one hand, and each of the Sponsor and each Insider, on the other hand, is hereby amended and restated in its entirety as
follows: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">&#147;The Insider acknowledges that the Insider has no right, title, interest or claim of any kind in or to any monies held in
the Trust Account as a result of any liquidation of the Company with respect to the Founder Shares held by the Insider, if any.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b)
The last sentence of paragraph 12(a) of each of the Existing Letter Agreements, is hereby amended and restated as follows: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">&#147;This
Letter Agreement may not be changed, amended, modified or waived (other than to correct a typographical error) as to any particular provision, except by a written instrument (i)&nbsp;executed by all parties hereto and (ii)&nbsp;solely with respect
to <U>paragraph 5</U> and prior to the Closing or valid termination of the OmniAb Merger Agreement (as defined below), in accordance with its terms, with the consent of OmniAb. &#147;OmniAb Merger Agreement&#148; means that certain Agreement and
Plan of Merger, dated as of March&nbsp;23, 2022 (the &#147;<I>OmniAb Merger Agreement</I>&#148;), by and among Ligand Pharmaceuticals Incorporated, a Delaware corporation (&#147;<I>Ligand</I>&#148;), OmniAb, Inc., a Delaware corporation and
wholly-owned subsidiary of Ligand, the Company, and Orwell Merger Sub Inc., a Delaware corporation.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Except as expressly
modified by <U>paragraph 5(a)</U>, the terms, representations, warranties, covenants and other provisions of the Existing Letter Agreements shall remain unchanged and are and shall continue to be in full force and effect in accordance with their
respective terms. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) This Letter Agreement shall terminate on the earlier of (i)&nbsp;termination of the Merger Agreement or
(ii)&nbsp;the vesting in full of all Earnout Founder Shares; <U>provided</U>, that terms and conditions set forth in this <U>paragraph 5</U> shall survive any such termination. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6. <U>Entire Agreement</U>. This Letter Agreement and each of the Existing Letter Agreements constitute the entire agreement and understanding
of the parties hereto in respect of the subject matter hereof and thereof and supersede all prior understandings, agreements or representations by or among the parties hereto and thereto, written or oral, to the extent they relate in any way to the
subject matter hereof or thereof or the transactions contemplated hereby or thereby. This Letter Agreement may not be changed, amended, modified or waived (other than to correct a typographical error) as to any particular provision, except by a
written instrument executed by all parties hereto. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7. <U>Assignment</U>. No party hereto may assign either this Letter Agreement or any of its
rights, interests or obligations hereunder without the prior written consent of the other parties. Any purported assignment in violation of this paragraph shall be void and ineffectual and shall not operate to transfer or assign any interest or
title to the purported assignee. This Letter Agreement shall be binding on the Sponsor and each Insider and each of their respective successors, heirs, personal representatives and assigns and permitted transferees. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8. <U>Counterparts</U>. This Letter Agreement may be executed in any number of original or facsimile counterparts, and each of such
counterparts shall for all purposes be deemed to be an original, and all such counterparts shall together constitute but one and the same instrument. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9. <U>Effect of Headings</U>. The paragraph headings herein are for convenience only and are not part of this Letter Agreement and shall not
affect the interpretation thereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">10. <U>Severability</U>. This Letter Agreement shall be deemed severable, and the invalidity or
unenforceability of any term or provision hereof shall not affect the validity or enforceability of this Letter Agreement or of any other term or provision hereof. Furthermore, in lieu of any such invalid or unenforceable term or provision, the
parties hereto intend that there shall be added as a part of this Letter Agreement a provision as similar in terms to such invalid or unenforceable provision as may be possible and be valid and enforceable. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">11. <U>Governing Law</U>. This Letter Agreement shall be governed by and construed and enforced in accordance with the laws of the State of
Delaware, without giving effect to conflicts of law principles that would result in the application of the substantive laws of another jurisdiction. The parties hereto (i)&nbsp;all agree that any action, proceeding, claim or dispute arising out of,
or relating in any way to, this Letter Agreement shall be brought and enforced in the Court of Chancery of the State of Delaware, and irrevocably submit to such jurisdiction and venue, which jurisdiction and venue shall be exclusive, and
(ii)&nbsp;waive any objection to such exclusive jurisdiction and venue or that such courts represent an inconvenient forum. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">12.
<U>Notices</U>. Any notice, consent or request to be given in connection with any of the terms or provisions of this Letter Agreement shall be in writing and shall be sent by express mail or similar private courier service, by certified mail (return
receipt requested), by hand delivery or facsimile or other electronic transmission to the address set forth for such person on the signature page hereto. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>[Signature Page Follows] </I></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="16%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="83%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Sincerely,</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">AVISTA ACQUISITION LP II</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Title:</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">email:</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Address:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
</TABLE></DIV> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Thompson Dean</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">email:</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Address:</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Number of issued and</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">outstanding Founder
Shares:</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">David Burgstahler</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">email:</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Address:</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Number of issued and</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">outstanding Founder
Shares:</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Sriram Venkataraman</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">email:</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Address:</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Number of issued and</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">outstanding Founder
Shares:</P></TD></TR>
</TABLE></DIV>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Robert Girardi</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">email:</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Address:</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Number of issued and</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">outstanding Founder
Shares:</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Amanda Heravi</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">email:</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Address:</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Number of issued and</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">outstanding Founder
Shares:</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">John Cafasso</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">email:</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Address:</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Number of issued and</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">outstanding Founder
Shares:</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Benjamin Silbert</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">email:</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Address:</P></TD></TR>
</TABLE></DIV>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Number of issued and</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">outstanding Founder
Shares:</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">William E. Klitgaard</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">email:</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Address:</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Number of issued and</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">outstanding Founder
Shares:</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">L&acirc;le White</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">email:</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Address:</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Number of issued and</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">outstanding Founder
Shares:</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Wendel Barr</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">email:</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Address:</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Number of issued and</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">outstanding Founder
Shares:</P></TD></TR>
</TABLE></DIV>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Acknowledged and Agreed:</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">AVISTA PUBLIC ACQUISITION CORP. II</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name: Benjamin Silbert</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Title: General Counsel</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">email:</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Address:</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">OMNIAB, INC.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name: Matthew W. Foehr</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Title: President and Chief Executive Officer</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">email:</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Address: 5980 Horton Street</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4.00em; font-size:10pt; font-family:Times New Roman">Suite 405</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; text-indent:4.00em; font-size:10pt; font-family:Times New Roman">Emeryville, CA
94608</P></TD></TR>
</TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>Exhibit&nbsp;A </U></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">FORM OF JOINDER TO LETTER AGREEMENT </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[______], 20__ </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Reference is made to the Letter
Agreement, dated as of March&nbsp;23, 2022, by and among Avista Public Acquisition Corp. II, a Cayman Islands exempted company (&#147;<I>Parent</I>&#148;), Avista Acquisition LP II (the &#147;<I>Sponsor</I>&#148;) and the other signatories thereto
(the &#147;<I>Insiders</I>&#148;), each of whom is a member of Parent&#146;s management team and/or the Board (the &#147;Letter Agreement&#148;). Capitalized terms used but not otherwise defined herein shall have the meanings ascribed to such terms
in the Letter Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Each of the Parent, Sponsor, the Insiders and each of the undersigned holder of Domesticated Parent Common Stock (each, a
&#147;<I>New Stockholder Party</I>&#148;) agrees that this Joinder to the Letter Agreement (this &#147;<I>Joinder</I>&#148;) is being executed and delivered for good and valuable consideration. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Each undersigned New Stockholder Party hereby agrees to and does become party to the Letter Agreement and to be subject to the same rights, remedies or
obligations as the Sponsor thereunder. This Joinder shall serve as a counterpart signature page to the Letter Agreement and by executing below each undersigned New Stockholder Party is deemed to have executed the Letter Agreement with the same force
and effect as if originally named a party thereto. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This Joinder may be executed in multiple counterparts, including by means of facsimile or electronic
signature, each of which shall be deemed an original, but all of which together shall constitute the same instrument. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[<I>Remainder of
Page Intentionally Left Blank.</I>] </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Exhibit G to the Merger Agreement </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">CERTIFICATE OF INCORPORATION </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">OF </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[OMNIAB, INC.] </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>ARTICLE I </U></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">NAME </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The name of the corporation is [OmniAb, Inc.] (the &#147;<U>Corporation</U>&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>ARTICLE II </U></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">REGISTERED
OFFICE AND AGENT </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The address of the Corporation&#146;s registered office in the State of Delaware is [Corporation Service Company, 251
Little Falls Drive, in the City of Wilmington, County of New Castle, 19808], and the name of its registered agent at such address is [Corporation Service Company.] </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>ARTICLE III </U></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">PURPOSE </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The purpose of the Corporation is to engage in any lawful act or activity for which corporations may be organized under the General
Corporation Law of the State of Delaware (the &#147;<U>DGCL</U>&#148;) as it now exists or may hereafter be amended and supplemented. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>ARTICLE IV </U></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">CAPITAL STOCK
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Corporation is authorized to issue two classes of stock to be designated, respectively, &#147;<U>Common Stock</U>,&#148; and
&#147;<U>Preferred Stock</U>.&#148; The total number of shares of capital stock which the Corporation shall have authority to issue is 1,100,000,000. The total number of shares of Common Stock that the Corporation is authorized to issue is
1,000,000,000, having a par value of $0.0001 per share, and the total number of shares of Preferred Stock that the Corporation is authorized to issue is 100,000,000, having a par value of $0.0001 per share. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Upon the filing and effectiveness of this Certificate with the Secretary of State of the State of Delaware (the &#147;<U>Effective
Time</U>&#148;), each Class&nbsp;A ordinary fully paid share, par value $0.0001 per share, and each Class&nbsp;B ordinary fully paid share, par value $0.0001 per share, of Avista Public Acquisition Corp. II, a Cayman Islands exempted company and the
Corporation&#146;s predecessor prior to its domestication as a Delaware corporation, issued and outstanding or held in treasury immediately prior to the Effective Time (&#147;<U>Old Common Stock</U>&#148;) and without any action on the part of the
holder thereof, shall be reclassified as and converted into one share of Common Stock, with a par value of $0.0001 per share. Any stock certificate or book entry representing shares of Old Common Stock shall thereafter represent a number of whole
shares of Common Stock into which such shares of Old Common Stock shall have been reclassified. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The designations and the powers,
privileges and rights, and the qualifications, limitations or restrictions thereof in respect of each class of capital stock of the Corporation are as follows: </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A. <U>COMMON STOCK</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">1. <U>General</U>. The voting, dividend, liquidation, and other rights and powers of the Common Stock are subject to and qualified by the
rights, powers and preferences of any series of Preferred Stock as may be designated by the Board of Directors of the Corporation (the &#147;<U>Board of Directors</U>&#148;) and outstanding from time to time. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">2. <U>Voting</U>. Except as otherwise provided herein or expressly required by law, each holder of Common Stock, as such, shall be entitled to
vote on each matter submitted to a vote of stockholders and shall be entitled to one (1)&nbsp;vote for each share of Common Stock held of record by such holder as of the record date for determining stockholders entitled to vote on such matter.
Except as otherwise required by law, holders of Common Stock, as such, shall not be entitled to vote on any amendment to this Certificate (including any Certificate of Designation (as defined below)) that relates solely to the terms of any
outstanding series of Preferred Stock if the holders of such affected series are entitled, either separately or together with the holders of one or more other such series, to vote thereon pursuant to this Certificate (including any Certificate of
Designation) or pursuant to the DGCL. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Subject to the rights of any holders of any outstanding series of Preferred Stock, the number of
authorized shares of Common Stock or Preferred Stock may be increased or decreased (but not below the number of shares thereof then outstanding), in each case by the affirmative vote of the holders of a majority of the stock of the Corporation
entitled to vote, irrespective of the provisions of Section&nbsp;242(b)(2) of the DGCL. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">3. <U>Dividends</U>. Subject to applicable law
and the rights and preferences of any holders of any outstanding series of Preferred Stock, the holders of Common Stock, as such, shall be entitled to the payment of dividends on the Common Stock when, as and if declared by the Board of Directors in
accordance with applicable law. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">4. <U>Liquidation</U>. Subject to the rights and preferences of any holders of any shares of any
outstanding series of Preferred Stock, in the event of any voluntary or involuntary liquidation, dissolution or winding up of the affairs of the Corporation, and after payment or provision for payment of the debts and other liabilities of the
Corporation, if any, the funds and assets of the Corporation that may be legally distributed to the Corporation&#146;s stockholders shall be distributed among the holders of the then outstanding Common Stock <I>pro rata</I> in accordance with the
number of shares of Common Stock held by each such holder. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">B. <U>PREFERRED STOCK</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Shares of Preferred Stock may be issued from time to time in one or more series, each of such series to have such terms as stated or expressed
herein and in the resolution or resolutions providing for the creation and issuance of such series adopted by the Board of Directors hereinafter provided. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Authority is hereby expressly granted to the Board of Directors from time to time to issue
the Preferred Stock in one or more series, and in connection with the creation of any such series, by adopting a resolution or resolutions providing for the issuance of the shares thereof and by filing a certificate of designation relating thereto
in accordance with the DGCL (a &#147;<U>Certificate of Designation</U>&#148;), to determine and fix the number of shares of such series and such voting powers, full or limited, or no voting powers, and such designations, preferences and relative
participating, optional or other special rights, and qualifications, limitations or restrictions thereof, including without limitation thereof, dividend rights, conversion rights, redemption privileges and liquidation preferences, and to increase or
decrease (but not below the number of shares of such series then outstanding) the number of shares of any series as shall be stated and expressed in such resolutions, all to the fullest extent now or hereafter permitted by the DGCL. Without limiting
the generality of the foregoing, the resolution or resolutions providing for the creation and issuance of any series of Preferred Stock may provide that such series shall be superior or rank equally or be junior to any other series of Preferred
Stock to the extent permitted by law and this Certificate (including any Certificate of Designation). Except as otherwise required by law, holders of any series of Preferred Stock shall be entitled only to such voting rights, if any, as shall
expressly be granted thereto by this Certificate (including any Certificate of Designation). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The number of authorized shares of Preferred
Stock may be increased or decreased (but not below the number of shares thereof then outstanding) by the affirmative vote of the holders of a majority of the stock of the Corporation entitled to vote, irrespective of the provisions of
Section&nbsp;242(b)(2) of the DGCL. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>ARTICLE V </U></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">BOARD OF DIRECTORS </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For the
management of the business and for the conduct of the affairs of the Corporation it is further provided that: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A. Other than those
directors, if any, elected by the holders of any series of Preferred Stock, the directors of the Corporation shall be classified with respect to the time for which they severally hold office into three (3)&nbsp;classes, as nearly equal in number as
possible, designated as Class&nbsp;I, Class&nbsp;II and Class&nbsp;III. Except for the terms of such additional directors, if any, as elected by the holders of any series of Preferred Stock, each director shall serve for a term ending on the date of
the third (3rd) annual meeting of stockholders following the annual meeting at which the director was elected. The initial Class&nbsp;I directors shall serve for a term expiring at the first (1st) annual meeting of the stockholders following the
date of this Certificate; the initial Class&nbsp;II directors shall serve for a term expiring at the second (2nd) annual meeting of the stockholders following the date of this Certificate; and the initial Class&nbsp;III directors shall serve for a
term expiring at the third (3rd) annual meeting of the stockholders following the date of this Certificate. At each annual meeting of the stockholders of the Corporation beginning with the first annual meeting of the stockholders following the date
of this Certificate, the successors of the class of directors whose term expires at that meeting shall be elected to hold office for a term expiring at the annual meeting of the stockholders held in the third year following the year of their
election. If the number of directors is changed, any increase or decrease shall be apportioned among the classes so as to maintain the number of directors in each class as nearly equal as possible, and any additional director of any class elected to
fill a vacancy resulting from an increase in such class or from the removal from office, death, resignation, retirement, disqualification, removal of a director or other cause shall hold office for a term that shall coincide with the remaining term
of that class. In no event, will a decrease in the number of directors have the effect of removing or shortening the term of any incumbent director. The Board of Directors is authorized to assign members of the Board of Directors already in office
to Class&nbsp;I, Class&nbsp;II and Class&nbsp;III. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">B. Except as otherwise expressly provided by the DGCL or this Certificate, the business and
affairs of the Corporation shall be managed by or under the direction of the Board of Directors. Except as otherwise provided for or fixed pursuant to <U>Part E</U> of this <U>Article V</U> relating to the rights of the holders of any series of
Preferred Stock to elect additional directors, the number of directors which shall constitute the whole Board of Directors shall be fixed exclusively by one or more resolutions adopted from time to time by the Board of Directors. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">C. Subject to any special rights of the holders of one or more outstanding series of Preferred Stock to elect directors, the Board of
Directors or any individual director may be removed from office at any time, but only for cause and only by the affirmative vote of the holders of at least <FONT STYLE="white-space:nowrap">two-thirds</FONT> (66 and 2/3%) of the voting power of all
of the then outstanding shares of voting stock of the Corporation entitled to vote generally in an election of directors. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">D. Subject to
any special rights of the holders of one or more outstanding series of Preferred Stock to elect directors, except as otherwise provided by law, any vacancies on the Board of Directors resulting from death, resignation, retirement, disqualification,
removal or other causes and any newly created directorships resulting from any increase in the number of directors shall be filled exclusively by the affirmative vote of a majority of the directors then in office, even though less than a quorum, or
by a sole remaining director (other than any directors elected by the separate vote of one or more outstanding series of Preferred Stock), and shall not be filled by the stockholders. Any director appointed in accordance with the preceding sentence
shall hold office until the expiration of the term of the class to which such director shall have been appointed or until his or her earlier death, resignation, retirement, disqualification, or removal. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>ARTICLE XV</B>E. Whenever the holders of any one or more series of Preferred Stock issued by the Corporation shall have the right, voting separately as a
series or separately as a class with one or more such other series, to elect directors at an annual or special meeting of stockholders, the election, term of office, removal and other features of such directorships shall be governed by the terms of
this Certificate (including any Certificate of Designation). Notwithstanding anything to the contrary in this <U>Article V</U>, the number of directors that may be elected by the holders of any such series of Preferred Stock shall be in addition to
the number fixed pursuant to <U>Part B</U> of this <U>Article V</U>, and the total number of directors constituting the whole Board of Directors shall be automatically adjusted accordingly. Except as otherwise provided in the Certificate of
Designation(s) in respect of one or more series of Preferred Stock, whenever the holders of any series of Preferred Stock having such right to elect additional directors are divested of such right pursuant to the provisions of such Certificate of
Designation(s), the terms of office of all such additional directors elected by the holders of such series of Preferred Stock, or elected to fill any vacancies resulting from the death, resignation, retirement, disqualification or removal of such
additional directors, shall forthwith terminate (in which case each such director thereupon shall cease to be qualified as, and shall cease to be, a director) and the total authorized number of directors of the Corporation shall automatically be
reduced accordingly. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">F. In furtherance and not in limitation of the powers conferred by statute, the Board of
Directors is expressly authorized to adopt, amend or repeal the Bylaws of the Corporation (as amended and/or restated from time to time, the &#147;<U>Bylaws</U>&#148;). The stockholders of the Corporation shall also have power to adopt, amend or
repeal the Bylaws; provided, however, in addition to any vote of the holders of any class or series of stock of the Corporation required by applicable law or by this Certificate (including any Certificate of Designation in respect of one or more
series of Preferred Stock) or the Bylaws of the Corporation, the adoption, amendment or repeal of the Bylaws of the Corporation by the stockholders of the Corporation shall require the affirmative vote of the holders of at least <FONT
STYLE="white-space:nowrap">two-thirds</FONT> (66 and 2/3%) of the voting power of all of the then outstanding shares of voting stock of the Corporation entitled to vote generally in an election of directors, voting together as a single class. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">G. The directors of the Corporation need not be elected by written ballot unless the Bylaws so provide. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>ARTICLE VI </U></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">STOCKHOLDERS
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A. Any action required or permitted to be taken by the stockholders of the Corporation may be effected only at a duly called annual or
special meeting of stockholders and may not be effected by any consent in writing by such stockholders in lieu of such meeting. Notwithstanding the foregoing, any action required or permitted to be taken by the holders of any series of Preferred
Stock, voting separately as a series or separately as a class with one or more other such series, may be taken without a meeting, without prior notice and without a vote, to the extent expressly so provided by the applicable Certificate of
Designation relating to such series of Preferred Stock, if a consent or consents in writing, setting forth the action so taken, shall be signed by the holders of outstanding shares of the relevant series of Preferred Stock having not less than the
minimum number of votes that would be necessary to authorize or take such action at a meeting at which all shares entitled to vote thereon were present and voted and shall be delivered to the Corporation in accordance with the applicable provisions
of the DGCL. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">B. Subject to the special rights of the holders of one or more series of Preferred Stock, special meetings of the
stockholders of the Corporation may be called, for any purpose or purposes, at any time only by or at the direction of (i)&nbsp;the Board of Directors, (ii)&nbsp;the Chairperson of the Board of Directors, (iii)&nbsp;the Chief Executive Officer, or
(iv)&nbsp;the President, and shall not be called by any other person or persons. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">C. Advance notice of stockholder nominations for the
election of directors and of other business proposed to be brought by stockholders before any meeting of the stockholders of the Corporation shall be given in the manner provided in the Bylaws of the Corporation. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>ARTICLE VII </U></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">LIABILITY </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">No director of the
Corporation shall have any personal liability to the Corporation or its stockholders for monetary damages for any breach of fiduciary duty as a director, except to the extent such exemption from liability or limitation thereof is not permitted under
the DGCL as the same exists or hereafter may be amended. Any amendment, repeal or modification of this <U>Article VII</U>, or the adoption of any provision of the Certificate inconsistent with this <U>Article VII</U>, shall not adversely affect any
right or protection of a director of the Corporation with respect to any act or omission occurring prior to the time of such amendment, repeal, modification or adoption. If the DGCL is amended after approval by the stockholders of this <U>Article
VII</U> to authorize corporate action further eliminating or limiting the personal liability of directors, then the liability of a director of the Corporation shall be eliminated or limited to the fullest extent permitted by the DGCL as so amended.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>ARTICLE VIII </U></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">INDEMNIFICATION </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Corporation
shall have the power to provide rights to indemnification and advancement of expenses to its current and former officers, directors, employees and agents and to any person who is or was serving at the request of the Corporation as a director,
officer, employee or agent of another corporation, partnership, joint venture, trust or other enterprise. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>ARTICLE IX </U></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">FORUM SELECTION </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Unless the
Corporation consents in writing to the selection of an alternative forum, (a)&nbsp;the Court of Chancery (the &#147;<U>Chancery Court</U>&#148;) of the State of Delaware (or, in the event that the Chancery Court does not have jurisdiction, the
federal district court for the District of Delaware or other state courts of the State of Delaware) shall, to the fullest extent permitted by law, be the sole and exclusive forum for (i)&nbsp;any derivative action, suit or proceeding
(&#147;<U>Proceeding</U>&#148;) brought on behalf of the Corporation, (ii)&nbsp;any Proceeding asserting a claim of breach of a fiduciary duty owed by any director, officer or stockholder of the Corporation to the Corporation or to the
Corporation&#146;s stockholders, (iii)&nbsp;any Proceeding arising pursuant to any provision of the DGCL, this Certificate or the Bylaws (in each case, as may be amended from time to time) or (iv)&nbsp;any Proceeding asserting a claim against the
Corporation governed by the internal affairs doctrine; and (b)&nbsp;subject to the preceding provisions of this <U>Article IX</U>, to the extent permitted by applicable law, the federal district courts of the United States of America shall be the
exclusive forum for the resolution of any complaint asserting a cause of action arising under the Securities Act of 1933, as amended. If any action the subject matter of which is within the scope of clause (a)&nbsp;of the immediately preceding
sentence is filed in a court other than the courts in the State of Delaware (a &#147;<U>Foreign Action</U>&#148;) in the name of any stockholder, such stockholder shall be deemed to have consented to (x)&nbsp;the personal jurisdiction of the state
and federal courts in the State of Delaware in connection with any action brought in any such court to enforce the provisions of clause (a)&nbsp;of the immediately preceding sentence and (y)&nbsp;having service of process made upon such stockholder
in any such action by service upon such stockholder&#146;s counsel in the Foreign Action as agent for such stockholder. If any action the subject matter of which is within the scope of clause (b)&nbsp;of this <U>Article IX</U> is filed in a court
other than the federal district courts of the United States of America (a &#147;<U>Foreign Securities Act Action</U>&#148;) in the name of any stockholder, such stockholder shall be deemed to have consented to (i)&nbsp;the personal jurisdiction of
the federal district courts of the United States of America in connection with any action brought in any such court to enforce clause (b) (a &#147;<U>Securities Act Enforcement Action</U>&#148;), and (ii)&nbsp;having service of process made upon
such stockholder in any such Securities Act Enforcement Action by service upon such stockholder&#146;s counsel in the Foreign Securities Act Action as agent for such stockholder. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For the avoidance of doubt, clause (b)&nbsp;of this <U>Article IX</U> is intended to benefit
and may be enforced by the Corporation, its officers and directors, the underwriters to any offering giving rise to any Proceeding, and any other professional or entity whose profession gives authority to a statement made by that person or entity
and who has prepared or certified any part of the documents underlying the offering. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any person or entity purchasing or otherwise
acquiring any interest in any security of the Corporation shall be deemed to have notice of and consented to this <U>Article IX</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Notwithstanding the foregoing, the provisions of this Article IX shall not apply to suits brought to enforce any liability or duty created by
the Securities Exchange Act of 1934, as amended, or any other claim for which the federal courts of the United States have exclusive jurisdiction. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If any provision or provisions of this <U>Article IX</U> shall be held to be invalid, illegal or unenforceable as applied to any circumstance
for any reason whatsoever, (i)&nbsp;the validity, legality and enforceability of such provisions in any other circumstance and of the remaining provisions of this <U>Article IX</U> (including, without limitation, each portion of any paragraph of
this <U>Article IX</U> containing any such provision held to be invalid, illegal or unenforceable that is not itself held to be invalid, illegal or unenforceable) shall not in any way be affected or impaired thereby and (ii)&nbsp;the application of
such provision to other persons or entities and circumstances shall not in any way be affected or impaired thereby. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>ARTICLE X </U></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">AMENDMENTS </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A. Notwithstanding
anything contained in this Certificate to the contrary, in addition to any vote required by applicable law, the following provisions in this Certificate may be amended, altered, repealed or rescinded, in whole or in part, or any provision
inconsistent therewith or herewith may be adopted, only by the affirmative vote of the holders of at least <FONT STYLE="white-space:nowrap">two-thirds</FONT> (66 and 2/3%) of the total voting power of all of the then outstanding shares of stock of
the Corporation entitled to vote thereon, voting together as a single class: <U>Part B</U> of <U>Article IV</U>, <U>Article V</U>, <U>Article VI</U>, <U>Article VII</U>, <U>Article VIII</U>, <U>Article IX</U>, and this <U>Article X</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">B. If any provision or provisions of this Certificate shall be held to be invalid, illegal or unenforceable as applied to any circumstance for
any reason whatsoever: (i)&nbsp;the validity, legality and enforceability of such provisions in any other circumstance and of the remaining provisions of this Certificate (including, without limitation, each portion of any paragraph of this
Certificate containing any such provision held to be invalid, illegal or unenforceable that is not itself held to be invalid, illegal or unenforceable) shall not, to the fullest extent permitted by applicable law, in any way be affected or impaired
thereby and (ii)&nbsp;to the fullest extent permitted by applicable law, the provisions of this Certificate (including, without limitation, each such portion of any paragraph of this Certificate containing any such provision held to be invalid,
illegal or unenforceable) shall be construed so as to permit the Corporation to protect its directors, officers, employees and agents from personal liability in respect of their good faith service to or for the benefit of the Corporation to the
fullest extent permitted by law. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>[Signature Page Follows] </I></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">IN WITNESS WHEREOF, the Corporation has caused this Certificate to be signed by a duly
authorized officer of the Corporation, on [&nbsp;&#9679;&nbsp;], 2022. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">[OMNIAB, INC.]</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Name: [ &#149; ]</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Title: [ &#149; ]</TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>[Signature Page to Certificate of Incorporation] </I></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Exhibit H to the Merger Agreement </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>[Signature Page to Certificate of Incorporation] </I></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B><I>Confidential </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Bylaws of </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[OmniAb, Inc.] </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(a Delaware corporation) </P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>TABLE OF CONTENTS </U></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="89%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD COLSPAN="3" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Page</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Article I - CORPORATE OFFICES</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">1.1</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Registered Office</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">1.2</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Other Offices</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Article II - MEETINGS OF STOCKHOLDERS</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2.1</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Place of Meetings</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2.2</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Annual Meeting</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2.3</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Special Meeting</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2.4</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Notice of Business to be Brought before a Meeting</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2.5</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Notice of Nominations for Election to the Board</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2.6</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Notice of Stockholders&#146; Meetings</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2.7</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Manner of Giving Notice; Affidavit of Notice</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2.8</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Quorum</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2.9</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Adjourned Meeting; Notice</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2.10</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Conduct of Business</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2.11</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Voting</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2.12</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Record Date for Stockholder Meetings and Other Purposes</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2.13</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Proxies</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">13</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2.14</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">List of Stockholders Entitled to Vote</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">13</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2.15</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Inspectors of Election</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2.16</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Delivery to the Corporation</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">15</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2.17</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Stockholder Action by Written Consent Without a Meeting</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">15</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Article III - DIRECTORS</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">15</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3.1</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Powers</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">15</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3.2</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Number of Directors</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">15</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3.3</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Election, Qualification and Term of Office of Directors</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">16</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3.4</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Resignation and Vacancies</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">16</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3.5</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Place of Meetings; Meetings by Telephone</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">16</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3.6</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Regular Meetings</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">17</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3.7</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Special Meetings; Notice</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">17</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3.8</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Quorum</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">17</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3.9</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Board Action by Written Consent without a Meeting</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">18</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3.10</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Fees and Compensation of Directors</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">18</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3.11</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Removal of Directors</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">18</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">i </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>TABLE OF CONTENTS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(continued) </B></P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="89%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD COLSPAN="3" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Page</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Article IV - COMMITTEES</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">18</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">4.1</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Committees of Directors</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">18</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">4.2</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Committee Minutes</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">19</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">4.3</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Meetings and Actions of Committees</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">19</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">4.4</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Subcommittees</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">19</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Article V - OFFICERS</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">20</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">5.1</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Officers</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">20</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">5.2</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Appointment of Officers</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">20</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">5.3</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Subordinate Officers</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">20</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">5.4</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Removal and Resignation of Officers</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">20</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">5.5</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Vacancies in Offices</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">20</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">5.6</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Representation of Shares of Other Corporations</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">21</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">5.7</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Authority and Duties of Officers</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">21</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">5.8</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Compensation</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">21</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Article VI - RECORDS</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">21</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Article VII - GENERAL MATTERS</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">21</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">7.1</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Execution of Corporate Contracts and Instruments</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">21</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">7.2</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Stock Certificates</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">22</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">7.3</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Special Designation of Certificates</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">22</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">7.4</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Lost Certificates</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">23</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">7.5</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Shares Without Certificates</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">23</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">7.6</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Construction; Definitions</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">23</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">7.7</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Dividends</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">23</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">7.8</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Fiscal Year</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">23</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">7.9</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Seal</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">23</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">7.10</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Transfer of Stock</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">24</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">7.11</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Stock Transfer Restrictions; Stock Forfeitures</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">24</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">7.12</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Registered Stockholders</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">24</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">7.13</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Waiver of Notice</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">24</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Article VIII - NOTICE</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">25</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">8.1</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Delivery of Notice; Notice by Electronic Transmission</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">25</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Article IX - INDEMNIFICATION</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">26</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">9.1</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Indemnification of Directors and Officers</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">26</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">9.2</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Indemnification of Others</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">26</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ii </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>TABLE OF CONTENTS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(continued) </B></P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="89%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD COLSPAN="3" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Page</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">9.3</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Prepayment of Expenses</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">27</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">9.4</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Determination; Claim</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">27</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">9.5</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="white-space:nowrap">Non-Exclusivity</FONT> of Rights</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">27</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">9.6</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Insurance</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">27</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">9.7</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Other Indemnification</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">27</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">9.8</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Continuation of Indemnification</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">28</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">9.9</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Amendment or Repeal; Interpretation</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">28</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="97%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Article X - AMENDMENTS</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">29</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Article XI - DEFINITIONS</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">29</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:18pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">iii </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Bylaws of </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[OmniAb, Inc.] </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE XX<U>-
CORPORATE OFFICES</U> </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;20.1 <U>Registered Office</U>. The address of the registered office of [OmniAb, Inc.] (the
&#147;<U>Corporation</U>&#148;) in the State of Delaware, and the name of its registered agent at such address, shall be as set forth in the Corporation&#146;s certificate of incorporation, as the same may be amended and/or restated from time to
time (the &#147;<U>Certificate of Incorporation</U>&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;20.2 <U>Other Offices</U>. The Corporation may have additional
offices at any place or places, within or outside the State of Delaware, as the Corporation&#146;s board of directors (the &#147;<U>Board</U>&#148;) may from time to time establish or as the business of the Corporation may require. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE XXI<U>- MEETINGS OF STOCKHOLDERS</U> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;21.1 <U>Place of Meetings</U>. Meetings of stockholders shall be held at any place, within or outside the State of Delaware,
designated by the Board. The Board may, in its sole discretion, determine that a meeting of stockholders shall not be held at any place, but may instead be held solely by means of remote communication as authorized by Section&nbsp;211(a) of the
General Corporation Law of the State of Delaware (the &#147;<U>DGCL</U>&#148;). In the absence of any such designation or determination, stockholders&#146; meetings shall be held at the Corporation&#146;s principal executive office. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;21.2 <U>Annual Meeting</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Board shall designate the date and time of the annual meeting. At the annual meeting, directors shall be elected and other proper business
properly brought before the meeting in accordance with <U>Section</U><U></U><U>&nbsp;2.4</U> may be transacted. The Board may postpone, reschedule or cancel any previously scheduled annual meeting of stockholders. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;21.3 <U>Special Meeting</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Special meetings of the stockholders may be called only by such persons and only in such manner as set forth in the Certificate of
Incorporation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">No business may be transacted at any special meeting of stockholders other than the business specified in the notice of
such meeting. The Board may postpone, reschedule or cancel any previously scheduled special meeting of stockholders. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;21.4 <U>Notice of Business to be Brought before a Meeting</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) At an annual meeting of the stockholders, only such business shall be conducted as shall have been properly brought before the meeting. To
be properly brought before an annual meeting, business must be (i)&nbsp;specified in a notice of meeting given by or at the direction of the Board, (ii)&nbsp;if not specified in a notice of meeting, otherwise brought before the meeting by the Board
or the Chairperson of the Board or (iii)&nbsp;otherwise properly brought before the meeting by a stockholder present in person who (A)&nbsp;(1) was a record owner of shares of the Corporation both at the time of giving the notice provided for in
this <U>Section</U><U></U><U>&nbsp;2.4</U> and at the time of the meeting, (2)&nbsp;is entitled to vote at the meeting and (3)&nbsp;has complied with this <U>Section</U><U></U><U>&nbsp;2.4</U> in all applicable respects or (B)&nbsp;properly made
such proposal in accordance with Rule <FONT STYLE="white-space:nowrap">14a-8</FONT> under the Securities Exchange Act of 1934, as amended, and the rules and regulations thereunder (as so amended and inclusive of such rules and regulations, the
&#147;<U>Exchange Act</U>&#148;). The foregoing clause (iii)&nbsp;shall be the exclusive means for a stockholder to propose business to be brought before an annual meeting of the stockholders. The only matters that may be brought before a special
meeting are the matters specified in the notice of meeting given by or at the direction of the person calling the meeting pursuant to <U>Section</U><U></U><U>&nbsp;2.3</U>, and stockholders shall not be permitted to propose business to be brought
before a special meeting of the stockholders. For purposes of this <U>Section</U><U></U><U>&nbsp;2.4</U>, &#147;<U>present in person</U>&#148; shall mean that the stockholder proposing that the business be brought before the annual meeting of the
Corporation, or a qualified representative of such proposing stockholder, appear at such annual meeting in person, or by remote communication, if applicable. A &#147;<U>qualified representative</U>&#148; of such proposing stockholder shall be a duly
authorized officer, manager or partner of such stockholder or any other person authorized by a writing executed by such stockholder or an electronic transmission delivered by such stockholder to act for such stockholder as proxy at the meeting of
stockholders and such person must produce such writing or electronic transmission, or a reliable reproduction of the writing or electronic transmission, at the meeting of stockholders. Stockholders seeking to nominate persons for election to the
Board must comply with <U>Section</U><U></U><U>&nbsp;2.5</U>, and this <U>Section</U><U></U><U>&nbsp;2.4</U> shall not be applicable to nominations except as expressly provided in <U>Section</U><U></U><U>&nbsp;2.5</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) Without qualification, for business to be properly brought before an annual meeting by a stockholder, the stockholder must
(i)&nbsp;provide Timely Notice (as defined below) thereof in writing and in proper form to the Secretary of the Corporation and (ii)&nbsp;provide any updates or supplements to such notice at the times and in the forms required by this
<U>Section</U><U></U><U>&nbsp;2.4</U>. To be timely, a stockholder&#146;s notice must be delivered to, or mailed and received at, the principal executive offices of the Corporation not less than ninety (90)&nbsp;days nor more than one hundred twenty
(120)&nbsp;days prior to the <FONT STYLE="white-space:nowrap">one-year</FONT> anniversary of the preceding year&#146;s annual meeting; <I>provided, however</I>, that if no annual meeting was held in the preceding year, to be timely, a
stockholder&#146;s notice must be so delivered, or mailed and received, not earlier than the close of business on the one hundred and twentieth (120<SUP STYLE="font-size:85%; vertical-align:top">th</SUP>) day prior to such annual meeting and not
later than the close of business on the later of the ninetieth (90<SUP STYLE="font-size:85%; vertical-align:top">th</SUP>) day prior to such annual meeting or, if later, the tenth (10<SUP STYLE="font-size:85%; vertical-align:top">th</SUP>) day
following the day on which public disclosure of the date of such annual meeting was first made by the Corporation; <I>provided, further</I>, that if the date of the annual meeting is more than thirty (30)&nbsp;days before or more than sixty
(60)&nbsp;days after such anniversary date, to be timely, a stockholder&#146;s notice must be so delivered, or mailed and received, not later than the ninetieth (90<SUP STYLE="font-size:85%; vertical-align:top">th</SUP>) day prior to such annual
meeting or, if later, the tenth (10<SUP STYLE="font-size:85%; vertical-align:top">th</SUP>) day following the day on which public disclosure of the date of such annual meeting was first made by the Corporation (such notice within such time periods,
&#147;<U>Timely Notice</U>&#148;). In no event shall any adjournment or postponement of an annual meeting or the announcement thereof commence a new time period for the giving of Timely Notice as described above. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) To be in proper form for purposes of this <U>Section</U><U></U><U>&nbsp;2.4</U>, a
stockholder&#146;s notice to the Secretary of the Corporation shall set forth: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) As to each Proposing Person (as defined
below), (A)&nbsp;the name and address of such Proposing Person (including, if applicable, the name and address that appear on the Corporation&#146;s books and records); and (B)&nbsp;the class or series and number of shares of the Corporation that
are, directly or indirectly, owned of record or beneficially owned (within the meaning of Rule <FONT STYLE="white-space:nowrap">13d-3</FONT> under the Exchange Act) by such Proposing Person, except that such Proposing Person shall in all events be
deemed to beneficially own any shares of any class or series of the Corporation as to which such Proposing Person has a right to acquire beneficial ownership at any time in the future (the disclosures to be made pursuant to the foregoing clauses
(A)&nbsp;and (B) are referred to as &#147;<U>Stockholder Information</U>&#148;); </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) As to each Proposing Person,
(A)&nbsp;the full notional amount of any securities that, directly or indirectly, underlie any &#147;derivative security&#148; (as such term is defined in Rule <FONT STYLE="white-space:nowrap">16a-1(c)</FONT> under the Exchange Act) that constitutes
a &#147;call equivalent position&#148; (as such term is defined in Rule <FONT STYLE="white-space:nowrap">16a-1(b)</FONT> under the Exchange Act) (&#147;<U>Synthetic Equity Position</U>&#148;) and that is, directly or indirectly, held or maintained
by such Proposing Person with respect to any shares of any class or series of shares of the Corporation; <I>provided</I> that, for the purposes of the definition of &#147;Synthetic Equity Position,&#148; the term &#147;derivative security&#148;
shall also include any security or instrument that would not otherwise constitute a &#147;derivative security&#148; as a result of any feature that would make any conversion, exercise or similar right or privilege of such security or instrument
becoming determinable only at some future date or upon the happening of a future occurrence, in which case the determination of the amount of securities into which such security or instrument would be convertible or exercisable shall be made
assuming that such security or instrument is immediately convertible or exercisable at the time of such determination; and, <I>provided, further</I>, that any Proposing Person satisfying the requirements of Rule
<FONT STYLE="white-space:nowrap">13d-1(b)(1)</FONT> under the Exchange Act (other than a Proposing Person that so satisfies Rule <FONT STYLE="white-space:nowrap">13d-1(b)(1)</FONT> under the Exchange Act solely by reason of Rule <FONT
STYLE="white-space:nowrap">13d-1(b)(1)(ii)(E))</FONT> shall not be deemed to hold or maintain the notional amount of any securities that underlie a Synthetic Equity Position held by such Proposing Person as a hedge with respect to a bona fide
derivatives trade or position of such Proposing Person arising in the ordinary course of such Proposing Person&#146;s business as a derivatives dealer, (B)&nbsp;any rights to dividends on the shares of any class or series of shares of the
Corporation owned beneficially by such Proposing Person that are separated or separable from the underlying shares of the Corporation, (C)&nbsp;any material pending or threatened legal proceeding in which such Proposing Person is a party or material
participant involving the Corporation or any of its officers or directors, or any affiliate of the Corporation, (D)&nbsp;any other </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
material relationship between such Proposing Person, on the one hand, and the Corporation or any affiliate of the Corporation, on the other hand, (E)&nbsp;any direct or indirect material interest
in any material contract or agreement of such Proposing Person with the Corporation or any affiliate of the Corporation (including, in any such case, any employment agreement, collective bargaining agreement or consulting agreement), (F) a
representation that such Proposing Person intends or is part of a group that intends to deliver a proxy statement or form of proxy to holders of at least the percentage of the Corporation&#146;s outstanding capital stock required to approve or adopt
the proposal or otherwise solicit proxies from stockholders in support of such proposal and (G)&nbsp;any other information relating to such Proposing Person that would be required to be disclosed in a proxy statement or other filing required to be
made in connection with solicitations of proxies or consents by such Proposing Person in support of the business proposed to be brought before the meeting pursuant to Section&nbsp;14(a) of the Exchange Act (the disclosures to be made pursuant to the
foregoing clauses (A)&nbsp;through (G) are referred to as &#147;<U>Disclosable Interests</U>&#148;); <I>provided</I>, <I>however</I>, that Disclosable Interests shall not include any such disclosures with respect to the ordinary course business
activities of any broker, dealer, commercial bank, trust company or other nominee who is a Proposing Person solely as a result of being the stockholder directed to prepare and submit the notice required by these bylaws on behalf of a beneficial
owner; and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii) As to each item of business that the stockholder proposes to bring before the annual meeting, (A)&nbsp;a
brief description of the business desired to be brought before the annual meeting, the reasons for conducting such business at the annual meeting and any material interest in such business of each Proposing Person, (B)&nbsp;the text of the proposal
or business (including the text of any resolutions proposed for consideration and in the event that such business includes a proposal to amend the bylaws, the language of the proposed amendment), (C)&nbsp;a reasonably detailed description of all
agreements, arrangements and understandings (x)&nbsp;between or among any of the Proposing Persons or (y)&nbsp;between or among any Proposing Person and any other person or entity (including their names) in connection with the proposal of such
business by such stockholder, and (D)&nbsp;any other information relating to such item of business that would be required to be disclosed in a proxy statement or other filing required to be made in connection with solicitations of proxies in support
of the business proposed to be brought before the meeting pursuant to Section&nbsp;14(a) of the Exchange Act; <I>provided</I>, <I>however</I>, that the disclosures required by this <U>Section</U><U></U><U>&nbsp;2.4(c)(iii)</U> shall not include any
disclosures with respect to any broker, dealer, commercial bank, trust company or other nominee who is a Proposing Person solely as a result of being the stockholder directed to prepare and submit the notice required by these bylaws on behalf of a
beneficial owner. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For purposes of this <U>Section</U><U></U><U>&nbsp;2.4</U>, the term &#147;<U>Proposing Person</U><I>&#148; </I>shall
mean (i)&nbsp;the stockholder providing the notice of business proposed to be brought before an annual meeting, (ii)&nbsp;the beneficial owner or beneficial owners, if different, on whose behalf the notice of the business proposed to be brought
before the annual meeting is made, and (iii)&nbsp;any participant (as defined in paragraphs (a)(ii)-(vi) of Instruction 3 to Item 4 of Schedule 14A) with such stockholder in such solicitation.<SUP STYLE="font-size:85%; vertical-align:top"> </SUP>
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) A Proposing Person shall update and supplement its notice to the Corporation of its
intent to propose business at an annual meeting, if necessary, so that the information provided or required to be provided in such notice pursuant to this <U>Section</U><U></U><U>&nbsp;2.4</U> shall be true and correct as of the record date for
stockholders entitled to vote at the meeting and as of the date that is ten (10)&nbsp;business days prior to the meeting or any adjournment or postponement thereof, and such update and supplement shall be delivered to, or mailed and received by, the
Secretary of the Corporation at the principal executive offices of the Corporation not later than five (5)&nbsp;business days after the record date for stockholders entitled to vote at the meeting (in the case of the update and supplement required
to be made as of such record date), and not later than eight (8)&nbsp;business days prior to the date for the meeting or, if practicable, any adjournment or postponement thereof (and, if not practicable, on the first practicable date prior to the
date to which the meeting has been adjourned or postponed) (in the case of the update and supplement required to be made as of ten (10)&nbsp;business days prior to the meeting or any adjournment or postponement thereof). For the avoidance of doubt,
the obligation to update and supplement as set forth in this paragraph or any other Section of these bylaws shall not limit the Corporation&#146;s rights with respect to any deficiencies in any notice provided by a stockholder, extend any applicable
deadlines hereunder or enable or be deemed to permit a stockholder who has previously submitted notice hereunder to amend or update any proposal or to submit any new proposal, including by changing or adding matters, business or resolutions proposed
to be brought before a meeting of the stockholders. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) Notwithstanding anything in these bylaws to the contrary, no business shall be
conducted at an annual meeting that is not properly brought before the meeting in accordance with this <U>Section</U><U></U><U>&nbsp;2.4</U>. The presiding officer of the meeting shall, if the facts warrant, determine that the business was not
properly brought before the meeting in accordance with this <U>Section</U><U></U><U>&nbsp;2.4</U>, and if he or she should so determine, he or she shall so declare to the meeting and any such business not properly brought before the meeting shall
not be transacted. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f) This <U>Section</U><U></U><U>&nbsp;2.4</U> is expressly intended to apply to any business proposed to be brought
before an annual meeting of stockholders other than any proposal made in accordance with Rule <FONT STYLE="white-space:nowrap">14a-8</FONT> under the Exchange Act and included in the Corporation&#146;s proxy statement. In addition to the
requirements of this <U>Section</U><U></U><U>&nbsp;2.4</U> with respect to any business proposed to be brought before an annual meeting, each Proposing Person shall comply with all applicable requirements of the Exchange Act with respect to any such
business. Nothing in this <U>Section</U><U></U><U>&nbsp;2.4</U> shall be deemed to affect the rights of stockholders to request inclusion of proposals in the Corporation&#146;s proxy statement pursuant to Rule
<FONT STYLE="white-space:nowrap">14a-8</FONT> under the Exchange Act. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(g) For purposes of these bylaws, &#147;<U>public
disclosure</U>&#148; shall mean disclosure in a press release reported by a national news service or in a document publicly filed by the Corporation with the Securities and Exchange Commission pursuant to Sections 13, 14 or 15(d) of the Exchange
Act. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;21.5 <U>Notice of Nominations for Election to the </U><U>Board</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) Subject in all respects to the provisions of the Certificate of Incorporation, nominations of any person for election to the Board at an
annual meeting or at a special meeting (but only if the election of directors is a matter specified in the notice of meeting given by or at the direction of the person calling such special meeting) may be made at such meeting only (i)&nbsp;by or at
the direction of the Board, including by any committee or persons authorized to do so by the Board or these bylaws, or (ii)&nbsp;by a stockholder present in person (A)&nbsp;who was a record owner of shares of the Corporation both at the time of
giving the notice provided for in this <U>Section</U><U></U><U>&nbsp;2.5</U> and at the time of the meeting, (B)&nbsp;is entitled to vote at the meeting, and (C)&nbsp;has complied with this <U>Section</U><U></U><U>&nbsp;2.5</U> as to such notice and
nomination. For purposes of this <U>Section</U><U></U><U>&nbsp;2.5</U>, &#147;<U>present in person</U>&#148; shall mean that the stockholder proposing that the business be brought before the meeting of the Corporation, or a qualified representative
of such stockholder, appear at such meeting in person, or by remote communication, if applicable. A &#147;<U>qualified representative</U>&#148; of such proposing stockholder shall be a duly authorized officer, manager or partner of such stockholder
or any other person authorized by a writing executed by such stockholder or an electronic transmission delivered by such stockholder to act for such stockholder as proxy at the meeting of stockholders and such person must produce such writing or
electronic transmission, or a reliable reproduction of the writing or electronic transmission, at the meeting of stockholders. The foregoing clause (iii)&nbsp;shall be the exclusive means for a stockholder to make any nomination of a person or
persons for election to the Board at an annual meeting or special meeting other than in accordance with the provisions of the Certificate of Incorporation. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) (i) For a stockholder to make any nomination of a person or persons for election to the Board at an annual meeting, the stockholder must
(1)&nbsp;provide Timely Notice (as defined in <U>Section</U><U></U><U>&nbsp;2.4</U>) thereof in writing and in proper form to the Secretary of the Corporation, (2)&nbsp;provide the information, agreements and questionnaires with respect to such
stockholder and its candidate for nomination as required to be set forth by this <U>Section</U><U></U><U>&nbsp;2.5</U> and (3)&nbsp;provide any updates or supplements to such notice at the times and in the forms required by this
<U>Section</U><U></U><U>&nbsp;2.5</U><I>. </I> </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) If the election of directors is a matter specified in the notice of
meeting given by or at the direction of the person calling a special meeting, then for a stockholder to make any nomination of a person or persons for election to the Board at a special meeting, the stockholder must (i)&nbsp;provide Timely Notice
thereof in writing and in proper form to the Secretary of the Corporation at the principal executive offices of the Corporation, (ii)&nbsp;provide the information with respect to such stockholder and its candidate for nomination as required by this
<U>Section</U><U></U><U>&nbsp;2.5</U> and (iii)&nbsp;provide any updates or supplements to such notice at the times and in the forms required by this <U>Section</U><U></U><U>&nbsp;2.5</U>. To be timely, a stockholder&#146;s notice for nominations to
be made at </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
a special meeting must be delivered to, or mailed and received at, the principal executive offices of the Corporation not earlier than the one hundred twentieth (120<SUP
STYLE="font-size:85%; vertical-align:top">th</SUP>) day prior to such special meeting and not later than the ninetieth (90<SUP STYLE="font-size:85%; vertical-align:top">th</SUP>) day prior to such special meeting or, if later, the tenth (10<SUP
STYLE="font-size:85%; vertical-align:top">th</SUP>) day following the day on which public disclosure (as defined in <U>Section</U><U></U><U>&nbsp;2.4</U>) of the date of such special meeting was first made. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii) In no event shall any adjournment or postponement of an annual meeting or special meeting or the announcement thereof
commence a new time period for the giving of a stockholder&#146;s notice as described above. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iv) In no event may a
Nominating Person provide Timely Notice with respect to a greater number of director candidates than are subject to election by stockholders at the applicable meeting. If the Corporation shall, subsequent to such notice, increase the number of
directors subject to election at the meeting, such notice as to any additional nominees shall be due on the later of (i)&nbsp;the conclusion of the time period for Timely Notice, (ii)&nbsp;the date set forth in
<U>Section</U><U></U><U>&nbsp;2.5(b)(ii)</U> or (iii)&nbsp;the tenth day following the date of public disclosure (as defined in <U>Section</U><U></U><U>&nbsp;2.4</U>) of such increase. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) To be in proper form for purposes of this <U>Section</U><U></U><U>&nbsp;2.5</U>, a stockholder&#146;s notice to the Secretary of the
Corporation shall set forth: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) As to each Nominating Person (as defined below), the Stockholder Information (as defined
in <U>Section</U><U></U><U>&nbsp;2.4(c)(i)</U> of these bylaws), except that for purposes of this <U>Section</U><U></U><U>&nbsp;2.5</U>, the term &#147;<U>Nominating Person</U>&#148; shall be substituted for the term &#147;<U>Proposing
Person</U>&#148; in all places it appears in <U>Section</U><U></U><U>&nbsp;2.4(c)(i)</U>); </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) As to each Nominating
Person, any Disclosable Interests (as defined in <U>Section</U><U></U><U>&nbsp;2.4(c)(ii)</U>, except that for purposes of this <U>Section</U><U></U><U>&nbsp;2.5</U>, the term &#147;<U>Nominating Person</U>&#148; shall be substituted for the term
&#147;<U>Proposing Person</U>&#148; in all places it appears in <U>Section</U><U></U><U>&nbsp;2.4(c)(ii)</U> and the disclosure with respect to the business to be brought before the meeting in <U>Section</U><U></U><U>&nbsp;2.4(c)(ii)</U> shall be
made with respect to the election of directors at the meeting); and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii) As to each candidate whom a Nominating Person
proposes to nominate for election as a director, (A)&nbsp;all information with respect to such candidate for nomination that would be required to be set forth in a stockholder&#146;s notice pursuant to this <U>Section</U><U></U><U>&nbsp;2.5</U> if
such candidate for nomination were a Nominating Person, (B)&nbsp;all information relating to such candidate for nomination that is required to be disclosed in a proxy statement or other filings required to be made in connection with solicitations of
proxies for election of directors in a contested election pursuant to Section&nbsp;14(a) under the Exchange Act (including such candidate&#146;s written consent to being named in the proxy statement as a nominee and to serving as a director if
elected), (C)&nbsp;a description of any direct or indirect material interest in any material contract or agreement between or among any Nominating Person, on the one hand, and each candidate for nomination or
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
his or her respective associates or any other participants in such solicitation, on the other hand, including, without limitation, all information that would be required to be disclosed pursuant
to Item 404 under Regulation <FONT STYLE="white-space:nowrap">S-K</FONT> if such Nominating Person were the &#147;registrant&#148; for purposes of such rule and the candidate for nomination were a director or executive officer of such registrant and
(D)&nbsp;a completed and signed questionnaire, representation and agreement as provided in <U>Section</U><U></U><U>&nbsp;2.5(f)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For
purposes of this <U>Section</U><U></U><U>&nbsp;2.5</U>, the term &#147;<U>Nominating Person</U>&#148; shall mean (i)&nbsp;the stockholder providing the notice of the nomination proposed to be made at the meeting, (ii)&nbsp;the beneficial owner or
beneficial owners, if different, on whose behalf the notice of the nomination proposed to be made at the meeting is made, and (iii)&nbsp;any other participant (as defined in paragraphs (a)(ii)-(vi) of Instruction 3 to Item 4 of Schedule 14A) in such
solicitation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) A stockholder providing notice of any nomination proposed to be made at a meeting shall further update and supplement
such notice, if necessary, so that the information provided or required to be provided in such notice pursuant to this <U>Section</U><U></U><U>&nbsp;2.5</U> shall be true and correct as of the record date for stockholders entitled to vote at the
meeting and as of the date that is ten (10)&nbsp;business days prior to the meeting or any adjournment or postponement thereof, and such update and supplement shall be delivered to, or mailed and received by, the Secretary of the Corporation at the
principal executive offices of the Corporation not later than five (5)&nbsp;business days after the record date for stockholders entitled to vote at the meeting (in the case of the update and supplement required to be made as of such record date),
and not later than eight (8)&nbsp;business days prior to the date for the meeting or, if practicable, any adjournment or postponement thereof (and, if not practicable, on the first practicable date prior to the date to which the meeting has been
adjourned or postponed) (in the case of the update and supplement required to be made as of ten (10)&nbsp;business days prior to the meeting or any adjournment or postponement thereof). For the avoidance of doubt, the obligation to update and
supplement as set forth in this paragraph or any other Section of these bylaws shall not limit the Corporation&#146;s rights with respect to any deficiencies in any notice provided by a stockholder, extend any applicable deadlines hereunder or
enable or be deemed to permit a stockholder who has previously submitted notice hereunder to amend or update any nomination or to submit any new nomination. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) In addition to the requirements of this <U>Section</U><U></U><U>&nbsp;2.5</U> with respect to any nomination proposed to be made at a
meeting, each Nominating Person shall comply with all applicable requirements of the Exchange Act with respect to any such nominations. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f) To be eligible to be a candidate for election as a director of the Corporation at an annual or special meeting, a candidate must be
nominated in the manner prescribed in <U>Section</U><U></U><U>&nbsp;2.5</U> and the candidate for nomination, whether nominated by the Board or by a stockholder of record, must have previously delivered (in accordance with the time period prescribed
for delivery in a notice to such candidate given by or on behalf of the Board), to the Secretary of the Corporation at the principal executive offices of the Corporation, (i)&nbsp;a completed written questionnaire (in a form provided by the
Corporation) with respect to the background, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
qualifications, stock ownership and independence of such proposed nominee and (ii)&nbsp;a written representation and agreement (in form provided by the Corporation) that such candidate for
nomination (A)&nbsp;is not and, if elected as a director during his or her term of office, will not become a party to (1)&nbsp;any agreement, arrangement or understanding with, and has not given and will not give any commitment or assurance to, any
person or entity as to how such proposed nominee, if elected as a director of the Corporation, will act or vote on any issue or question (a &#147;<U>Voting Commitment</U>&#148;) or (2)&nbsp;any Voting Commitment that could limit or interfere with
such proposed nominee&#146;s ability to comply, if elected as a director of the Corporation, with such proposed nominee&#146;s fiduciary duties under applicable law, (B)&nbsp;is not, and will not become a party to, any agreement, arrangement or
understanding with any person or entity other than the Corporation with respect to any direct or indirect compensation or reimbursement for service as a director that has not been disclosed to the Corporation and (C)&nbsp;if elected as a director of
the Corporation, will comply with all applicable corporate governance, conflict of interest, confidentiality, stock ownership and trading and other policies and guidelines of the Corporation applicable to directors and in effect during such
person&#146;s term in office as a director (and, if requested by any candidate for nomination, the Secretary of the Corporation shall provide to such candidate for nomination all such policies and guidelines then in effect). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(g) The Board may also require any proposed candidate for nomination as a Director to furnish such other information as may reasonably be
requested by the Board in writing prior to the meeting of stockholders at which such candidate&#146;s nomination is to be acted upon in order for the Board to determine the eligibility of such candidate for nomination to be an independent director
of the Corporation in accordance with the Corporation&#146;s corporate governance guidelines. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(h) A candidate for nomination as a
director shall further update and supplement the materials delivered pursuant to this <U>Section</U><U></U><U>&nbsp;2.5</U>, if necessary, so that the information provided or required to be provided pursuant to this
<U>Section</U><U></U><U>&nbsp;2.5</U> shall be true and correct as of the record date for stockholders entitled to vote at the meeting and as of the date that is ten (10)&nbsp;business days prior to the meeting or any adjournment or postponement
thereof, and such update and supplement shall be delivered to, or mailed and received by, the Secretary of the Corporation at the principal executive offices of the Corporation (or any other office specified by the Corporation in any public
announcement) not later than five (5)&nbsp;business days after the record date for stockholders entitled to vote at the meeting (in the case of the update and supplement required to be made as of such record date), and not later than eight
(8)&nbsp;business days prior to the date for the meeting or, if practicable, any adjournment or postponement thereof (and, if not practicable, on the first practicable date prior to the date to which the meeting has been adjourned or postponed) (in
the case of the update and supplement required to be made as of ten (10)&nbsp;business days prior to the meeting or any adjournment or postponement thereof). For the avoidance of doubt, the obligation to update and supplement as set forth in this
paragraph or any other Section of these bylaws shall not limit the Corporation&#146;s rights with respect to any deficiencies in any materials delivered pursuant to this <U>Section</U><U></U><U>&nbsp;2.5</U> by a candidate for director, extend any
applicable deadlines hereunder or enable or be deemed to permit a stockholder who has previously submitted notice hereunder to amend or update any proposal or to submit any new proposal, including by changing or adding nominees, matters, business or
resolutions proposed to amend or update any nomination or to submit any new nomination. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) No candidate shall be eligible for nomination as a director of the Corporation unless
such candidate for nomination and the Nominating Person seeking to place such candidate&#146;s name in nomination has complied with this <U>Section</U><U></U><U>&nbsp;2.5</U>. The presiding officer at the meeting shall, if the facts warrant,
determine that a nomination was not properly made in accordance with <U>Section</U><U></U><U>&nbsp;2.5</U>, and if he or she should so determine, he or she shall so declare such determination to the meeting, the defective nomination shall be
disregarded and any ballots cast for the candidate in question (but in the case of any form of ballot listing other qualified nominees, only the votes cast for the nominee in question) shall be void and of no force or effect. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(j) Notwithstanding anything in these bylaws to the contrary, no candidate for nomination shall be eligible to be seated as a director of the
Corporation unless nominated and elected in accordance with <U>Section</U><U></U><U>&nbsp;2.5</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;21.6 <U>Notice of
Stockholders</U><U>&#146;</U><U> Meetings</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Unless otherwise provided by law, the Certificate of Incorporation or these bylaws, the
notice of any meeting of stockholders shall be sent or otherwise given in accordance with <U>Section</U><U></U><U>&nbsp;8.1</U> not less than ten (10)&nbsp;nor more than sixty (60)&nbsp;days before the date of the meeting to each stockholder
entitled to vote at such meeting. The notice shall specify the place, if any, date and time of the meeting, the means of remote communication, if any, by which stockholders and proxy holders may be deemed to be present in person and vote at such
meeting, and, in the case of a special meeting, the purpose or purposes for which the meeting is called. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;21.7 <U>Manner of
Giving Notice; Affidavit of Notice</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Notice of any meeting of stockholders shall be deemed given: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) if mailed, when deposited in the U.S. mail, postage prepaid, directed to the stockholder at his or her address as it appears on the
Corporation&#146;s records; or </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) if electronically transmitted as provided in the DGCL. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">An affidavit of the secretary or an assistant secretary of the Corporation or of the transfer agent or any other agent of the Corporation that
the notice has been given by mail or by a form of electronic transmission, as applicable, shall, in the absence of fraud, be prima facie evidence of the facts stated therein. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;21.8 <U>Quorum</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Unless otherwise provided by law, the Certificate of Incorporation or these bylaws, the holders of a majority in voting power of the stock
issued and outstanding and entitled to vote, present in person, or by remote communication, if applicable, or represented by proxy, shall constitute a quorum for the transaction of business at all meetings of the stockholders. A quorum, once
established at a meeting, shall not be broken by the withdrawal of enough votes to leave less than a quorum. If, however, a quorum is not present or represented at any meeting of the stockholders, then either (i)&nbsp;the person presiding over the
meeting or (ii)&nbsp;a majority in voting power of the stockholders entitled to vote at the meeting, present in person, or by remote communication, if applicable, or represented by proxy, shall have power to recess the meeting or adjourn the meeting
from time to time in the manner provided in <U>Section</U><U></U><U>&nbsp;2.9</U> until a quorum is present or represented. At any recessed or adjourned meeting at which a quorum is present or represented, any business may be transacted that might
have been transacted at the meeting as originally noticed. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;21.9 <U>Adjourned Meeting; Notice</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">When a meeting is adjourned to another time or place, unless these bylaws otherwise require, notice need not be given of the adjourned meeting
if the time, place, if any, thereof, and the means of remote communications, if any, by which stockholders and proxy holders may be deemed to be present in person and vote at such adjourned meeting are announced at the meeting at which the
adjournment is taken. At any adjourned meeting, the Corporation may transact any business which might have been transacted at the original meeting. If the adjournment is for more than thirty (30)&nbsp;days, a notice of the adjourned meeting shall be
given to each stockholder of record entitled to vote at the meeting. If after the adjournment a new record date for determination of stockholders entitled to vote is fixed for the adjourned meeting, the Board shall fix as the record date for
determining stockholders entitled to notice of such adjourned meeting the same or an earlier date as that fixed for determination of stockholders entitled to vote at the adjourned meeting, and shall give notice of the adjourned meeting to each
stockholder of record entitled to vote at such meeting as of the record date so fixed for notice of such adjourned meeting. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;21.10 <U>Conduct of Business</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The date and time of the opening and the closing of the polls for each matter upon which the stockholders will vote at a meeting shall be
announced at the meeting by the person presiding over the meeting. The Board may adopt by resolution such rules and regulations for the conduct of the meeting of stockholders as it shall deem appropriate. At every meeting of the stockholders, the
Chairperson of the Board, or in his or her absence or inability to act, the Chief Executive Officer, or in his or her absence or inability to act, the officer or director whom the Board shall appoint, shall act as chairperson of, and preside at the
meeting. Except to the extent inconsistent with such rules and regulations as adopted by the Board, the person presiding over any meeting of stockholders shall have the right and authority to convene and (for any or no reason) to recess and/or
adjourn the meeting, to prescribe such rules, regulations and procedures (which need not be in writing) and to do all such acts as, in the judgment of such presiding person, are appropriate </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
for the proper conduct of the meeting. Such rules, regulations or procedures, whether adopted by the Board or prescribed by the person presiding over the meeting, may include, without limitation,
the following: (i)&nbsp;the establishment of an agenda or order of business for the meeting; (ii)&nbsp;rules and procedures for maintaining order at the meeting and the safety of those present (including, without limitation, rules and procedures for
removal of disruptive persons from the meeting); (iii) limitations on attendance at or participation in the meeting to stockholders entitled to vote at the meeting, their duly authorized and constituted proxies or such other persons as the person
presiding over the meeting shall determine; (iv)&nbsp;restrictions on entry to the meeting after the time fixed for the commencement thereof; and (v)&nbsp;limitations on the time allotted to questions or comments by participants. The presiding
person at any meeting of stockholders, in addition to making any other determinations that may be appropriate to the conduct of the meeting (including, without limitation, determinations with respect to the administration and/or interpretation of
any of the rules, regulations or procedures of the meeting, whether adopted by the Board or prescribed by the person presiding over the meeting), shall, if the facts warrant, determine and declare to the meeting that a matter of business was not
properly brought before the meeting and if such presiding person should so determine, such presiding person shall so declare to the meeting and any such matter or business not properly brought before the meeting shall not be transacted or
considered. Unless and to the extent determined by the Board or the person presiding over the meeting, meetings of stockholders shall not be required to be held in accordance with the rules of parliamentary procedure. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;21.11 <U>Voting</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Except as may be otherwise provided in the Certificate of Incorporation, these bylaws or the DGCL, each stockholder shall be entitled to one
(1)&nbsp;vote for each share of capital stock held by such stockholder. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Except as otherwise provided by the Certificate of Incorporation,
at all duly called or convened meetings of stockholders at which a quorum is present, for the election of directors, a plurality of the votes cast shall be sufficient to elect a director. Except as otherwise provided by the Certificate of
Incorporation, these bylaws, the rules or regulations of any stock exchange applicable to the Corporation, or applicable law or pursuant to any regulation applicable to the Corporation or its securities, each other matter presented to the
stockholders at a duly called or convened meeting at which a quorum is present shall be decided by the affirmative vote of the holders of a majority in voting power of the votes cast (excluding abstentions and broker
<FONT STYLE="white-space:nowrap">non-votes)</FONT> on such matter. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;21.12 <U>Record Date for Stockholder Meetings and Other
Purposes</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In order that the Corporation may determine the stockholders entitled to notice of or to vote at any meeting of
stockholders or any adjournment thereof, the Board may fix a record date, which record date shall not precede the date upon which the resolution fixing the record date is adopted by the Board, and which record date shall, unless otherwise required
by law, not be more than sixty (60)&nbsp;days nor less than ten (10)&nbsp;days before the date of such meeting. If the Board so fixes a date, such date shall also be the record date for determining the stockholders entitled to vote at such meeting
unless the Board determines, at the time it fixes such record date, that a later date on or before the date of the meeting shall be the date for making such determination. If no record date is fixed by the
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Board, the record date for determining stockholders entitled to notice of or to vote at a meeting of stockholders shall be the close of business on the next day preceding the day on which notice
is first given, or, if notice is waived, at the close of business on the day next preceding the day on which the meeting is held. A determination of stockholders of record entitled to notice of or to vote at a meeting of stockholders shall apply to
any adjournment of the meeting; <I>provided, however</I>, that the Board may fix a new record date for determination of stockholders entitled to vote at the adjourned meeting; and in such case shall also fix as the record date for stockholders
entitled to notice of such adjourned meeting the same or an earlier date as that fixed for determination of stockholders entitled to vote in accordance herewith at the adjourned meeting. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In order that the Corporation may determine the stockholders entitled to receive payment of any dividend or other distribution or allotment or
any rights or the stockholders entitled to exercise any rights in respect of any change, conversion or exchange of capital stock, or for the purposes of any other lawful action, the Board may fix a record date, which record date shall not precede
the date upon which the resolution fixing the record date is adopted, and which record date shall be not more than sixty (60)&nbsp;days prior to such action. If no record date is fixed, the record date for determining stockholders for any such
purpose shall be at the close of business on the day on which the Board adopts the resolution relating thereto. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;21.13
<U>Proxies</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Each stockholder entitled to vote at a meeting of stockholders may authorize another person or persons to act for such
stockholder by proxy authorized by an instrument in writing or by a transmission permitted by law filed in accordance with the procedure established for the meeting, but no such proxy shall be voted or acted upon after three (3)&nbsp;years from its
date, unless the proxy provides for a longer period. The revocability of a proxy that states on its face that it is irrevocable shall be governed by the provisions of Section&nbsp;212 of the DGCL. A proxy may be in the form of an electronic
transmission which sets forth or is submitted with information from which it can be determined that the electronic transmission was authorized by the stockholder. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any stockholder directly or indirectly soliciting proxies from other stockholders must use a proxy card color other than white, which shall be
reserved for the exclusive use by the Board. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;21.14 <U>List of Stockholders Entitled to Vote</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Corporation shall prepare, at least ten (10)&nbsp;days before every meeting of stockholders, a complete list of the stockholders entitled
to vote at the meeting (<I>provided, however</I>, that if the record date for determining the stockholders entitled to vote is less than ten (10)&nbsp;days before the date of the meeting, the list shall reflect the stockholders entitled to vote as
of the tenth (10<SUP STYLE="font-size:85%; vertical-align:top">th</SUP>) day before the meeting date), arranged in alphabetical order, and showing the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
address of each stockholder and the number of shares registered in the name of each stockholder. The Corporation shall not be required to include electronic mail addresses or other electronic
contact information on such list. Such list shall be open to the examination of any stockholder, for any purpose germane to the meeting for a period of at least ten (10)&nbsp;days prior to the meeting: (i)&nbsp;on a reasonably accessible electronic
network, <I>provided</I> that the information required to gain access to such list is provided with the notice of the meeting, or (ii)&nbsp;during ordinary business hours, at the Corporation&#146;s principal executive office. In the event that the
Corporation determines to make the list available on an electronic network, the Corporation may take reasonable steps to ensure that such information is available only to stockholders of the Corporation. If the meeting is to be held at a place, then
the list shall be produced and kept at the time and place of the meeting during the whole time thereof, and may be inspected by any stockholder who is present. If the meeting is to be held solely by means of remote communication, then the list shall
also be open to the examination of any stockholder during the whole time of the meeting on a reasonably accessible electronic network, and the information required to access such list shall be provided with the notice of the meeting. Such list shall
presumptively determine the identity of the stockholders entitled to vote at the meeting and the number of shares held by each of them. Except as otherwise provided by law, the stock ledger shall be the only evidence as to who are the stockholders
entitled to examine the list of stockholders required by this <U>Section</U><U></U><U>&nbsp;2.14</U> or to vote in person or by proxy at any meeting of stockholders. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;21.15 <U>Inspectors of Election</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Before any meeting of stockholders, the Corporation shall appoint an inspector or inspectors of election to act at the meeting or its
adjournment and make a written report thereof. The Corporation may designate one or more persons as alternate inspectors to replace any inspector who fails to act. If any person appointed as inspector or any alternate fails to appear or fails or
refuses to act, then the person presiding over the meeting shall appoint a person to fill that vacancy. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Such inspectors shall: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) determine the number of shares outstanding and the voting power of each, the number of shares represented at the meeting and the validity
of any proxies and ballots; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) count all votes or ballots; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) count and tabulate all votes; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) determine and retain for a reasonable period a record of the disposition of any challenges made to any determination by the inspector(s);
and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) certify its or their determination of the number of shares represented at the meeting and its or their count of all votes and
ballots. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Each inspector, before entering upon the discharge of the duties of inspector, shall take
and sign an oath faithfully to execute the duties of inspection with strict impartiality and according to the best of such inspector&#146;s ability. Any report or certificate made by the inspectors of election is <I>prima facie</I> evidence of the
facts stated therein. The inspectors of election may appoint such persons to assist them in performing their duties as they determine. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;21.16 <U>Delivery to the Corporation</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Whenever this <U>Article II</U> requires one or more persons (including a record or beneficial owner of stock) to deliver a document or
information to the Corporation or any officer, employee or agent thereof (including any notice, request, questionnaire, revocation, representation or other document or agreement), such document or information shall be in writing exclusively (and not
in an electronic transmission) and shall be delivered exclusively by hand (including, without limitation, overnight courier service) or by certified or registered mail, return receipt requested, and the Corporation shall not be required to accept
delivery of any document not in such written form or so delivered. For the avoidance of doubt, the Corporation expressly opts out of Section&nbsp;116 of the DGCL with respect to the delivery of information and documents to the Corporation required
by this <U>Article II</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;21.17 <U>Stockholder Action by Written Consent Without a Meeting</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to the rights of the holders of any series of Preferred Stock of the Corporation, any action required or permitted to be taken by the
stockholders of the Corporation may be effected only at a duly called annual or special meeting of stockholders and may not be effected by any consent in writing by such stockholders in lieu of such meeting. Notwithstanding the foregoing, any action
required or permitted to be taken by the holders of any series of preferred stock of the Corporation, voting separately as a series or separately as a class with one or more other such series, may be taken without a meeting, without prior notice and
without a vote, to the extent expressly so provided by the applicable certificate of designation relating to such series of preferred stock of the Corporation, if a consent or consents in writing, setting forth the action so taken, shall be signed
by the holders of outstanding shares of the relevant series of preferred stock of the Corporation having not less than the minimum number of votes that would be necessary to authorize or take such action at a meeting at which all shares entitled to
vote thereon were present and voted and shall be delivered to the Corporation in accordance with the applicable provisions of the DGCL. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE XXII<U>- DIRECTORS</U> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;22.1 <U>Powers</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Except as otherwise provided by the Certificate of Incorporation or the DGCL, the business and affairs of the Corporation shall be managed by
or under the direction of the Board. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;22.2 <U>Number of Directors</U>. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to the Certificate of Incorporation, the total number of directors constituting the
Board shall be determined from time to time by resolution of the Board. No reduction of the authorized number of directors shall have the effect of removing any director before that director&#146;s term of office expires. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;22.3 <U>Election, Qualification and Term of Office of Directors</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Except as provided in <U>Section</U><U></U><U>&nbsp;3.4</U>, and subject to the Certificate of Incorporation, each director, including a
director elected to fill a vacancy or newly created directorship, shall hold office until the expiration of the term of the class, if any, for which elected and until such director&#146;s successor is elected and qualified or until such
director&#146;s earlier death, resignation, retirement, disqualification or removal. Directors need not be stockholders. The Certificate of Incorporation or these bylaws may prescribe qualifications for directors. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;22.4 <U>Resignation and Vacancies</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any director may resign at any time upon notice given in writing or by electronic transmission to the Corporation. The resignation shall take
effect at the time specified therein or upon the happening of an event specified therein, and if no time or event is specified, at the time of its receipt. When one or more directors so resigns and the resignation is effective at a future date or
upon the happening of an event to occur on a future date, a majority of the directors then in office, including those who have so resigned, shall have the power to fill such vacancy or vacancies, the vote thereon to take effect when such resignation
or resignations shall become effective, and each director so chosen shall hold office as provided in <U>Section</U><U></U><U>&nbsp;3.3</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Unless otherwise provided in the Certificate of Incorporation or these bylaws, vacancies resulting from the death, resignation, retirement,
disqualification or removal of any director, and newly created directorships resulting from any increase in the authorized number of directors shall be filled only by a majority of the directors then in office, although less than a quorum, or by a
sole remaining director. Any director elected in accordance with the preceding sentence shall hold office for the remainder of the full term of the director for which the vacancy was created or occurred and until such director&#146;s successor shall
have been elected and qualified. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;22.5 <U>Place of Meetings; Meetings by Telephone</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Board may hold meetings, both regular and special, either within or outside the State of Delaware. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Unless otherwise restricted by the Certificate of Incorporation or these bylaws, members of the Board, or any committee or subcommittee
designated by the Board, in each case, may participate in a meeting of the Board, or any committee or subcommittee, by means of conference telephone or other communications equipment by means of which all persons participating in the meeting can
hear each other, and such participation in a meeting pursuant to this bylaw shall constitute presence in person at the meeting. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">16 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;22.6 <U>Regular Meetings</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Regular meetings of the Board may be held within or outside the State of Delaware and at such time and at such place as which has been
designated by the Board and publicized among all directors, either orally or in writing, by telephone, including a voice-messaging system or other system designed to record and communicate messages, facsimile, telegraph or telex, or by electronic
mail or other means of electronic transmission. No further notice shall be required for regular meetings of the Board. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;22.7
<U>Special Meetings; Notice</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Special meetings of the Board for any purpose or purposes may be called at any time by the Chairperson
of the Board, the Chief Executive Officer, the President or the Secretary of the Corporation or a majority of the total number of directors constituting the Board. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Notice of the time and place of special meetings shall be: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) delivered personally by hand, by courier or by telephone; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) sent by United States first-class mail, postage prepaid; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) sent by facsimile or electronic mail; or </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) sent by other means of electronic transmission, </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">directed to each director at that director&#146;s address, telephone number, facsimile number or electronic mail address, or other address for electronic
transmission, as the case may be, as shown on the Corporation&#146;s records. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If the notice is (i)&nbsp;delivered personally by hand, by
courier or by telephone, (ii)&nbsp;sent by facsimile or electronic mail, or (iii)&nbsp;sent by other means of electronic transmission, it shall be delivered or sent at least twenty-four (24)&nbsp;hours before the time of the holding of the meeting.
If the notice is sent by U.S. mail, it shall be deposited in the U.S. mail at least four (4)&nbsp;days before the time of the holding of the meeting. The notice need not specify the place of the meeting (if the meeting is to be held at the
Corporation&#146;s principal executive office) nor the purpose of the meeting. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;22.8 <U>Quorum</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">At all meetings of the Board, unless otherwise provided by the Certificate of Incorporation, a majority of the total number of directors shall
constitute a quorum for the transaction of business. The vote of a majority of the directors present at any meeting at which a quorum is present shall be the act of the Board, except as may be otherwise specifically provided by statute, the
Certificate of Incorporation or these bylaws. If a quorum is not present at any meeting of the Board, then the directors present thereat may adjourn the meeting from time to time, without notice other than announcement at the meeting, until a quorum
is present. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">17 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;22.9 <U>Board Action by Written Consent without a Meeting</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Unless otherwise restricted by the Certificate of Incorporation or these bylaws, any action required or permitted to be taken at any meeting
of the Board, or of any committee or subcommittee thereof, may be taken without a meeting if all members of the Board or committee or subcommittee, as the case may be, consent thereto in writing or by electronic transmission. After an action is
taken by written consent without a meeting, the consent or consents relating thereto shall be filed with the minutes of the proceedings of the Board, or the applicable committee or subcommittee thereof, in the same paper or electronic form as the
minutes are maintained. Such action by written consent or consent by electronic transmission shall have the same force and effect as a unanimous vote of the Board. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;22.10 <U>Fees and Compensation of Directors</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Unless otherwise restricted by the Certificate of Incorporation or these bylaws, the Board shall have the authority to fix the compensation,
including fees and reimbursement of expenses, of directors for services to the Corporation in any capacity. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;22.11 <U>Removal
of Directors</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to any special rights of the holders of one or more outstanding series of preferred stock of the Corporation to
elect directors, the Board or any individual director may be removed from office at any time, but only for cause and only by the affirmative vote of the holders of at least <FONT STYLE="white-space:nowrap">two-thirds</FONT> (66 and 2/3%) of the
voting power of all the then outstanding shares of voting stock of the Corporation entitled to vote generally in an election of directors. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE XXIII<U>- COMMITTEES</U> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;23.1 <U>Committees of Directors</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Board may designate one (1)&nbsp;or more committees, each committee to consist of one (1)&nbsp;or more of the directors of the
Corporation. The Board may designate one (1)&nbsp;or more directors as alternate members of any committee, who may replace any absent or disqualified member at any meeting of the committee. In the absence or disqualification of a member of a
committee, the member or members thereof present at any meeting and not disqualified from voting, whether or not such member or members constitute a quorum, may unanimously appoint another member of the Board to act at the meeting in the place of
any such absent or disqualified member. Any such committee, to the extent provided in the resolution of the Board or in these bylaws, shall have and may exercise all the powers and authority of the Board in the management of the business and affairs
of the Corporation, and may authorize the seal of the Corporation to be affixed to all papers that may require it; but no such committee or subcommittee shall have the power or authority to (i)&nbsp;approve or adopt, or recommend to the
stockholders, any action or matter expressly required by the DGCL to be submitted to stockholders for approval, or (ii)&nbsp;adopt, amend or repeal any bylaw of the Corporation. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">18 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;23.2 <U>Committee Minutes</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Each committee shall keep regular minutes of its meetings and report the same to the Board when required. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;23.3 <U>Meetings and Actions of Committees</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Meetings and actions of committees shall be governed by, and held and taken in accordance with, the provisions of: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) <U>Section</U><U></U><U>&nbsp;3.5</U> (<I>Place of Meetings; Meetings by Telephone</I>); </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) <U>Section</U><U></U><U>&nbsp;3.6</U> (<I>Regular Meetings</I>); </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) <U>Section</U><U></U><U>&nbsp;3.7</U> (<I>Special Meetings; Notice</I>); </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) <U>Section</U><U></U><U>&nbsp;3.9</U> (<I>Board Action Without a Meeting</I>); and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) <U>Section 7.13</U> (<I>Waiver of Notice</I>), </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">with such changes in the context of those bylaws as are necessary to substitute the committee and its members for the Board and its members; <I>provided,
however</I>, that: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) the time of regular meetings of committees may be determined either by resolution of the Board or
by resolution of the committee; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) special meetings of committees may also be called by resolution of the Board or the
chairperson of the applicable committee; and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii) the Board may adopt rules for the governance of any committee to
override the provisions that would otherwise apply to the committee pursuant to this <U>Section</U><U></U><U>&nbsp;4.3</U>, <I>provided</I> that such rules do not violate the provisions of the Certificate of Incorporation or applicable law. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;23.4 <U>Subcommittees</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Unless otherwise provided in the Certificate of Incorporation, these bylaws or the resolutions of the Board designating the committee, a
committee may create one (1)&nbsp;or more subcommittees, each subcommittee to consist of one (1)&nbsp;or more members of the committee, and delegate to a subcommittee any or all of the powers and authority of the committee. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">19 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE XXIV<U>- OFFICERS</U> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;24.1 <U>Officers</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The officers of the Corporation shall include a Chief Executive Officer and a President. The Corporation may also have, at the discretion of
the Board, a Secretary, a Chairperson of the Board, a Vice Chairperson of the Board (each of such Chairperson or Vice Chairperson shall be a director but need not be elected as an officer), a Chief Legal Officer, a Chief Financial Officer or
principal financial officer, a Treasurer, one (1)&nbsp;or more Vice Presidents, one (1)&nbsp;or more Assistant Vice Presidents, one (1)&nbsp;or more Assistant Treasurers, one (1)&nbsp;or more Assistant Secretaries,<SUP
STYLE="font-size:85%; vertical-align:top"> </SUP>and any such other officers as may be appointed in accordance with the provisions of these bylaws. Any number of offices may be held by the same person. No officer need be a stockholder or director of
the Corporation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;24.2 <U>Appointment of Officers</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Board shall appoint the officers of the Corporation, except such officers as may be appointed in accordance with the provisions of
<U>Section</U><U></U><U>&nbsp;5.3</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;24.3 <U>Subordinate Officers</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Board may appoint, or empower the Chief Executive Officer or, in the absence of a Chief Executive Officer, the President, to appoint, such
other officers and agents as the business of the Corporation may require. Each of such officers and agents shall hold office for such period, have such authority, and perform such duties as are provided in these bylaws or as the Board may from time
to time determine. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;24.4 <U>Removal and Resignation of Officers</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to the rights, if any, of an officer under any contract of employment any officer may be removed, either with or without cause, by the
Board or, except in the case of an officer chosen by the Board, by any officer upon whom such power of removal may be conferred by the Board. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any officer may resign at any time by giving written notice to the Corporation. Any resignation shall take effect at the date of the receipt
of that notice or at any later time specified in that notice. Unless otherwise specified in the notice of resignation, the acceptance of the resignation shall not be necessary to make it effective. Any resignation is without prejudice to the rights,
if any, of the Corporation under any contract to which the officer is a party. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;24.5 <U>Vacancies in Offices</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any vacancy occurring in any office of the Corporation shall be filled by the Board or as provided in <U>Section</U><U></U><U>&nbsp;5.2</U>.
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">20 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;24.6 <U>Representation of Shares of Other Corporations</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Chairperson of the Board (if an officer), the Chief Executive Officer, or the President of this Corporation, or any other person
authorized by the Board, the Chief Executive Officer or the President,<SUP STYLE="font-size:85%; vertical-align:top"> </SUP>is authorized to vote, represent and exercise on behalf of this Corporation all rights incident to any and all shares or
voting securities of any other corporation or other person standing in the name of this Corporation. The authority granted herein may be exercised either by such person directly or by any other person authorized to do so by proxy or power of
attorney duly executed by such person having the authority. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;24.7 <U>Authority and Duties of Officers</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">All officers of the Corporation shall respectively have such authority and perform such duties in the management of the business of the
Corporation as may be provided herein or designated from time to time by the Board and, to the extent not so provided, as generally pertain to their respective offices, subject to the control of the Board. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;24.8 <U>Compensation</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The compensation of the officers of the Corporation for their services as such shall be fixed from time to time by or at the direction of the
Board. An officer of the Corporation shall not be prevented from receiving compensation by reason of the fact that he or she is also a director of the Corporation. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE XXV<U>- RECORDS </U> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A stock ledger consisting of one or more records in which the names of all of the Corporation&#146;s stockholders of record, the address and
number of shares registered in the name of each such stockholder, and all issuances and transfers of stock of the corporation are recorded in accordance with Section&nbsp;224 of the DGCL shall be administered by or on behalf of the Corporation. Any
records administered by or on behalf of the Corporation in the regular course of its business, including its stock ledger, books of account, and minute books, may be kept on, or by means of, or be in the form of, any information storage device, or
method, or one or more electronic networks or databases (including one or more distributed electronic networks or databases), <I>provided</I> that the records so kept can be converted into clearly legible paper form within a reasonable time and,
with respect to the stock ledger, that the records so kept (i)&nbsp;can be used to prepare the list of stockholders specified in Sections 219 and 220 of the DGCL, (ii)&nbsp;record the information specified in Sections 156, 159, 217(a) and 218 of the
DGCL, and (iii)&nbsp;record transfers of stock as governed by Article 8 of the Uniform Commercial Code as adopted in the State of Delaware. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE XXVI<U>- GENERAL MATTERS</U> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;26.1 <U>Execution of Corporate Contracts and Instruments</U>. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">21 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Board, except as otherwise provided in these bylaws, may authorize any officer or
officers, or agent or agents, to enter into any contract or execute any instrument in the name of and on behalf of the Corporation; such authority may be general or confined to specific instances. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;26.2 <U>Stock Certificates</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The shares of the Corporation shall be represented by certificates or shall be uncertificated. Certificates for the shares of stock, if any,
shall be in such form as is consistent with the Certificate of Incorporation and applicable law. Every holder of stock represented by a certificate shall be entitled to have a certificate signed by, or in the name of the Corporation by, any two
officers authorized to sign stock certificates representing the number of shares registered in certificate form. The Chairperson or Vice Chairperson of the Board (in each case, if an officer), the Chief Executive Officer, the President, Vice
President, the Treasurer, any Assistant Treasurer, the Secretary or any Assistant Secretary of the Corporation shall be specifically authorized to sign stock certificates. Any or all of the signatures on the certificate may be a facsimile. In case
any officer, transfer agent or registrar who has signed or whose facsimile signature has been placed upon a certificate has ceased to be such officer, transfer agent or registrar before such certificate is issued, it may be issued by the Corporation
with the same effect as if he or she were such officer, transfer agent or registrar at the date of issue. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Corporation may issue the
whole or any part of its shares as partly paid and subject to call for the remainder of the consideration to be paid therefor. Upon the face or back of each stock certificate issued to represent any such partly paid shares, or upon the books and
records of the Corporation in the case of uncertificated partly paid shares, the total amount of the consideration to be paid therefor and the amount paid thereon shall be stated. Upon the declaration of any dividend on fully paid shares, the
Corporation shall declare a dividend upon partly paid shares of the same class, but only upon the basis of the percentage of the consideration actually paid thereon. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;26.3 <U>Special Designation of Certificates</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If the Corporation is authorized to issue more than one class of stock or more than one series of any class, then the powers, the
designations, the preferences and the relative, participating, optional or other special rights of each class of stock or series thereof and the qualifications, limitations or restrictions of such preferences and/or rights shall be set forth in full
or summarized on the face or on the back of the certificate that the Corporation shall issue to represent such class or series of stock (or, in the case of uncertificated shares, set forth in a notice provided pursuant to Section&nbsp;151 of the
DGCL); <I>provided, however</I>, that except as otherwise provided in Section&nbsp;202 of the DGCL, in lieu of the foregoing requirements, there may be set forth on the face of back of the certificate that the Corporation shall issue to represent
such class or series of stock (or, in the case of any uncertificated shares, included in the aforementioned notice) a statement that the Corporation will furnish without charge to each stockholder who so requests the powers, the designations, the
preferences and the relative, participating, optional or other special rights of each class of stock or series thereof and the qualifications, limitations or restrictions of such preferences and/or rights. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">22 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;26.4 <U>Lost Certificates</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Except as provided in this <U>Section</U><U></U><U>&nbsp;7.4</U>, no new certificates for shares shall be issued to replace a previously
issued certificate unless the latter is surrendered to the Corporation and cancelled at the same time. The Corporation may issue a new certificate of stock or uncertificated shares in the place of any certificate theretofore issued by it, alleged to
have been lost, stolen or destroyed, and the Corporation may require the owner of the lost, stolen or destroyed certificate, or such owner&#146;s legal representative, to give the Corporation a bond sufficient to indemnify it against any claim that
may be made against it on account of the alleged loss, theft or destruction of any such certificate or the issuance of such new certificate or uncertificated shares. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;26.5 <U>Shares Without Certificates</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Corporation may adopt a system of issuance, recordation and transfer of its shares of stock by electronic or other means not involving the
issuance of certificates, provided the use of such system by the Corporation is permitted in accordance with applicable law. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;26.6 <U>Construction; Definitions</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Unless the context requires otherwise, the general provisions, rules of construction and definitions in the DGCL shall govern the construction
of these bylaws. Without limiting the generality of this provision, the singular number includes the plural and the plural number includes the singular. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;26.7 <U>Dividends</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Board, subject to any restrictions contained in either (i)&nbsp;the DGCL or (ii)&nbsp;the Certificate of Incorporation, may declare and
pay dividends upon the shares of its capital stock. Dividends may be paid in cash, in property or in shares of the Corporation&#146;s capital stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Board may set apart out of any of the funds of the Corporation available for dividends a reserve or reserves for any proper purpose and
may abolish any such reserve. Such purposes shall include but not be limited to equalizing dividends, repairing or maintaining any property of the Corporation, and meeting contingencies. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;26.8 <U>Fiscal Year</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The fiscal year of the Corporation shall be fixed by resolution of the Board and may be changed by the Board. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;26.9 <U>Seal</U>. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">23 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Corporation may adopt a corporate seal, which shall be adopted and which may be altered
by the Board. The Corporation may use the corporate seal by causing it or a facsimile thereof to be impressed or affixed or in any other manner reproduced. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;26.10 <U>Transfer of Stock</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Shares of the stock of the Corporation shall be transferable in the manner prescribed by law and in these bylaws. Shares of stock of the
Corporation shall be transferred on the books of the Corporation only by the holder of record thereof or by such holder&#146;s attorney duly authorized in writing, upon surrender to the Corporation of the certificate or certificates representing
such shares endorsed by the appropriate person or persons (or by delivery of duly executed instructions with respect to uncertificated shares), with such evidence of the authenticity of such endorsement or execution, transfer, authorization and
other matters as the Corporation may reasonably require, and accompanied by all necessary stock transfer stamps. No transfer of stock shall be valid as against the Corporation for any purpose until it shall have been entered in the stock records of
the Corporation by an entry showing the names of the persons from and to whom it was transferred. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;26.11 <U>Stock Transfer
</U><U>Restrictions; Stock Forfeitures</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) The Corporation shall have power to enter into and perform any agreement with any number
of stockholders of any one or more classes or series of stock of the Corporation to restrict the transfer of shares of stock of the Corporation of any one or more classes owned by such stockholders in any manner not prohibited by the DGCL. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) The Corporation&#146;s Earnout Shares (as defined in the Merger Agreement referenced below in this sentence) are subject to the
restrictive transfer and forfeiture provisions set forth in that certain Agreement and Plan of Merger, dated March&nbsp;23, 2022, by and among Ligand Pharmaceuticals Incorporated, a Delaware corporation, OmniAb, Inc., a Delaware corporation, the
Corporation and Orwell Merger Sub Inc., a Delaware corporation and wholly owned subsidiary of the Corporation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;26.12
<U>Registered Stockholders</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Corporation: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) shall be entitled to recognize the exclusive right of a person registered on its books as the owner of shares to receive dividends and to
vote as such owner; and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) shall not be bound to recognize any equitable or other claim to or interest in such share or shares on the
part of another person, whether or not it shall have express or other notice thereof, except as otherwise provided by the laws of the State of Delaware. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;26.13 <U>Waiver of Notice</U>. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">24 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Whenever notice is required to be given under any provision of the DGCL, the Certificate of
Incorporation or these bylaws, a written waiver, signed by the person entitled to notice, or a waiver by electronic transmission by the person entitled to notice, whether before or after the time of the event for which notice is to be given, shall
be deemed equivalent to notice. Attendance of a person at a meeting shall constitute a waiver of notice of such meeting, except when the person attends a meeting for the express purpose of objecting at the beginning of the meeting, to the
transaction of any business because the meeting is not lawfully called or convened. Neither the business to be transacted at, nor the purpose of, any regular or special meeting of the stockholders need be specified in any written waiver of notice or
any waiver by electronic transmission unless so required by the Certificate of Incorporation or these bylaws. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE XXVII<U>- NOTICE
</U> </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;27.1 <U>Delivery of Notice; Notice by Electronic Transmission</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Without limiting the manner by which notice otherwise may be given effectively to stockholders, any notice to stockholders given by the
Corporation under any provisions of the DGCL, the Certificate of Incorporation, or these bylaws may be given in writing directed to the stockholder&#146;s mailing address (or by electronic transmission directed to the stockholder&#146;s electronic
mail address, as applicable) as it appears on the records of the Corporation and shall be given (1)&nbsp;if mailed, when the notice is deposited in the U.S. mail, postage prepaid, (2)&nbsp;if delivered by courier service, the earlier of when the
notice is received or left at such stockholder&#146;s address or (3)&nbsp;if given by electronic mail, when directed to such stockholder&#146;s electronic mail address unless the stockholder has notified the Corporation in writing or by electronic
transmission of an objection to receiving notice by electronic mail. A notice by electronic mail must include a prominent legend that the communication is an important notice regarding the Corporation. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Without limiting the manner by which notice otherwise may be given effectively to stockholders, any notice to stockholders given by the
Corporation under any provision of the DGCL, the Certificate of Incorporation or these bylaws shall be effective if given by a form of electronic transmission consented to by the stockholder to whom the notice is given. Any such consent shall be
revocable by the stockholder by written notice or electronic transmission to the Corporation. Notwithstanding the provisions of this paragraph, the Corporation may give a notice by electronic mail in accordance with the first paragraph of this
section without obtaining the consent required by this paragraph. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any notice given pursuant to the preceding paragraph shall be deemed
given: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) if by facsimile telecommunication, when directed to a number at which the stockholder has consented to receive notice; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">25 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) if by a posting on an electronic network together with separate notice to the
stockholder of such specific posting, upon the later of (A)&nbsp;such posting and (B)&nbsp;the giving of such separate notice; and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) if
by any other form of electronic transmission, when directed to the stockholder. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Notwithstanding the foregoing, a notice may not be given
by an electronic transmission from and after the time that (1)&nbsp;the Corporation is unable to deliver by such electronic transmission two (2)&nbsp;consecutive notices given by the Corporation and (2)&nbsp;such inability becomes known to the
Secretary or an Assistant Secretary of the Corporation or to the transfer agent, or other person responsible for the giving of notice; <I>provided, however</I>, that the inadvertent failure to discover such inability shall not invalidate any meeting
or other action. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">An affidavit of the Secretary or an Assistant Secretary of the Corporation or of the transfer agent or other agent of
the Corporation that the notice has been given shall, in the absence of fraud, be prima facie evidence of the facts stated therein. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE XXVIII<U>- INDEMNIFICATION</U> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;28.1 <U>Indemnification of Directors and Officers</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Corporation shall indemnify and hold harmless, to the fullest extent permitted by the DGCL as it presently exists or may hereafter be
amended, any director or officer of the Corporation who was or is made or is threatened to be made a party or is otherwise involved in any action, suit or proceeding, whether civil, criminal, administrative or investigative (a
&#147;<U>Proceeding</U>&#148;) by reason of the fact that he or she, or a person for whom he or she is the legal representative, is or was a director or officer of the Corporation or, while serving as a director or officer of the Corporation, is or
was serving at the request of the Corporation as a director, officer, employee or agent of another corporation or of a partnership (a &#147;<U>covered person</U>&#148;), joint venture, trust, enterprise or
<FONT STYLE="white-space:nowrap">non-profit</FONT> entity, including service with respect to employee benefit plans, against all liability and loss suffered and expenses (including, without limitation, attorneys&#146; fees, judgments, fines, ERISA
excise taxes or penalties, and amounts paid in settlement) reasonably incurred by such person in connection with any such Proceeding. Notwithstanding the preceding sentence, except as otherwise provided in <U>Section</U><U></U><U>&nbsp;9.4</U>, the
Corporation shall be required to indemnify a person in connection with a Proceeding initiated by such person only if the Proceeding was authorized in the specific case by the Board. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;28.2 <U>Indemnification of Others</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Corporation shall also have the power to indemnify and hold harmless, to the fullest extent permitted by applicable law as it presently
exists or may hereafter be amended, any employee or agent of the Corporation who was or is made or is threatened to be made a party or is otherwise involved in any Proceeding by reason of the fact that he or she, or a person for whom he or she is
the legal representative, is or was an employee or agent of the Corporation or </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">26 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
is or was serving at the request of the Corporation as a director, officer, employee or agent of another corporation or of a partnership, joint venture, trust, enterprise or <FONT
STYLE="white-space:nowrap">non-profit</FONT> entity, including service with respect to employee benefit plans, against all liability and loss suffered and expenses reasonably incurred by such person in connection with any such Proceeding. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;28.3 <U>Prepayment of Expenses</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Corporation shall to the fullest extent not prohibited by applicable law pay the expenses (including, without limitation, attorneys&#146;
fees) incurred by any covered person, and may also pay the expenses incurred by any employee or agent of the Corporation, in defending any Proceeding in advance of its final disposition; <I>provided, however</I>, that such payment of expenses in
advance of the final disposition of the Proceeding shall be made only upon receipt of an undertaking by the person to repay all amounts advanced if it should be ultimately determined that the person is not entitled to be indemnified under this
<U>Article IX</U> or otherwise. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;28.4 <U>Determination; Claim</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If a claim for indemnification (following the final disposition of such Proceeding) under this <U>Article IX</U> is not paid in full within
sixty (60)&nbsp;days, or a claim for advancement of expenses under this <U>Article IX</U> is not paid in full within thirty (30)&nbsp;days, after a written claim therefor has been received by the Corporation the claimant may thereafter (but not
before) file suit to recover the unpaid amount of such claim and, if successful in whole or in part, shall be entitled to be paid the expense of prosecuting such claim to the fullest extent permitted by law. In any such action the Corporation shall
have the burden of proving that the claimant was not entitled to the requested indemnification or payment of expenses under applicable law. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;28.5 <U><FONT STYLE="white-space:nowrap">Non-Exclusivity</FONT> of Rights</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The rights conferred on any person by this <U>Article IX</U> shall not be exclusive of any other rights which such person may have or
hereafter acquire under any statute, provision of the Certificate of Incorporation, these bylaws, agreement, vote of stockholders or disinterested directors or otherwise. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;28.6 <U>Insurance</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Corporation may purchase and maintain insurance on behalf of any person who is or was a director, officer, employee or agent of the
Corporation, or is or was serving at the request of the Corporation as a director, officer, employee or agent of another corporation, partnership, joint venture, trust enterprise or <FONT STYLE="white-space:nowrap">non-profit</FONT> entity against
any liability asserted against him or her and incurred by him or her in any such capacity, or arising out of his or her status as such, whether or not the Corporation would have the power to indemnify him or her against such liability under the
provisions of the DGCL. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;28.7 <U>Other Indemnification</U>. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">27 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Corporation&#146;s obligation, if any, to indemnify or advance expenses to any person
who was or is serving at its request as a director, officer, employee or agent of another corporation, partnership, joint venture, trust, enterprise or <FONT STYLE="white-space:nowrap">non-profit</FONT> entity shall be reduced by any amount such
person actually collects as indemnification or advancement of expenses from such other corporation, partnership, joint venture, trust, enterprise or <FONT STYLE="white-space:nowrap">non-profit</FONT> enterprise. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;28.8 <U>Continuation of Indemnification</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The rights to indemnification and to prepayment of expenses provided by, or granted pursuant to, this <U>Article IX</U> shall continue
notwithstanding that the person has ceased to be a director or officer of the Corporation and shall inure to the benefit of the estate, heirs, executors, administrators, legatees and distributees of such person. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;28.9 <U>Amendment or Repeal; Interpretation</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The provisions of this <U>Article IX</U> shall constitute a contract between the Corporation, on the one hand, and, on the other hand, each
individual who serves or has served as a director or officer of the Corporation (whether before or after the adoption of these bylaws), in consideration of such person&#146;s performance of such services, and pursuant to this <U>Article IX</U> the
Corporation intends to be legally bound to each such current or former director or officer of the Corporation. With respect to current and former directors and officers of the Corporation, the rights conferred under this <U>Article IX</U> are
present contractual rights and such rights are fully vested, and shall be deemed to have vested fully, immediately upon adoption of theses bylaws. With respect to any directors or officers of the Corporation who commence service following adoption
of these bylaws, the rights conferred under this provision shall be present contractual rights and such rights shall fully vest, and be deemed to have vested fully, immediately upon such director or officer commencing service as a director or
officer of the Corporation. Any repeal or modification of the foregoing provisions of this <U>Article IX</U> shall not adversely affect any right or protection (i)&nbsp;hereunder of any person in respect of any act or omission occurring prior to the
time of such repeal or modification or (ii)&nbsp;under any agreement providing for indemnification or advancement of expenses to an officer or director of the Corporation in effect prior to the time of such repeal or modification. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any reference to an officer of the Corporation in this <U>Article IX</U> shall be deemed to refer exclusively to the Chief Executive Officer,
the President and the Secretary of the Corporation, or other officer of the Corporation appointed by (x)&nbsp;the Board pursuant to <U>Article V</U> or (y)&nbsp;an officer to whom the Board has delegated the power to appoint officers pursuant to
<U>Article V</U>, and any reference to an officer of any other corporation, partnership, joint venture, trust, employee benefit plan or other enterprise shall be deemed to refer exclusively to an officer appointed by the board of directors (or
equivalent governing body) of such other entity pursuant to the certificate of incorporation and bylaws (or equivalent organizational documents) of such other corporation, partnership, joint venture, trust, employee benefit plan or other enterprise.
The fact that any person who is or was an employee of the Corporation or an employee of any other corporation, partnership, joint venture, trust, employee benefit plan or other enterprise has been </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">28 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
given or has used the title of &#147;Vice President&#148; or any other title that could be construed to suggest or imply that such person is or may be an officer of the Corporation or of such
other corporation, partnership, joint venture, trust, employee benefit plan or other enterprise shall not result in such person being constituted as, or being deemed to be, an officer of the Corporation or of such other corporation, partnership,
joint venture, trust, employee benefit plan or other enterprise for purposes of this <U>Article IX</U>. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE XXIX<U>- AMENDMENTS
</U> </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Board is expressly empowered to adopt, amend or repeal the bylaws of the Corporation. The stockholders also shall have power
to adopt, amend or repeal the bylaws of the Corporation; <I>provided, however</I>, in addition to any vote of the holders of any class or series of stock of the Corporation required by applicable law or by the Certificate of Incorporation (including
any Certificate of Designation in respect of one or more series of Preferred Stock), the adoption, amendment or repeal of the bylaws of the Corporation by the stockholders of the Corporation shall require the affirmative vote of the holders of at
least <FONT STYLE="white-space:nowrap">two-thirds</FONT> (66 and 2/3%) of the voting power of all of the then outstanding shares of voting stock of the Corporation entitled to vote generally in an election of directors, voting together as a single
class. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE XXX<U>- DEFINITIONS</U> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As used in these bylaws, unless the context otherwise requires, the following terms shall have the following meanings: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">An &#147;<U>electronic transmission</U>&#148; means any form of communication, not directly involving the physical transmission of paper,
including the use of, or participation in, one or more electronic networks or databases (including one or more distributed electronic networks or databases), that creates a record that may be retained, retrieved and reviewed by a recipient thereof,
and that may be directly reproduced in paper form by such a recipient through an automated process. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">An &#147;<U>electronic mail</U>&#148;
means an electronic transmission directed to a unique electronic mail address (which electronic mail shall be deemed to include any files attached thereto and any information hyperlinked to a website if such electronic mail includes the contact
information of an officer or agent of the Corporation who is available to assist with accessing such files and information). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">An
&#147;<U>electronic mail address</U>&#148; means a destination, commonly expressed as a string of characters, consisting of a unique user name or mailbox (commonly referred to as the &#147;local part&#148; of the address) and a reference to an
internet domain (commonly referred to as the &#147;domain part&#148; of the address), whether or not displayed, to which electronic mail can be sent or delivered. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The term &#147;<U>person</U>&#148; means any individual, general partnership, limited partnership, limited liability company, corporation,
trust, business trust, joint stock company, joint venture, unincorporated association, cooperative or association or any other legal entity or organization of whatever nature, and shall include any successor (by merger or otherwise) of such entity.
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">29 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Exhibit I to the Merger Agreement </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B><I>Execution Version </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">AMENDED AND RESTATED FORWARD PURCHASE AGREEMENT </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This Amended and Restated Forward Purchase Agreement (this &#147;<U>Agreement</U>&#148;) is entered into as of March&nbsp;23, 2022, by and
among Avista Public Acquisition Corp. II, a Cayman Islands exempted company (the &#147;<U>Company</U>&#148;), Avista Acquisition LP II, a Cayman Islands exempted limited partnership (the &#147;<U>Purchaser</U>&#148;), and OmniAb, Inc., a Delaware
corporation (&#147;<U>SpinCo</U>&#148;), and amends and restates in its entirety that certain Forward Purchase Agreement (the &#147;<U>Original Agreement</U>&#148;), dated as of August&nbsp;9, 2021, by and between the Company and the Purchaser.
Capitalized terms used but not defined in this Agreement shall have the meanings ascribed to such terms in that certain Merger Agreement, dated as of the date of this Agreement, by and among the Company, Orwell Merger Sub Inc., a Delaware
corporation and wholly owned Subsidiary of the Company, Ligand Pharmaceuticals Incorporated, a Delaware corporation, and SpinCo (the &#147;<U>Merger Agreement</U>&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, the parties wish to amend and restate the Original Agreement as set forth in this Agreement, pursuant to which at the Closing under
the Merger Agreement (the &#147;<U>Merger Closing</U>&#148;), the Company shall issue and sell, and the Purchaser shall purchase, on a private placement basis, 1,500,000 shares of Domesticated Parent Common Stock (the &#147;<U>Forward Purchase
Shares</U>&#148;) and 1,666,667 Domesticated Parent Warrants (the &#147;<U>Forward Purchase Warrants</U>&#148; and together with the Forward Purchase Shares, the &#147;<U>Forward Purchase Securities</U>&#148;) on the terms and conditions set forth
herein; and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, in connection with the entry into the Merger Agreement, an allocation of up to $100,000,000.00 of committed capital
of the Purchaser has been made to subscribe for up to 10,000,000 shares of Domesticated Parent Common Stock and up to 1,666,667 Domesticated Parent Warrants to the extent that the number of shares of Domesticated Parent Common Stock that are
redeemed in connection with the consummation of the Transactions would result in the Trust Amount being less than $100,000,000.00, on the terms and conditions set forth herein (the &#147;<U>Backstop Commitment</U>&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">NOW, THEREFORE, in consideration of the premises, representations, warranties and the mutual covenants contained in this Agreement, and for
other good and valuable consideration, the receipt, sufficiency and adequacy of which are hereby acknowledged, the parties hereto agree as follows: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1. Backstop Subscription; Funding Notice. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) <U>Backstop Subscription</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">To the extent that the Trust Amount is less than $100,000,000 immediately prior to the Effective Time, the Purchaser agrees to purchase
(i)&nbsp;a number of shares of Domesticated Parent Common Stock equal to (A) (x) $100,000,000 minus (y)&nbsp;the Trust Amount (such amount, the &#147;<U>Backstop Subscription Amount</U>&#148;), divided by (B) $10.00, rounded down to the nearest
whole number (the &#147;<U>Backstop Shares</U>&#148;) and (ii)&nbsp;a number of Domesticated Parent Warrants equal to (I) 1,666,667 multiplied by (II)&nbsp;a number, the numerator of which is the Backstop Subscription Amount and the denominator of
which is $100,000,000 (the &#147;<U>Backstop Warrants</U>&#148; and, together with the Backstop Shares, the &#147;<U>Backstop Securities</U>&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) <U>Funding Notice</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On
the date by which Avista Shareholder Redemptions are required to be made in accordance with the Company&#146;s memorandum and articles of association, as they may be amended from time to time (the &#147;<U>Memorandum and Articles</U>&#148;) (which
date is two (2)&nbsp;Business Days prior to the date of the Parent Shareholders Meeting), the Company shall deliver a written notice (the &#147;<U>Funding Notice</U>&#148;) to the Purchaser setting forth: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) the Parent Share Redemption Amount; </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) the Backstop Subscription Amount (as calculated in accordance with
<U>Section</U><U></U><U>&nbsp;1(a)</U> of this Agreement); </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii) the number of Backstop Shares; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iv) the number of Backstop Warrants; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(v) the anticipated Closing Date; and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(vi) the Company&#146;s wire instructions. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Notwithstanding the foregoing, for the avoidance of doubt, the &#147;Backstop Subscription Amount&#148; shall be finally calculated without
including any shares of Domesticated Parent Common Stock subject to the Parent Shareholder Redemption that have been offered for redemption but subsequently and validly withdrawn by the applicable holder in accordance with the Company&#146;s
Memorandum and Articles and applicable Law. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2. Sale and Purchase. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <U>Forward Purchase Securities; Backstop Securities</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) The Company shall issue and sell to the Purchaser, and the Purchaser shall purchase from the Company, on a private placement basis,
1,500,000 Forward Purchase Shares and 1,666,667 Forward Purchase Warrants for an aggregate purchase price of $15,000,000 (the &#147;<U>FPS Purchase Price</U>&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) Subject to the terms and conditions hereof, the Company shall issue and sell to the Purchaser, and the Purchaser shall purchase from the
Company, on a private placement basis, the Backstop Shares and the Backstop Warrants for an aggregate purchase price equal to the Backstop Subscription Amount. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iii) Each Forward Purchase Warrant and Backstop Warrant will have the same terms as the Parent Private Placement Warrants, and will be
subject to the terms and conditions of the Warrant Agreement. Each Forward Purchase Warrant and Backstop Warrant will entitle the holder thereof to purchase one share of Domesticated Parent Common Stock at a price of $11.50 per share, subject to
adjustment as described in the Warrant Agreement. The Forward Purchase Warrants and Backstop Warrants will become exercisable thirty (30)&nbsp;days after the Merger Closing and will expire five (5)&nbsp;years after the Merger Closing or upon
redemption or the liquidation of the Company, if earlier, as described in the Warrant Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iv) The delivery of the Funding Notice
hereunder shall serve as notice to the Purchaser that the Purchaser will be required to pay the FPS Purchase Price and the Backstop Subscription Amount, and acquire the Forward Purchase Securities and the Backstop Securities, at the FPS/BPS Closing
(as defined below). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(v) The closing of the sale of the Forward Purchase Securities and the Backstop Securities (the &#147;<U>FPS/BPS
Closing</U>&#148;) shall be held on the Closing Date and immediately prior to the Merger Closing. At the FPS/BPS Closing, the Company will issue to the Purchaser the Forward Purchase Securities and the Backstop Securities, if any, each registered in
the name of the Purchaser, against (and concurrently with) the payment of the FPS Purchase Price and the Backstop Subscription Amount to the Company by wire transfer of immediately available funds to the account notified to the Purchaser by the
Company in the Funding Notice. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <U>Delivery of Securities</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) The Company shall register the Purchaser as the owner of the Forward Purchase Securities and the Backstop Securities purchased by the
Purchaser hereunder (together, the &#147;<U>Securities</U>&#148;) on the Company&#146;s share register and with the Company&#146;s transfer agent by book entry on or promptly after (but in no event more than two (2)&nbsp;Business Days after) the
date of the FPS/BPS Closing. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) Each register and book entry for the Securities shall contain a notation, and each
certificate (if any) evidencing the Securities shall be stamped or otherwise imprinted with a legend, in substantially the following form: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">&#147;THE SECURITIES REPRESENTED HEREBY HAVE NOT BEEN REGISTERED UNDER THE U.S. SECURITIES ACT OF 1933, AS AMENDED, OR THE SECURITIES LAWS OF
ANY STATE OR OTHER JURISDICTION, AND MAY NOT BE TRANSFERRED IN VIOLATION OF SUCH ACT AND LAWS.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) <U>Legend Removal</U>. If the
Securities are eligible to be sold without restriction under, and without the Company being in compliance with the current public information requirements of, Rule 144 under the Securities Act, then at the Purchaser&#146;s request, the Company will
cause the Company&#146;s transfer agent to remove the legend set forth in <U>Section</U><U></U><U>&nbsp;2(b)(ii)</U>. In connection therewith, if required by the Company&#146;s transfer agent, the Company will promptly cause an opinion of counsel to
be delivered to and maintained with its transfer agent, together with any other authorizations, certificates and directions required by the transfer agent that authorize and direct the transfer agent to transfer such Securities without any such
legend; <U>provided</U>, <U>however</U>, that the Company will not be required to deliver any such opinion, authorization or certificate or direction if it reasonably believes that removal of the legend could result in or facilitate transfers of the
Securities in violation of applicable Law. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) <U>Registration Rights</U>. The Purchaser shall have registration rights with respect to
the Securities as referenced in the Amended and Restated Registration Rights Agreement that will be entered into by and among the Company, the Purchaser, SpinCo and certain other parties thereto in connection with the consummation of the
Transactions and the form of which is attached to the Merger Agreement as Exhibit E (the &#147;<U>Registration Rights Agreement</U>&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) <U>Adjustments to Notional Amounts</U>. In the event of any change to the capital structure of the Company, whether dilutive or otherwise,
by way of a share dividend, share split, or any other similar transaction however described, the number of Forward Purchase Securities and Backstop Securities, and/or the FPS Purchase Price and Backstop Subscription Amount, as applicable, will be
adjusted as necessary to account for such changes. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3. Representations and Warranties of the Purchaser. The Purchaser represents and
warrants to each of the Company and SpinCo as follows, as of the date hereof: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <U>Organization and Power</U>. The Purchaser is duly
organized, validly existing, and in good standing under the Laws of the jurisdiction of its formation and has all requisite power and authority to carry on its business as presently conducted and as proposed to be conducted. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <U>Authorization</U>. The Purchaser has full power and authority to enter into this Agreement. This Agreement, when executed and delivered
by the Purchaser, will constitute the valid and legally binding obligation of the Purchaser, enforceable in accordance with its terms, except (a)&nbsp;as limited by applicable bankruptcy, insolvency, reorganization, moratorium, fraudulent conveyance
and any other Laws of general application affecting enforcement of creditors&#146; rights generally, (b)&nbsp;as limited by Laws relating to the availability of specific performance, injunctive relief or other equitable remedies, or (c)&nbsp;to the
extent the indemnification provisions contained in the Registration Rights Agreement may be limited by applicable federal or state securities Laws. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) <U>Governmental Consents and Filings</U>. No consent, approval, order or authorization of, or registration, qualification, designation,
declaration or filing with, any federal, state or local governmental authority is required on the part of the Purchaser in connection with the consummation of the transactions contemplated by this Agreement. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) <U>Compliance with Other Instruments</U>. The execution, delivery and performance by the
Purchaser of this Agreement and the consummation by the Purchaser of the transactions contemplated by this Agreement will not result in any violation or default (i)&nbsp;of any provisions of its organizational documents, (ii)&nbsp;of any instrument,
judgment, order, writ or decree to which it is a party or by which it is bound, (iii)&nbsp;under any note, indenture or mortgage to which it is a party or by which it is bound, (iv)&nbsp;under any lease, agreement, contract or purchase order to
which it is a party or by which it is bound or (v)&nbsp;of any provision of federal or state statute, rule or regulation applicable to the Purchaser, in each case (other than clause (i)), which would have a material adverse effect on the Purchaser
or its ability to consummate the transactions contemplated by this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) <U>Purchase Entirely for Own Account</U>. This
Agreement is made with the Purchaser in reliance upon the Purchaser&#146;s representation to the Company, which by the Purchaser&#146;s execution of this Agreement, the Purchaser hereby confirms, that the Securities to be acquired by the Purchaser
will be acquired for investment for the Purchaser&#146;s own account, not as a nominee or agent, and not with a view to the resale or distribution of any part thereof, and that the Purchaser has no present intention of selling, granting any
participation in, or otherwise distributing the same in violation of Law. By executing this Agreement, the Purchaser further represents that the Purchaser does not presently have any contract, undertaking, agreement or arrangement with any Person to
sell, transfer or grant participations to such Person or to any third Person, with respect to any of the Securities. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) <U>Disclosure of
Information</U>. The Purchaser has had an opportunity to discuss the Company&#146;s existing and planned or expected business, management, financial affairs and the terms and conditions of the purchase and sale of the Securities, as well as the
terms of the Transactions, with the Company&#146;s management. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) <U>Restricted Securities</U>. The Purchaser understands that the offer
and sale of the Securities to the Purchaser has not been, and will not be, registered under the Securities Act, by reason of a specific exemption from the registration provisions of the Securities Act which depends upon, among other things, the bona
fide nature of the investment intent and the accuracy of the Purchaser&#146;s representations as expressed herein. The Purchaser understands that the Securities are &#147;restricted securities&#148; under applicable U.S. federal and state securities
Laws and that, pursuant to these Laws, the Purchaser must hold the Securities indefinitely unless they are registered with the SEC and qualified by state authorities, or an exemption from such registration and qualification requirements is
available. The Purchaser acknowledges that the Company has no obligation to register or qualify the Securities, or any securities into which the Securities may be converted into or exercised for, for resale, except pursuant to the Registration
Rights Agreement. The Purchaser further acknowledges that if an exemption from registration or qualification is available, it may be conditioned on various requirements including, but not limited to, the time and manner of sale, the holding period
for the Securities, and on requirements relating to the Company which are outside of the Purchaser&#146;s control, and which the Company is under no obligation and may not be able to satisfy. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h) <U>High Degree of Risk</U>. The Purchaser understands that its agreement to purchase the Securities involves a high degree of risk, which
could cause the Purchaser to lose all or part of its investment. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) <U>Accredited Investor</U>. The Purchaser is an &#147;accredited
investor&#148; as defined in Rule 501(a) of Regulation D promulgated under the Securities Act. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(j) <U>No General Solicitation</U>.
Neither the Purchaser, nor any of its officers, directors, employees, agents, stockholders or partners has either directly or indirectly, including, through a broker or finder (i)&nbsp;to its knowledge, engaged in any general solicitation, or
(ii)&nbsp;published any advertisement in connection with the purchase and sale of the Securities. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(k)
<U><FONT STYLE="white-space:nowrap">Non-Public</FONT> Information</U>. The Purchaser acknowledges its obligations under applicable securities Laws with respect to the treatment of material <FONT STYLE="white-space:nowrap">non-public</FONT>
information relating to the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(l) <U>Adequacy of Financing</U>. The Purchaser will have at the FPS/BPS Closing available to it
sufficient funds to satisfy its obligations under this Agreement. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(m) <U>Affiliation of Certain FINRA Members</U>. The Purchaser is neither a person
associated nor affiliated with any underwriter of the IPO or, to its actual knowledge, any other member of the Financial Industry Regulatory Authority (&#147;<U>FINRA</U>&#148;) that participated in the IPO. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(n) <U>No Other Representations and Warranties; <FONT STYLE="white-space:nowrap">Non-Reliance</FONT></U>. Except for the specific
representations and warranties contained in this <U>Section</U><U></U><U>&nbsp;3</U> and in any certificate or agreement delivered pursuant hereto, none of the Purchaser nor any person acting on behalf of the Purchaser nor any of the
Purchaser&#146;s affiliates (the &#147;<U>Purchaser Parties</U>&#148;) has made, makes or shall be deemed to make any other express or implied representation or warranty with respect to the Purchaser or the purchase and sale of the Securities, and
the Purchaser Parties disclaim any such representation or warranty. Except for the specific representations and warranties expressly made by the Company in <U>Section</U><U></U><U>&nbsp;4</U> of this Agreement and in any certificate or agreement
delivered pursuant hereto, the Purchaser Parties specifically disclaim that they are relying upon any other representations or warranties that may have been made by the Company, any person on behalf of the Company or any of the Company&#146;s
affiliates (collectively, the &#147;<U>Company Parties</U>&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4. Representations and Warranties of the Company. The Company
represents and warrants to the Purchaser as follows: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <U>Incorporation and Corporate Power</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) Until the occurrence of the Domestication, the Company is an exempted company duly incorporated, validly existing and in good standing
under the Laws of the Cayman Islands and has all requisite corporate power and authority to carry on its business as presently conducted and as proposed to be conducted. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) Upon the occurrence of the Domestication, the Company will be a corporation duly incorporated, validly existing and in good standing
under the Laws of the State of Delaware and will have all requisite corporate power and authority to carry on its business as presently conducted and as proposed to be conducted. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iii) The Company has no subsidiaries other than Merger Sub. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <U>Capitalization</U>. The authorized share capital of the Company consists, as of the date hereof, of: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) 500,000,000 shares of Parent Class&nbsp;A Common Stock, 23,000,000 of which are issued and outstanding. All of the issued and outstanding
shares of Parent Class&nbsp;A Common Stock have been duly authorized, are fully paid and nonassessable and were issued in compliance with all applicable federal and state securities Laws. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) 50,000,000 shares of Parent Class&nbsp;B Common Stock, 5,750,000 of which are issued and outstanding. All of the issued and outstanding
shares of Parent Class&nbsp;B Common Stock have been duly authorized, are fully paid and nonassessable and were issued in compliance with all applicable federal and state securities Laws. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iii) 5,000,000 shares of Parent Preferred Stock, none of which are issued and outstanding. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) <U>Authorization</U>. All corporate action required to be taken by the Company&#146;s Board of Directors and shareholders in order to
authorize the Company to enter into this Agreement, and to issue the Securities at the FPS/BPS Closing, and the securities issuable upon conversion or exercise of the Securities, has been taken or will be taken prior to the FPS/BPS Closing, as
applicable. All action on the part of the shareholders, directors and officers of the Company necessary for the execution and delivery of this Agreement, the performance of all obligations of </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
the Company under this Agreement to be performed as of the FPS/BPS Closing, and the issuance and delivery of the Securities and the securities issuable upon conversion or exercise of the
Securities has been taken or will be taken prior to the FPS/BPS Closing. This Agreement, when executed and delivered by the Company, shall constitute a valid and legally binding obligation of the Company, enforceable against the Company in
accordance with its terms except (i)&nbsp;as limited by applicable bankruptcy, insolvency, reorganization, moratorium, fraudulent conveyance, or other Laws of general application relating to or affecting the enforcement of creditors&#146; rights
generally, (ii)&nbsp;as limited by Laws relating to the availability of specific performance, injunctive relief, or other equitable remedies, or (iii)&nbsp;to the extent the indemnification provisions contained in the Registration Rights Agreement
may be limited by applicable federal or state securities Laws. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) <U>Valid Issuance of Securities</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) The Securities, when issued, sold and delivered in accordance with the terms and for the consideration set forth in this Agreement and
registered in the register of members of the Company, and the securities issuable upon conversion or exercise of the Securities, when issued in accordance with the terms of the Securities and this Agreement, and registered on the Company&#146;s
share register, will be validly issued, fully paid and nonassessable and free of all preemptive or similar rights, liens, encumbrances and charges with respect to the issue thereof and restrictions on transfer other than restrictions on transfer
specified under this Agreement, applicable state and federal securities Laws and liens or encumbrances created by or imposed by the Purchaser. Assuming the accuracy of the representations of the Purchaser in this Agreement and subject to the filings
described in <U>Section</U><U></U><U>&nbsp;4(e)</U> below, the Securities and the securities issuable upon conversion of the Securities will be issued in compliance with all applicable federal and state securities Laws. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) No &#147;bad actor&#148; disqualifying event described in Rule 506(d)(1)(i)-(viii) of the Securities Act (a &#147;<U>Disqualification
Event</U>&#148;) is applicable to the Company or, to the Company&#146;s knowledge, any Company Covered Person (as defined below), except for a Disqualification Event as to which Rule 506(d)(2)(ii&#151;iv) or (d)(3), is applicable. &#147;<U>Company
Covered Person</U>&#148; means, with respect to the Company as an &#147;issuer&#148; for purposes of Rule 506 promulgated under the Securities Act, any Person listed in the first paragraph of Rule 506(d)(1). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) <U>Governmental Consents and Filings</U>. Assuming the accuracy of the representations and warranties made by the Purchaser in this
Agreement, no consent, approval, order or authorization of, or registration, qualification, designation, declaration or filing with, any federal, state or local governmental authority is required on the part of the Company in connection with the
consummation of the transactions contemplated by this Agreement, except for filings pursuant to Regulation D of the Securities Act, applicable state securities Laws and pursuant to the Registration Rights Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) <U>Compliance with Other Instruments</U>. The execution, delivery and performance of this Agreement and the consummation of the
transactions contemplated by this Agreement will not result in any violation or default (i)&nbsp;of any provisions of the Company&#146;s Governing Documents, as they may be amended from time to time, (ii)&nbsp;of any instrument, judgment, order,
writ or decree to which the Company is a party or by which it is bound, (iii)&nbsp;under any note, indenture or mortgage to which the Company is a party or by which it is bound, (iv)&nbsp;under any lease, agreement, contract or purchase order to
which the Company is a party or by which it is bound or (v)&nbsp;of any provision of federal or state statute, rule or regulation applicable to the Company, in each case (other than clause (i)) which would have a material adverse effect on the
Company or its ability to consummate the transactions contemplated by this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) <U>Operations</U>. As of the date hereof, the
Company has not conducted any operations other than organizational activities and activities in connection with its initial public offering (the &#147;<U>IPO</U>&#148;), its search for a potential business combination and financing in connection
therewith. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h) <U>Foreign Corrupt Practices</U>. Neither the Company, nor any director, officer, agent,
employee or other Person acting on behalf of the Company has, in the course of its actions for, or on behalf of, the Company (i) used any corporate funds for any unlawful contribution, gift, entertainment or other unlawful expenses relating to
political activity; (ii)&nbsp;made any direct or indirect unlawful payment to any foreign or domestic government official or employee from corporate funds; (iii)&nbsp;violated or is in violation of any provision of the U.S. Foreign Corrupt Practices
Act of 1977, as amended; or (iv)&nbsp;made any unlawful bribe, rebate, payoff, influence payment, kickback or other unlawful payment to any foreign or domestic government official or employee. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) <U>Compliance with Anti-Money Laundering Laws</U>. The operations of the Company are and have been conducted at all times in compliance
with applicable financial recordkeeping and reporting requirements and all other applicable U.S. and <FONT STYLE="white-space:nowrap">non-U.S.</FONT> anti-money laundering Laws and regulations, including, but not limited to, those of the Currency
and Foreign Transactions Reporting Act of 1970, as amended, the USA PATRIOT Act of 2001 and the applicable money laundering statutes of all applicable jurisdictions, the rules and regulations thereunder and any related or similar rules, regulations
or guidelines, issued, administered or enforced by any governmental agency (collectively, the &#147;<U>Anti-Money Laundering Laws</U>&#148;), and no action, suit or proceeding by or before any court or governmental agency, authority or body or any
arbitrator involving the Company with respect to the Anti-Money Laundering Laws is pending or, to the knowledge of the Company, threatened. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(j) <U>Absence of Litigation</U>. There is no Action before or by any Governmental Authority or, to the Knowledge of the Company, threatened
against or affecting the Company or any of the Company&#146;s officers or directors, whether of a civil or criminal nature or otherwise, in their capacities as such. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(k) <U>No General Solicitation</U>. Neither the Company, nor any of its officers, directors, employees, agents or shareholders has either
directly or indirectly, including, through a broker or finder (i)&nbsp;engaged in any general solicitation, or (ii)&nbsp;published any advertisement in connection with the offer and sale of the Securities. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(l) <U>No Other Representations and Warranties; <FONT STYLE="white-space:nowrap">Non-Reliance</FONT></U>. Except for the specific
representations and warranties contained in this <U>Section</U><U></U><U>&nbsp;4</U> and in any certificate or agreement delivered pursuant hereto, none of the Company Parties has made, makes or shall be deemed to make any other express or implied
representation or warranty with respect to the Company, the transactions contemplated by the Merger Agreement or the offer and sale of the Securities, and the Company Parties disclaim any such representation or warranty. Except for the specific
representations and warranties expressly made by the Purchaser in <U>Section</U><U></U><U>&nbsp;3</U> of this Agreement and in any certificate or agreement delivered pursuant hereto, the Company Parties specifically disclaim that they are relying
upon any other representations or warranties that may have been made by the Purchaser Parties. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5. Additional Agreements, Acknowledgements
and Waivers of the Purchaser. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <U>Trust Account</U>. The Purchaser acknowledges that the Company is a blank check company with the
powers and privileges to effect a Business Combination. The Purchaser further acknowledges that, as described in the prospectus included in the registration statement of the Company (the &#147;<U>Prospectus</U>&#148;) available at www.sec.gov,
substantially all of the Company&#146;s assets consist of the cash proceeds of the IPO and private placements of its securities, and substantially all of those proceeds have been deposited in a trust account for the benefit of the Company, certain
of its public shareholders and the underwriters of the IPO (the &#147;<U>Trust Account</U>&#148;). The Purchaser acknowledges that, except with respect to interest earned on the funds held in the Trust Account that may be released to the Company to
pay its franchise Tax, income Tax and similar obligations, the Trust Agreement provides that cash in the Trust Account may be disbursed only (i)&nbsp;if the Company completes one or more transactions that constitute a Business Combination, then to
those Persons and in such amounts as described in the Prospectus; (ii)&nbsp;if the Company fails to complete a Business Combination within the allotted time period and liquidates, subject to the terms of the Trust Agreement, to the Company in
limited amounts to permit the Company to pay the costs and expenses of its liquidation and dissolution, and then to the Company&#146;s public shareholders; and (iii)&nbsp;if the Company holds a shareholder vote to amend the Company&#146;s Governing
Documents to modify the substance or timing of the obligation to redeem 100% of the shares of Parent Common Stock if the Company fails to complete a Business Combination within the allotted time period, then for the redemption of any shares of
Parent Common Stock properly tendered in connection with such vote. For and in consideration of the Company entering </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
into this Agreement, the receipt and sufficiency of which are hereby acknowledged, the Purchaser hereby irrevocably waives any right, title, interest or claim of any kind they have or may have in
the future in or to any monies in the Trust Account (including any distributions therefrom) and agree not to seek recourse against the Trust Account or any funds distributed therefrom as a result of, or arising out of, this Agreement and any
negotiations, Contracts or agreements with the Company; <U>provided</U>, <U>however</U>, that nothing herein shall serve to limit or prohibit the Purchaser&#146;s right to pursue a claim against the Company for legal relief against monies or other
assets held outside the Trust Account, for specific performance or other equitable relief in connection with the consummation of the Transactions so long as such claim would not affect the Company&#146;s ability to fulfill its obligation to
effectuate the Parent Share Redemptions. The Purchaser agrees and acknowledges that such irrevocable waiver is material to this Agreement and specifically relied upon by the Company to induce it to enter in this Agreement, and the Purchaser further
intends and understands such waiver to be valid, binding and enforceable under applicable Law. To the extent the Purchaser commences any action or proceeding based upon, in connection with, relating to or arising out of any matter relating to the
Company, which proceeding seeks, in whole or in part, monetary relief against the Company, the Purchaser hereby acknowledges and agrees that its sole remedy shall be against funds held outside of the Trust Account and that such claim shall not
permit the Purchaser (or any party claiming on the Purchaser&#146;s behalf or in lieu of the Purchaser) to have any claim against the Trust Account (including any distributions therefrom) or any amounts contained therein. In the event that the
Purchaser commences any action or proceeding based upon, in connection with, relating to or arising out of any matter relating to the Company, which proceeding seeks, in whole or in part, relief against the Trust Account (including any distributions
therefrom) or the holders of Parent Common Stock, whether in the form of money damages or injunctive relief, the Company shall be entitled to recover from the Purchaser the associated legal fees and costs in connection with any such action, in the
event the Company prevails in such action or proceeding. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <U>No Short Sales</U>. The Purchaser hereby agrees that neither it, nor any
person or entity acting on its behalf or pursuant to any understanding with it, will engage in any Short Sales with respect to securities of the Company prior to the Merger Closing. For purposes of this <U>Section</U><U></U><U>&nbsp;5</U>,
&#147;<U>Short Sales</U>&#148; shall include, without limitation, all &#147;short sales&#148; as defined in Rule 200 promulgated under Regulation SHO under the Exchange Act and all types of direct and indirect stock pledges (other than pledges in
the ordinary course of business as part of prime brokerage arrangements), forward sale contracts, options, puts, calls, swaps and similar arrangements (including on a total return basis), and sales and other transactions through <FONT
STYLE="white-space:nowrap">non-U.S.</FONT> broker dealers or foreign regulated brokers. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) <U>Voting</U>. The Purchaser hereby agrees
that if the Company seeks shareholder approval of the Transaction Proposals, then the Purchaser shall vote any shares of Parent Class&nbsp;A Common Stock owned by it in favor of such Transaction Proposals. If the Purchaser fails to vote any shares
of Parent Class&nbsp;A Common Stock it is required to vote hereunder in favor of the Transaction Proposals, the Purchaser hereby grants hereunder to the Company and any representative designated by the Company, without further action by the
Purchaser or any other Person, a limited irrevocable power of attorney to effect such vote on behalf of the Purchaser, which power of attorney shall be deemed to be coupled with an interest. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6. QEF Election Information. The Company shall use commercially reasonable efforts to determine whether, in any year, the Company or any
subsidiary of the Company is deemed to be a &#147;passive foreign investment company&#148; (a &#147;<U>PFIC</U>&#148;) within the meaning of U.S. Internal Revenue Code of 1986, as amended, and the regulations promulgated thereunder (collectively,
the &#147;<U>Code</U>&#148;). If the Company determines that the Company or any subsidiary of the Company is a PFIC in any year, for the year of determination and for each year thereafter during which the Purchaser holds an equity interest in the
Company, including any Parent Warrants, the Company or such subsidiary shall use commercially reasonable efforts to (a)&nbsp;make available to the Purchaser the information that may be required to make or maintain a &#147;qualified electing
fund&#148; election under the Code with respect to the Company and (b)&nbsp;furnish the information required to be reported under Section&nbsp;1298(f) of the Code. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7. Listing. The Company will use commercially reasonable efforts to maintain the listing of the Parent Class&nbsp;A Common Stock and
Domesticated Class&nbsp;A Common Stock (as applicable) on the NASDAQ (or another national securities exchange). </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8. FPS/BPS Closing Conditions. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) The obligation of the Purchaser to purchase the Securities at the FPS/BPS Closing under this Agreement shall be subject to the
fulfillment, at or prior to the FPS/BPS Closing of each of the following conditions, any of which, to the extent permitted by applicable Laws, may be waived by the Purchaser: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) The Transactions shall be completed substantially concurrently with, and (except in the case of the Domestication) immediately following,
the purchase and sale of the Securities hereunder; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) The Company shall not have delivered to the Purchaser a revocation of the
Funding Notice; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iii) The representations and warranties of the Company set forth in <U>Section</U><U></U><U>&nbsp;4</U> of this
Agreement shall have been true and correct as of the date hereof and shall be true and correct as of the FPS/BPS Closing, as applicable, with the same effect as though such representations and warranties had been made on and as of such date (other
than any such representation or warranty that is made by its terms as of a specified date, which shall be true and correct as of such specified date), except where the failure to be so true and correct would not have a material adverse effect on the
Company, or its ability to consummate the transactions contemplated by this Agreement; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iv) The Company shall have performed, satisfied
and complied in all material respects with the covenants, agreements and conditions required by this Agreement to be performed, satisfied or complied with by the Company, at or prior to the FPS/BPS Closing; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(v) No order, writ, judgment, injunction, decree, determination, or award shall have been entered by or with any governmental, regulatory, or
administrative authority or any court, tribunal, or judicial, or arbitral body, and no other legal restraint or prohibition shall be in effect, preventing the purchase by the Purchaser of the Securities. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(b) The obligation of the Company to sell the Securities at the FPS/BPS Closing under this Agreement shall be subject to the fulfillment, at
or prior to the FPS/BPS Closing of each of the following conditions, any of which, to the extent permitted by applicable Laws, may be waived by the Company: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) The Transactions shall be completed substantially concurrently with, and (except in the case of the Domestication) immediately following,
the purchase and sale of the Securities hereunder; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) The representations and warranties of the Purchaser set forth in
<U>Section</U><U></U><U>&nbsp;3</U> of this Agreement shall have been true and correct as of the date hereof and shall be true and correct as of the FPS/BPS Closing, as applicable, with the same effect as though such representations and warranties
had been made on and as of such date (other than any such representation or warranty that is made by its terms as of a specified date, which shall be true and correct as of such specified date), except where the failure to be so true and correct
would not have a material adverse effect on the Purchaser or its ability to consummate the transactions contemplated by this Agreement; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iii) The Purchaser shall have performed, satisfied and complied in all material respects with the covenants, agreements and conditions
required by this Agreement to be performed, satisfied or complied with by the Purchaser at or prior to the FPS/BPS Closing; and </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iv) No order, writ, judgment, injunction, decree, determination, or award shall have been
entered by or with any governmental, regulatory, or administrative authority or any court, tribunal, or judicial, or arbitral body, and no other legal restraint or prohibition shall be in effect, preventing the purchase by the Purchaser of the
Securities. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9. Termination. This Agreement may be terminated at any time prior to the FPS/BPS Closing: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) by mutual written consent of the Company, the Purchaser and SpinCo; or </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) automatically: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) if a
Business Combination is not completed within eighteen (18)&nbsp;months from the closing of the IPO, or such later date as may be approved by the Company&#146;s shareholders in accordance with its Governing Documents; or </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) upon the termination of the Merger Agreement in accordance with the terms and conditions thereof. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the event of any termination of this Agreement pursuant to this <U>Section</U><U></U><U>&nbsp;9</U>, the FPS Purchase Price and the
Backstop Subscription Amount (and interest thereon, if any), if previously paid, and all Purchaser&#146;s funds paid in connection herewith shall be promptly returned to the Purchaser, and thereafter this Agreement shall forthwith become null and
void and have no effect, without any liability on the part of the Purchaser or the Company and their respective directors, officers, employees, partners, managers, members, or shareholders and all rights and obligations of each party shall cease;
<U>provided</U>, <U>however</U>, that nothing contained in this <U>Section</U><U></U><U>&nbsp;9</U> shall relieve either party from liabilities or damages arising out of any fraud or willful breach by such party of any of its representations,
warranties, covenants or agreements contained in this Agreement. Notwithstanding anything herein to the contrary, from and after any termination of this Agreement pursuant to <U>Section</U><U></U><U>&nbsp;9(b)</U>, the Original Agreement shall
automatically resume and continue in full force and effect in accordance with its terms as though it were never amended and restated by this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">10. Termination Fee. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) In
the event that this Agreement is terminated by reason of a termination of the Merger Agreement pursuant to Section&nbsp;9.1(i) thereof, then, concurrently with and as a condition to such termination, the Company shall pay the Purchaser or its
designee(s) a termination fee of $12,500,000.00 (the &#147;<U>FPA Termination Fee</U>&#148;) by wire transfer of immediately available funds to an account designated by the Purchaser in writing. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) Notwithstanding anything to the contrary set forth in this Agreement, except in the case of Actual Fraud or Willful Breach, if the FPA
Termination Fee is paid pursuant to <U>Section</U><U></U><U>&nbsp;10(a)</U>, such payment shall constitute the sole and exclusive remedy of the Purchaser, any of its Subsidiaries or any of its or their respective former, current or future general or
limited partners, shareholders, Representatives or assignees against the Company Related Parties for all losses and damages suffered as a result of the failure of the Transactions to be consummated or for a breach or failure to perform hereunder or
otherwise, and none of the Company Related Parties shall have any further liability or obligation to Purchaser and such other Persons relating to or arising out of this Agreement or the Transactions. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) If the Company fails to pay promptly the FPA Termination Fee when due under this <U>Section</U><U></U><U>&nbsp;10</U>, and in order to
obtain such payment, the Purchaser commences an Action that results in a judgment against the Company for any amount owed thereby under this Section&nbsp;10, the Company shall reimburse the Purchaser for its reasonable and documented costs and
expenses (including reasonable and documented attorneys&#146; fees) in connection with such Action, together with interest on such amount at a rate equal to (x)&nbsp;the prime rate as published in The Wall Street Journal in effect on the date such
payment was required to be made through the date such payment was actually received, plus (y)&nbsp;five percent (5%). </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) Each of the parties acknowledges that (i)&nbsp;the agreements contained in this
<U>Section</U><U></U><U>&nbsp;10</U> are an integral part of the Transactions, (ii)&nbsp;without these agreements, the parties would not enter into this Agreement and (iii)&nbsp;the FPA Termination Fee does not constitute a penalty, but rather
represents liquidated damages in a reasonable amount that will compensate the Purchaser for the efforts and resources expended and opportunities foregone while negotiating this Agreement and in reliance on this Agreement and on the expectation of
the consummation of the Transactions, which amount would otherwise be impossible to calculate with precision. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">11. General Provisions.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <U>Notices</U>. All notices and other communications given or made pursuant to this Agreement shall be in writing and shall be deemed
effectively given upon the earlier of actual receipt, or (i)&nbsp;personal delivery to the party to be notified, (ii)&nbsp;when sent, if sent by electronic mail or facsimile (if any) during normal business hours of the recipient, and if not sent
during normal business hours, then on the recipient&#146;s next Business Day, (iii)&nbsp;five (5) Business Days after having been sent by registered or certified mail, return receipt requested, postage prepaid, or (iv)&nbsp;one (1) Business Day
after deposit with a nationally recognized overnight courier, freight prepaid, specifying next Business Day delivery, with written verification of receipt. All communications sent to the Company shall be sent to: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Avista Public Acquisition Corp. II </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">65 East 55th Street, 18th Floor </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">New York, New York 10022 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Attn:
Benjamin Silbert, General Counsel </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">email: Silbert@avistacap.com </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">with a copy to the Company&#146;s counsel (which shall not constitute notice) at: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Weil, Gotshal&nbsp;&amp; Manges LLP </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">767 Fifth Avenue </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">New York, New
York 10153 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Attn: &nbsp;&nbsp;Jaclyn L. Cohen, Esq. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">&nbsp;Raymond O. Gietz, Esq. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">email: Jackie.Cohen@weil.com </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">&nbsp;Raymond.Gietz@weil.com </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">All
communications to the Purchaser or SpinCo shall be sent to the Purchaser&#146;s or SpinCo&#146;s address as set forth on the signature page hereof, or to such <FONT STYLE="white-space:nowrap">e-mail</FONT> address, facsimile number (if any) or
address as subsequently modified by written notice given in accordance with this <U>Section</U><U></U><U>&nbsp;11(a)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <U>No
Finder</U><U>&#146;</U><U>s Fees</U>. Each party represents that it neither is nor will be obligated for any finder&#146;s fee or commission in connection with this transaction. The Purchaser agrees to indemnify and to hold harmless the Company from
any liability for any commission or compensation in the nature of a finder&#146;s or broker&#146;s fee arising out of this transaction (and the costs and expenses of defending against such liability or asserted liability) for which the Purchaser or
any of its officers, employees or representatives is responsible. The Company agrees to indemnify and hold harmless the Purchaser from any liability for any commission or compensation in the nature of a finder&#146;s or broker&#146;s fee arising out
of this transaction (and the costs and expenses of defending against such liability or asserted liability) for which the Company or any of its officers, employees or representatives is responsible. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) <U>Survival of Representations and Warranties</U>. All of the representations and warranties contained herein shall survive the FPS/BPS
Closing. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) <U>Entire Agreement</U>. This Agreement, together with any documents, instruments and
writings that are delivered pursuant hereto or referenced herein, constitutes the entire agreement and understanding of the parties hereto in respect of its subject matter and supersedes all prior understandings, agreements or representations by or
among the parties hereto, written or oral, to the extent they relate in any way to the subject matter hereof or the transactions contemplated hereby. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) <U>Successors</U>. All of the terms, agreements, covenants, representations, warranties and conditions of this Agreement are binding upon,
and inure to the benefit of and are enforceable by, the parties hereto and their respective successors. Nothing in this Agreement, express or implied, is intended to confer upon any party other than the parties hereto or their respective successors
and assigns any rights, remedies, obligations or liabilities under or by reason of this Agreement, except as expressly provided in this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) <U>Assignments</U>. Except as otherwise specifically provided herein, no party hereto may assign either this Agreement or any of its
rights, interests, or obligations hereunder without the prior written approval of the other parties except that the Purchaser may assign its rights, interests or obligations hereunder to any of its affiliates. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) <U>Counterparts</U>. This Agreement may be executed in two or more counterparts, each of which will be deemed an original but all of which
together will constitute one and the same instrument. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h) <U>Headings</U>. The section headings contained in this Agreement are inserted
for convenience only and will not affect in any way the meaning or interpretation of this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) <U>Governing Law</U>. This
Agreement, the entire relationship of the parties hereto, and any dispute between the parties (whether at law or in equity, and whether grounded in contract, tort or statute) shall be governed by, construed in accordance with, and interpreted
pursuant to the Laws of the State of Delaware, without giving effect to its choice of laws principles. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(j) <U>Jurisdiction</U>. The
parties (a)&nbsp;hereby irrevocably and unconditionally submit to the jurisdiction of the Court of Chancery of the State of Delaware for the purpose of any suit, action or other proceeding arising out of or based upon this Agreement, (b)&nbsp;agree
not to commence any suit, action or other proceeding arising out of or based upon this Agreement except in the Court of Chancery of the State of Delaware, and (c)&nbsp;hereby waive, and agree not to assert, by way of motion, as a defense, or
otherwise, in any such suit, action or proceeding, any claim that it is not subject personally to the jurisdiction of the above-named courts, that its property is exempt or immune from attachment or execution, that the suit, action or proceeding is
brought in an inconvenient forum, that the venue of the suit, action or proceeding is improper or that this Agreement or the subject matter hereof may not be enforced in or by such court. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(k) <U>Waiver of Jury Trial</U>. The parties hereto hereby waive any right to a jury trial in connection with any litigation pursuant to this
Agreement and the transactions contemplated hereby. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(l) <U>Amendments</U>. This Agreement may not be amended, modified or waived as to
any particular provision, except with the prior written consent of the Company, the Purchaser and SpinCo. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(m) <U>Severability</U>. The
provisions of this Agreement will be deemed severable and the invalidity or unenforceability of any provision will not affect the validity or enforceability of the other provisions hereof; <U>provided</U> that if any provision of this Agreement, as
applied to any party hereto or to any circumstance, is adjudged by a governmental authority, arbitrator, or mediator not to be enforceable in accordance with its terms, the parties hereto agree that the governmental authority, arbitrator, or
mediator making such determination will have the power to modify the provision in a manner consistent with its objectives such that it is enforceable, and/or to delete specific words or phrases, and in its reduced form, such provision will then be
enforceable and will be enforced. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(n) <U>Expenses</U>. Each of the Company and the Purchaser will bear its own costs and
expenses incurred in connection with the preparation, execution and performance of this Agreement and the consummation of the transactions contemplated hereby, including all fees and expenses of agents, representatives, financial advisors, legal
counsel and accountants. The Company shall be responsible for the fees of its transfer agent, stamp taxes and all of The Depository Trust Company&#146;s fees associated with the issuance of the Securities and the securities issuable upon conversion
or exercise of the Securities. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(o) <U>Construction</U>. The parties hereto have participated jointly in the negotiation and drafting of
this Agreement. If an ambiguity or question of intent or interpretation arises, this Agreement will be construed as if drafted jointly by the parties hereto and no presumption or burden of proof will arise favoring or disfavoring any party hereto
because of the authorship of any provision of this Agreement. Any reference to any federal, state, local or foreign Law will be deemed also to refer to Law as amended and all rules and regulations promulgated thereunder, unless the context requires
otherwise. The words &#147;<I>include</I>,&#148; &#147;<I>includes</I>&#148; and &#147;<I>including</I>&#148; will be deemed to be followed by &#147;<I>without limitation</I>.&#148; Pronouns in masculine, feminine, and neuter genders will be
construed to include any other gender, and words in the singular form will be construed to include the plural and vice versa, unless the context otherwise requires. The words &#147;<I>this Agreement</I>,&#148; &#147;<I>herein</I>,&#148;
&#147;<I>hereof</I>,&#148; &#147;<I>hereby</I>,&#148; &#147;<I>hereunder</I>&#148; and words of similar import refer to this Agreement as a whole and not to any particular subdivision unless expressly so limited. The parties hereto intend that each
representation, warranty and covenant contained herein will have independent significance. If any party hereto has breached any representation, warranty or covenant contained herein in any respect, the fact that there exists another representation,
warranty or covenant relating to the same subject matter (regardless of the relative levels of specificity) which such party hereto has not breached will not detract from or mitigate the fact that such party hereto is in breach of the first
representation, warranty or covenant. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(p) <U>Waiver</U>. No waiver by any party hereto of any default, misrepresentation or breach of
warranty or covenant hereunder, whether intentional or not, may be deemed to extend to any prior or subsequent default, misrepresentation or breach of warranty or covenant hereunder or affect in any way any rights arising because of any prior or
subsequent occurrence. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(q) <U>Confidentiality</U>. Except as may be required by Law, regulation or applicable stock exchange listing
requirements, unless and until the transactions contemplated hereby and the terms hereof are publicly announced or otherwise publicly disclosed by the Company, the parties hereto shall keep confidential and shall not publicly disclose the existence
or terms of this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(r) <U>Specific Performance; Enforcement</U>. Each party hereto agrees that irreparable damage may occur in
the event any provision of this Agreement was not performed by the Purchaser in accordance with the terms hereof and that the other party(ies) shall be entitled to specific performance of the terms hereof, in addition to any other remedy at law or
in equity. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[<I>Signature Page Follows</I>] </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">IN WITNESS WHEREOF, the undersigned have executed this Agreement to be effective as of the
date first set forth above. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">PURCHASER:</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Avista Acquisition LP II</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">By: Avista
Acquisition GP LLC II, its general partner</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name: David Burgstahler</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title: President</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Address for Notices:</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">65 East 55th Street</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">18th Floor</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">New York, NY 10022</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Attn:</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">email:</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">COMPANY:</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Avista Public Acquisition Corp. II</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name: Benjamin Silbert</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Title: General Counsel</P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Address for Notices:</P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Attn:</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">email:</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">SPINCO:</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">OmniAb, Inc.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name: Matthew W. Foehr</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Title: President and Chief Executive Officer</P></TD></TR>
</TABLE></DIV> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Address for Notices:</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">5980 Horton Street</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Suite 405</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Emeryville, CA 94608</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Attn:</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">email:</P></TD></TR>
</TABLE></DIV>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-2.2
<SEQUENCE>3
<FILENAME>d337089dex22.htm
<DESCRIPTION>EX-2.2
<TEXT>
<HTML><HEAD>
<TITLE>EX-2.2</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 2.2 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Execution Version </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">SEPARATION AND DISTRIBUTION AGREEMENT </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">by and among </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">LIGAND
PHARMACEUTICALS INCORPORATED, </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">OMNIAB, INC. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">AVISTA PUBLIC ACQUISITION
CORP. II </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Dated as of March&nbsp;23, 2022 </P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">TABLE OF CONTENTS </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="14%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="82%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center">Page</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ARTICLE I DEFINITIONS AND INTERPRETATION</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;1.1</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">General</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;1.2</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">References; Interpretation</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">21</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ARTICLE II THE SEPARATION</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">21</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.1</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">General</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">21</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.2</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Restructuring: Transfer of Assets; Assumption of Liabilities</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">21</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.3</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Treatment of Shared Contracts</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">23</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.4</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Intercompany Accounts, Loans and Agreements</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">24</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.5</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Limitation of Liability; Intercompany Contracts</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">25</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.6</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Transfers Not Effected at or Prior to the Distribution Time; Transfers Deemed Effective as of the Distribution Time</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">25</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.7</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Conveyancing and Assumption Instruments</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">27</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.8</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Further Assurances; Ancillary Agreements</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">28</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.9</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Novation of Liabilities; Indemnification</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">29</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.10</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Guarantees; Credit Support Instruments</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">30</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.11</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Disclaimer of Representations and Warranties</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">32</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.12</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Cash Management; Consideration</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">33</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ARTICLE III</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">34</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">COMPLETION OF THE DISTRIBUTION</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">34</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.1</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Actions Prior to the Distribution</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">34</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.2</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Effecting the Distribution</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">35</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.3</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Conditions to the Distribution</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">36</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ARTICLE IV CERTAIN COVENANTS</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">36</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.1</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Cooperation</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">36</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.2</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Retained Names</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">37</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.3</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Ligand Limited License</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">38</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.4</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">No Restriction on Competition</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">38</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ARTICLE V INDEMNIFICATION</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">39</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.1</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Release of <FONT STYLE="white-space:nowrap">Pre-Distribution</FONT> Claims</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">39</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.2</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Indemnification by Ligand</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">43</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.3</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Indemnification by OmniAb and APAC</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">43</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.4</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Procedures for Indemnification</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">43</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.5</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Cooperation in Defense and Settlement</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">46</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.6</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Indemnification Payments</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">47</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">i </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="14%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="82%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.7</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Indemnification Obligations Net of Insurance Proceeds and Other Amounts</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">47</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.8</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Contribution</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">48</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.9</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Additional Matters; Survival of Indemnities</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">48</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ARTICLE VI PRESERVATION OF RECORDS; ACCESS TO INFORMATION; CONFIDENTIALITY;
PRIVILEGE</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">49</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.1</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Preservation of Corporate Records</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">49</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.2</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Access to Information</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">49</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.3</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Auditors and Audits.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">51</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.4</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Witness Services</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">52</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.5</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Reimbursement; Other Matters</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">52</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.6</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Confidentiality</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">52</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.7</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Privilege Matters</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">54</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.8</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Ownership of Information</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">56</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.9</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Processing of Personal Information</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">56</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.10</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Other Agreements</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">56</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ARTICLE VII DISPUTE RESOLUTION</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">56</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.1</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Negotiation</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">56</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.2</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Relief in Court</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">57</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.3</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Continuity of Service and Performance</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">57</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ARTICLE VIII INSURANCE</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">57</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;8.1</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Insurance Matters</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">57</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ARTICLE IX MISCELLANEOUS</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">59</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.1</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Entire Agreement; Construction</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">59</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.2</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Ancillary Agreements</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">59</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.3</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Counterparts</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">59</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.4</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Survival of Agreements</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">59</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.5</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Expenses</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">60</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.6</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Notices</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">60</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.7</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Consents</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">61</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.8</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Assignment</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">61</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.9</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Successors and Assigns</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">62</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.10</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Termination and Amendment</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">62</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.11</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Payment Terms</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">62</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.12</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Subsidiaries</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">62</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.13</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Third Party Beneficiaries</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">63</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.14</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Title and Headings</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">63</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.15</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Exhibits&nbsp;and Schedules</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">63</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.16</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Governing Law and Venue; Submission to Jurisdiction; Selection of Forum; Waiver of Trial by Jury</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">63</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ii </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="14%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="82%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.17</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Specific Performance</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">64</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.18</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Severability</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">65</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.19</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Interpretation</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">65</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.20</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">No Duplication; No Double Recovery</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">65</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.21</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Tax Treatment of Payments</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">65</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.22</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">No Waiver</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">65</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.23</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">No Admission of Liability</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">65</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>List of Schedules </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="11%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="88%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">1.1(75)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Ligand Retained Liabilities</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">1.1(76)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Ligand Retained Names</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">1.1(86)(ii)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">OmniAb Assets &#150; General</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">1.1(86)(v)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">OmniAb Assets &#150; Leases/Subleases</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">1.1(86)(vi)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">OmniAb Assets &#150; Contracts</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">1.1(86)(vii)&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">OmniAb Assets &#150; Intellectual Property</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">1.1(86)(x)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">OmniAb Assets &#150; IT Assets</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">1.1(97)(ii)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">OmniAb Liabilities &#150; General</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">1.1(97)(vii)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">OmniAb Liabilities &#150; Actions</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">2.3(a)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Shared Contracts</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">2.10(a)(i)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Guarantees Provided by OmniAb Group</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">2.10(a)(ii)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Guarantees Provided by Ligand Group</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">2.12(c)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Other Reimbursable Expenses</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>List of Exhibits </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="11%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="88%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Exhibit&nbsp;A</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Reorganization Plan</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Exhibit B&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Illustrative Adjustments pursuant to Section&nbsp;2.12(c)</TD></TR>
</TABLE> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">iii </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SEPARATION AND DISTRIBUTION AGREEMENT </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This SEPARATION AND DISTRIBUTION AGREEMENT (this &#147;<B><I>Agreement</I></B>&#148;), dated as of March&nbsp;23, 2022, is entered into by and
among Ligand Pharmaceuticals Incorporated, a Delaware corporation (&#147;<B><I>Ligand</I></B>&#148;), OmniAb, Inc., a Delaware corporation and a wholly owned subsidiary of Ligand (&#147;<B><I>OmniAb</I></B>&#148;), and Avista Public Acquisition
Corp. II, a Cayman Islands exempted company (which will migrate to and domesticate as a Delaware corporation prior to the Closing (the &#147;<B><I>Domestication</I></B>&#148;)) (&#147;<B><I>APAC</I></B>&#148;). &#147;<B><I>Party</I></B>&#148; or
&#147;<B><I>Parties</I></B>&#148; means Ligand or OmniAb, individually or collectively, as the case may be. Capitalized terms used and not defined herein shall have the meaning set forth in <U>Section</U><U></U><U>&nbsp;1.1</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">W I T N E S S E T H: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS,
Ligand owns 100% of the common stock, par value $0.001 per share, of OmniAb (the &#147;<B><I>OmniAb Stock</I></B>&#148;); </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS,
Ligand, acting through its direct and indirect Subsidiaries, currently conducts the Ligand Retained Business and the OmniAb Business; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, the Board of Directors of Ligand (the &#147;<B><I>Ligand Board</I></B>&#148;) has determined that it is appropriate, desirable and in
the best interests of Ligand and its stockholders to separate Ligand into two separate companies, one for each of (i)&nbsp;the Ligand Retained Business, which shall be owned and conducted, directly or indirectly, by Ligand and its Subsidiaries
(other than OmniAb and its Subsidiaries) and (ii)&nbsp;the OmniAb Business, which shall be owned and conducted, directly or indirectly, by OmniAb and its Subsidiaries (the &#147;<B><I>Separation</I></B>&#148;); </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, in order to effect the Separation, the Ligand Board has determined that it is appropriate, desirable and in the best interests of
Ligand and its stockholders for Ligand to undertake the Internal Reorganization and, in connection therewith, effect the Contribution to OmniAb; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, the Ligand Board has further determined that it is appropriate and desirable, on the terms and conditions contemplated hereby,
following such separation to make a distribution of the OmniAb Business to the holders of common stock, par value $0.001 per share, of Ligand (the &#147;<B><I>Ligand Stock</I></B>&#148;) on the Record Date through the distribution of all of the
outstanding shares of OmniAb Stock to holders of Ligand on the Record Date on a pro rata basis in accordance with a distribution ratio to be determined by the Ligand Board (the &#147;<B><I>Distribution</I></B>&#148;), in each case, on the terms and
conditions set forth in this Agreement; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, immediately following the Distribution, Ligand will hold none of the outstanding shares
of OmniAb Stock; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, the Ligand Board has further determined that it is appropriate and desirable, on the terms and conditions
contemplated in the Agreement and Plan of Merger, dated as of the date hereof (the &#147;<B><I>Merger Agreement</I></B>&#148;), among Ligand, OmniAb, APAC and Orwell Merger Sub Inc., a Delaware corporation and wholly owned subsidiary of APAC
(&#147;<B><I>Merger Sub</I></B>&#148;), following the Domestication, Separation and Distribution, Merger Sub will merge with and into OmniAb, with OmniAb continuing as the surviving corporation (the &#147;<B><I>Merger</I></B>&#148;); </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, pursuant to the Merger, shares of OmniAb Stock will be exchanged for shares of
Domesticated Parent Common Stock, on the terms and conditions set forth in the Merger Agreement; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, Ligand and OmniAb will prepare,
and OmniAb will file with the SEC, the Form 10, which will include the Information Statement and will set forth certain disclosure concerning OmniAb, the Separation, the Distribution and the Merger; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, (i)&nbsp;the Ligand Board has (x)&nbsp;determined that the transactions contemplated by this Agreement, the Merger Agreement and the
Ancillary Agreements have a valid business purpose, are in furtherance of and consistent with its business strategy and are in the best interests of Ligand and its stockholders and (y)&nbsp;approved this Agreement, the Merger Agreement and each of
the Ancillary Agreements and (ii)&nbsp;the Board of Directors of OmniAb (the &#147;<B><I>OmniAb Board</I></B>&#148;) has approved this Agreement, the Merger Agreement and each of the Ancillary Agreements (to the extent OmniAb is a party thereto);
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, the board of directors of APAC has approved this Agreement and the Merger Agreement; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, the Parties and APAC desire to set forth the principal corporate transactions required to effect the Separation and the Distribution,
and certain other agreements relating to the relationship of Ligand and OmniAb and their respective Subsidiaries following the Distribution; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, it is the intention of the Parties and APAC that the (i)&nbsp;Contribution and Distribution, together with certain related
transactions, will qualify as a &#147;reorganization&#148; under Sections&nbsp;355 and 368(a)(1)(D) of the Internal Revenue Code of 1986, as amended (the &#147;<B><I>Code;</I></B>&#148;) and (ii)&nbsp;the Merger will qualify as a
&#147;reorganization&#148; within the meaning of Section&nbsp;368(a) of the Code; and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, this Agreement is intended to be, and is
hereby adopted as, a &#147;plan of reorganization&#148; within the meaning of Treasury <FONT STYLE="white-space:nowrap">Regulations&nbsp;Sections&nbsp;1.368-2(g)</FONT> and <FONT STYLE="white-space:nowrap">1.368-3(a).</FONT> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">NOW, THEREFORE, in consideration of the foregoing and the mutual agreements, provisions and covenants contained in this Agreement, the Parties
and APAC hereby agree as follows: </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE I </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>DEFINITIONS AND INTERPRETATION </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;1.1 <U>General</U>. As used in this Agreement, the following terms shall have the following meanings: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1) &#147;<B><I>Action</I></B>&#148; shall mean any demand, action, claim, suit, countersuit, arbitration, inquiry, subpoena, case,
litigation, proceeding or investigation (whether civil, criminal, administrative or investigative) by or before any court or grand jury, any Governmental Entity or any arbitration or mediation tribunal. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2) &#147;<B><I>Affiliate</I></B>&#148; shall mean, when used with respect to a specified
Person and at a point in, or with respect to a period of, time, a Person that directly or indirectly, through one or more intermediaries, controls, is controlled by, or is under common control with, such specified Person at such point in or during
such period of time. For the purposes of this definition, &#147;control&#148;, when used with respect to any specified Person shall mean the possession, directly or indirectly, of the power to direct or cause the direction of the management and
policies of such Person, whether through the ownership of voting securities or other interests, by Contract or otherwise. It is expressly agreed that, from and after the Distribution Time, solely for purposes of this Agreement, (i)&nbsp;no member of
the OmniAb Group shall be deemed an Affiliate of any member of the Ligand Group and (ii)&nbsp;no member of the Ligand Group shall be deemed an Affiliate of any member of the OmniAb Group. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(3) &#147;<B><I>Agent</I></B>&#148; means Computershare Trust Company, N.A., as the distribution agent appointed by Ligand to distribute to
the stockholders of Ligand all of the outstanding shares of OmniAb Stock pursuant to the Distribution. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(4)
&#147;<B><I>Agreement</I></B>&#148; shall have the meaning set forth in in the Preamble. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(5) &#147;<B><I>Amended Financial
Report</I></B>&#148; shall have the meaning set forth in Section&nbsp;6.3(b). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(6) &#147;<B><I>Ancillary Agreements</I></B>&#148; shall
mean the Transition Services Agreements, the Employee Matters Agreement, the Tax Matters Agreement, any Continuing Arrangements, any and all Conveyancing and Assumption Instruments, and any other agreements to be entered into by and between any
member of the Ligand Group, on one hand, and any member of the OmniAb Group, on the other hand, at, prior to or after the Distribution Time in connection with the Separation, the Distribution and the other transactions contemplated by this
Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(7) &#147;<B><I>APAC</I></B>&#148; shall have the meaning set forth in the Preamble. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(8) &#147;<B><I>APAC Released Liabilities</I></B>&#148; shall have the meaning set forth in <U>Section</U><U></U><U>&nbsp;5.1(a)(iii)</U>.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(9) &#147;<B><I>Assets</I></B>&#148; shall mean all rights (including Intellectual Property), title and ownership interests in and to all
properties, claims, Contracts, businesses, or assets (including goodwill), wherever located (including in the possession of vendors or other third parties or elsewhere), of every kind, character and description, whether real, personal or mixed,
tangible or intangible, whether accrued, contingent or otherwise, in each case, whether or not recorded or reflected on the books and records or financial statements of any Person. Except as otherwise specifically set forth herein, in the Employee
Matters Agreement or in the Tax Matters Agreement, the rights and obligations of the Parties with respect to Taxes shall be governed by the Tax Matters Agreement and, therefore, Tax assets (including any Tax items, attributes or rights to receive
any Refunds (as defined in the Tax Matters Agreement)) shall not be treated as Assets. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(10) &#147;<B><I>Asset Transferors</I></B>&#148;
shall mean the entities transferring Assets to OmniAb or one of its Subsidiaries in order to consummate the transactions contemplated hereby. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(11) &#147;<B><I>Assume</I></B>&#148; shall have the meaning set forth in
<U>Section</U><U></U><U>&nbsp;2.2(c)</U>; and the terms &#147;<B><I>Assumed</I></B>&#148; and &#147;<B><I>Assumption</I></B>&#148; shall have their correlative meanings. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(12) &#147;<B><I>Business</I></B>&#148; shall mean the Ligand Retained Business or the OmniAb Business, as applicable. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(13) &#147;<B><I>Business Day</I></B>&#148; shall mean any day other than Saturday or Sunday and any other day on which commercial banking
institutions located in New York, New York are required, or authorized by Law, to remain closed. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(14) &#147;<B><I>Business
Entity</I></B>&#148; shall mean any corporation, partnership, limited liability company, joint venture or other entity which may legally hold title to Assets. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(15) &#147;<B><I>Cash Equivalents</I></B>&#148; shall mean (i)&nbsp;cash and (ii)&nbsp;checks, certificates of deposit having a maturity of
less than one year, money orders, marketable securities, money market funds, commercial paper, short-term instruments and other cash equivalents, funds in time and demand deposits or similar accounts, and any evidence of indebtedness issued or
guaranteed by any Governmental Entity, minus the amount of any outbound checks, plus the amount of any deposits in transit. For the purposes of <U>Section</U><U></U><U>&nbsp;2.12</U>, &#147;<B><I>Cash Equivalents</I></B>&#148; shall not include any
cash in transit at the Distribution Time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(16) &#147;<B><I>Chosen Courts</I></B>&#148; shall have the meaning set forth in
<U>Section</U><U></U><U>&nbsp;9.16(b)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(17) &#147;<B><I>Closing</I></B>&#148; shall have the meaning set forth in the Merger
Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(18) &#147;<B><I>Code</I></B>&#148; shall have the meaning set forth in the Recitals. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(19) &#147;<B><I>Commission</I></B>&#148; shall mean the United States Securities and Exchange Commission. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(20) &#147;<B><I>Confidential Information</I></B>&#148; shall mean all <FONT STYLE="white-space:nowrap">non-public,</FONT> confidential or
proprietary Information to the extent concerning a Party, its Group and/or its Subsidiaries or with respect to OmniAb, the OmniAb Business, any OmniAb Assets or any OmniAb Liabilities or with respect to Ligand, the Ligand Retained Business, any
Ligand Retained Assets or any Ligand Retained Liabilities, including any such Information that was acquired by any Party after the Distribution Time pursuant to <U>Article</U><U></U><U>&nbsp;VI</U> or otherwise in accordance with this Agreement, or
that was provided to a Party by a third party in confidence, including (a)&nbsp;any and all technical information relating to the design, operation, testing, test results, development, and manufacture of any Party&#146;s products, compounds,
technologies or biological, chemical or other materials or that of a Party&#146;s partners (including specifications and documentation; engineering, design, and manufacturing drawings, diagrams, layouts, maps and illustrations; formulations and
material specifications; laboratory studies and benchmark tests; preclinical and clinical data; quality assurance policies, procedures and specifications; evaluation and validation studies; process control and/or shop-floor control strategy, logic
or algorithms; assembly code, Software, firmware, programming data, databases, and all information referred to in the same); costs, margins and pricing; as well as product marketing studies and strategies; all other methodologies, procedures,
techniques and <FONT STYLE="white-space:nowrap">Know-How</FONT> related to discovery, research, engineering, development and manufacturing; (b)&nbsp;information, documents and materials relating to the Party&#146;s financial
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
condition, management and other business conditions, prospects, plans, procedures, partners, infrastructure, security, information technology procedures and systems, and other business or
operational affairs; (c)&nbsp;pending unpublished patent applications and Trade Secrets; and (d)&nbsp;any other data or documentation resident, existing or otherwise provided in a database or in a storage medium, permanent or temporary, intended for
confidential, proprietary and/or privileged use by a Party; except for any Information that is (i)&nbsp;in the public domain or known to the public through no fault of the receiving Party or its Subsidiaries, (ii)&nbsp;lawfully acquired after the
Distribution Time by such Party or its Subsidiaries from other sources not known to be subject to confidentiality obligations with respect to such Information or (iii)&nbsp;independently developed by the receiving Party after the Distribution Time
without reference to any Confidential Information. As used herein, by example and without limitation, Confidential Information shall include any information of a Party intended or marked as confidential, proprietary and/or privileged. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(21) &#147;<B><I>Consents</I></B>&#148; shall mean any consents, waivers, notices, reports or other filings to be obtained from or made,
including with respect to any Contract, or any registrations, licenses, permits, authorizations to be obtained from, or approvals from, or notification requirements to, any third parties, including any third party to a Contract and any Governmental
Entity. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(22) &#147;<B><I>Continuing Arrangements</I></B>&#148; shall mean: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) this Agreement and the Ancillary Agreements (and each other Contract expressly contemplated by this Agreement or any Ancillary Agreement
to be entered into or continued by any of the Parties or any of the members of their respective Groups); and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) any Contracts or
intercompany accounts solely between or among members of the OmniAb Group. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(23) &#147;<B><I>Contract</I></B>&#148; shall mean any
agreement, contract, subcontract, obligation, binding understanding, note, indenture, instrument, option, lease, promise, arrangement, release, warranty, license, sublicense, insurance policy, benefit plan, purchase order or legally binding
commitment or undertaking of any nature (whether written or oral and whether express or implied). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(24)
&#147;<B><I>Contribution</I></B>&#148; shall mean (i)&nbsp;the Transfer, directly or indirectly, of the capital stock of or membership or other equity interests in the Transferred Entities and the other OmniAb Assets from Ligand or its Subsidiaries
to OmniAb or its Subsidiaries, (ii)&nbsp;the contribution by Ligand to OmniAb of $15,000,000 (fifteen million dollars) in cash, decreased by the amount of Reimbursable Transaction-related Expenses and Other Reimbursable Expenses, and increased by
the amount of any Specific Milestone Payments,<SUP STYLE="font-size:85%; vertical-align:top"> </SUP>and (iii)&nbsp;the Assumption of Liabilities, directly or indirectly, by OmniAb or its Subsidiaries pursuant to the Internal Reorganization or
otherwise relating to, arising out of or resulting from the transactions contemplated by this Agreement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(25) &#147;<B><I>Conveyancing and Assumption Instruments</I></B>&#148; shall mean,
collectively, the various Contracts, including the related local asset transfer agreements and local stock transfer agreements, and other documents entered into prior to the Distribution Time and to be entered into to effect the Transfer of Assets
and the Assumption of Liabilities in the manner contemplated by this Agreement, or otherwise relating to, arising out of or resulting from the transactions contemplated by this Agreement, in such form or forms as the applicable Parties thereto
agree. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(26) &#147;<B><I>Covered Matter</I></B>&#148; shall have the meaning set forth in <U>Section</U><U></U><U>&nbsp;8.1(i)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(27) &#147;<B><I>Credit Support Instruments</I></B>&#148; shall mean any letters of credit, performance bonds, surety bonds, bankers
acceptances, or other similar arrangements. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(28) &#147;<B><I>Dispute Notice</I></B>&#148; shall have the meaning set forth in
<U>Section</U><U></U><U>&nbsp;7.1</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(29) &#147;<B><I>Disputes</I></B>&#148; shall have the meaning set forth in
<U>Section</U><U></U><U>&nbsp;7.1</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(30) &#147;<B><I>Distribution</I></B>&#148; shall have the meaning set forth in the Recitals. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(31) &#147;<B><I>Distribution Date</I></B>&#148; shall mean the date on which Ligand, through the Agent, distributes all of the issued and
outstanding shares of OmniAb Stock to holders of Ligand Stock in the Distribution, and &#147;<B><I>Distribution Time</I></B>&#148; shall mean the time at which the Distribution occurs on the Distribution Date, which shall be deemed to be 12:01 a.m.,
New York time on the Distribution Date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(32) &#147;<B><I>Domesticated Parent Common Stock</I></B>&#148; shall have the meaning set forth
in the Merger Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(33) &#147;<B><I>Domestication</I></B>&#148; shall have the meaning set forth in the Merger Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(34) &#147;<B><I>Effective Time</I></B>&#148; shall have the meaning set forth in the Merger Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(35) &#147;<B><I>Employee Matters Agreement</I></B>&#148; shall mean that certain Employee Matters Agreement to be entered into between Ligand
and OmniAb or any members of their respective Groups in connection with the Separation, the Distribution, the Merger or the other transactions contemplated by this Agreement, as such agreement may be modified or amended from time to time in
accordance with its terms. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(36) &#147;<B><I>Environmental Laws</I></B>&#148; shall mean all Laws relating to pollution or protection of
human health or safety or the environment, including Laws relating to the exposure to, or Release, threatened Release or the presence of Hazardous Substances, or otherwise relating to the manufacture, processing, distribution, use, treatment,
storage, transport or handling of Hazardous Substances and all Laws with regard to recordkeeping, notification, disclosure and reporting requirements respecting Hazardous Substances, and all laws relating to endangered or threatened species of fish,
wildlife and plants and the management or use of natural resources. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(37) &#147;<B><I>Environmental Liabilities</I></B>&#148; shall mean
Liabilities relating to Environmental Law or the Release or threatened Release of or exposure to Hazardous Substances, including, without limitation, the following: (i)&nbsp;actual or alleged violations of or
<FONT STYLE="white-space:nowrap">non-compliance</FONT> with any Environmental Law, including a failure to obtain, maintain or comply with any Environmental Permits; (ii)&nbsp;obligations arising under or pursuant to any applicable Environmental Law
or </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Environmental Permit; (iii)&nbsp;the presence of Hazardous Substances or the introduction of Hazardous Substances to the environment at, in, on, under or migrating from any of the building,
facility, structure or real property, including Liabilities relating to, resulting from or arising out of the investigation, remediation, or monitoring of such Hazardous Substances; (iv)&nbsp;natural resource damages, property damages, personal or
bodily injury or wrongful death relating to the presence of or exposure to Hazardous Substances (including asbestos-containing materials), at, in, on, under or migrating to or from any building, facility, structure or real property; (v)&nbsp;the
transport, disposal, recycling, reclamation, treatment or storage, Release or threatened Release of Hazardous Substances at <FONT STYLE="white-space:nowrap">Off-Site</FONT> Locations; and (vi)&nbsp;any agreement, decree, judgment, or order relating
to the foregoing. The term &#147;<B><I>Environmental Liabilities</I></B>&#148; does not include Liabilities arising in connection with claims for injuries to persons or property from products sold by or services provided by the OmniAb Group, the
Ligand Group or their predecessors. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(38) &#147;<B><I>Environmental Permit</I></B>&#148; shall mean any permit, license, approval or other
authorization under any applicable Law or of any Governmental Entity relating to Environmental Laws or Hazardous Substances. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(39)
&#147;<B><I>Exchange Act</I></B>&#148; shall mean the United States Securities Exchange Act of 1934, as amended, together with the rules and regulations promulgated thereunder. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(40) &#147;<B><I>Excluded Environmental Liabilities</I></B>&#148; shall mean any and all Environmental Liabilities whether arising before, at
or after the Distribution Time, to the extent relating to, resulting from, or arising out of the past, present or future operation, conduct or actions of any Ligand Retained Business. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(41) &#147;<B><I>Final Determination</I></B>&#148; shall have the meaning set forth in the Tax Matters Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(42) &#147;<B><I>Form 10</I></B>&#148; means the registration statement on Form 10 filed by OmniAb with the SEC to effect the registration of
the OmniAb Stock pursuant to Section&nbsp;12(b) or 12(g) of the Exchange Act in connection with the Distribution, including any amendments or supplements thereto. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(43) &#147;<B><I>Former Business</I></B>&#148; shall mean any corporation, partnership, entity, division, business unit or business (in each
case, including any assets and liabilities comprising the same) that has been sold, conveyed, assigned, transferred, <FONT STYLE="white-space:nowrap">spun-off,</FONT> <FONT STYLE="white-space:nowrap">split-off</FONT> or otherwise disposed of or
divested (in whole or in part) to a Person or Persons that is not a member of the OmniAb Group or the Ligand Group or the operations, activities or production of which has been discontinued, abandoned, completed or otherwise terminated (in whole or
in part), in each case, prior to the Distribution Time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(44) &#147;<B><I>Governmental Approvals</I></B>&#148; shall mean any notices or
reports to be submitted to, or other registrations or filings to be made with, or any consents, approvals, licenses, permits or authorizations to be obtained from, any Governmental Entity. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(45) &#147;<B><I>Governmental Filing</I></B>&#148; shall have the meaning set forth in <U>Section</U><U></U><U>&nbsp;5.5(c)</U>. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(46) &#147;<B><I>Governmental Entity</I></B>&#148; shall mean any nation or government, any
state, municipality or other political subdivision thereof and any entity, body, agency, commission, department, board, bureau or court, whether domestic, foreign, multinational, or supranational exercising executive, legislative, judicial,
regulatory, self-regulatory or administrative functions of or pertaining to government and any executive official thereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(47)
&#147;<B><I>Group</I></B>&#148; shall mean (i)&nbsp;with respect to Ligand, the Ligand Group and (ii)&nbsp;with respect to OmniAb, the OmniAb Group. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(48) &#147;<B><I>Hazardous Substance</I></B>&#148; shall mean (a)&nbsp;any substances defined, listed, classified or regulated as
&#147;hazardous substances,&#148; &#147;hazardous wastes,&#148; &#147;hazardous materials,&#148; &#147;extremely hazardous wastes,&#148; &#147;restricted hazardous wastes,&#148; &#147;toxic substances,&#148; &#147;toxic pollutants,&#148;
&#147;contaminants,&#148; &#147;pollutants,&#148; &#147;wastes,&#148; &#147;radioactive materials,&#148; &#147;petroleum,&#148; &#147;oils&#148; or designations of similar import under any Environmental Law, or (b)&nbsp;any other chemical, material
or substance that is regulated or for which liability can be imposed under any Environmental Law. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(49)
&#147;<B><I>Indebtedness</I></B>&#148; shall mean, with respect to any Person, (i)&nbsp;the principal amount, prepayment and redemption premiums and penalties (if any), unpaid fees and other monetary obligations in respect of any indebtedness for
borrowed money, whether short term or long term, and all obligations evidenced by bonds, debentures, notes, other debt securities or similar instruments, (ii)&nbsp;any indebtedness arising under any capital leases (excluding, for the avoidance of
doubt, any real estate leases), whether short term or long term, (iii)&nbsp;all liabilities secured by any Security Interest on any assets of such Person, (iv)&nbsp;all liabilities under any interest rate, currency, commodity or other swap, collar,
cap or other hedging or similar agreements or arrangements, (v)&nbsp;all liabilities under any interest rate protection agreement, interest rate future agreement, interest rate option agreement, interest rate swap agreement or other similar
agreement designed to protect such Person against fluctuations in interest rates, (vi)&nbsp;all interest bearing indebtedness for the deferred purchase price of property or services, (vii)&nbsp;all liabilities under any Credit Support Instruments,
(viii)&nbsp;all interest, fees and other expenses owed with respect to indebtedness described in the foregoing clauses (i)&nbsp;through (vii), and (ix)&nbsp;without duplication, all guarantees of indebtedness referred to in the foregoing clauses
(i)&nbsp;through (viii), excluding in each case any obligations related to Taxes. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(50) &#147;<B><I>Indemnifiable Loss</I></B>&#148; and
&#147;<B><I>Indemnifiable Losses</I></B>&#148; shall mean any and all damages, losses, deficiencies, Liabilities, obligations, penalties, judgments, settlements, claims, payments, fines, interest, costs and expenses (including the costs and expenses
of any and all Actions and demands, assessments, judgments, settlements and compromises relating thereto and the costs and expenses of attorneys&#146;, accountants&#146;, consultants&#146; and other professionals&#146; fees and expenses incurred in
the investigation or defense thereof or the enforcement of rights hereunder). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(51) &#147;<B><I>Indemnifying Party</I></B>&#148; shall
have the meaning set forth in <U>Section</U><U></U><U>&nbsp;5.4(a)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(52) &#147;<B><I>Indemnitee</I></B>&#148; shall have the meaning
set forth in <U>Section</U><U></U><U>&nbsp;5.4(a)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(53) &#147;<B><I>Indemnity Payment</I></B>&#148; shall have the meaning set forth
in <U>Section</U><U></U><U>&nbsp;5.7(a)</U>. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(54) &#147;<B><I>Information</I></B>&#148; shall mean information, content and data
(including Personal Information) in written, oral, electronic, computerized, digital or other tangible or intangible media, including (i)&nbsp;books and records, whether accounting, legal or otherwise, ledgers, studies, reports, surveys, designs,
specifications, drawings, blueprints, diagrams, models, prototypes, samples, flow charts, marketing plans, customer names and information (including prospects), technical information relating to the design, operation, testing, test results,
development, and manufacture of any Party&#146;s or its Group&#146;s, or any of their partners&#146;, products, compounds, technologies or biological, chemical or other materials or facilities (including specifications and documentation;
engineering, design and manufacturing drawings, diagrams, layouts, maps and illustrations; formulations and material specifications; laboratory studies and benchmark tests; preclinical and clinical data; quality assurance policies, procedures and
specifications; evaluation and validation studies; process control and/or shop-floor control strategy, logic or algorithms; assembly code, Software, firmware, programming data, databases, and all information referred to in the same); costs, margins
and pricing; as well as product marketing studies and strategies; all other methodologies, procedures, techniques and <FONT STYLE="white-space:nowrap">Know-How</FONT> related to discovery, research, engineering, development and manufacturing;
communications, correspondence, materials, product literature, artwork, files, documents; and (ii)&nbsp;financial and business information, including earnings reports and forecasts, macro-economic reports and forecasts, all cost information
(including partner and supplier records and lists), sales and pricing data, business plans, market evaluations, surveys, credit-related information, and other such information as may be needed for reasonable compliance with reporting, disclosure,
filing or other requirements, including under applicable securities laws or regulations of securities exchanges. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(55)
&#147;<B><I>Information Statement</I></B>&#148; shall mean the Information Statement attached as an exhibit to the Form 10 and any related documents to be provided to the holders of Ligand Stock in connection with the Distribution, including any
potential revision of such Information Statement to be a combined proxy statement, prospectus and/or information statement in connection with the Merger, and including any amendment or supplement thereto. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(56) &#147;<B><I>Insurance Proceeds</I></B>&#148; shall mean those monies: (a)&nbsp;received by an insured Person from any insurer, insurance
underwriter, mutual protection and indemnity club or other risk collective; or (b)&nbsp;paid on behalf of an insured Person by any insurer, insurance underwriter, mutual protection and indemnity club or other risk collective, on behalf of the
insured, in either such case net of any costs or expenses incurred in the collection thereof; provided, however, that with respect to a captive insurance arrangement, Insurance Proceeds shall only include net amounts received by the captive insurer
from a Third Party in respect of any captive reinsurance arrangement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(57) &#147;<B><I>Intellectual Property</I></B>&#148; shall mean all
U.S. and foreign rights, title and interest (whether statutory, common law or otherwise) in or relating to any intellectual property, including all: (i)&nbsp;trademarks, trade dress, service marks, certification marks, logos, slogans, design rights,
names, corporate names, trade names, brand names and other similar designations of source or origin, together with the goodwill symbolized by any of the foregoing, and all applications, registrations, renewals and extensions of any of the foregoing
(collectively, &#147;<B><I>Trademarks</I></B>&#148;); (ii) patents and patent applications, and all related national or international counterparts thereto, including any divisionals, continuations, <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">continuations-in-part,</FONT></FONT> reissues, reexaminations, substitutions provisionals, renewals, extensions, patents of addition, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
supplementary protection certificates, utility models, inventors&#146; certificates, or the like, and any foreign equivalents of any of the foregoing (including certificates of invention and any
applications therefor) and all rights to claim priority from any of the foregoing (collectively, &#147;<B><I>Patents</I></B>&#148;); (iii) copyrights and copyrightable subject matter, whether or not registered or published, and all applications,
registrations, reversions, extensions and renewals of any of the foregoing, and all moral rights, however denominated; (iv)&nbsp;trade secrets, and all other confidential or proprietary information, ideas, technology, Software, compositions,
discoveries, improvements, <FONT STYLE="white-space:nowrap">know-how,</FONT> inventions, designs, processes, techniques, formulae, models, and methodologies, in each case, whether or not patentable or copyrightable, but excluding issued Patents
(collectively, &#147;<B><I><FONT STYLE="white-space:nowrap">Know-How</FONT></I></B>,&#148; and trade secrets together with confidential <FONT STYLE="white-space:nowrap">Know-How,</FONT> &#147;<B><I>Trade Secrets</I></B>&#148;); (v) Internet domain
names and social media accounts and addresses, and all registrations for any of the foregoing (collectively, &#147;<B><I>Domain Names</I></B>&#148;); and (vi)&nbsp;rights and remedies with respect to any past, present, or future infringement,
misappropriation, or other violation of any of the foregoing in clauses (i)&nbsp;through (v). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(58) &#147;<B><I>Intellectual Property
Documentation</I></B>&#148; shall mean: (i)&nbsp;all correct and complete physical and electronic copies of all prosecution and maintenance files and dockets, registration certificates, litigation files and related opinions of counsel and
correspondence for all issued, registered and <FONT STYLE="white-space:nowrap">applied-for</FONT> items of OmniAb Intellectual Property; (ii)&nbsp;all litigation files to the extent relating to any Actions brought for the infringement, dilution,
misappropriation or other violation of any of the OmniAb Intellectual Property; (iii)&nbsp;all books, records, files, ledgers or similar documentation used to track, organize or maintain any of the OmniAb Intellectual Property; and (iv)&nbsp;copies
of all acquisition agreements relating to the acquisition of any of the OmniAb Intellectual Property. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(59) &#147;<B><I>Internal
Reorganization</I></B>&#148; shall mean the allocation and transfer or assignment of Assets and Liabilities, including by means of the Conveyancing and Assumption Instruments, resulting in (i)&nbsp;the OmniAb Group owning and operating the OmniAb
Business, and (ii)&nbsp;the Ligand Group continuing to own and operate the Ligand Retained Business, as described in the internal reorganization plan attached hereto as Exhibit A (the &#147;<B><I>Reorganization Plan</I></B>&#148;), as may be amended
prior to the Distribution Date only by written consent of Ligand, OmniAb and APAC. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(60) &#147;<B><I>IT Assets</I></B>&#148; shall mean
all information technology, Software, computers, computer systems, communication systems, telecommunications equipment, databases, internet protocol addresses, data rights and documentation, reference, resource and training materials relating to any
of the foregoing, and all Contracts (including Contract rights) relating to any of the foregoing (including Software license agreements, source code escrow agreements, support and maintenance agreements, electronic database access contracts, Domain
Name registration agreements, website hosting agreements, Software or website development agreements, outsourcing agreements, service provider agreements, interconnection agreements, governmental permits, radio licenses and telecommunications
agreements). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(61) &#147;<B><I>Joint Claim</I></B>&#148; shall mean any claim or series of related claims under any insurance policy that
results or could reasonably be expected to result in the payment of Insurance Proceeds to or for the benefit of both one or more members of the Ligand Group and one or more members of the OmniAb Group. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(62) &#147;<B><I>Law</I></B>&#148; shall mean any applicable U.S. or <FONT
STYLE="white-space:nowrap">non-U.S.</FONT> federal, national, supranational, state, provincial, local or similar statute, law, ordinance, regulation, rule, code, income tax treaty, order, requirement or rule of law (including common law) or other
binding directives promulgated, issued, entered into or taken by any Governmental Entity. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(63) &#147;<B><I>Liabilities</I></B>&#148;
shall mean any and all Indebtedness, liabilities, costs, expenses, interest and obligations, whether accrued or fixed, absolute or contingent, matured or unmatured, known or unknown, reserved or unreserved, or determined or determinable, including
those arising under any Law (including Environmental Law), Action, whether asserted or unasserted, or order, writ, judgment, injunction, decree, stipulation, determination or award entered by or with any Governmental Entity and those arising under
any Contract or any fines, damages or equitable relief which may be imposed and including all costs and expenses related thereto. Except as otherwise specifically set forth herein, in the Employee Matters Agreement or in the Tax Matters Agreement,
the rights and obligations of the Parties with respect to Taxes shall be governed by the Tax Matters Agreement and, therefore, Taxes shall not be treated as Liabilities governed by this Agreement other than for purposes of indemnification related to
the <FONT STYLE="white-space:nowrap">Spin-off</FONT> Disclosure Documents. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(64) &#147;<B><I>Liable Party</I></B>&#148; shall have the
meaning set forth in <U>Section</U><U></U><U>&nbsp;2.9(b)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(65) &#147;<B><I>Ligand</I></B>&#148; shall have the meaning set forth in
the Preamble. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(66) &#147;<B><I>Ligand Board</I></B>&#148; shall have the meaning set forth in the Recitals. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(67) &#147;<B><I>Ligand CSIs</I></B>&#148; shall have the meaning set forth in <U>Section</U><U></U><U>&nbsp;2.10(d)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(68) &#147;<B><I>Ligand Former Business</I></B>&#148; shall mean any Former Business (other than the OmniAb Business or the OmniAb Former
Businesses) that, at the time of sale, conveyance, assignment, transfer, disposition, divestiture (in whole or in part) or discontinuation, abandonment, completion or termination of the operations, activities or production thereof, was primarily
managed by or associated with the Ligand Retained Business as then conducted. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(69) &#147;<B><I>Ligand Group</I></B>&#148; shall mean
(i)&nbsp;Ligand, the Ligand Retained Business and each Person that is a direct or indirect Subsidiary of Ligand as of immediately following the Distribution Time and (ii)&nbsp;each Business Entity that becomes a Subsidiary of Ligand after the
Distribution Time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(70) &#147;<B><I>Ligand Indemnitees</I></B>&#148; shall mean each member of the Ligand Group and each of their
respective Affiliates from and after the Distribution Time and each member of the Ligand Group&#146;s and such Affiliates&#146; respective current, former and future directors, officers, employees and agents (solely in their respective capacities as
current, former and future directors, officers, employees or agents of any member of the Ligand Group or their respective Affiliates) and each of the heirs, executors, successors and assigns of any of the foregoing, except, for the avoidance of
doubt, the OmniAb Indemnitees. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(71) &#147;<B><I>Ligand Released Liabilities</I></B>&#148; shall have the meaning set forth in
<U>Section</U><U></U><U>&nbsp;5.1(a)(i)</U>. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(72) &#147;<B><I>Ligand Retained Assets</I></B>&#148; shall mean: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) any and all Assets that are expressly contemplated by this Agreement or any Ancillary Agreement as Assets to be retained by Ligand or any
other member of the Ligand Group, including for the avoidance of doubt all Ligand Retained IP; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) any and all Assets that are owned,
leased or licensed, at or prior to the Distribution Time, by Ligand and/or any of its Subsidiaries, that are not OmniAb Assets; and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iii)
any and all Assets that are acquired or otherwise become an Asset of the Ligand Group after the Distribution Time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(73)
&#147;<B><I>Ligand Retained Business</I></B>&#148; shall mean (i)&nbsp;those businesses operated by the Ligand Group prior to the Distribution Time other than the OmniAb Business, (ii)&nbsp;those Business Entities or businesses acquired or
established by or for any member of the Ligand Group after the Distribution Time, and (iii)&nbsp;any Ligand Former Business; <U>provided</U> that Ligand Retained Business shall not include any OmniAb Former Business or OmniAb Former Real Property.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(74) &#147;<B><I>Ligand Retained IP</I></B>&#148; shall mean (i)&nbsp;all Intellectual Property owned or controlled by the Ligand Group
other than OmniAb Intellectual Property and (ii)&nbsp;the Ligand Retained Names. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(75) &#147;<B><I>Ligand Retained
Liabilities</I></B>&#148; shall mean: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) any and all Liabilities that are expressly contemplated by this Agreement or any Ancillary
Agreement as Liabilities to be retained or assumed by Ligand or any other member of the Ligand Group, and all agreements, obligations and other Liabilities of Ligand or any member of the Ligand Group under this Agreement or any of the Ancillary
Agreements, including as set forth in Section&nbsp;2.12(c)(ii); </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) any and all Liabilities of a member of the Ligand Group to the
extent relating to, arising out of or resulting from any Ligand Retained Assets (other than Liabilities arising under any Shared Contracts to the extent such Liabilities relate to the OmniAb Business); </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iii) the Liabilities listed on <U>Schedule</U><U></U><U>&nbsp;1.1(75)</U>; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iv) any and all Liabilities of Ligand and each of its Subsidiaries that are not OmniAb Liabilities. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Notwithstanding the foregoing, the Ligand Retained Liabilities shall not include any Liabilities for Taxes that are governed by the Tax
Matters Agreement or the Employee Matters Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(76) &#147;<B><I>Ligand Retained Names</I></B>&#148; shall mean the names and marks
set forth in <U>Schedule</U><U></U><U>&nbsp;1.1(76)</U>, and any Trademarks containing or comprising any of such names or marks, and any Trademarks derivative thereof or confusingly similar thereto, or any telephone numbers or other alphanumeric
addresses or mnemonics containing any of the foregoing names or marks. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(77) &#147;<B><I>Ligand Stock</I></B>&#148; shall have the meaning set forth in the
Recitals. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(78) &#147;<B><I>Litigation Hold</I></B>&#148; shall have the meaning set forth in <U>Section</U><U></U><U>&nbsp;6.1</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(79) &#147;<B><I>Merger</I></B>&#148; shall have the meaning set forth in the Recitals. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(80) &#147;<B><I>Merger Agreement</I></B>&#148; shall have the meaning set forth in the Recitals. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(81) &#147;<B><I>Merger Sub</I></B>&#148; shall have the meaning set forth in the Recitals. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(82) &#147;<B><I>Negotiation Period</I></B>&#148; shall have the meaning set forth in <U>Section</U><U></U><U>&nbsp;7.1</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(83) &#147;<B><I><FONT STYLE="white-space:nowrap">Off-Site</FONT> Location</I></B>&#148; shall mean any third party location that is not now
nor has ever been owned, leased or operated by the Ligand Group or the OmniAb Group or any of their respective predecessors. &#147;<B><I><FONT STYLE="white-space:nowrap">Off-Site</FONT> Location</I></B>&#148; does not include any property that is
adjacent to or neighboring any property formerly, currently or in the future owned, leased or operated by the Ligand Group, the OmniAb Group, or their respective predecessors that has been impacted by any Release of a Hazardous Substance from such
properties. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(84) &#147;<B><I>OmniAb</I></B>&#148; shall have the meaning set forth in the Preamble. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(85) &#147;<B><I>OmniAb Asset Transferee</I></B>&#148; shall mean any Business Entity that is or will be a member of the OmniAb Group or a
Subsidiary of OmniAb to which OmniAb Assets shall be or have been transferred at or prior to the Distribution Time, or which is contemplated by the Internal Reorganization or this Agreement or the Ancillary Agreements to occur after the Distribution
Time, by an Asset Transferor in order to consummate the transactions contemplated hereby. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(86) &#147;<B><I>OmniAb Assets</I></B>&#148;
shall mean, without duplication: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) all interests in the capital stock of, or membership or other equity interests in, the members of
the OmniAb Group (other than OmniAb) held, directly or indirectly, by Ligand immediately prior to the Distribution Time; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) the Assets
set forth on <U>Schedule</U><U></U><U>&nbsp;1.1(86)(ii)</U> (which for the avoidance of doubt is not a comprehensive listing of all OmniAb Assets and is not intended to limit other clauses of this definition of OmniAb Assets); </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iii) any and all Assets that are expressly contemplated by this Agreement or any Ancillary Agreement as Assets which have been or are to be
Transferred to or retained by any member of the OmniAb Group; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iv) any and all Assets (other than Cash Equivalents, which shall be
governed solely by <U>Section</U><U></U><U>&nbsp;2.12</U>) reflected on the OmniAb Balance Sheet or the accounting records supporting such balance sheet and any Assets acquired by or for OmniAb or any member of the OmniAb Group subsequent to the
date of the OmniAb Balance Sheet which, had they been so acquired on or before such date and owned as of such date, would have been reflected on the OmniAb Balance Sheet if prepared on a consistent basis, subject to any dispositions of any of such
Assets subsequent to the date of the OmniAb Balance Sheet; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(v) all rights, title and interest in, to and under the leases or subleases of the real
property set forth on <U>Schedule</U><U></U><U>&nbsp;1.1(86)(v)</U> and other leases exclusively related to the OmniAb Business, including, to the extent provided for in such leases or subleases, any land and land improvements, structures, buildings
and building improvements, other improvements and appurtenances (the &#147;<B><I>OmniAb Leased Real Property</I></B>&#148;); </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(vi) all
Contracts set forth on <U>Schedule 1.1(86)(vi)</U> and all other Contracts exclusively related to the OmniAb Business or the OmniAb Intellectual Property and any rights or claims arising under any of the foregoing (the &#147;<B><I>OmniAb
Contracts</I></B>&#148;); </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(vii) all Intellectual Property exclusively used, exclusively practiced, exclusively held for the use or
practice, or otherwise exclusively related to the OmniAb Business, including the Intellectual Property applications, registrations and issuances set forth on <U>Schedule</U><U></U><U>&nbsp;1.1(86)(vii)</U> (the &#147;<B><I>OmniAb Intellectual
Property</I></B>&#148;), and all Intellectual Property Documentation relating to any of the foregoing; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(viii) all licenses, permits,
registrations, approvals and authorizations which have been issued by any Governmental Entity and are held by a member of the OmniAb Group, or to the extent transferable, relate exclusively to or, are used exclusively in the OmniAb Business (other
than to the extent that any member of the Ligand Group benefits from such licenses, permits, registrations, approvals and authorizations in connection with the Ligand Retained Business); </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ix) all Information exclusively related to, or exclusively used in, the OmniAb Business; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(x) excluding any OmniAb Intellectual Property (which is addressed in <U>Section</U><U></U><U>&nbsp;1.1(86)(vii)</U> above), all IT Assets
listed on <U>Schedule 1.1(86)(x)</U> and other IT Assets exclusively used or exclusively held for use in the OmniAb Business; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(xi) all
goodwill exclusively related to the OmniAb Business; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(xii) all office equipment and furnishings located at the physical site of which the
ownership or a leasehold or sub leasehold interest is being transferred to or retained by a member of the OmniAb Group, and which as of the Distribution Time is not subject to a lease or sublease back to a member of the Ligand Group (excluding any
office equipment and furnishings owned by persons other than Ligand and its Subsidiaries); </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(xiii) subject to
<U>Article</U><U></U><U>&nbsp;VIII</U>, any rights of any member of the OmniAb Group under any insurance policies held solely by one or more members of the OmniAb Group and which provide coverage solely to one or more members of the OmniAb Group
(excluding any insurance policies issued by any captive insurance company of the Ligand Group); and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(xiv) all other Assets (other than
Assets that are of the type that would be listed in clauses (v), (vii), (viii), (x), (xii) and (xiii)) that are held by the OmniAb Group or the Ligand </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Group immediately prior to the Distribution Time and that are exclusively used and exclusively held for use in the OmniAb Business as conducted immediately prior to the Distribution Time (the
intention of this clause (xiv)&nbsp;is only to rectify an inadvertent omission of transfer or assignment of any Asset that, had the Parties given specific consideration to such Asset as of the date of this Agreement, would have otherwise been
classified as an OmniAb Asset based on the principles of this <U>Section</U><U></U><U>&nbsp;1.1(86))</U>; <U>provided</U> that no Asset shall be an OmniAb Asset solely as a result of this clause (xiv)&nbsp;unless a written claim with respect thereto
is made by OmniAb on or prior to the date that is twenty-four (24)&nbsp;months after the Distribution Time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Notwithstanding anything to
the contrary herein, the OmniAb Assets shall not include (i)&nbsp;any Assets that are expressly contemplated by this Agreement or by any Ancillary Agreement (or the Schedules hereto or thereto) as Assets to be retained by or Transferred to any
member of the Ligand Group (including all Ligand Retained Assets), or (ii)&nbsp;any Assets governed by the Tax Matters Agreement or Employee Matters Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(87) &#147;<B><I>OmniAb Balance Sheet</I></B>&#148; shall mean OmniAb&#146;s unaudited pro forma combined condensed balance sheet, including
the notes thereto, as of December&nbsp;31, 2021, as included in the Form 10. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(88) &#147;<B><I>OmniAb Board</I></B>&#148; shall have the
meaning set forth in the Recitals. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(89) &#147;<B><I>OmniAb Business</I></B>&#148; shall mean the businesses comprising the OmniAb Group,
including the businesses and operations conducted prior to the Distribution Time by any member of the OmniAb Group and any other businesses or operations conducted primarily through the use of the OmniAb Assets, as such businesses are described in
the Form 10, or established by or for OmniAb or any of its Subsidiaries after the Distribution Time and shall include the OmniAb Former Businesses; <U>provided</U> that the OmniAb Business shall not include any Ligand Former Business. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(90) &#147;<B><I>OmniAb Debt Obligations</I></B>&#148; shall mean all Indebtedness of OmniAb or any other member of the OmniAb Group. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(91) &#147;<B><I>OmniAb Disclosure</I></B>&#148; shall mean any form, statement, schedule or other material (other than the <FONT
STYLE="white-space:nowrap">Spin-off</FONT> Disclosure Documents) filed with or furnished to the Commission, including in connection with OmniAb&#146;s obligations under the Securities Act and the Exchange Act, any other Governmental Entity, or
holders of any securities of any member of the OmniAb Group, in each case, on or after the Distribution Time by or on behalf of any member of the OmniAb Group in connection with the registration, sale, or distribution of securities or disclosure
related thereto (including periodic disclosure obligations). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(92) &#147;<B><I>OmniAb Environmental Liabilities</I></B>&#148; shall mean
any and all Environmental Liabilities, whether arising before, at or after the Distribution Time, to the extent relating to or resulting from or arising out of (i)&nbsp;the past, present or future operation, conduct or actions of the OmniAb Group,
OmniAb Business or the past, present or future use of the OmniAb Assets or (ii)&nbsp;the OmniAb Former Businesses or OmniAb Former Real Property, including, without limitation, any agreement, decree, judgment, or order relating to the foregoing
entered into by Ligand or any Affiliate of Ligand prior to the Distribution Time, but in any event excluding the Excluded Environmental Liabilities. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(93) &#147;<B><I>OmniAb Former Businesses</I></B>&#148; shall mean any Former Business that,
at the time of sale, conveyance, assignment, transfer, disposition, divestiture (in whole or in part) or discontinuation, abandonment, completion or termination of the operations, activities or production thereof, was (a)&nbsp;primarily managed by
or associated with the OmniAb Business as then conducted or (b)&nbsp;part of a business the majority of which as of the Distribution Time is or was transferred to OmniAb. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(94) &#147;<B><I>OmniAb Former Real Property</I></B>&#148; shall mean any real property that at the time of sale, conveyance, assignment,
transfer, disposition, divestiture (in whole or in part) or discontinuation, abandonment, completion or termination of the operations, activities or production thereof, was primarily owned, leased or operated in connection with the OmniAb Business
or any of the OmniAb Former Businesses. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(95) &#147;<B><I>OmniAb Group</I></B>&#148; shall mean OmniAb and each Person that is a direct or
indirect Subsidiary of OmniAb as of the Distribution Time (but after giving effect to the Internal Reorganization) including the Transferred Entities, and each Person that becomes a Subsidiary of OmniAb after the Distribution Time; provided,
however, that for the avoidance of doubt, no member of the Ligand Group shall be treated as a member of the OmniAb Group. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(96)
&#147;<B><I>OmniAb Indemnitees</I></B>&#148; shall mean each member of the OmniAb Group and each of their respective Affiliates from and after the Distribution Time and each member of the OmniAb Group&#146;s and such respective Affiliates&#146;
respective current, former and future directors, officers, employees and agents (solely in their respective capacities as current, former and future directors, officers, employees or agents of any member of the OmniAb Group or their respective
Affiliates) and each of the heirs, administrators, executors, successors and assigns of any of the foregoing, except, for the avoidance of doubt, the Ligand Indemnitees. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(97) &#147;<B><I>OmniAb Liabilities</I></B>&#148; shall mean: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) any and all Liabilities to the extent relating to, arising out of or resulting from (a)&nbsp;the operation or conduct of the OmniAb
Business, as conducted at any time prior to, at or after the Distribution Time (including any Liability relating to, arising out of or resulting from any act or failure to act by any director, officer, employee, agent or representative (whether or
not such act or failure to act is or was within such Person&#146;s authority) of the OmniAb Group and any and all Liability relating to, arising out of or resulting from any unclaimed property); (b) the operation or conduct of any business conducted
by any member of the OmniAb Group at any time after the Distribution Time (including any Liability relating to, arising out of or resulting from any act or failure to act by any director, officer, employee, agent or representative (whether or not
such act or failure to act is or was within such Person&#146;s authority) of the OmniAb Group and any and all Liability relating to, arising out of or resulting from any unclaimed property); or (c)&nbsp;any OmniAb Asset, whether arising before, at
or after the Distribution Time (including any Liability relating to, arising out of or resulting from OmniAb Contracts, Shared Contracts (to the extent such Liability relates to the OmniAb Business) and any real property and leasehold interests):
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">16 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) the Liabilities set forth on <U>Schedule 1.1(97)(ii)</U> and any and all other
Liabilities that are expressly provided by this Agreement or any of the Ancillary Agreements as Liabilities to be assumed by OmniAb or any other member of the OmniAb Group, and all agreements, obligations and Liabilities of OmniAb or any other
member of the OmniAb Group under this Agreement or any of the Ancillary Agreements; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iii) any and all Liabilities reflected on the OmniAb
Balance Sheet or the accounting records supporting such balance sheet and any Liabilities incurred by or for OmniAb or any member of the OmniAb Group subsequent to the date of the OmniAb Balance Sheet which, had they been so incurred on or before
such date, would have been reflected on the OmniAb Balance Sheet if prepared on a consistent basis, subject to any discharge of any of such Liabilities subsequent to the date of the OmniAb Balance Sheet; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iv) any and all Liabilities to the extent relating to, arising out of, or resulting from, whether prior to, at or after the Distribution
Time, any infringement, misappropriation or other violation of any Intellectual Property of any other Person related to the conduct of the OmniAb Business; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(v) any and all OmniAb Environmental Liabilities; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(vi) any and all Liabilities (including under applicable federal and state securities Laws) relating to, arising out of or resulting from
(A)&nbsp;the <FONT STYLE="white-space:nowrap">Spin-off</FONT> Disclosure Documents or (B)&nbsp;any OmniAb Disclosure; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(vii) for the
avoidance of doubt, and without limiting any other matters that may constitute OmniAb Liabilities, any Liabilities resulting from any Action to the extent relating to, arising out of or resulting from the OmniAb Business, including all Actions
listed on <U>Schedule</U><U></U><U>&nbsp;1.1(97)(vii)</U>; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(viii) all Liabilities relating to, arising out of or resulting from any
Indebtedness of any member of the OmniAb Group or any Indebtedness secured exclusively by any of the OmniAb Assets; and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ix) any and all
other Liabilities that are held by the OmniAb Group or the Ligand Group immediately prior to the Distribution Time that were inadvertently omitted or assigned that, had the parties given specific consideration to such Liability as of the date of
this Agreement, would have otherwise been classified as an OmniAb Liability based on the principles set forth in this <U>Section</U><U></U><U>&nbsp;1.1(97)</U>; <U>provided</U>, that no Liability shall be an OmniAb Liability solely as a result of
this clause (ix)&nbsp;unless a claim with respect thereto is made by Ligand on or prior to the date that is twenty-four (24)&nbsp;months after the Distribution Time. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Notwithstanding the foregoing, the OmniAb Liabilities shall not include any Liabilities that are (A)&nbsp;expressly contemplated by this
Agreement or by any Ancillary Agreement (or the Schedules hereto or thereto) as Liabilities to be Assumed by any member of the Ligand Group, (B)&nbsp;expressly discharged pursuant to <U>Section</U><U></U><U>&nbsp;2.4</U> of this Agreement,
(C)&nbsp;Ligand Retained Liabilities or (D)&nbsp;for Taxes that are governed by the Tax Matters Agreement or Employee Matters Agreement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">17 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(98) &#147;<B><I>OmniAb Released Liabilities</I></B>&#148; shall have the meaning set forth
in <U>Section</U><U></U><U>&nbsp;5.1(a)(ii)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(99) &#147;<B><I>OmniAb Stock</I></B>&#148; shall have the meaning set forth in the
Recitals. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(100) &#147;<B><I>Other Party</I></B>&#148; shall have the meaning set forth in <U>Section</U><U></U><U>&nbsp;2.9(a)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(101) &#147;<B><I>Other Reimbursable Expenses</I></B>&#148; shall have the meaning set forth in <U>Section</U><U></U><U>&nbsp;2.12(c)</U>.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(102) &#147;<B><I>Party</I></B>&#148; and &#147;<B><I>Parties</I></B>&#148; shall have the meanings set forth in the Preamble. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(103) &#147;<B><I>Person</I></B>&#148; shall mean any natural person, firm, individual, corporation, business trust, joint venture,
association, bank, land trust, trust company, company, limited liability company, partnership, or other organization or entity, whether incorporated or unincorporated, or any Governmental Entity. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(104) &#147;<B><I>Personal Information</I></B>&#148; shall mean any data or information that identifies, relates to, describes, is reasonably
capable of being associated with, or could reasonably be linked, directly or indirectly, with a particular natural person or household (including any information related to the health of a person) and any information derived from any of the
foregoing, in addition to any definition for &#147;personal information&#148; or any similar term provided by applicable Law or by the applicable Party&#146;s privacy policies, notices or contracts (e.g., &#147;personal data,&#148; &#147;personally
identifiable information&#148; or &#147;PII&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(105) &#147;<B><I>Policies</I></B>&#148; or &#147;<B><I>Policy</I></B>&#148; shall
mean insurance policies and insurance contracts of any kind, including primary, excess and umbrella, comprehensive general liability, fiduciary, directors and officers, automobile, products, workers&#146; compensation, employee dishonesty, property
and crime insurance policies and self-insurance and captive insurance arrangements, and interests in insurance pools and programs held in the name of Ligand or any of its Affiliates, together with the rights, benefits and privileges thereunder. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(106) &#147;<B><I>Prime Rate</I></B>&#148; shall mean the rate last quoted as of the time of determination by The Wall Street Journal as the
&#147;Prime Rate&#148; in the United States or, if the Wall Street Journal ceases to quote such rate, the highest per annum interest rate published by the Federal Reserve Board in Federal Reserve Statistical Release H.15 (519) (Selected Interest
Rates) as the &#147;bank prime loan&#148; rate as of such time, or, if such rate is no longer quoted therein, any similar rate quoted therein (as determined by Ligand) or any similar release by the Federal Reserve Board (as determined by Ligand).
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(107) &#147;<B><I>Privacy </I></B><B><I>Laws</I></B>&#148; shall mean any and all applicable Laws, legal requirements and self-regulatory
guidelines (including of any applicable foreign jurisdiction) relating to the Processing of any Personal Information. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(108)
&#147;<B><I>Privacy Requirements</I></B>&#148; shall mean all applicable Privacy Laws and all applicable policies, notices, and contractual obligations relating to the Processing of any Personal Information. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">18 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(109) &#147;<B><I>Privilege</I></B>&#148; shall have the meaning set forth in
<U>Section</U><U></U><U>&nbsp;6.7(a)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(110) &#147;<B><I>Privileged Information</I></B>&#148; shall have the meaning set forth in
<U>Section</U><U></U><U>&nbsp;6.7(a)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(111) &#147;<B><I>Processing</I></B>&#148; shall mean any operation or set of operations which
is performed on any Personal Information or on any sets of any Personal Information, whether or not by automated means, such as, without limitation: receipt; collection; compilation; use; disposal; destruction; disclosure or transfer (including
cross-border); recording; organization; structuring; safeguarding; storage; security (technical, physical and/or administrative); sharing; adaptation or alteration; retrieval; consultation; disclosure by transmission, dissemination or otherwise
making available; alignment or combination; restriction; erasure; and/or destruction. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(112) &#147;<B><I>Record Date</I></B>&#148; shall
mean 5:00 p.m. New York time on the date to be determined by the Ligand Board as the record date for determining stockholders of Ligand entitled to receive shares of OmniAb Stock in the Distribution. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(113) &#147;<B><I>Record Holders</I></B>&#148; shall mean the holders of record of Ligand Stock as of the Record Date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(114) &#147;<B><I>Reimbursable Transaction-related Expenses</I></B>&#148; shall have the meaning set forth in
<U>Section</U><U></U><U>&nbsp;9.5</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(115) &#147;<B><I>Release</I></B>&#148; shall mean any release, spill, emission, discharge,
leaking, pumping, injection, deposit, disposal, dispersal, leaching or migration into the indoor or outdoor environment (including ambient air, surface water, groundwater and surface or subsurface strata) or into or out of any property, including
the movement of Hazardous Substances through or in the air, soil, surface water, groundwater or property. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(116) &#147;<B><I>Securities
Act</I></B>&#148; shall mean the Securities Act of 1933, together with the rules and regulations promulgated thereunder. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(117)
&#147;<B><I>Security Interest</I></B>&#148; shall mean any mortgage, security interest, pledge, lien, charge, claim, option, right to acquire, voting or other restriction,
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">right-of-entry,</FONT></FONT> covenant, condition, easement, encroachment, restriction on transfer, or other encumbrance of any nature whatsoever, excluding restrictions on transfer
under securities Laws. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(118) &#147;<B><I>Separation</I></B>&#148; shall have the meaning set forth in the Recitals. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(119) &#147;<B><I>Shared Contract</I></B>&#148; shall have the meaning set forth in <U>Section</U><U></U><U>&nbsp;2.3(a)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(120) &#147;<B><I>Software</I></B>&#148; shall mean all: (i)&nbsp;computer programs, including all software implementations of algorithms,
models and methodologies, whether in source code, object code, human readable form or other form; (ii)&nbsp;databases and compilations, including all data and collections of data, whether machine readable or otherwise; (iii)&nbsp;descriptions, flow
charts and other work products used to design, plan, organize and develop any of the foregoing, screens, user interfaces, report formats, firmware, development tools, templates, menus, buttons, icons, web content and links; and
(iv)&nbsp;documentation relating to any of the foregoing, including user manuals and other training documentation. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">19 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(121) &#147;<B><I>Specific Milestone Payments</I></B>&#148; shall have the meaning set forth
in <U>Section</U><U></U><U>&nbsp;2.12(c)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(122) &#147;<B><I><FONT STYLE="white-space:nowrap">Spin-off</FONT> Disclosure
Documents</I></B>&#148; shall mean the Form 10 and all exhibits thereto including the Information Statement, and any current reports on Form <FONT STYLE="white-space:nowrap">8-K,</FONT> in each case as filed or furnished by OmniAb with or to the
Commission in connection with the Distribution or Merger or filed or furnished by Ligand with or to the Commission solely to the extent such documents relate to OmniAb, the Distribution or the Merger. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(123) &#147;<B><I>Subsidiary</I></B>&#148; shall mean with respect to any Person (i)&nbsp;a corporation, fifty percent (50%) or more of the
voting or capital stock of which is, as of the time in question, directly or indirectly owned by such Person and (ii)&nbsp;any other Person in which such Person, directly or indirectly, owns fifty percent (50%) or more of the equity or economic
interest thereof or has the power to elect or direct the election of fifty percent (50%) or more of the members of the governing body of such entity. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(124) &#147;<B><I>Tax</I></B>&#148; or &#147;<B><I>Taxes</I></B>&#148; shall have the meaning set forth in the Tax Matters Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(125) &#147;<B><I>Tax Contest</I></B>&#148; shall have the meaning as set forth in the Tax Matters Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(126) &#147;<B><I>Tax Matters Agreement</I></B>&#148; shall mean that certain Tax Matters Agreement to be entered into between Ligand and
OmniAb in connection with the Separation, the Distribution or the other transactions contemplated by this Agreement, as such agreement may be modified or amended from time to time in accordance with its terms. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(127) &#147;<B><I>Tax Returns</I></B>&#148; shall have the meaning set forth in the Tax Matters Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(128) &#147;<B><I>Taxing Authority</I></B>&#148; shall have the meaning set forth in the Tax Matters Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(129) &#147;<B><I>Third Party Agreements</I></B>&#148; shall mean any agreements, arrangements, commitments or understandings between or among
a Party (or any member of its Group) and any other Persons (other than either Party or any member of its respective Groups) (it being understood that to the extent that the rights and obligations of the Parties and the members of their respective
Groups under any such Contracts constitute OmniAb Assets or OmniAb Liabilities, or Ligand Retained Assets or Ligand Retained Liabilities, such Contracts shall be assigned or retained pursuant to <U>Article</U><U></U><U>&nbsp;II</U>). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(130) &#147;<B><I>Third Party Claim</I></B>&#148; shall have the meaning set forth in <U>Section</U><U></U><U>&nbsp;5.4(b)</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(131) &#147;<B><I>Third Party Proceeds</I></B>&#148; shall have the meaning set forth in <U>Section</U><U></U><U>&nbsp;5.7(a).</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(132) &#147;<B><I>Transaction-related Expenses</I></B>&#148; shall have the meaning set forth in <U>Section</U><U></U><U>&nbsp;9.5</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(133) &#147;<B><I>Transfer</I></B>&#148; shall have the meaning set forth in <U>Section</U><U></U><U>&nbsp;2.2(b)(i)</U>; and the term
&#147;<B><I>Transferred</I></B>&#148; shall have its correlative meaning. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">20 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(134) &#147;<B><I>Transferred Entities</I></B>&#148; shall mean Ab Initio Biotherapeutics,
Inc., Crystal Bioscience, Inc., Icagen, LLC, Taurus Biosciences, LLC and xCella Biosciences, Inc. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(135) &#147;<B><I>Transition Services
Agreements</I></B>&#148; shall mean either or both, as applicable, of those certain Transition Services Agreements to be entered into between Ligand and OmniAb or any members of their respective Groups in connection with the Distribution or the
other transactions contemplated by this Agreement, as such agreements may be modified or amended from time to time in accordance with their terms. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;1.2 <U>References; Interpretation</U>. References in this Agreement to any gender include references to all genders, and
references to the singular include references to the plural and vice versa. Unless the context otherwise requires, the words &#147;include&#148;, &#147;includes&#148; and &#147;including&#148; when used in this Agreement shall be deemed to be
followed by the phrase &#147;without limitation&#148;. Unless the context otherwise requires, references in this Agreement to Articles, Sections, Annexes, Exhibits&nbsp;and Schedules shall be deemed references to Articles and Sections&nbsp;of, and
Annexes, Exhibits&nbsp;and Schedules to, this Agreement. Unless the context otherwise requires, the words &#147;hereof&#148;, &#147;hereby&#148; and &#147;herein&#148; and words of similar meaning when used in this Agreement refer to this Agreement
in its entirety and not to any particular Article, Section&nbsp;or provision of this Agreement. The words &#147;written request&#148; when used in this Agreement shall include email. Reference in this Agreement to any time shall be to New York City,
New York time unless otherwise expressly provided herein. Unless the context requires otherwise, references in this Agreement to &#147;<B><I>Ligand</I></B>&#148; shall also be deemed to refer to the applicable member of the Ligand Group, references
to &#147;<B><I>OmniAb</I></B>&#148; shall also be deemed to refer to the applicable member of the OmniAb Group and, in connection therewith, any references to actions or omissions to be taken, or refrained from being taken, as the case may be, by
Ligand or OmniAb shall be deemed to require Ligand or OmniAb, as the case may be, to cause the applicable members of the Ligand Group or the OmniAb Group, respectively, to take, or refrain from taking, any such action. In the event of any
inconsistency or conflict which may arise in the application or interpretation of any of the definitions set forth in <U>Section</U><U></U><U>&nbsp;1.1</U>, for the purpose of determining what is and is not included in such definitions, any item
explicitly included on a Schedule&nbsp;referred to in any such definition shall take priority over any provision of the text thereof. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE II </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>THE
SEPARATION </U></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.1 <U>General</U>. Subject to the terms and conditions of this Agreement, the Parties shall use, and
shall cause their respective Affiliates to use, their respective commercially reasonable efforts to consummate the transactions contemplated hereby, including the completion of the Internal Reorganization, a portion of which may have already been
implemented prior to the date hereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.2 <U>Restructuring: Transfer of Assets; Assumption of Liabilities</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <U>Internal Reorganization</U>. Prior to the Distribution Time, except for Transfers contemplated by the Internal Reorganization or this
Agreement or the Ancillary Agreements to occur after the Distribution Time, the Parties shall complete the Internal Reorganization, including by taking the actions referred to in <U>Sections</U><U></U><U>&nbsp;2.2(b)</U> and <U>2.2(c)</U> below.
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">21 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <U>Transfer of Assets</U>. At or prior to the Distribution Time (it being understood
that some of such Transfers may occur following the Distribution Time in accordance with <U>Section</U><U></U><U>&nbsp;2.2(a)</U> and <U>Section</U><U></U><U>&nbsp;2.6</U>), pursuant to the Conveyancing and Assumption Instruments and in connection
with the Contribution: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) Ligand shall, and shall cause the applicable Asset Transferors to, transfer, contribute,
distribute, assign and/or convey or cause to be transferred, contributed, distributed, assigned and/or conveyed (&#147;<B><I>Transfer</I></B>&#148;) to OmniAb and/or the respective OmniAb Asset Transferees, all of its and the applicable Asset
Transferors&#146; right, title and interest in and to the OmniAb Assets, and the applicable OmniAb Asset Transferees shall accept from Ligand and the applicable members of the Ligand Group all of Ligand&#146;s and the other members of the Ligand
Group&#146;s respective direct or indirect rights, title and interest in and to the applicable Assets, including all of the outstanding shares of capital stock or other ownership interests, that are included in the OmniAb Assets. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) Any costs and expenses incurred after the Distribution Time to effect any Transfer contemplated by this
<U>Section</U><U></U><U>&nbsp;2.2(b)</U> (including any transfer effected pursuant to <U>Section</U><U></U><U>&nbsp;2.6</U>) shall be paid by the Parties as set forth in <U>Section</U><U></U><U>&nbsp;9.5</U>. Other than costs and expenses incurred
in accordance with the foregoing sentence, nothing in this <U>Section</U><U></U><U>&nbsp;2.2(b)</U> shall require any member of any Group to incur any material obligation or grant any material concession for the benefit of any member of any other
Group in order to effect any transaction contemplated by this <U>Section</U><U></U><U>&nbsp;2.2(b)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For the avoidance of doubt any
OmniAb Assets already held by OmniAb prior to the Internal Reorganization shall not need to be Transferred and shall remain with OmniAb prior to and following the Distribution Time. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) <U>Assumption of Liabilities</U>. Except as pursuant to this Agreement or as otherwise specifically set forth in any Ancillary Agreement,
in connection with the Internal Reorganization and the Contribution or, if applicable, from and after, the Distribution Time (i)&nbsp;pursuant to this Agreement or the applicable Conveyancing and Assumption Instruments, OmniAb shall, or shall cause
a member of the OmniAb Group to accept, assume (or, as applicable, retain) and perform, discharge and fulfill, in accordance with their respective terms (&#147;<B><I>Assume</I></B>&#148;), all of the OmniAb Liabilities and (ii)&nbsp;pursuant to this
Agreement or the applicable Conveyancing and Assumption Instruments, Ligand shall, or shall cause a member of the Ligand Group to, Assume all of the Ligand Retained Liabilities, in each case, regardless of (A)&nbsp;when or where such Liabilities
arose or arise, (B)&nbsp;whether the facts upon which they are based occurred prior to, at or subsequent to the Distribution Time, (C)&nbsp;whether accruals for such Liabilities have been transferred to OmniAb or included on a combined balance sheet
of the OmniAb Business or whether any such accruals are sufficient to cover such Liabilities, (D)&nbsp;where or against whom such Liabilities are asserted or determined, (E)&nbsp;whether arising from or alleged to arise from negligence, gross
negligence, recklessness, violation of Law, fraud or misrepresentation by any member of the Ligand Group or the OmniAb Group, as the case may be, or any of their past or present respective directors, officers, employees, agents, Subsidiaries or
Affiliates, (F)&nbsp;which entity is named in any Action associated with any Liability, or (G)&nbsp;any benefits, or lack thereof, that have been or may be obtained by the Ligand Group or the OmniAb Group in respect of such Liabilities. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">22 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) <U>Consents</U>. The Parties shall use their commercially reasonable efforts to obtain
the Consents required to Transfer any Assets, Contracts, licenses, permits and authorizations issued by any Governmental Entity or parts thereof as contemplated by this Agreement. Notwithstanding anything herein to the contrary, no Contract or other
Asset shall be transferred if it would violate applicable Law or, in the case of any Contract, the rights of any third party to such Contract; <U>provided</U> that <U>Section</U><U></U><U>&nbsp;2.6</U>, to the extent provided therein, shall apply
thereto. The foregoing shall not preclude OmniAb or any member of the OmniAb Group from disputing in good faith with any third party (other than Ligand or any member of the Ligand Group) the validity of any OmniAb Liabilities or raising any
available defenses in connection therewith. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) It is understood and agreed by the Parties that certain of the Transfers referenced in
<U>Section</U><U></U><U>&nbsp;2.2(b)</U> or Assumptions referenced in <U>Section</U><U></U><U>&nbsp;2.2(c)</U> have occurred prior to the date hereof and, as a result, no additional Transfers or Assumptions by any member of the Ligand Group or the
OmniAb Group, as applicable, shall be deemed to occur upon the execution of this Agreement with respect thereto. Moreover, to the extent that any member of the Ligand Group or the OmniAb Group, as applicable, is liable for any Ligand Retained
Liability or OmniAb Liability, respectively, by operation of law immediately following any Transfer in accordance with this Agreement or any Conveyancing and Assumption Instruments, there shall be no need for any other member of the Ligand Group or
the OmniAb Group, as applicable, to Assume such Liability in connection with the operation of <U>Section</U><U></U><U>&nbsp;2.2(c)</U> and, accordingly, no other member of such Group shall Assume any such Liability in connection with
<U>Section</U><U></U><U>&nbsp;2.2(c)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.3 <U>Treatment of Shared Contracts</U>. Without limiting the generality of the
obligations set forth in <U>Sections</U><U></U><U>&nbsp;2.2(a)</U> and <U>(b)</U>: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Unless the Parties otherwise agree or the benefits
of any Contract described in this <U>Section</U><U></U><U>&nbsp;2.3</U> are expressly conveyed to the applicable Party pursuant to an Ancillary Agreement, and other than as provided by <U>Article VIII</U>, any Contract that is listed on
<U>Schedule</U><U></U><U>&nbsp;2.3(a)</U> (a &#147;<B><I>Shared Contract</I></B>&#148;) shall be assigned in part to the applicable member(s) of the applicable Group, if so assignable, or appropriately amended prior to, at or after the Distribution
Time, so that each Party or the members of their respective Groups as of the Distribution Time shall be entitled to the rights and benefits, and shall Assume the related portion of any Liabilities, inuring to their respective Businesses;
<U>provided</U>, <U>however</U>, that (x)&nbsp;in no event shall any member of any Group be required to assign (or amend) any Shared Contract in its entirety or to assign a portion of any Shared Contract which is not assignable (or cannot be
amended) by its terms (including any terms imposing consents or conditions on an assignment where such consents or conditions have not been obtained or fulfilled, subject to <U>Section</U><U></U><U>&nbsp;2.2(d)</U>), and (y)&nbsp;if any Shared
Contract cannot be so partially assigned by its terms or otherwise, cannot be amended or has not for any other reason been assigned or amended, or if such assignment or amendment would impair the benefit the parties thereto derive from such Shared
Contract, (A)&nbsp;at the reasonable request of the Party (or the member of such Party&#146;s Group) to which the benefit of </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">23 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
such Shared Contract inures in part, the Party for which such Shared Contract is, as applicable, a Ligand Retained Asset or OmniAb Asset shall, and shall cause each of its respective Subsidiaries
to, for a period ending not later than six (6)&nbsp;months after the Distribution Date (unless the term of a Shared Contract (excluding any extensions thereof) ends at a later date, in which case for a period ending on such date), take such other
reasonable and permissible actions to cause such member of the OmniAb Group or the Ligand Group, as the case may be, to receive the benefit of that portion of each Shared Contract that relates to the OmniAb Business or the Ligand Retained Business,
as the case may be (in each case, to the extent so related) as if such Shared Contract had been assigned to (or amended to allow) a member of the applicable Group pursuant to this <U>Section</U><U></U><U>&nbsp;2.3</U> and to bear the burden of the
corresponding Liabilities (including any Liabilities that may arise by reason of such arrangement) as if such Liabilities had been Assumed by a member of the applicable Group pursuant to this <U>Section</U><U></U><U>&nbsp;2.3</U>; <U>provided</U>
that the Party for which such Shared Contract is a Ligand Retained Asset or an OmniAb Asset, as applicable, shall be indemnified for all Indemnifiable Losses or other Liabilities arising out of any actions (or omissions to act) of such retaining
Party taken at the direction of the other Party (or relevant member of its Group) in connection with and relating to such Shared Contract, as the case may be, and (B)&nbsp;the Party to which the benefit of such Shared Contract inures in part shall
use commercially reasonable efforts to enter into a separate contract pursuant to which it procures such rights and obligations as are necessary such that it no longer needs to avail itself of the arrangements provided pursuant to this
<U>Section</U><U></U><U>&nbsp;2.3(a)</U>; <U>provided</U> that, the Party for which such Shared Contract is, as applicable, a Ligand Retained Asset or OmniAb Asset, any such Party&#146;s applicable Subsidiaries shall not be liable for any actions or
omissions taken in accordance with clause (y)&nbsp;of this <U>Section</U><U></U><U>&nbsp;2.3(a)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Unless the Parties otherwise
agree, each of Ligand and OmniAb shall, and shall cause the members of its Group to, (A)&nbsp;treat for all Tax purposes the portion of each Shared Contract inuring to its respective Businesses as Assets owned by, and/or Liabilities of, as
applicable, such Party as of the Distribution Time and (B)&nbsp;neither report nor take any Tax position (on a Tax Return or otherwise) inconsistent with such treatment (unless required by applicable Law or good faith resolution of a Tax Contest).
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.4 <U>Intercompany Accounts, Loans and Agreements</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Except as set forth in <U>Section</U><U></U><U>&nbsp;5.1(b)</U>, all intercompany receivables and payables (other than
(x)&nbsp;intercompany loans (which shall be governed by <U>Section</U><U></U><U>&nbsp;2.4(c)</U>), and (y)&nbsp;payables created or required by this Agreement, any Ancillary Agreement or any Continuing Arrangements) and intercompany balances,
including in respect of any cash balances, any cash balances representing deposited checks or drafts or any cash held in any centralized cash management system between any member of the Ligand Group, on the one hand, and any member of the OmniAb
Group, on the other hand, which exist and are reflected in the accounting records of the relevant Parties immediately prior to the Distribution Time, shall be paid, performed or otherwise settled on or prior to the Distribution Time, and all
arrangements, understandings and agreements relating thereto are hereby terminated. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">24 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) As between the Parties (and the members of their respective Group) all payments and
reimbursements received after the Distribution Time by one Party (or member of its Group) that relate to a Business, Asset or Liability of the other Party (or member of its Group), shall be held by such Party in trust for the use and benefit of the
Party entitled thereto (at the expense of the Party entitled thereto) and, promptly upon receipt by such Party of any such payment or reimbursement, such Party shall pay or shall cause the applicable member of its Group to pay over to the Party
entitled thereto the amount of such payment or reimbursement without right of <FONT STYLE="white-space:nowrap">set-off.</FONT> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Each
of Ligand or any member of the Ligand Group, on the one hand, and OmniAb or any member of the OmniAb Group, on the other hand, will settle with the other Party, as the case may be, all intercompany loans, including any promissory notes, owned or
owed by the other Party on or prior to the Distribution Time, it being understood and agreed by the Parties that all guarantees and Credit Support Instruments shall be governed by <U>Section</U><U></U><U>&nbsp;2.10</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.5 <U>Limitation of Liability; Intercompany Contracts</U>. No Party nor any Subsidiary thereof shall be liable to the other
Party or any Subsidiary of the other Party based upon, arising out of or resulting from any Contract, arrangement, course of dealing or understanding between or among it and the other Party existing at or prior to the Distribution Time (other than
pursuant to this Agreement, any Ancillary Agreement, any Continuing Arrangements, any Third Party Agreements, or pursuant to any other Contract entered into in connection herewith or in order to consummate the transactions contemplated hereby or
thereby) and each Party hereby terminates any and all Contracts, arrangements, courses of dealing or understandings between or among it and the other Party effective as of the Distribution Time (other than as set forth in this Agreement, any
Ancillary Agreement, any Continuing Arrangements, any Third Party Agreements, or pursuant to any Contract entered into in connection herewith or in order to consummate the transactions contemplated hereby or thereby), provided, however, that with
respect to any Contract, arrangement, course of dealing or understanding between or among the Parties or any Subsidiaries thereof discovered after the Distribution Time, the Parties agree that such Contract, arrangement, course of dealing or
understanding shall nonetheless be deemed terminated as of the Distribution Time with the only liability of the Parties in respect thereof to be the obligations incurred between the Parties pursuant to such Contract, arrangement, course of dealing
or understanding between the Distribution Time and the time of discovery or later termination of any such Contract, arrangement, course of dealing or understanding. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.6 <U>Transfers Not Effected at or Prior to the Distribution Time; Transfers Deemed Effective as of the Distribution Time</U>.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) To the extent that any Transfers or Assumptions contemplated by this <U>Article</U><U></U><U>&nbsp;II</U> shall not have been
consummated at or prior to the Distribution Time, the Parties shall use commercially reasonable efforts (taking into account any applicable restrictions or considerations, in each case relating to the contemplated Tax treatment of the transactions
contemplated hereby) to effect such Transfers or Assumptions as promptly following the Distribution Time as shall be practicable. Nothing herein shall be deemed to require or constitute the Transfer of any Assets or the Assumption of any Liabilities
which by their terms or operation of Law cannot be Transferred; <U>provided</U>, <U>however</U>, that the Parties and their respective Subsidiaries shall cooperate and use commercially reasonable efforts to seek to obtain, in accordance with
applicable Law, any necessary Consents or Governmental Approvals for the Transfer of all Assets and Assumption of all Liabilities contemplated to be Transferred and </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">25 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Assumed pursuant to this <U>Article</U><U></U><U>&nbsp;II</U> to the fullest extent permitted by applicable Law. In the event that any such Transfer of Assets or Assumption of Liabilities has not
been consummated, from and after the Distribution Time, (i)&nbsp;the Party (or relevant member in its Group) retaining such Asset shall thereafter hold (or shall cause such member in its Group to hold) such Asset in trust for the use and benefit of
the Party entitled thereto (at the expense of the Party entitled thereto) and (ii)&nbsp;the Party intended to Assume such Liability shall, or shall cause the applicable member of its Group to, pay or reimburse the Party retaining such Liability for
all amounts paid or incurred in connection with the retention of such Liability. To the extent the foregoing applies to any Contracts (other than Shared Contracts, which shall be governed solely by <U>Section</U><U></U><U>&nbsp;2.3</U>) to be
assigned for which any necessary Consents or Governmental Approvals are not received prior to the Distribution Time, the treatment of such Contracts shall, for the avoidance of doubt, be subject to <U>Section</U><U></U><U>&nbsp;2.8</U> and
<U>Section</U><U></U><U>&nbsp;2.9</U>, to the extent applicable. In addition, the Party retaining such Asset or Liability (or relevant member of its Group) shall (or shall cause such member in its Group to) treat, insofar as reasonably possible and
to the extent permitted by applicable Law, such Asset or Liability in the ordinary course of business in accordance with past practice and take such other actions as may be reasonably requested by the Party to which such Asset is to be Transferred
or by the Party Assuming such Liability in order to place such Party, insofar as reasonably possible and to the extent permitted by applicable Law, in the same position as if such Asset or Liability had been Transferred or Assumed as contemplated
hereby and so that all the benefits and burdens relating to such Asset or Liability, including possession, use, risk of loss, potential for income and gain, and dominion, control and command over such Asset or Liability, are to inure from and after
the Distribution Time to the relevant member or members of the Ligand Group or the OmniAb Group entitled to the receipt of such Asset or required to Assume such Liability. In furtherance of the foregoing, the Parties agree that, as of the
Distribution Time, subject to <U>Section</U><U></U><U>&nbsp;2.2(c)</U> and <U>Section</U><U></U><U>&nbsp;2.9(b)</U>, each Party shall be deemed to have acquired complete and sole beneficial ownership over all of the Assets, together with all rights,
powers and privileges incident thereto, and shall be deemed to have Assumed in accordance with the terms of this Agreement all of the Liabilities, and all duties, obligations and responsibilities incident thereto, which such Party is entitled to
acquire or required to Assume pursuant to the terms of this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) If and when the Consents, Governmental Approvals and/or
conditions, the absence or <FONT STYLE="white-space:nowrap">non-satisfaction</FONT> of which caused the deferral of Transfer of any Asset or deferral of the Assumption of any Liability pursuant to <U>Section</U><U></U><U>&nbsp;2.6(a)</U>, are
obtained or satisfied, the Transfer, assignment, Assumption or novation of the applicable Asset or Liability shall be effected without further consideration in accordance with and subject to the terms of this Agreement (including
<U>Section</U><U></U><U>&nbsp;2.2</U>) and/or the applicable Ancillary Agreement, and shall, to the extent possible without the imposition of any undue cost on any Party, be deemed to have become effective as of the Distribution Time. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) The Party (or relevant member of its Group) retaining any Asset or Liability due to the deferral of the Transfer of such Asset or the
deferral of the Assumption of such Liability pursuant to <U>Section</U><U></U><U>&nbsp;2.6(a)</U> or otherwise shall (i)&nbsp;not be obligated, in connection with the foregoing, to expend any money unless the necessary funds are advanced, assumed,
or agreed in advance to be reimbursed by the Party (or relevant member of its Group) entitled to such Asset or the Person intended to be subject to such Liability, other than reasonable attorneys&#146; fees and recording or similar or other
incidental fees, all of which shall be promptly reimbursed </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">26 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
by the Party (or relevant member of its Group) entitled to such Asset or the Person intended to be subject to such Liability and (ii)&nbsp;be indemnified for all Indemnifiable Losses or other
Liabilities arising out of any actions (or omissions to act) of such retaining Party taken at the direction of the other Party (or relevant member of its Group) in connection with and relating to such retained Asset or Liability, as the case may be.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) After the Distribution Time, each Party (or any member of its Group) may receive mail, packages, electronic mail or other electronic
communications and any other written communications properly belonging to another Party (or any member of its Group). Accordingly, at all times after the Distribution Time, each Party is hereby authorized to receive and, if reasonably necessary to
identify the proper recipient in accordance with this <U>Section</U><U></U><U>&nbsp;2.6(d)</U>, open all mail, packages, electronic mail or other electronic communication and any other written communications received by such Party that belongs to
such other Party, and to the extent that they do not relate to the business of the receiving Party, the receiving Party shall promptly deliver such mail, packages, electronic mail or other electronic communication or any other written communications
(or, in case the same also relates to the business of the receiving Party or another Party, copies thereof) to such other Party as provided for in <U>Section</U><U></U><U>&nbsp;9.6</U>; it being understood that if a Party receives a telephone call
that relates to the business of the other Party, then the receiving Party shall inform the person making such telephone call to contact the other Party. The provisions of this <U>Section</U><U></U><U>&nbsp;2.6(d)</U> are not intended to, and shall
not, be deemed to constitute an authorization by any Party to permit the other to accept service of process on its behalf and no Party is or shall be deemed to be the agent of any other Party for service of process purposes. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) With respect to Assets and Liabilities described in <U>Section</U><U></U><U>&nbsp;2.6(a)</U>, each of Ligand and OmniAb shall, and shall
cause the members of its respective Group to, (i)&nbsp;treat for all Tax purposes (A)&nbsp;the deferred Assets as assets having been Transferred to and owned by the Party entitled to such Assets not later than the Distribution Time and (B)&nbsp;the
deferred Liabilities as liabilities having been Assumed and owned by the Person intended to be subject to such Liabilities not later than the Distribution Time and (ii)&nbsp;neither report nor take any Tax position (on a Tax Return or otherwise)
inconsistent with such treatment (unless required by applicable Law or good faith resolution of a Tax Contest). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.7
<U>Conveyancing and Assumption Instruments</U>. In connection with, and in furtherance of, the Transfers of Assets and the Assumptions of Liabilities contemplated by this Agreement, the Parties shall execute or cause to be executed, on or after the
date hereof by the appropriate entities to the extent not executed prior to the date hereof, any Conveyancing and Assumption Instruments necessary to evidence the valid Transfer to the applicable Party or member of such Party&#146;s Group of all
right, title and interest in and to its accepted Assets and the valid and effective Assumption by the applicable Party of its Assumed Liabilities for Transfers and Assumptions to be effected pursuant to Delaware Law or the Laws of one of the other
states of the United States or, if not appropriate for a given Transfer or Assumption, and for Transfers or Assumptions to be effected pursuant to <FONT STYLE="white-space:nowrap">non-U.S.</FONT> Laws, in such form as the Parties shall reasonably
agree, including the Transfer of real property by mutually acceptable conveyance deeds as may be appropriate and in form and substance as may be required by the jurisdiction in which the real property is located; <U>provided</U>, that the allocation
of Assets and Liabilities provided for in any Conveyancing and Assumption Instruments shall be consistent with the terms of this </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">27 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Agreement, unless otherwise approved in writing by the Parties and APAC . The Transfer of capital stock shall, to the extent necessary to evidence a valid Transfer, be effected by means of
executed stock powers and notation on the stock record books of the corporation or other legal entities involved, or by such other means as may be required in any <FONT STYLE="white-space:nowrap">non-U.S.</FONT> jurisdiction to Transfer title to
stock and, only to the extent required by applicable Law, by notation on public registries. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.8 <U>Further Assurances;
Ancillary Agreements</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) In addition to and without limiting the actions specifically provided for elsewhere in this Agreement and
subject to the limitations expressly set forth in this Agreement, including <U>Section</U><U></U><U>&nbsp;2.6</U>, each of the Parties shall cooperate with each other and use (and shall cause its respective Subsidiaries and Affiliates to use)
commercially reasonable efforts, at and after the Distribution Time, to take, or to cause to be taken, all actions, and to do, or to cause to be done, all things reasonably necessary on its part under applicable Law or contractual obligations to
consummate and make effective the transactions contemplated by this Agreement and the Ancillary Agreements. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Without limiting the
foregoing, at and after the Distribution Time, each Party shall cooperate with the other Party, and without any further consideration, but at the expense of the requesting Party (except as provided in <U>Sections</U><U></U><U>&nbsp;2.2(b)(ii)</U>
and <U>2.6(c)</U>) from and after the Distribution Time, to execute and deliver, or use commercially reasonable efforts to cause to be executed and delivered, all instruments, including instruments of Transfer or title, and to make all filings with,
and to obtain all Consents and/or Governmental Approvals, any permit, license, Contract, indenture or other instrument (including any Consents or Governmental Approvals), and to take all such other actions as such Party may reasonably be requested
to take by any other Party from time to time, consistent with the terms of this Agreement and the Ancillary Agreements, in order to effectuate the provisions and purposes of this Agreement and the Ancillary Agreements and the Transfers of the
applicable Assets and the assignment and Assumption of the applicable Liabilities and the other transactions contemplated hereby and thereby. Without limiting the foregoing, each Party shall, at the reasonable request, cost and expense of any other
Party (except as provided in <U>Sections</U><U></U><U>&nbsp;2.2(b)(ii)</U> and <U>2.6(c)</U>), take such other actions as may be reasonably necessary to vest in such other Party such title and such rights as possessed by the transferring Party to
the Assets allocated to such other Party under this Agreement or any of the Ancillary Agreements, free and clear of any Security Interest. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Without limiting the foregoing, in the event that any Party (or member of such Party&#146;s Group) receives or retains any Assets
(including the receipt of payments made pursuant to Contracts and proceeds from accounts receivable with respect to such Asset) or is liable for any Liability that is otherwise allocated to any Person that is a member of the other Group pursuant to
this Agreement or the Ancillary Agreements, such Party agrees to promptly Transfer, or cause to be Transferred such Asset or Liability to the other Party so entitled thereto (or member of such other Party&#146;s Group as designated by such other
Party) at such other Party&#146;s expense. Prior to any such Transfer, such Asset or Liability, as the case may be, shall be held in accordance with the provisions of <U>Section</U><U></U><U>&nbsp;2.6</U>. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">28 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) At or prior to the Distribution Time, each of Ligand and OmniAb shall enter into, and/or
(where applicable) shall cause a member or members of their respective Group to enter into, the Ancillary Agreements and any other Contracts reasonably necessary or appropriate in connection with the transactions contemplated hereby and thereby.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) On or prior to the Distribution Time, Ligand and OmniAb in their respective capacities as direct or indirect stockholders of their
respective Subsidiaries, shall each ratify any actions that are reasonably necessary or desirable to be taken by any Subsidiary of Ligand or Subsidiary of OmniAb, as the case may be, to effectuate the transactions contemplated by this Agreement and
the Ancillary Agreements. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.9 <U>Novation of Liabilities; Indemnification</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Each Party, at the request of any member of the other Party&#146;s Group (such other Party, the &#147;<B><I>Other Party</I></B>&#148;),
shall use commercially reasonable efforts (taking into account any applicable restrictions or considerations, in each case relating to the contemplated Tax treatment of the transactions contemplated hereby) to obtain, or to cause to be obtained, any
Consent, Governmental Approval, substitution or amendment required to novate or assign to the fullest extent permitted by applicable Law all obligations under Contracts (other than Shared Contracts, which shall be governed by
<U>Section</U><U></U><U>&nbsp;2.3</U>) and Liabilities (other than with regard to guarantees or Credit Support Instruments, which shall be governed by <U>Section</U><U></U><U>&nbsp;2.10</U>), but solely to the extent that the Parties are jointly or
each severally liable with regard to any such Contracts or Liabilities and such Contracts or Liabilities have been, in whole, but not in part, allocated to the first Party, or, if permitted by applicable Law, to obtain in writing the unconditional
release of the applicable Other Party so that, in any such case, the members of the applicable Group shall be solely responsible for such Contracts or Liabilities; <U>provided</U>, <U>however</U>, that no Party shall be obligated to pay any
consideration therefor to any third party from whom any such Consent, Governmental Approval, substitution or amendment is requested (unless such Party is fully reimbursed by the requesting Party). In addition, with respect to any Action where any
Party hereto is a defendant, when and if requested by such Party, the Other Party at its own cost will use commercially reasonable efforts to remove the requesting Party as a defendant to the extent that such Action relates solely to Assets or
Liabilities that the Other Party (or any member of such requesting Party&#146;s Group) has been allocated pursuant to this <U>Article</U><U></U><U>&nbsp;II</U>, and the Other Party will cooperate and assist in any required communication with any
plaintiff or other related third party. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) If the Parties are unable to obtain, or to cause to be obtained, any such required Consent,
Governmental Approval, release, substitution or amendment referenced in <U>Section</U><U></U><U>&nbsp;2.9(a)</U>, the Other Party or a member of such Other Party&#146;s Group shall continue to be bound by such Contract, license or other obligation
that does not constitute a Liability of such Other Party and, unless not permitted by Law or the terms thereof, as agent or subcontractor for such Party, the Party or member of such Party&#146;s Group who Assumed or retained such Liability as set
forth in this Agreement (the &#147;<B><I>Liable Party</I></B>&#148;) shall, or shall cause a member of its Group to, pay, perform and discharge fully all the obligations or other Liabilities of such Other Party or member of such Other Party&#146;s
Group thereunder from and after the Distribution Time. For the avoidance of doubt, in furtherance of the foregoing, the Liable Party or a member of such Liable Party&#146;s Group, as agent or subcontractor of the Other Party or a member of such
Other Party&#146;s </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">29 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Group, to the extent reasonably necessary to pay, perform and discharge fully any Liabilities, or retain the benefits (including pursuant to <U>Section</U><U></U><U>&nbsp;2.6)</U> associated with
such Contract or license, is hereby granted the right to, among other things, (i)&nbsp;prepare, execute and submit invoices under such Contract or license in the name of the Other Party (or the applicable member of such Other Party&#146;s Group),
(ii) send correspondence relating to matters under such Contract or license in the name of the Other Party (or the applicable member of such Other Party&#146;s Group), (iii) file Actions in the name of the Other Party (or the applicable member of
such Other Party&#146;s Group) in connection with such Contract or license and (iv)&nbsp;otherwise exercise all rights in respect of such Contract or license in the name of the Other Party (or the applicable member of such Other Party&#146;s Group);
provided that (y)&nbsp;such actions shall be taken in the name of the Other Party (or the applicable member of such Other Party&#146;s Group) only to the extent reasonably necessary or advisable in connection with the foregoing and (z)&nbsp;to the
extent that there shall be a conflict between the provisions of this <U>Section</U><U></U><U>&nbsp;2.9(b)</U> and the provisions of any more specific arrangement between a member of such Liable Party&#146;s Group and a member of such Other
Party&#146;s Group, such more specific arrangement shall control. The Liable Party shall indemnify each Other Party and hold each of them harmless against any Liabilities (other than Liabilities of such Other Party) arising in connection therewith;
<U>provided</U>, that the Liable Party shall have no obligation to indemnify the Other Party with respect to any matter to the extent that such Liabilities arise from such Other Party&#146;s willful breach, knowing violation of Law, fraud,
misrepresentation or gross negligence in connection therewith, in which case such Other Party shall be responsible for such Liabilities; it being understood that any exercise of rights under this Agreement by such Other Party shall not be deemed to
be willful breach, knowing violation of Law, fraud, misrepresentation or gross negligence. The Other Party shall, without further consideration, promptly pay and remit, or cause to be promptly paid or remitted, to the Liable Party or, at the
direction of the Liable Party, to another member of the Liable Party&#146;s Group, all money, rights and other consideration received by it or any member of its Group in respect of such performance by the Liable Party (unless any such consideration
is an Asset of such Other Party pursuant to this Agreement). If and when any such Consent, Governmental Approval, release, substitution or amendment shall be obtained or such agreement, lease, license or other rights or obligations shall otherwise
become assignable or able to be novated, the Other Party shall, to the fullest extent permitted by applicable Law, promptly Transfer or cause the Transfer of all rights, obligations and other Liabilities thereunder of such Other Party or any member
of such Other Party&#146;s Group to the Liable Party or to another member of the Liable Party&#146;s Group without payment of any further consideration and the Liable Party, or another member of such Liable Party&#146;s Group, without the payment of
any further consideration, shall Assume such rights and Liabilities to the fullest extent permitted by applicable Law. Each of the applicable Parties shall, and shall cause their respective Subsidiaries to, take all actions and do all things
reasonably necessary on its part, or such Subsidiaries&#146; part, under applicable Law or contractual obligations to consummate and make effective the transactions contemplated by this <U>Section</U><U></U><U>&nbsp;2.9</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.10 <U>Guarantees; Credit Support Instruments</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Except as otherwise specified in any Ancillary Agreement, at or prior to the Distribution Time or as soon as practicable thereafter,
(i)&nbsp;Ligand shall (with the reasonable cooperation of the applicable member of the OmniAb Group) use its commercially reasonable efforts to have each member of the OmniAb Group removed as guarantor of or obligor for any Ligand Retained Liability
to the fullest extent permitted by applicable Law, including in respect </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">30 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
of those guarantees set forth on <U>Schedule</U><U></U><U>&nbsp;2.10(a)(i)</U>, to the extent that they relate to Ligand Retained Liabilities and (ii)&nbsp;OmniAb shall (with the reasonable
cooperation of the applicable member of the Ligand Group) use commercially reasonable efforts to have each member of the Ligand Group removed as guarantor of or obligor for any OmniAb Liability, to the fullest extent permitted by applicable Law,
including in respect of those guarantees set forth on <U>Schedule</U><U></U><U>&nbsp;2.10(a)(ii)</U>, to the extent that they relate to OmniAb Liabilities. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) At or prior to the Distribution Time, to the extent required to obtain a release from a guaranty: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) of any member of the Ligand Group, OmniAb shall execute a guaranty agreement substantially in the form of the existing
guaranty or such other form as is agreed to by the relevant parties to such guaranty agreement, except to the extent that such existing guaranty contains representations, covenants or other terms or provisions either (A)&nbsp;with which OmniAb would
be reasonably unable to comply or (B)&nbsp;which would be reasonably expected to be breached; and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) of any member of
the OmniAb Group, Ligand shall execute a guaranty agreement substantially in the form of the existing guaranty or such other form as is agreed to by the relevant parties to such guaranty agreement, except to the extent that such existing guaranty
contains representations, covenants or other terms or provisions either (A)&nbsp;with which Ligand would be reasonably unable to comply or (B)&nbsp;which would be reasonably expected to be breached. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) If Ligand or OmniAb is unable to obtain, or to cause to be obtained, any such required removal as set forth in clauses (a)&nbsp;and (b) of
this <U>Section</U><U></U><U>&nbsp;2.10</U>, (i) Ligand, to the extent a member of the Ligand Group has assumed the underlying Liability with respect to such guaranty or OmniAb, to the extent a member of the OmniAb Group has assumed the underlying
Liability with respect to such guaranty, as the case may be, shall indemnify and hold harmless the guarantor or obligor for any Indemnifiable Loss arising from or relating thereto (in accordance with the provisions of
<U>Article</U><U></U><U>&nbsp;V</U>) and shall or shall cause one of its Subsidiaries, as agent or subcontractor for such guarantor or obligor to pay, perform and discharge fully all the obligations or other Liabilities of such guarantor or obligor
thereunder, (ii)&nbsp;OmniAb shall reimburse the applicable member of the Ligand Group for all <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> expenses incurred by it arising out of or related to any
such guaranty; and (iii)&nbsp;each of Ligand and OmniAb, on behalf of themselves and the members of their respective Groups, agree not to renew or extend the term of, increase its obligations under, or Transfer to a third party, any loan, guaranty,
lease, contract or other obligation for which another Party or member of such Party&#146;s Group is or may be liable without the prior written consent of such other Party, unless all obligations of such other Party and the other members of such
Party&#146;s Group with respect thereto are thereupon terminated by documentation reasonably satisfactory in form and substance to such Party. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) Ligand and OmniAb shall cooperate and OmniAb shall use commercially reasonable efforts to replace all Credit Support Instruments issued by
Ligand or other members of the Ligand Group on behalf of or in favor of any member of the OmniAb Group or the OmniAb Business (the &#147;<B><I>Ligand CSIs</I></B>&#148;) as promptly as practicable with Credit Support Instruments from OmniAb or a
member of the OmniAb Group as of the Distribution Time. With </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">31 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
respect to any Ligand CSIs that remain outstanding after the Distribution Time, (i)&nbsp;OmniAb shall, and shall cause the members of the OmniAb Group to, jointly and severally indemnify and hold
harmless the Ligand Indemnitees for any Liabilities arising from or relating to such Credit Support Instruments, including, without limitation, any fees in connection with the issuance and maintenance thereof and any funds drawn by (or for the
benefit of), or disbursements made to, the beneficiaries of such Ligand CSIs in accordance with the terms thereof, (ii)&nbsp;OmniAb shall reimburse the applicable member of the Ligand Group for all out of pocket expenses incurred by it arising out
of or related to any such Credit Support Instrument, and (iii)&nbsp;without the prior written consent of Ligand, OmniAb shall not, and shall not permit any member of the OmniAb Group to, enter into, renew or extend the term of, increase its
obligations under, or transfer to a third party, any loan, lease, Contract or other obligation in connection with which Ligand or any member of the Ligand Group has issued any Credit Support Instruments which remain outstanding. Neither Ligand nor
any member of the Ligand Group will have any obligation to renew any Credit Support Instruments issued on behalf of or in favor of any member of the OmniAb Group or the OmniAb Business after the expiration of any such Credit Support Instrument. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.11 <U>Disclaimer of Representations and Warranties</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) EACH OF LIGAND (ON BEHALF OF ITSELF AND EACH MEMBER OF THE LIGAND GROUP), OMNIAB (ON BEHALF OF ITSELF AND EACH MEMBER OF THE OMNIAB GROUP)
AND APAC UNDERSTANDS AND AGREES THAT, EXCEPT AS EXPRESSLY SET FORTH HEREIN, IN ANY ANCILLARY AGREEMENT OR IN ANY CONTINUING ARRANGEMENT, NO PARTY TO THIS AGREEMENT, ANY ANCILLARY AGREEMENT OR ANY OTHER AGREEMENT OR DOCUMENT CONTEMPLATED BY THIS
AGREEMENT, ANY ANCILLARY AGREEMENTS OR OTHERWISE, IS REPRESENTING OR WARRANTING IN ANY WAY, AND HEREBY DISCLAIMS ALL REPRESENTATIONS AND WARRANTIES, AS TO THE ASSETS, BUSINESSES OR LIABILITIES CONTRIBUTED, TRANSFERRED OR ASSUMED AS CONTEMPLATED
HEREBY OR THEREBY, AS TO ANY CONSENTS OR GOVERNMENTAL APPROVALS REQUIRED IN CONNECTION HEREWITH OR THEREWITH, AS TO THE VALUE OR FREEDOM FROM ANY SECURITY INTERESTS OF, AS TO NONINFRINGEMENT, VALIDITY OR ENFORCEABILITY OR ANY OTHER MATTER
CONCERNING, ANY ASSETS OR BUSINESS OF SUCH PARTY, OR AS TO THE ABSENCE OF ANY DEFENSES OR RIGHT OF SETOFF OR FREEDOM FROM COUNTERCLAIM WITH RESPECT TO ANY ACTION OR OTHER ASSET, INCLUDING ACCOUNTS RECEIVABLE, OF ANY PARTY, OR AS TO THE LEGAL
SUFFICIENCY OF ANY CONTRIBUTION, ASSIGNMENT, DOCUMENT, CERTIFICATE OR INSTRUMENT DELIVERED HEREUNDER TO CONVEY TITLE TO ANY ASSET OR THING OF VALUE UPON THE EXECUTION, DELIVERY AND FILING HEREOF OR THEREOF. FOR THE AVOIDANCE OF DOUBT, THIS
<U>SECTION 2.11</U> SHALL HAVE NO EFFECT ON ANY REPRESENTATION OR WARRANTY MADE HEREIN, IN THE MERGER AGREEMENT OR IN ANY ANCILLARY AGREEMENT OR ANY OTHER AGREEMENT OR DOCUMENT CONTEMPLATED BY THIS AGREEMENT, THE MERGER AGREEMENT OR ANY ANCILLARY
AGREEMENT. EXCEPT AS MAY EXPRESSLY BE SET FORTH HEREIN OR THEREIN, ALL SUCH ASSETS ARE BEING TRANSFERRED ON AN &#147;<U>AS IS, WHERE IS</U>&#148; BASIS (AND, IN THE CASE OF ANY REAL PROPERTY, BY MEANS OF A
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">32 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
QUITCLAIM OR SIMILAR FORM DEED OR CONVEYANCE) AND THE RESPECTIVE TRANSFEREES SHALL BEAR THE ECONOMIC AND LEGAL RISKS THAT (I)&nbsp;ANY CONVEYANCE SHALL PROVE TO BE INSUFFICIENT TO VEST IN THE
TRANSFEREE GOOD TITLE, FREE AND CLEAR OF ANY SECURITY INTEREST AND (II)&nbsp;ANY NECESSARY CONSENTS OR GOVERNMENTAL APPROVALS ARE NOT OBTAINED OR THAT ANY REQUIREMENTS OF LAWS OR JUDGMENTS ARE NOT COMPLIED WITH. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Each of Ligand (on behalf of itself and each member of the Ligand Group), OmniAb (on behalf of itself and each member of the OmniAb Group)
and APAC further understands and agrees that if the disclaimer of express or implied representations and warranties contained in <U>Section</U><U></U><U>&nbsp;2.11(a)</U> is held unenforceable or is unavailable for any reason under the Laws of any
jurisdiction outside the United States or if, under the Laws of a jurisdiction outside the United States, both Ligand or any member of the Ligand Group, on the one hand, and OmniAb or any member of the OmniAb Group, on the other hand, are jointly or
severally liable for any Ligand Retained Liability or any OmniAb Liability, respectively, then, the Parties and APAC intend that, notwithstanding any provision to the contrary under the Laws of such foreign jurisdictions, the provisions of this
Agreement, the Merger Agreement and the Ancillary Agreements (including the disclaimer of all representations and warranties (except as otherwise provided in any such agreements), allocation of Liabilities among the Parties and their respective
Subsidiaries, releases, indemnification and contribution of Liabilities) shall prevail for any and all purposes among the Parties and APAC and their respective Subsidiaries. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) OmniAb hereby waives compliance by Ligand and each and every member of the Ligand Group with the requirements and provisions of any
&#147;bulk-sale&#148; or &#147;bulk transfer&#148; Laws of any jurisdiction that may otherwise be applicable with respect to the transfer or sale of any or all of the OmniAb Assets to OmniAb or any member of the OmniAb Group. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.12 <U>Cash Management; Consideration</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Except as provided in this <U>Section</U><U></U><U>&nbsp;2.12</U>, all cash and Cash Equivalents held by any member of the OmniAb Group as
of the Distribution Time shall be an OmniAb Asset and all cash and Cash Equivalents held by any member of the Ligand Group as of the Distribution Time shall be a Ligand Retained Asset. To the extent that following the Distribution Time any Cash
Equivalents are required to be transferred from any member of the Ligand Group to any member of the OmniAb Group or from any member of the OmniAb Group to any member of the Ligand Group to make effective the Internal Reorganization or the
Contribution pursuant to this Agreement and the Ancillary Agreements (including if required by Law or regulation to effect the foregoing), the Party receiving such Cash Equivalents shall promptly transfer an amount in cash equal to such transferred
Cash Equivalents back to the transferring Party so as not to override the allocations of Assets, Liabilities and expenses related to the Internal Reorganization and the Contribution contemplated by this Agreement and the Ancillary Agreements. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">33 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) In exchange for the Contribution, OmniAb agrees, on or prior to the Distribution Date,
to issue to Ligand a number of newly issued, fully paid and nonassessable shares of OmniAb Stock as is necessary to effect the Distribution and such that immediately following the Distribution Ligand will hold none of the outstanding shares of
OmniAb Stock. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Notwithstanding anything to the contrary in this Agreement, the Merger Agreement or any Ancillary Document, and except
as otherwise provided in Section&nbsp;9.5 (relating to Reimbursable Transaction-related Expenses) or the Tax Matters Agreement (relating to Taxes), (i) Ligand shall have all rights to and shall retain all payments received or accrued by it, any
member of the Ligand Group or any member of the OmniAb Group at any time up to and until the Distribution Time relating to current accounts receivable of any member of the OmniAb Group (such current accounts receivable being included in Ligand
Retained Assets), and (ii)&nbsp;Ligand shall pay all costs and expenses relating to current accounts payable and current accrued liabilities of any member of the OmniAb Group that are outstanding or accrued at any time up to and until the
Distribution Time (such current accounts payable and current accrued liabilities being included in Ligand Retained Liabilities). For illustrative purposes only, an example showing such current accounts receivable, accounts payable and accrued
liabilities being retained by Ligand is attached to this Agreement as <U>Exhibit B</U>. Notwithstanding the foregoing and anything to the contrary in this Agreement, the Merger Agreement or any Ancillary Document, the cash portion of the
Contribution to be made by Ligand in connection with the Separation shall be (i)&nbsp;increased by any amounts received by any member of the Ligand Group or the OmniAb Group that is actually retained by any member of the Ligand Group in respect of a
Commercial Milestone Event (as defined in that certain Platform License Agreement, by and between Open Monoclonal Technologies Inc. and CNA Development LLC, dated as of October&nbsp;4, 2013) (the &#147;<B><I>Specific Milestone
Payments</I></B>&#148;) (such amounts being included in OmniAb Assets) and (ii)&nbsp;decreased by those certain costs and expenses relating solely to the OmniAb Business paid by Ligand through and including the Distribution Date that are set forth
on Schedule 2.12(c) (the &#147;<B><I>Other Reimbursable Expenses</I></B>&#148;) (such costs and expenses being included in OmniAb Liabilities). </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE III </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>COMPLETION OF THE DISTRIBUTION </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.1 <U>Actions Prior to the Distribution</U>. Prior to the Distribution Time, subject to the terms and conditions set forth
herein, the Parties shall take, or cause to be taken, the following actions in connection with the Distribution:<SUP STYLE="font-size:85%; vertical-align:top"> </SUP> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <U>Notice to Nasdaq</U>. Ligand shall give Nasdaq not less than ten (10)&nbsp;days&#146; advance notice of the Record Date in compliance
with Rule <FONT STYLE="white-space:nowrap">10b-17</FONT> under the Exchange Act. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <U>Securities Law Matters</U>. OmniAb shall file with
the Commission any amendments or supplements to the Form 10 as may be necessary or advisable in order to cause the Form 10 to become and remain effective as required by the Commission or federal, state or other applicable securities Laws. Ligand and
OmniAb shall take all such action as may be necessary or advisable under the securities or &#147;blue sky&#148; Laws of the United States (and any comparable Laws under any <FONT STYLE="white-space:nowrap">non-U.S.</FONT> jurisdiction) in connection
with the transactions contemplated by this Agreement, the Merger Agreement and the Ancillary Agreements. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">34 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) <U>Authorized Number of Shares</U>. Prior to the Distribution, the Parties shall take
all necessary action required to file an amendment to the Certificate of Incorporation of OmniAb with the Secretary of State of the State of Delaware to increase the number of authorized shares of OmniAb Stock so that OmniAb Stock then authorized
shall be equal to the number of shares of OmniAb Stock necessary to effect the Distribution. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) <U>Availability of Information</U>.
Ligand shall, as soon as is reasonably practicable after the Form 10 is declared effective under the Exchange Act and the Ligand Board has approved the Distribution, cause the Information Statement to be mailed to the Record Holders or, in
connection with the delivery of a notice of Internet availability of the Information Statement to such holders, posted on the Internet. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) <U>The Distribution Agent</U>. Ligand shall enter into a distribution agent agreement with the Agent or otherwise provide instructions to
the Agent regarding the Distribution. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) <U>Officers and Directors</U>. At or prior to the Distribution Time, the Parties shall take all
necessary action so that, as of the Distribution Time, the executive officers and directors of OmniAb will be as set forth in the Information Statement. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) <U>Satisfying Conditions to the Distribution</U>. Each of Ligand, OmniAb and APAC shall cooperate to cause the conditions to the
Distribution set forth in <U>Section</U><U></U><U>&nbsp;3.3</U> to be satisfied and to effect the Distribution at the Distribution Time. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h) <U>Resignations and Removals</U>. On or prior to the Distribution Date or as soon thereafter as practicable, (i)&nbsp;Ligand shall cause
all its employees and any employees of its Subsidiaries (excluding any employees of any member of the OmniAb Group) to resign or be removed, effective as of the Distribution Time, from all positions as officers or directors of any member of the
OmniAb Group in which they serve, and (ii)&nbsp;OmniAb shall cause all its employees and any employees of its Subsidiaries to resign, effective as of the Distribution Time, from all positions as officers or directors of any members of the Ligand
Group in which they serve. Notwithstanding the foregoing, no Person shall be required by any Party to resign from any position or office with another Party if such Person is disclosed in the Form 10 as a Person who is to hold such position or office
following the Distribution. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) <U>Contribution</U>. On or prior to the Distribution Date, the Contribution shall have been made. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.2 <U>Effecting the Distribution</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <U>Delivery of OmniAb Stock</U>. Upon consummation of the Distribution, Ligand shall deliver to the Agent, a book-entry authorization
representing the OmniAb Stock being distributed in the Distribution for the account of the Record Holders and shall take all such other actions (including delivering any other instruments of transfer required by applicable law) as may be necessary
to effect the Distribution. The Agent shall hold such book-entry shares for the account of the Record Holders pending the Merger, as provided in Section&nbsp;3.2 of the Merger Agreement. Immediately after the Distribution Time and prior to the
Effective Time, the shares of OmniAb Stock shall not be transferable and the transfer agent for the OmniAb Stock shall not </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">35 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
transfer any shares of OmniAb Stock; <U>provided</U>, for the avoidance of doubt, that the exchange of such shares of OmniAb Stock for shares of Domesticated Parent Common Stock pursuant to the
Merger shall not be deemed a transfer subject to the foregoing restrictions. The Distribution shall be deemed to be effective at the Distribution Time upon written authorization from Ligand to the Agent to proceed with the Distribution. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.3 <U>Conditions to the Distribution</U>. The consummation of the Distribution shall be subject to the satisfaction or waiver by
Ligand in its sole and absolute discretion, of the following conditions (other than the condition set forth in <U>Section</U><U></U><U>&nbsp;3.3(a)</U>, which prior to the termination of the Merger Agreement may not be waived without APAC&#146;s
written consent, which consent shall not be unreasonably withheld, conditioned or delayed): </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <U>Completion of the Separation</U>. The
Separation shall have been completed substantially in accordance with the Reorganization Plan, other than any Transfers and Assumptions or other actions that may occur after the Distribution Time in accordance with the terms of this Agreement. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <U>Execution of Ancillary Agreements</U>. Each of the Ancillary Agreements shall have been duly executed and delivered by the parties
thereto. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) <U>Conditions to Ligand Obligations in Merger Agreement</U>. Each of the conditions in Section&nbsp;8.1 (other than
Section&nbsp;8.1(b)) and Section&nbsp;8.2 of the Merger Agreement to Ligand&#146;s obligations to consummate the Merger shall have been satisfied or waived (other than those conditions that by their nature are to be satisfied contemporaneously with
the Distribution and/or the Merger; <U>provided</U>, that such conditions are capable of being satisfied at such time). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d)
<U>Confirmation of Satisfaction of APAC Conditions in Merger Agreement</U>. APAC shall have irrevocably confirmed to Ligand that each condition in Section&nbsp;8.1 (other than Section&nbsp;8.1(b)) and Section&nbsp;8.3 of the Merger Agreement to
APAC&#146;s obligations to consummate the Merger (i)&nbsp;has been satisfied, (ii)&nbsp;will be satisfied at the time of the Distribution, or (iii)&nbsp;subject to applicable Law, is or has been waived by APAC. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE IV </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>CERTAIN
COVENANTS </U></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.1 <U>Cooperation</U>. From and after the Distribution Time, and subject to the terms of and limitations
contained in this Agreement and the Ancillary Agreements, each Party shall, and shall cause each of its respective Affiliates and employees to, (i)&nbsp;provide reasonable cooperation and assistance to the other Party (and any member of its
respective Group) in connection with the completion of the transactions contemplated herein and in each Ancillary Agreement, (ii)&nbsp;reasonably assist the other Party in the orderly and efficient transition in becoming a separate company to the
extent set forth in the Transition Services Agreements or as otherwise set forth herein (including, but not limited to, complying with <U>Articles V</U>, <U>VI</U> and <U>VIII</U>) and (iii)&nbsp;reasonably assist the other Party to the extent such
Party is providing or has provided services, as applicable, pursuant to the Transition Services Agreements in connection with requests for information from, audits or other examinations of, such other Party by a Governmental Entity; in each case,
except as otherwise set forth in this Agreement or may </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">36 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
otherwise be agreed to by the Parties in writing, at no additional cost to the Party requesting such assistance other than for the actual <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> costs (which shall not include the costs of salaries and benefits of employees of such Party or any pro rata portion of overhead or other costs of employing such employees which would have been
incurred by such employees&#146; employer regardless of the employees&#146; service with respect to the foregoing) incurred by any such Party, if applicable. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.2 <U>Retained Names</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) No later than ninety (90)&nbsp;days following the Distribution Date, OmniAb shall, and shall cause the members of the OmniAb Group, to
change their respective names and cause their certificates of incorporation and bylaws (or equivalent organizational documents), as applicable, to be amended to remove the Ligand Retained Names. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Subject to <U>Section</U><U></U><U>&nbsp;4.2(c),</U> following the Distribution Date, unless otherwise directed by Ligand in writing,
OmniAb shall, and shall cause the members of the OmniAb Group to, as soon as reasonably practicable, but in no event later than six (6)&nbsp;months following the Distribution Date, cease to make any use of any Ligand Retained Names. In furtherance
thereof, as soon as reasonably practicable but in no event later than six (6)&nbsp;months following the Distribution Date, OmniAb shall, and shall cause the members of the OmniAb Group, to remove, strike over, or otherwise obliterate all Ligand
Retained Names from all assets and other materials owned by or in the possession of any member of the OmniAb Group, including any vehicles, business cards, schedules, stationery, packaging materials, displays, signs, promotional materials, manuals,
forms, websites, email, Software and other materials and systems. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Notwithstanding anything to the contrary in this
<U>Section</U><U></U><U>&nbsp;4.2</U>, no member of the OmniAb Group shall (i)&nbsp;be obligated to cease using or displaying any of the Ligand Retained Names on any <FONT STYLE="white-space:nowrap">(A)&nbsp;non-public-facing,</FONT> <FONT
STYLE="white-space:nowrap">non-customer</FONT> facing and <FONT STYLE="white-space:nowrap">non-vendor</FONT> facing documents or materials or (B)&nbsp;executed copies of any Contract, in each case of (A)&nbsp;and (B), in existence, used or
disseminated as of the Distribution Date which bear any of the Ligand Retained Names, or (ii)&nbsp;be in breach of this <U>Section</U><U></U><U>&nbsp;4.2</U> if, after the Distribution Date, it (x)&nbsp;uses any of the Ligand Retained Names in a
nominative manner in textual sentences referencing the historical relationship between Ligand and the Ligand Group, on the one hand, and the OmniAb Group, on the other hand, which references are factually accurate and reasonably necessary to
describe such historical relationship, (y)&nbsp;retains any copies of any books, records or other materials that, as of the Distribution Date, contain or display any of the Ligand Retained Names and such copies are used solely for internal or
archival purposes (and not public display) or (z)&nbsp;uses any of the Ligand Retained Names to comply with applicable Laws or stock exchange regulations or for litigation, regulatory or corporate filings and documents filed by a member of the
OmniAb Group or any of its Affiliates with any Governmental Entity. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) Ligand hereby grants to the OmniAb Group a <FONT
STYLE="white-space:nowrap">non-exclusive,</FONT> royalty-free, <FONT STYLE="white-space:nowrap">non-transferable,</FONT> license to use and display the Ligand Retained Names for the periods set forth in this <U>Section</U><U></U><U>&nbsp;4.2</U> as
permitted by this <U>Section</U><U></U><U>&nbsp;4.2</U> in connection with the transactions contemplated herein. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">37 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) Any and all use of the Ligand Retained Names by the OmniAb Group and the goodwill
afforded thereby shall inure to the sole benefit of Ligand. Any use by the members of the OmniAb Group of any of the Ligand Retained Names as permitted in this <U>Section</U><U></U><U>&nbsp;4.2</U> is subject to their use of the Ligand Retained
Names in a form and manner, and with standards of quality, of that in effect for the Ligand Retained Names as of the Distribution Date. OmniAb and the other members of the OmniAb Group shall not use the Ligand Retained Names in a manner that
reflects negatively on the Ligand Retained Names or on Ligand or any member of the Ligand Group. Upon expiration or termination of the rights granted to the OmniAb Group pursuant to this Section&nbsp;4.2, OmniAb hereby assigns, and shall cause the
other members of the OmniAb Group to assign, to Ligand their respective rights (if any) to any Trademarks forming a part of the Ligand Retained Names. Ligand shall have the right to terminate the foregoing license, effective immediately, if any
member of the OmniAb Group fails to comply with the foregoing terms and conditions in this Section&nbsp;4.2 in any material respect or otherwise fails to comply with any reasonable written direction of Ligand in relation to any member of the OmniAb
Group&#146;s use of the Ligand Retained Names, and, in each case, such member of the OmniAb Group has not cured such failure within thirty (30)&nbsp;days after such member of the OmniAb Group&#146;s receipt of written notice from Ligand of such
failure. OmniAb shall indemnify, defend and hold harmless Ligand and the members of the Ligand Group from and against any and all Indemnifiable Losses arising from or relating to the use by any member of the OmniAb Group of the Ligand Retained Names
pursuant to this <U>Section</U><U></U><U>&nbsp;4.2</U>. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) Each of the Parties acknowledges and agrees that the remedy at Law for any
breach of the requirements of this <U>Section</U><U></U><U>&nbsp;4.2</U> would be inadequate and agrees and consents that without intending to limit any additional remedies that may be available, Ligand and the members of the Ligand Group shall be
entitled to a temporary or permanent injunction, without proof of actual damage or inadequacy of legal remedy, and without posting any bond or other undertaking, in any Action which may be brought to enforce any of the provisions of this
<U>Section</U><U></U><U>&nbsp;4.2</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.3 <U>Ligand Limited License</U><U> Grant</U>. Solely to the extent that any Patents
or <FONT STYLE="white-space:nowrap">Know-How</FONT> owned by any member of the Ligand Group are used, practiced or otherwise exploited in the OmniAb Business immediately prior to the Distribution Time, Ligand hereby grants, on behalf of itself and
each member of the Ligand Group, to each member of the OmniAb Group, a royalty-free, fully <FONT STYLE="white-space:nowrap">paid-up,</FONT> perpetual, irrevocable, <FONT STYLE="white-space:nowrap">non-sublicensable</FONT> (except to subcontractors),
<FONT STYLE="white-space:nowrap">non-transferable</FONT> (except in connection with the transfer of all or substantially all of (i)&nbsp;the assets of the OmniAb Business or (ii)&nbsp;the capital stock of OmniAb), worldwide, <FONT
STYLE="white-space:nowrap">non-exclusive</FONT> license in, to and under such Patents or <FONT STYLE="white-space:nowrap">Know-How</FONT> to use, practice and otherwise exploit such Patents and <FONT STYLE="white-space:nowrap">Know-How</FONT> solely
in or for the conduct of the OmniAb Business as conducted on or prior to the Distribution Time (and natural evolutions thereof). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.4 <U>No Restriction on Competition</U>. It is the explicit intent of each of the Parties that the provisions of this Agreement
shall not include any <FONT STYLE="white-space:nowrap">non-competition</FONT> or other similar restrictive arrangements with respect to the range of business activities which may be conducted by the Parties. Accordingly, each of the Parties
acknowledges and agrees that nothing set forth in this Agreement shall be construed to create any explicit or implied restriction or other limitation on (i)&nbsp;the ability of any party hereto to engage in any business or other activity which
competes with the business of any other Party hereto or (ii)&nbsp;the ability of any party to engage in any specific line of business or engage in any business activity in any specific geographic area. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">38 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE V </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>INDEMNIFICATION </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.1 <U>Release of <FONT STYLE="white-space:nowrap">Pre-Distribution</FONT> Claims</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Except (i)&nbsp;as provided in <U>Section</U><U></U><U>&nbsp;5.1(b)</U>, (ii) as may be otherwise expressly provided in this Agreement or
in any Ancillary Agreement and (iii)&nbsp;for any matter for which any Party is entitled to indemnification pursuant to this <U>Article</U><U></U><U>&nbsp;V</U>: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) Ligand, for itself and each member of the Ligand Group, its Affiliates as of the Distribution Time and, to the extent
permitted by Law, all Persons who at any time prior to the Distribution Time were directors, officers, agents or employees of any member of the Ligand Group (in their respective capacities as such), in each case, together with their respective
heirs, executors, administrators, successors and assigns, does hereby remise, release and forever discharge OmniAb and the other members of the OmniAb Group, its Affiliates and all Persons who at any time prior to the Distribution Time were
stockholders, directors, officers, agents or employees of any member of the OmniAb Group (in their respective capacities as such), in each case, together with their respective heirs, executors, administrators, successors and assigns, from any and
all Ligand Retained Liabilities, whether at Law or in equity (including any right of contribution), whether arising under any Contract, by operation of Law or otherwise, in each case, existing or arising from any acts or events occurring or failing
to occur or alleged to have occurred or to have failed to occur or any conditions existing or alleged to have existed at or before the Distribution Time, including in connection with the Internal Reorganization, the Separation, the Distribution, the
Merger and any of the other transactions contemplated hereunder and under the Merger Agreement and the Ancillary Agreements (such liabilities, the &#147;<B><I>Ligand Released Liabilities</I></B>&#148;) and in any event shall not, and shall cause its
respective Subsidiaries not to, bring any Action against any member of the OmniAb Groups in respect of any Ligand Released Liabilities; <U>provided</U>, <U>however</U>, that nothing in this <U>Section</U><U></U><U>&nbsp;5.1(a)(i)</U> shall relieve
any Person released in this <U>Section</U><U></U><U>&nbsp;5.1(a)(i)</U> who, after the Distribution Time, is a director, officer or employee of any member of the OmniAb Group and is no longer a director, officer or employee of any member of the
Ligand Group from Liabilities arising out of, relating to or resulting from his or her service as a director, officer or employee of any member of the OmniAb Group after the Distribution Time. Notwithstanding the foregoing, nothing in this Agreement
shall be deemed to limit Ligand, any member of the Ligand Group, or their respective Affiliates from commencing any Actions against any OmniAb officer, director, agent or employee, or their respective heirs, executors, administrators, successors and
assigns with regard to matters arising from, or relating to, (i)&nbsp;theft of Ligand Trade Secrets or (ii)&nbsp;intentional criminal acts by any such officers, directors, agents or employees. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">39 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) OmniAb, for itself and each member of the OmniAb Group, its Affiliates
as of the Distribution Time and, to the extent permitted by Law, all Persons who at any time prior to the Distribution Time were directors, officers, agents or employees of any member of the OmniAb Group (in their respective capacities as such), in
each case, together with their respective heirs, executors, administrators, successors and assigns, does hereby remise, release and forever discharge Ligand and the other members of the Ligand Group, its Affiliates and all Persons who at any time
prior to the Distribution Time were stockholders, directors, officers, agents or employees of any member of the Ligand Group (in their respective capacities as such), in each case, together with their respective heirs, executors, administrators,
successors and assigns, from any and all OmniAb Liabilities, whether at Law or in equity (including any right of contribution), whether arising under any Contract, by operation of Law or otherwise, in each case, existing or arising from any acts or
events occurring or failing to occur or alleged to have occurred or to have failed to occur or any conditions existing or alleged to have existed at or before the Distribution Time, including in connection with the Internal Reorganization, the
Separation, the Distribution, the Merger and any of the other transactions contemplated hereunder and under the Merger Agreement and the Ancillary Agreements (such liabilities, the &#147;<B><I>OmniAb Released Liabilities</I></B>&#148;) and in any
event shall not, and shall cause its respective Subsidiaries not to, bring any Action against any member of the Ligand Group in respect of any OmniAb Released Liabilities; <U>provided</U>, <U>however</U> that for purposes of this
<U>Section</U><U></U><U>&nbsp;5.1(a)(ii)</U>, the members of the OmniAb Group shall also release and discharge any officers or other employees of any member of the Ligand Group, to the extent any such officers or employees served as a director or
officer of any members of the OmniAb Group prior to the Distribution Time, from any and all Liability, obligation or responsibility for any and all past actions or failures to take action, in each case in their capacity as a director or officer of
any such member of the OmniAb Group, prior to the Distribution Time, including actions or failures to take action that may be deemed to have been negligent or grossly negligent. Notwithstanding the foregoing, nothing in this Agreement shall be
deemed to limit OmniAb, any member of the OmniAb Group, or their respective Affiliates from commencing any Actions against any Ligand officer, director, agent or employee, or their respective heirs, executors, administrators, successors and assigns
with regard to matters arising from, or relating to, (i)&nbsp;theft of OmniAb Trade Secrets or (ii)&nbsp;intentional criminal acts by any such officers, directors, agents or employees. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iii) APAC, for itself and each of its Affiliates as of the Distribution Time and, to the extent permitted by Law, all Persons
who at any time prior to the Distribution Time were directors, officers, agents or employees of APAC or any of its Affiliates (in their respective capacities as such), in each case, together with their respective heirs, executors, administrators,
successors and assigns, does hereby remise, release and forever discharge Ligand and the other members of the Ligand Group, its Affiliates and all Persons who at any time prior to the Distribution Time were stockholders, directors, officers, agents
or employees of any member of the Ligand Group (in their respective capacities as such), in each case, together with their respective heirs, executors, administrators, successors and assigns, from any and all OmniAb Liabilities, whether at Law or in
equity (including any right of contribution), whether arising under any Contract, by operation of Law or otherwise, in each case, existing or arising from any acts or events occurring or failing to occur or alleged to have occurred or to have failed
to occur or any conditions existing or alleged to have existed at or before </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">40 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
the Distribution Time, including in connection with the Internal Reorganization, the Separation, the Distribution, the Merger and any of the other transactions contemplated hereunder and under
the Merger Agreement and the Ancillary Agreements (such liabilities, the &#147;<B><I>APAC Released Liabilities</I></B>&#148;) and in any event shall not, and shall cause its respective Subsidiaries not to, bring any Action against any member of the
Ligand Group in respect of any APAC Released Liabilities; <U>provided</U>, <U>however</U> that for purposes of this <U>Section</U><U></U><U>&nbsp;5.1(a)(iii)</U>, APAC and each of its Affiliates shall also release and discharge any officers or other
employees of any member of the Ligand Group, to the extent any such officers or employees served as a director or officer of any members of the OmniAb Group prior to the Distribution Time, from any and all Liability, obligation or responsibility for
any and all past actions or failures to take action, in each case in their capacity as a director or officer of any such member of the OmniAb Group, prior to the Distribution Time, including actions or failures to take action that may be deemed to
have been negligent or grossly negligent. Notwithstanding the foregoing, nothing in this Agreement shall be deemed to limit APAC or any of its Affiliates from commencing any Actions against any Ligand officer, director, agent or employee, or their
respective heirs, executors, administrators, successors and assigns with regard to matters arising from, or relating to, (i)&nbsp;theft of OmniAb Trade Secrets or (ii)&nbsp;intentional criminal acts by any such officers, directors, agents or
employees. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Nothing contained in this Agreement, including <U>Section</U><U></U><U>&nbsp;5.1(a)</U> or
<U>Section</U><U></U><U>&nbsp;2.5</U>, shall impair or otherwise affect any right of any Party or APAC and, as applicable, a member of such Party&#146;s Group or any of its Affiliates, as well as their respective heirs, executors, administrators,
successors and assigns, to enforce this Agreement, the Merger Agreement any Ancillary Agreement or any agreements, arrangements, commitments or understandings contemplated in this Agreement, the Merger Agreement or in any Ancillary Agreement to
continue in effect after the Distribution Time. In addition, nothing contained in <U>Section</U><U></U><U>&nbsp;5.1(a)</U> shall release any person from: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) any Liability Assumed, Transferred or allocated to a Party or a member of such Party&#146;s Group pursuant to or as
contemplated by, or any other Liability of any member of such Group under, this Agreement or any Ancillary Agreement, including (A)&nbsp;with respect to Ligand, any Ligand Retained Liability and (B)&nbsp;with respect to OmniAb, any OmniAb Liability;
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) any Liability provided for in or resulting from any other Contract or arrangement that is entered into after the
Distribution Time between any Party (and/or a member of such Party&#146;s or Parties&#146; Group), on the one hand, and any other Party or Parties (and/or a member of such Party&#146;s or Parties&#146; Group), on the other hand; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iii) any Liability with respect to any Continuing Arrangements; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iv) any Liability that the Parties may have with respect to indemnification pursuant to this Agreement or otherwise for
Actions brought against the Parties by third Persons, which Liability shall be governed by the provisions of this Agreement and, in particular, this <U>Article</U><U></U><U>&nbsp;V</U> and, if applicable, the appropriate provisions of the Ancillary
Agreements; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">41 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(v) the obligations of Ligand, OmniAb, APAC or the other parties to the
Merger Agreement to consummate the Merger and the other transactions expressly contemplated to occur at the Closing, subject to the terms and conditions of the Merger Agreement; and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(vi) any Liability the release of which would result in a release of any Person other than the Persons released in
<U>Section</U><U></U><U>&nbsp;5.1(a)</U>; <U>provided</U> that the Parties and APAC agree not to bring any Action or permit any other member of their respective Group or any of their Affiliates to bring any Action against a Person released in
<U>Section</U><U></U><U>&nbsp;5.1(a)</U> with respect to such Liability. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition, nothing contained in <U>Section</U><U></U><U>&nbsp;5.1(a)</U> shall
release: (i)&nbsp;Ligand from indemnifying any director, officer or employee of the OmniAb Group who was a director, officer or employee of Ligand or any of its Affiliates prior to the Distribution Time, as the case may be, to the extent such
director, officer or employee is or becomes a named defendant in any Action with respect to which he or she was entitled to such indemnification pursuant to then-existing obligations; it being understood that if the underlying obligation giving rise
to such Action is an OmniAb Liability, OmniAb shall indemnify Ligand for such Liability (including Ligand&#146;s costs to indemnify the director, officer or employee) in accordance with the provisions set forth in this
<U>Article</U><U></U><U>&nbsp;V</U>; and (ii)&nbsp;OmniAb from indemnifying any director, officer or employee of the Ligand Group who was a director, officer or employee of OmniAb or any of its Affiliates prior to the Distribution Time, as the case
may be, to the extent such director, officer or employee is or becomes a named defendant in any Action with respect to which he or she was entitled to such indemnification pursuant to then-existing obligations; it being understood that if the
underlying obligation giving rise to such Action is a Ligand Retained Liability, Ligand shall indemnify OmniAb for such Liability (including OmniAb&#146;s costs to indemnify the director, officer or employee) in accordance with the provisions set
forth in this <U>Article</U><U></U><U>&nbsp;V</U>. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Each Party and APAC shall not, and shall not permit any member of its Group or any
of their respective Affiliates to, make any claim for offset, or commence any Action, including any claim of contribution or any indemnification, against any other Party or APAC or any member of any other Party&#146;s Group or their respective
Affiliates, or any other Person released pursuant to <U>Section</U><U></U><U>&nbsp;5.1(a)</U>, with respect to any Liabilities released pursuant to <U>Section</U><U></U><U>&nbsp;5.1(a)</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) If any Person associated with a Party or APAC (including any director, officer or employee of a Party or APAC) initiates any Action with
respect to claims released by this <U>Section</U><U></U><U>&nbsp;5.1</U>, the Party or APAC with which such Person is associated shall be responsible for the fees and expenses of counsel of the other Party or APAC, as the case may be (and/or the
members of such Party&#146;s Group or their Affiliates, as applicable) and such other Party or APAC, as the case may be, shall be indemnified for all Liabilities incurred in connection with such Action in accordance with the provisions set forth in
this <U>Article</U><U></U><U>&nbsp;V</U>. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">42 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.2 <U>Indemnification by Ligand</U>. In addition to any other provisions of
this Agreement requiring indemnification and except as otherwise specifically set forth in any provision of this Agreement or of any Ancillary Agreement, following the Distribution Time, Ligand shall indemnify, defend and hold harmless the OmniAb
Indemnitees from and against any and all Indemnifiable Losses of the OmniAb Indemnitees to the extent relating to, arising out of, by reason of or otherwise in connection with (a)&nbsp;the Ligand Retained Liabilities, including the failure of any
member of the Ligand Group or any other Person to pay, perform or otherwise discharge any Ligand Retained Liability in accordance with its respective terms, whether arising prior to, at or after the Distribution Time, (b)&nbsp;any Ligand Retained
Asset or Ligand Retained Business, whether arising prior to, at or after the Distribution Time, or (c)&nbsp;any breach by Ligand of any provision of this Agreement or any Ancillary Agreement unless such Ancillary Agreement expressly provides for
separate indemnification therein, in which case any such indemnification claims shall be made thereunder. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.3
<U>Indemnification by OmniAb and APAC</U>. In addition to any other provisions of this Agreement requiring indemnification and except as otherwise specifically set forth in any provision of this Agreement or of any Ancillary Agreement, following the
Distribution Time, OmniAb shall and shall cause the other members of the OmniAb Group to indemnify, defend and hold harmless the Ligand Indemnitees from and against any and all Indemnifiable Losses of the Ligand Indemnitees to the extent relating
to, arising out of, by reason of or otherwise in connection with (a)&nbsp;the OmniAb Liabilities, including the failure of any member of the OmniAb Group or any other Person to pay, perform or otherwise discharge any OmniAb Liability in accordance
with its respective terms, whether prior to, at or after the Distribution Time, (b)&nbsp;any OmniAb Asset or OmniAb Business, whether arising prior to, at or after the Distribution Time, or (c)&nbsp;any breach by OmniAb of any provision of this
Agreement or any Ancillary Agreement unless such Ancillary Agreement expressly provides for separate indemnification therein, in which case any such indemnification claims shall be made thereunder. From and following the Closing, APAC shall and
shall cause its Subsidiaries to indemnify, defend and hold harmless the Ligand Indemnitees from and against any and all Indemnifiable Losses of the Ligand Indemnitees pursuant to this <U>Article V</U> to the extent not paid by a member of the OmniAb
Group. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.4 <U>Procedures for Indemnification</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <U>Direct Claims</U>. Other than with respect to Third Party Claims, which shall be governed by <U>Section</U><U></U><U>&nbsp;5.4(b)</U>,
each Ligand Indemnitee and OmniAb Indemnitee (each, an &#147;<B><I>Indemnitee</I></B>&#148;) shall notify in writing, with respect to any matter that such Indemnitee has determined has given or could give rise to a right of indemnification under
this Agreement or any Ancillary Agreement, the Party which is or may be required pursuant to this <U>Article</U><U></U><U>&nbsp;V</U> or pursuant to any Ancillary Agreement to make such indemnification (the &#147;<B><I>Indemnifying
Party</I></B>&#148;), within forty-five (45)&nbsp;days of such determination, stating in such written notice the amount of the Indemnifiable Loss claimed, if known, and, to the extent practicable, method of computation thereof, and referring to the
provisions of this Agreement in respect of which such right of indemnification is claimed by such Indemnitee or arises; <U>provided</U>, <U>however</U>, that the failure to provide such written notice shall not release the Indemnifying Party from
any of its obligations except and solely to the extent the Indemnifying Party shall have been actually materially prejudiced as a result of such failure. The Indemnifying Party will have a period of forty-five (45)&nbsp;days after receipt of a
notice under this <U>Section</U><U></U><U>&nbsp;5.4(a)</U> within which to respond thereto. If the Indemnifying Party fails to respond within such period, the Liability specified in such notice from the Indemnitee shall be conclusively determined to
be a Liability of the Indemnifying Party hereunder. If such Indemnifying Party responds within such period and rejects such claim in whole or in part, the disputed matter shall be resolved in accordance with <U>Article</U><U></U><U>&nbsp;VII</U>.
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">43 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <U>Third Party Claims</U>. If a claim or demand is made against an Indemnitee by any
Person who is not a member of the Ligand Group or the OmniAb Group or APAC or their respective Affiliates (a &#147;<B><I>Third Party Claim</I></B>&#148;) as to which such Indemnitee is or may be entitled to indemnification pursuant to this Agreement
or any Ancillary Agreement, such Indemnitee shall notify the Indemnifying Party in writing (which notice obligation may be satisfied by providing copies of all notices and documents received by the Indemnitee relating to the Third Party Claim), and
in reasonable detail, of the Third Party Claim promptly (and in any event within the earlier of (x)&nbsp;forty-five (45)&nbsp;days or (y)&nbsp;two (2) Business Days prior to the final date of the applicable response period under such Third Party
Claim) after receipt by such Indemnitee of written notice of the Third Party Claim; <U>provided</U>, <U>however</U>, that the failure to provide notice of any such Third Party Claim pursuant to this or the preceding sentence shall not release the
Indemnifying Party from any of its obligations except and solely to the extent the Indemnifying Party shall have been actually materially prejudiced as a result of such failure. Thereafter, the Indemnitee shall deliver to the Indemnifying Party,
promptly (and in any event within ten (10)&nbsp;Business Days) after the Indemnitee&#146;s receipt thereof, copies of all notices and documents (including court papers) received by the Indemnitee relating to the Third Party Claim. For all purposes
of this <U>Section</U><U></U><U>&nbsp;5.4(b)</U>, each Party shall be deemed to have notice of the matters set forth on <U>Schedule</U><U></U><U>&nbsp;1.1(97)(vii)</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Other than in the case of (i)&nbsp;Taxes addressed in the Tax Matters Agreement or Employee Matters Agreement, which shall be addressed as
set forth therein or (ii)&nbsp;indemnification by a beneficiary Party of a guarantor Party pursuant to <U>Section</U><U></U><U>&nbsp;2.10(c)</U> (the defense of which shall be controlled by the beneficiary Party), the Indemnifying Party shall be
entitled, if it so chooses, to assume the defense thereof, and if it does not assume the defense of such Third Party Claim, to participate in the defense of any Third Party Claim in accordance with the terms of <U>Section</U><U></U><U>&nbsp;5.5</U>
at such Indemnifying Party&#146;s own cost and expense and by such Indemnifying Party&#146;s own counsel, that is reasonably acceptable to the Indemnitee, within thirty (30)&nbsp;days of the receipt of an indemnification notice from such Indemnitee;
<U>provided</U>, <U>however</U>, that the Indemnifying Party shall not be entitled to assume the defense of any Third Party Claim to the extent such Third Party Claim (x)&nbsp;is an Action by a Governmental Entity, (y)&nbsp;involves an allegation of
a criminal violation or (z)&nbsp;seeks injunctive relief against the Indemnitee. In connection with the Indemnifying Party&#146;s defense of a Third Party Claim, such Indemnitee shall have the right to employ separate counsel and to participate in
(but not control) the defense, compromise, or settlement thereof, at its own expense and, in any event, shall cooperate with the Indemnifying Party in such defense and make available to the Indemnifying Party, at the Indemnifying Party&#146;s
expense, all witnesses, pertinent Information, materials and information in such Indemnitee&#146;s possession or under such Indemnitee&#146;s control relating thereto as are reasonably required by the Indemnifying Party; <U>provided</U>,
<U>however</U>, that in the event of a conflict of interest between the Indemnifying Party and the applicable Indemnitee(s), or in the event that any Third Party Claim seeks equitable relief which would restrict or limit the future conduct of the
Indemnitee&#146;s business or operations, such Indemnitee(s) shall be entitled to retain, at the Indemnifying Party&#146;s expense, separate counsel as required by the applicable rules of professional conduct with respect to such matter;
<U>provided</U> <U>further</U>, that if the Indemnifying Party has assumed the defense of the Third Party Claim but has specified, and continues to assert, any </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">44 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
reservations or exceptions to such defense or to its liability therefor, then, in any such case, the reasonable fees and expenses of one separate counsel for all Indemnitees shall be borne by the
Indemnifying Party. The Indemnifying Party shall have the right to compromise or settle a Third Party Claim the defense of which it shall have assumed pursuant to this <U>Section</U><U></U><U>&nbsp;5.4(c)</U> and any such settlement or compromise
made or caused to be made of a Third Party Claim in accordance with this <U>Article</U><U></U><U>&nbsp;V</U> shall be binding on the Indemnitee, in the same manner as if a final judgment or decree had been entered by a court of competent
jurisdiction in the amount of such settlement or compromise. Notwithstanding the foregoing sentence, the Indemnifying Party shall not settle any such Third Party Claim without the written consent of the Indemnitee unless such settlement
(A)&nbsp;completely and unconditionally releases the Indemnitee in connection with such matter, (B)&nbsp;provides relief consisting solely of money damages borne by the Indemnifying Party and (C)&nbsp;does not involve any admission by the Indemnitee
of any wrongdoing or violation of Law. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) If an Indemnifying Party fails for any reason to assume responsibility for defending a Third
Party Claim within the period specified in this <U>Section</U><U></U><U>&nbsp;5.4</U>, such Indemnitee may defend such Third Party Claim at the cost and expense of the Indemnifying Party. If an Indemnifying Party has failed to assume the defense of
the Third Party Claim within the time period specified in clause (c)&nbsp;above, it shall not be a defense to any obligation to pay any amount in respect of such Third Party Claim that the Indemnifying Party was not consulted in the defense thereof,
that such Indemnifying Party&#146;s views or opinions as to the conduct of such defense were not accepted or adopted, that such Indemnifying Party does not approve of the quality or manner of the defense thereof or that such Third Party Claim was
incurred by reason of a settlement rather than by a judgment or other determination of liability. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) Except as otherwise set forth in
<U>Section</U><U></U><U>&nbsp;6.6</U> and <U>Section</U><U></U><U>&nbsp;7.3</U>, or to the extent set forth in any Ancillary Agreement, absent fraud or willful misconduct by an Indemnifying Party, the indemnification provisions of this
<U>Article</U><U></U><U>&nbsp;V</U> shall be the sole and exclusive remedy of an Indemnitee for any monetary or compensatory damages or losses resulting from any breach of this Agreement or any Ancillary Agreement and each Indemnitee expressly
waives and relinquishes any and all rights, claims or remedies such Person may have with respect to the foregoing other than under this <U>Article</U><U></U><U>&nbsp;V</U> against any Indemnifying Party. For the avoidance of doubt, all disputes in
respect of this <U>Article</U><U></U><U>&nbsp;V</U> shall be resolved in accordance with <U>Article</U><U></U><U>&nbsp;VII</U>. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f)
Notwithstanding the foregoing, to the extent any Ancillary Agreement provides procedures for indemnification that differ from the provisions set forth in this <U>Section</U><U></U><U>&nbsp;5.4</U>, the terms of the Ancillary Agreement will govern.
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) The provisions of this <U>Article</U><U></U><U>&nbsp;V</U> shall apply to Third Party Claims that are already pending or asserted as
well as Third Party Claims brought or asserted after the date of this Agreement. There shall be no requirement under this <U>Section</U><U></U><U>&nbsp;5.4</U> to give a notice with respect to any Third Party Claim that exists as of the Distribution
Time. The Parties acknowledge that Liabilities for Actions (regardless of the parties to the Actions) may be partly Ligand Liabilities and partly OmniAb Liabilities. If the Parties cannot agree on the allocation of any such Liabilities for Actions,
they shall resolve the matter pursuant to the procedures set forth in <U>Article</U><U></U><U>&nbsp;VII</U>. Neither Party shall, nor shall either Party permit its Subsidiaries to, file Third Party claims or cross-claims against the other Party or
its Subsidiaries in an Action in which a Third Party Claim is being resolved. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">45 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.5 <U>Cooperation in Defense and Settlement</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) With respect to any Third Party Claim that implicates both the OmniAb Group (or APAC and its Subsidiaries, as applicable) and the Ligand
Group in any material respect due to the allocation of Liabilities, responsibilities for management of defense and related indemnities pursuant to this Agreement or any of the Ancillary Agreements, OmniAb (or APAC, as applicable) and Ligand agree to
use commercially reasonable efforts to cooperate fully and maintain a joint defense (in a manner that, to the extent reasonably practicable, will preserve for all Parties any Privilege with respect thereto). The Party that is not responsible for
managing the defense of any such Third Party Claim shall, upon reasonable request, be consulted with respect to significant matters relating thereto and may, if necessary or helpful, retain counsel to assist in the defense of such claims.
Notwithstanding the foregoing, nothing in this <U>Section</U><U></U><U>&nbsp;5.5(a)</U> shall derogate from any Party&#146;s rights to control the defense of any Action in accordance with <U>Section</U><U></U><U>&nbsp;5.4</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Notwithstanding anything to the contrary in this Agreement, with respect to any Action (i)&nbsp;by a Governmental Entity against OmniAb
relating to matters involving anti-bribery, anti-corruption, anti-money laundering, export control and similar laws, where the facts and circumstances giving rise to the Action occurred prior to the Distribution Time and (ii)&nbsp;where the
resolution of such Action by order, judgment, settlement or otherwise, would reasonably be expected to include any condition, limitation or other stipulation that adversely impacts the conduct of the Ligand Retained Businesses, Ligand shall have, at
Ligand&#146;s expense, the reasonable opportunity to consult, advise and comment on preparation regarding any such Action, including with regard to any drafts of notices and other conferences and communications to be provided or submitted by OmniAb
to any third party involved in such Action (including any Governmental Entity), to the extent that Ligand&#146;s participation does not affect the defense of any such Action or any privilege in an adverse manner; <U>provided</U> that to the extent
that any such action requires the submission by OmniAb of any content relating to any current or former officer or director of Ligand, such content will only be submitted in a form approved by Ligand in its reasonable discretion. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Notwithstanding anything to the contrary in this Agreement, with respect to any notices or reports to be submitted to, or reporting,
disclosure, filing or other requirements to be made with, any Governmental Entity by OmniAb or its Subsidiaries (&#147;<B><I>Governmental Filing</I></B>&#148;) where the Governmental Filing requires disclosure of facts, information or data that
relate, in whole or in part, to periods prior to the Distribution Time, Ligand shall have the reasonable opportunity to consult, advise and comment on the preparation and content of any such Governmental Filing in advance of its submission to a
Governmental Entity, and OmniAb shall in good faith consider and take into account any comments so provided by Ligand with respect to such Governmental Filing. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">46 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) Each of Ligand and OmniAb agrees that at all times from and after the Distribution Time,
if an Action is commenced by a third party naming two (2)&nbsp;or more Parties (or any member of such Parties&#146; respective Groups) as defendants and with respect to which one or more named Parties (or any member of such Party&#146;s respective
Group) is a nominal defendant and/or such Action is otherwise not a Liability allocated to such named Party under this Agreement or any Ancillary Agreement, then the other Party or Parties shall use commercially reasonable efforts at its own expense
to cause such nominal defendant to be removed from such Action, as soon as reasonably practicable. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.6 <U>Indemnification
Payments</U>. Indemnification required by this <U>Article</U><U></U><U>&nbsp;V</U> shall be made by periodic payments of the amount of Indemnifiable Losses in a timely fashion during the course of the investigation or defense, as and when bills are
received or an Indemnifiable Loss incurred. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.7 <U>Indemnification Obligations Net of Insurance Proceeds and Other
Amounts</U>. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Any recovery by any Indemnitee for any Indemnifiable Loss subject to indemnification pursuant to this
<U>Article</U><U></U><U>&nbsp;V</U> shall be calculated (i)&nbsp;net of Insurance Proceeds actually received by such Indemnitee with respect to any Indemnifiable Loss (which such proceeds shall be reduced by the present value, based on that
Party&#146;s then cost of short-term borrowing, of future premium increases known at such time) and (ii)&nbsp;net of any proceeds actually received by the Indemnitee from any unaffiliated third party with respect to any such Liability corresponding
to the Indemnifiable Loss (&#147;<B><I>Third Party Proceeds</I></B>&#148;). Accordingly, the amount which any Indemnifying Party is required to pay pursuant to this <U>Article</U><U></U><U>&nbsp;V</U> to any Indemnitee pursuant to this
<U>Article</U><U></U><U>&nbsp;V</U> shall be reduced by any Insurance Proceeds or Third Party Proceeds theretofore actually recovered by or on behalf of the Indemnitee corresponding to the related Indemnifiable Loss. If an Indemnitee receives a
payment required by this Agreement from an Indemnifying Party corresponding to any Indemnifiable Loss (an &#147;<B><I>Indemnity Payment</I></B>&#148;) and subsequently receives Insurance Proceeds or Third Party Proceeds, then the Indemnitee shall
pay to the Indemnifying Party an amount equal to the excess of the Indemnity Payment received over the amount of the Indemnity Payment that would have been due if the Insurance Proceeds or Third Party Proceeds had been received, realized or
recovered before the Indemnity Payment was made. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Any Indemnity Payment shall be increased as necessary so that after making all
payments corresponding to Taxes imposed on or attributable to such Indemnity Payment, the Indemnitee receives an amount equal to the sum it would have received had no such Taxes been imposed. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) The Parties hereby agree that an insurer or other third party that would otherwise be obligated to pay any amount shall not be relieved of
the responsibility with respect thereto or have any subrogation rights with respect thereto by virtue of any provision contained in this Agreement or any Ancillary Agreement, and that no insurer or any other third party shall be entitled to a
&#147;windfall&#148; (<I>e.g.</I>, a benefit they would not otherwise be entitled to receive, or the reduction or elimination of an insurance coverage obligation that they would otherwise have, in the absence of the indemnification or release
provisions) by virtue of any provision contained in this Agreement or any Ancillary Agreement. Each Party shall, and shall cause its Subsidiaries to, use commercially reasonable efforts to collect or recover, or allow the Indemnifying Party to
collect or recover, or cooperate with each other in collecting or recovering, any Insurance </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">47 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Proceeds that may be collectible or recoverable respecting the Liabilities for which indemnification may be available under this <U>Article</U><U></U><U>&nbsp;V</U>. Notwithstanding the
foregoing, an Indemnifying Party may not delay making any indemnification payment required under the terms of this Agreement, or otherwise satisfying any indemnification obligation, pending the outcome of any Actions to collect or recover Insurance
Proceeds, and an Indemnitee need not attempt to collect any Insurance Proceeds prior to making a claim for indemnification or receiving any Indemnity Payment otherwise owed to it under this Agreement or any Ancillary Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.8 <U>Contribution</U>. If the indemnification provided for in this <U>Article</U><U></U><U>&nbsp;V</U> is unavailable for any
reason to an Indemnitee (other than failure to provide notice with respect to any Third Party Claims in accordance with <U>Section</U><U></U><U>&nbsp;5.4(b)</U>) in respect of any Indemnifiable Loss, then the Indemnifying Party shall, in accordance
with this <U>Section</U><U></U><U>&nbsp;5.8</U>, contribute to the Indemnifiable Losses incurred, paid or payable by such Indemnitee as a result of such Indemnifiable Loss in such proportion as is appropriate to reflect the relative fault of OmniAb
and each other member of the OmniAb Group, on the one hand, and Ligand and each other member of the Ligand Group, on the other hand, in connection with the circumstances which resulted in such Indemnifiable Loss. With respect to any Indemnifiable
Losses arising out of or related to information contained in the <FONT STYLE="white-space:nowrap">Spin-off</FONT> Disclosure Documents or other securities law filing, the relative fault shall be determined by reference to, among other things,
whether the untrue or alleged untrue statement of a material fact or omission or alleged omission of a material fact relates to information regarding the OmniAb Business supplied by a member of the OmniAb Group, on the one hand, or regarding the
Ligand Retained Business supplied by a member of the Ligand Group, on the other hand. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.9 <U>Additional Matters; Survival of
Indemnities</U>. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) The indemnity agreements contained in this <U>Article</U><U></U><U>&nbsp;V</U> shall remain operative and in full
force and effect, regardless of (i)&nbsp;any investigation made by or on behalf of any Indemnitee; and (ii)&nbsp;the knowledge by the Indemnitee of Indemnifiable Losses for which it might be entitled to indemnification hereunder. The indemnity
agreements contained in this <U>Article</U><U></U><U>&nbsp;V</U> shall survive the Distribution. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) The rights and obligations of any
member of the Ligand Group, any member of the OmniAb Group or APAC, in each case, under this <U>Article</U><U></U><U>&nbsp;V</U> shall survive (i)&nbsp;the sale or other Transfer by any Party or its Affiliates of any Assets or businesses or the
assignment by it of any Liabilities and (ii)&nbsp;any merger, consolidation, business combination, restructuring, recapitalization, reorganization or similar transaction involving either Party or any of its Subsidiaries. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">48 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE VI </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>PRESERVATION OF RECORDS; ACCESS TO INFORMATION; </U></B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>CONFIDENTIALITY; PRIVILEGE </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.1 <U>Preservation of Corporate Records</U>. Except as otherwise required or agreed in writing, or as otherwise provided in any
Ancillary Agreement, with regard to any Information referenced in <U>Section</U><U></U><U>&nbsp;6.2</U>, each Party shall use its commercially reasonable efforts, at such Party&#146;s sole cost and expense, to retain, until the latest of, as
applicable, (i)&nbsp;the date on which such Information is no longer required to be retained pursuant to the applicable record retention policy of Ligand or such other member of the Ligand Group, respectively, as in effect immediately prior to the
Distribution Time, including, without limitation, pursuant to any &#147;<B><I>Litigation Hold</I></B>&#148; issued by Ligand or any of its Subsidiaries prior to the Distribution Time, (ii)&nbsp;the concluding date of any period as may be required by
any applicable Law, (iii)&nbsp;the concluding date of any period during which such Information relates to a pending or threatened Action which is known to the members of the Ligand Group or the OmniAb Group, as applicable, in possession of such
Information at the time any retention obligation with regard to such Information would otherwise expire, and (iv)&nbsp;the concluding date of any period during which the destruction of such Information could interfere with a pending or threatened
investigation by a Governmental Entity which is known to the members of the Ligand Group or the OmniAb Group, as applicable, in possession of such Information at the time any retention obligation with regard to such Information would otherwise
expire; provided that with respect to any pending or threatened Action arising after the Distribution Time, clause (iii)&nbsp;of this sentence applies only to the extent that whichever member of the Ligand Group or the OmniAb Group, as applicable,
is in possession of such Information has been notified in writing pursuant to a &#147;<B><I>Litigation Hold</I></B>&#148; by the other Party of the relevant pending or threatened Action. The Parties agree that upon written request from the other
that certain Information relating to the OmniAb Business, the Ligand Retained Businesses or the transactions contemplated hereby be retained in connection with an Action, the Parties shall use reasonable efforts to preserve and not to destroy or
dispose of such Information without the consent of the requesting Party. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.2 <U>Access to Information</U>. Other than in
circumstances in which indemnification is sought pursuant to <U>Article</U><U></U><U>&nbsp;V</U> (in which event the provisions of such <U>Article</U><U></U><U>&nbsp;V</U> shall govern) or for matters related to provision of Tax records (in which
event the provisions of the Tax Matters Agreement and Employee Matters Agreement shall govern) and subject to appropriate restrictions for Privileged Information or Confidential Information: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) After the Distribution Time, and subject to compliance with the terms of the Ancillary Agreements, upon the prior written reasonable
request by, and at the expense of, OmniAb for specific and identified Information: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) that (x)&nbsp;relates to OmniAb or
the OmniAb Business, as the case may be, prior to the Distribution Time or (y)&nbsp;is necessary for OmniAb to comply with the terms of, or otherwise perform under, any Ancillary Agreement to which Ligand and/or OmniAb are parties, Ligand shall
provide, as soon as reasonably practicable following the receipt of such request, appropriate copies of such Information (or the originals thereof if OmniAb has a reasonable need for such originals) in the possession or control of Ligand or any of
its Affiliates or Subsidiaries, but only to the extent such items so relate and are not already in the possession or control of OmniAb; <U>provided</U> that, to the extent any originals are delivered to OmniAb pursuant to this Agreement or the
Ancillary Agreements, OmniAb shall, at its own expense, return them to Ligand within a reasonable time after the need to retain such originals has ceased; <U>provided</U> <U>further</U> that, such obligation to provide any requested Information
shall terminate and be of no further force and effect on the date that is the first anniversary of the date of this Agreement; <U>provided</U> <U>further</U> that, in the event that Ligand, in its sole discretion, determines that any such access or
the provision of any such Information (including information requested under <U>Section</U><U></U><U>&nbsp;6.3</U>) would violate any Law or Contract with a third party or could reasonably result in the waiver of any Privilege, Ligand shall not be
obligated to provide such Information requested by OmniAb; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">49 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) that (x)&nbsp;is required by OmniAb with regard to reasonable
compliance with reporting, disclosure, filing or other requirements imposed on OmniAb (including under applicable securities laws) by a Governmental Entity having jurisdiction over OmniAb, or (y)&nbsp;is for use in any other judicial, regulatory,
administrative or other proceeding or in order to satisfy audit, accounting, claims, regulatory, litigation, Action or other similar requirements, as applicable, Ligand shall provide, as soon as reasonably practicable following the receipt of such
request, appropriate copies of such Information (or the originals thereof if OmniAb has a reasonable need for such originals) in the possession or control of Ligand or any of its Affiliates or Subsidiaries, but only to the extent such items so
relate and are not already in the possession or control of OmniAb; <U>provided</U> that, to the extent any originals are delivered to OmniAb pursuant to this Agreement or the Ancillary Agreements, OmniAb shall, at its own expense, return them to
Ligand within a reasonable time after the need to retain such originals has ceased; <U>provided</U> <U>further</U> that, in the event that Ligand, in its sole discretion, determines that any such access or the provision of any such Information
(including information requested under <U>Section</U><U></U><U>&nbsp;6.3</U>) would violate any Law or Contract with a third party or waive any Privilege, Ligand shall not be obligated to provide such Information requested by OmniAb; or </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) After the Distribution Time, and subject to compliance with the terms of the Ancillary Agreements, upon the prior written reasonable
request by, and at the expense of, Ligand for specific and identified Information: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) that (x)&nbsp;relates to matters
prior to the Distribution Time or (y)&nbsp;is necessary for Ligand to comply with the terms of, or otherwise perform under, any Ancillary Agreement to which Ligand and/or OmniAb are parties, OmniAb shall provide, as soon as reasonably practicable
following the receipt of such request, appropriate copies of such Information (or the originals thereof if Ligand has a reasonable need for such originals) in the possession or control of OmniAb or any of its Affiliates or Subsidiaries, but only to
the extent such items so relate and are not already in the possession or control of Ligand; <U>provided</U> that, to the extent any originals are delivered to Ligand pursuant to this Agreement or the Ancillary Agreements, Ligand shall, at its own
expense, return them to OmniAb within a reasonable time after the need to retain such originals has ceased; <U>provided</U> <U>further</U> that, in the event any such access or the provision of any such Information (including information requested
under <U>Section</U><U></U><U>&nbsp;6.3</U>) would violate any Law or Contract with a third party or waive any Privilege, OmniAb shall not be obligated to provide such Information requested by Ligand. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) that (x)&nbsp;is required by Ligand with regard to reasonable compliance with reporting, disclosure, filing or other
requirements imposed on Ligand (including under applicable securities laws) by a Governmental Entity having jurisdiction over Ligand, or (y)&nbsp;is for use in any other judicial, regulatory, administrative or other proceeding or in order to satisfy
audit, accounting, claims, regulatory, litigation, Action </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">50 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
or other similar requirements, as applicable, OmniAb shall provide, as soon as reasonably practicable following the receipt of such request, appropriate copies of such Information (or the
originals thereof if Ligand has a reasonable need for such originals) in the possession or control of OmniAb or any of its Affiliates or Subsidiaries, but only to the extent such items so relate and are not already in the possession or control of
Ligand; <U>provided</U> that, to the extent any originals are delivered to Ligand pursuant to this Agreement or the Ancillary Agreements, Ligand shall, at its own expense, return them to OmniAb within a reasonable time after the need to retain such
originals has ceased. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Each of Ligand and OmniAb shall inform their respective officers, employees, agents, consultants, advisors,
authorized accountants, counsel and other designated representatives who have or have access to the other Party&#146;s Confidential Information or other information provided pursuant to this <U>Article</U><U></U><U>&nbsp;VI</U> of their obligation
to hold such information confidential in accordance with the provisions of this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.3 <U>Auditors and
Audits</U>.<U> </U> </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Until the first OmniAb fiscal year end occurring after the Distribution Time and for a reasonable period of time
afterwards as required for each Party to prepare consolidated financial statements or complete a financial statement audit for the fiscal year during which the Distribution Date occurs, each Party shall provide or provide access to the other Party
on a timely basis, all information reasonably required to meet its schedule for the preparation, printing, filing, and public dissemination of its annual financial statements and for management&#146;s assessment of the effectiveness of its
disclosure controls and procedures and its internal control over financial reporting in accordance with Items 307 and 308, respectively, of Regulation <FONT STYLE="white-space:nowrap">S-K</FONT> promulgated by the Commission and, to the extent
applicable to such Party, its auditor&#146;s audit of its internal control over financial reporting and management&#146;s assessment thereof in accordance with Section&nbsp;404 of the Sarbanes-Oxley Act of 2002 and the Commission&#146;s and Public
Company Accounting Oversight Board&#146;s rules and auditing standards thereunder. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) In the event a Party restates any of its financial
statements that include such Party&#146;s audited or unaudited financial statements with respect to any balance sheet date or period of operation as of the end of and for the 2021 fiscal year and the five (5)&nbsp;year period ending
December&nbsp;31, 2021, such Party will deliver to the other Party a substantially final draft, as soon as the same is prepared, of any report to be filed by such first Party with the Commission that includes such restated audited or unaudited
financial statements (the &#147;<B><I>Amended Financial Report</I></B>&#148;); provided, however, that such first Party may continue to revise its Amended Financial Report prior to its filing thereof with the Commission, which changes will be
delivered to the other Party as soon as reasonably practicable; provided, further, however, that such first Party&#146;s financial personnel will actively consult with the other Party&#146;s financial personnel regarding any changes which such first
Party may consider making to its Amended Financial Report and related disclosures prior to the anticipated filing of such report with the Commission, with particular focus on any changes which would have an effect upon the other Party&#146;s
financial statements or related disclosures. Each Party will reasonably cooperate with, and permit and make any necessary employees available to, the other Party, in connection with the other Party&#146;s preparation of any Amended Financial
Reports. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">51 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.4 <U>Witness Services</U>. At all times from and after the Distribution Time,
each of Ligand and OmniAb shall use its commercially reasonable efforts to make available to the other, upon reasonable written request, its and its Subsidiaries&#146; officers, directors, employees and agents (taking into account the business
demands of such individuals) as witnesses to the extent that (i)&nbsp;such Persons may reasonably be required to testify in connection with the prosecution or defense of any Action in which the requesting Party may from time to time be involved
(except for claims, demands or Actions in which one or more members of one Group is adverse to one or more members of the other Group) and (ii)&nbsp;there is no conflict in the Action between the requesting Party and the other Party. A Party
providing a witness to the other Party under this <U>Section</U><U></U><U>&nbsp;6.4</U> shall be entitled to receive from the recipient of such witness services, upon the presentation of invoices therefor, payments for such amounts, relating to
supplies, disbursements and other <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> expenses (which shall not include the costs of salaries and benefits of employees who are witnesses or any pro rata
portion of overhead or other costs of employing such employees which would have been incurred by such employees&#146; employer regardless of the employees&#146; service as witnesses), as may be reasonably incurred and properly paid under applicable
Law. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.5 <U>Reimbursement; Other Matters</U>. Except to the extent otherwise contemplated by this Agreement or any Ancillary
Agreement, a Party providing Information or access to Information to the other Party under this <U>Article</U><U></U><U>&nbsp;VI</U> shall be entitled to receive from the recipient, upon the presentation of invoices therefor, payments for such
amounts, relating to supplies, disbursements and other <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> expenses (which shall not include the costs of salaries and benefits of employees of such Party or
any pro rata portion of overhead or other costs of employing such employees which would have been incurred by such employees&#146; employer regardless of the employees&#146; service with respect to the foregoing), as may be reasonably incurred in
providing such Information or access to such Information. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.6 <U>Confidentiality</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Notwithstanding any termination of this Agreement, and except as otherwise provided in the Ancillary Agreements, each of Ligand and OmniAb
shall hold, and shall cause their respective Affiliates and their officers, employees, agents, consultants and advisors to hold, in strict confidence (and not to disclose or release or, except as otherwise permitted by this Agreement or any
Ancillary Agreement, use, including for any ongoing or future commercial purpose, without the prior written consent of the Party to whom the Confidential Information relates (which may be withheld in such Party&#146;s sole and absolute discretion,
except where disclosure is required by applicable Law)), any and all Confidential Information concerning or belonging to the other Party or its Affiliates; <U>provided</U> that each Party may disclose, or may permit disclosure of, Confidential
Information (i)&nbsp;to its respective auditors, attorneys, financial advisors, bankers and other appropriate consultants and advisors who have a need to know such Information for auditing and other
<FONT STYLE="white-space:nowrap">non-commercial</FONT> purposes and are informed of the obligation to hold such Information confidential and in respect of whose failure to comply with such obligations, the applicable Party will be responsible,
(ii)&nbsp;if any Party or any of its respective Subsidiaries is required or compelled to disclose any such Confidential Information by judicial or administrative process or by other requirements of Law or stock exchange rule or is advised by outside
counsel in connection with a proceeding brought by a Governmental Entity that it is advisable to do so, (iii)&nbsp;as required in connection with any legal or </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">52 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
other proceeding by one Party against the other Party or in respect of claims by one Party against the other Party brought in a proceeding, (iv)&nbsp;as necessary in order to permit a Party to
prepare and disclose its financial statements in connection with any regulatory filings or Tax Returns, (v)&nbsp;as necessary for a Party to enforce its rights or perform its obligations under this Agreement (including pursuant to
<U>Section</U><U></U><U>&nbsp;2.3</U>) or an Ancillary Agreement, (vi)&nbsp;to Governmental Entities in accordance with applicable procurement regulations and contract requirements or (vii)&nbsp;to other Persons in connection with their evaluation
of, and negotiating and consummating, a potential strategic transaction, to the extent reasonably necessary in connection therewith, provided an appropriate and customary confidentiality agreement has been entered into with the Person receiving such
Confidential Information. Notwithstanding the foregoing, in the event that any demand or request for disclosure of Confidential Information is made by a third party pursuant to clause (ii), (iii), (v) or (vi)&nbsp;above, each Party, as applicable,
shall promptly notify (to the extent permissible by Law) the Party to whom the Confidential Information relates of the existence of such request, demand or disclosure requirement and shall provide such affected Party a reasonable opportunity to seek
an appropriate protective order or other remedy, which such Party will cooperate in obtaining to the extent reasonably practicable. In the event that such appropriate protective order or other remedy is not obtained, the Party which faces the
disclosure requirement shall furnish only that portion of the Confidential Information that is required to be disclosed and shall take commercially reasonable steps to ensure that confidential treatment is accorded such Confidential Information.
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Each Party acknowledges that it and the other members of its Group may have in its or their possession confidential or proprietary
Information of third parties that was received under confidentiality or <FONT STYLE="white-space:nowrap">non-disclosure</FONT> agreements with such third party while such Party and/or members of its Group were part of the Ligand Group. Each Party
shall comply, and shall cause the other members of its Group to comply, and shall cause its and their respective officers, employees, agents, consultants and advisors (or potential buyers) to comply, with all terms and conditions of any such
third-party agreements entered into prior to the Distribution Time, with respect to any confidential and proprietary Information of third parties to which it or any other member of its Group has had access. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Notwithstanding anything to the contrary set forth herein, (i)&nbsp;the Parties shall be deemed to have satisfied their obligations
hereunder with respect to Confidential Information if they exercise at least the same degree of care that applies to Ligand&#146;s confidential and proprietary information pursuant to policies in effect as of the Distribution Time and
(ii)&nbsp;confidentiality obligations provided for in any Contract between each Party or its Subsidiaries and their respective employees shall remain in full force and effect. Notwithstanding anything to the contrary set forth herein, Confidential
Information of any Party in the possession of and used by any other Party as of the Distribution Time may continue to be used by such Party in possession of the Confidential Information in and only in the operation of the OmniAb Business (in the
case of the OmniAb Group) or the Ligand Retained Business (in the case of the Ligand Group); <U>provided</U> that such Confidential Information may only be used by such Party and its officers, employees, agents, consultants and advisors in the
specific manner and for the specific purposes for which it is used as of the date of this Agreement, and may only be shared with additional officers, employees, agents, consultants and advisors of such Party on a <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">need-to-know</FONT></FONT> basis exclusively with regard to such specified use; <U>provided</U> <U>further</U> that such Confidential Information may be used only so long as the Confidential Information is maintained in
confidence and not disclosed in violation of <U>Section</U><U></U><U>&nbsp;6.6(a)</U>. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">53 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) The Parties agree that irreparable damage may occur in the event that the provisions of
this <U>Section</U><U></U><U>&nbsp;6.6</U> were not performed in accordance with their specific terms. Accordingly, it is hereby agreed that the Parties shall be entitled to seek an injunction or injunctions to enforce specifically the terms and
provisions hereof in any court having jurisdiction, this being in addition to any other remedy to which they are entitled at law or in equity. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) For the avoidance of doubt and notwithstanding any other provision of this <U>Section</U><U></U><U>&nbsp;6.6</U>, (i) the disclosure and
sharing of Privileged Information shall be governed solely by <U>Section</U><U></U><U>&nbsp;6.7</U>, and (ii)&nbsp;Information that is subject to any confidentiality provision or other disclosure restriction in any Ancillary Agreement shall be
governed by the terms of such Ancillary Agreement. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) For the avoidance of doubt and notwithstanding any other provision of this
<U>Section</U><U></U><U>&nbsp;6.6</U>, following the Distribution Time, the confidentiality obligations under this Agreement shall continue to apply to any and all Confidential Information concerning or belonging to each Party or its Affiliates that
is shared or disclosed with the other Party or its Affiliates, whether or not such Confidential Information is shared pursuant to this Agreement, any Ancillary Agreement or otherwise. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.7 <U>Privilege Matters</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <U><FONT STYLE="white-space:nowrap">Pre-Distribution</FONT> Services</U>. The Parties recognize that legal and other professional services
that have been and will be provided prior to the Distribution Time have been and will be rendered for the collective benefit of each of the members of the Ligand Group and the OmniAb Group, and that each of the members of the Ligand Group and the
OmniAb Group should be deemed to be the client with respect to such <FONT STYLE="white-space:nowrap">pre-Distribution</FONT> services for the purposes of asserting all privileges, immunities, or other protections from disclosure which may be
asserted under applicable Law, including, but not limited to, the attorney-client privilege, business strategy privilege, joint defense privilege, common interest privilege, and protection under the work-product doctrine
(&#147;<B><I>Privilege</I></B>&#148;). The Parties shall have a shared Privilege with respect to all Information subject to Privilege (&#147;<B><I>Privileged Information</I></B>&#148;) which relates to such
<FONT STYLE="white-space:nowrap">pre-Distribution</FONT> services. For the avoidance of doubt, Privileged Information within the scope of this <U>Section</U><U></U><U>&nbsp;6.7</U> includes, but is not limited to, services rendered by legal counsel
retained or employed by any Party (or any member of such Party&#146;s respective Group), including outside counsel and <FONT STYLE="white-space:nowrap">in-house</FONT> counsel. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <U>Post-Distribution Services</U>. The Parties recognize that legal and other professional services will be provided following the
Distribution Time to each of Ligand and OmniAb. The Parties further recognize that certain of such post-Distribution services will be rendered solely for the benefit of Ligand or OmniAb, as the case may be, while other such post-Distribution
services may be rendered with respect to claims, proceedings, litigation, disputes, or other matters which involve both Ligand and OmniAb. With respect to such post-Distribution services and related Privileged Information, the Parties agree as
follows: </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">54 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) All Privileged Information relating to any claims, proceedings,
litigation, disputes or other matters which involve both Ligand and OmniAb shall be subject to a shared Privilege among the Parties involved in the claims, proceedings, litigation, disputes, or other matters at issue; and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) Except as otherwise provided in <U>Section</U><U></U><U>&nbsp;6.7(c)(i)</U>, Privileged Information relating to
post-Distribution services provided solely to one of Ligand or OmniAb shall not be deemed shared between the Parties, <U>provided</U>, that the foregoing shall not be construed or interpreted to restrict the right or authority of the Parties
(x)&nbsp;to enter into any further agreement, not otherwise inconsistent with the terms of this Agreement, concerning the sharing of Privileged Information or (y)&nbsp;otherwise to share Privileged Information without waiving any Privilege which
could be asserted under applicable Law. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) The Parties agree as follows regarding all Privileged Information with respect to which the
Parties shall have a shared Privilege under <U>Section</U><U></U><U>&nbsp;6.7(a) or (b)</U>: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) Subject to
<U>Section</U><U></U><U>&nbsp;6.7(c)(iii)</U>, neither Party may waive, allege or purport to waive, any Privilege which could be asserted under any applicable Law, and in which the other Party has a shared Privilege, without the written consent of
the other Party, which shall not be unreasonably withheld or delayed; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) If a dispute arises between or among the
Parties or their respective Subsidiaries regarding whether a Privilege should be waived to protect or advance the interest of any Party, each Party agrees that it shall negotiate in good faith, and shall endeavor to minimize any prejudice to the
rights of the other Party. Neither party shall unreasonably withhold consent to any request for waiver by the other Party, and each Party specifically agrees that it shall not withhold consent to waive for any purpose except to protect its own
legitimate interests; and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iii) In the event of any litigation or dispute between the Parties, or any members of their
respective Groups, either such Party may waive a Privilege in which the other Party or member of such Group has a shared Privilege, without obtaining the consent of the other Party; <U>provided</U> that such waiver of a shared Privilege shall be
effective only as to the use of Privileged Information with respect to the litigation or dispute between the Parties and/or the applicable members of their respective Groups, and shall not operate as a waiver of the shared Privilege with respect to
third parties. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) The transfer of all Information pursuant to this Agreement is made in reliance on the agreement of Ligand and OmniAb as
set forth in <U>Section</U><U></U><U>&nbsp;6.6</U> and this <U>Section</U><U></U><U>&nbsp;6.7</U>, to maintain the confidentiality of Privileged Information and to assert and maintain any applicable Privilege. The access to Information being granted
pursuant to <U>Section</U><U></U><U>&nbsp;5.5</U>, <U>Section</U><U></U><U>&nbsp;6.1</U>, <U>Section</U><U></U><U>&nbsp;6.2</U> and <U>Section</U><U></U><U>&nbsp;6.3 </U>, the agreement to provide witnesses and individuals pursuant to
<U>Section</U><U></U><U>&nbsp;5.5</U> and <U>Section</U><U></U><U>&nbsp;6.4</U>, the furnishing of notices and documents and other cooperative efforts contemplated by <U>Section</U><U></U><U>&nbsp;5.5</U>, and the transfer of Privileged Information
between the Parties and their respective Subsidiaries pursuant to this Agreement shall not be deemed a waiver of any Privilege that has been or may be asserted under this Agreement or otherwise. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">55 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.8 <U>Ownership of Information</U>. Any Information owned by one Party or any
of its Subsidiaries that is provided to a requesting Party pursuant to this <U>Article</U><U></U><U>&nbsp;VI</U> shall be deemed to remain the property of the providing Party. Unless expressly set forth herein, or unless expressly agreed in a
subsequent and separate agreement, nothing contained in this Agreement shall be construed as granting a license or other rights to any Party with respect to any such Information, whether by implication, estoppel or otherwise. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.9 <U>Processing of Personal Information</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Both Parties shall cooperate to ensure that their respective Processing of Personal Information hereunder does and will materially comply
with all applicable Privacy Requirements and take all reasonable precautions to avoid acts that place the other Party in breach of its obligations under any applicable Privacy Requirements. Nothing in this <U>Section</U><U></U><U>&nbsp;6.9</U> shall
be deemed to prevent any Party from taking the steps it reasonably deems necessary to comply with any applicable Privacy Laws. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) To the
extent required to do so by applicable Privacy Requirements as a result of or in connection with the transactions contemplated hereby, including the completion of the Internal Reorganization, the Parties agree to enter into such data processing
agreements as required to comply with applicable Privacy Laws and shall act reasonably and in good faith in doing so. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) It is understood
and agreed by the Parties that the transfer of Personal Information in connection with the Transfer of Assets will not violate any Privacy Requirements in any material respect. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.10 <U>Other Agreements</U>. The rights and obligations granted under this <U>Article</U><U></U><U>&nbsp;VI</U> are subject to
any specific limitations, qualifications or additional provisions on the sharing, exchange or confidential treatment of Information set forth in any Ancillary Agreement. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE VII </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>DISPUTE
RESOLUTION </U></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.1 <U>Negotiation</U>. Except as otherwise provided in any Ancillary Agreement, in the event of a
controversy, dispute or Action arising out of, in connection with, or in relation to the interpretation, performance, nonperformance, validity or breach of this Agreement or the Ancillary Agreements or otherwise arising out of, or in any way related
to, this Agreement or the Ancillary Agreements or the transactions contemplated hereby, including any Action based on contract, tort, statute or constitution (collectively, &#147;<B><I>Disputes</I></B>&#148;), where such Dispute is between the
Parties or between Ligand and APAC, the general counsels or chief legal officers of the parties to the Dispute (or such other individuals designated by the respective general counsels or chief legal officers) and/or the executive officers designated
by the parties to the Dispute shall negotiate for a reasonable period of time to settle such Dispute; provided, that such reasonable period shall not, unless otherwise agreed by the parties to such Dispute in writing, exceed sixty (60)&nbsp;days
(the &#147;<B><I>Negotiation Period</I></B>&#148;) from the time of receipt by a party to such Dispute of written notice of such Dispute (&#147;<B><I>Dispute Notice</I></B>&#148;) and settlement of such Dispute pursuant to this
<U>Section</U><U></U><U>&nbsp;7.1</U> shall be confidential, and no written or oral statements or offers made by the parties to the Dispute during such settlement negotiations shall be admissible for any purpose in any subsequent proceedings. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">56 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.2 <U>Relief in Court</U>. If the Dispute has not been resolved for any reason
after the Negotiation Period, each party to such Dispute shall be entitled to seek relief in a court of competent jurisdiction pursuant to <U>Section</U><U></U><U>&nbsp;9.16</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.3 <U>Continuity of Service and Performance</U>. Unless otherwise agreed in writing, the Parties shall continue to provide
service and honor all other commitments under this Agreement and each Ancillary Agreement during the course of dispute resolution pursuant to the provisions of this <U>Article</U><U></U><U>&nbsp;VII</U> with respect to all matters not subject to
such dispute resolution. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE VIII </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>INSURANCE </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;8.1 <U>Insurance Matters</U>. The provisions of this <U>Section</U><U></U><U>&nbsp;8.1</U> shall apply only to the extent not
otherwise provided for in the Employee Matters Agreement. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) The Parties intend by this Agreement that, to the extent permitted under the
terms of any applicable insurance policy, OmniAb, each other member of the OmniAb Group and each of their respective directors, officers and employees will be successors in interest and/or additional insureds and will have and be fully entitled to
continue to exercise all rights that any of them may have as of the Distribution Time (with respect to events occurring or claimed to have occurred before the Distribution Time) as a Subsidiary, Affiliate, division, director, officer or employee of
Ligand before the Distribution Time under any insurance policy, including any rights that OmniAb, any other member of the OmniAb Group or any of its or their respective directors, officers, or employees may have as an insured or additional named
insured, Subsidiary, Affiliate, division, director, officer or employee to avail itself, himself or herself of any policy of insurance or any agreements related to the policies in effect before the Distribution Time, with respect to events occurring
before the Distribution Time. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) After the Distribution Time, Ligand (and each other member of the Ligand Group) and OmniAb (and each
other member of the OmniAb Group) shall not, without the consent of OmniAb or Ligand, respectively (such consent not to be unreasonably withheld, conditioned or delayed), provide any insurance carrier with a release or amend, modify or waive any
rights under any insurance policy if such release, amendment, modification or waiver thereunder would materially adversely affect any rights of any member of the Group of the other Party with respect to insurance coverage otherwise afforded to such
other Party for <FONT STYLE="white-space:nowrap">pre-Distribution</FONT> claims; provided, however, that the foregoing shall not (i)&nbsp;preclude any member of any Group from presenting any claim or from exhausting any policy limit,
(ii)&nbsp;require any member of any Group to pay any premium or other amount or to incur any Liability or (iii)&nbsp;require any member of any Group to renew, extend or continue any policy in force. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) The provisions of this Agreement are not intended to relieve any insurer of any Liability under any policy. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">57 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) No member of the Ligand Group or any Ligand Indemnitee will have any Liabilities
whatsoever as a result of the insurance policies as in effect at any time before the Distribution Time, including as a result of (i)&nbsp;the level or scope of any insurance, (ii)&nbsp;the creditworthiness of any insurance carrier, (iii)&nbsp;the
terms and conditions of any policy, or (iv)&nbsp;the adequacy or timeliness of any notice to any insurance carrier with respect to any claim or potential claim. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) Except to the extent otherwise provided in <U>Section</U><U></U><U>&nbsp;8.1(b)</U>, in no event will Ligand, any other member of the
Ligand Group or any Ligand Indemnitee have any Liability or obligation whatsoever to any member of the OmniAb Group if any insurance policy is terminated or otherwise ceases to be in effect for any reason, is unavailable or inadequate to cover any
Liability of any member of the OmniAb Group for any reason whatsoever or is not renewed or extended beyond the current expiration date of any such insurance policy. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) This Agreement shall not be considered as an attempted assignment of any policy of insurance or as a contract of insurance and shall not be
construed to waive any right or remedy of any members of the Ligand Group in respect of any insurance policy or any other contract or policy of insurance. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) Nothing in this Agreement will be deemed to restrict any member of the OmniAb Group from acquiring at its own expense any other insurance
policy in respect of any Liabilities or covering any period. After the Distribution Time, OmniAb will acquire its own insurance policies covering the OmniAb Group and each of their respective directors, officers and employees. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h) To the extent that any insurance policy provides for the reinstatement of policy limits, and both Ligand and OmniAb desire to reinstate
such limits, the cost of reinstatement will be shared by Ligand and OmniAb as the Parties may agree. If either Party, in its sole discretion, determines that such reinstatement would not be beneficial, that Party shall not contribute to the cost of
reinstatement and will not make any claim thereunder nor otherwise seek to benefit from the reinstated policy limits. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) For purposes of
this Agreement, &#147;<B><I>Covered Matter</I></B>&#148; shall mean any matter, whether arising before or after the Distribution Time, with respect to which any OmniAb Indemnitee may seek to exercise any right under any insurance policy pursuant to
this <U>Section</U><U></U><U>&nbsp;8.1</U>. If OmniAb receives notice or otherwise learns of any Covered Matter, OmniAb shall promptly give Ligand written notice thereof. Any such notice shall describe the Covered Matter in reasonable detail. With
respect to each Covered Matter and any Joint Claim, OmniAb shall have sole responsibility for reporting the claim to the insurance carrier and will provide a copy of such report to OmniAb. If Ligand or another member of the Ligand Group fails to
notify OmniAb within fifteen (15)&nbsp;days that it has submitted an insurance claim with respect to a Covered Matter or Joint Claim, OmniAb shall be permitted to submit (on behalf of the applicable OmniAb Indemnitee) such insurance claim. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(j) Each of OmniAb and Ligand will share such information as is reasonably necessary in order to permit the other Party to manage and conduct
its insurance matters in an orderly fashion and provide the other Party with any assistance that is reasonably necessary or beneficial in connection with such Party&#146;s insurance matters. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">58 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE IX </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>MISCELLANEOUS </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.1 <U>Entire Agreement; Construction</U>. This Agreement, including the Exhibits&nbsp;and Schedules, and the Ancillary
Agreements shall constitute the entire agreement among the Parties and APAC with respect to the subject matter hereof and shall supersede all previous negotiations, commitments, course of dealings and writings with respect to such subject matter. In
the event of any inconsistency between this Agreement and any Schedule&nbsp;hereto, the Schedule&nbsp;shall prevail. In the event and to the extent that there shall be a conflict between the provisions of (a)&nbsp;this Agreement and the provisions
of any Ancillary Agreement or Continuing Arrangement, such Ancillary Agreement or Continuing Arrangement shall control (except with respect to any Conveyancing and Assumption Instruments, in which case this Agreement shall control) and (b)&nbsp;this
Agreement and any agreement which is not an Ancillary Agreement, this Agreement shall control unless specifically stated otherwise in such agreement. For the avoidance of doubt, the Conveyancing and Assumption Instruments are intended to be
ministerial in nature and only to effect the transactions contemplated by this Agreement with respect to the applicable local jurisdiction and shall not expand or modify the rights and obligations of the Parties, APAC or their respective Affiliates
under this Agreement or any of the Ancillary Agreements that are not Conveyancing and Assumption Instruments. Except as expressly set forth in this Agreement or any Ancillary Agreement: (i)&nbsp;all matters relating to Taxes and Tax Returns of the
Parties and their respective Subsidiaries shall be governed exclusively by the Tax Matters Agreement; and (ii)&nbsp;for the avoidance of doubt, in the event of any conflict between this Agreement or any Ancillary Agreement (other than the Tax
Matters Agreement), on the one hand, and the Tax Matters Agreement, on the other hand, with respect to such matters, the terms and conditions of the Tax Matters Agreement shall govern, except as otherwise provided in the Tax Matters Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.2 <U>Ancillary Agreements</U>. Except as expressly set forth herein, this Agreement is not intended to address, and should not
be interpreted to address, the matters specifically and expressly covered by the Ancillary Agreements. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.3
<U>Counterparts</U>. This Agreement may be executed in more than one counterpart, all of which shall be considered one and the same agreement, and shall become effective when one or more such counterparts have been signed by each of the Parties and
APAC and delivered to each of the Parties and APAC. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.4 <U>Survival of Agreements</U>. Except as otherwise contemplated by
this Agreement or any Ancillary Agreement, all covenants and agreements of the Parties and APAC contained in this Agreement and each Ancillary Agreement shall survive the Distribution Time and remain in full force and effect in accordance with their
applicable terms. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">59 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.5 <U>Expenses</U>. Except as otherwise specified in this Agreement or the
Ancillary Agreements, or as otherwise agreed in writing among Ligand, OmniAb and APAC, Ligand and OmniAb shall each be responsible for its own fees, costs and expenses paid or incurred in connection with this Agreement, any Ancillary Agreement and
the Form 10 and the consummation of the Internal Reorganization, the Contribution, the Distribution and the Merger (the &#147;<B><I>Transaction-related Expenses</I></B>&#148;). OmniAb shall reimburse Ligand for all documented, <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> Transaction-related Expenses of OmniAb that have been paid by Ligand through and including the Distribution Date (the &#147;<B><I>Reimbursable
Transaction-related Expenses</I></B>&#148;) by Ligand&#146;s deducting such amount from the cash portion of the Contribution to be made by it in connection with the Separation. On or prior to the date that is three (3)&nbsp;Business Days prior to
the Distribution Date, Ligand shall furnish to APAC a schedule of the Reimbursable Transaction-related Expenses, together with supporting documentation. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.6 <U>Notices</U>. All notices, requests, claims, demands and other communications under this Agreement and, to the extent
applicable and unless otherwise provided therein, under each of the Ancillary Agreements shall be in English, shall be in writing and shall be given or made (and shall be deemed to have been duly given or made upon receipt) by delivery in person, by
overnight courier service, by registered or certified mail (return receipt requested), or by email (provided confirmation of transmission is electronically generated and kept on file by the sending party and so long as the sender of such email does
not receive an automatic reply from the recipient&#146;s email server indicating that the recipient did not receive such email), to the respective Parties or APAC at the following addresses (or at such other address for a Party or APAC as shall be
specified in a notice given in accordance with this Section&nbsp;9.6): </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>To Ligand: </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Ligand Pharmaceuticals Incorporated </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">3911 Sorrento Valley Blvd., Suite 110 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">San Diego, CA 92121 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Attn: Chief
Financial Officer </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Email: tespinoza@ligand.com </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">With a copy (which shall not constitute notice) to: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Latham&nbsp;&amp; Watkins, LLP </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">12670 High Bluff Dr. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">San Diego,
California 92130 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Attn: &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Matthew Bush </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Scott Shean </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Email: &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;matt.bush@lw.com </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
scott.shean@lw.com </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>To OmniAb: </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">OmniAb, Inc. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">5980 Horton Street,
Suite 405 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Emeryville, CA 94608 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Attn: Chief Legal Officer </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Email:
cberkman@omniab.com </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">60 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">With a copy (which shall not constitute notice) to: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Latham&nbsp;&amp; Watkins, LLP </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">12670 High Bluff Dr. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">San Diego,
California 92130 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Attn: &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Matthew Bush </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Scott Shean </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Email: &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;matt.bush@lw.com </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
scott.shean@lw.com </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B>To APAC: </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Avista Public Acquisition Corp. II </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">65 East 55th Street, 18th Floor </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">New York, New York 10022 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Attn:
Benjamin Silbert, General Counsel </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Email: Silbert@avistacap.com </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">with a copy (which shall not constitute notice) to: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Weil, Gotshal&nbsp;&amp; Manges LLP </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">767 5<SUP STYLE="font-size:85%; vertical-align:top">th</SUP> Avenue </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">New York, NY 10153 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Attn:
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Jaclyn L. Cohen, Esq. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Raymond O. Gietz,
Esq. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Email: &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;jackie.cohen@weil.com </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
raymond.gietz@weil.com </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.7 <U>Consents</U>. Any consent required or permitted to be given by any Party or APAC to the other
Party or APAC under this Agreement shall be in writing and signed by the Party or APAC, as the case may be, giving such consent and shall be effective only against such Party (and its Group) or APAC (and its Affiliates), as the case may be. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.8 <U>Assignment</U>. This Agreement shall not be assignable, in whole or in part, directly or indirectly, by any Party or APAC
without the prior written consent of the other Party and APAC, and any attempt to assign any rights or obligations arising under this Agreement without such consents shall be void. Notwithstanding the foregoing, and subject to any restrictions on
assignment pursuant to Article IV of the Tax Matters Agreement, this Agreement shall be assignable to a bona fide third party in connection with a merger, reorganization, consolidation or the sale of all or substantially all the assets of a party
hereto so long as the resulting, surviving or transferee entity assumes all the obligations of the relevant party hereto by operation of law or pursuant to an agreement in form and substance reasonably satisfactory to the other parties to this
Agreement; <U>provided,</U> <U>however,</U> that no assignment permitted by this <U>Section</U><U></U><U>&nbsp;9.8</U> shall release the assigning Party or APAC, as the case may be, from liability for the full performance of its obligations under
this Agreement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">61 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.9 <U>Successors and Assigns</U>. The provisions of this Agreement and the
obligations and rights hereunder shall be binding upon, inure to the benefit of and be enforceable by (and against) the Parties, APAC and their respective successors and permitted assigns. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.10 <U>Termination and Amendment</U>. This Agreement may not be terminated, modified or amended except by an agreement in
writing signed by each of Ligand, OmniAb and APAC; <U>provided</U>, <U>however</U>, that this Agreement shall terminate immediately upon termination of the Merger Agreement if the Merger Agreement is terminated in accordance with its terms prior to
the Distribution. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.11 <U>Payment Terms</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Except as set forth in <U>Article</U><U></U><U>&nbsp;V</U> or as otherwise expressly provided to the contrary in this Agreement or in any
Ancillary Agreement, any amount to be paid or reimbursed by a Party or APAC (and/or a member of such Party&#146;s Group or its Affiliates), on the one hand, to the other Party or APAC (and/or a member of such Party&#146;s Group or its Affiliate), on
the other hand, under this Agreement shall be paid or reimbursed hereunder within forty-five (45)&nbsp;days after presentation of an invoice or a written demand therefor and setting forth, or accompanied by, reasonable documentation or other
reasonable explanation supporting such amount. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Except as set forth in <U>Article</U><U></U><U>&nbsp;V</U> or as expressly provided to
the contrary in this Agreement or in any Ancillary Agreement, any amount not paid when due pursuant to this Agreement (and any amount billed or otherwise invoiced or demanded and properly payable that is not paid within forty-five (45)&nbsp;days of
such bill, invoice or other demand) shall bear interest at a rate per annum equal to the Prime Rate, from time to time in effect, calculated for the actual number of days elapsed, accrued from the date on which such payment was due up to the date of
the actual receipt of payment. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Without the consent of the Party or APAC, as the case may be, receiving any payment under this
Agreement specifying otherwise, all payments to be made by either Party or APAC under this Agreement shall be made in US Dollars. Except as expressly provided herein, any amount which is not expressed in US Dollars shall be converted into US Dollars
by using the exchange rate published on Bloomberg at 5:00 pm Eastern Standard time (EST) on the day before the relevant date or in the Wall Street Journal on such date if not so published on Bloomberg. Except as expressly provided herein, in the
event that any indemnification payment required to be made hereunder or under any Ancillary Agreement may be denominated in a currency other than US Dollars, the amount of such payment shall be converted into US Dollars on the date in which notice
of the claim is given to the Indemnifying Party. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.12 <U>Subsidiaries</U>. Each of the Parties and APAC shall cause to be
performed, and hereby guarantees the performance of, all actions, agreements and obligations set forth herein to be performed by any Subsidiary of such Party or APAC, as the case may be, or by any entity that becomes a Subsidiary of such Party or
APAC, as the case may be, at and after the Distribution Time, to the extent such Subsidiary remains a Subsidiary of the applicable Party or APAC, as the case may be. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">62 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.13 <U>Third Party Beneficiaries</U>. Except (i)&nbsp;as provided in
<U>Article</U><U></U><U>&nbsp;V</U> relating to Indemnitees and for the release under <U>Section</U><U></U><U>&nbsp;5.1</U> of any Person provided therein and (ii)&nbsp;as specifically provided in any Ancillary Agreement, this Agreement is solely
for the benefit of the Parties and APAC and should not be deemed to confer upon third parties any remedy, claim, liability, reimbursement, claim of Action or other right in excess of those existing without reference to this Agreement. For the
avoidance of doubt, no stockholder of Ligand, OmniAb or APAC shall be third-party beneficiaries for any purpose prior to the Distribution, and no stockholder (or Party or APAC on behalf of their respective stockholders) shall be entitled to bring
any claim for damages prior to the Distribution based on a decrease in share value or lost premiums. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.14 <U>Title and
Headings</U>. Titles and headings to sections&nbsp;herein are inserted for the convenience of reference only and are not intended to be a part of or to affect the meaning or interpretation of this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.15 <U>Exhibits</U><U></U><U>&nbsp;and Schedules</U>. The Exhibits&nbsp;and Schedules shall be construed with and as an integral
part of this Agreement to the same extent as if the same had been set forth verbatim herein. Nothing in the Exhibits&nbsp;or Schedules constitutes an admission of any liability or obligation of any member of the Ligand Group or the OmniAb Group or
any of their respective Affiliates to any third party, nor, with respect to any third party, an admission against the interests of any member of the Ligand Group or the OmniAb Group or any of their respective Affiliates. The inclusion of any item or
liability or category of item or liability on any Exhibit&nbsp;or Schedule&nbsp;is made solely for purposes of allocating potential liabilities among the Parties and shall not be deemed as or construed to be an admission that any such liability
exists. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.16 <U>Governing Law and Venue; Submission to Jurisdiction; Selection of Forum; Waiver of Trial by Jury</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) This Agreement and any dispute arising out of, in connection with or relating to this Agreement shall be governed by and construed in
accordance with the Laws of the State of Delaware, without giving effect to the conflicts of laws principles thereof. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Each of the
Parties and APAC agrees that any Action related to this agreement shall be brought exclusively in the Court of Chancery of the State of Delaware or, if under applicable Law, exclusive jurisdiction over such matter is vested in the federal courts,
any federal court in the State of Delaware and any appellate court from any thereof (the &#147;<B><I>Chosen Courts</I></B>&#148;). By executing and delivering this Agreement, each of the Parties and APAC irrevocably: (i)&nbsp;accepts generally and
unconditionally submits to the exclusive jurisdiction of the Chosen Courts for any Action relating to this Agreement, including any Action brought for any remedy contemplated by <U>Section</U><U></U><U>&nbsp;9.17</U>; (ii) waives any objections
which such Party or APAC, as the case may be, may now or hereafter have to the laying of venue of any such Action contemplated by this <U>Section</U><U></U><U>&nbsp;9.16(b)</U> and hereby further irrevocably waives and agrees not to plead or claim
that any such Action has been brought in an inconvenient forum; (iii)&nbsp;agrees that it will not attempt to deny or defeat the personal jurisdiction of the Chosen Courts by motion or other request for leave from any such court; (iv)&nbsp;agrees
that it will not bring any Action contemplated by this <U>Section</U><U></U><U>&nbsp;9.16(b)</U> in any court other than the Chosen Courts; (v)&nbsp;agrees that service of all process, including the summons and complaint, in any Action may be made
by </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">63 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
registered or certified mail, return receipt requested, to such party at their respective addresses provided in accordance with <U>Section</U><U></U><U>&nbsp;9.6</U> or in any other manner
permitted by Law; and (vi)&nbsp;agrees that service as provided in the preceding clause (v)&nbsp;is sufficient to confer personal jurisdiction over such Party or APAC in the Action, and otherwise constitutes effective and binding service in every
respect. Each of the Parties and APAC agrees that a final judgment in any Action in a Chosen Court as provided above may be enforced in other jurisdictions by suit on the judgment or in any other manner provided by Law, and each Party and APAC
further agrees to the <FONT STYLE="white-space:nowrap">non-exclusive</FONT> jurisdiction of the Chosen Courts for the enforcement or execution of any such judgment. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) EACH OF LIGAND, OMNIAB AND APAC HEREBY UNCONDITIONALLY AND IRREVOCABLY WAIVE THEIR RIGHT TO TRIAL BY JURY IN ANY JUDICIAL PROCEEDING IN ANY
COURT RELATING TO ANY DISPUTE, CONTROVERSY OR CLAIM ARISING OUT OF, RELATING TO OR IN CONNECTION WITH THIS AGREEMENT OR ANY INSTRUMENT OR DOCUMENT DELIVERED PURSUANT TO THIS AGREEMENT (INCLUDING ANY SCHEDULE OR EXHIBIT HERETO AND THERETO) OR THE
BREACH, TERMINATION OR VALIDITY OF SUCH AGREEMENT, INSTRUMENTS OR DOCUMENTS OR THE NEGOTIATION, EXECUTION OR PERFORMANCE OF SUCH AGREEMENTS, INSTRUMENTS OR DOCUMENTS. NEITHER LIGAND, OMNIAB NOR APAC SHALL SEEK A JURY TRIAL IN ANY LAWSUIT,
PROCEEDING, COUNTERCLAIM OR ANY OTHER LITIGATION PROCEDURE BASED UPON, OR ARISING OUT OF, THIS AGREEMENT OR ANY RELATED INSTRUMENTS OR DOCUMENTS. NEITHER LIGAND, OMNIAB NOR APAC WILL SEEK TO CONSOLIDATE ANY SUCH ACTION IN WHICH A JURY TRIAL HAS BEEN
WAIVED WITH ANY OTHER ACTION IN WHICH A JURY TRIAL CANNOT BE OR HAS NOT BEEN WAIVED. EACH OF LIGAND, OMNIAB AND APAC CERTIFIES THAT IT HAS BEEN INDUCED TO ENTER INTO THIS AGREEMENT, INSTRUMENT OR DOCUMENT BY, AMONG OTHER THINGS, THE MUTUAL WAIVERS
AND CERTIFICATIONS SET FORTH ABOVE IN THIS <U>SECTION 9.16(c)</U>. NONE OF LIGAND, OMNIAB OR APAC HAS IN ANY WAY AGREED WITH OR REPRESENTED TO ANY OF THE OTHERS THAT THE PROVISIONS OF THIS <U>SECTION 9.16(c)</U> WILL NOT BE FULLY ENFORCED IN ALL
INSTANCES. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.17 <U>Specific Performance</U>. From and after the Distribution Time, in the event of any actual or threatened
default in, or breach of, any of the terms, conditions and provisions of this Agreement or any Ancillary Agreement, the Parties and APAC agree that APAC and the Party or Parties to this Agreement or such Ancillary Agreement who are or are to be
thereby aggrieved shall have the right to specific performance and injunctive or other equitable relief of its or their rights under this Agreement or such Ancillary Agreement, in addition to any and all other rights and remedies at law or in
equity, and all such rights and remedies shall be cumulative. The Parties and APAC agree that, from and after the Distribution Time, the remedies at law for any breach or threatened breach of this Agreement or any Ancillary Agreement, including
monetary damages, are inadequate compensation for any Indemnifiable Loss, that any defense in any action for specific performance that a remedy at law would be adequate is hereby waived, and that any requirements for the securing or posting of any
bond with such remedy are hereby waived. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">64 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.18 <U>Severability</U>. In the event any one or more of the provisions
contained in this Agreement should be held invalid, illegal or unenforceable in any respect, the validity, legality and enforceability of the remaining provisions contained herein and therein shall not in any way be affected or impaired thereby. The
Parties and APAC shall endeavor in good-faith negotiations to replace the invalid, illegal or unenforceable provisions with valid provisions, the economic effect of which comes as close as possible to that of the invalid, illegal or unenforceable
provisions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.19 <U>Interpretation</U>. The Parties and APAC have participated jointly in the negotiation and drafting of
this Agreement. This Agreement shall be construed without regard to any presumption or rule requiring construction or interpretation against the Party or APAC, as the case may be, drafting or causing any instrument to be drafted. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.20 <U>No Duplication; No Double Recovery</U>. Nothing in this Agreement is intended to confer to or impose upon any Party or
APAC a duplicative right, entitlement, obligation or recovery with respect to any matter arising out of the same facts and circumstances (including with respect to the rights, entitlements, obligations and recoveries that may arise out of one or
more of the following Sections: <U>Section</U><U></U><U>&nbsp;5.2</U>; <U>Section</U><U></U><U>&nbsp;5.3</U>; and <U>Section</U><U></U><U>&nbsp;5.4</U>). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.21 <U>Tax Treatment of Payments</U>. Unless otherwise required by a Final Determination, this Agreement or the Tax Matters
Agreement or otherwise agreed to among the Parties and APAC, for U.S. federal Tax purposes, any payment made pursuant to this Agreement (other than any payment of interest pursuant to <U>Section</U><U></U><U>&nbsp;9.11</U>) by: (i)&nbsp;OmniAb to
Ligand shall be treated for all Tax purposes as a distribution by OmniAb to Ligand with respect to stock of OmniAb occurring on or immediately before the Distribution Time; or (ii)&nbsp;Ligand to OmniAb shall be treated for all Tax purposes as a <FONT
STYLE="white-space:nowrap">tax-free</FONT> contribution by Ligand to OmniAb with respect to its stock occurring on or immediately before the Distribution Time; and in each case, no Party or APAC shall take any position inconsistent with such
treatment. In the event that a Taxing Authority asserts that a Party&#146;s treatment of a payment pursuant to this Agreement should be other than as set forth in the preceding sentence, such Party shall use its commercially reasonable efforts to
contest such challenge. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.22 <U>No Waiver</U>. No failure to exercise and no delay in exercising, on the part of any Party,
any right, remedy, power or privilege hereunder or under the other Ancillary Agreements shall operate as a waiver hereof or thereof; nor shall any single or partial exercise of any right, remedy, power or privilege hereunder or thereunder preclude
any other or further exercise thereof or the exercise of any other right, remedy, power or privilege. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;9.23 <U>No Admission
of Liability</U>. The allocation of Assets and Liabilities herein (including on the Schedules hereto) is solely for the purpose of allocating such Assets and Liabilities between Ligand and OmniAb and is not intended as an admission of liability or
responsibility for any alleged Liabilities <FONT STYLE="white-space:nowrap">vis-&agrave;</FONT> <FONT STYLE="white-space:nowrap">-vis</FONT> any third party, including with respect to the Liabilities of any
<FONT STYLE="white-space:nowrap">non-wholly</FONT> owned Subsidiary of Ligand or OmniAb. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[<I>Signature Page Follows</I>] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">65 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">IN WITNESS WHEREOF, each of Ligand, OmniAb and APAC have caused this Agreement to be duly
executed as of the day and year first above written. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">LIGAND PHARMACEUTICALS INCORPORATED</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Matthew Korenberg</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name: Matthew Korenberg</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Title: Executive Vice President, Finance and Chief Financial Officer</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">OMNIAB, INC.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Matthew W. Foehr</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name: Matthew W. Foehr</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Title: President and Chief Executive Officer</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">AVISTA PUBLIC ACQUISITION</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">CORP.
II</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Benjamin Silbert</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name: Benjamin Silbert</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title: General Counsel</TD></TR>
</TABLE></DIV>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">66 </P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-2.3
<SEQUENCE>4
<FILENAME>d337089dex23.htm
<DESCRIPTION>EX-2.3
<TEXT>
<HTML><HEAD>
<TITLE>EX-2.3</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 2.3 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B></B><B><I>Execution Version</I></B><B> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">March&nbsp;23, 2022 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Avista Public Acquisition
Corp. II </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">65 East 55th Street, 18th Floor </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">New York, NY 10022
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Re: <U>Letter Agreement</U> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Ladies and Gentlemen: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Reference is made to that certain Agreement and Plan of Merger, dated as of March&nbsp;23, 2022 (the &#147;<B><I>Merger
Agreement</I></B>&#148;), by and among Ligand Pharmaceuticals Incorporated (&#147;<B><I>Ligand</I></B>&#148;), a Delaware corporation, OmniAb, Inc., a Delaware corporation (&#147;<B><I>SpinCo</I></B>&#148;, and together with Ligand, the
&#147;<B><I>Companies</I></B>&#148;), Avista Public Acquisition Corp. II, a Cayman Islands exempted company (&#147;<B><I>Parent</I></B>&#148;), and Orwell Merger Sub Inc., a Delaware corporation. This letter agreement (this &#147;<B><I>Letter
Agreement</I></B>&#148;) is being entered into and delivered by Parent, Avista Acquisition LP II (the &#147;<B><I>Sponsor</I></B>&#148;), SpinCo and each of the undersigned, each of whom is a member of Parent&#146;s management team and/or
Parent&#146;s Board of Directors (the &#147;<B><I>Board</I></B>&#148;) (each, an &#147;<B><I>Insider</I></B>&#148;), in connection with the transactions contemplated by the Merger Agreement (the &#147;<B><I>Merger</I></B>&#148;). Capitalized terms
used but not otherwise defined herein shall have the respective meanings ascribed to such terms in the Merger Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In order to
induce the Companies to enter into the Merger Agreement and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Sponsor and each Insider hereby agrees with Parent as follows: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1. <U>Definitions</U>. As used herein, (i) &#147;<B><I>Earnout Period</I></B>&#148; shall mean the period from the Closing Date to and
including the fifth (5th) anniversary of the Closing Date; (ii) &#147;<B><I>Founder Shares</I></B>&#148; shall mean the 5,750,000 shares of Domesticated Parent Common Stock into which the 5,750,000 Class&nbsp;B ordinary shares of Parent are to be
converted in the Domestication, equitably adjusted for stock splits, reverse stock splits, stock dividends, reorganizations, recapitalizations, reclassifications, combinations, exchanges of shares or other like changes or transactions with respect
to such Founder Shares; (iii) &#147;<B><I>Post-Transaction VWAP</I></B>&#148; shall mean the daily volume-weighted average share price for any 20 Trading Days over any consecutive <FONT STYLE="white-space:nowrap">30-day</FONT> period; (iv)
&#147;<B><I>Trading Day</I></B>&#148; shall mean any day on which Domesticated Parent Common Stock are actually traded on the principal securities exchange or securities market on which shares of Domesticated Parent Common Stock are then traded; and
(v) &#147;<B><I>Triggering Event</I></B>&#148; shall mean, (a)&nbsp;with respect to fifty percent (50%) of the Earnout Founder Shares (as hereinafter defined), the first date during the Earnout Period on which the Post-Transaction VWAP is $12.50 per
share or higher, and (b)&nbsp;with respect any Earnout Founder Shares for which a Triggering Event has not occurred with respect to clause (a), the first date during the Earnout Period on which the Post-Transaction VWAP is $15.00 per share or
higher; <U>provided</U>, that in the event of a Change of Control during the Earnout Period pursuant to which Parent or any of its stockholders have the right to receive, directly or indirectly, cash, securities or other property attributing a value
of at least $12.50 (with respect to fifty percent (50%) of the Earnout Founder Shares) or $15.00 (with respect to all Earnout Founder Shares) per share of Domesticated Parent Common Stock, as agreed in good faith by the Sponsor and the Board), then
a Triggering Event shall be deemed to have occurred immediately prior to such Change of Control. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2. <U>Representations and Warranties</U>.
Each Insider hereby severally represents and warrants to Parent that as of the date hereof such Insider holds the number of issued and outstanding Founder Shares set forth next to such Insider&#146;s name on the signature pages hereto. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3. <U>Business Combination Vote</U>. The Sponsor and each Insider agrees that if Parent
seeks shareholder approval of the Merger, then in connection with the Merger, the Sponsor or such Insider shall vote all of the (a)&nbsp;Parent Class&nbsp;A Common Stock and Founder Shares, in each case owned by such Person (beneficially or of
record) as of the date hereof and (b)&nbsp;any additional Parent Class&nbsp;A Common Stock or Founder Shares (or any securities convertible into or exercisable or exchangeable for Parent Class&nbsp;A Common Stock or Founder Shares) of which the
Sponsor or such Insider acquires record or beneficial ownership on or after the date hereof (including by purchase, as a result of stock splits, reverse stock splits, stock dividends, reorganizations, recapitalizations, reclassifications,
combinations, exchanges of shares or other like changes or transactions) (clauses (a)&nbsp;and (b), the &#147;<B><I>Covered Shares</I></B>&#148;) held by the Sponsor or such Insider in favor of the Merger (including the Transaction Proposals and any
other proposals recommended by the Board in connection with the Merger) and not elect to redeem any Covered Shares held by the Sponsor and each Insider in connection with such shareholder approval or the Merger (including, without limitation, the
Transactions). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4. <U>Founder Shares Earnout</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Upon and subject to the Closing, a number of Founder Shares beneficially owned by Sponsor as of the date hereof equal to (i) 1,916,667
minus (ii) (A) 718,750 multiplied by (B)&nbsp;a number, the numerator of which is the number of shares of Domesticated Parent Common Stock actually purchased pursuant to the Redemption Backstop in connection with the Closing and the denominator of
which is 10,000,000 (the &#147;<B><I>Earnout Founder Shares</I></B>&#148;), all or fifty percent (50%) of which shall be automatically forfeited for no consideration if an applicable Triggering Event has not occurred with respect to such Earnout
Founder Shares during the Earnout Period, with such Earnout Founder Shares vesting (and therefore no longer subject to forfeiture), if at all, in accordance with the terms of this Letter Agreement. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) The holders of the Earnout Founder Shares shall not (i)&nbsp;sell, transfer, assign, pledge, encumber, hypothecate, or similarly dispose
of, (ii)&nbsp;enter into, establish or increase a put or equivalent position or liquidation with respect to, or increase a call equivalent position with respect to, (iii)&nbsp;enter into any swap or other arrangement that transfers to another, in
whole or in part, any of the economic consequences of ownership of, whether any such transaction is to be settled by delivery of securities, in cash or otherwise, or (iv)&nbsp;announce the intent to take any of the actions set forth in clauses
(i)-(iii) with respect to, any Earnout Founder Shares until the date on which a Triggering Event has occurred; <U>provided</U>, that the Sponsor may distribute the Earnout Founder Shares held by it to its members in accordance with its Governing
Documents and the A&amp;R Registration Rights Agreement, in each case, provided that the recipient of such distribution enters into a joinder to this Letter Agreement substantially in the form attached hereto as <U>Exhibit</U><U></U><U>&nbsp;A</U>.
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Any certificates or book entries representing the Earnout Founder Shares shall bear a legend referencing that they are subject to
forfeiture pursuant to the provisions of this Letter Agreement, and any transfer agent for the shares of Domesticated Parent Common Stock will be given appropriate stop transfer orders that will be applicable until the Earnout Founder Shares are
vested; <U>provided</U>, however, that upon the vesting of any Earnout Founder Shares in accordance with the terms herein, Parent shall immediately cause the removal of such legend and direct such transfer agent that such stop transfer orders are no
longer applicable. Holders of the Earnout Founder Shares shall be entitled to vote such Earnout Founder Shares and receive dividends and other distributions in respect thereof prior to the vesting of such Earnout Founder Shares in accordance with
the terms herein; <U>provided</U>, that any such dividends and other distributions in respect of the Earnout Founder Shares that are subject to vesting pursuant to the terms herein shall be set aside by Parent and shall only be paid to the holder of
such Earnout Founder Shares upon the vesting thereof. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) The Earnout Founder Shares shall immediately become fully vested and no longer subject
to forfeiture upon the occurrence of the applicable Triggering Event during the Earnout Period. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) If Parent at any time combines or
subdivides the Domesticated Parent Common Stock (by any stock split, stock dividend, recapitalization, reorganization, merger, amendment of the applicable Governing Documents, scheme, arrangement or otherwise or extraordinary dividend resulting from
an asset sale or leveraged recapitalization), the number of Earnout Founder Shares and the share prices set forth in the definition of &#147;Triggering Events&#148; shall be equitably adjusted by Parent in good faith to take into account such stock
split, stock dividend, recapitalization, reorganization, merger, amendment of the applicable Governing Documents, scheme, arrangement or extraordinary dividend or other applicable transaction. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5. <U>Amendment to Original Letter Agreements; Effects of Termination</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) The first sentence of paragraph 4(b) of each of the Letter Agreements (collectively, as amended and restated pursuant to this <U>paragraph
5(a)</U>, the &#147;<B><I>Existing Letter Agreements</I></B>&#148;), dated August&nbsp;9, 2021, entered into between Parent, on the one hand, and each of the Sponsor and each Insider, on the other hand, is hereby amended and restated in its entirety
as follows: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">&#147;The Insider acknowledges that the Insider has no right, title, interest or claim of any kind in or to any monies held
in the Trust Account as a result of any liquidation of the Company with respect to the Founder Shares held by the Insider, if any.&#148; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) The last sentence of paragraph 12(a) of each of the Existing Letter Agreements, is hereby amended and restated as follows: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">&#147;This Letter Agreement may not be changed, amended, modified or waived (other than to correct a typographical error) as to any particular
provision, except by a written instrument (i)&nbsp;executed by all parties hereto and (ii)&nbsp;solely with respect to <U>paragraph 5</U> and prior to the Closing or valid termination of the OmniAb Merger Agreement (as defined below), in accordance
with its terms, with the consent of OmniAb. &#147;OmniAb Merger Agreement&#148; means that certain Agreement and Plan of Merger, dated as of March&nbsp;23, 2022 (the &#147;<B><I>OmniAb Merger Agreement</I></B>&#148;), by and among Ligand
Pharmaceuticals Incorporated, a Delaware corporation (&#147;<B><I>Ligand</I></B>&#148;), OmniAb, Inc., a Delaware corporation and wholly-owned subsidiary of Ligand, the Company, and Orwell Merger Sub Inc., a Delaware corporation.&#148; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Except as expressly modified by <U>paragraph 5(a)</U>, the terms, representations, warranties, covenants and other provisions of the
Existing Letter Agreements shall remain unchanged and are and shall continue to be in full force and effect in accordance with their respective terms. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) This Letter Agreement shall terminate on the earlier of (i)&nbsp;termination of the Merger Agreement or (ii)&nbsp;the vesting in full of
all Earnout Founder Shares; <U>provided</U>, that terms and conditions set forth in this <U>paragraph 5</U> shall survive any such termination. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6. <U>Entire Agreement</U>. This Letter Agreement and each of the Existing Letter Agreements
constitute the entire agreement and understanding of the parties hereto in respect of the subject matter hereof and thereof and supersede all prior understandings, agreements or representations by or among the parties hereto and thereto, written or
oral, to the extent they relate in any way to the subject matter hereof or thereof or the transactions contemplated hereby or thereby. This Letter Agreement may not be changed, amended, modified or waived (other than to correct a typographical
error) as to any particular provision, except by a written instrument executed by all parties hereto. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7. <U>Assignment</U>. No party
hereto may assign either this Letter Agreement or any of its rights, interests or obligations hereunder without the prior written consent of the other parties. Any purported assignment in violation of this paragraph shall be void and ineffectual and
shall not operate to transfer or assign any interest or title to the purported assignee. This Letter Agreement shall be binding on the Sponsor and each Insider and each of their respective successors, heirs, personal representatives and assigns and
permitted transferees. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8. <U>Counterparts</U>. This Letter Agreement may be executed in any number of original or facsimile counterparts,
and each of such counterparts shall for all purposes be deemed to be an original, and all such counterparts shall together constitute but one and the same instrument. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9. <U>Effect of Headings</U>. The paragraph headings herein are for convenience only and are not part of this Letter Agreement and shall not
affect the interpretation thereof. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">10. <U>Severability</U>. This Letter Agreement shall be deemed severable, and the invalidity or
unenforceability of any term or provision hereof shall not affect the validity or enforceability of this Letter Agreement or of any other term or provision hereof. Furthermore, in lieu of any such invalid or unenforceable term or provision, the
parties hereto intend that there shall be added as a part of this Letter Agreement a provision as similar in terms to such invalid or unenforceable provision as may be possible and be valid and enforceable. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">11. <U>Governing Law</U>. This Letter Agreement shall be governed by and construed and enforced in accordance with the laws of the State of
Delaware, without giving effect to conflicts of law principles that would result in the application of the substantive laws of another jurisdiction. The parties hereto (i)&nbsp;all agree that any action, proceeding, claim or dispute arising out of,
or relating in any way to, this Letter Agreement shall be brought and enforced in the Court of Chancery of the State of Delaware, and irrevocably submit to such jurisdiction and venue, which jurisdiction and venue shall be exclusive, and
(ii)&nbsp;waive any objection to such exclusive jurisdiction and venue or that such courts represent an inconvenient forum. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">12.
<U>Notices</U>. Any notice, consent or request to be given in connection with any of the terms or provisions of this Letter Agreement shall be in writing and shall be sent by express mail or similar private courier service, by certified mail (return
receipt requested), by hand delivery or facsimile or other electronic transmission to the address set forth for such person on the signature page hereto. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>[Signature Page Follows] </I></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="16%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="83%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Sincerely,</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>AVISTA ACQUISITION LP II</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Benjamin Silbert</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Benjamin Silbert</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Authorized Signatory</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">email:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Silbert@avistacap.com</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Address:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">65 East 55th Street</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">18th Floor</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">New York, NY 10022</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Thompson Dean</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Thompson Dean</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Number of issued and</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">outstanding Founder Shares: 0</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ David Burgstahler</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">David Burgstahler</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Number of issued and</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">outstanding Founder Shares: 0</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Sriram Venkataraman</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Sriram Venkataraman</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Number of issued and</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">outstanding Founder Shares: 0</TD></TR></TABLE></DIV>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
<DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="14%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="85%"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Robert Girardi</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Robert Girardi</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Number of issued and</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">outstanding Founder Shares: 0</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Amanda Heravi</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Amanda Heravi</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Number of issued and</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">outstanding Founder Shares: 0</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ John Cafasso</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">John Cafasso</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Number of issued and</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">outstanding Founder Shares: 0</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Benjamin Silbert</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Benjamin Silbert</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Number of issued and</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">outstanding Founder Shares: 0</TD></TR></TABLE></DIV>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
<DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="14%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="85%"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ William E. Klitgaard</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">William E. Klitgaard</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Number of issued and</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">outstanding Founder Shares: 35,000</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ L&acirc;le White</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">L&acirc;le White</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Number of issued and</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">outstanding Founder Shares: 35,000</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Wendel Barr</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Wendel Barr</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Number of issued and</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">outstanding Founder Shares: 35,000</TD></TR>
</TABLE></DIV>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Acknowledged and Agreed:</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>AVISTA PUBLIC ACQUISITION CORP. II</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Benjamin Silbert</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name: Benjamin Silbert</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Title: General Counsel</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">email:
Silbert@avistacap.com</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Address:</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">65 East 55th Street</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">18th Floor</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">New York, NY 10022</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Attn: Benjamin Silbert</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">email: Silbert@avistacap.com</P></TD></TR>

<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>OMNIAB, INC.</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Matthew W. Foehr</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name: Matthew W. Foehr</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Title: President and Chief Executive Officer</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Address for Notices: 5980 Horton Street</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4.00em; font-size:10pt; font-family:Times New Roman">Suite
405</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4.00em; font-size:10pt; font-family:Times New Roman">Emeryville, CA 94608</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4.00em; font-size:10pt; font-family:Times New Roman">Attn: Matt Foehr</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:4.00em; font-size:10pt; font-family:Times New Roman">Email:
matt@omniab.com</P></TD></TR>
</TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>Exhibit&nbsp;A </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>FORM OF JOINDER TO LETTER AGREEMENT </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>[</B>______<B>], 20__</B> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Reference is made
to the Letter Agreement, dated as of March&nbsp;23, 2022, by and among Avista Public Acquisition Corp. II, a Cayman Islands exempted company (&#147;<B><I>Parent</I></B>&#148;), Avista Acquisition LP II (the &#147;<B><I>Sponsor</I></B>&#148;) and the
other signatories thereto (the &#147;<B><I>Insiders</I></B>&#148;), each of whom is a member of Parent&#146;s management team and/or the Board (the &#147;Letter Agreement&#148;). Capitalized terms used but not otherwise defined herein shall have the
meanings ascribed to such terms in the Letter Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Each of the Parent, Sponsor, the Insiders and each of the undersigned holder of Domesticated
Parent Common Stock (each, a &#147;<B><I>New Stockholder Party</I></B>&#148;) agrees that this Joinder to the Letter Agreement (this &#147;<B><I>Joinder</I></B>&#148;) is being executed and delivered for good and valuable consideration. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Each undersigned New Stockholder Party hereby agrees to and does become party to the Letter Agreement and to be subject to the same rights, remedies or
obligations as the Sponsor thereunder. This Joinder shall serve as a counterpart signature page to the Letter Agreement and by executing below each undersigned New Stockholder Party is deemed to have executed the Letter Agreement with the same force
and effect as if originally named a party thereto. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This Joinder may be executed in multiple counterparts, including by means of facsimile or electronic
signature, each of which shall be deemed an original, but all of which together shall constitute the same instrument. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[<I>Remainder of
Page Intentionally Left Blank.</I>] </P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000">&nbsp;</P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-2.4
<SEQUENCE>5
<FILENAME>d337089dex24.htm
<DESCRIPTION>EX-2.4
<TEXT>
<HTML><HEAD>
<TITLE>EX-2.4</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 2.4 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B><I>Execution Version </I></B></P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>AMENDED AND RESTATED FORWARD PURCHASE AGREEMENT </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This Amended and Restated Forward Purchase Agreement (this &#147;<U>Agreement</U>&#148;) is entered into as of March&nbsp;23, 2022, by and
among Avista Public Acquisition Corp. II, a Cayman Islands exempted company (the &#147;<U>Company</U>&#148;), Avista Acquisition LP II, a Cayman Islands exempted limited partnership (the &#147;<U>Purchaser</U>&#148;), and OmniAb, Inc., a Delaware
corporation (&#147;<U>SpinCo</U>&#148;), and amends and restates in its entirety that certain Forward Purchase Agreement (the &#147;<U>Original Agreement</U>&#148;), dated as of August&nbsp;9, 2021, by and between the Company and the Purchaser.
Capitalized terms used but not defined in this Agreement shall have the meanings ascribed to such terms in that certain Merger Agreement, dated as of the date of this Agreement, by and among the Company, Orwell Merger Sub Inc., a Delaware
corporation and wholly owned Subsidiary of the Company, Ligand Pharmaceuticals Incorporated, a Delaware corporation, and SpinCo (the &#147;<U>Merger Agreement</U>&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, the parties wish to amend and restate the Original Agreement as set forth in this Agreement, pursuant to which at the Closing under
the Merger Agreement (the &#147;<U>Merger Closing</U>&#148;), the Company shall issue and sell, and the Purchaser shall purchase, on a private placement basis, 1,500,000 shares of Domesticated Parent Common Stock (the &#147;<U>Forward Purchase
Shares</U>&#148;) and 1,666,667 Domesticated Parent Warrants (the &#147;<U>Forward Purchase Warrants</U>&#148; and together with the Forward Purchase Shares, the &#147;<U>Forward Purchase Securities</U>&#148;) on the terms and conditions set forth
herein; and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, in connection with the entry into the Merger Agreement, an allocation of up to $100,000,000.00 of committed capital
of the Purchaser has been made to subscribe for up to 10,000,000 shares of Domesticated Parent Common Stock and up to 1,666,667 Domesticated Parent Warrants to the extent that the number of shares of Domesticated Parent Common Stock that are
redeemed in connection with the consummation of the Transactions would result in the Trust Amount being less than $100,000,000.00, on the terms and conditions set forth herein (the &#147;<U>Backstop Commitment</U>&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">NOW, THEREFORE, in consideration of the premises, representations, warranties and the mutual covenants contained in this Agreement, and for
other good and valuable consideration, the receipt, sufficiency and adequacy of which are hereby acknowledged, the parties hereto agree as follows: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>1. Backstop Subscription; Funding Notice. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) <U>Backstop Subscription</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">To the extent that the Trust Amount is less than $100,000,000 immediately prior to the Effective Time, the Purchaser agrees to purchase
(i)&nbsp;a number of shares of Domesticated Parent Common Stock equal to (A) (x) $100,000,000 minus (y)&nbsp;the Trust Amount (such amount, the &#147;<U>Backstop Subscription Amount</U>&#148;), divided by (B) $10.00, rounded down to the nearest
whole number (the &#147;<U>Backstop Shares</U>&#148;) and (ii)&nbsp;a number of Domesticated Parent Warrants equal to (I) 1,666,667 multiplied by (II)&nbsp;a number, the numerator of which is the Backstop Subscription Amount and the denominator of
which is $100,000,000 (the &#147;<U>Backstop Warrants</U>&#148; and, together with the Backstop Shares, the &#147;<U>Backstop Securities</U>&#148;). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) <U>Funding Notice</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On
the date by which Avista Shareholder Redemptions are required to be made in accordance with the Company&#146;s memorandum and articles of association, as they may be amended from time to time (the &#147;<U>Memorandum and Articles</U>&#148;) (which
date is two (2)&nbsp;Business Days prior to the date of the Parent Shareholders Meeting), the Company shall deliver a written notice (the &#147;<U>Funding Notice</U>&#148;) to the Purchaser setting forth: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) the Parent Share Redemption Amount; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) the Backstop Subscription Amount (as calculated in accordance with <U>Section</U><U></U><U>&nbsp;1(a)</U> of this
Agreement); </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii) the number of Backstop Shares; </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iv) the number of Backstop Warrants; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(v) the anticipated Closing Date; and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(vi) the Company&#146;s wire instructions. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Notwithstanding the foregoing, for the avoidance of doubt, the &#147;Backstop Subscription Amount&#148; shall be finally calculated without
including any shares of Domesticated Parent Common Stock subject to the Parent Shareholder Redemption that have been offered for redemption but subsequently and validly withdrawn by the applicable holder in accordance with the Company&#146;s
Memorandum and Articles and applicable Law. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>2. Sale and Purchase. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <U>Forward Purchase Securities; Backstop Securities</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) The Company shall issue and sell to the Purchaser, and the Purchaser shall purchase from the Company, on a private placement basis,
1,500,000 Forward Purchase Shares and 1,666,667 Forward Purchase Warrants for an aggregate purchase price of $15,000,000 (the &#147;<U>FPS Purchase Price</U>&#148;). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) Subject to the terms and conditions hereof, the Company shall issue and sell to the Purchaser, and the Purchaser shall purchase from the
Company, on a private placement basis, the Backstop Shares and the Backstop Warrants for an aggregate purchase price equal to the Backstop Subscription Amount. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iii) Each Forward Purchase Warrant and Backstop Warrant will have the same terms as the Parent Private Placement Warrants, and will be
subject to the terms and conditions of the Warrant Agreement. Each Forward Purchase Warrant and Backstop Warrant will entitle the holder thereof to purchase one share of Domesticated Parent Common Stock at a price of $11.50 per share, subject to
adjustment as described in the Warrant Agreement. The Forward Purchase Warrants and Backstop Warrants will become exercisable thirty (30)&nbsp;days after the Merger Closing and will expire five (5)&nbsp;years after the Merger Closing or upon
redemption or the liquidation of the Company, if earlier, as described in the Warrant Agreement. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iv) The delivery of the Funding Notice
hereunder shall serve as notice to the Purchaser that the Purchaser will be required to pay the FPS Purchase Price and the Backstop Subscription Amount, and acquire the Forward Purchase Securities and the Backstop Securities, at the FPS/BPS Closing
(as defined below). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(v) The closing of the sale of the Forward Purchase Securities and the Backstop Securities (the &#147;<U>FPS/BPS
Closing</U>&#148;) shall be held on the Closing Date and immediately prior to the Merger Closing. At the FPS/BPS Closing, the Company will issue to the Purchaser the Forward Purchase Securities and the Backstop Securities, if any, each registered in
the name of the Purchaser, against (and concurrently with) the payment of the FPS Purchase Price and the Backstop Subscription Amount to the Company by wire transfer of immediately available funds to the account notified to the Purchaser by the
Company in the Funding Notice. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <U>Delivery of Securities</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) The Company shall register the Purchaser as the owner of the Forward Purchase Securities and the Backstop Securities purchased by the
Purchaser hereunder (together, the &#147;<U>Securities</U>&#148;) on the Company&#146;s share register and with the Company&#146;s transfer agent by book entry on or promptly after (but in no event more than two (2)&nbsp;Business Days after) the
date of the FPS/BPS Closing. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) Each register and book entry for the Securities shall contain a notation, and each certificate (if any)
evidencing the Securities shall be stamped or otherwise imprinted with a legend, in substantially the following form: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">&#147;THE SECURITIES
REPRESENTED HEREBY HAVE NOT BEEN REGISTERED UNDER THE U.S. SECURITIES ACT OF 1933, AS AMENDED, OR THE SECURITIES LAWS OF ANY STATE OR OTHER JURISDICTION, AND MAY NOT BE TRANSFERRED IN VIOLATION OF SUCH ACT AND LAWS.&#148; </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) <U>Legend Removal</U>. If the Securities are eligible to be sold without restriction
under, and without the Company being in compliance with the current public information requirements of, Rule 144 under the Securities Act, then at the Purchaser&#146;s request, the Company will cause the Company&#146;s transfer agent to remove the
legend set forth in <U>Section</U><U></U><U>&nbsp;2(b)(ii)</U>. In connection therewith, if required by the Company&#146;s transfer agent, the Company will promptly cause an opinion of counsel to be delivered to and maintained with its transfer
agent, together with any other authorizations, certificates and directions required by the transfer agent that authorize and direct the transfer agent to transfer such Securities without any such legend; <U>provided</U>, <U>however</U>, that the
Company will not be required to deliver any such opinion, authorization or certificate or direction if it reasonably believes that removal of the legend could result in or facilitate transfers of the Securities in violation of applicable Law. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) <U>Registration Rights</U>. The Purchaser shall have registration rights with respect to the Securities as referenced in the Amended and
Restated Registration Rights Agreement that will be entered into by and among the Company, the Purchaser, SpinCo and certain other parties thereto in connection with the consummation of the Transactions and the form of which is attached to the
Merger Agreement as Exhibit E (the &#147;<U>Registration Rights Agreement</U>&#148;). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) <U>Adjustments to Notional Amounts</U>. In the
event of any change to the capital structure of the Company, whether dilutive or otherwise, by way of a share dividend, share split, or any other similar transaction however described, the number of Forward Purchase Securities and Backstop
Securities, and/or the FPS Purchase Price and Backstop Subscription Amount, as applicable, will be adjusted as necessary to account for such changes. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>3.</B> <B>Representations and Warranties of the Purchaser</B>. The Purchaser represents and warrants to each of the Company and SpinCo as
follows, as of the date hereof: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <U>Organization and Power</U>. The Purchaser is duly organized, validly existing, and in good standing
under the Laws of the jurisdiction of its formation and has all requisite power and authority to carry on its business as presently conducted and as proposed to be conducted. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <U>Authorization</U>. The Purchaser has full power and authority to enter into this Agreement. This Agreement, when executed and delivered
by the Purchaser, will constitute the valid and legally binding obligation of the Purchaser, enforceable in accordance with its terms, except (a)&nbsp;as limited by applicable bankruptcy, insolvency, reorganization, moratorium, fraudulent conveyance
and any other Laws of general application affecting enforcement of creditors&#146; rights generally, (b)&nbsp;as limited by Laws relating to the availability of specific performance, injunctive relief or other equitable remedies, or (c)&nbsp;to the
extent the indemnification provisions contained in the Registration Rights Agreement may be limited by applicable federal or state securities Laws. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) <U>Governmental Consents and Filings</U>. No consent, approval, order or authorization of, or registration, qualification, designation,
declaration or filing with, any federal, state or local governmental authority is required on the part of the Purchaser in connection with the consummation of the transactions contemplated by this Agreement. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) <U>Compliance with Other Instruments</U>. The execution, delivery and performance by the Purchaser of this Agreement and the consummation
by the Purchaser of the transactions contemplated by this Agreement will not result in any violation or default (i)&nbsp;of any provisions of its organizational documents, (ii)&nbsp;of any instrument, judgment, order, writ or decree to which it is a
party or by which it is bound, (iii)&nbsp;under any note, indenture or mortgage to which it is a party or by which it is bound, (iv)&nbsp;under any lease, agreement, contract or purchase order to which it is a party or by which it is bound or
(v)&nbsp;of any provision of federal or state statute, rule or regulation applicable to the Purchaser, in each case (other than clause (i)), which would have a material adverse effect on the Purchaser or its ability to consummate the transactions
contemplated by this Agreement. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) <U>Purchase Entirely for Own Account</U>. This Agreement is made with the Purchaser in
reliance upon the Purchaser&#146;s representation to the Company, which by the Purchaser&#146;s execution of this Agreement, the Purchaser hereby confirms, that the Securities to be acquired by the Purchaser will be acquired for investment for the
Purchaser&#146;s own account, not as a nominee or agent, and not with a view to the resale or distribution of any part thereof, and that the Purchaser has no present intention of selling, granting any participation in, or otherwise distributing the
same in violation of Law. By executing this Agreement, the Purchaser further represents that the Purchaser does not presently have any contract, undertaking, agreement or arrangement with any Person to sell, transfer or grant participations to such
Person or to any third Person, with respect to any of the Securities. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) <U>Disclosure of Information</U>. The Purchaser has had an
opportunity to discuss the Company&#146;s existing and planned or expected business, management, financial affairs and the terms and conditions of the purchase and sale of the Securities, as well as the terms of the Transactions, with the
Company&#146;s management. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) <U>Restricted Securities</U>. The Purchaser understands that the offer and sale of the Securities to the
Purchaser has not been, and will not be, registered under the Securities Act, by reason of a specific exemption from the registration provisions of the Securities Act which depends upon, among other things, the bona fide nature of the investment
intent and the accuracy of the Purchaser&#146;s representations as expressed herein. The Purchaser understands that the Securities are &#147;restricted securities&#148; under applicable U.S. federal and state securities Laws and that, pursuant to
these Laws, the Purchaser must hold the Securities indefinitely unless they are registered with the SEC and qualified by state authorities, or an exemption from such registration and qualification requirements is available. The Purchaser
acknowledges that the Company has no obligation to register or qualify the Securities, or any securities into which the Securities may be converted into or exercised for, for resale, except pursuant to the Registration Rights Agreement. The
Purchaser further acknowledges that if an exemption from registration or qualification is available, it may be conditioned on various requirements including, but not limited to, the time and manner of sale, the holding period for the Securities, and
on requirements relating to the Company which are outside of the Purchaser&#146;s control, and which the Company is under no obligation and may not be able to satisfy. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h) <U>High Degree of Risk</U>. The Purchaser understands that its agreement to purchase the Securities involves a high degree of risk, which
could cause the Purchaser to lose all or part of its investment. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) <U>Accredited Investor</U>. The Purchaser is an &#147;accredited
investor&#148; as defined in Rule 501(a) of Regulation D promulgated under the Securities Act. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(j) <U>No General Solicitation</U>. Neither
the Purchaser, nor any of its officers, directors, employees, agents, stockholders or partners has either directly or indirectly, including, through a broker or finder (i)&nbsp;to its knowledge, engaged in any general solicitation, or
(ii)&nbsp;published any advertisement in connection with the purchase and sale of the Securities. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(k)
<U><FONT STYLE="white-space:nowrap">Non-Public</FONT> Information</U>. The Purchaser acknowledges its obligations under applicable securities Laws with respect to the treatment of material <FONT STYLE="white-space:nowrap">non-public</FONT>
information relating to the Company. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(l) <U>Adequacy of Financing</U>. The Purchaser will have at the FPS/BPS Closing available to it
sufficient funds to satisfy its obligations under this Agreement. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(m) <U>Affiliation of Certain FINRA Members</U>. The Purchaser is
neither a person associated nor affiliated with any underwriter of the IPO or, to its actual knowledge, any other member of the Financial Industry Regulatory Authority (&#147;<U>FINRA</U>&#148;) that participated in the IPO. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(n) <U>No Other Representations and Warranties; <FONT STYLE="white-space:nowrap">Non-Reliance</FONT></U>. Except for the specific
representations and warranties contained in this <U>Section</U><U></U><U>&nbsp;3</U> and in any certificate or agreement delivered pursuant hereto, none of the Purchaser nor any person acting on behalf of the Purchaser nor any of the
Purchaser&#146;s affiliates (the &#147;<U>Purchaser Parties</U>&#148;) has made, makes or shall be deemed to make any other express or implied representation or warranty with respect to the Purchaser or the purchase and sale of the Securities, and
the Purchaser Parties disclaim any such representation or warranty. Except for the specific representations and warranties expressly made by the Company in <U>Section</U><U></U><U>&nbsp;4</U> of this Agreement and in any certificate or agreement
delivered pursuant hereto, the Purchaser Parties specifically disclaim that they are relying upon any other representations or warranties that may have been made by the Company, any person on behalf of the Company or any of the Company&#146;s
affiliates (collectively, the &#147;<U>Company Parties</U>&#148;). </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>4.</B> <B>Represe</B>n<B>tations and Warranties of the Company</B>. The Company
represents and warrants to the Purchaser as follows: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <U>Incorporation and Corporate Power</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) Until the occurrence of the Domestication, the Company is an exempted company duly incorporated, validly existing and in good standing
under the Laws of the Cayman Islands and has all requisite corporate power and authority to carry on its business as presently conducted and as proposed to be conducted. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) Upon the occurrence of the Domestication, the Company will be a corporation duly incorporated, validly existing and in good standing under
the Laws of the State of Delaware and will have all requisite corporate power and authority to carry on its business as presently conducted and as proposed to be conducted. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iii) The Company has no subsidiaries other than Merger Sub. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <U>Capitalization</U>. The authorized share capital of the Company consists, as of the date hereof, of: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) 500,000,000 shares of Parent Class&nbsp;A Common Stock, 23,000,000 of which are issued and outstanding. All of the issued and outstanding
shares of Parent Class&nbsp;A Common Stock have been duly authorized, are fully paid and nonassessable and were issued in compliance with all applicable federal and state securities Laws. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) 50,000,000 shares of Parent Class&nbsp;B Common Stock, 5,750,000 of which are issued and outstanding. All of the issued and outstanding
shares of Parent Class&nbsp;B Common Stock have been duly authorized, are fully paid and nonassessable and were issued in compliance with all applicable federal and state securities Laws. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iii) 5,000,000 shares of Parent Preferred Stock, none of which are issued and outstanding. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) <U>Authorization</U>. All corporate action required to be taken by the Company&#146;s Board of Directors and shareholders in order to
authorize the Company to enter into this Agreement, and to issue the Securities at the FPS/BPS Closing, and the securities issuable upon conversion or exercise of the Securities, has been taken or will be taken prior to the FPS/BPS Closing, as
applicable. All action on the part of the shareholders, directors and officers of the Company necessary for the execution and delivery of this Agreement, the performance of all obligations of the Company under this Agreement to be performed as of
the FPS/BPS Closing, and the issuance and delivery of the Securities and the securities issuable upon conversion or exercise of the Securities has been taken or will be taken prior to the FPS/BPS Closing. This Agreement, when executed and delivered
by the Company, shall constitute a valid and legally binding obligation of the Company, enforceable against the Company in accordance with its terms except (i)&nbsp;as limited by applicable bankruptcy, insolvency, reorganization, moratorium,
fraudulent conveyance, or other Laws of general application relating to or affecting the enforcement of creditors&#146; rights generally, (ii)&nbsp;as limited by Laws relating to the availability of specific performance, injunctive relief, or other
equitable remedies, or (iii)&nbsp;to the extent the indemnification provisions contained in the Registration Rights Agreement may be limited by applicable federal or state securities Laws. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) <U>Valid Issuance of Securities</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) The Securities, when issued, sold and delivered in accordance with the terms and for the consideration set forth in this Agreement and
registered in the register of members of the Company, and the securities issuable upon conversion or exercise of the Securities, when issued in accordance with the terms of the Securities and this Agreement, and registered on the Company&#146;s
share register, will be validly issued, fully paid and </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
nonassessable and free of all preemptive or similar rights, liens, encumbrances and charges with respect to the issue thereof and restrictions on transfer other than restrictions on transfer
specified under this Agreement, applicable state and federal securities Laws and liens or encumbrances created by or imposed by the Purchaser. Assuming the accuracy of the representations of the Purchaser in this Agreement and subject to the filings
described in <U>Section</U><U></U><U>&nbsp;4(e)</U> below, the Securities and the securities issuable upon conversion of the Securities will be issued in compliance with all applicable federal and state securities Laws. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) No &#147;bad actor&#148; disqualifying event described in Rule 506(d)(1)(i)-(viii) of the Securities Act (a &#147;<U>Disqualification
Event</U>&#148;) is applicable to the Company or, to the Company&#146;s knowledge, any Company Covered Person (as defined below), except for a Disqualification Event as to which Rule 506(d)(2)(ii&#151;iv) or (d)(3), is applicable. &#147;<U>Company
Covered Person</U>&#148; means, with respect to the Company as an &#147;issuer&#148; for purposes of Rule 506 promulgated under the Securities Act, any Person listed in the first paragraph of Rule 506(d)(1). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) <U>Governmental Consents and Filings</U>. Assuming the accuracy of the representations and warranties made by the Purchaser in this
Agreement, no consent, approval, order or authorization of, or registration, qualification, designation, declaration or filing with, any federal, state or local governmental authority is required on the part of the Company in connection with the
consummation of the transactions contemplated by this Agreement, except for filings pursuant to Regulation D of the Securities Act, applicable state securities Laws and pursuant to the Registration Rights Agreement. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) <U>Compliance with Other Instruments</U>. The execution, delivery and performance of this Agreement and the consummation of the
transactions contemplated by this Agreement will not result in any violation or default (i)&nbsp;of any provisions of the Company&#146;s Governing Documents, as they may be amended from time to time, (ii)&nbsp;of any instrument, judgment, order,
writ or decree to which the Company is a party or by which it is bound, (iii)&nbsp;under any note, indenture or mortgage to which the Company is a party or by which it is bound, (iv)&nbsp;under any lease, agreement, contract or purchase order to
which the Company is a party or by which it is bound or (v)&nbsp;of any provision of federal or state statute, rule or regulation applicable to the Company, in each case (other than clause (i)) which would have a material adverse effect on the
Company or its ability to consummate the transactions contemplated by this Agreement. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) <U>Operations</U>. As of the date hereof, the
Company has not conducted any operations other than organizational activities and activities in connection with its initial public offering (the &#147;<U>IPO</U>&#148;), its search for a potential business combination and financing in connection
therewith. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h) <U>Foreign Corrupt Practices</U>. Neither the Company, nor any director, officer, agent, employee or other Person acting on
behalf of the Company has, in the course of its actions for, or on behalf of, the Company (i)&nbsp;used any corporate funds for any unlawful contribution, gift, entertainment or other unlawful expenses relating to political activity; (ii)&nbsp;made
any direct or indirect unlawful payment to any foreign or domestic government official or employee from corporate funds; (iii)&nbsp;violated or is in violation of any provision of the U.S. Foreign Corrupt Practices Act of 1977, as amended; or
(iv)&nbsp;made any unlawful bribe, rebate, payoff, influence payment, kickback or other unlawful payment to any foreign or domestic government official or employee. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) <U>Compliance with Anti-Money Laundering Laws</U>. The operations of the Company are and have been conducted at all times in compliance
with applicable financial recordkeeping and reporting requirements and all other applicable U.S. and <FONT STYLE="white-space:nowrap">non-U.S.</FONT> anti-money laundering Laws and regulations, including, but not limited to, those of the Currency
and Foreign Transactions Reporting Act of 1970, as amended, the USA PATRIOT Act of 2001 and the applicable money laundering statutes of all applicable jurisdictions, the rules and regulations thereunder and any related or similar rules, regulations
or guidelines, issued, administered or enforced by any governmental agency (collectively, the &#147;<U>Anti-Money Laundering Laws</U>&#148;), and no action, suit or proceeding by or before any court or governmental agency, authority or body or any
arbitrator involving the Company with respect to the Anti-Money Laundering Laws is pending or, to the knowledge of the Company, threatened. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(j) <U>Absence of Litigation</U>. There is no Action before or by any Governmental Authority or, to the Knowledge of the Company, threatened
against or affecting the Company or any of the Company&#146;s officers or directors, whether of a civil or criminal nature or otherwise, in their capacities as such. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(k) <U>No General Solicitation</U>. Neither the Company, nor any of its officers, directors,
employees, agents or shareholders has either directly or indirectly, including, through a broker or finder (i)&nbsp;engaged in any general solicitation, or (ii)&nbsp;published any advertisement in connection with the offer and sale of the
Securities. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(l) <U>No Other Representations and Warranties; <FONT STYLE="white-space:nowrap">Non-Reliance</FONT></U>. Except for the
specific representations and warranties contained in this <U>Section</U><U></U><U>&nbsp;4</U> and in any certificate or agreement delivered pursuant hereto, none of the Company Parties has made, makes or shall be deemed to make any other express or
implied representation or warranty with respect to the Company, the transactions contemplated by the Merger Agreement or the offer and sale of the Securities, and the Company Parties disclaim any such representation or warranty. Except for the
specific representations and warranties expressly made by the Purchaser in <U>Section</U><U></U><U>&nbsp;3</U> of this Agreement and in any certificate or agreement delivered pursuant hereto, the Company Parties specifically disclaim that they are
relying upon any other representations or warranties that may have been made by the Purchaser Parties. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>5. Additional Agreements,
Acknowledgements and Waivers of the Purchaser. </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <U>Trust Account</U>. The Purchaser acknowledges that the Company is a blank check
company with the powers and privileges to effect a Business Combination. The Purchaser further acknowledges that, as described in the prospectus included in the registration statement of the Company (the &#147;<U>Prospectus</U>&#148;) available at
www.sec.gov, substantially all of the Company&#146;s assets consist of the cash proceeds of the IPO and private placements of its securities, and substantially all of those proceeds have been deposited in a trust account for the benefit of the
Company, certain of its public shareholders and the underwriters of the IPO (the &#147;<U>Trust Account</U>&#148;). The Purchaser acknowledges that, except with respect to interest earned on the funds held in the Trust Account that may be released
to the Company to pay its franchise Tax, income Tax and similar obligations, the Trust Agreement provides that cash in the Trust Account may be disbursed only (i)&nbsp;if the Company completes one or more transactions that constitute a Business
Combination, then to those Persons and in such amounts as described in the Prospectus; (ii)&nbsp;if the Company fails to complete a Business Combination within the allotted time period and liquidates, subject to the terms of the Trust Agreement, to
the Company in limited amounts to permit the Company to pay the costs and expenses of its liquidation and dissolution, and then to the Company&#146;s public shareholders; and (iii)&nbsp;if the Company holds a shareholder vote to amend the
Company&#146;s Governing Documents to modify the substance or timing of the obligation to redeem 100% of the shares of Parent Common Stock if the Company fails to complete a Business Combination within the allotted time period, then for the
redemption of any shares of Parent Common Stock properly tendered in connection with such vote. For and in consideration of the Company entering into this Agreement, the receipt and sufficiency of which are hereby acknowledged, the Purchaser hereby
irrevocably waives any right, title, interest or claim of any kind they have or may have in the future in or to any monies in the Trust Account (including any distributions therefrom) and agree not to seek recourse against the Trust Account or any
funds distributed therefrom as a result of, or arising out of, this Agreement and any negotiations, Contracts or agreements with the Company; <U>provided</U>, <U>however</U>, that nothing herein shall serve to limit or prohibit the Purchaser&#146;s
right to pursue a claim against the Company for legal relief against monies or other assets held outside the Trust Account, for specific performance or other equitable relief in connection with the consummation of the Transactions so long as such
claim would not affect the Company&#146;s ability to fulfill its obligation to effectuate the Parent Share Redemptions. The Purchaser agrees and acknowledges that such irrevocable waiver is material to this Agreement and specifically relied upon by
the Company to induce it to enter in this Agreement, and the Purchaser further intends and understands such waiver to be valid, binding and enforceable under applicable Law. To the extent the Purchaser commences any action or proceeding based upon,
in connection with, relating to or arising out of any matter relating to the Company, which proceeding seeks, in whole or in part, monetary relief against the Company, the Purchaser hereby acknowledges and agrees that its sole remedy shall be
against funds held outside of the Trust Account and that such claim shall not permit the Purchaser (or any party claiming on the Purchaser&#146;s behalf or in lieu of the Purchaser) to have any claim against the Trust Account (including any
distributions therefrom) or any amounts contained therein. In the event that the Purchaser commences any action or proceeding based upon, in connection with, relating to or arising out of any matter relating to the Company, which proceeding seeks,
in whole or in part, relief against the Trust Account (including any distributions therefrom) or the holders of Parent Common Stock, whether in the form of money damages or injunctive relief, the Company shall be entitled to recover from the
Purchaser the associated legal fees and costs in connection with any such action, in the event the Company prevails in such action or proceeding. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <U>No Short Sales</U>. The Purchaser hereby agrees that neither it, nor any person or
entity acting on its behalf or pursuant to any understanding with it, will engage in any Short Sales with respect to securities of the Company prior to the Merger Closing. For purposes of this <U>Section</U><U></U><U>&nbsp;5</U>, &#147;<U>Short
Sales</U>&#148; shall include, without limitation, all &#147;short sales&#148; as defined in Rule 200 promulgated under Regulation SHO under the Exchange Act and all types of direct and indirect stock pledges (other than pledges in the ordinary
course of business as part of prime brokerage arrangements), forward sale contracts, options, puts, calls, swaps and similar arrangements (including on a total return basis), and sales and other transactions through
<FONT STYLE="white-space:nowrap">non-U.S.</FONT> broker dealers or foreign regulated brokers. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) <U>Voting</U>. The Purchaser hereby
agrees that if the Company seeks shareholder approval of the Transaction Proposals, then the Purchaser shall vote any shares of Parent Class&nbsp;A Common Stock owned by it in favor of such Transaction Proposals. If the Purchaser fails to vote any
shares of Parent Class&nbsp;A Common Stock it is required to vote hereunder in favor of the Transaction Proposals, the Purchaser hereby grants hereunder to the Company and any representative designated by the Company, without further action by the
Purchaser or any other Person, a limited irrevocable power of attorney to effect such vote on behalf of the Purchaser, which power of attorney shall be deemed to be coupled with an interest. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>6.</B> <B>QEF Election Information</B>. The Company shall use commercially reasonable efforts to determine whether, in any year, the
Company or any subsidiary of the Company is deemed to be a &#147;passive foreign investment company&#148; (a &#147;<U>PFIC</U>&#148;) within the meaning of U.S. Internal Revenue Code of 1986, as amended, and the regulations promulgated thereunder
(collectively, the &#147;<U>Code</U>&#148;). If the Company determines that the Company or any subsidiary of the Company is a PFIC in any year, for the year of determination and for each year thereafter during which the Purchaser holds an equity
interest in the Company, including any Parent Warrants, the Company or such subsidiary shall use commercially reasonable efforts to (a)&nbsp;make available to the Purchaser the information that may be required to make or maintain a &#147;qualified
electing fund&#148; election under the Code with respect to the Company and (b)&nbsp;furnish the information required to be reported under Section&nbsp;1298(f) of the Code. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>7. Listing. </B>The Company will use commercially reasonable efforts to maintain the listing of the Parent Class&nbsp;A Common Stock and
Domesticated Class&nbsp;A Common Stock (as applicable) on the NASDAQ (or another national securities exchange). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>8.</B> <B>FPS/BPS
Closing Conditions</B>. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) The obligation of the Purchaser to purchase the Securities at the FPS/BPS Closing under this Agreement shall
be subject to the fulfillment, at or prior to the FPS/BPS Closing of each of the following conditions, any of which, to the extent permitted by applicable Laws, may be waived by the Purchaser: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) The Transactions shall be completed substantially concurrently with, and (except in the case of the Domestication) immediately following,
the purchase and sale of the Securities hereunder; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) The Company shall not have delivered to the Purchaser a revocation of the Funding
Notice; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iii) The representations and warranties of the Company set forth in <U>Section</U><U></U><U>&nbsp;4</U> of this Agreement shall
have been true and correct as of the date hereof and shall be true and correct as of the FPS/BPS Closing, as applicable, with the same effect as though such representations and warranties had been made on and as of such date (other than any such
representation or warranty that is made by its terms as of a specified date, which shall be true and correct as of such specified date), except where the failure to be so true and correct would not have a material adverse effect on the Company, or
its ability to consummate the transactions contemplated by this Agreement; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iv) The Company shall have performed, satisfied and complied
in all material respects with the covenants, agreements and conditions required by this Agreement to be performed, satisfied or complied with by the Company, at or prior to the FPS/BPS Closing; and </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(v) No order, writ, judgment, injunction, decree, determination, or award shall have been
entered by or with any governmental, regulatory, or administrative authority or any court, tribunal, or judicial, or arbitral body, and no other legal restraint or prohibition shall be in effect, preventing the purchase by the Purchaser of the
Securities. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) The obligation of the Company to sell the Securities at the FPS/BPS Closing under this Agreement shall be subject to the
fulfillment, at or prior to the FPS/BPS Closing of each of the following conditions, any of which, to the extent permitted by applicable Laws, may be waived by the Company: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) The Transactions shall be completed substantially concurrently with, and (except in the case of the Domestication) immediately following,
the purchase and sale of the Securities hereunder; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) The representations and warranties of the Purchaser set forth in
<U>Section</U><U></U><U>&nbsp;3</U> of this Agreement shall have been true and correct as of the date hereof and shall be true and correct as of the FPS/BPS Closing, as applicable, with the same effect as though such representations and warranties
had been made on and as of such date (other than any such representation or warranty that is made by its terms as of a specified date, which shall be true and correct as of such specified date), except where the failure to be so true and correct
would not have a material adverse effect on the Purchaser or its ability to consummate the transactions contemplated by this Agreement; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iii) The Purchaser shall have performed, satisfied and complied in all material respects with the covenants, agreements and conditions
required by this Agreement to be performed, satisfied or complied with by the Purchaser at or prior to the FPS/BPS Closing; and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iv) No
order, writ, judgment, injunction, decree, determination, or award shall have been entered by or with any governmental, regulatory, or administrative authority or any court, tribunal, or judicial, or arbitral body, and no other legal restraint or
prohibition shall be in effect, preventing the purchase by the Purchaser of the Securities. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>9.</B> <B>Termination</B>. This Agreement
may be terminated at any time prior to the FPS/BPS Closing: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) by mutual written consent of the Company, the Purchaser and SpinCo; or
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) automatically: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) if
a Business Combination is not completed within eighteen (18)&nbsp;months from the closing of the IPO, or such later date as may be approved by the Company&#146;s shareholders in accordance with its Governing Documents; or </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) upon the termination of the Merger Agreement in accordance with the terms and conditions thereof. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the event of any termination of this Agreement pursuant to this <U>Section</U><U></U><U>&nbsp;9</U>, the FPS Purchase Price and the Backstop
Subscription Amount (and interest thereon, if any), if previously paid, and all Purchaser&#146;s funds paid in connection herewith shall be promptly returned to the Purchaser, and thereafter this Agreement shall forthwith become null and void and
have no effect, without any liability on the part of the Purchaser or the Company and their respective directors, officers, employees, partners, managers, members, or shareholders and all rights and obligations of each party shall cease;
<U>provided</U>, <U>however</U>, that nothing contained in this <U>Section</U><U></U><U>&nbsp;9</U> shall relieve either party from liabilities or damages arising out of any fraud or willful breach by such party of any of its representations,
warranties, covenants or agreements contained in this Agreement. Notwithstanding anything herein to the contrary, from and after any termination of this Agreement pursuant to <U>Section</U><U></U><U>&nbsp;9(b)</U>, the Original Agreement shall
automatically resume and continue in full force and effect in accordance with its terms as though it were never amended and restated by this Agreement. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>10. Termination Fee</B>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) In the event that this Agreement is terminated by reason of a termination of the Merger Agreement pursuant to Section&nbsp;9.1(i) thereof,
then, concurrently with and as a condition to such termination, the Company shall pay the Purchaser or its designee(s) a termination fee of $12,500,000.00 (the &#147;<U>FPA Termination Fee</U>&#148;) by wire transfer of immediately available funds
to an account designated by the Purchaser in writing. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) Notwithstanding anything to the contrary set forth in this Agreement, except in
the case of Actual Fraud or Willful Breach, if the FPA Termination Fee is paid pursuant to <U>Section</U><U></U><U>&nbsp;10(a)</U>, such payment shall constitute the sole and exclusive remedy of the Purchaser, any of its Subsidiaries or any of its
or their respective former, current or future general or limited partners, shareholders, Representatives or assignees against the Company Related Parties for all losses and damages suffered as a result of the failure of the Transactions to be
consummated or for a breach or failure to perform hereunder or otherwise, and none of the Company Related Parties shall have any further liability or obligation to Purchaser and such other Persons relating to or arising out of this Agreement or the
Transactions. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) If the Company fails to pay promptly the FPA Termination Fee when due under this <U>Section</U><U></U><U>&nbsp;10</U>,
and in order to obtain such payment, the Purchaser commences an Action that results in a judgment against the Company for any amount owed thereby under this Section&nbsp;10, the Company shall reimburse the Purchaser for its reasonable and documented
costs and expenses (including reasonable and documented attorneys&#146; fees) in connection with such Action, together with interest on such amount at a rate equal to (x)&nbsp;the prime rate as published in The Wall Street Journal in effect on the
date such payment was required to be made through the date such payment was actually received, plus (y)&nbsp;five percent (5%). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) Each
of the parties acknowledges that (i)&nbsp;the agreements contained in this <U>Section</U><U></U><U>&nbsp;10</U> are an integral part of the Transactions, (ii)&nbsp;without these agreements, the parties would not enter into this Agreement and
(iii)&nbsp;the FPA Termination Fee does not constitute a penalty, but rather represents liquidated damages in a reasonable amount that will compensate the Purchaser for the efforts and resources expended and opportunities foregone while negotiating
this Agreement and in reliance on this Agreement and on the expectation of the consummation of the Transactions, which amount would otherwise be impossible to calculate with precision. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>11.</B> <B>General Provisions</B>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <U>Notices</U>. All notices and other communications given or made pursuant to this Agreement shall be in writing and shall be deemed
effectively given upon the earlier of actual receipt, or (i)&nbsp;personal delivery to the party to be notified, (ii)&nbsp;when sent, if sent by electronic mail or facsimile (if any) during normal business hours of the recipient, and if not sent
during normal business hours, then on the recipient&#146;s next Business Day, (iii)&nbsp;five (5) Business Days after having been sent by registered or certified mail, return receipt requested, postage prepaid, or (iv)&nbsp;one (1) Business Day
after deposit with a nationally recognized overnight courier, freight prepaid, specifying next Business Day delivery, with written verification of receipt. All communications sent to the Company shall be sent to: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Avista Public Acquisition Corp. II </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">65 East 55th Street, 18th Floor </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">New York, New York 10022 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Attn:
Benjamin Silbert, General Counsel </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">email: Silbert@avistacap.com </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">with a copy to the Company&#146;s counsel (which shall not constitute notice) at: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Weil, Gotshal&nbsp;&amp; Manges LLP </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">767 Fifth Avenue </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">New York, New
York 10153 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Attn: </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Jaclyn L.
Cohen, Esq. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Raymond O. Gietz, Esq. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">email: Jackie.Cohen@weil.com </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Raymond.Gietz@weil.com </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">All communications to the Purchaser or SpinCo shall be sent to the Purchaser&#146;s or SpinCo&#146;s address
as set forth on the signature page hereof, or to such <FONT STYLE="white-space:nowrap">e-mail</FONT> address, facsimile number (if any) or address as subsequently modified by written notice given in accordance with this
<U>Section</U><U></U><U>&nbsp;11(a)</U>. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <U>No Finder</U><U>&#146;</U><U>s Fees</U>. Each party represents that it neither is nor will
be obligated for any finder&#146;s fee or commission in connection with this transaction. The Purchaser agrees to indemnify and to hold harmless the Company from any liability for any commission or compensation in the nature of a finder&#146;s or
broker&#146;s fee arising out of this transaction (and the costs and expenses of defending against such liability or asserted liability) for which the Purchaser or any of its officers, employees or representatives is responsible. The Company agrees
to indemnify and hold harmless the Purchaser from any liability for any commission or compensation in the nature of a finder&#146;s or broker&#146;s fee arising out of this transaction (and the costs and expenses of defending against such liability
or asserted liability) for which the Company or any of its officers, employees or representatives is responsible. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) <U>Survival of
Representations and Warranties</U>. All of the representations and warranties contained herein shall survive the FPS/BPS Closing. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d)
<U>Entire Agreement</U>. This Agreement, together with any documents, instruments and writings that are delivered pursuant hereto or referenced herein, constitutes the entire agreement and understanding of the parties hereto in respect of its
subject matter and supersedes all prior understandings, agreements or representations by or among the parties hereto, written or oral, to the extent they relate in any way to the subject matter hereof or the transactions contemplated hereby. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) <U>Successors</U>. All of the terms, agreements, covenants, representations, warranties and conditions of this Agreement are binding upon,
and inure to the benefit of and are enforceable by, the parties hereto and their respective successors. Nothing in this Agreement, express or implied, is intended to confer upon any party other than the parties hereto or their respective successors
and assigns any rights, remedies, obligations or liabilities under or by reason of this Agreement, except as expressly provided in this Agreement. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) <U>Assignments</U>. Except as otherwise specifically provided herein, no party hereto may assign either this Agreement or any of its
rights, interests, or obligations hereunder without the prior written approval of the other parties except that the Purchaser may assign its rights, interests or obligations hereunder to any of its affiliates. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) <U>Counterparts</U>. This Agreement may be executed in two or more counterparts, each of which will be deemed an original but all of which
together will constitute one and the same instrument. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h) <U>Headings</U>. The section headings contained in this Agreement are inserted
for convenience only and will not affect in any way the meaning or interpretation of this Agreement. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) <U>Governing Law</U>. This
Agreement, the entire relationship of the parties hereto, and any dispute between the parties (whether at law or in equity, and whether grounded in contract, tort or statute) shall be governed by, construed in accordance with, and interpreted
pursuant to the Laws of the State of Delaware, without giving effect to its choice of laws principles. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(j) <U>Jurisdiction</U>. The
parties (a)&nbsp;hereby irrevocably and unconditionally submit to the jurisdiction of the Court of Chancery of the State of Delaware for the purpose of any suit, action or other proceeding arising out of or based upon this Agreement, (b)&nbsp;agree
not to commence any suit, action or other proceeding arising out of or based upon this Agreement except in the Court of Chancery of the State of Delaware, and (c)&nbsp;hereby waive, and agree not to assert, by way of motion, as a defense, or
otherwise, in any such suit, action or proceeding, any claim that it is not subject personally to the jurisdiction of the above-named courts, that its property is exempt or immune from attachment or execution, that the suit, action or proceeding is
brought in an inconvenient forum, that the venue of the suit, action or proceeding is improper or that this Agreement or the subject matter hereof may not be enforced in or by such court. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(k) <U>Waiver of Jury Trial</U>. The parties hereto hereby waive any right to a jury trial
in connection with any litigation pursuant to this Agreement and the transactions contemplated hereby. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(l) <U>Amendments</U>. This
Agreement may not be amended, modified or waived as to any particular provision, except with the prior written consent of the Company, the Purchaser and SpinCo. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(m) <U>Severability</U>. The provisions of this Agreement will be deemed severable and the invalidity or unenforceability of any provision will
not affect the validity or enforceability of the other provisions hereof; <U>provided</U> that if any provision of this Agreement, as applied to any party hereto or to any circumstance, is adjudged by a governmental authority, arbitrator, or
mediator not to be enforceable in accordance with its terms, the parties hereto agree that the governmental authority, arbitrator, or mediator making such determination will have the power to modify the provision in a manner consistent with its
objectives such that it is enforceable, and/or to delete specific words or phrases, and in its reduced form, such provision will then be enforceable and will be enforced. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(n) <U>Expenses</U>. Each of the Company and the Purchaser will bear its own costs and expenses incurred in connection with the preparation,
execution and performance of this Agreement and the consummation of the transactions contemplated hereby, including all fees and expenses of agents, representatives, financial advisors, legal counsel and accountants. The Company shall be responsible
for the fees of its transfer agent, stamp taxes and all of The Depository Trust Company&#146;s fees associated with the issuance of the Securities and the securities issuable upon conversion or exercise of the Securities. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(o) <U>Construction</U>. The parties hereto have participated jointly in the negotiation and drafting of this Agreement. If an ambiguity or
question of intent or interpretation arises, this Agreement will be construed as if drafted jointly by the parties hereto and no presumption or burden of proof will arise favoring or disfavoring any party hereto because of the authorship of any
provision of this Agreement. Any reference to any federal, state, local or foreign Law will be deemed also to refer to Law as amended and all rules and regulations promulgated thereunder, unless the context requires otherwise. The words
&#147;<I>include</I>,&#148; &#147;<I>includes</I>&#148; and &#147;<I>including</I>&#148; will be deemed to be followed by &#147;<I>without limitation</I>.&#148; Pronouns in masculine, feminine, and neuter genders will be construed to include any
other gender, and words in the singular form will be construed to include the plural and vice versa, unless the context otherwise requires. The words &#147;<I>this Agreement</I>,&#148; &#147;<I>herein</I>,&#148; &#147;<I>hereof</I>,&#148;
&#147;<I>hereby</I>,&#148; &#147;<I>hereunder</I>&#148; and words of similar import refer to this Agreement as a whole and not to any particular subdivision unless expressly so limited. The parties hereto intend that each representation, warranty
and covenant contained herein will have independent significance. If any party hereto has breached any representation, warranty or covenant contained herein in any respect, the fact that there exists another representation, warranty or covenant
relating to the same subject matter (regardless of the relative levels of specificity) which such party hereto has not breached will not detract from or mitigate the fact that such party hereto is in breach of the first representation, warranty or
covenant. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(p) <U>Waiver</U>. No waiver by any party hereto of any default, misrepresentation or breach of warranty or covenant hereunder,
whether intentional or not, may be deemed to extend to any prior or subsequent default, misrepresentation or breach of warranty or covenant hereunder or affect in any way any rights arising because of any prior or subsequent occurrence. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(q) <U>Confidentiality</U>. Except as may be required by Law, regulation or applicable stock exchange listing requirements, unless and until
the transactions contemplated hereby and the terms hereof are publicly announced or otherwise publicly disclosed by the Company, the parties hereto shall keep confidential and shall not publicly disclose the existence or terms of this Agreement.
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(r) <U>Specific Performance; Enforcement</U>. Each party hereto agrees that irreparable damage may occur in the event any provision of
this Agreement was not performed by the Purchaser in accordance with the terms hereof and that the other party(ies) shall be entitled to specific performance of the terms hereof, in addition to any other remedy at law or in equity. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[<I>Signature Page Follows</I>] </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>IN WITNESS WHEREOF</B>, the undersigned have executed this Agreement to be effective as
of the date first set forth above. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>PURCHASER:</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Avista Acquisition LP II</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman"><B>By: Avista Acquisition GP LLC II, its general partner</B></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Benjamin Silbert</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name: Benjamin Silbert</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title: Authorized Signatory</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Address for Notices:</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">65 East 55th Street</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">18th Floor</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">New York, NY 10022</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Attn: Benjamin Silbert</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">email: Silbert@avistacap.com</P></TD></TR>

<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>COMPANY:</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>Avista Public Acquisition Corp. II</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Benjamin Silbert</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name: Benjamin Silbert</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Title: General Counsel</P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Address for Notices:</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">65 East 55th Street</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">18th Floor</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">New York, NY 10022</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Attn: Benjamin Silbert</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">email: Silbert@avistacap.com</P></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman"><B>SPINCO:</B></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>OmniAb, Inc.</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Matthew W. Foehr</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name: Matthew W. Foehr</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Title: President and Chief Executive Officer</P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Address for Notices:</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">5980 Horton Street</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Suite 405</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Emeryville, CA 94608</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Attn: Matt Foehr</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">email: matt@omniab.com</P></TD></TR>
</TABLE></DIV>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>6
<FILENAME>d337089dex101.htm
<DESCRIPTION>EX-10.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-10.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 10.1 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Execution Version </B></P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>EMPLOYEE MATTERS AGREEMENT </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This EMPLOYEE MATTERS AGREEMENT (this &#147;<U>Agreement</U>&#148;), dated as of March&nbsp;23, 2022, is entered into by and among Ligand
Pharmaceuticals Incorporated, a Delaware corporation (the &#147;<U>Company</U>&#148;), OmniAb, Inc., a Delaware corporation and a wholly owned subsidiary of the Company (&#147;<U>SpinCo</U>&#148;), Avista Public Acquisition Corp. II, a Cayman
Islands exempted company (which will migrate to and domesticate as a Delaware corporation) (&#147;<U>Parent</U>&#148;), and Orwell Merger Sub Inc., a Delaware corporation and wholly owned Subsidiary of Parent (&#147;<U>Merger Sub</U>&#148;).
&#147;<U>Party</U>&#148; or &#147;<U>Parties</U>&#148; means the Company, SpinCo, Parent or Merger Sub, individually or collectively, as the case may be. Capitalized terms used in this Agreement, but not otherwise defined in this Agreement, the
Separation Agreement or the Merger Agreement, shall have the meaning set forth in Section&nbsp;1.1. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">W I T N E S S E T H: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, the Company, acting through its direct and indirect Subsidiaries, currently conducts the Company Retained Business and the SpinCo
Business; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, the Company Board has determined that it is appropriate, desirable and in the best interests of the Company and its
stockholders to separate the Company into two separate companies, one for each of (i)&nbsp;the Company Retained Business, which shall be owned and conducted, directly or indirectly, by the Company and its Subsidiaries (other than SpinCo and its
Subsidiaries) and (ii)&nbsp;the SpinCo Business, which shall be owned and conducted, directly or indirectly, by SpinCo and its Subsidiaries, in the manner contemplated by the Separation and Distribution Agreement by and among the Parties, dated as
of the date hereof (the &#147;<U>Separation Agreement</U>&#148;) and the other Transaction Documents; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, following the
Domestication and the Separation and pursuant to the Merger Agreement, Merger Sub shall merge with and into SpinCo and SpinCo will be the surviving corporation and a wholly owned Subsidiary of Parent; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, in connection with the transactions contemplated by the Separation Agreement and the Merger Agreement, the Parties have agreed to
enter into this Agreement for the purpose of allocating assets, Liabilities and responsibilities with respect to certain employee matters and employee compensation and benefit plans and programs among them and to address certain other
employment-related matters. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">NOW, THEREFORE, in consideration of the foregoing and the mutual agreements, provisions and covenants
contained in this Agreement, the Parties hereby agree as follows: </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE I </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>DEFINITIONS AND INTERPRETATION </U></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.1 <U>General</U>. As used in this Agreement, the following terms shall have the following meanings: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) &#147;<U>401(k) Plan Transition Date</U>&#148; shall mean (i)&nbsp;December&nbsp;31 of the calendar year in which the Distribution Time
occurs, or (ii)&nbsp;such earlier date as mutually agreed by the Parties. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) &#147;<U>Adjusted Parent Equity Award</U>&#148; shall mean an Adjusted Parent Option,
Adjusted Parent RSU Award or Adjusted Parent PSU Award. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) &#147;<U>Adjusted Parent Option</U>&#148; shall have the meaning set forth
in&nbsp;Section 4.2(d). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) &#147;<U>Adjusted Parent PSU Award</U>&#148; shall have the meaning set forth in&nbsp;Section 4.4(f). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) &#147;<U>Adjusted Parent RSU Award</U>&#148; shall have the meaning set forth in&nbsp;Section 4.3(d). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) &#147;<U>Agreement</U>&#148; shall have the meaning set forth in the Preamble. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) &#147;<U>Benefit Plan</U>&#148; shall mean an &#147;employee benefit plan&#148; (within the meaning of Section&nbsp;3(3) of ERISA but
regardless of whether such plan is subject to ERISA) and each compensation plan, program, agreement or arrangement, including each pension, retirement, profit sharing, 401(k), severance, health and welfare, disability, deferred compensation,
employment, termination, <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">change-in-control,</FONT></FONT> retention, fringe benefit, stock purchase, cash bonus or equity-based incentive or other benefit plan, program, agreement,
policy or other arrangement, in each case, that is or was maintained for the benefit of current and/or former directors, officers, consultants or employees. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h) &#147;<U>Code</U>&#148; means the Internal Revenue Code of 1986, as amended, or any successor federal income tax law. Reference to a
specific Code provision also includes any proposed, temporary or final regulation in force under that provision. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i)
&#147;<U>Company</U>&#148; shall have the meaning set forth in the Preamble. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(j) &#147;<U>Company 2021 TSR PSU Award</U>&#148; shall mean
a Company PSU Award granted in 2021 (or portion thereof) the vesting of which is tied to the Company&#146;s total shareholder return for the three-year performance period ending December&nbsp;31, 2023. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(k) &#147;<U>Company 401(k) Plan</U>&#148; shall mean the Company&#146;s Section&nbsp;401(k) Savings/Retirement Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(l) &#147;<U>Company Allocation Factor</U>&#148; shall mean the quotient obtained by dividing (i)&nbsp;the Company Post-Adjustment Stock
Value, by (ii)&nbsp;the sum of (A)&nbsp;the Company Post-Adjustment Stock Value, plus (B)&nbsp;the product of (x)&nbsp;the SpinCo Stock Value times (y)&nbsp;the Distribution Ratio. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(m) &#147;<U>Company Benefit Plan</U>&#148; shall mean any Benefit Plan sponsored, maintained or contributed to (or required to be contributed
to) by any member of the Company Group that (i)&nbsp;is or has been maintained, sponsored, contributed to or entered into by any member of the Company Group for the benefit of any SpinCo Employee or SpinCo Independent Contractor or for which any
member of the SpinCo Group could have any Liability and (ii)&nbsp;that is not a SpinCo Benefit Plan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(n) &#147;<U>Company
Employee</U>&#148; shall mean each employee of the Company or any of its Subsidiaries or Affiliates who does not qualify as a SpinCo Employee. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(o) &#147;<U>Company Employee List</U>&#148; shall have the meaning set forth in Section&nbsp;2.2(d). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(p) &#147;<U>Company Equity Award</U>&#148; shall mean a Company Option, Company RSU Award or a Company PSU Award. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(q) &#147;<U>Company Equity Plan</U>&#148; shall mean the Company&#146;s 2002 Stock
Incentive Plan, as amended from time to time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(r) &#147;<U>Company ESPP</U>&#148; shall mean the Company&#146;s 2002 Employee Stock
Purchase Plan, as amended from time to time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(s) &#147;<U>Company Group</U>&#148; shall mean (i)&nbsp;the Company, the Company Retained
Business and each Person that is a direct or indirect Subsidiary of the Company as of immediately following the Distribution Time and (ii)&nbsp;each Business Entity that becomes a Subsidiary of the Company after the Distribution Time. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(t) &#147;<U>Company Independent Contractor</U>&#148; shall mean each individual who is engaged as an independent contractor or consultant by
the Company or any of its Subsidiaries or Affiliates who does not qualify as a SpinCo Independent Contractor. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(u) &#147;<U>Company
Individual Agreement</U>&#148; shall mean each Benefit Plan sponsored, maintained entered into or contributed to by the Company under which no more than one service provider is eligible to receive compensation and/or benefits. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(v) &#147;<U>Company Option</U>&#148; shall mean an option to purchase shares of Company Common Stock granted pursuant to the Company Equity
Plan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(w) &#147;<U>Company Post-Adjustment Stock Value</U>&#148; shall mean the average closing price per share of Company Common Stock
trading on an <FONT STYLE="white-space:nowrap">ex-dividend</FONT> basis on the Nasdaq Stock Market during regular trading hours for the five (5)&nbsp;trading days ending on the date on which the Distribution Time occurs (or, if the Distribution Time
occurs prior to regular trading hours, for the five (5)&nbsp;trading days ending on the date prior to the date on which the Distribution Time occurs). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(x) &#147;<U>Company <FONT STYLE="white-space:nowrap">Pre-Adjustment</FONT> Stock Value</U>&#148; shall mean the average closing price per
share of Company Common Stock trading &#147;regular way with due bills&#148; (if applicable) on the Nasdaq Stock Market during regular trading hours for the five (5)&nbsp;trading days ending on the date on which the Distribution Time occurs (or, if
the Distribution Time occurs prior to regular trading hours, for the five (5)&nbsp;trading days ending on the date prior to the date on which the Distribution Time occurs). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(y) &#147;<U>Company PSU Award</U>&#148; shall mean a performance stock unit award granted pursuant to the Company Equity Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(z) &#147;<U>Company Ratio</U>&#148; shall mean the quotient obtained by dividing the Company
<FONT STYLE="white-space:nowrap">Pre-Adjustment</FONT> Stock Value by the Company Post-Adjustment Stock Value. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(aa) &#147;<U>Company RSU
Award</U>&#148; shall mean a restricted stock unit award granted pursuant to the Company Equity Plan that vests solely based on the continued employment or service of the recipient. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(bb) &#147;<U>Company Service Provider</U>&#148; shall mean a Company Employee, a Company Independent Contractor or a member of the Company
Board. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(cc) &#147;<U>Company Severance Plan</U>&#148; shall mean the Company&#146;s Amended and Restated Severance Plan, as amended from
time to time. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(dd) &#147;<U>Distribution Ratio</U>&#148; shall mean the number of shares (and/or fraction
of a share, expressed as a decimal) of SpinCo Common Stock to be distributed in respect of one share of Company Common Stock in the Distribution, as determined by the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ee) &#147;<U>Distribution Time</U>&#148; shall mean the effective time of the Distribution pursuant to the Separation Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ff) &#147;<U>Effective Time</U>&#148; shall mean the &#147;Effective Time&#148; as defined in the Merger Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(gg) &#147;<U>ERISA</U>&#148; shall mean the Employee Retirement Income Security Act of 1974, as amended. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(hh) &#147;<U>Former Company Service Provider</U>&#148; means (i)&nbsp;any individual (other than a SpinCo Employee or SpinCo Independent
Contractor) who, as of the Distribution Time is a former employee or independent contractor of the Company or any of its Subsidiaries, or (ii)&nbsp;any individual who is a Company Employee or Company Independent Contractor as of the Distribution
Time or thereafter who ceases to be an employee or independent contractor of the Company or any of its Subsidiaries following the Distribution Time. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) &#147;<U>Former SpinCo Service Provider</U>&#148; shall mean any individual who is a SpinCo Employee or SpinCo Independent Contractor as
of the Distribution Time and thereafter ceases to be an employee or independent contractor of the SpinCo Group following the Distribution Time. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(jj) &#147;<U>Merger Agreement</U>&#148; shall mean the Agreement and Plan of Merger, dated as of March&nbsp;23, 2022, by and among the
Company, SpinCo, Parent, and Merger Sub. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(kk) &#147;<U>Parent</U>&#148; shall have the meaning set forth in the Preamble. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ll) &#147;<U>Parent Equity Plan</U>&#148; shall have the meaning set forth in Section&nbsp;4.6. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(mm) &#147;<U>Parent Equity Plan Share Reserve</U>&#148; shall have the meaning set forth in Section&nbsp;4.6. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(nn) &#147;<U>Parent ESPP</U>&#148; shall have the meaning set forth in Section&nbsp;4.6. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(oo) &#147;<U>Parent ESPP Share Reserve</U>&#148; shall have the meaning set forth in Section&nbsp;4.6. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(pp) &#147;<U>Party</U>&#148; and &#147;<U>Parties</U>&#148; shall have the meanings set forth in the Preamble. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(qq) &#147;<U>Plan Transition Date</U>&#148; shall mean the date that is the earlier to occur of (i)&nbsp;January&nbsp;1, 2023 or
(ii)&nbsp;such earlier date as agreed among the Parties. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(rr) &#147;<U>SpinCo</U>&#148; shall have the meaning set forth in the Preamble.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ss) &#147;<U>SpinCo 401(k) Plan</U>&#148; shall have the meaning set forth in&nbsp;Section 3.3(b). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(tt) &#147;<U>SpinCo Allocation Factor</U>&#148; shall mean the quotient obtained by dividing (i)&nbsp;the product of (A)&nbsp;the SpinCo
Stock Value times (B)&nbsp;the Distribution Ratio, by (ii)&nbsp;the sum of (A)&nbsp;the Company Post-Adjustment Stock Value, plus (B)&nbsp;the product of (x)&nbsp;the SpinCo Stock Value times (y)&nbsp;the Distribution Ratio. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(uu) &#147;<U>SpinCo Benefit Plan</U>&#148; shall mean any Benefit Plan sponsored,
maintained or contributed to exclusively by any member of the SpinCo Group. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(vv) &#147;<U>SpinCo Common Stock</U>&#148; shall mean the
common stock, par value $0.001 per share, of SpinCo. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ww) &#147;<U>SpinCo Employee</U>&#148; shall mean each individual listed on the
SpinCo Employee List. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(xx) &#147;<U>SpinCo Employee List</U>&#148; shall have the meaning set forth in Section&nbsp;2.2(d). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(yy) &#147;<U>SpinCo Equity Award</U>&#148; shall mean a SpinCo Option, SpinCo RSU Award or SpinCo PSU Award. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(zz) &#147;<U>SpinCo Equity Plans</U>&#148; shall have the meaning set forth in&nbsp;Section 4.5. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(aaa) &#147;<U>SpinCo Group</U>&#148; shall mean SpinCo and each SpinCo Entity as of the Distribution Time (but after giving effect to the
Separation), and, following the Effective Time, Parent and each Person that becomes a Subsidiary of Parent or SpinCo thereafter, provided, however, that for the avoidance of doubt, no member of the Company Group shall be treated as a member of the
SpinCo Group. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(bbb) &#147;<U>SpinCo Independent Contractor</U>&#148; shall mean each individual engaged as an independent contractor or
consultant by the SpinCo Group as of the Distribution Time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ccc) &#147;<U>SpinCo Individual Agreement</U>&#148; shall mean each Benefit
Plan sponsored, maintained entered into or contributed to by SpinCo under which no more than one service provider is eligible to receive compensation and/or benefits. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ddd) &#147;<U>SpinCo Option</U>&#148; shall mean an option to purchase shares of SpinCo Common Stock issued pursuant to the SpinCo Equity
Plans as part of an equitable adjustment to a Company Option made in connection with the Distribution. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(eee) &#147;<U>SpinCo PSU
Award</U>&#148; shall mean an award of restricted stock units covering SpinCo Common Stock issued pursuant to the SpinCo Equity Plans as part of an equitable adjustment to a Company PSU Award made in connection with the Distribution. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(fff) &#147;<U>SpinCo Ratio</U>&#148; shall mean the quotient obtained by dividing the Company
<FONT STYLE="white-space:nowrap">Pre-Adjustment</FONT> Stock Value by the SpinCo Stock Value. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ggg) &#147;<U>SpinCo RSU Award</U>&#148;
shall mean an award of restricted stock units covering SpinCo Common Stock that vests solely based on the continued employment or service of the recipient issued pursuant to the SpinCo Equity Plans as part of an equitable adjustment to a Company RSU
Award made in connection with the Distribution. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(hhh) &#147;<U>SpinCo Service Provider</U>&#148; shall mean a SpinCo Employee, a SpinCo
Independent Contractor or a member of the board of directors of SpinCo, or any individual independent contractor, consultant or director who is reasonably expected to become a SpinCo Service Provider prior to the Distribution Time. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iii) &#147;<U>SpinCo Severance Plan</U>&#148; shall have the meaning set forth in&nbsp;Section 5.2(a). </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(jjj) &#147;<U>SpinCo Stock Value</U>&#148; shall mean (i)&nbsp;the Base Exchange Ratio,
multiplied by (ii) $10 per share. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(kkk) &#147;<U>Separation Agreement</U>&#148; shall have the meaning set forth in the Recitals. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(lll) &#147;<U>Specified Service Provider</U>&#148; shall mean a Company Service Provider or SpinCo Service Provider who, in either case, is
set forth on <U>Schedule C</U> attached hereto. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.2 <U>References; Interpretation</U>. References in this Agreement to any gender include
references to all genders, and references to the singular include references to the plural and vice versa. Unless the context otherwise requires, the words &#147;include&#148;, &#147;includes&#148; and &#147;including&#148; when used in this
Agreement shall be deemed to be followed by the phrase &#147;without limitation&#148;. Unless the context otherwise requires, references in this Agreement to Articles, Sections, Annexes, Exhibits and Schedules shall be deemed references to Articles
and Sections of, and Annexes, Exhibits and Schedules to, this Agreement. Unless the context otherwise requires, the words &#147;hereof&#148;, &#147;hereby&#148; and &#147;herein&#148; and words of similar meaning when used in this Agreement refer to
this Agreement in its entirety and not to any particular Article, Section or provision of this Agreement. The words &#147;written request&#148; when used in this Agreement shall include email. Reference in this Agreement to any time shall be to New
York City, New York time unless otherwise expressly provided herein. Unless the context requires otherwise, references in this Agreement to the &#147;Company&#148; shall also be deemed to refer to the applicable member of the Company Group,
references to &#147;SpinCo&#148; shall also be deemed to refer to the applicable member of the SpinCo Group (including, with respect to periods of time following the Effective Time, Parent), and, in connection therewith, any references to actions or
omissions to be taken, or refrained from being taken, as the case may be, by the Company or SpinCo shall be deemed to require the Company, SpinCo or Parent, as the case may be, to cause the applicable members of the Company Group or the SpinCo
Group, respectively, to take, or refrain from taking, any such action. In the event of any inconsistency or conflict which may arise in the application or interpretation of any of the definitions set forth in&nbsp;Section 1.1, for the purpose of
determining what is and is not included in such definitions, any item explicitly included on a Schedule referred to in any such definition shall take priority over any provision of the text thereof. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE II </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>GENERAL
PRINCIPLES </U></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.1 <U>Nature of Liabilities</U>. All Liabilities assumed or retained by a member of the Company Group under this
Agreement shall be &#147;Ligand Retained Liabilities&#148; for purposes of the Separation Agreement. All Liabilities assumed or retained by a member of the SpinCo Group under this Agreement shall be &#147;OmniAb Liabilities&#148; for purposes of the
Separation Agreement.<SUP STYLE="font-size:85%; vertical-align:top"> </SUP> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.2 <U>Transfers of Employees and Independent Contractors
Generally</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <U>Schedule A</U> attached hereto sets forth a complete list of each Company Employee as of the date hereof (the
&#147;<U>Company Employee List</U>&#148;), and <U>Schedule B</U> attached hereto sets forth a complete list of each employee of the Company Group whose employment will be transferred to SpinCo prior to the Distribution Time (the &#147;<U>SpinCo
Employee List</U>&#148;). The Company and SpinCo shall mutually update the Company Employee List and the SpinCo Employee List from time to time between the date hereof and the Distribution Time to remove terminated employees and to add any new
Company Employees or SpinCo Employees hired following the date hereof. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) All SpinCo Employees who are employed by the SpinCo Group as of the Distribution Time
shall continue to be employees of the SpinCo Group immediately after the Distribution Time. The Company and SpinCo will cooperate to cause each of the SpinCo Employees to be employed by a member of the SpinCo Group prior to the Distribution Time.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) The Company and SpinCo will cooperate to cause the contract of any individual who is engaged as an independent contractor or
consultant and who provides services on behalf of the SpinCo Business to the extent of such service, to be transferred to a member of the SpinCo Group prior to the Distribution Time. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) The Company Group and SpinCo Group agree to execute, and to seek to have the applicable SpinCo Employees execute, such documentation, if
any, as may be necessary to reflect the transfers described in this&nbsp;Section 2.2. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.3 <U>Assumption and Retention of Liabilities
Generally</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Except as pursuant to this Agreement, from and after the Distribution Time, the Company shall, or shall cause one or
more members of the Company Group to, accept, assume (or, as applicable, retain) and perform, discharge and fulfill (i)&nbsp;all Liabilities under all Company Benefit Plans with respect to Company Employees, Former Company Service Providers and
their respective dependents and beneficiaries (and any alternate payees in respect thereof), whenever incurred, unless this Agreement expressly provides for such Liabilities to be assumed by the SpinCo Group or subject to reimbursement by the SpinCo
Group; (ii)&nbsp;all Liabilities with respect to the employment, service, termination of employment or termination of service of all Company Employees, Former Company Service Providers and their respective dependents and beneficiaries (and any
alternate payees in respect thereof), in each case to the extent arising in connection with or as a result of employment with or the performance of services to any member of the Company Group; and (iii)&nbsp;all other Liabilities or obligations
expressly assigned to or assumed by a member of the Company Group under this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Except as pursuant to this Agreement, from
and after the Distribution Time, SpinCo shall, or shall cause one or more members of the SpinCo Group to, accept, assume (or, as applicable, retain) and perform, discharge and fulfill (i)&nbsp;all Liabilities under all SpinCo Benefit Plans, whenever
incurred; (ii)&nbsp;all Liabilities with respect to the employment, service, termination of employment or termination of service of all SpinCo Employees, Former SpinCo Service Providers and SpinCo Independent Contractors and their respective
dependents and beneficiaries (and any alternate payees in respect thereof), in each case to the extent arising in connection with or as a result of employment with or the performance of services to any member of the SpinCo Group or the Company
Group; and (iii)&nbsp;all other Liabilities or obligations expressly assigned to or assumed by a member of the SpinCo Group under this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) The Parties shall promptly reimburse one another, upon reasonable request of the Party requesting reimbursement and the presentation by
such Party of such substantiating documentation as the other Party shall reasonably request, for the cost of any obligations or Liabilities satisfied or assumed by the Party requesting reimbursement or its Affiliates that are, or that have been made
pursuant to this Agreement, the responsibility of the other Parties or any of its Affiliates. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) Notwithstanding any provision of this
Agreement or the Separation Agreement to the contrary, SpinCo shall, or shall cause one or more members of the SpinCo Group to, accept, assume (or, as applicable, retain) and perform, discharge and fulfill all Liabilities that have been accepted,
assumed or retained under this Agreement. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.4 <U>Treatment of Compensation and Benefit Plans; Terms of Employment</U>. Except as
otherwise (i)&nbsp;required by applicable Law, or (ii)&nbsp;expressly provided for in this Agreement, for a period of twelve (12)&nbsp;months following the Distribution Time (or if shorter, during the period of employment), SpinCo shall, or shall
cause a member of the SpinCo Group to provide or cause to be provided to each SpinCo Employee (A)&nbsp;a base salary or hourly wage rate, as applicable, that is at least equal to the base salary or hourly wage rate provided to such SpinCo Employee
immediately prior to the Distribution Time, (B)&nbsp;subject to&nbsp;Section 5.1, a cash incentive or sales commission opportunity no less favorable than the cash incentive or sales commission opportunity in effect for such SpinCo Employee, if any,
immediately prior to the Distribution Time, (C)&nbsp;health, welfare and retirement benefits that are substantially similar in the aggregate to those provided to such SpinCo Employee immediately prior to the Distribution Time, and (D)&nbsp;severance
benefits (including severance payments, transition payments and continued health coverage) that are substantially similar to those provided to such SpinCo Employee immediately prior to the Distribution Time. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.5 <U>Participation in Company Benefit Plans</U>. Except as otherwise provided pursuant to this Agreement or as required by Applicable Law,
effective no later than the Plan Transition Date, (i)&nbsp;SpinCo and each member of the SpinCo Group, to the extent applicable, shall cease to be a participating company in any Company Benefit Plan and (ii)&nbsp;each then active SpinCo Employee
shall cease to participate in, be covered by, accrue benefits under, be eligible to contribute to or have any rights under any Company Benefit Plan (except to the extent of previously accrued obligations that remain a Liability of any member of the
Company Group pursuant to this Agreement). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.6 <U>Service Recognition</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) From and after the Distribution Time, and in addition to any applicable obligations under applicable Law, SpinCo shall, and shall cause
each member of the SpinCo Group to, give each SpinCo Employee full credit for purposes of eligibility, vesting, and determination of level of benefits under any SpinCo Benefit Plan for such SpinCo Employee&#146;s prior service with any member of the
Company Group or SpinCo Group or any predecessor thereto, to the same extent such service was recognized by the applicable Company Benefit Plan;&nbsp;provided, that, such service shall not be recognized to the extent it would result in the
duplication of benefits or accruals under any defined benefit pension plan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Except to the extent prohibited by applicable Law, as
soon as administratively practicable on or after the Plan Transition Date with respect to any applicable SpinCo Benefit Plan that is a health or welfare benefit plan: (i)&nbsp;SpinCo shall waive or cause to be waived all limitations as to
preexisting conditions or waiting periods with respect to participation and coverage requirements applicable to each SpinCo Employee under any SpinCo Benefit Plan in which SpinCo Employees participate (or are eligible to participate) to the same
extent that such conditions and waiting periods were satisfied or waived under an analogous Company Benefit Plan, and (ii)&nbsp;SpinCo shall use commercially reasonable efforts to provide or cause each SpinCo Employee to be provided with credit for
any <FONT STYLE="white-space:nowrap">co-payments,</FONT> deductibles or other <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> amounts paid during the plan year in which the SpinCo Employees become
eligible to participate in the SpinCo Benefit Plans in satisfying any applicable <FONT STYLE="white-space:nowrap">co-payments,</FONT> deductibles or other <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT>
requirements under any such plans for such plan year. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.7 <U>WARN</U>. Notwithstanding anything set forth in this Agreement to the
contrary, none of the transactions contemplated by or undertaken by this Agreement is intended to and shall not constitute or give rise to an &#147;employment loss&#148; or employment separation within the meaning of the federal Worker Adjustment
and Retraining Notification (WARN) Act, or any other federal, state, or local law or legal requirement addressing mass employment separations. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.8 <U>No Termination; No Change in Control</U>. No Company Employee or SpinCo Employee
shall be deemed to (a)&nbsp;terminate employment or service solely by virtue of the consummation of the Distribution, any transfer of employment or other service relationship contemplated hereby, or any related transactions or events contemplated by
the Separation Agreement, this Agreement, the Merger Agreement, or any other Transaction Document, or (b)&nbsp;become entitled to any severance, termination, separation or similar rights, payments or benefits, whether under any Benefit Plan, the
Company Equity Plan, the SpinCo Equity Plans, the Company Severance Plan, any Company Individual Agreement or any other compensatory agreement or arrangement maintained by the Company or SpinCo or otherwise, in connection with any of the foregoing.
The Parties hereto agree that none of the transactions contemplated by the Separation Agreement, the Merger Agreement, or this Agreement, constitutes a &#147;change in control,&#148; &#147;change of control&#148; or similar term, as applicable,
within the meaning of any Benefit Plan, the Company Equity Plan, the SpinCo Equity Plans, the Company Severance Plan, any Company Individual Agreement or any other compensatory agreement or arrangement maintained by the Company or SpinCo. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE III </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>CERTAIN
BENEFIT PLAN PROVISIONS </U></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.1 <U>Health and Welfare Benefit Plans</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) (i) Effective as of the Plan Transition Date, the participation of each then-active SpinCo Employee who is a participant in a Company
Benefit Plan shall automatically cease and (ii)&nbsp;SpinCo shall or shall cause a member of the SpinCo Group to (A)&nbsp;have in effect, no later than the Business Day immediately prior to the Plan Transition Date, SpinCo Benefit Plans providing
health and welfare benefits for the benefit of each such SpinCo Employee with terms that are substantially similar to those provided to the applicable SpinCo Employee immediately prior to the date on which such SpinCo Benefit Plans become effective;
and (B)&nbsp;effective on and after the Plan Transition Date, fully perform, pay and discharge all claims of SpinCo Employees or Former SpinCo Service Providers, including but not limited to any claims incurred under any Company Benefit Plan (to the
extent not fully covered by insurance) on or prior to the date on which such SpinCo Benefit Plans become effective, that remain unpaid as of the date on which such SpinCo Benefit Plans become effective, regardless of whether any such claim was
presented for payment prior to, on or after such date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Without duplication of amounts otherwise already covered in this Agreement or
the Transition Services Agreement, the applicable member of the SpinCo Group shall reimburse the Company or the applicable Company Benefit Plan in the ordinary course of business consistent with past practice for any premiums and its proportionate
share of any administrative or services costs related to SpinCo Employees or Former SpinCo Service Providers paid by a Company Benefit Plan (whether prior to or after the Distribution Time) and not charged back to the appropriate and applicable
member of the SpinCo Group prior to the Plan Transition Date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Notwithstanding anything to the contrary in this Section&nbsp;3.1,
SpinCo Employees will continue to be considered to be &#147;participants&#148; in any Company Benefit Plan that is either a health care flexible spending account program or a dependent-care flexible spending account program for the duration of any
grace period and/or claims <FONT STYLE="white-space:nowrap">run-out</FONT> period following the calendar year in which the Plan Transition Date occurs (in either case, solely as provided under the terms of such Company Benefit Plans), provided that
such SpinCo Employees will be considered to be participants solely for purposes of utilizing such grace period and/or claims <FONT STYLE="white-space:nowrap">run-out</FONT> period; will not be allowed to make any deferral or contribution elections
under such Company Benefit Plans beyond the Plan Transition Date; and will cease to be participants in such Company Benefit Plans upon the expiration of any grace period and/or claims <FONT STYLE="white-space:nowrap">run-out</FONT> period. Effective
as of the Plan Transition Date, SpinCo shall establish a health care flexible spending account program or a dependent-care flexible spending account program for SpinCo Employees. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.2 <U>Disability</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) To the extent any SpinCo Employee is, as of the Plan Transition Date, receiving payments as part of any short-term disability program that
is part of a Company Benefit Plan, such SpinCo Employee&#146;s rights to continued short-term disability benefits (a)&nbsp;will end under any Company Benefit Plan as of the Plan Transition Date; and (b)&nbsp;all remaining rights will be recognized
under a SpinCo Benefit Plan as of the Plan Transition Date, and the remainder (if any) of such SpinCo Employee&#146;s short-term disability benefits will be paid by a SpinCo Benefit Plan. In the event that any SpinCo Employee described above shall
have any dispute with the short-term disability benefits they are receiving under a SpinCo Benefit Plan, any and all appeal rights of such employees shall be realized through the SpinCo Benefit Plan (and any appeal rights such SpinCo Employee may
have under any Company Benefit Plan will be limited to benefits received and time periods occurring prior to the Plan Transition Date). Any SpinCo Employee or Former SpinCo Service Provider who is receiving short-term disability benefits under a
Company Benefit Plan as of the Plan Transition Date and thereafter becomes entitled to long-term disability benefits upon the expiration of such short-term disability period (whether under a Company Benefit Plan or SpinCo Benefit Plan), shall be
provided long-term disability benefits under the long-term disability plan which is a Company Benefit Plan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) For any Former SpinCo
Service Provider who is, as of the Distribution Time, receiving payments as part of any long-term disability program that is part of a Company Benefit Plan, and has been receiving payments from such plan for twelve (12)&nbsp;months or fewer before
the Distribution Time, to the extent such Former SpinCo Service Provider may have any &#147;return to work&#148; rights under the terms of such Company Benefit Plan, such Former SpinCo Service Provider&#146;s eligibility for <FONT
STYLE="white-space:nowrap">re-employment</FONT> shall be with SpinCo or a member of the SpinCo Group, subject to availability of a suitable position (with such availability to be determined in the sole discretion by SpinCo or the applicable member
of the SpinCo Group),&nbsp;provided&nbsp;however&nbsp;that, notwithstanding the foregoing, no Former SpinCo Service Provider described in this subsection will be eligible for <FONT STYLE="white-space:nowrap">re-employment</FONT> as described in this
subsection after the first anniversary of the Distribution Time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.3 <U>401(k) Plans</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) From the Distribution Time and continuing until the 401(k) Plan Transition Date, SpinCo shall become an &#147;adopting employer&#148; (as
defined in the Company 401(k) Plan) and the Company 401(k) Plan shall provide for the SpinCo Group to participate in the Company 401(k) Plan for the benefit of SpinCo Employees and Former SpinCo Service Providers, and the Company consents to such
adoption and maintenance, in accordance with the terms of the Company 401(k) Plan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) (i) Effective no later than the 401(k) Plan
Transition Date, SpinCo shall establish a defined contribution savings plan and related trust that satisfies the requirements of Sections 401(a) and 401(k) of the Code in which each SpinCo Employee who participated in the Company 401(k) Plan
immediately prior thereto shall be eligible to participate (the &#147;<U>SpinCo 401(k) Plan</U>&#148;), with terms that are substantially similar to those provided by the Company 401(k) Plan immediately prior to the date on which such SpinCo 401(k)
Plan become effective, (ii)&nbsp;the <U>active</U> participation of each SpinCo Employee who is a participant in the Company 401(k) Plan shall automatically cease effective upon the date on which the SpinCo 401(k) Plan becomes effective, <U>and</U>
(iii)&nbsp;as soon as practicable after the SpinCo 401(k) Plan becomes effective, subject to the consent of the SpinCo 401(k) Plan administrator and reasonable proof of qualification of the Company 401(k) Plan, the Company shall cause the accounts
(including any outstanding participant loan balances) in the Company 401(k) Plan attributable to SpinCo Employees and all of the assets in the Company 401(k) Plan related thereto to be transferred <FONT STYLE="white-space:nowrap">in-kind</FONT> to
the SpinCo 401(k) Plan. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) The Company shall retain all accounts and all assets and Liabilities relating to the
Company 401(k) Plan in respect of each Former SpinCo Service Provider whose employment terminated prior to the 401(k) Plan Transition Date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.4 <U>Chargeback of Certain Costs</U>. Without duplication of amounts otherwise already covered in this Agreement or the Transition Services
Agreement, nothing contained in this Agreement shall limit the Company&#146;s ability to charge back any Liabilities that it incurs in respect of any SpinCo Service Provider under a Company Benefit Plan which is a retirement plan or health or
welfare benefit plan to any of its operating companies in the ordinary course of business consistent with its past practices. Subject, and in addition, to the foregoing, the Company shall allocate and charge back to SpinCo or a member of the SpinCo
Group (without duplication) its proportionate share of Liabilities (other than those arising from the Company&#146;s or its agent&#146;s gross misconduct or negligence) that the Company incurs by reason of the continued participation of SpinCo
Employees, SpinCo Independent Contractors and Former SpinCo Service Providers in <U>such</U> Company Benefit Plans following the Distribution Time (which Liabilities shall, for the avoidance of doubt, be subject to reimbursement under
Section&nbsp;2.3(c) of this Agreement). </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE IV </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>EQUITY INCENTIVE AWARDS </U></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.1 <U>Equity Awards</U>. The Parties shall use commercially reasonable efforts to take all actions necessary or appropriate so that each
outstanding Company Equity Award and SpinCo Equity Award held by any individual shall be adjusted as set forth in this Article IV and in accordance with applicable Law, the applicable equity plan and the applicable award agreement. The adjustments
set forth below shall be the sole adjustments made with respect to Company Equity Awards in connection with the Distribution. The adjustments set forth below shall be the sole adjustments made with respect to SpinCo Equity Awards in connection with
the Merger and are subject to the terms and conditions of the Merger Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.2 <U>Treatment of Company Options</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <U>Company Options Other than (i)</U><U></U><U>&nbsp;Company Options Held by Former Company Service Providers or
(ii)</U><U></U><U>&nbsp;SpinCo Service Providers who are Specified Service Providers</U>. As determined by the Compensation Committee of the Company Board (the &#147;<U>Company Compensation Committee</U>&#148;) pursuant to its authority under the
Company Equity Plan, each Company Option outstanding as of immediately prior to the Distribution Time, other than (x)&nbsp;any Company Option held by a Former Company Service Provider and (y)&nbsp;any Company Option held by a Specified Service
Provider, shall, immediately prior to the Distribution Time, be converted into both a SpinCo Option and a Company Option and shall otherwise be, subject to Section&nbsp;4.2(d) below, subject to the same terms and conditions after the Distribution
Time as the terms and conditions applicable to such Company Option immediately prior to the Distribution Time; <U>provided</U>, <U>however</U>, that from and after the Distribution Time: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) <U>Shares Subject to Post-Distribution Company Option</U>. The number of shares of Company Common Stock subject to such
Company Option shall be equal to the product obtained by multiplying (I)&nbsp;the number of shares of Company Common Stock subject to such Company Option immediately prior to the Distribution Time by (II)&nbsp;the Company Ratio by (III)&nbsp;the
Company Allocation Factor, and rounding such result down to the nearest whole share. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) <U>Shares Subject to
Post-Distribution SpinCo Option</U>. The number of shares of SpinCo Common Stock subject to such SpinCo Option shall be equal to the product obtained by multiplying (I)&nbsp;the number of shares of Company Common Stock subject to the Company Option
immediately prior to the Distribution Time by (II)&nbsp;the SpinCo Ratio by (III)&nbsp;the SpinCo Allocation Factor, and rounding such result down to the nearest whole share. Each SpinCo Option that is outstanding as of the Effective Time will be
further adjusted to reflect the Transactions as set forth in Section&nbsp;4.2(d) below. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iii) <U>Exercise Price of Post-Distribution Company Option</U>. The per
share exercise price of such Company Option shall be equal to the quotient obtained by dividing (I)&nbsp;the per share exercise price of such Company Option immediately prior to the Distribution Time by (II)&nbsp;the Company Ratio, and rounding such
quotient up to the nearest whole cent. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iv) <U>Exercise Price of Post-Distribution SpinCo Option</U>. The per share
exercise price of such SpinCo Option shall be equal to the quotient obtained by dividing (I)&nbsp;the per share exercise price of the Company Option immediately prior to the Distribution Time by (II)&nbsp;the SpinCo Ratio, and rounding such quotient
up to the nearest whole cent. Each SpinCo Option that is outstanding as of the Effective Time will be further adjusted to reflect the Transactions as set forth in Section&nbsp;4.2(d) below. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <U>Company Options Held by (i)</U><U></U><U>&nbsp;Former Company Service Providers and (ii)</U><U></U><U>&nbsp;Specified Service Providers
who are Company Service Providers</U>. As determined by the Company Compensation Committee pursuant to its authority under the Company Equity Plan, each Company Option outstanding as of immediately prior to the Distribution Time (x)&nbsp;that is
held by a Former Company Service Provider or (y)&nbsp;that is held by a Specified Service Provider who is a Company Service Provider, shall be subject to the same terms and conditions after the Distribution Time as the terms and conditions
applicable to such Company Option immediately prior to the Distribution Time; <U>provided</U>, <U>however</U>, that from and after the Distribution Time: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) <U>Shares Subject to Post-Distribution Company Option</U>. The number of shares of Company Common Stock subject to such
Company Option shall be equal to the product obtained by multiplying (A)&nbsp;the number of shares of Company Common Stock subject to such Company Option immediately prior to the Distribution Time by (B)&nbsp;the Company Ratio, and rounding such
product down to the nearest whole share. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) <U>Exercise Price of Post-Distribution Company Option</U>. The per share
exercise price of such Company Option shall be equal to the quotient obtained by dividing (A)&nbsp;the per share exercise price of such Company Option immediately prior to the Distribution Time by (B)&nbsp;the Company Ratio, and rounding such
quotient up to the nearest whole cent. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) <U>Company Options Held by Specified Service Providers who are SpinCo Service Providers</U>.
As determined by the Company Compensation Committee pursuant to its authority under the Company Equity Plan, each Company Option outstanding as of immediately prior to the Distribution Time that is held by a Specified Service Provider who is an
SpinCo Service Provider, shall, immediately prior to the Distribution Time, be converted solely into an SpinCo Option and shall otherwise be, subject to Section&nbsp;4.2(d) below, subject to the same terms and conditions after the Distribution Time
as the terms and conditions applicable to such Company Option immediately prior to the Distribution Time; <U>provided</U>, <U>however</U>, that from and after the Distribution Time: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) <U>Shares Subject to Post-Distribution SpinCo Option</U>. The number of shares of Company Common Stock subject to such
SpinCo Option shall be equal to the product obtained by multiplying (A)&nbsp;the number of shares of Company Common Stock subject to such Company Option immediately prior to the Distribution Time by (B)&nbsp;the SpinCo Ratio, and rounding such
product down to the nearest whole share. Each SpinCo Option that is outstanding as of the Effective Time will be further adjusted to reflect the Transactions as set forth in Section&nbsp;4.2(d) below. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) <U>Exercise Price of Post-Distribution SpinCo Option</U>. The per share
exercise price of such Company Option shall be equal to the quotient obtained by dividing (A)&nbsp;the per share exercise price of such Company Option immediately prior to the Distribution Time by (B)&nbsp;the SpinCo Ratio, and rounding such
quotient up to the nearest whole cent. Each SpinCo Option that is outstanding as of the Effective Time will be further adjusted to reflect the Transactions as set forth in Section&nbsp;4.2(d) below. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) <U>SpinCo Options Outstanding as of Immediately Prior to the Effective Time.</U> As of the Effective Time, each SpinCo Option that is then
outstanding and unexercised shall be converted into the right to receive an option relating to shares of Domesticated Parent Common Stock upon substantially the same terms and conditions as are in effect with respect to such option immediately prior
to the Effective Time (other than terms that have been rendered inoperative by the Transactions), including with respect to vesting and termination-related provisions (each, an &#147;<U>Adjusted Parent Option</U>&#148;), except that (A)&nbsp;such
Adjusted Parent Option shall relate to that whole number of shares of Domesticated Parent Common Stock (rounded down to the nearest whole share) equal to the number of shares of SpinCo Common Stock subject to such SpinCo Option, multiplied by the
Base Exchange Ratio, and (B)&nbsp;the exercise price per share for each such Adjusted Parent Option shall be equal to the exercise price per share of such SpinCo Option in effect immediately prior to the Effective Time, divided by the Base Exchange
Ratio (the exercise price per share, as so determined, being rounded up to the nearest full cent). In addition, at the Effective Time, Parent will issue to each holder of a SpinCo Option a number of Earnout Shares equal to the product of
(A)&nbsp;the number of shares of SpinCo Common Stock subject to the SpinCo Option, multiplied by (B)&nbsp;the Earnout Exchange Ratio, which Earnout Shares will be subject to the restrictions set forth in the Merger Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.3 <U>Treatment of Company RSU Awards</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <U>Company RSU Awards Other than (i)</U><U></U><U>&nbsp;Company RSU Awards Held by Former Company Service Providers and
(ii)</U><U></U><U>&nbsp;Company RSU Awards Held by Specified Service Providers</U>. As determined by the Company Compensation Committee pursuant to its authority under the Company Equity Plan, each Company RSU Award outstanding as of immediately
prior to the Distribution Time, other than (x)&nbsp;any Company RSU Award held by a Specified Service Provider and (y)&nbsp;any Company RSU Award held by a Former Company Service Provider, shall, immediately prior to the Distribution Time, be
converted into both a SpinCo RSU Award and a Company RSU Award and shall otherwise be, subject to Section&nbsp;4.3(d) below, subject to the same terms and conditions after the Distribution Time as the terms and conditions applicable to such Company
RSU Award immediately prior to the Distribution Time;<U>&nbsp;provided</U>,<U>&nbsp;however</U>, that from and after the Distribution Time: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) <U>Shares Subject to Post-Distribution Company RSU</U>. The number of shares of Company Common Stock subject to such
Company RSU Award shall be equal to the number of shares of Company Common Stock subject to such Company RSU Award immediately prior to the Distribution Time, and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) <U>Shares Subject to Post-Distribution SpinCo RSU.</U> The number of shares of SpinCo Common Stock subject to such SpinCo
RSU Award shall be equal to the product obtained by multiplying (A)&nbsp;the number of shares of Company Common Stock subject to the Company RSU Award immediately prior to the Distribution Time by (B)&nbsp;the Distribution Ratio, and rounding such
product down to the nearest whole share. Each SpinCo RSU Award that is outstanding as of the Effective Time will be further adjusted to reflect the Transactions as set forth in Section&nbsp;4.3(d) below. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;<U>Company RSU Awards Held by (i)</U><U></U><U>&nbsp;Former Company Service
Providers or Former SpinCo Service Providers and (ii)</U><U></U><U>&nbsp;Specified Service Providers who are Company Service Providers</U>. As determined by the Company Compensation Committee pursuant to its authority under the Company Equity Plan,
each Company RSU Award that is outstanding as of immediately prior to the Distribution Time (x)&nbsp;that is held by a Former Company Service Provider or a Former SpinCo Service Provider or (y)&nbsp;that is held by a Specified Service Provider who
is a Company Service Provider, shall be subject to the same terms and conditions after the Distribution Time as the terms and conditions applicable to such Company RSU Award immediately prior to the Distribution Time; <U>provided</U>,
<U>however</U>, that from and after the Distribution Time, the number of shares of Company Common Stock covered by such Company RSU Award held by the participant, as applicable, rounded to the nearest whole share, shall be equal to the product
obtained by multiplying (i)&nbsp;the number of shares of Company Common Stock covered by such Company RSU Award immediately prior to the Distribution Time by (ii)&nbsp;the Company Ratio. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;<U>Company RSU Awards Held by Specified Service Providers who are SpinCo Service Providers</U>. As determined by the Company
Compensation Committee pursuant to its authority under the Company Equity Plan, each Company RSU Award that is outstanding as of immediately prior to the Distribution Time that is held by a Specified Service Provider who is <U>a</U> SpinCo Service
Provider shall, immediately prior to the Distribution Time, be converted solely into <U>a</U> SpinCo RSU Award and shall otherwise be, subject to Section&nbsp;4.3(d) below, subject to the same terms and conditions after the Distribution Time as the
terms and conditions applicable to such Company RSU Award immediately prior to the Distribution Time;<U>&nbsp;provided</U>,<U>&nbsp;however</U>, that from and after the Distribution Time the number of shares of SpinCo Common Stock subject to such
SpinCo RSU Award shall be equal to the product obtained by multiplying (x)&nbsp;the number of shares of Company Common Stock subject to the Company RSU Award immediately prior to the Distribution Time by (y)&nbsp;the SpinCo Ratio, and rounding down
to the nearest whole share. Each SpinCo RSU Award that is outstanding as of the Effective Time will be further adjusted to reflect the Transactions as set forth in Section&nbsp;4.3(d) below. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) <U>SpinCo RSU Awards Outstanding as of the Effective Time</U>. As of the Effective Time, each SpinCo RSU Award that is outstanding
immediately prior to the Effective Time shall be converted into the right to receive restricted stock units relating to shares of Domesticated Parent Common Stock (each, an &#147;<U>Adjusted Parent RSU Award</U>&#148;) with substantially the same
terms and conditions as were applicable to such SpinCo RSU Award immediately prior to the Effective Time (other than terms that have been rendered inoperative by the Transactions), including with respect to vesting and termination-related
provisions, except that such Adjusted Parent RSU Award shall relate to that whole number of shares of Domesticated Parent Common Stock as is equal to the product of (B)&nbsp;the number of shares of SpinCo Common Stock subject to such SpinCo RSU
Awards immediately prior to the Effective Time, multiplied by (B)&nbsp;the Base Exchange Ratio, with any fractional shares rounded down to the nearest whole share. In addition, at the Effective Time, Parent will issue to each holder of a SpinCo RSU
Award a number of Earnout Shares equal to the product of (A)&nbsp;the number of shares of SpinCo Common Stock subject to the SpinCo RSU Award, multiplied by (B)&nbsp;the Earnout Exchange Ratio, which Earnout Shares will be subject to the
restrictions set forth in the Merger Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.4 <U>Treatment of Company PSU Awards</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <U>Company PSU Awards (Other than Company 2021 TSR PSU Awards) Not Held by Former Company Service Providers</U>. As determined by the
Company Compensation Committee pursuant to its authority under the Company Equity Plan, each Company PSU Award outstanding as of immediately prior to the Distribution Time, other than (x)&nbsp;any Company PSU Award held by a Former Company Service
Provider and (y)&nbsp;any Company PSU Award that is a Company 2021 TSR PSU Award, shall, immediately prior to the Distribution Time, be converted into both a SpinCo PSU Award and a </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Company PSU Award and shall, subject to Sections 4.4(e) and (f)&nbsp;below, otherwise be subject to the same terms and conditions after the Distribution Time as the terms and conditions
applicable to such Company PSU Award immediately prior to the Distribution Time;<U>&nbsp;provided</U>,<U>&nbsp;however</U>, that from and after the Distribution Time: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) <U>Shares Subject to Post-Distribution Company PSU.</U> The number of shares of Company Common Stock subject to such
Company PSU Award shall be equal to the number of shares of Company Common Stock subject to such Company PSU Award immediately prior to the Distribution Time, and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) <U>Shares Subject to Post-Distribution SpinCo PSU.</U> The number of shares of SpinCo Common Stock subject to such SpinCo
PSU Award shall be equal to the product obtained by multiplying (A)&nbsp;the number of shares of Company Common Stock subject to the Company PSU Award immediately prior to the Distribution Time by (B)&nbsp;the Distribution Ratio, and rounding such
product down to the nearest whole share. Each SpinCo PSU Award that is outstanding as of the Effective Time will be further adjusted to reflect the Transactions as set forth in Section&nbsp;4.4(f) below. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <U>Company 2021 TSR PSU Awards </U><U>Not</U><U> </U><U>Held by Former Company Service Providers</U>. As determined by the Company
Compensation Committee pursuant to its authority under the Company Equity Plan, each Company 2021 TSR PSU Award outstanding as of immediately prior to the Distribution Time, other than any 2021 TSR PSU Award that is held by a Former Company Service
Provider, shall, immediately prior to the Distribution Time, be converted into both an SpinCo PSU Award and a Company PSU Award and shall, subject to Sections 4.4(e) and (f)&nbsp;below, otherwise be subject to the same terms and conditions after the
Distribution Time as the terms and conditions applicable to such Company PSU Award immediately prior to the Distribution Time;<U>&nbsp;provided</U>,<U>&nbsp;however</U>, that from and after the Distribution Time: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) <U>Shares Subject to Post-Distribution Company PSU.</U> The number of shares of Company Common Stock subject to such
Company PSU Award shall be equal to (x)&nbsp;the number of shares of Company Common Stock subject to such Company 2021 TSR PSU Award immediately prior to the Distribution Time, multiplied by (y)&nbsp;such percentage (not to exceed 200%) as is
mutually determined by the Company and SpinCo prior to the Distribution Time, and rounding such product down to the nearest whole share, and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) <U>Shares Subject to Post-Distribution SpinCo PSU.</U> The number of shares of SpinCo Common Stock subject to such SpinCo
PSU Award shall be equal to the product obtained by multiplying (A) (x)&nbsp;the number of shares of Company Common Stock subject to the Company PSU Award immediately prior to the Distribution Time, multiplied by (y)&nbsp;such percentage (not to
exceed 200%) as is mutually determined by the Company and SpinCo prior to the Distribution Time by (B)&nbsp;the Distribution Ratio, and rounding such product down to the nearest whole share; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">provided, further, that from and after the Distribution Time, such Company 2021 TSR PSU Award shall no longer vest based on the performance objectives
applicable to such Company 2021 TSR PSU Award immediately prior to the Distribution Time and shall instead be amended to vest solely based on continuous employment or service on December&nbsp;31, 2023. Each SpinCo PSU Award that is outstanding as of
the Effective Time will be further adjusted to reflect the Transactions as set forth in Section&nbsp;4.4(f) below. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;<U>Company PSU Awards (Other than Company 2021 TSR PSU Awards) Held by Former
Company Service Providers</U>. As determined by the Company Compensation Committee pursuant to its authority under the Company Equity Plan, each Company PSU Award that is not a Company 2021 TSR PSU Award and is held by a Former Company Service
Provider outstanding as of immediately prior to the Distribution Time shall be, subject to Sections 4.4(e) and (f)&nbsp;below, subject to the same terms and conditions after the Distribution Time as the terms and conditions applicable to such
Company PSU Award immediately prior to the Distribution Time;<U>&nbsp;provided</U>,<U>&nbsp;however</U>, that from and after the Distribution Time, the number of shares of Company Common Stock covered by such Company PSU Award held by the
participant, as applicable, rounded to the nearest whole share, shall be equal to the product obtained by multiplying (i)&nbsp;the number of shares of Company Common Stock covered by such Company PSU Award immediately prior to the Distribution Time
by (ii)&nbsp;the Company Ratio. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) <U>Company 2021 TSR PSU Awards Held by Former Company Service Providers</U>. As determined by the
Company Compensation Committee pursuant to its authority under the Company Equity Plan, each Company 2021 TSR PSU Award held by a Former Company Service Provider that is outstanding as of immediately prior to the Distribution Time shall be, subject
to Sections 4.4(e) and (f)&nbsp;below, subject to the same terms and conditions after the Distribution Time as the terms and conditions applicable to such Company 2021 TSR PSU Award immediately prior to the Distribution
Time;<U>&nbsp;provided</U>,<U>&nbsp;however</U>, that from and after the Distribution Time, the number of shares of Company Common Stock covered by such Company 2021 TSR PSU Award held by the participant, as applicable, rounded to the nearest whole
share, shall be equal to the product obtained by multiplying (i)&nbsp;the number of shares of Company Common Stock covered by such Company 2021 TSR PSU Award immediately prior to the Distribution Time by (ii)&nbsp;such percentage (not to exceed
200%) as is mutually determined by the Company and SpinCo prior to the Distribution Time by (iii)&nbsp;the Company Ratio; provided, further, that from and after the Distribution Time, such Company 2021 TSR PSU Award shall no longer vest based on the
performance objectives applicable to such Company 2021 TSR PSU Award immediately prior to the Distribution Time and shall instead be amended to vest solely based on continuous employment or service on December&nbsp;31, 2023. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) <U>Amendment to Vesting Terms</U>. Prior to the Distribution Time, the Company and SpinCo may mutually agree to amend the vesting terms of
any or all outstanding Company PSU Awards. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) <U>SpinCo PSU Awards Outstanding as of the Effective Time</U>. As of the Effective Time,
each SpinCo PSU Award that is outstanding immediately prior to the Effective Time shall be converted into the right to receive (i)&nbsp;performance-vesting restricted stock units relating to shares of Domesticated Parent Common Stock (each, an
&#147;<U>Adjusted Parent PSU Award</U>&#148;) with substantially the same terms and conditions as were applicable to such SpinCo PSU Award immediately prior to the Effective Time (other than terms that have been rendered inoperative by the
Transactions), including with respect to vesting and termination-related provisions, except that such Adjusted Parent PSU Award shall relate to that whole number of shares of Domesticated Parent Common Stock as is equal to the product of
(A)&nbsp;the number of shares of SpinCo Common Stock subject to such SpinCo PSU Awards immediately prior to the Effective Time, multiplied by (B)&nbsp;the Base Exchange Ratio, with any fractional shares rounded down to the nearest whole share. Any
performance targets to which an Adjusted Parent PSU Awards are subject will be adjusted to reflect the Transactions contemplated hereby. In addition, at the Effective Time, Parent will issue to each holder of a SpinCo PSU Award a number of Earnout
Shares equal to the product of (A)&nbsp;the number of shares of SpinCo Common Stock subject to the SpinCo PSU Award, multiplied by (B)&nbsp;the Earnout Exchange Ratio, which Earnout Shares will be subject to the restrictions set forth in the Merger
Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.5 <U>SpinCo Equity Plans</U>. Effective as of immediately prior to the Distribution Time, SpinCo shall have adopted the
SpinCo 2022 Incentive Award Plan (Company Service Provider Awards) and the SpinCo 2022 Incentive Award Plan (SpinCo Service Provider Awards) (the &#147;<U>SpinCo Equity Plans</U>&#148;), which shall permit the grant and issuance of equity incentive
awards denominated in SpinCo Common Stock as described in this Article IV. In addition, prior to the Distribution<B> </B>Time, the Company<B> </B>shall approve the SpinCo Equity Plans as the sole stockholder of SpinCo. As of the Effective Time,
Parent will assume the SpinCo Equity Plans and all outstanding equity awards thereunder in accordance with the terms of this Article IV. </P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.6 <U>Parent Equity Plan and Parent ESPP</U>. Prior to the Effective Time, Parent shall
approve and adopt, subject to receipt of Parent Shareholder Approval: (i)&nbsp;an incentive equity plan (the &#147;<U>Parent Equity Plan</U>&#148;); and (ii)&nbsp;an employee stock purchase plan (the &#147;<U>Parent ESPP</U>&#148;), in each case, in
form and substance reasonably acceptable to the Company and SpinCo in consultation with Parent, and effective as of the Effective Time. The Parent Equity Plan will provide for the grant of awards of Domesticated Parent Common Stock with a total pool
of shares equal to (i) 14% of the aggregate number of Fully Diluted SpinCo Shares as of the Effective Time, plus (ii)&nbsp;any shares which, as of the effective date of the Parent Equity Plan, are subject to Adjusted Parent Equity Awards under the
SpinCo Equity Plans which, on or following such effective date, become available for issuance under the Parent Equity Plan pursuant to its terms, plus (iii)&nbsp;an annual &#147;evergreen&#148; increase of 5% of the shares of Parent Common Stock
outstanding as of the day prior to such increase (the &#147;<U>Parent Equity Plan Share Reserve</U>&#148;). The ESPP will provide for the grant of purchase rights with respect to Domesticated Parent Common Stock with a total pool of shares equal to
1.5% of the aggregate number of Fully Diluted SpinCo Shares as of the Effective Time, plus an annual &#147;evergreen&#148; increase of 1% of the shares of Parent Common Stock outstanding as of the day prior to such increase (the &#147;<U>Parent ESPP
Share Reserve</U>&#148;). <U>As soon as reasonably practicable</U> following the expiration of the sixty (60)&nbsp;day period following the date Parent has filed current Form 10 information with the SEC reflecting its status as an entity that is not
a shell company, Parent shall file an effective registration statement on Form <FONT STYLE="white-space:nowrap">S-8</FONT> (or other applicable form, including Form <FONT STYLE="white-space:nowrap">S-1</FONT> or Form
<FONT STYLE="white-space:nowrap">S-3)</FONT> with respect to the Domesticated Parent Common Stock issuable under the Parent Equity Plan and the Parent ESPP, and Parent shall use commercially reasonable efforts to maintain the effectiveness of such
registration statement(s) (and maintain the current status of the prospectus or prospectuses contained therein) for so long as awards granted pursuant to the Parent Equity Plan and the Parent ESPP remain outstanding. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.7 <U>Vesting; Accelerated Vesting</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) The Distribution Time shall not constitute a termination of employment or service for any SpinCo Service Providers for purposes of any
Company Equity Award and, except as otherwise provided in this Agreement, with respect to grants adjusted pursuant to this Article IV, continued employment with the SpinCo Group shall be treated as continued employment with the Company Group with
respect to Company Equity Awards held by SpinCo Service Providers and continued employment with the Company Group shall be treated as continued employment with the SpinCo Group with respect to SpinCo Equity Awards (or, following the Effective Time,
Adjusted Parent Equity Awards) held by Company Service Providers. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Notwithstanding the foregoing, with respect to any unvested SpinCo
Equity Awards (or, following the Effective Time, Adjusted Parent Equity Awards) granted to a Company Service Provider in accordance with this Agreement, if the original Company Equity Award (that was partially adjusted into the SpinCo Equity Award
(or, following the Effective Time, Adjusted Parent Equity Award)) was subject, as of immediately prior to the Distribution, to accelerated vesting provisions (i)&nbsp;by reference to a termination of employment or service with the Company and/or
(ii)&nbsp;in connection with a &#147;Change in Control&#148; (as defined in the applicable award agreement and/or Company Equity Plan) of the Company, then the SpinCo Equity Awards (or, following the Effective Time, Adjusted Parent Equity Awards)
also shall be subject to such same acceleration provisions upon the Company Service Provider&#146;s termination of employment or service with the Company Group and/or in connection with a &#147;Change in Control&#148; (as defined in the applicable
award agreement and/or Company Equity Plan) of the Company. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Further notwithstanding the foregoing, with respect to any unvested Company Equity
Awards or unvested SpinCo Equity Awards (or, following the Effective Time, Adjusted Parent Equity Awards) granted to an SpinCo Service Provider in accordance with this Agreement, if the original Company Equity Award (including any Company Equity
Award that was solely or partially adjusted into the SpinCo Equity Award (or, following the Effective Time, Adjusted Parent Equity Award)), was subject, as of immediately prior to the Distribution, to accelerated vesting provisions (i)&nbsp;by
reference to a termination of employment or service with the Company and/or (ii)&nbsp;in connection with a &#147;Change in Control&#148; (as defined in the applicable award agreement and/or Company Equity Plan) of the Company, then the Company
Equity Award or SpinCo Equity Award (or, following the Effective Time, Adjusted Parent Equity Award), as applicable, also shall be subject to such same acceleration provisions upon the SpinCo Service Provider&#146;s termination of employment or
service with the relevant member of the SpinCo Group and/or in connection with a &#147;Change in Control&#148; (as defined in the applicable award agreement and/or SpinCo Equity Plan) of SpinCo. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) In addition, with respect to any unvested SpinCo Equity Awards (or, following the Effective Time, Adjusted Parent Equity Awards) held by a
Company Service Provider following the Distribution Time, notwithstanding anything herein or in the applicable award agreement to the contrary, such SpinCo Equity Awards (or, following the Effective Time, Adjusted Parent Equity Awards) will vest in
full upon a &#147;Change in Control&#148; (as defined in the applicable award agreement and/or SpinCo Equity Plans) of SpinCo (or, following the Effective Time, Parent). Further, with respect to any unvested Company Equity Awards which are adjusted
as of immediately prior to the Distribution Time and continue to be held by a SpinCo Service Provider following the Distribution, in each case, in accordance with this Agreement, notwithstanding anything herein or in the applicable award agreement
to the contrary, such Company Equity Awards will vest in full upon a &#147;Change in Control&#148; (as defined in the applicable award agreement and/or Company Equity Plan) of the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) Additionally, notwithstanding anything herein or in the applicable award agreement to the contrary, if, following the Distribution Time,
the Company Board determines, in its discretion, to accelerate in full the vesting of all Company Equity Awards then held by Company Service Providers and Former Company Service Providers (other than in connection with a &#147;Change in
Control&#148; (as defined in the applicable award agreement and/or Company Equity Plan)), the Company Board shall also accelerate in full the vesting of all outstanding Company Equity Awards which are then held by SpinCo Service Providers and Former
SpinCo Service Providers. Further notwithstanding anything herein or in the applicable award agreement to the contrary, if, following the Distribution Time, the SpinCo Board or Parent Board determines, in its discretion, to accelerate in full the
vesting of all SpinCo Equity Awards (or, following the Effective Time, Adjusted Parent Equity Awards) then held by SpinCo Service Providers and Former SpinCo Service Providers (other than in connection with a &#147;Change in Control&#148; (as
defined in the applicable award agreement and/or SpinCo Equity Plans)), the SpinCo Board or Parent Board shall also accelerate in full the vesting of all outstanding SpinCo Equity Awards (or, following the Effective Time, Adjusted Parent Equity
Awards) which are then held by Company Service Providers and Former Company Service Providers. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) The Parties hereto acknowledge and
agree that in no event shall the vesting of any Company Equity Awards or SpinCo Equity Awards (or, following the Effective Time, Adjusted Parent Equity Awards), in any case, accelerate solely by reason of the transactions or events contemplated by
the Separation Agreement, this Agreement, the Merger Agreement or any other Transaction Document. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.8 <U>General Terms</U>. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) The adjustments contemplated by this Article IV are all intended to comply in all
respects with the requirements of Sections 409A and 424 of the Code, in each case, to the extent applicable, and all such provisions shall be interpreted and implemented in accordance with the foregoing. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) The Parties shall use their commercially reasonable efforts to maintain effective registration statements with the Securities Exchange
Commission with respect to the awards described in this Article IV, to the extent any such registration statement is required by applicable Law. For the avoidance of doubt, Parent shall use commercially reasonable efforts to file an effective
registration statement on Form <FONT STYLE="white-space:nowrap">S-8</FONT> (or other applicable form, including Form <FONT STYLE="white-space:nowrap">S-1</FONT> or Form <FONT STYLE="white-space:nowrap">S-3)</FONT> with respect to the Domesticated
Parent Common Stock issuable under the Adjusted Parent Equity Awards issuable under the SpinCo Equity Plans, and Parent shall use commercially reasonable efforts to maintain the effectiveness of such registration statement(s) (and maintain the
current status of the prospectus or prospectuses contained therein) for so long as such awards remain outstanding. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) The Parties hereby
acknowledge that the provisions of this Article IV are intended to achieve certain tax, legal and accounting objectives and, in the event such objectives are not achieved, the Parties agree to negotiate in good faith regarding such other actions
that may be necessary or appropriate to achieve such objectives. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) After the Distribution Time, Company Equity Awards adjusted pursuant
to this Article IV, regardless of by whom held, shall be settled by the Company pursuant to the terms of the Company Equity Plan, and SpinCo Equity Awards (or, following the Effective Time, Adjusted Parent Equity Awards), regardless of by whom held,
shall be settled by SpinCo or Parent (as applicable) pursuant to the terms of the SpinCo Equity Plan. Accordingly, it is intended that, to the extent of the issuance of such SpinCo Equity Awards (or, following the Effective Time, Adjusted Parent
Equity Awards) and in connection with the adjustment provisions of this Article IV, the SpinCo Equity Plan shall be considered a successor to the Company Equity Plan and to have assumed the obligations of the Company Equity Plan to make the
adjustments of the Company Equity Awards as set forth in this Article IV. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) The Parties acknowledge and agree that each of the
applicable tax deductions for which they may be eligible for federal income tax purposes with regard to the Company Equity Awards and SpinCo Equity Awards (or, following the Effective Time, Adjusted Parent Equity Awards), in any case, shall be
determined in accordance with Revenue Ruling <FONT STYLE="white-space:nowrap">2002-1.</FONT> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) By approving the form, terms and
conditions of, and the entrance by the Parties into, this Agreement, the Company Board, the SpinCo Board and the Parent Board intend to exempt from the short-swing profit recovery provisions of Section&nbsp;16(b) of the Exchange Act, by reason of
the application of Rule <FONT STYLE="white-space:nowrap">16b-3</FONT> thereunder, all acquisitions and dispositions of Company Equity Awards, SpinCo Equity Awards and/or Adjusted Parent Equity Awards by directors and executive officers of each of
the Parties contemplated herein, and the Company Board, the SpinCo Board and the Parent Board also intend to expressly approve, in respect of any Company Equity Awards, SpinCo Equity Awards and/or Adjusted Parent Equity Awards, the use of any method
for the payment of an exercise price and the satisfaction of any applicable tax withholding (specifically including the actual or constructive tendering of shares in payment of an exercise price and the withholding of shares from delivery in
satisfaction of applicable tax withholding requirements) to the extent such method is permitted under the Company Equity Plan or SpinCo Equity Plan (as applicable) and the applicable award agreement. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) Each of the Parties shall establish an appropriate administration system in order to
handle, in an orderly manner that complies with applicable Laws, (i)&nbsp;exercises of Ligand Options and SpinCo Options (or, following the Effective Time, Adjusted Parent Options), (ii) the settlement of other Ligand Equity Awards and SpinCo Equity
Awards (or, following the Effective Time, Adjusted Parent Equity Awards), (iii) the vesting of Ligand Equity Awards and SpinCo Equity Awards (or, following the Effective Time, Adjusted Parent Equity Awards) and (iv)&nbsp;the satisfaction of
applicable withholding taxes with respect to Ligand Equity Awards and SpinCo Equity Awards (or, following the Effective Time, Adjusted Parent Equity Awards). The Parties shall work together to unify and consolidate all indicative data and payroll
and employment information on regular timetables and make certain that each applicable entity&#146;s data and records in respect of such awards are correct and updated on a timely basis. The foregoing shall include employment status and information
required for tax withholding/remittance and reporting, compliance with trading windows and compliance with the requirements of the Exchange Act and other applicable Laws. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE V </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>ADDITIONAL
MATTERS </U></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.1 <U>Cash Incentive Programs</U>. SpinCo shall assume all Liabilities with respect to all cash incentive compensation,
commissions or similar cash payments earned by or payable to SpinCo Employees for the year in which the Distribution Time occurs and thereafter. The Company shall retain all Liabilities with respect to any cash incentive compensation, commissions or
similar cash payments earned by or payable to Company Employees for the year in which the Distribution Time occurs and thereafter. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.2
<U>Severance</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Effective as of the Distribution Time, SpinCo shall have adopted a severance plan (the &#147;<U>SpinCo Severance
Plan</U>&#148;) for the benefit of eligible SpinCo Employees containing terms substantially similar to those set forth in the Company Severance Plan. Following the Distribution Time, the Company shall be responsible for any and all Liabilities and
other obligations with respect to the Company Severance Plan, and SpinCo shall be responsible for any and all Liabilities and other obligations with respect to the SpinCo Severance Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) A SpinCo Employee shall not be deemed to have terminated employment for purposes of determining eligibility for severance benefits in
connection with or in anticipation of the consummation of the transactions contemplated by the Separation Agreement or Merger Agreement. SpinCo shall be solely responsible for all Liabilities in respect of all costs arising out of payments and
benefits relating to the termination or alleged termination of any SpinCo Employee&#146;s employment that occurs on or after the Distribution Time, including as a result of, in connection with or following the consummation of the transactions
contemplated by the Separation Agreement or Merger Agreement, including any amounts required to be paid (including any payroll or other taxes), and the costs of providing benefits, under any applicable severance, separation, redundancy, termination
or similar plan, program, practice, contract, agreement, law or regulation (such benefits to include any medical or other welfare benefits, outplacement benefits, accrued vacation, and taxes). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.3 <U><FONT STYLE="white-space:nowrap">Time-Off</FONT> Benefits</U>. Unless otherwise required under applicable Law (or as would result in
duplication of benefits), SpinCo shall (i)&nbsp;credit each SpinCo Employee with the amount of accrued but unused vacation time, paid <FONT STYLE="white-space:nowrap">time-off</FONT> and other <FONT STYLE="white-space:nowrap">time-off</FONT>
benefits as such SpinCo Employee had with the Company Group as of immediately before the date on which the employment of the SpinCo Employee transfers to SpinCo and (ii)&nbsp;permit each such SpinCo Employee to use such accrued but unused vacation
time, paid time off and other <FONT STYLE="white-space:nowrap">time-off</FONT> benefits in the same manner and upon the same terms and conditions as the SpinCo Employee would have been so permitted under the terms and conditions of the applicable
Company policies in effect for the year in which such transfer of employment occurs, up to and including full exhaustion of such transferred unused vacation time, paid-time off and other <FONT STYLE="white-space:nowrap">time-off</FONT> benefits (if
such full exhaustion would be permitted under the applicable Company policies in effect for that year in which the transfer of employment occurs). </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.4 <U>Workers&#146; Compensation Liabilities</U>. Effective no later than the Distribution
Time, SpinCo shall assume all Liabilities for SpinCo Employees, SpinCo Independent Contractors and Former SpinCo Service Providers related to any and all workers&#146; compensation injuries, incidents, conditions, claims or coverage, whenever
incurred (including claims incurred prior to the Distribution Time but not reported until after the Distribution Time), and SpinCo shall be fully responsible for the administration, management and payment of all such claims and satisfaction of all
such Liabilities. Notwithstanding the foregoing, if SpinCo is unable to assume any such Liability or the administration, management or payment of any such claim solely because of the operation of applicable Law, the Company shall retain such
Liabilities and SpinCo shall reimburse and otherwise fully indemnify the Company for all such Liabilities, including the costs of administering the plans, programs or arrangements under which any such Liabilities have accrued or otherwise arisen.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.5 <U>COBRA Compliance</U>. The Company shall retain responsibility for compliance with the health care continuation requirements of
COBRA with respect to SpinCo Employees or Former SpinCo Service Providers who, as of <U>the Plan Transition Date</U>, were covered under a Company Benefit Plan or who had incurred a COBRA qualifying event and were eligible to elect COBRA under a
Company Benefit Plan. SpinCo shall be responsible for administering compliance with the health care continuation requirements of COBRA, and the corresponding provisions of the SpinCo Benefit Plans with respect to SpinCo Employees and their covered
dependents who incur a COBRA qualifying event or loss of coverage at any time after the Plan Transition Date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.6 <U>Code
Section</U><U></U><U>&nbsp;409A</U>. Notwithstanding anything in this Agreement to the contrary, the Parties shall negotiate in good faith regarding the need for any treatment different from that otherwise provided herein with respect to the payment
of compensation to ensure that the treatment of such compensation does not cause the imposition of a Tax under Section&nbsp;409A of the Code. In no event, however, shall any Party be liable to another in respect of any Taxes imposed under, or any
other costs or Liabilities relating to, Section&nbsp;409A of the Code. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.7 <U>Payroll Taxes and Reporting</U>. The Parties shall, to the
extent practicable, (i)&nbsp;treat SpinCo or a member of the SpinCo Group as a &#147;successor employer&#148; and the Company (or the appropriate member of the Company Group) as a &#147;predecessor,&#148; within the meaning of Sections 3121(a)(1)
and 3306(b)(1) of the Code, with respect to SpinCo Employees for purposes of Taxes imposed under the United States Federal Unemployment Tax Act or the United States Federal Insurance Contributions Act, and (ii)&nbsp;cooperate with each other to
avoid, to the extent <U>reasonably practicable</U>, the filing of more than one IRS Form <FONT STYLE="white-space:nowrap">W-2</FONT> with respect to each SpinCo Employee for the calendar year in which the Distribution Time occurs. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.8 <U>Regulatory Filings</U>. Subject to applicable Law and the Tax Matters Agreement, the Company shall retain responsibility for all
employee-related regulatory filings for reporting periods ending at or prior to the Distribution Time, except for Equal Employment Opportunity Commission <FONT STYLE="white-space:nowrap">EEO-1</FONT> reports and affirmative action program (AAP)
reports and responses to Office of Federal Contract Compliance Programs (OFCCP) submissions, for which the Company shall provide data and information (to the extent permitted by applicable Laws) to SpinCo, which shall be responsible for making such
filings in respect of SpinCo Employees. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.9 <U>Certain Requirements</U>. Notwithstanding anything in this Agreement to the contrary, if
applicable Law requires that any assets or Liabilities be retained by the Company Group or transferred to or assumed by the SpinCo Group in a manner that is different from that set forth in this Agreement, such retention, transfer or assumption
shall be made in accordance with the terms of such applicable Law and shall not be made as otherwise set forth in this Agreement and the Parties shall reasonably cooperate to adjust for any related economic consequences. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE VI </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>OBLIGATIONS OF PARENT AND MERGER SUB </U></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6.1 <U>Obligations of Parent</U>. Following the Merger Effective Time, Parent agrees to cause, and to take all actions to enable, SpinCo and
the members of the SpinCo Group to adhere to each provision of this Agreement which requires an act on the part of SpinCo or any member of the SpinCo Group or any of its or their Affiliates, and to cause or enable SpinCo and the SpinCo Group to
comply with their obligations to provide or establish compensation or benefits to SpinCo Service Providers in accordance with this Agreement pursuant to a Benefit Plan sponsored or maintained by Parent or any of its Subsidiaries. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE VII </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>GENERAL
AND ADMINISTRATIVE </U></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7.1 <U>Employer Rights</U>. Nothing in this Agreement shall be deemed to be an amendment to any Company Benefit
Plan or SpinCo Benefit Plan or to prohibit any member of the Company Group or SpinCo Group, as the case may be, from amending, modifying or terminating any Company Benefit Plan or SpinCo Benefit Plan at any time within its sole discretion. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7.2 <U>Effect on Employment</U>. Nothing in this Agreement is intended to or shall confer upon any employee or former employee of the Company,
SpinCo or any of their respective Affiliates any right to continued employment, or any recall or similar rights to any such individual on layoff or any type of approved leave. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7.3 <U>Consent of Third Parties</U>. If any provision of this Agreement is dependent on the consent of any third party and such consent is
withheld, the Parties shall use their reasonable efforts to implement the applicable provisions of this Agreement to the fullest extent practicable. If any provision of this Agreement cannot be implemented due to the failure of such third party to
consent, the Parties hereto shall negotiate in good faith to implement the provision (as applicable) in a mutually satisfactory manner. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7.4 <U>Access to Employees</U>. On and after the Distribution Time, the Parties shall, or shall cause each of their respective Affiliates to,
make available to each other those of their employees who may reasonably be needed in order to defend or prosecute any legal or administrative action (other than a legal action among the Parties) to which any employee or director of the Company
Group or the SpinCo Group or any Company Benefit Plan or SpinCo Benefit Plan is a party and which relates to a Company Benefit Plan or SpinCo Benefit Plan. The Party to whom an employee is made available in accordance with this&nbsp;Section
7.4&nbsp;shall pay or reimburse the other Parties for all reasonable expenses which may be incurred by such employee in connection therewith, including all reasonable travel, lodging, and meal expenses, but excluding any amount for such
employee&#146;s time spent in connection herewith. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7.5 <U>Beneficiary Designation/Release of Information/Right to Reimbursement</U>. To
the extent permitted by applicable Law and except as otherwise provided for in this Agreement, all beneficiary designations, authorizations for the release of information and rights to reimbursement made by or relating to SpinCo Employees under
Company Benefit Plan shall be transferred to and be in full force and effect under the corresponding SpinCo Benefit Plan until such beneficiary designations, authorizations or rights are replaced or revoked by, or no longer apply, to the relevant
SpinCo Employee. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7.6 <U>No Third Party Beneficiaries</U>. This Agreement is solely for the benefit of the
Parties and, except to the extent otherwise expressly provided herein, nothing in this Agreement, express or implied, is intended to confer any rights, benefits, remedies, obligations or Liabilities under this Agreement upon any Person, including
any SpinCo Employee or other current or former employee, officer, director or contractor of the Company Group or SpinCo Group, other than the Parties and their respective successors and assigns. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7.7 <U>Employee Benefits Administration</U>. At all times following the date hereof, the Parties will cooperate in good faith as necessary to
facilitate the administration of employee benefits and the resolution of related employee benefit claims with respect to SpinCo Employees, Former SpinCo Service Providers and employees and other service providers of the Company, as applicable,
including with respect to the provision of employee level information necessary for the other Parties to manage, administer, finance and file required reports with respect to such administration. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7.8 <U>Audit Rights With Respect to Information Provided</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Each Party, and their duly authorized representatives, shall have the right to conduct reasonable audits with respect to all information
required to be provided to it by the other Parties under this Agreement. The Party conducting the audit (the &#147;<U>Auditing Party</U>&#148;) may adopt reasonable procedures and guidelines for conducting audits and the selection of audit
representatives under this Section&nbsp;7.8. The Auditing Party shall have the right to make copies of any records at its expense, subject to any restrictions imposed by applicable laws and to any confidentiality provisions set forth in the
Separation Agreement, which are incorporated by reference herein. The Party being audited shall provide the Auditing Party&#146;s representatives with reasonable access during normal business hours to its operations, computer systems and paper and
electronic files, and provide workspace to its representatives. After any audit is completed, the Party being audited shall have the right to review a draft of the audit findings and to comment on those findings in writing within thirty business
days after receiving such draft. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) The Auditing Party&#146;s audit rights under this Section&nbsp;7.8 shall include the right to audit,
or participate in an audit facilitated by the Party being audited, of any Subsidiaries and Affiliates of the Party being audited and to require the other Parties to request any benefit providers and third parties with whom the Party being audited
has a relationship, or agents of such Party, to agree to such an audit to the extent any such Persons are affected by or addressed in this Agreement (collectively, the &#147;<U><FONT STYLE="white-space:nowrap">Non-parties</FONT></U>&#148;). The
Party being audited shall, upon written request from the Auditing Party, provide an individual (at the Auditing Party&#146;s expense) to supervise any audit of a <FONT STYLE="white-space:nowrap">Non-party.</FONT> The Auditing Party shall be
responsible for supplying, at the Auditing Party&#146;s expense, additional personnel sufficient to complete the audit in a reasonably timely manner. The responsibility of the Party being audited shall be limited to providing, at the Auditing
Party&#146;s expense, a single individual at each audited site for purposes of facilitating the audit. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7.9 <U>C</U><U>ooperation</U>.
Each of the Parties hereto will use its commercially reasonable efforts to share information and promptly take, or cause to be taken, all actions and to do, or cause to be done, all things necessary, proper or advisable under applicable Laws to
consummate the transactions contemplated by this Agreement. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE VIII </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>MISCELLANEOUS </U></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8.1
<U>Entire Agreement</U>. This Agreement, the Separation Agreement, the Merger Agreement, and the other Transaction Documents, including the Exhibits and Schedules thereto, shall constitute the entire agreement among the Parties with respect to the
subject matter hereof and shall supersede all previous negotiations, commitments, course of dealings and writings with respect to such subject matter. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8.2 <U>Counterparts</U>. This Agreement may be executed in two or more counterparts
(including by electronic or .pdf transmission), each of which shall be deemed an original, but all of which together shall constitute one and the same instrument. Delivery of any signature page by facsimile, electronic or .pdf transmission shall be
binding to the same extent as an original signature page. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8.3 <U>Survival of Agreements</U>. Except as otherwise contemplated by this
Agreement, all covenants and agreements of the Parties contained in this Agreement shall survive the Distribution Time and Merger Effective Time and remain in full force and effect in accordance with their applicable terms. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8.4 <U>Notices</U>. All notices and other communications among the Parties shall be in writing and shall be deemed to have been duly given
(a)&nbsp;when delivered in person, (b)&nbsp;when delivered after posting in the national mail having been sent registered or certified mail return receipt requested, postage prepaid, (c)&nbsp;when delivered by FedEx or other internationally
recognized overnight delivery service or (d)&nbsp;when delivered by facsimile (solely if receipt is confirmed) or email (so long as the sender of such email does not receive an automatic reply from the recipient&#146;s email server indicating that
the recipient did not receive such email), addressed as follows: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">To the Company: </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">Ligand Pharmaceuticals Incorporated </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">3911 Sorrento Valley Boulevard, Suite 110 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">San Diego, California 92121 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">Attn: Chief Financial Officer </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">Email: tespinoza@ligand.com </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">with a copy (which shall not constitute notice) to: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">Latham&nbsp;&amp; Watkins, LLP </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">12670 High Bluff Dr. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">San
Diego, California 92130 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">Attention: Matthew Bush </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Scott Shean </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">Email: matt.bush@lw.com </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;scott.shean@lw.com </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">To SpinCo: </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">OmniAb, Inc. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">5980 Horton Street, Suite 405 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">Emeryville, California 94608 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">Attn: Chief Legal Officer </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">Email: cberkman@omniab.com </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">with a copy (which shall not constitute notice) to: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">Latham&nbsp;&amp; Watkins, LLP </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">12670 High Bluff Dr. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">San
Diego, California 92130 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">Attention: Matthew Bush </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Scott Shean </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">Email: matt.bush@lw.com </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;scott.shean@lw.com </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">To Parent or Merger Sub: </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">Avista Public Acquisition Corp. II </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">65 East 55<SUP STYLE="font-size:85%; vertical-align:top">th</SUP> Street, 18<SUP STYLE="font-size:85%; vertical-align:top">th</SUP> Floor </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">New York, New York 10022 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">Attn:
General Counsel </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">Email: Silbert@avistacap.com </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">with a copy (which shall not constitute notice) to: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">Weil, Gotshal&nbsp;&amp; Manges LLP </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">767 5th Avenue </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">New York, New
York 10153 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">Attention: Jaclyn L. Cohen, Esq. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Raymond O. Gietz, Esq. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">Email: jackie.cohen@weil.com </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Raymond.gietz@weil.com </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">or to such other address or addresses as the Parties may from time to time designate in writing by like notice. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8.5 <U>Consents</U>. Any consent required or permitted to be given by any Party to the other Parties under this Agreement shall be in writing
and signed by the Party giving such consent and shall be effective only against such Party (and its Group). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8.6 <U>Assignment</U>. This
Agreement shall not be assignable, in whole or in part, directly or indirectly, by any Party hereto without the prior written consent of the other Parties, and any attempt to assign any rights or obligations arising under this Agreement without such
consent shall be void. Notwithstanding the foregoing, and subject to any restrictions on assignment by SpinCo pursuant to Article IV of the Tax Matters Agreement, this Agreement shall be assignable to (i)&nbsp;with respect to the Company, an
Affiliate of the Company, and with respect to SpinCo, and Affiliate of SpinCo, or (ii)&nbsp;a bona fide third party in connection with a merger, reorganization, consolidation or the sale of all or substantially all the assets of a party hereto so
long as the resulting, surviving or transferee entity assumes all the obligations of the relevant party hereto by operation of Law or pursuant to an agreement in form and substance reasonably satisfactory to the other Parties to this
Agreement;&nbsp;provided&nbsp;however&nbsp;that in the case of each of the preceding clauses (i)&nbsp;and (ii), no assignment permitted by this&nbsp;Section 8.6&nbsp;shall release the assigning Party from liability for the full performance of its
obligations under this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8.7 <U>Successors and Assigns</U>. The provisions of this Agreement and the obligations and rights
hereunder shall be binding upon, inure to the benefit of and be enforceable by (and against) the Parties and their respective successors and permitted assigns. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8.8 <U>Termination and Amendment</U>. This Agreement may be amended or modified, in whole or in part, only by a duly authorized agreement in
writing executed by the Parties in the same manner (but not necessarily by the same Persons) as this Agreement, and which makes reference to this Agreement. This Agreement shall terminate automatically without any further action of the Parties upon
a termination of the Merger Agreement, and no Party will have any further obligations to the other Parties hereunder. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8.9 <U>Subsidiaries</U>. Each of the Parties shall cause to be performed, and hereby
guarantees the performance of, all actions, agreements and obligations set forth herein to be performed by any Subsidiary of such Party or by any entity that becomes a Subsidiary of such Party at and after the Distribution Time, to the extent such
Subsidiary remains a Subsidiary of the applicable Party. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8.10 <U>Title and Headings</U>. Titles and headings to sections herein are
inserted for the convenience of reference only and are not intended to be a part of or to affect the meaning or interpretation of this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8.11 <U>Governing Law</U>. This Agreement, and all claims, disputes, controversies or causes of action (whether in contract, tort, equity or
otherwise) that may be based upon, arise out of or relate to this Agreement (including any schedule or exhibit hereto) or the negotiation, execution or performance of this Agreement (including any claim, dispute, controversy or cause of action based
upon, arising out of or related to any representation or warranty made in or in connection with this Agreement or as an inducement to enter into this Agreement), shall be governed by and construed in accordance with the Laws of the State of
Delaware, without regard to any choice or conflict of law provision or rule (whether of the State of Delaware or any other jurisdiction) that would cause the application of the Laws of any jurisdiction other than the State of Delaware. Each of the
Parties agrees that any Action related to this agreement shall be brought exclusively in the <U>Chosen Courts</U>. By executing and delivering this Agreement, each of the Parties irrevocably: (a)&nbsp;accepts generally and unconditionally submits to
the exclusive jurisdiction of the Chosen Courts for any Action relating to this Agreement; (b)&nbsp;waives any objections which such party may now or hereafter have to the laying of venue of any such Action contemplated by this Section&nbsp;8.11 and
hereby further irrevocably waives and agrees not to plead or claim that any such Action has been brought in an inconvenient forum; (c)&nbsp;agrees that it will not attempt to deny or defeat the personal jurisdiction of the Chosen Courts by motion or
other request for leave from any such court; (d)&nbsp;agrees that it will not bring any Action contemplated by this Section&nbsp;8.11 in any court other than the Chosen Courts; (e)&nbsp;agrees that service of all process, including the summons and
complaint, in any Action may be made by registered or certified mail, return receipt requested, to such party at their respective addresses provided in accordance with Section&nbsp;8.4 or in any other manner permitted by Law; and (f)&nbsp;agrees
that service as provided in the preceding clause (e)&nbsp;is sufficient to confer personal jurisdiction over such party in the Action, and otherwise constitutes effective and binding service in every respect. Each of the parties hereto agrees that a
final judgment in any Action in a Chosen Court as provided above may be enforced in other jurisdictions by suit on the judgment or in any other manner provided by Law, and each party further agrees to the
<FONT STYLE="white-space:nowrap">non-exclusive</FONT> jurisdiction of the Chosen Courts for the enforcement or execution of any such judgment. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8.12 WAIVER OF JURY TRIAL. THE PARTIES HEREBY UNCONDITIONALLY AND IRREVOCABLY WAIVE THEIR RIGHT TO TRIAL BY JURY IN ANY JUDICIAL PROCEEDING IN
ANY COURT RELATING TO ANY DISPUTE, CONTROVERSY OR CLAIM ARISING OUT OF, RELATING TO OR IN CONNECTION WITH THIS AGREEMENT (INCLUDING ANY SCHEDULE OR EXHIBIT HERETO) OR THE BREACH, TERMINATION OR VALIDITY OF THIS AGREEMENT OR THE NEGOTIATION,
EXECUTION OR PERFORMANCE OF THIS AGREEMENT. NO PARTY TO THIS AGREEMENT SHALL SEEK A JURY TRIAL IN ANY LAWSUIT, PROCEEDING, COUNTERCLAIM OR ANY OTHER LITIGATION PROCEDURE BASED UPON, OR ARISING OUT OF, THIS AGREEMENT OR ANY RELATED INSTRUMENTS. NO
PARTY WILL SEEK TO CONSOLIDATE ANY SUCH ACTION IN WHICH A JURY TRIAL HAS BEEN WAIVED WITH ANY OTHER ACTION IN WHICH A JURY TRIAL CANNOT BE OR HAS NOT BEEN WAIVED. EACH PARTY TO THIS AGREEMENT CERTIFIES THAT IT HAS BEEN INDUCED TO ENTER INTO THIS
AGREEMENT OR INSTRUMENT BY, </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
AMONG OTHER THINGS, THE MUTUAL WAIVERS AND CERTIFICATIONS SET FORTH ABOVE IN THIS SECTION 8.12. NO PARTY HAS IN ANY WAY AGREED WITH OR REPRESENTED TO ANY OTHER PARTY THAT THE PROVISIONS OF THIS
SECTION 8.12 WILL NOT BE FULLY ENFORCED IN ALL INSTANCES. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8.13 <U>Severability</U>. If any provision of this Agreement, or the
application of any such provision to any Person or circumstance, shall be held invalid, illegal or unenforceable in any respect by a court of competent jurisdiction, such invalidity, illegality or unenforceability shall not affect any other
provision hereof. The Parties further agree that if any provision contained herein is, to any extent, held invalid or unenforceable in any respect under the Laws governing this Agreement, they shall take any actions necessary to render the remaining
provisions of this Agreement valid and enforceable to the fullest extent permitted by Law and, to the extent necessary, shall amend or otherwise modify this Agreement to replace any provision contained herein that is held invalid or unenforceable
with a valid and enforceable provision giving effect to the intent of the Parties. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8.14 <U>Interpretation</U>. The Parties have
participated jointly in the negotiation and drafting of this Agreement. This Agreement shall be construed without regard to any presumption or rule requiring construction or interpretation against the Party drafting or causing any instrument to be
drafted. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8.15 <U>No Duplication; No Double Recovery</U>. Nothing in this Agreement is intended to confer to or impose upon any Party a
duplicative right, entitlement, obligation or recovery with respect to any matter arising out of the same facts and circumstances. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8.16
<U>No Waiver</U>. No failure to exercise and no delay in exercising, on the part of any Party, any right, remedy, power or privilege hereunder shall operate as a waiver hereof; nor shall any single or partial exercise of any right, remedy, power or
privilege hereunder preclude any other or further exercise thereof or the exercise of any other right, remedy, power or privilege. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8.17
<U>No Admission of Liability</U>. The allocation of Assets and Liabilities herein is solely for the purpose of allocating such Assets and Liabilities among the Parties and is not intended as an admission of liability or responsibility for any
alleged Liabilities <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">vis-&agrave;-vis</FONT></FONT> any third party, including with respect to the Liabilities of any <FONT STYLE="white-space:nowrap">non-wholly</FONT> owned
subsidiary of any Party. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>[Signature Page Follows] </I></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">IN WITNESS WHEREOF, the Parties have caused this Agreement to be duly executed as of the day
and year first above written. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="13%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="86%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">LIGAND PHARMACEUTICALS INCORPORATED</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Matthew Korenberg</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Matthew Korenberg</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Executive Vice President, Finance and Chief Financial Officer</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">OMNIAB, INC.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Matthew W. Foehr</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Matthew W. Foehr</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">President and Chief Executive Officer</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">AVISTA PUBLIC ACQUISITION CORP. II</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Benjamin Silbert</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Benjamin Silbert</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">General Counsel</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">ORWELL MERGER SUB INC.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ David Burgstahler</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">David Burgstahler</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">President</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>[Signature Page to Employee Matters Agreement] </I></P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>7
<FILENAME>lgnd-20220323.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20220115.12 -->
<!-- Creation date: 3/24/2022 4:30:51 PM Eastern Time -->
<!-- Copyright (c) 2022 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema
  xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric"
  xmlns:num="http://www.xbrl.org/dtr/type/numeric"
  xmlns:us-types="http://fasb.org/us-types/2021-01-31"
  xmlns:lgnd="http://www.ligand.com/20220323"
  xmlns:dei="http://xbrl.sec.gov/dei/2021"
  xmlns:xbrli="http://www.xbrl.org/2003/instance"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
  attributeFormDefault="unqualified"
  elementFormDefault="qualified"
  targetNamespace="http://www.ligand.com/20220323"
  xmlns:xsd="http://www.w3.org/2001/XMLSchema">
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance" />
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2021/dei-2021.xsd" namespace="http://xbrl.sec.gov/dei/2021" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/numeric" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/non-numeric" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/naics/2021/naics-2021.xsd" namespace="http://xbrl.sec.gov/naics/2021" />
    <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt" />
  <xsd:annotation>
    <xsd:appinfo>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="lgnd-20220323_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:title="Label Links, all" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="lgnd-20220323_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:title="Presentation Links, all" xlink:type="simple" />
      <link:roleType roleURI="http://www.ligand.com//20220323/taxonomy/role/DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>8
<FILENAME>lgnd-20220323_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20220115.12 -->
<!-- Creation date: 3/24/2022 4:30:51 PM Eastern Time -->
<!-- Copyright (c) 2022 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
  xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cover [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Registrant Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amendment Flag</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Central Index Key</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Type</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Period End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation State Country Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Incorporation State Country Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity File Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity File Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Tax Identification Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line One</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line One</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine2" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine2" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line Two</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line Two</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, City or Town</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, City or Town</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, State or Province</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, State or Province</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Postal Zip Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">City Area Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Local Phone Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Written Communications</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Written Communications</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Soliciting Material</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Soliciting Material</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Issuer Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Issuer Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security 12b Title</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security 12b Title</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Trading Symbol</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security Exchange Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Emerging Growth Company</link:label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>9
<FILENAME>lgnd-20220323_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20220115.12 -->
<!-- Creation date: 3/24/2022 4:30:52 PM Eastern Time -->
<!-- Copyright (c) 2022 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
    xmlns:link="http://www.xbrl.org/2003/linkbase"
    xmlns:xlink="http://www.w3.org/1999/xlink"
    xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
    xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
    xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.ligand.com//20220323/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="lgnd-20220323.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.ligand.com//20220323/taxonomy/role/DocumentDocumentAndEntityInformation">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityRegistrantName" order="22.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AmendmentFlag" order="23.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCentralIndexKey" order="24.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentType" order="26.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentPeriodEndDate" order="27.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode" order="28.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFileNumber" order="29.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber" order="30.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine1" order="31.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine2" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine2" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine2" order="32.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCityOrTown" order="33.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressStateOrProvince" order="34.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode" order="35.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CityAreaCode" order="36.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_LocalPhoneNumber" order="37.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_WrittenCommunications" order="38.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SolicitingMaterial" order="39.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementTenderOffer" order="40.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementIssuerTenderOffer" order="41.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_Security12bTitle" order="42.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_TradingSymbol" order="43.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SecurityExchangeName" order="44.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany" order="45.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140044522340600">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Mar. 23, 2022</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">LIGAND PHARMACEUTICALS INC<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000886163<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Mar. 23,  2022<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation State Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-33093<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">77-0160744<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">5980 Horton Street<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 405<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Emeryville<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">94608<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(858)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">550-7500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre Commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre Commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">Common Stock, par value $0.001 per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">LGND<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>d337089d8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2021"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="lgnd-20220323.xsd" xlink:type="simple"/>
    <context id="duration_2022-03-23_to_2022-03-23">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
        </entity>
        <period>
            <startDate>2022-03-23</startDate>
            <endDate>2022-03-23</endDate>
        </period>
    </context>
    <dei:EntityRegistrantName
      contextRef="duration_2022-03-23_to_2022-03-23"
      id="Hidden_dei_EntityRegistrantName">LIGAND PHARMACEUTICALS INC</dei:EntityRegistrantName>
    <dei:AmendmentFlag contextRef="duration_2022-03-23_to_2022-03-23">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="duration_2022-03-23_to_2022-03-23"
      id="Hidden_dei_EntityCentralIndexKey">0000886163</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="duration_2022-03-23_to_2022-03-23">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="duration_2022-03-23_to_2022-03-23">2022-03-23</dei:DocumentPeriodEndDate>
    <dei:EntityIncorporationStateCountryCode contextRef="duration_2022-03-23_to_2022-03-23">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="duration_2022-03-23_to_2022-03-23">001-33093</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="duration_2022-03-23_to_2022-03-23">77-0160744</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="duration_2022-03-23_to_2022-03-23">5980 Horton Street</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="duration_2022-03-23_to_2022-03-23">Suite 405</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="duration_2022-03-23_to_2022-03-23">Emeryville</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="duration_2022-03-23_to_2022-03-23">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="duration_2022-03-23_to_2022-03-23">94608</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="duration_2022-03-23_to_2022-03-23">(858)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="duration_2022-03-23_to_2022-03-23">550-7500</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="duration_2022-03-23_to_2022-03-23">true</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="duration_2022-03-23_to_2022-03-23">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="duration_2022-03-23_to_2022-03-23">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="duration_2022-03-23_to_2022-03-23">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="duration_2022-03-23_to_2022-03-23">Common Stock, par value $0.001 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="duration_2022-03-23_to_2022-03-23">LGND</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="duration_2022-03-23_to_2022-03-23">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="duration_2022-03-23_to_2022-03-23">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>12
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M?!^2!F.,6_0T7X\48JVFL:W&VC$,>8!8\PRA9CC?AT6:&C/5BZPYC0IO0=5
MY3_;U UH]@TT')$%7C&9MC:CY$X*/-S^[PVPPL2.X>V+OP%02P,$%     @
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M;%!+ 0(4 Q0    (  %)>%1$OV:[[0   "L"   1              "  :\
M  !D;V-0<F]P<R]C;W)E+GAM;%!+ 0(4 Q0    (  %)>%297)PC$ 8  )PG
M   3              "  <L!  !X;"]T:&5M92]T:&5M93$N>&UL4$L! A0#
M%     @  4EX5.@H_\Q8!   ZA   !@              ("!# @  'AL+W=O
M<FMS:&5E=',O<VAE970Q+GAM;%!+ 0(4 Q0    (  %)>%2?H!OPL0(  .(,
M   -              "  9H,  !X;"]S='EL97,N>&UL4$L! A0#%     @
M 4EX5)>*NQS     $P(   L              ( !=@\  %]R96QS+RYR96QS
M4$L! A0#%     @  4EX5!PX9>H_ 0  / (   \              ( !7Q
M 'AL+W=O<FMB;V]K+GAM;%!+ 0(4 Q0    (  %)>%0D'INBK0   /@!   :
M              "  <L1  !X;"]?<F5L<R]W;W)K8F]O:RYX;6PN<F5L<U!+
M 0(4 Q0    (  %)>%1ED'F2&0$  ,\#   3              "  ; 2  !;
H0V]N=&5N=%]4>7!E<UTN>&UL4$L%!@     )  D /@(  /H3      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="d337089d8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com//20220323/taxonomy/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="d337089d8k.htm">d337089d8k.htm</File>
    <File>d337089dex101.htm</File>
    <File>d337089dex21.htm</File>
    <File>d337089dex22.htm</File>
    <File>d337089dex23.htm</File>
    <File>d337089dex24.htm</File>
    <File>lgnd-20220323.xsd</File>
    <File>lgnd-20220323_lab.xml</File>
    <File>lgnd-20220323_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="23">http://xbrl.sec.gov/dei/2021</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>18
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "d337089d8k.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "d337089d8k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "lgnd-20220323_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "lgnd-20220323_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "lgnd-20220323.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.sec.gov/dei/2021/dei-2021.xsd",
      "https://xbrl.sec.gov/naics/2021/naics-2021.xsd"
     ]
    }
   },
   "elementCount": 24,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2021": 3,
    "total": 3
   },
   "keyCustom": 0,
   "keyStandard": 23,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "lgnd",
   "nsuri": "http://www.ligand.com/20220323",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d337089d8k.htm",
      "contextRef": "duration_2022-03-23_to_2022-03-23",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "100000 - Document - Document and Entity Information",
     "role": "http://www.ligand.com//20220323/taxonomy/role/DocumentDocumentAndEntityInformation",
     "shortName": "Document and Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d337089d8k.htm",
      "contextRef": "duration_2022-03-23_to_2022-03-23",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.ligand.com//20220323/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.ligand.com//20220323/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.ligand.com//20220323/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.ligand.com//20220323/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.ligand.com//20220323/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two",
        "terseLabel": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.ligand.com//20220323/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.ligand.com//20220323/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.ligand.com//20220323/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.ligand.com//20220323/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.ligand.com//20220323/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.ligand.com//20220323/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.ligand.com//20220323/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation State Country Code",
        "terseLabel": "Entity Incorporation State Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.ligand.com//20220323/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.ligand.com//20220323/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.ligand.com//20220323/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.ligand.com//20220323/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre Commencement Issuer Tender Offer",
        "terseLabel": "Pre Commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.ligand.com//20220323/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre Commencement Tender Offer",
        "terseLabel": "Pre Commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.ligand.com//20220323/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Security 12b Title",
        "terseLabel": "Security 12b Title"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.ligand.com//20220323/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.ligand.com//20220323/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.ligand.com//20220323/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.ligand.com//20220323/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications",
        "terseLabel": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.ligand.com//20220323/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>19
<FILENAME>0001193125-22-083443-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001193125-22-083443-xbrl.zip
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M[RMPT^FM &[]FJ3#,Q^C$+\813(3M 19RXP.CW_Q#ZS\,JZZ=OPIG&@:FH_
MA[+B?5#(=W9M^DW[FUUKV/"L_L5,:^;9\J!CH&FAM^7RBRW@*_"/PUWPK78
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M1?X8&%>@@F5]M[?;]61H1_RL!) %:3HE5MDB-U86T3FR%3Q+4&Z3;T9FE(6
MRW1_VW3VPB>@4GJ;L^@J."I*673+NVW?1TN-F@!P7R\>;V6P 6R*Y/[G1K$?
MZ@1P\%IRQ2]A$U29ZD2U%)JC.A_F3(LP\[C^9\?%Y__@.ADILZ,Q"-#B]"?/
M$?/"D<;P=I3I83,TNX#<4;NBI1%#J*XI"'^?D60JK\-G$4_@\ '8AZP#MM"2
M(=.'&7-+C"L\PV-U5? 3E (,*&5R*)'!RB!+@%V39F1%FU(QD;7@X(%=!*@-
M9?5_$;=UY8Y:XI&:\9Q>*SEZ=EE_SV>89JL>5.-?H08& F4V5=J,BNF9(+0-
MY W'D;QBSP"N7DS3O&B[7H&K-)Y-I/*$((L$_ "V@%((&.FZ,<E__'9P6K:M
MD,GW^IW=KJ/PU4)HE'(5>+^+"C*)3#!-<T;9@,Y%=_38[BZ70FJ,-HRAY1"G
M9K4,#6=R$D2D=GD@70XUW"=O;/?KV16@*N?]8UC'9(X1 NGMI<,A4+4(9YFV
MW48P<1L;2=N\-=>T4P3V] KG$2E""&+/ D'UA6#^.0.PH!N3B>F)M-'C^@!T
MO6%ER-??T::V^=%LC;#"3;D('%62T0P-+15R!--9[5_Q"'S#>>#'R@,J&8 T
M1Q*E: L.8<YYBW3"Y:BX] %0 =N _FWXUQP'HRRHGA'%?[![1#/39*?04FC4
MVUBU>^,IS0NHSV*(/),+>7?)&;-@*:QS>NO(V5DCM?.H:5%H.R_@(_CV2A O
MQE&FDYMP*!Q7;1CW:P*_E2F>GLC/))@..5!>8/U%O_'2(ZDPF0+.L.XKF00<
M)G@*0C\M*4=5%Y2;,T4;T5H@LNA)$(+4!CT+1LO0P*KN^]KLFT2(YT?3N>5X
MS19F*@=9J!CV))?QE2)_5O]@X*DR(;7'5^;LIU@R+2VRK 66-\HXCFG1'("2
MOMCPE#;7*]<T'*4CA"I$,4A!MZ#\;.4+')ICIU0*<KL;*"X$$^_8OD^;LRZ7
MRCHNV1L/Q+EH@RTWR6@HIRIZXF1YV!E)N=;CJPT,YNJ45/PQDVKGRIKEL@9T
M2U-/)<P:"9![&$^"78=U=NEUU@0A;*BS(;;Y]#S@T#IZ 11J?T]$Y1<-H:TF
M)Y/CV[9HZ7BN*Q@:):!_4] 6B50UX@!M4[)84IE;0QW1<3(FO%A<OF^U!L;%
M::3LEY1Q2R]2;> ZX/X?2N>S=/ SH%?[? @ ;)_A;:I@)F*9".7B'4]0J53H
M:VI?7KTD,U0E&[D2FPRK*3V621*R(:N[AAJPY]05IOE2]$V3S"6JQ@E.@V41
MLV*<<N%-RY7!L#*;N320Q;64B6:QL&>3_H6J=^V \YHLR=+[6/BA^)&J^RA%
M$6KQ@.,-9( /<%':\XC+O[*K;U@4^\VG$F_B%+\[_;?=<8&C\(A*"X$%7R+7
MEKS?.+@6FZ:<2DXPG(A1+.#V<31A+3 EA1^P'.9Y4;(=B#51CR^U>)75BR :
MJW0#:?1Q\LG!N1%2RN3WE/ZD";)T' T8TYJBQ XY ("NW!0Z9\,F</G=;JO;
M[;8P?  #)!).)4@N(RQA %U7(F(9WF9XX^:52QQ5U0JA2%4096&WTODR%G-J
M'7GU:?>).#DX?W_P/RV7*:38B!*I'- )S6M8*,T-_)E6J9?IIY^V+#8[B2>\
M##HT6HN5&*QG3J:QNE %GS.-?I0ZD%MY8'NSY:UF<64HF$76XHSTL@S3I5"X
M()H7!HD*/%7"$N7OYEYQ+?PN$!@:S2AW3E@JQ''GKAK!4--@LSQW0/9MF%XG
M+OO5 5>='XG&<# T(4XUIG*>N(I325%JN5K22GHY>L3](((#Z<8HYF9TX^!M
M'?7XJ4Y^>IL35_9D#I7VP6$0*!0X5TQEW-3K(;139HJ3-:X]FN8K747'A(,9
MJ&X&"ARX1@A:Q-&A3UR ,TX$!*>/'/Y@)B&CB1V 1J14J#0=H&Q1U $#N1Q!
M"RH AI-_243GQ*&+X$:D4V!N%+2M*+8.NC@4Y3@D'1M@14D2Y19[8>7H+_!3
M< #1)B8#IQR#_Z R?4]-IJ_R>IW)$&M6\-$?@^$7H)FIV*03K62]FJU%EU:!
M""C3 (!6I)GB$\B)3+M=XG)NIK7)24*"XT"2QE_7\]'QT<GI&;DZO,BCZP)-
M9S,A*B!/(&0 \:L<F[9$*N3J _8SZ1(3>%N=7DX]2\GQKZZ#6Z ^?YO!I>WG
MX-*C!I>664(7CM[^=/9/Q3*>!'-DWMJJD-I\,!:OD<)(]ZAP4GE<E UG$[[X
M/D?)CXHJQ;2]>+?1V6QJN+%LE*R:S(H9$.RU:<Y)%H7';+3^9&T1>)?Y>69^
MC#PM40D,U/,YDX5Y%3$0>(E1F%Y(L"Z9KF"$N1+,5LI5^BSE,P&&L8^_D)[!
M4K\"K:X#ZYJB JMJ1*[361P"I+_(LI(LL+'^91"[UD3]T,:$P3T9\<?\G&U+
M:<4E&6#HNG2$:>XHY)4I-/A8$*'JA%H72A&9.]G\C7I3BY5"I0.1"9F[MP#6
M:T0L2=!Q0E,AV&8)J>ZL4<"9H5F$KA+>M_H"=0P8=+M+L1?7(K R/[J%V$2'
M#4UCI!,INXXJ;\=G1/*S.^A&44K4P'S5WAZOS_'O+!(V-).GR/#3N@N/,7;J
MM3!\D!H[+]5>S]L[6FNE0R5%9YDO))3#.$ "<A0XS.;+0C80B%_KA!63BSIT
M!K'VO3^K,09?[7[O1-^IB-"EE*H:4.<*J2*9"9T1IJG1D9"FF.;$3,8;:23I
MC+07XKN=;L?/:2$<^NY5^>L6 &DJB3=S, AL]L1?(\?K;I.SY$J/#U)6<I<R
M&4T&,+A46T+K%1F "T&=CTJP35#UG-%2\?R^>]79K6Z20$3*O*[RJD"J;BR,
M#U<S:6LB:34'Z)2@/7Y2P@&L<CIOI%"@ \_(@<^'I +KSO>K$R'=#<Y$N$D#
MK9O#YLU;J7W"MC;DK!']3D]5T^*YV_)[@6HT'(N;$&9#Z3;CEQ-2IHMH#(?F
M;%KGSE>\M"J3*$:\C#-.HWZ"JI25;.+'+@QI:I]P^\IG3@/R2WD;:DO< B17
MS:HX4NL+139]]Q8'*PA#"U1T I%+7>Z':==90NZJBDN#_(VS8:%R&%S7!HH5
M]DL:K6G$XI4S <EHY4 *__U"8*Y_EH^CJ890N=# EG(IK:2$%U8"-R9QNA58
M1K*OF</O!ID7YO/;='[K(''3^M4N_'S^QV:;%TTH1O8[^7$YPY\QR/%#,F)5
MRV1+OCT7NM:4L-=)(+6 EIIHU[0K5ZA*019%;#* "!U-RS%NU)1;MP;IUJI@
M!D@0L 8- M_!;T(=_%:4A6U6FG5$A .4*P&E'$4DO.'IC.H=*#>ON6XC9AT<
M,;T4+G&@6)^BW !"8@=:+RLPD0[5,E*%0/6+)A2N ITY,7<1MA!XBJB<SE?&
M3QDEW$A,GX)]FG0+/35''3"R^035$X=+W+"E.*";C&U=T8V!O)8?R*MZ]5S$
MWBP%#!RWJXF\U7DOR_DLQ<(Z'%4]HYWH"V+FFYK?!\AC,(KIO&<"]FRI\7R1
MJK,JT"BD:+OR3H/*H:^3,<*LG(:[E;KK*.OME/?FS$^Y L&4C$52UHF3FE7H
M-] E\>*I]<A:+K!<E_24N/Y]*W%-B_KJ%;D%35G^%-K;FNUJ%F>4.WDDBI[(
M,I3J%5.T.%&O-MEI;EC7N1,NCM.A89T#F<@1(.L4HX<Z?$L^PV 0Q=QLLU%6
M86\)&1161*,'F/*X2UGXM;RCV77!*B9OTH^&8CU;5+#<]4.&'7'$W9!5]+<F
MX5\):9-5A"QP"GOD4[$YG]0@LNY]7]?DYVKJ!UJVU21(SPRS [CL1@$BS2)
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M32)/8LW&V%?NLA62^J97&2>P\Q+E%>ZF*0KI9#'93 V5S^1E+$5N5D4IMJY
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M1R"FLF@X+[$D1S+C8\*)C9!OMX0,\(('JQ/B?CEBN([964) GQM>W(L,.'M
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M43@=AAG_]7Q?'2$PG,-D'&3>(@R0U8G.@3\Y A_'!8)\!"HO:E^9I;KD<W@
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M:0AZ4#T@Q&+!8QF&:,"2'&C^^J0(L_KO;(.M%C7[5J]6+!&H!JU&HI$ DY?
M\PA6B;XQZX4C1T\Q?@Y0D$ ]>Q!I7#^?+1R2>9W"TC>+U^RE-6N]AEKLZ)U5
M';D$'6+7!RN+2>I-X74,&4)84QYFU]%(G"UX'^XM"),(L5;P+CAJ(?+A,@P
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M&G/,%(EP5F%-T-K*HD(V<9D"D]IKM^R(JD#F!7B(ZM_:0F(9W33029F@C*A
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M7&/N"CPTI^-I*5CRA/YI5?L%8+EH7K ?D Y5$<7+U-).O64VF<<UJCF#2NR
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MW0T'K,@!:_ E7>9]6*C 3X)ZC,D-U5>F^AJ<217[OFX^V"0IK<H':W H/9I
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M!S?-AEQYE '7,<Y@HA(/4B\1(Y$@0\$D;X"S@HB7PYY/9G$"C6P  T-OSZV
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M=XT8_L+HM=Y=G(<44,W#3!T",,%ASFWDM[Y;A#Q&%?),EEMX/9P32,4QW!G
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M SAN0N\=, KA= ?CE"-O>#_=UT7O 9LEQ+CL5H?7T"'%KUTT+SNZ1 (XY3'
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M=.!S%(=A?"=!Q, LZ^-QAR5W<E+C5(2WH ^!]A-PQ">DNQ/>X%H=;ZD.NUG
M,4(4'@M>5)%I @^M2BXABY!8M2_8-EI$J;ZHZFKLD@GI,9^#<"<T&W;J"^6"
MF=*;UX08;S*6") :G4DP>$J<EU!5TAO2\@2L43S&8D]-WI96(?DBV3-'5_\8
M?.66E7>&[U0/E^_^_1AT@-^.WRK%E)J H63N9];KN$ZV]$(U_B"R<B YV8AS
ML1+VT\ (@E*B%N/0F(@IHO; O0C>!79:4FRJHR*SC)! KX.3J]#X"1& @]N*
M5Q56&']2P-?#(/6Y6Y%;UWV3)PD,#3LFI;"F8UB.D- NT>/L#^,69I3![\$
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MX%L*:Z$9F/FY%G:KR&[@53/CK5PWY>91BCDHRM<!X?&1]%I**<%323D*6!-
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M>. PJ2ESO"TM7ZLRIX?MFI;=#UZ9A:Q0$@@[O V.>OHD,)DMI59[""M)W&G
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M=_+'-&AILT$9_5Q9HS&%*%F*QT&Y/2H)B/9E56(?KIR*V898Z@B#L9*)N/P
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MMK@S:<O#[@<A8:?B60HGF]H7'K.\7'#='!@^6PL(3&[AO)O59/E7^Q+<5JV
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M68SHNC\(MB&=H*(#HPZBVY@B;NINM'RN8_AIY_?++Q=@N4@>MVR^0V#?6]R
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MS0II63:E$!U[' UG.2'BE):;3KH301C]R&LP0C-B-] Z:0M?2FA04#O8)8&
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MRE,/GS[J*BH=:H5R0LLS)6U[PE?3R;"I>7=DD=:['E2C)330O2Z;#11D%$P
M@W8[=SS'B"-UKN,Y#UE2Q-"1-)D*XR/]24@W!\TD63&I"12 "-*(YC28^:TD
M)WM$BJI;N026?)7#I[R9\E.PZ^05R3'0;365+1%:+1-*8MY:2M1L'59D^IOC
MTK'*HL*5["VF85'$!:^C:K4P?L3Q#&:6P/$)76WEVI)\;*VJU[48NV MN;J
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MIH,4P7Z2 TX*<GZ7;B:EQF[1NBV,Y!^G)\GQ?.WJQ)?(?]=T3>V)]<Y.\G.
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M-<Z-=JV665%+!RYC4U';&J#LF1WRN]MZ:IHB/#NK6]R'[=F83F@Z-%#9[O$
M&4?0G4UFFQNKT+O;S&S$7UX)JZF_ PY^.=9;P)^DH*V"GJJ.>ELUA"Z!H;:X
MEAA4&:%YD?&23/$KDK6J@$4X"FPTQE81:\KONM+RYQ]1VR]1Z/;/KUYG%Q2Z
M)>/KW$X_O'GWXOW7#](\>(U;<I<2M^GD?T&-6W*7$C>4@3NI<4-3NKFJR,YM
M<ALR-U:A_:L#;J&JX8HUU_[@9!F%5W$QK3-G5;D;5<YFJZ:BLH);RQC,=H]?
MY*:*T6[5:J'SZ5>W87%;JWIPH#2/U?F7J\R+5MN!#WO/<KN=.7Q'\6H[K_R:
MH2&T9[Q2.\B%W*?6+HF5VN'E#UMAMT5)'=?0S3 ^UP$: ;<&NA3O!:5V$'(9
M5VF7]!3:J8G^PC5V]"3[Q#&5<]/)]D5G_SLJYZ:3H'3NP> +8Z!B.Q00CY&=
MH:.F3FW6;[":;MT)^>JML;/]GBC9J^$M\&_+F%]I98K\,!P>$(!JRB/$@2$!
MH\>+YUJM* AQB'W;X[:I]ZSZV[I693KI*59IE9R@X;9=!<OLR]7[W;-*Q7CP
MH\O]>/6_ &2Q>_-&\(IZ&,%F#NO]5!6+JOTS'Z,%YR@([U()2,%/M5<'#\CH
MJD&GI!Z\8#!>'Q2;__O6)6VYVF)L(0JCKVB&;Y=N4:AD6_,\<+62>UD'Y^BN
M4>I]_3O5)T6?.L-R;U67%"U+\C"@(Q\G+9MB)4>R9<>6'9$D#BMQON= V"\_
M F%?R"K#FJ@7U"ZMWW';29>AXUB:+<AX*>W3U?<-.5H;\E8.@Z8[T>Z$7L++
M6&_4Q0C]094$'&XXM_6#F4A3GEY60UVP :"-KI_D3)RT0.D ;L.FOJ5H/L_E
MX.O$>YD#66T\[SDCPAGTJ+K:Z'DV' MN8Y2RZVM^21@7DI'&(*1VB0!Y"@P^
M\NN[R >TTJ+W3"F*M@'/"JEMB66@!&?1Z'^4M')+XO+,2[OD(;4EX=QS2*)P
M6$VB;I3MW4_>C.LC*/3?HL*\Y'(TBQM;_OX&5_TE-3_M'S[=U=$^VT.XJ+&K
M&T#HFO5>$U;"+$"N^K_" \Z,V2'^ 8:5%83Q5CJ](4A*ZB2N*VAE1-48UP#N
M8*Q310S3F-'#=5]"9E55OW7=; _AF 0L0<Z^2J(.BC!Q6!JH3'>TE>AE=LMC
MM\@GONZ?1,;[TDR& CWAQN:-"E/FMM NUG2.[;@<O-T*:;VU*\%?2' S%9B$
MP_:Z]8BO'X$CA7XU6$]>!JH=B:^#[7(@'@,@KSB:5;LTH_06@F&+#P*3317:
M3;;"H(P/[5B@8&!"^J']H-6,>BIO\T\%A(!QD\&^8'/1ND'KBE8^M>"2%)^?
M7Z(;XK(VV9R+G1S8HW-DM=8]3 "]KC?-FA!-GPM]-O60:PGSTS+'6S7S#0?G
M9=>8Y".J:M20F!V:0$Z()V9@TH5P. /C8%+@A3 42OO1&O$SHQ@2E\PQ11HO
MVQL+-#OQ6 GVQ%OU<6DZ.HNKK'\3MQ_8'0X'=ALXKN+L<2$+U3:RK\H/L=F#
MWE^,RRS,A.Z$ T;*874)0&1@X&/EQ:4K:L7.,S7N!_Y,1=,7^A)@:'B8'$9'
MZ@)0PSVYBZ25ND@?*'?QU=G^C3VBMB!T2;=[<& OW8$D\!O-=$PG#TT2&!0X
M["KQ\7X=*X'1\@^,P"YZ 1*ZPP*WTS?J%:I)(%,ME?VBRKF+V VFCL'03+EE
MB\R4_$4EUWA+:!O&%<2DI:G:ZCL._CP]^!'\^4)FSE$\^-,V?#YV!PUDUY'%
MG=NP=MS.L'[[L$P-?'I02S/YS1IBV*!]?$^?T@:!U.ES_/>M)=YUL,SI4_(?
MSF(X6.A.WQFZR&BP@Y/7,V? $95S6GX%K4+8/WA;Y&58WU<U>2M#Y5MGT12^
ML2",GL$*!D5%H^P=Y9*1_6),@SESW+<*&"G7Y?S N[M_VK4+/3_PR+SI0QLF
M.G\/XNHA.J?3UQL]D@6'?7ANQKM]*O*A:[4[O<!DR FT0]Z]N_5LD)A+/D@>
MFI?+W,!FL#BBM"T]5V?J=ESJT"4D1R>TQ+X;G;S5N=1?H>BU10V5A,Q0< NA
MV=J:'>OKT&#UC#[":R6M!NY);"6L6G<AMF(2H['$5G P!LW.$;Q6J)F_(K'5
MM\U9=405YW?EK-J>QVR0L^J^V(\[2) [X#^^#E65)'M"GH(8@]6O=R*JLA4B
M@XQ5[61#M15OU73"U$G_NWFKX->:NDKX8KTLRMVHJ[)@_COHJ\C*[6(/LUZ#
M;[FC_R +)"K%?U5\+97X Y.;6H8K/C?W, R\RRALTL?56=('4N"@+4-BUUH,
M;.8^#&[DS'1R:RE*K13V)FF0^?:46HI(XEZ@U.\R+''X(RSQA?3SSY1]63JV
M V]_'^,)^R9 *8%6=? W93UDC C+T=L5:=WHH#T3HD ]"9=P5J*J,-NL7?JA
M;K':QAQEGL"Q'T[^!''*M+T@'(N.ZV\4P&EG2^"X@> 7AD.,%LMX&U7*X/(J
M> L$Z4JYK[*D&FOP4!P@^CR/9%QW*A8NF*#!$@<NE ATB%*PE52-16Q&5&9$
M?6T+VA2.9CJ)FTI=):\BJ!LH..<,C\VWV"Q+M /23A(O#N;[P6*R,;J%"I7B
M7"K:A&9276W.X]!0KQFLQ@UI'B543UQ'[%L%8S*AP6'HWES-7G3IJ=J-A@!Y
M%04/G4ZH@IQL4&!'0]\+R_'I(LST8%/: I)\E++A"C0: $).G>FU:2@W84T
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M]P8T9:E8[8G_P[EH9T[N4XJO;YQ(^4&L>[#%A:.2(P+U!@(JN#]!1WB$5 "
M-K=8<965.R"BF!>;6DP;.?1$1<89,WCT=&(,/>3WPHW@RRC+Y\@DD.Z@P^,K
MHS5Q9T9) OV*-]FIP[_SYR,"O@6FP1U!:SM0\T*KQLL\0*BKDR? W0!G9KFI
M2ZCU0\ZXJKY,>>KAO^> [R9[R$Y3.IV8O8N*9:-2? NI\7%Y@E<O=EZ@>GC
M<>$_2\=T\;8@JD6="D?0+63OY,O;4 5;2P^CCT3TZI=Y6FD34%.HY]E?PCJM
M"3LOH<F/V6<(B@J9DKD"58@Y>LGZ]BH/,U\L9870 ARIG#0M"CAOMY]E*]S$
MS46>AYA!.VH7#2+ ]IJ8PF"Y^T^$5]5GP[?^6W>-5<)8HL*\D39L7KPTR@6P
M\]P4'CD%'Q^RQ!:.B%Y1I^*U>ERH+RBJ51?&=D@:9#!$S_0W'LDISME+CH6B
M2P \@N 1&HE8N]I?:SQU3+ *2>HQ2)H>8L>(%XPG*W42(>W)($3R"T$H,IP
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MR^!%G;&3::6B&;4,&#OMV#3$E8T2#81I"AT3TB_E7B3:((D6)DI;$E^3Y]^
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M@MQM)Z-:$C3Y4@+T>X;+'?T(97U)P[CE=50^Z>)(D]<C!'EP8:_("&VLMP-
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MZ%33-4HBIJAZC#O>7!17W@$!X,<Y'I%OXAW#K1*27&)K F9NA&RK,4"-UT>
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ME+Y?/PXQW^L KVW+7Z<CBP(4:]4F 6)\H>V&EZJU?>H!S*(-7R'A:!:%"8S
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M^XO^Y+N3_-/).-'_RD_X'?\_V>75\Y.$P:;)!YD;)8G&K7W$CW"-'/6!=MO
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MDFV)?F<$_P-BHL\-,0+6L>QRV6YW5(S*=E7K1#T\MKOK3-RX'T 2E% F 39
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M6&J@A;;-NN=QLL7C*9]+.9@,?/1&$5B[T5D!$UVIXL"*T^!H76R(Y1N=6#L
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MJO0+SHP]_9H9NSTUV1WMD&O>(%=%S<$(E7TJ2RF0H P@ZIL%GZ%HD40&E.Y
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M_9!L_GNUK<N.F;/K2(DS0"SUKVU5;U?H !%3A[%W(-H\71;-53Y_I93?\=S
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M;3$4421@86QE)S6C!'S&?K7_H;JL\Q&A!(4^L=."[9]6HH8/BA(/.'1F^L$
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MK>OF"IFZ2]NIZ_X^ <"%B6O+2X%(BPO8)-=%M<PDG((;VU6*@;%/S"*3Q*T
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M]SPXWCG[6()J%S@1%905049ZEU("=O#U[$$9:HS>([,-'YG_\MN3EXBYW%2
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MGI_$3A*@FDD'F4Q69=Z"SBNKOXU'_$=G^1R-\9>;NGSQ-75YR[G\SE?K]$
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M-XI@3GS F+F'JIBWL5U\ ]U/HNL2B^W2[,PEI22J.LQ_]/#9I%RR3"*$_O2
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MY_FF2T&FP2;>J3CBYJVLP#TA\9UJ@:GD*X37P!\*%"$![D&TR6F8^]>O']H
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MO&@PPIH3E8TNNKD($6G=@3,'V[97E90>;"('[Z5]S-A6Q@&7E'C5]-WLSJF
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MRZQ8R?1\*K!RB0<P=C[OR/$0PCDJA&#J4F(\,WM%WL0/5I73@X_.563*BCH
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MYRH-'O<F CYXI?)0J?1Q;3Q"<[YI/#YSE.!CT<;VY4S,-+48]BUIHZJ?[:2
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M9Y3)'UES)CRWX8WY.+E$-@].@5W$4;%6F%[IL7'M9X^I>V00X_A+53[Z@'T
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MSTAD'<REF\?VVSB-(RY58D E0]3FP-7:E@\ &BI HFY<*\ER)V'=ZVI++=]
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MG."?HJ6XH-"5F*V?S5T=SNY+-3 'AY$)QF .T2? ]%5PM6>[>J6KQWX*D*#
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M&P5PVLI#XP=^IP2T=N/XF]D*UI"WAODHM3Q-*UCH[X3EW81);)Q?(D/&.*
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MAEUP?J/!^1X2BIQ]O3P)SD\NOGS>*JW((TC++LC^@)KKS6:"[*?Q50K^S^X
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M0W#^D; >'BF^64ZT>/B!YY%73&S)/M@%N!YJ ^KH*,Z\D?V:,X"6'#1T_'T
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M)Z'QD>]";Z?;P^.NI-3N<LDLE-\'=9 ]WE!]CD91DL%NWAO(WIC%C#193,E
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M8H4DDV6,X';+R0)#G,5D511V(&=@Z^"KH.G=\"Y;T!PZA-533&IU'5Z4 J"
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M:M/$6%_MUD_ BOOF18.";G:O%/  0W9]ZR098( --NGQMUM+&GPW.VBAAU/
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M6:OW_NCA]+<0GG[[ND:0FKJUI(MYNZ7:#?SR^-&U3J ;,>26 4S:E^1$HX=
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M??1Y&*@&<9F&K<9SBL R#GO9/84R&T%]FCNQ0)9H<\6*"%H2*12GPEG@,M?
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MCG :KB:>4#3AR SS2O&8& 2]1NR8#?XE<=/>2LI&\VEI?;K:J9G 4I?H>I<
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M1:?)G[,6^RGO;8+*7$9KSBWI_+Y"5KZH>14Q(*00D8$0AHM1+ZY=&E8S1U4
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MVE5=N*=G<'.H)!1*'L%0+J_SW#6I=7^)<*!@4WN.;S6^W!W:'U"U('9B-!-
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M&DQ.\?"9K>[.(#\EW9>B;>_!M)KF]<2L7L[8]?A,TF3GVD88J-4D55=IL0.
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MUDDMY4Y*Q MTA743'WF^Y0YYC'[\&"KH)MQ@J$9C>A &'I?E:8X7LMS7WA.
ME+F 01$>!4>:3<^+18&=!_#?YK& .BBYPM9&QJ=E7HOW6>7G!;R-&POB%^$J
M@1)PJ.\^,R*2WS@UT=Q1C@O>84^,H0J>E&7ZN]L6^1TV'F2+DMOOD&51P@"
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M3@.Z:H5NA<)<6(%O B%T1@VUB#!;4 TWNFRS3W;;5P:,$-=Q(>YNQDT8M09
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M-IV0ST#'UA3"ES2F\6<X;G9N]!MDA\")-);9TLYO!__&[BSL7VBSJ02?5V&
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MCK5QB[*+8@FA5/N%LC++S?]&<"+C8)<PTTR@RP*W]6J)''0_##ETZJF7KQ_
MI_GGNY_WCDY&^Q^'R6\C\_9W/W>,X"&<*C, Z %R-#P>'OVV=S(Z/$@./R1'
MP_W#H_?'/R5[^_O#X^/DY# 9'7PX//J$W_@I05G<UF#W#P\^C-X;3VMD/C[Y
MXZ?D\]'HM]''X2_#3<:U"67HW>[(M[LOJ*^*8YL"8=LO*V,V@XU\E(,#P#=C
MK)C>1DM 5$&[3KW^(%AWJ;YN'3(AI(I&1B/PX)%G&+$9-]VD@O]E"R.L!/+6
MQ.Q2FW/UTKE8&!\2<J2:]LP8BP55*Z!U1YVQ@"35U=6DOB*D<M2%3Q&N^/,
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MHT-*;TK"%SF4&LGFW':W,2L668:4;[S)6;: KJ+84& <> R-K8M% $"?VQ"
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MI8>BC&WY?3:*8X;]<4-V>7+<$*5G< &$FP]J6N94MITIMN/![PI-./GX5C$
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M_!YLHH.A&8#1-,V+-QJGX<QQSTQ(K1\Y,A ^3:[/5>X5DD@;$1O&4N'I?P&
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MM.:E#6CCC4T:%0;@J P XQ_)0 Y+6!%G-%<'Y8NCN>16X^;N^3GW+N> C^7
M-KZSRJ_)Z8EZ&%4V 6]S 2C*%"ESKB"*#;M+;WSL7(F0KEXYWGGO$ZNWF/6Z
M8TUN!*=!65,@I*Z)W3M*O;6E'^AT$Z16,13DSG].HSQYXR5\4-EY<H.QNLNT
M9ZO3O2[L>#UOC=W%L+C!>DNS AZCV> "7CMPMN;K=<U]6KOFEG=&='[A0N&4
M@J'A&1G(7L6GL8H8T\Y>]61*Z7CZQ,,?173*JGH$89%>2GXU ]; *XN9:WY.
MI?G.I5*6JZU6PDX]]XJ$"!!PQ0J&>IJI@V5F/4E 9>G?@G464;9GS)D&)I\&
MY$M\@T[48E;!,R<7[FCO2TWY65W1-M^'!3@F'=&4JYG4.A VV%>!Y*OGU,ZI
MV#(*6 !@:UL4N>)S[I%CBP+F5<X)46UE0:7.2SNXJ20(RT0B<\F2E=:622<V
MOAFL/9=$) ,Q^VC'JN>MY98M:-Z#XM>GR1E*PD3#C('633J6[^S_YQ3U.Y/R
M5$-?.^^?0,K]^.6GUNEY9_^P'?S>@;=_^>D!1_Z1 T#$[]8?WT":G34V6D<'
MP7GK]^"T_?7BZ. L((?"PX;UJ'/G!QRWM[8QKT!AN\!&&LPVR_>W@C;'4K"B
MS::_69?0?(?)SM9[1D'V'JVJU/C][+KK@T:6WN8_S&#2>PNLS*=[<Z2(<BS,
M$%V2N5F$&31<-R#Y"I43VJK'#3!I.KEJUZZ(%T@YDFBHP<]5<RD:A/ )I1%F
M;2K71BE/LK%149/<#'K3N.1B+!MJUI4(!.;20.#E7E/RSD\5>':JI%9UHC6-
MF199!#4IYMA97 3,ULJ) 2.H1NZIZ^JI$U)&RC-3P@W!;-1]=65U"62EVW8N
M5Y_=]?$E$#!0\ -W\9&D3!MI:+FJO+XYBV;ON5%U1#)+[WP:EG;9)-9L%L\6
MR,!EI\K-H(^A,+N',1K]@H?QF0?M39&-N'C%"^$C]Z.0>Y[1QY%(UY-Z=112
M(/M7+Q$?3Z@U G%1R3<+=LH3)<\M(%ZC3VO[[=JI]8)E]C$'[IY=+"Q-9#^K
M9Z1HH>V4+;1"F2S\OD5@+7/,M+D5&&*EJ<<;I)H:(^WY-1HVTHIUP$O69PPZ
MPQ+LIJ7H,\]D%C4VGD:?>5Z-=P'Z,!P!_:]$(WQ\[C_6%6LSCZ!2;HKZ<#)]
M'<K,:[5V'\5^_J:V;I=MW0(4Q+(MW?+C7X1<:&RL[=S9Y-%3@N%?W<I=%I'^
MJ]JXKULL/&I?*9=NJ5+!#'*.)'B-;H7MM5OAB8S:=Q5A1T%OT&9M,#_\B.6;
MBQJVWBM>:/A1ACC;MBT8+O?T@5:]XD5H,8M8M\HC\3?48BX7(Y*B(K,56 /W
M=6DR2Z35M3+SLI291V[MW]O*-8MG=<$EQW.+CU_'<U^+A.AY$J*:/O[EQ,/:
MU/U7E0X/V]F7)!Q>H^&[LS9\G\CP?8_<>5_*URNK++:"HW2"=(;YZ[;HB 1@
M3AG9ME2Y8/KFU;;O-MN^\,W.U@[_34W[\/,[_+P24[>.+8PCY@'5[*&Q45HR
MJG!@J*9R^KJ6[YS(3H7?B&!:K%BY/TI 5=W)==1C7N0A$]#[$,-@.N1B1[A:
M(^O<1MQ<0EW"M<6KL"\+$GCVAEA^75YT58(SN8:5KKA$ [<ND$.^,A"-XB'>
MQ=/CR1,TOPUP!6ZL<FWA"AFX57%UJ;/^%=%"-<C<X\]S6.O?<A4L#(9D2H&H
M&A:K73)N-&.K8=D9!I/ZX?E)$9C$;P5IZU66S6@M7^P03Z4INLL)M]U@F.*\
MND.)@^XT'B>$6"8 ND%*N,K";B[3]"]LM0%$;N Q*B'@_O/?M_<^?)ZOU6UO
M(0[<FP][H='GIB-N^N60AQ$5WH< 0!)@GKH:KY1#,S3(IR76CMAY <-'\(J,
M8F3;U#2) $2R=)PEU!4EI46.RQN')>-8PUW?ZH=A&Z4PT4$>1E8\\)/E0[E[
MC7]"QGC$)Q-!D7<8)X1O4B1//G:&,YH&/*Y"P/3 2_J%1[GV0OR^F6V;W.HD
M!$CH5J>Q(;*L@ICA:_XM\ISN#F#-(1E[JK$IEXY--72<*] 705NL,IL)7<!A
MR!56 QL$T1F2IF;87(AP6*AG4 4"#^V-Y6C#J!?CCG!G",3>C:J/)1)AQA@P
MMHNQ+.VB%/%9P?4BVXB_Q\.Q5!+B8MXBR\S#PAI:ET(W&G2GC+E P@#^&TVE
M@)V6(ND&EU&>5,8C+N/)+>H.-&Y94=)X\*SP1X)*P(&/IH9B>J!:6[0#?:N@
MK>N.?A:;@UHO6/O*0*&:7QXP'7P5E4)2\;W!/-&VDU<NF.J>@I[V5+$N!M1O
M42*KH2>#N#KG,07JK'F8MRO!XIOR E),]\K1N+9MPJ"UE4,/I[QXC=LIRS5Z
M)7A4OBF.$6P-+LH;&\4FWBM<B ^!169!P)*')X \6O4I^\%BU1(=OY(A6D07
M*X!\_!X'[H5G4I^@JN:-0:&M>F.CZ+19^C#D!3,&\7K]*._6?I0EZIBE-K+.
M0M7DS/Y8 ARR"*]>I]]"$]H9JA9<XK6A->WZF(!%VZD_1_,LV@_D=A^E 1X=
M:RLGU%3XW5N1TC;P<( 2Q$D@:1%DU1J><BG2(ZMC,<;-VA#J@5T<>U-:U0BY
M@.91N0IUQW@E:_"U@-R.(YGO8/A@K&E+/Z+V)'E%Q #%9#^/)Z;Q1^CT8H/(
M=<F-,@KX:B7W2*3G0<C$2I ""W0^:MDP46A Y1\DO$L6GH\PK*C3G,%:CJCR
MQIC#L".,DT7@7(1\2' 2BT[%1[PKOTUUZR%?'+R9?U#N-V?(DF.,@.2BRYP@
MEN\U&)@,%J!O*G7#X'^ L0F3(VQW!]5.#BMG>9&-1S[5YE9P[ME]!DM#M1M2
M9.'OIRRSG3IZ\\A ,6@L"Y\"N)!/08:&A&G;706PB_Z:0'6Z"'GE,F. 5-;M
MB ;&7<OA@\+\E(GAT-WU#SS+#!/G&?11[\]I3M%'LTB>*?<"5."/1O.3YC8^
M\$4-,*:YN*[5%JUVED[P74#W[][M;<;-H"V 8VAP@>5JW0+IR.P-H:\6?*W&
MG5&C)/F6':&ST)&Q#_3T-HTZ+0V54MWXUQPPC45GL6$WHSGM@)K*W<#OUR\W
MSVELF-7S!)6[J;@$=@#E<TE,$W_*"08.EP]4E?_E$T3'V@R 'UW8)_MD&5'(
M#;#ZRN=1:"98/I.$TFA48.Z]Z7M%0C99%:MGB*&,S.>J0?CASM(X0/,C]N/Z
MZ=$F"O-\@$2E$926$JU^LYP+LDE]-)*1 ]%8$K/\^&AFJ=@@SL *5K;+/18E
MT)7>+SXCQ2?0% K7<"LLUW? Y]"K-W8_X4*?9 FLD&4C);R?0G/2$LMA%+<\
MZ<46]U):@$TG4VH_0[WS)@;'EGF,ZZ]GU3/WW- ++(UI@$20U\!FF<B5$S.R
M0V=,2/0:(4JX<9W-U68-JND,,\ **Q/QJ?!F,7;=N/#@JO=9OV-%5_2C5(TC
M3D1'+%LE%<]5P-;$$E-$+IOB@F7)U34OCUYW/G"1 12+%NHT^_1@70ZMZ[[Z
MP!+@ND[;)ZW3UGGG^"A P*ZOG</.T<_!\5>![CJ_.#WRH;M6J+/L,':7H0+#
M(T$"[WV6#QB5%!E*7IC*5,!QAI%O=H:B:4"RBW_J4EM1-C[D,CPK8#N2#4%8
MT"-6P5G?#A94M^ED>UF*H3WP=:E4>5$@,MD*[K#W,#+R*W+<7JD7Z?W:B_1$
M)XBP%9BW+GY^JMU0F*-Z[X,4+.,<5:>JS3XN-?>LW!#;X<J@4Y18J&N>8E/P
M6Q7/%P6E0@V-1!_;Q!^L@<(/P#6@7Y61(AX)#-6G(UC8.]@<;!.% MVZ7*(>
M@O#'\",C>CJ+P@!%FYYP:;'7,0.&EU[AHJOR(-0I*K0@'( $'M&:-GH4*;1#
MBJ1;5=-$G-E"<)F,,W'X_,$V-A(.0+-BX0PO6K6P^NN" %&1M-PS:&0]RLUO
M:81DA"5VAK;YF"Q/80-#^U)9FJ"7@?5BWS=S &G5$SEA &/I&1,;MZL8LHH[
M"08Q-N,M&5 4SV/E5)Z+YY><89ZQ:H#_\*F"89OVL)?TW.$R<T86(1:X)*Q4
M38+95NY(+393> EGFI,>4^DHS68=G&$QH1(;.91-U8LEG/,Z3C+5LD(=#L+H
M3S!7LAO+UMGWD!&64NX"VQT5:4X8^80Q=&'%?NUTR+*L4.V%R%U&E^P*NW.K
M6"X/K]A?H7 @"VUU_+%TJK-!X> ",3)%4/8")B5B$HT8:"J@&A9U/3SAF@5A
M@D>22ZY-6I9L8DC8_"K"Z[]$1VL(0TXF\-H*]ZS6Q;3-/],,2W*9#77]'-N1
ME!M.V#@C2S2_(E+[U4NWD;L['2 []XL[: B?<?W-CM@D.^1:5466A@'Q('J]
MA.&DO9>:0(D2 ';I$Q00N.E]M]Q>OHVXS^/J]!I3#&G\.%M!AV(25L!75&GS
M/I0VN>!M]!TQAAZ%'/EBCX8YG%".CM!(B(F2<X3<CAYE:&<F7C]%-R1[BIEX
M/2>BXQ+ $,C%D&3FD*)SE=A=UDT0T5NSP;B/[@OB&* U33/!R?:UH<)B=;$'
M8I6FQJXDX'&C6)((X9H\SFY@<'!.^@GRRZ1 !8GJ'@%T=L6IE5-..=)WH73W
MW1DH=7K4S.S.ZI?9"O#KBPQ]U^5)F"XR)\;S4O0@+0Y ]FYKCX]=@0%C1V)/
MLU(*C\G1H<V@1)T\X&PB$9^XUGD,RXS;.$I0G:.,P[K\OR+SKS\T-:I248Q;
MYY$E)TU$-G!'7K2<U%D:PABT#MQS6=50H]%SLBFVF3*A!)%\HQND)/R\:37@
M$U1?O-TQ"O"T*BO+1.V,*:U@W(--R41%%AL'I#'"=?:H?:&\+Y-P*P1.R^&/
MH<D"WL^T)#Y/O9<C1"+C='C8+1.\UP^@7E;2#CJ^T8[H1PZK0C]0K 271>V"
M\S7FM \\4J:/8FLP'%\Q^[JXX]U!1*P-2"(,L$'0$$XGDQDN!&7.6C>[)-!/
M6><!2X!&F(Y*Y&>R84TX2ECIY9U3E$A'0:/"AH,=7:6VM1]_QL==&2\DRUH0
MK4G<-VY93H<,HIL(= $<D^S3A!WS7H,>VP\87UH9I@;U1[R@<@)'Q>P/SBI&
M"]D\L[BN$^X -)6L35U&5A?7PWZN399;,$8CDTG[@E>ZIE74R^F&B$6,L5Q%
M^$?2I<B9"!4>WP[87D9]P+C3[-E>QBXE6:O).G=XMB^[D-+B.F88_<:8$CQP
MTPN4.G!B.S$R$DGP3T=*KZ$H5#P@#7'$LXFEX=<@NHM[3:)^,5R[U]@5E$)#
ME(/*'>F$JY'ZH#IOB/??IG/@]P/.(W<^$>Q]-IUPLL< #LY$D2M>^LA:RIS]
MZO'W,2H^K]B5N+MV)3Z12K3'SGBC#@$=^A5DJTLE/1>)/H%]FICD'/((3N(Q
MVR&E#.C[]F RL2Z/P:E"7_8[48$")4 7VL4:O=MR;N$H],PE=K,)@RK_*EY5
M+Y<\;2C*8N.S7507<K+-;@!R_:+R$GD^-6T&+J+9N-P(\X[0J#CNH<"ZT?%4
M3 XI9 K<PLUWP>9.=:: %6?&+57L*"5;:9N\^[8;YGR#',85ODJQ]7!$NYRR
MW6,2VT0WMMO@O>2QI%I5MKGI-71NEBEW-455G;[S.EB*("^3^"LM): 7)XO-
MC,DNM6E'3IECT][C7)*3)(M)7<,V343<K4AC@YJ+XMIAX)UKJPZCVZ:?QU5I
M3'@+K9P=^)8YM5PNTS3HI4-4N[K (T /$$<</JW<&,2I"GXH0&5BS3)":4$:
M&S9+JYS7Y!7=>>H922MA+D9U"H/+1#QWVK=/JE A0:QJ9U2V&+ZN_MW8  [8
MYKV?ZQL]T@3ZD16,\(XW.YO7S2W#DK_*J8MNTH2-*RR)2:>7AD^YM4EP1!/I
M)IN23)@DJ-RYOF^U"RO=X!ZRO#QQ,59,5W#4Y9>S$IO;3;#K['H\/VQ0J4*3
M _D>"1F+,%;VX/U(-"'-0OO!14ZPOB$-BG/I%ZQ2VW3HGMC41)FC4FUHRQ.M
MU>$J2)%2H@P=.U):/WO,ZGR7$B)\%RR37'0%)(9=%TU&-E:U39#MVH:Q(!F[
ML1"@48?D9O)IPDUSZ04L:RR5>S,=&T*A6CIYZB:K3E@WWZ=D9TGA4;I4!;$V
MG2SV:S_EW"TV,4[/>.Q$T($A-$7OL4J:FH,1!YG\E=<$#)PD$4.65J>ZD!VF
M[EZ@H#2PE\(<:4CSGKW"!3DS5[AH=( S<R:4F-D*VI%5W8BW26PV==X.NSN;
MXDKC0!FM =O3C0T5+ZN[O6E%;+7?Y!XGW^N17'5QU:S#<BBZLC6WN40R.*G=
M=UKH+F_E/KK0O%[?\7>="&&7C@/W^!PX3D OZ+C7_CUY7),>(-YL[+=9".)7
M @P]/S)<KTF^)&=6$/81*-@##'H(22_5EDJ4>BKI SK1NQC0QX7&8.PUL"U<
M.A U77(IH?W?-$9IN5TO"ZJ%1G[*P4$S^$-D0L7XF6EF+RG[U$276*$L52EH
M6BAZ_.<4SF6<@?2Q+C]Z1BE$$&/?61NOJS@0.DWZA!<CNK);!<L,][/E:'*Q
MDWY(D38LU4!-M)CF[N>?ZAGBKQHPB[+\B24[=VAHG>15:IK-(:I^S*MUB>VM
M76(/6\F?ROUB[(D@:_">]4/OMO: B>%738DD>]2[H"@*=?%YJIM%DQBQ%6(L
M:QL;<@C(;V(DA,)Q2 GE(IN(/Z$R%E]](&9/H31J3YHA9,5-S&'*^C-'O "?
M.\ X%@?/J*P/>X/+\S0^B!+2L'6VB!)8[<!,3YBPB]Y0(8P-$PV H;*>#<^_
MC;)>WJR ;PY5B-U0Q \NTJF<*ZYP@RHM5.Y2/B&5!/M+VZ*;V9@H9%%4F1.T
MI(V-*US1$0X&N#);)7DIFV1!(BM$]UP,!A6%F'5_OR2F6JPM)H_O(=4*JG)C
M@Y>'HS:5KL]['<M:H?D$^@5G7=BTE7MH&HT-E</R8M E=AA=XL05R"I@C9>
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M&I>92!DC3NP[-[OI8, 1\8'@P'C@G]_,>+PT>>K\A]?VH^XD#V09I)(^\PD
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MFT-C\]G,B[K7!.=!B.%W\"H:=!'+ S?[P*R,0:ZB(AX74"=%:Z3AZ0C.OSO
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M:K/JW]\,4='$-&*F14KRV$][N%6*H;Q_^ZD5LCDR8R[^@JXVA>&3:7TBR(M
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MVIS5NZ>WN2,KEFCRQO\21X38*FOD?KB6'\B/$W$7N9R?H^* <'09;-NDKEF
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M%5*5FTT).R.L._AP *^Z_?_9>].F-K8L7?B[(O0?,JIO=Z"(-&7P< :?=K0
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M+Q<-6W,!_Z-BP>3?O*O;UUD;K.3>U[NHHRP16UL0K%%4M7WG7YJ-I02#J?_
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M=Q-"UB_;-%YD#?J3Y2,EEACF1.^Q!WCQG]%D'LT6 NO"6<74.6I%G::49Y:
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M8WBO*4PG4L/&@>?*RH"\W*5D$5S&9/,).!>BZ)EG\!>PP?R++!0L;?=K"O
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M_0)'=*P0N*G+[QB9'Y=([)5J!)@4,!(0=)*7TH^8B*6YO+1EY@EH#J%Q*8V
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MNP+QDTBC]3?)RI^-IE@4W_8#&KS-QJ.PQ <Q>._C%#>)"_<V2[[_"&;)8KT
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MB^2,N_/V77;'DV%6)INUZ4,1G^V=3N4)NQ]_>78_;K!+X@?)8)_<0][X]&8
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M$) CS*'/.VT_COK]&5;_7T=]60UM#VW5%B SWNR^0DUQI6L?'WQQ,ARJ;_]
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M'IC2"W1\#RB9S$/$\CW3>K^]U1M3ZS2>9=S.000,!I5+)4*V+$1Q$<N66:B
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M,2)RND-*H>E:NX#("09'D-=5KL#E!")J?JB0"EQ!GY5RX!\\(^[]\<G7L-G
MFJ;.AY.S3BAP$NAA\_=H.HO'2691PX+Q/,>6W]C$VGSN+(47P)7V%B*'T/#,
M7[?96J?$-[A,4[X/U]%H3E4 WI1#*8W@$FH&X),ZX_["-C<EIB25^E'_&R@E
MHWAP2:76-L$KE/1. 2+ INE8FX+X7>D<ZR(&::!C4%5)5$8$6G:*^Z\?1@?3
M+LPK6S _C/5Z@';*4>=#][C+97ELJ!P\>B/F/6G$?"@,Y$AN-8+)"5[&E\F(
M4'A-X4K&!@Z#I)EJ:CY+8$71-,E!CT-D.+[$F/S'S7,Q'=B.(QPD5 G%F>$,
M.V'!@A#RMP_T3@F$7&=^FWNQ&[1Y!F:"Q+VY:211+<W1O-5^H>]__%3OG:CE
M:%B*0KJ3M1P9C;/+PG(1@]2_S$?13/&R0"_A K80,RI--1O5#S$@SPCO<:9_
MC*BTB<KD$@66Q$ZO4H0$OU X&QA ,I,_E'/'25&D,TZ8Z_"29 A9!B%9X%H4
M7M<%UZ5\Z%EVE4QQ/.KU3"@5;U[^JRG+ !V.4ZZS/.U_T\(/DH[7:1YK4GNS
M07V4A6'S\.F,V)>'!1JYREYH6DP77RLX352\@Z5AQ5%,(4&^F-(G7!#(!P)"
M,(_R><9:F #&T+E-8@-9('_BXD,?L(<PCBX%W5=X:WX5ETZ;6QSCX1*NBT+!
M4C]9KJVAHR20S!3KE]R-(0@"6"1($'R/K<KKI8-%::-L.UM=H9982BX_OL_
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M$QT_?7]1(L5&C__UZ.)(]6$H+.7$](S.&A"'5&%E4 ""#G_G+I"FHC@LC"
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M*7?$R?)JI65:ZTG([_I>TRGCVL@OE71\\:6-0C,;:/$AX-%%/SP(2TY+0<3
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M*C]6/]H(N@VT[^\%*SU5P&4GD!^4PZR<%TV<YJGJ  /G[_0#\+,H\$"?1DF
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MZP5N1?0KQ?1X7Q$UH=71Q1@;EJ=A/JBZF*V7TU@H?(S=/ Y^MY*9$%+[PP9
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M;,)L"<CSU^4<!1$>9!%Q+'LB7(5"3O)5V3KKZI_2-H=98S+/[1*>(UHD&T7
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MZDO99)%(&:QF-B*/B8@1; $!_7H]US7U1K3\6WY;4!^7Y7I&A02U8D*]_$Y
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M"U!\;^YP]G9^JZ092.FFO/-AEZ/< W+ [",*-7C>[[^#;T35?6:,K0C,07>
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M;=E##QQ9GBVN]07F;A8WN?-O)<A3MKYIVG(:&#^C,6RC6@\HB.UYN7J-9'7
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M6CQ@] V__X'6>=[)+.,._8-J]F!53=X6K3+)(&24,;%7 ]F(+F.5,9DKX(3
M%O3' 0VT+.2XOP1I/I$"0N/9%U3N[570"RWZWDU2\/+:].'B4B=SMX>K_>Z;
MO:\ZPE(V*6" >X;:WJ(D::CQ1TT!><"+185&KF6;E'(05Y'O7KY]BM#2LVG1
MU(8R*;\22^&'659HBCH)V^9F._.]U-$"=]RI,U@RU;3G__$.O7T6^[%IPA4F
MMM;^!C>/'!4UUD&IU;R-(,G.+G#FS;K1:C2RTSFLYD%1*V\AR+W"L3[Z'AY'
M@P,%Q_RVA\#V!.$)]RK*LQF(MS'_G(H>@PKCJJX:NH*N-$U'< EG7,_6E"!R
M]QMW>LR$Z\H/AI2#VPKH[Q/"P[@M^6UT\#1NV'J8?BV/\8<A\J*$GM%%]>CH
MN]'!F?OY8NDY6QBC:[%5'3,J5)K?=4^E]Q.X*2F^EBM%D-A8$3TC44 (^EPI
M(^@U0J%%S!%NL[$*+ V(Y;D3A551]A(K$>Z\M"*LG&W,*4Y%&'J!@%7@!&.7
MS+.?U$PYTA0%#2?3,@>T[355[I-Y7BZZH)2@(7RI#+-K>GGQ '5CDNB1CH%=
MKZJ6C@TRJ'(>J.[+OXOO>X4J&LILC_6!>QB.)BD7Y@S@+N>=Q#>27:BI!+F#
M#!$3F#G+/S+G^ROS*0&%CM=Q'%947Z?,=1N/1!C$;85: %++8,6MIDEM06-7
M%P]D%FI(5'6<P.J!_S"&SSBQI$8C ^('=WD%+"#:36ZK%$:I3O!*,,:DK F7
M/+1@H H9NRMLO3(D<NF2P]-:5DEXMBXD$@CR&IH95;>Z+:O=F1;ZJJX53ED!
M=[CSI3*LKNL &_^ ;:!#X+=BR*0G(8 4E=5R!\BF[\"?G:A-&"Y1!?H]\T>G
MUG<IXP,3[*Q8,KX1;"O4K0(XDR@KU*/D(UH1+@T2/SEH>W,%;%#\J5=B5#]\
M"_YW3DRO(\O!Z96YT@*5S [' MWF[^D_Q&M!W(R%.XS\@<!:)6W<&T,QD_G8
MP=P;H9D]/F"V0A?FM?OJ_)#",9*+EN0<B^:B+YD/;8CK@8V"IW0]]#8VH9L@
MLY71+]RTX@X=V6@#J.<%5L$@>>P=U,<OZG;$7;W SM*:DY6!U#Q=43YITM'8
MOO2,39*>1"F% GT@$$RY6^FWR/S-;,0^==NV2<"2-^>1G5*<XCO0F]=0C"F$
MXSNSE>H;LO\JXZ" $HZ*O80MLM?0_S"0DK<]W;>PL,#CNGW 4AS*@FAYJ ZX
M)X;,<@![Q22)RU@_[>]9BH#4"G2.P4YP.G[E;->(Q@Y_D_JR_=Z']-?^7K!6
M=Z"_9&\^[& >#)V#;8XB2?='G,5^T8VSMTVO>=HOQ^[+!V$8C'?K2X!L);RC
MC;*;'WX)S7PR_,QE):G:]^5BO>BM!(PSV5F/1^//7CB/0AJ)*]D D7L/9WS6
MY)MZ8OF?YMSJ#_SI-:_B(RH_0$A9_.7YNJ$WU41UT /[-2?X3O>N6V$0ZUK)
ML\7RK!=:'Q=0*N!']V[A/AEU#5S2U<([O3OD_IF4&<&F@E^R$'B]1I_RR#=/
M> 7SB>9NX!45GI&3%*-PJL'Y67I8CO]MW% +03J!3FG=<E&\97Q_O&YQ-9U?
MU4(,1&N_<5Z0V5G=T_11[N%#P1M+M)0:G2DSR*CS[I#)X3HPJHSW""FB#0'Q
M"R.K%,9NB^[ZIW;KZW7CN4VQ(FI_6X-;<S!H(1(G==@)3Z?&GP+,G@<(BFP<
M67"'J\F6LI2C'EF2Y'BR$9:CT0EB&_1B<5S-@DD!-2T#5DE6!_K+K4SA0[&P
M5D([F%Z1H_P"D*=S*IE<+L%UD! X)7O]A,0_1,G@N7"@+GCO8FMV]V% ? ;*
MOFEA]O=ZGD(%:Q/-BX$PV<.EG;7TNSMG$^7*'N^ @G8L+&S:Z@Q)6=DGX []
M:5)2T.Z)V&@F8P_Z[HH!^>Q9PJ3CE>_*(VB26( \AIO0DN+(,L3FUO]8?-0L
M( \[@SE2./S0>"A*2)7/7=!=N0"K>UOP%D\*J74B/44A/LA5F[\M. *WD/YW
MK)K%:A\:%H658X:B?ATEEH(O[/=L YFOV!Q2;)*T0<&V$'WKU'H%7-T(651?
M*&DF-LO\Y&@SV.3?M/H_C/I"@9OE ['HHFT9,&]>/_R:" ^1@%Q]661WG0[H
M57S3K9>&"X>>1O4\6<"W\@4Y=7;0+=V&:VX2A]'P6#468,;KG S1%65=%S?5
M! ]WME0!/OS^O>L)J@S,&7Q\O+0-XT]GF@)F1GL4=5'2?>'&?^M#^QZ!W[\+
M?0'WJ(_8P.8-G>.-E]B0['9UA#!#-9SKD]Z+00$$C0 ?U-U8HC(RO:6XL+I<
M(:FXC 8IM_P.HJG'#\G8?%E-@\747QORIS! +V(4ON_%<K<9[^897[/!C8HK
M=]S_G#[E2OH^PD(&R.SO:3U=H\= %@=WG?CQ&PG/$KH"3C!X#2.E_#&S"A/2
M2-%BRDD5K@UI_F.[#+%B:-H- ;'NL:,/>MIN-V-S[T#Y>*RD.\IP19,,!X;M
M3@VK)IZ:KV=@)*],09>[E3*$P<6%Z28V&T.;=:#;5W#)Z#L,I(9/0<:QOZ<#
MHR?YV5VAY#)\GW3]P?'#/I8&**5IOA)#(H!<$Y"!V?,4J#J09?H2=/ED9NLS
M0QY+Q2R=N)[3[C%4Q/N)4!:!>D/ ITZ-.(,N(.]CAIK <-2K%]),D@+]0IF/
M</O/W;4HY*&WO@>?RBM!^ B.8BH/R(8D?TB4WGC=JBI1XI%0_;Q)I%E$PLE6
M=G)_6G[8DHJE1UV,BPB!G<\5G,ZMMKA!(+G]91M,C\TK*LET+B=M;:5H,.<&
MZF"LEA6E(RY;[DN:B.8JZ<D;S3\CT##=[[Y/4!:;H>KT1F@DR[%((Q0_RG"8
M867((BP):=YTP78V<&P>-[A*EC\[!=WHM+GM"XQ9';9YM R2^$9Z2GFG/<4L
MG-X>KVLGQITY#^%U[]<^DG;-E=?=;/U8S!K0^EMBNFWSC\JV/XI9(CI!V1X>
MP-Y'X8(DK UA;K5'(G)G;D+4HT@%F<M/?,/5^-+9WXNH<9U9739M"DQ"A\Z/
M25@,MU**E:54(&DT8=!NN<#E&7;(I^"9-<#)+NDECOQ$G4V*&XDTP%[?Q$4:
M6U)W#PKGAF>O7G(?A2FOYG3MF4K:G.!O>:-4HF9,7B]^Y)".?*D@HE=RXYG&
M+-__&7 3G.KH0B-2^3>G2\@;I0!#2Z+\G>6F7*.XP=17$9[<;'@A1>FLP XU
MKD1@F\S7P,$2]:3"4O. &RDTZ:"7H/*NV&#Z)Y=RE"FWI8NS?$*0"SK5G8Q\
MFN*. 6LG>K'Y/I(Z"2G5C N:/<#Q:/03W^T&9Z_'A\T<WSK)]$P:XE3HM6[:
M5&^:,KF<QRN0*9@T/K/:4Y8:)\*:W=# ?P2.SM".HFLR@D3 V*!&BW"1>4E2
MA"(8HKN^H6ZLD49.CPFQ8"AP+E7"7A4E=HF:(\'[7&_%1#/V4>^8#)JAU:)4
M*=BA-M:6];Z=O#M%O-=++7.2-3/+0!$=-VV&@6Z[C#:3R)6[,M(-AM'0CL)8
MR@SZ1D'D'5OFCI=DUKK7Z),SPV-LH#H;-.=;7]R>1L#9W%U+K961 V@JOFJM
M\;OMRBE7@7^WEDP:3>)K3K2+0U#OGJ>.[SP[,'V0P8J'[WGIS0"MZ,B(+PJ/
M9-+[9;"3ETPPFM=U+KT0/6L5(W.3V,NVLJ0#9]%T;SX@ITJK"E.L1?1Z'K;"
M-?OEZS!!2W7G;'TEI"S'=973)[2;I;"1SO*;J@XBVYM%V7K60A-%:'VC@N-<
MA:%X07Q#^2'4?Q"((.%OQL((ZH&LNJR@O[A;LNX_TS7IFBVJT,D[\PIJTXHB
M6=JCVYFA _GMK=KA#.C\?B#[EXC1)VT5MLM.84]?OWQS^NH"_&-19[#^E?@\
MC<&.'QZI>^RD<QHYR"<-YX+TI]YMV2[HE4.%VF*F4;X@OIH/Z>F4)_@>RPD5
M0U,81;%R-]"#]KJNUE?7K*$$"^QC/:%;#[> $I:MJ!L1A0: 81ZJ[-)6+Z2\
M6_$!IFM*WI=#!A.90LW:39TY:0+[!/M^B\HVV[1]F")X(M>2I2]W2HA;MB)S
M0;8YA;O0Q.C($CIEIIXDK3$U_)'K% 00[@CYJ6TR86$H@5@B!HZ4LWXGZ;"O
MGE6_2DO#"$\N50TWCL4+IWY+%SO<SV9K1F%$R90:4E?=%4N7=*ZGN?%\>"2V
MQ;9<B&J7E<MF76,,OOTJ5P,>9C98(($;0N%'C9[P@ZI+'D,E18OB$(6(:=VO
M5/#Z.D&W=NAE&2]>'0#]'I,O_I[E7(U7IT,"D'8OC=N9B-E4Y\J;5RWIQM2
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MK1RG(-9Z-XMTRSS HZ#-HUF8XV(+Z(7.;*);2PBQ37+\'5#QIC26R%@T@LM
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MX"Q4KH?YP8+AIPON;.R+&/F?UIK.N=7SM!B[/YTR+VINO]UPSDSTX73M;D4
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M2^2LKS\\"O.L/+= _-C'4(T6-U*DX^6SK@?I5,!H6<3G08^LZ-WV.SS318:
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M6;H@F2V/T5(_$E<,P<&XUPW61KDB#=Y6N\5B"\W/C>T*9>0KOE_K,,R"W'
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M"2XY2"SFVE)Q8RL&T*I7,D&W?CNY$+6+!9$*''A94R[<C4BXF0#N]_22W)E
M66&(CRI/S'8[@?*(ROSKFIH<NS7M2;)AL*3,H>R?:X L0DQ=W=U&MUD5YK_N
M&UC$; 4)T.\M$P%1( %N<=WAQW"5OHGTS-=LE;5J#GMQG2?2Y\U2P-\#H$G?
MJ6GLF;NUQ_B-9"U.N[(6WWJ^0@U>L-[N*D<1U5,4J%;^TCF*2*<H;"?H7SI'
M$36D*/J]IQS%[7,4HTT77B*@"N;)K:!9!0#CS)PP/&5!C[#F/4'R.X17BZGV
M>I8"9!3LR[I8BYH*9)4BT59;$4=5QCZU+8],Z)3Q'.$LDS'MBZULQMMQ63B,
M&5O1IP&T= .W;=HUAY$&&30O R?[-<6>RQIK%V9NS@!>A&AC]*NE8O ]ESK>
M"-S\UC6]+XPMT5+R+P7MMC&9(?IL'PEU,;A&&>YVAFZ.BX3!H5/JS$L8FFDZ
MFPCIZS(ZT-<,XB&&YGCA,4?>1?X2F3FP7QS!=F V9'C 4Z&W=NZX6&JEY7%T
M!DH,!0!(#FFAQQ)Q(,89+::GR!'$X%9&76937B9J=,B,&F,@8AM /%NASZ1&
MO#ZO<R0WE[9OK;'=#!++$HXV7/K/\SGWF &QMJ6)SW+SIH7$H(.* @DX!Z3R
MR3F@;-(B6.U0"+Y@V()PM_EK/IR ;$B=M6B(+UW"]GNZ\_(> CQ_>_?SX.AD
M;W=_&+TT[W[W<X=*N8\ T][!^^''@[T/>[N#D[W#@VAP\#[:->MXM/?N,_[B
MODD97FYMF^E^_GF/X'ZE@?I1P-1> N6&!_O@L)09COCL.@YP&IR]:.2>PW*5
MJ]T.X6\$#[2)<UT\930]OMO$972O+@I!HZR\_O.-Y@;:>:VC?M->1I1C106@
M_"RV@+-N:FZL^8>Y)BBLLA"77S<<"<4L$PX B/\F@959LEUC_0(:28'4!^DY
MQEK@-_U>I1$\!3HG C(U@>5U -1M>&2:P1Z232G $&"'CO\7W$)K3:CTFH*9
M%;M/VAXU5R</W?WN#*G>U)@A+/N=AI9?/(66;XS,$<  X9EF.JH,CXX'"HV=
M^7 E/9A:^BQ"BF45]$$2YYZHK:HX2TH)%E5 :8MTAO:6,:*:=U\TZI0#R%%H
MQR2ZG),=P(#8_E$TS!A\$(;9"+DI$A%'Z%-)4CKYQL+-PVQ<0\19\I2I%<^)
M!VM/H%-.]S=1XV2^)I)WT1(]BD[: :#9)A#65C1G+A)(G!IRC.0A^U?E$SW%
MWHE@#'*!G*J%G.5@A=3.N,G@'8V3RVQNN73EFW4(I,H>N3; V2XL: _=?0./
MN.VGKE.@^( $X^4:O>G .Z! "(![A]L[]T3,WGWH]=+<1*,#80YI=&/LWD2E
M"_Z/@O-1:&O-"I\"V)@=IWJ*=JT?K:3T"7ND*&=%*7XD(AD#F(;$:UHL @^O
M_I%-@A C[@Z5 V!=%_GDVLIQ#5Z(%Z2^WJ4;:U;Y*F.#(2WU+^.&.C5YP&9-
MR<"*R"6/JJ)9Z9"R*B#V:.[1F76#ERF=>D0;/07N] XHX5T4RK/672RR@B\1
M2.,\^M-(?ZHBM+].IH7(,4&/ZS#>!:E6+A<ZS'B_]=3:6XOML !-IBPP6"NQ
MK#%=0X=FEZ=S;'4G5D:;I0N4MV7$Z.8.6T)B;^\4J?RE2[&V,1"O8PDH/OB[
M-@6B;DN@Q0JX#7KGK>V %]& $A2P5I"J1F2@AL&R^*"ML7 [YYC:;@0O#DR?
M:P142THZUHBG!EH%%\D115CP%+C[:?JEJHUCHPZ1?99D$XBMFR_K\? X5+;+
MK'-62D9&D1?9VL6F23.>G*?.*4G KQ6.1)'82+"<_FFTX(AD=,,:;%)QET,2
M8O8E(:BP S%/P"_8H3H5:DDB$D2[GV1$M&&9PD_3^17 6M8>2,CYP9"RM&+F
M-G,C:T>72#]APV*V9?S'JMT%>5,!E0E%88VVS57)&3ZCW\/G.RJ^5A9TSWB6
MM=@"MA)\FCP="M[QG>.X[=!Y<,"5 [='0\=*W#/!"'1U#9AKXYK;VE"LE<-D
M @B7M $ZE6;+O[$OAX)]HU #=E4H/=G<,C>Q:> @P#(Z8>I^4N$.X/TP02>@
ME34N>\(7S5L 5FV,YB-4&TW,B3[(M*8M@L?)R=$+(SI$SP5*FF2YVLZ5NP*4
MCZT?=!8<]5UHN0'N/+?>!?X^ XX++5_SYRS3=.,$D ZPOG_]'L/WR4E!0XC/
MA>LK\ <4VT^$ 708I5N/,@JAZ%1E%PE2BZDV@A3F7.._<9TWSZ9R'+VV],38
M+ZEQ'Q)AG**?,\@%FH]EX_!>Z&F'H+T^JYD;Z"8"ZUE<'RR=4I9F,E9F\5D"
M]2V885A,9M9,RGG<5$?2(D ML)R UUGB2XN=!*??'$.;GX7TI1FU->GA+0S8
MSQ/'G4<DI1++N,Q&9&=G]F#43QI>2.-)((XA.3F8 Y*Y:&!I?;H('G'.]NBC
MA P(L3]0D0J0%4UM1V?B"$@ET0J\$0ATM" .,BYE9(! @C2?,(L$W7,L86(3
M7.1P:/<WRV7QL\A"= :BQ+B,.8@E$]+>U'9LR*"_(*SK\A+,"_22=.K)=2OX
M,2UKBBXUW;UH"8,[6?*!9&)NF\L:3"TLM$)22JB&L8V;O%EJGLE:2,>3G#CZ
MLQ!\"!.1#?$YT(DF?M?0ALHJCS9+-"P-]5$.\BMA.PN':H\R%])TIYQ?4NV!
M@+%;7ZE!AP=K@%&):@%G,V,A#QTUQI(LIW@!DKQANY1HX NR?LI%TS@ITH2<
M]K<^<G3=)UFZ(+VJ_MRBM[@T1DZ5=0.,*[Q ,+9L3'!(U[@2K7954/J)YVS]
MZ8HYK=SA!,.3V$PU*['3$0 [S;I,A..7NN(N4]8V@8A1NRH.>\,RF+=< 88V
MTR (/\LDO01E@=6_.'_DO3=G+>%4\<FZ[Z^OG(*XMYQD7M@+346(3 @;.[)K
M5#YZ;&*KNX18-?Y^.QY>/J6E;IR6\D$A5XO&AM%+'3!L"GB"WH'OAU^$BOU*
M%#\7E0GFHQ<SQ$ K^1YQN_.!8K=^5?,V)UTT6N,]<PXYWU9"/8ZC+WEQQ4C;
M"0+-AX/%</X,Y!'T)UQ3,0[2H7*8^=*&&.@6-I?A-L<L=?"PWU,4+*U$<Z@1
M?0:C(%;(LIL%49XBJ4UWX% $KS5BV&PNH<U$S P[5I)[[2HB:58*.%_4";:4
MM=_3NJ!&6MC$_\'6?ZR# K22DK?HJD&L</VV[:Y@;@U7DRN&,<A&OR#:1%3<
MQ!T@];?@>,?86G].<U'ZVAIT9IP+G(PLM5@%4(Q4SVWYQC,>+-PSLPNTW.+1
M<F*"^2&Y)H_P;=E?_'-1D=/E]%9VYEN.(2E*ZQF[,F\+-),96%0"BXO9FF)D
MQWNJJ<VF1C,10Z?[4-SOD8MK'3DLOA105#X@;;K6.QQHZK:/&EU[]A3.%]F$
M_+BS,EF,%X@];P29K7+D,.4J*/3;&V>V-#L,-CLZ,1?TP9V^P:+;9)J*B5]Q
MU-+-AX*:'9-ZQ$JV?N^5+65[.,/A^.1P]^^_'NZ_'QY%1WN__'IR?.^U:Z^V
MMK'2U779]WN:.'V@6).1<0J]#DWJ(BFT)L(H^ :15Z.$ UT+.[^A&T4TYZ4M
M.AY!O(+Y Z38'Q!)KI#'&:(9<T K@ .&8!H;V\__W1[MT&U<S"T@\&5!J7[J
MZO%#XDH>-U5;$BZZ>04(LX.D&B?_XF:"CUB32Y%@(.R%V%X.=> 5HZ389<%_
MFXOS$>$97,CB1J##M_)+7]DZ05ER$@!8;3P7? 5*UZ*H\_*36&Y 8.G"=.J
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M;P^$4PJOTE#F8W?;EF=E<XIC5QB-QO[RLR0#FPLM^U,=H:-G<HSC% ;2[R'
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ME/5^;V/'CG88_38\^#R,/AP>X0(,Z&,G@[\/#_"5YGW'GX;F!?C"YLG!%WG
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M<>\YJ@RH<83N'2,LX'+EMOQ8"@5PX+XU1;G!LFV[W<V:+N8+%)78ZE(1_:E
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ML'N1I6?1\*L0@Q^>G66C;[*D_P8%-BS1HE<_OGD>_5J4<X2/-];631)S'N+
MUG.TYM<:SO$BFZ?1R^>OUO=Q;OWNX30MKR^S"8#5[ [ZO1]?OG[^ILWA^:NZ
M.O=VTFJH I:;2+A+D9SH@;$-/AP>?8P./T3_>;AW8'RSZ.0PVA^>F/6+!K\<
M#8<?S5H^.-["/_X+_^^?@+_[7_]U$^"/M8[]$;,EI0!8/4W&%N.-<#CZ/<5Y
MM 0K.(#^'5QFU3R)/BU.)]DH&@"K+).W[1;E#-PEP-/=3:[-.**]:I( XTSZ
M%:@64T#F(41Q!P),Z/ >"#"_0C\;._(#U&(&F],$K )'19 =!+51(/44 U[V
M>_XS&)_.![@74+6KBV(*ZY<PXQC\CH8KW-MFCHFPSJ4),%J,_S=#7A(!JWI;
MB(#"K]LR:\6<#^F8(506P%<)N&J(Z&>)-01TVB/307)V> N 1".265*-RNR4
M -XL6FO5[S$03S,1XGT>QJ%"7A4R -Z\6 /&5S6<5L(]!2C"L2, 6H$C!9X1
M U2GW6@8#OZ1'V.^!J!GZN@HOG%$K/E/S=I67S;86O,I^P+^N'YD!FA["!DE
M.'\*9X;).I$T!%&$DLD"$;L\[L[[!X:AW=$+W;A4%O6>EXE@9,<%(@HB;Q&!
M<+:M%MY,8D7T26H1+E# -TO EX/K"B!R&GPSJ3Q\R;D%XV1L,-DLQBM.2P!R
M@INK0 Q#Z)VNH2+N$)J&0'4-(.]T+I>O4U8I?$6\G';W&]]F8<AP(1 S"_A]
M+"ZVF47F\" GUU&>P,,366\-('2?E]A;Y@;\2F;Y#4$J/<)PPK$W-]C#5W+(
M2OV>W2(MA3WF6UY<#[821&5"X-A,A"XXE1:#7&,Z-R)4WN/:U6P!(RZ.$#E=
M&,T0?VD/N3VS@K9YWQAOT3NC/K]L@4SYYQ.$\!VL/!NGT2]R^6L([$^K?/M5
MWAT>G>Q]V-L=G S!#-\[@$#ZX=$ @^KW[&"'8S'OOU]GNW:Y=?3MGP^/Z_;Y
MYX%9_=W]8;1GG:^'F_W!X./PX8%# 183U**8C9HLQ&BM?VA6D7]Z7@1 -MO/
MPG)9J_PQ-^XQ=NYH^,O>L9$NP_?]WN$'<WN'T>#@O?&8Q5M^2)S*$X6H:+FH
M[#Z)]U4BAS.:T@5&[P1KM 8IBJ= /2$Z)K!(1P^S\VJ[W]O/@+ [^F 4<!6]
M+Q$C5.!+&77X]VPR-=;,'&!5$>T;?PM#WTTJY.G:_O'-\S?_=-#(<C"SN3=B
M(KD5P%"9[))Q/K) >92#^>FS41['CR15&#:]X1 RS7N:GX/MQCBYYK2=+2:
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MM3EN(]GR.R/X'Q#W[FR0$9!L/2U97D50).5AK$7IDK0]-R;N![ ;3<+N!GH
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M.WZ0\@" 1F1 )2(-0WQFCNV8,Q#&;4OTI2QVK_,:_4J21E3&U8VXL>&M#V^
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MI_A?74*QO25NH_F'DEL,ZJ%FJ,Z#=WB ( @ LTD!6(M?BU4#7UUT413#:)3
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MF&';\[X5_V;SE]C\-4#K-+[FD6[T)IYSE_$<*-8\.=S_?'+07SQG(R,/7$9
M2'X^/#X\V?LE^K1W=M9G\&_3#^"A7UP_K"/V>/@U'<S$=A5;%1@I\KI,!C4E
MJ(ZP,SJ$KC96S(,5AC7$*)&>0K?J[&>[-QQC2VSW&IL&'/B1JLW^/X;]7P?[
M6%'5_>_VAFELB=U>0VR2 U-"+K39]\>P[VL(44+IE['>$&/TSNCZ499G_44C
M-[N^Q*ZO(1IYD%U!#_#A9I<?["ZO(>SX,:L&QH#[[S0I-_O\4/=Y#66]IVDR
MWFSP0]W@=53JGI5)7HV(?@O=\%ZV>\, N\QVKR'L1I$6N^DGJ3'1,H*!OZ/]
MCSX6Y2C-ZEG9DWV^D85E9&$M]/^V-[CF =]L^H/=]#7$WGY/@ &ZWWY<:]CM
M34+P;A."D!$\_GQVM'_86R)P0_#[T#72FW4D BTGO55)P@D&/$+(%5H6>38@
MHV62555?4)<-,?F#UEI'_S ZZ^CXX/#3\=''H_V]LZ//Q[TIKV\GC]PHK[M5
M7F_7H;R.S @FN:,PUE7SU#FK3Q#FAL%T"2E8@R,5D +$8#^>7?_I,5->;3BO
M-IQ7&\XKT08;SJO;*]M_'\ZK!W/]KJ5C93I-;J3 ^? K%$3T%+O>T TOL>5K
M0) =I.9,3C+"#KZ+]L=)U@N_]&;#E]GP-8#(?OIHS!%K+5UF=?JDFB:#],>\
MN"X3,]?C(G]R^'4PGE7955;?_/0=_. ]*(03V*J-.GBPTK$&J-E17LW*).\I
MF['9Y25V>0W0,JIK;CC;FQU_J#N^ENI6] %M5.4A[/V&EW*)O5\#]&S/&/1#
M,NH!IS)-D_$[(P#&[IN6:?VX]A\"4QQ@<QNDEO2Y"V%T1C2\X-JCC5^\O6T
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M?RDJ;/2CG*O'&H-YO8G!K*WTJAT@N"_&OQ;O7(O4SZ>6L\6XWTBWU9QO ,V
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M U$J=<P=7IB+/D^P.="@R$?F&PCAD^P0_14:A]3&;#+K%U9_T/]$PB,<B,,
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MV4;M-/W\,*G"*PX+X_"B;2:I:\=]4#&@2+@8*I<D<IOCV5Y--"'&@FCX<$6
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M,_.F9\$N',1I"#8!./S*/])I?X(OJCI"&'=?U%[;6*'8,G36I*0F1N Q.JG
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MN4^QEPT7K]NU0=-8_=N5]@Z*2>J6C3;0T]$PZ@',(P]HUQ4OC1</KJW$$H1
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MRKBY+6NL:XO=E ?7'/"WO;TY*R\Z4+P[B!.@=<?]T3'L8"ZH/%>MW%PO7;8
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M&S6G4AG($2/N.]O2H"",,N :(N'L'QB?)\4V7U7(INQR0!!_0W6IO<V9'_
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M,.NW6J619J?:WB)"&1EJ EA:K%5<>%:,U3Q 2W/_]7??$74<Z?2W%!*]#9?
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MWT_8CVX+K1WL"=0H*$/D$@J@M_M[3TDJ5NG7"AHY@C%^^T1=7$?8O#\Z!Y4
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M*V5&'TAGE%,)K_NMQ@W/C>_W\D4%:NML1/W&1I36B4P?PPY9G5$G?OV3N/Q
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MM'RLJ9 NT4!0])P79@K6YDC6L3W&:HEG_US("Y:>#/\'_O'DU_Q6'0N"-I?
M/M<#B7$CIDBQ%/M+5V_+^O(]C$"78]%@C5BL]T(ICZA-YDL'9Y^-36#ZL?H@
MGV]]D/>DG;32Y&,/)"4[0N=^F:Q'VA>D$9 UF,S<G:(E-YYEXR)!0YB.DUB9
MU'>QL]/UV7%7$VIWI40QZNW!@U8?;R@^Q^,D*V W[PQE;\Q31L$L9J2@E=<I
M'KF5 &XFSC%R620C#(0/BQ3E,CD;1M;QJSQ=54+@.?O0P2U,ZAYLX:\9';*N
MUJ"U %0?M-B3\%*"D)X"QITPKXLI1>5@)B0 A8$"^+F@(9/DAC%VW58R:?BU
MABEB'/Z^R28IIKPB+([4#MKXAY@,B^&RL:AB-=4J*XWO184GF?=LE)/?#1[\
M M)-:[#RJP+-S?)HG(!ZH:)@'&O"<6$5**#'QI9O9Y+<CA?HPM+JG=;H^KVZ
M2C<0#;'QW0RKXQDLP<!&N GZ"G07!IB?/OA+5%Q[9,EQ9(7U?'6XIIK"YRE\
MK@9OE.(J9$8HD>DFS.>/2XOBVN_AIT$_X7.1?#X"JFPR; R(7L4\X;/IUV0Z
MEQBX>B,Y'>4(:7J9V$66>\79PD9],\L4@\IX]%)8<(WEVHFQN%\S%LMVYR3[
M<?FN&)1]K/(#_X!UA7 F/-<1Y&5%\!'F"!JGK+=\('8/KTT<JA'B]8VN&\+/
M*OA!K*RH C08K:&B^WA([,4L1#+R%(K_7!9PX.O\,LK;1&5!7\*N*(52^>05
M\HGM2 >4X%MMMHE#YH\&Q"KGI>V&5([S#GPY!P>UN0_!QQJ7PK>GEKQ9N\W9
M;E.";3B[V.0@TUK44V%PR.TYZ&J]!=X.BG$="">V PRC,<X]2(2\40&T"?2F
M<!-N\BHY0,K=C60;WF.HLUUG[['F0:@A1>JI_/(*F:WP?]A%HH5Q>Q< -3_L
M@G]67_#8LU9AU^\EQLDQU'((SDWSASDIX:S)E/*%@14!))-\)!_'B.-8L14H
M06\%/TM(-SHEIAFS%>AMB()5?KZERZA,BMBCUNA_PXMMFQE)[=)9.LXJ4EF)
M2&1XS7K8B/%)*G(F34<="^S52JU_Q= F6: X\;.$W"0Z>>H6E-N*)QZ4MHG0
M^/!OLM5(08%]EJ6C+L"[!S[8VDZ<7B$4I^&[8Z)0:L_1&#)K*X/6\2)E=M%6
MH&P*'<.$LT4T!XW$LS^$8N5$P7-</*KKRJ3#U/#-UOD5'1Q/FPY*S;=SRAU@
MOGK'./J?^R_BIT^?XO^/=L89*' P_3#V$WQFE*.L+'?)Q9>4UVC6#PN&<8H*
M:&)H3AF"2X,7>J+\!JHT 2?[5XVE"R3M>6:^Q*D#;KA.EZ;^#;0NF*!9J@M4
MQN\N?@^0I[]^ :OM!N.MPV3RA&S4MU+*[T=XX+T$:.T1M##55B4\&NKES),A
M3=[/7&CB223C4!M@EO\#A4E&G,FH^?*29%\H7J/UTX[7JAV-CQ>Z]6+K-MF8
M6/5!#JME%S3G+>+A8Y-BXZ*\@:6;+TH;A&Q4[DJ1@R!Z)"=_,@$@%9K1SES
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M.',FS(FPDO,P5FY'[?ZSVN@-M/G@&#5Y@GV3.[%DOA]F!V#EN2&9!]Z(';<
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M:=:92GO1P;D]U(9T8(WYC+$-/>@&[GA*2?I<@ 0;IS2,N%&_(*P@.3A&JO0
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M_O>]"YUBA;V+=:UATI*2,K ;C%FB^1'<HJNV'Q)NGHB)4A%"8KJH%DP.1VN
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M,*\9&8V$ZXPQYJ3N++M:;M&$K/ F50YJT9W-[2V)00]-QCE&KP6]PFRQXEJ
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M'4SFZ,C_?O]\<'+,JZS/Z)_U<'5I[GWX+UA<^,OK#V>#8UCM/HWF"/9M<#3
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M&F3P?J_*&U>=;6CLS BZ:">;&BY!+ZG](G@P!8?<QZYB/<<4F+:6,M>.+;V
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M-?I6U<Q^)G_- 3X?RU_36UE:AWVZOR;+\LC^VF;S(^@=('E:VC=HUH5]3@\
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M0$:/=0K3AI\24JU[(= -HD:Z@>3;3&#8(Y!;:A@#C558YQ;LMC6R-*9,@SZ
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M^YXC:?(%$KU&?QV;"#XJG87XMIJ,PC0P+%:]"%"L[;?;2I!P:%1R-P_R9;2
MG%(-TF2C;C07NEAR6Q>S%4?Y'3UV_><*NJI%-(Q'E]LZ^?D5"#1L-XQ"FU]K
M%R2&D\BDHYZ$J[HC1 6"9*U9_DZ.E*"OXX<HU#QS+LU9&C$TZ:'HX#?F&2>-
MX-R5"'QGN^KV8:O)M1AL6=FBH$$0:\ 7$\DGZAYM5YY<:F32L?Y+:RG6(^Y%
M]J6W@CAB82]^]2J>\[F)N$^G@&KXI[.CH7),^1.DH7G7-H"6!,WS:8+K/Q?P
M$%*\WK,S2+S>L-OU&FN.I%N4H*=V&V5P389J[AY*3KS: ':KI-:3XA:?V+76
M$7.$S]13I:H2Y4F9JN<WJ1BT2-\<%C.J*VTH(P,P:C2S-,N<*%[313<>"[O/
MR--,<4"!%MAK+Q&N=$!QWP0N!".G4[*NB!B'APD4^!MIAXKY%Y!@IS*%LL&9
M,#R#$;^@K*)A\MEHM.H5MS3?'Q(J":9HIM'H9XA40F'@U]%,Q+$0/(%,N1)Q
M]:_TV7?<,Y7V..:6H>5>W_UG8IQ=*5$+:Z<%2V+[G6(C!+:0:C\6T&HM@\&_
MI'LGH-RT-T^(!B=@-<70VGR!,C?3&W$&KH)]% @=?')03<<E2@6&>,UGOVR$
MG6&_2W-'$R8JS;*E_\"\E;" %!1O"IIN7E7IB<;,&:NM"RF1DDO/$R<ZV@/J
M12MMHSEH24M)2KJQF/>+MLF?T%NG _MI:UONLGIV=/[&[',5>XQ\:NC<7$J(
M\[H0 [6WJH"Z,MV,2@N:PP63%^@6+IO;%^7&M04SA?)Z;0E?7SOCLUA_\Z]#
M.BAA*0IK]P0'-"K6J/>(N@";_@_<0U)I&>QA]*UP&DI_1^ZK:E9>8FF*X'31
MT="<'E.%VPN'TO-CYV_I3W<UE16RX6LA?>"IL3?#A$ V5#F+&$R0=3QA!'$[
M4KA4J>R/)8D/BK)4"NW6JA'Q%-/%R"F^-;].^";I><0*65:KF\V$7,E.'A,%
M:C6*B8@&8S&C"5'K#%/A2"4M9H?8.G:JC#;,>??1MM'^#@E>VER'D%5>EH5_
M'S*>2NZ>+7*2P5 !:5]JY=>4%BH%E\UG\I(LSK1HIHS<(*4VP3^,RQF%+Z:X
M 4P8,O;?;&!=UIQ9LW>!EH!+!3=%3GSM=L\G3;4PT!>K,V9:=%IP7;LO!4?1
M5^Z'B4U=3<XCK(H8O6!D WLXS'+,VP)NNURW<U0GZ@5::&:E+8V#)A0$()"5
M(3;*F<[!7>I1+3)#6K>W0O"K[3,[2,[0%6__^NW&['_^'K/_8B9$PX8HP_8:
MHD(C[]\:5K')YLD(LK6Y" QX7KFG_-'E0VJB92$0@W&^Z8C*54YIK8"7GE!S
M_)9>;-/@#4QQX*E!6E,S/["D*46-)6C5##OO(4'Z%(TDSFZ[B4FIE4R6VIV-
MN(F?P &S'!Z(]@27W--*#:4-O'E#-G&^?L_P@ @61=)X=A4;D9] @7PN>\A9
MTM^(0=1(W3[$'E*"B6_%(.KF=5O;'G+ G,<WB+Z$V9"M935L;WT=9@/9!6O8
M!-DGF 3PFDV0G7TS$0%9[O^(B( $O- S?KB;+PNR23<_X+99_U9#R-FCN?DR
MB\]WJWD"IOO?:NPM?6XWGZ?X66XU6:V'WFI6)]I;S;0IC-Q\8]1N\%9[Z 6U
MTJW=WMK<!16<SH=?4+RG#ZI:?60'*23%:CI(C0ML/?^(KZ>4@R0O_,(.DEI;
M#W:0L@?[1^!:/=A!^E9C'"^??H]QM!_A>Q8OWL]+?J ]\66R!CCXK]V>^!)9
M _4TOV9[HC5K\$GFA-UQ;T\\/I1_V,73IT229,K#1,J90?PIU2LL72%Y;CQE
ME[R:PI"9\]%#ELQJAI5.^6)^!3-'2A'1\[E\WW?;U@YB"*0G^P'N3N97HCL%
M"\XJ9FMPK T.P! !812GV98:]_>3-:D<=NF^5$'4*$0\5%@LG]DA)J2K:B*=
M_:+Z-3^T9"/09'>=J#AV@Q"2%[0J>'?#%F?4#X'^Q7#AOZ-13);QXQ<X?7#8
M6TYR::8?["]8ZV4!=P0V6V0J\15HLTPC L%!%R A;@I\!\0;'W"7(WK$-JS&
MWQGD,>.+;G+NO2T%'_@UT =3-*E\K1]WA9%.H]*N-?H*!Y;I'3Q5/[L&P#&8
MUB$E^'#R=0(8K19[-?,YR;9C!MK,4 %>Y'59<Q^RT%%I]F/' $51L*ZMAU?%
M:"%ESRSUCD*74 IB$VH%)BM[.&)#M*CKPC*0E%27-$4.G>2BZF;Z_AJJ*7*Z
MJ;3,DFX?RI^"XIE*D1H\W!(NZWTF#9!\CR%M)4)X4>E'SA<?FMI^7,XU2!W_
M =VR+Y[^2(][\?2G&'4- SIEZY@LX97%KT_^6^M>L0?O8L(NFF (#ZIKK1@E
M/R!B$3?.AH)!I?,@+3CK +>2)):R&>NO 3>QZ-@69R U%RO03#\\_4&W\"R?
M7>2P?4]._IH41*V GSQ_^O1YIJU<_,S=*^&3]R1?VUOPZ0V3,JAODIU@NIP*
M U]7<. =72MUHJ>+%.=/W7J1J()TPMP4"6Z@:&\0Q"'DM"/ C(P_8Q*Z?=G>
M,H>&40/2SZ!9"T'SY1*0Q53_D3Q]*33P13ZA?:RO4!\P]F!F]*OO1.2[H)'R
M'KO#C']Z_O3YLT %ZOZ.J0;PI?BT])$\O!"NPD.PY1$"S-]X\:Q'#^N9F3)C
MO1B="36(75+!?$:3ANM(N+DVM34(?(OYE33C+FN]"48]#?SP49"*CC$UZ%5.
M K[&="QB')@S:W>H5H^$%GZ4W)[MK>3^[.!C+?YX'_Z.]M ;]^U3&F1$NN=1
MWSTP=NX*(B3R#6?MZ!%\AJJ@G"Z$$X&(U,D?:7F9!ZJQB$Y<ZQM8N,1J].3>
M&U[E4^PW2IN'8(K :VALX2H/T$Y20GVK9JLGQ"_V#?41G8+!2Z/*19NKV>RG
MD[!E4T\).VZX&?LR$1J-=K*6Q6=">*%YD65M77S;<\K??5'5# H^-;N@D\^1
M+><9TV/2^X1_Y$X9"W3<Q]5P@9#]Q&0,!U[N:HU<UJ>Y6BT2;N@DS&0"GB_:
M&","(:N6F!_<Y8^OK(\<%?69$^<6&:XCI("(1MK*LI'8>]M50*N1XQW;WN(M
M^X;K=5\^^QX7^S+.V@_HK/U1SLF6/2MFM]AKA*'^^P]@XB]6Q [6K*X4NJDB
M."C^##2;ID55*6)_)EKW"7N_CU5H5QH;MN")7LK=Q_HP:(^!(]%:?+P_8&5'
M/J '6U/"A;"@$%Q.YHW4L"0*CERII^DGS<6"80\IZR)AW6@Y7K;I";B/,/0?
M\:HW^Z)Y-S N0Z'W<V4/NKKX2OS_1)C*W9&VMW8*KOM%2TO#\FXE?$-9]Q[;
M]< 4L^&?I5UB[3H9(0%G^NM>#TKO@P:]QZR0DE@,I("Q[A"6VLVKF-\50CO5
MF+=:AT;5PD%0IY8O>B9!DTU-F0QKMP)^):V D\2=0K#I"ZS@#^5-*8XH28N.
MH99S&^ =-$ F#C#L&[41HA6"/>MY<G\7.6;V5$JON%HML/B9?(?.2GV!%/[>
M9^9IKW0R5WZA6LR?5.,G-]7P8S$7?U3=4HFW>@9VEU14WV-^Q477? 3!<9@I
MJX:PFM('_GACO##G<DU?7";$H!G<ILAB+81=**$@DU=%/O*Q0?<N?B3Y=+A^
M]@V1<<(LO$(RYNQW]P-12_)O)4:R79CCK\J>!_IEMQ<4&COUX=XK 0DP4]"&
M1:*S.&FXO764WVT\A$C=9D^+\MJ)VZ]2>2:54P'S0*A5/>@DJ YLLI#'_(+;
M6Y9X5_LVNR,?18GS5(W<:FVP.EI\3V7PB6=^>RMUZ+/_O#,?]-*AX@%[X+-O
MYKS'L1**92C7Z4H%@#6;7J0;Z<= KN-/-ZX57@GIIDN/E//EYKI-)_K\N1H<
MD:28%98Y09IL*9;^I#TAV6I;:P40YI.:1-2-/)W)[XJY4\ZR=9-W;!I+_BZ3
M)!9YK%R6ZM)7(*H[ME::O>K"D'1GJ)"2RT%>=)?2;B&(6=26.\0UJ*FF=#BH
MY)?;J'CW U-ZB*GQ1"--M&A4L^UR-F!&7$OLHB6;J+A+T6)R,/%-5\7$,V,V
M*61HE2^H(6T ;T8P&RT8]T\T28<(CQ2RBNSN,N:2'@N2T3I@Y,<H9E-9K8L"
M:65,S7[4R2M$"[0T'C6)))R_"@)ABO /$C,).CWV@A&&C"&>&Z>2UI].LB7A
M0.0\\/^GQ;+NF?"82SMG%_GT8S&SUUF(SV@1=Y=GSET*'SDZFGJ4)$_#_>XE
MH*%6W8G3:OK$"Z=+S+",U@Y2P6FT8N0\HJ!DT.>5!VUY92%A-!2],+>ZL*3!
M%MD;U24*68.1,1,BNS -%H@(PWMGY3BDTS,9!K.+ 0F/%6O)?!83,8J<3G'P
MR%:YAA.A\#1Z<0A*HQP=0R\O%,T6X.Y0ZS(8LIZ#N8):BZ*0E-VADU!+ZT_N
MM[.88RP5BZ(8Q9#BH; (N(L9LR.T O0XD#]W[]&0R BNZ2K@#+)IYB3]Q3*;
M@+$Q4=#_-QD.?/X]'/A@3O\&_!(%=JI'6/O I[1]H"\XY+/>CU6\"1;EW]PS
MY$Q!^QV+!M60NFESH5@)5&).!P1I2AO:;SD$'D$JF0GN@Y3_A>0SBQGJN)WD
MX!CSX8R 8LJ5U:3$F "5\Y0$DB(WQ'"A)HGN#8;7 (RH?UA'\.BY K=)D:;;
MQ^S<FLNRJ5?*(LGR;O0Z;M:"M:"N&,TCEP[&,R:.MJIRAF\UKQ5!D,!F.F0)
M!FB!K?($&T64>&@[@E<#JMS=HG0Q7U_GC/M IVTNNIY4>7%9#BT_4(P7- Y1
M(&MF0.0I<S['&>78A,E8!S20!=P#U_CS8>B.>-9D3^U$9Y^T,=J,&J3E!<E\
MNP3VQMMNL&27"^_XI2KE4,HY(,M&M_ U840XZ*K=>FF6M2-9#E'_%@;G.;=V
MY1ZB@R-RH ?HHL(V/MX4;-)E.9#1]0UV9R,^K&6V$^X@*8.:# L"W8-E^U"3
M7-WLO\ ,T*9"(637KYU9+R/KQM,*JAER2D*ZOKD!/BSJ&UX7Q4<,1 0"!O\U
M5T@E:4%3+ TVW[)G\[C&\/()2=2?%P@M-:9[\PP$O6X'#?'AN=QC7!QVG\NK
M,1WNMX9'/,XE&A7 I>R2\G*.0?^6]94@C7$P)CS3N;M*9!'Q8.HM,3)[1DW/
MV_)0(!,W-:MW&B.SFMFWSI$UC<:,-AEIT&+4;87NH;7RZ" ?D\+.AX[ZO'8F
M99CR,*D6O+LX,X-N&OD]4G3+V!I0V@;''2P.8P1!;HHY!5:#&-/8Z))2!W)'
M=JLTL>-;,E:MU1I!1_2?O&BI_V0(U[T[$S0RO2HG%L*DA8?)U;@KI XQQ0UH
M(0.JU-B32D9FNE;=^6#IYF(^=O, #';HUV+5@;]++Q9+>,*N?3^;!4(RXVY_
M;FG@:-#Y J-E?7(C]J!;]^ 27,6LFL*#-=Q7(V!9MWQ5GKE?G4ZSZN&BXZV-
M/10Y#+J9?HF)R")U!M$58\,+VU06=)_#8J'9@NS" 7%PR&U(?4A045.( $\S
M%UJ5A8L!>D-U>\LA$QN[T6XOT'%8PE6#*A7]\GF&D;ZYQ[>-"J*31/\A5[6J
ME)RN9$,C89U;'N#SC3U"[,5BV H<R ,$DRAN&Z%HZ!QCN\==G%"07&VD9I5-
MM$L"9$$X(WEH?1HA:)DA33(:S$U-4_ > M(>5ZML<"91I\.XRD7M>Q1',+G6
M-8ZQ?2")^ABC<AMDJ9T7/:W_B"T$&:Q'A(8M)%P7F1W^XO86T=TE^DSL:D50
M:R,:>41FGV#5_VY+$+0[.H4+1#-)KXSB6!ZFW'72CKD ],RTF 4H6?>9BS0&
M_4ZP#9GTR.WD NL)\LW/!@0:M3[?'[X'SL-F$J7P,)BP9A9R>ZO+9BB*$2CT
M)V@;16E(JES :-\$!(  F2G^8UF]@D['6B7@:\B#B@*M9,T$[PH5[O;82M]2
M!B.0+AVCV1AO#(-H<+VW')I5:)57._FNZ4[T+48.7WR/''XN2V6TVT847<X8
MEHJ>U"B_QF:_I!2PM"@1J)C'%6UD1:X&3[VB\T3F.,JUQ-RDBT2S:JXT["UD
MQ^Y1^0;!I"=4LH+GQS:H'OGQ-6PIB\Y -SXC1N1_+::.HLO_J[:!0AT#N9QS
M1YE"AHA9!5/40M8O:)!4F7Z/5?!%H>5"HF35; X<=&<)DYF&!IB;!9IJG.%
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MO#S@6@L\1J"@JQ'6!H_T$I(XCRZ?2T0$%FU*J;1L\[GYW3Z8EG-)@:.9:MO
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MT![T"]OL8(A*Q$N*9A>+-TX+E8YDJ["%%I<5V1'$REL4QR&^< /L@] C2GS
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MNE"^%A:JKM#YL;</QJ[&N?&G%693*638$!AG69J7"7#9=FCY:#J5;;XRC$;
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MQ."X22R",!8A:L"5-@J8.=) 6@&?@=O"C"5(VUC.% $0*3-%J.'C1($Z!!=
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MHI7%KB@"?R<8('*(P/U,%=W2N59$VW>[6$):*C,P)D;.KMLZURL24%)B"U]
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MNI,[P;Z='/X!7[[MOSO:^W]02P,$%     @  4EX5 F9,4<B00  M#@! !
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M19'KBRK\ DHJG!6*H0F(]N*R>O/X)P)VQ\Y69 GEE"_P')?^-OH( @ZI\["
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MK+?!RQ$!F6J21#KFXV&FZ62,V1YD@ZR&TC=,)@&OD\$D 'Z^2P9Z5POV[K:
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MRCI)^CVD,]0;'":=/QIA5@4]S3R.%05\(JR2^!J>/:GE);+O>II,VT^(KGS
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M]V>.M]6'H76*D<<_B4Q #:YXTT>VH3@%H;F_+H.K.VO#@\,3P6..EM2)JAU
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M,I^$4(:BOQ==-%\4R5<+F9=:@D#9^)E'R&( D["=<5FIAM,7/I%]7W8R[""
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M;:!7USN[#XVS>Q7_^.KQCN[#MZ/K8H"O5A_=,>5.H1TB!V;LVZO/ZHGPNAW
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M*$V,B\'(H-O4;Y%FW2Z!UG]LA_/#IBZQ.ZG!Y+R\W*I4N@7J>]QH9Y1DS30
MFT9:5:JN3%* ^5*:5.?&5K#D@JG/9A.#;JNVAFC58&(K)E%01U49W,-@@X58
M:0E )L!@D3#\ O(XB1&H!1-=6\EM>;+MI\!3$2]DH+,8ONJE=0>+"[>\19@V
MR? *^K11KJ8,T=0S @9529F[ !P[T:B/H%!(\&C'BJ@/"3G^,2\VC Y+]TBJ
MFHZ0CG-$/)TE7TD-PW:A\#>?B9BP'O@U]A]J6;&T2Y$[1Q31.3V9&7#?$3H8
M<5F9YS74S>P3$).*C/3<A$<:PI2?YX-(S?VDXS875'H T3X@1;%/M#)BAN1C
MP@T@.F^HNU*^3[$QW0E<L(KC!3SO%=R"SEH&!CH''HE*"(:II)@1(V^X/2I>
MC\XVN;9T77 2L2GHY8=GC2O&K!#/'\;0=1=5L/NW$BE@/:UR5?RNK83[TQ4H
MW>*\E3O3K.MIV$?'-7M+O_&<HXTMQ:]5IC^&].J]*&H*"I$K*+C8:V*$I.05
M8U.W2YA-2E15ZYG7&K19^ N5Q C-O@"0'N2,^&DB#T030L!60?/[Z;+/>/VT
M,(U.E=BL#OUGI4$FA48/70/<7O(UF\L1XC0;DH=L7HZN=*0IL 1+E9X;\);4
M$F%HA4L+D7JM'GL<=Y=T!7V\+-5%D5(CI$O442IVO&&<'GZ#G9UCQSW1^T!Z
MGNS2%\TT([H:\A2CMQDDRX)\%-JO[0G[*,&L-DO;L*:K1&9<M5;Q$&)$8),]
MA%3["KVC5'%4?2$'+X5:?.AZ^ #C.F/6;\=78S<ZUY>5<+O 1I)2<\?;12UA
MFI:"S:D2TZ+6AK?O2ERX"C3MJM7+\KH]LF"I6(-1BB$&'9"QKA?R)?$T<C.A
MX,@M");.5HJ,45MX.=,NN#_>$,H>,.T,S)?D#&WX0I09;LDK)=]:F\\5^+H
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M4'2D./F,R?H1$8,":L>8%<84M4];TM@OODK*G:LDQF)J8I@K*]T=PL-Z\$R
M3H<DX&8T!SY,"J>U:3J._UM0Y3XK+!P6($&+$N1HDG67XC:\T6.%IKZ<KN-F
MM2]T.1,]+;W"7U0OP[(D'Z]J\T]M*0_!6$FJ$ =*C"O5FVG+X> A8QLZ?I $
M*IYJFP/ZL0$HOX;/_Q4KB*[/.LZJW[,;*%!UOE[B$(MMMU92&DWK;_@"#U/1
MRM!);FID=Q13?;F]W8%S]W#$IY^.//#[\*MT?$1L@0%8U,LY+U2@0VPDR8N*
M;2T1@#XVT;PG5[<HX:Q Q%+A6T%:!051!&<-6P\F(,?!\!R])@;5)BFGU->1
M@@,&TXFIEG/1Y^<+?(DZ%KH1+I-Y%?AU_.%\)EN03ZVH28L&<RA'D:$K@0K0
M+G/^-2\P=,A0] ZN[DWQ)A+M&RL8G@/+!DDDT D,E]!WGB#PQN4"?BOJ%74U
MC74:*#SA-2(1&'@R3 9 AS6 'B>X4TE6&==5\#B^&^0)Z;;]5U8@*2YS#CMI
MBGM.DHN"*VNCN.B<@.T$[NG5QJMA9G"C(B@,&O9+*M P#DSCSVO]OK39[)1+
MA;G!FIDQ%JCC(CH7RN91M%IK.\;CG/H,S%@VQ;L)EM<.=0D7QGK??"N)"R2A
M,@4$6J+:X4(,U@NSIN2CU;!:XW0$-ZELT@(YD-$GK'_D:5JK_F +QOW7\&,T
MS$39"4H#-XK"R;H0WTT*;IEJ,1RE*S;!N4$&5-QU&WVDP$V-JA<;";A42=G
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M.><W3>.;IO$G%J&BQ#1*U:PWM*,K)^&;V@\J/[XI -\4@,=3 ![?#W&GF_>
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M;5>N;HC9^A2W-_UI;ZZ:;4,__P!02P,$%     @  4EX5('@1A5_!@  ND8
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MJVH)D>2J:;]N2)ZSA";;+V1.=2&6?/9C8DNF.;<C0&N-\.H8%URK]9"HS0K
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M;1A>Y+/U4CYQI8[T?[F2GZ+9?SRBSOP/4$L#!!0    (  %)>%26-\6KQ00
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M9C4?/SD1HKD$7[1M0?X/6R'7P5%J[G6!>>AU>\2\F4<X=<E?4$L! A0#%
M  @  4EX5+@/N97P,0  *14!  X              ( !     &0S,S<P.#ED
M.&LN:'1M4$L! A0#%     @  4EX5)!&-)908P  'C0" !$
M ( !'#(  &0S,S<P.#ED97@Q,#$N:'1M4$L! A0#%     @  4EX5 \[Y@)1
M @4 ''$= !               ( !FY4  &0S,S<P.#ED97@R,2YH=&U02P$"
M% ,4    "  !27A4WO:<]B?]  "EKP4 $               @ $:F 4 9#,S
M-S X.61E>#(R+FAT;5!+ 0(4 Q0    (  %)>%2A8X67)1P  '6A   0
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I;F0M,C R,C S,C-?<')E+GAM;%!+!08     "0 ) #@"   J @<    !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
